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Abstract 
Background: Pain is a common consequence of Spinal Cord Injury (SCI). While research 
into pain in SCI is vast, examining musculoskeletal pain (MSKP) and low back pain (LBP) are 
limited. This thesis aims to investigate these categories of pain in incomplete SCI (iSCI). The 
experience of pain is known to affect quality of life (QoL) and function. The impact of the 
experience of pain, particularly of LBP, on both the QoL and function are examined in this 
research. While research in similar fields is predominantly conducted in single nation 
populations this research is set out to study three different nations.  
Method: The following were part of this study:  
• A systematic literature review on the prevalence on chronic back pain (BP), LBP 
and MSKP in SCI.  
• A translation, and preliminary validation, into Greek of the Spinal Cord 
Independence Measure (SCIM version III).  
• A cross-national survey conducted in the USA, UK and Greece. Questionnaires 
included the short-form McGill Pain questionnaire (SF-MPQ), EQ-5D and the SCIM III. 
They were collected either online or via post and 219 questionnaires were analysed.    
Results: The papers included in the systematic literature review were considerably 
heterogeneous not allowing meta-analysis to be made. 95% confidence intervals (CI) 
for the total number of participants in the studies were used. Among people with pain 
the prevalence of chronic MSKP (CMSKP) was 49% (95%CI 44%, 55%), of chronic BP 
(CBP) was 47% (95%CI 43%, 50%) and chronic LBP (CLBP) was 49% (95%CI 44%, 55%). 
GR-SCIM III maintains its unidimensionality and has acceptable internal consistency 
(α=0.78). Concurrent/criterion validity for the two cross-examined subscales were 
strong for “self-care” (ρ=-0.78) and moderate for “mobility” (ρ=-0.58). 
Unidimensionality was also confirmed for the English version of SCIM III, which had 
accepted internal consistency (α=0.79) and strong concurrent/criterion validity for 
“self-care” (ρ=-0.75) and moderate for “mobility” (ρ=-0.45).   
The survey results showed that the prevalence of current LBP is 67.9% (95%CI 61%, 
73%) and of MSKP is 38.8% (95%CI 32%, 45%). LBP was of moderate intensity and most 
commonly described as “aching”. People who report pain, LBP or MSKP reported 
worse QoL. The impact of LBP on QoL was greater than that of pain in general or 
MSKP. The increased intensity of LBP correlated with worse function. Among the three 
participating countries, people from the UK had the worst experience of pain and LBP, 
classified themselves with the worst health status and reported the worst functional 
independence.  
Conclusion: This study offers the first systematic review on CLBP, CBP and CMSKP in 
SCI. It is unique in using SCIM III by self-report and into Greek. The results show that 
LBP is highly present in iSCI affecting both QoL and function. Both the GR-SCIM III and 
the SCIM III are reliable for use, however studies are needed to examine further their 
psychometric properties. The findings of the study fit with features of the currently 
used patients’ rehabilitation models.  
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Ithaca (translated in English) 
As you set out for Ithaca 
hope your road is a long one, 
full of adventure, full of discovery. 
Laistrygonians, Cyclops, 
angry Poseidon - don't be afraid of them: 
you' ll never find things like that on your way 
as long as you keep your thoughts raised high, 
as long as a rare excitement 
stirs your spirit and your body. 
Laistrygonians, Cyclops, 
wild Poseidon - you won't encounter them 
unless you bring them along inside your soul, 
unless your soul sets them up in front of you. 
 
Hope your road is a long one. 
May there be many summer mornings when, 
with what pleasure, what joy, 
you enter harbours you're seeing for the first 
time; 
may you stop at Phoenician trading stations 
to buy fine things, 
mother of pearl and coral, amber and ebony, 
sensual perfume of every kind - 
as many sensual perfumes as you can; 
and may you visit many Egyptian cities 
to learn and go on learning from their scholars. 
 
Keep Ithaca always in your mind. 
Arriving there is what you're destined for. 
But don't hurry the journey at all. 
Better if it lasts for years, 
so you're old by the time you reach the island, 
wealthy with all you've gained on the way, 
not expecting Ithaca to make you rich. 
 
Ithaca gave you the marvellous journey. 
Without her you wouldn't have set out. 
She has nothing left to give you now. 
And if you find her poor, Ithaca won't have 
fooled you. 
Wise as you will have become, so full of 
experience, 
you'll have understood by then what these 
Ithakas mean. 
Konstantine P. Kavafis (1911)
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Ιθάκη (original in Greek) 
Σα βγεις στον πηγαιμό για την Ιθάκη, 
να εύχεσαι νάναι μακρύς ο δρόμος, 
γεμάτος περιπέτειες, γεμάτος γνώσεις. 
Τους Λαιστρυγόνας και τους Κύκλωπας, 
τον θυμωμένο Ποσειδώνα μη φοβάσαι, 
τέτοια στον δρόμο σου ποτέ σου δεν θα βρεις, 
αν μέν’ η σκέψις σου υψηλή, αν εκλεκτή 
συγκίνησις το πνεύμα και το σώμα σου αγγίζει. 
Τους Λαιστρυγόνας και τους Κύκλωπας, 
τον άγριο Ποσειδώνα δεν θα συναντήσεις, 
αν δεν τους κουβανείς μες στην ψυχή σου, 
αν η ψυχή σου δεν τους στήνει εμπρός σου. 
 
Να εύχεσαι νάναι μακρύς ο δρόμος. 
Πολλά τα καλοκαιρινά πρωιά να είναι 
που με τι ευχαρίστηση, με τι χαρά 
θα μπαίνεις σε λιμένας πρωτοειδωμένους· 
να σταματήσεις σ’ εμπορεία Φοινικικά, 
και τες καλές πραγμάτειες ν’ αποκτήσεις, 
σεντέφια και κοράλλια, κεχριμπάρια κ’ 
έβενους, 
και ηδονικά μυρωδικά κάθε λογής, 
όσο μπορείς πιο άφθονα ηδονικά μυρωδικά· 
σε πόλεις Aιγυπτιακές πολλές να πας, 
να μάθεις και να μάθεις απ’ τους 
σπουδασμένους. 
 
Πάντα στον νου σου νάχεις την Ιθάκη. 
Το φθάσιμον εκεί είν’ ο προορισμός σου. 
Aλλά μη βιάζεις το ταξίδι διόλου. 
Καλλίτερα χρόνια πολλά να διαρκέσει· 
και γέρος πια ν’ αράξεις στο νησί, 
πλούσιος με όσα κέρδισες στον δρόμο, 
μη προσδοκώντας πλούτη να σε δώσει η Ιθάκη. 
 
Η Ιθάκη σ’ έδωσε τ’ ωραίο ταξίδι. 
Χωρίς αυτήν δεν θά βγαινες στον δρόμο. 
Άλλα δεν έχει να σε δώσει πια. 
Κι αν πτωχική την βρεις, η Ιθάκη δεν σε γέλασε. 
Έτσι σοφός που έγινες, με τόση πείρα, 
ήδη θα το κατάλαβες η Ιθάκες τι σημαίνουν. 
Κωνσταντίνος Π. Καβάφης (1911) 
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 Kavafis (1863-1933BC) was a Greek poet who 
mainly lived in Alexandria of Egypt. He is 
considered to be one of Greece’s and Europe’s 
elite modern poets. The poem “Ithaca” was 
inspired by the return journey of Odysseus back 
to his home island, as described by Homer; a 
journey that lasted 10 years and was full of 
adventures.   
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VAS = Visual Analogue Scale 
WHO= World Health Organisation 
WHOQOL-BREF= World Health Organisation QoL-BREF 
WWW= World Wide Web 
α= Cronbach’s alpha 
γ= Gamma test 
η²= Eta-Squared (effect size) 
ρ= Spearman’s rank correlation rho 
φ= Phi test 
χ²= Chi-Square test 
ω²= Omega-squared (effect size) 
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1.1 Introduction 
The research described in this thesis examines the experience of pain for people with 
incomplete spinal cord injury (iSCI). Pain is one of the most commonly reported 
problems for people with Spinal Cord Injury (SCI) and one which has negative 
consequences for their lives.  Because the boundaries of this research field are 
extensive, it should be stated that the emphasis of this project is to examine the 
presence of low back pain (LBP) in this population. Further, it seeks to understand how 
the experience of pain relates to both the quality of life (QoL) and function of the 
person with the injury.  
This chapter is an overview of the study to be presented which will set the context of 
the study, explain the reasons for and the significance of conducting it, as well as 
stating how it may contribute to what is already known in the field. Emphasis will be 
placed on the main aim and objectives of this research and the chapter will conclude 
with a description of the thesis formation.  
1.2 Research rationale and setting 
Disability, which is part of the human condition, is believed to affect the lives of 15% of 
the world’s population and the number of people with a disability is growing.499 The 
reasons for this increase include an ageing population and technological advances that 
help to keep people alive. As life expectancy has increased over the last century for 
people who sustain SCI,53,499 emphasis is now placed on improving the QoL of a person 
living with any form of disability or impairment. Disability increases societal costs both 
via direct health-related expenses and incapacity benefits260 and the cost of SCI is very 
high.24,113 
The impact of the disability is primarily a challenge for the patient him/herself who has 
to adjust to a routine that often has, in the case of SCI, a sudden and violent onset. 
Living with a disability can impact negatively on the QoL and mental health of the 
patient, which can be compounded by factors like unemployment260 or social 
factors.111,254 QoL is also reduced by the presence of pain.12,22,55,90,103,186,240,406,422,489 
Pain also interferes with activities and function,90,381,427,469 thus adding another 
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challenge to the daily routine of the person. It is not just the presence of pain that 
needs to be considered when thinking about QoL or function but also the intensity of 
pain as increased pain intensity is linked to increased catastrophising, depression, 
distress, reduced QoL15,51,257,370,387,450 and leads to decreased levels of activity.228 These 
factors give a clear indication of the complexity and the interaction between the 
psychological, physiological and the pain experience in cases of impairment and 
disability, including SCI.  
Pain has been studied possibly more than any other symptom in the literature over 
many centuries. The reason for this is probably because it is experienced as a negative 
sensation and emotion that accompanies the vast majority of physiological and/or 
psychological ill health, impairment and disabilities. Despite the multitude of papers 
written about pain and the huge progress made in understanding it, it still remains a 
rather elusive area that raises debate on its origin, its impact and its treatment. Pain is 
a subjective experience as felt and reported by the patient. It is also a 
multidimensional experience according to the most recent theory,306,308,309 which 
explains why it has been so difficult to understand pain. For many years researchers 
have been studying pain via examining groups of patients with the same condition, for 
example, studying pain in SCI. This may have developed from the need to understand 
pain in the hope of identifying similar pain characteristics as reported by people who 
have similar health problems. This approach has been successful as it seems that 
people who come from the same patient group describe their pain in a similar way. 
Thus studying a single condition, here SCI and in particular iSCI, is an appropriate step 
towards understanding pain. 
The prevalence of pain in SCI is frequently reported to be high often exceeding 70%. 
58,317,331,380,381,451,489 Consequently, the wealth of research available for this patient 
group is justifiable. This research into pain in SCI has helped not only with the 
development of a particular language when referring to pain in this population, but 
also in identifying directions which research should follow and gaps that need to be 
filled.  It is becoming more apparent that research should move away from examining 
pain in general and consider examining specific types or locations of pain. As such, in 
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the SCI literature, studies have examined particular aspects of pain but there is a 
tendency to focus on neuropathic pain or, when reporting on specific locations, the 
focus tends to be on the shoulder or the upper limbs.7,92,196,322 Certainly information 
gained so far has been most valuable in understanding pain in SCI, but there are other 
pain categories than need to be addressed in more detail.  Two that this study will seek 
to explore are musculoskelatal pain (MSKP) and low back pain (LBP). MSKP has been 
addressed in SCI fairly often when referring to pain in areas like the shoulder or when 
discussing pain classification.19,58,381,406 However, this study will seek to explore MSKP 
in more detail in relation to QoL and function. LBP is one of the two most common 
causes of disability in Western society238 with millions of GP visits11 and high reported 
prevalence (ranges from 12% to 49%) 107,248,263,346 in the general population. Although 
it is a pain location commonly seen, it is not examined for people with SCI who may be 
more vulnerable to developing LBP.  
As it can happen with any pain type and probably pain location, LBP can be disabling, 
having a negative impact on the lives of people living with it. Indeed, people from the 
general population who have LBP, which is often of musculoskeletal origin, risk having 
recurrent episodes of it88,348 increasing the likelihood of it becoming chronic as well as 
increasing the socio-economic impact.107,280 The experience of pain is known to affect 
the QoL of the person living with pain. In both the general population but also when 
there are other health problems, such as SCI, pain negatively affects mood, is 
associated with anxiety or depression and with an overall reduction in QoL.12,49,219,230, 
288,331,235,362,366,409,481, 498 There does not appear to be specific information on the impact 
of LBP on the psychological health or the overall QoL of people with SCI, whereas 
related information about the general population and other patient groups is gradually 
emerging.215,330,439,496,498 The negative relation between pain and function, including for 
people with SCI, has also been reported.94,362,446,496,498  The relation between LBP, in 
particular, and function in SCI has not been examined.   
From anecdotal sources, and personal communication with doctors and other health 
professionals, the problem of back or lower back pain in SCI is not uncommon: 
however, there is lack of published research into understanding its origin and 
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consequences. These identified gaps in the field of SCI, could have a significant effect 
on the lives of people with SCI. A lack of awareness can lead to underreporting of a 
problem, reducing appropriate assessment and not implementing treatment in a 
timely manner. It is, therefore, essential when studying location of pain in SCI to 
include the lower back in the areas examined and not solely the whole back, which is 
now gradually being investigated.90,380,381,457  
Research in the above fields, but also in other related fields in the literature, has been 
predominantly done by examining populations from a single nation. More recently, 
cross-national, cross-cultural or international research has increased rapidly.  
Globalisation, the ease of transport between countries and technological 
developments, both demand and facilitate the conduct of such studies. Among the 
benefits of cross-national research is the fact that it raises questions about single-
nation studies and it forces revisions and interpretations of results because of the 
differences found between countries.245 A number of single-nation studies have 
investigated pain, MSKP or LBP in the general population11,35,59,75,128,132,157,192, 
358,417,424,460,475 and in the SCI population.80,145,228,284,380,427,450,451,457,484 But the number 
of cross-national studies looking at pain, MSKP or LBP in the general population and in 
the SCI population is considerably less.38,121,182 This is also noticeable when examining 
QoL or function, particularly in SCI, as cross-national studies are limited.64,171,255  
There is no doubt that a better understanding of the experience of pain and how this  
impacts on other aspects of patients’ lives requires that researchers investigate the 
different categories and locations of pain. Melzack et. al305 quoted their early work 
with Casey saying that pain is a subjective, personal experience with psychological 
dimensions,307 which can be affected by personal and cultural factors, thus cross-
national studies become an appropriate and effective way to understand pain better. 
This is exactly what this study aims to investigate.  
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1.3 Research aim, objectives and hypotheses 
The core aim of the study is: 
 
 
The core research question of the study is:  
 “Do people with iSCI have LBP, and what is their present and usual pain experience?”  
In addition LBP, pain in general and MSKP will be explored and examined in relation to 
QoL and function.  
Seven objectives have been developed as an appropriate method to address the 
aforementioned aims: 
Objective 1: To explore the research background that will assist in guiding the 
development of the elements to be included in the project. To focus on pain at the 
lower back location and to investigate QoL and function. 
Objective 2: To carry out a survey in order to report on the prevalence of LBP, MSKP 
and pain for the total group and each national group. In addition, to investigate 
differences and similarities between subgroups of the total group and each nation 
based on the demographic profiles and injury related characteristics. 
Objective 3: To carry out a survey in order to report on the quality and intensity of LBP 
for the total group and each national group. In addition, to examine for differences and 
similarities between subgroups based on the demographic profiles and injury related 
characteristics. 
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Objective 4: To report on the QoL for the total group and each national group. In 
addition, to examine the differences and similarities between subgroups based on the 
demographic profiles and injury-related characteristics. 
Objective 5: To report on the function for the total group and each national group. In 
addition, to examine the differences and similarities between subgroups based on the 
demographic profiles and injury-related characteristics. 
Objective 6: To examine the relation and possible impact of the presence of LBP, MSKP 
and pain on QoL and function for the total group and for each national group. 
Objective 7: To examine how the quality and intensity of LBP relate to QoL and 
function for the total group and for each national group. 
The first objective is answered by examination of the literature and the remainder by 
conducting a survey study. In total, 13 hypotheses were created at the onset of the 
study which will be analysed in Chapters 6 to 9. These hypotheses have been grouped 
into three “hypotheses themes”, each theme focusing on factors related to the pain 
experience. The first theme investigates the presence of pain, MSKP and LBP. The 
second theme investigates the impact of the onset of pain and LBP post iSCI. Finally, 
the third theme investigates the relationships between LBP quality or intensity and 
other variables of interest. To assist reading, when referring to all types of pain (i.e. 
pain in general, MSKP and LBP) they will be referred to as “pain categories”. All the 
hypotheses were examined for the whole group and across each national group. 
In particular, the first hypothesis theme includes the following three hypotheses: 
Table 1.1: First hypotheses theme 
Hypotheses about presence of pain, MSKP and LBP 
H 1: In people with iSCI there is a significant difference in the percentage of those with 
LBP and those without. 
H 2: In people with iSCI there is a significant difference in QoL between those with pain, 
MSKP or LBP and those without.  
H 3: In people with iSCI there is a significant difference in function between those with 
pain, MSKP or LBP and those without.  
Abbreviations: MSKP, Musculoskeletal pain; LBP, Low Back Pain; iSCI, Incomplete Spinal 
 Cord Injury  
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The hypotheses falling into the second theme are: 
Table 1.2: Second hypotheses theme  
Hypotheses about the impact of pain and LBP onset post iSCI 
H 4: In people with iSCI there is a significant correlation between pain onset post iSCI 
and the number of pain or LBP days felt in a month. 
H 5 In people with iSCI there is a significant correlation between the number of areas 
with pain and the onset of pain or LBP post iSCI. 
H 6: In people with iSCI there is a significant correlation between QoL and the onset of 
pain or LBP post iSCI. 
H 7: In people with iSCI there is a significant correlation between function and the 
onset of pain or LBP post iSCI. 
Abbreviations: LBP, Low Back Pain; iSCI, Incomplete Spinal Cord Injury 
 
Finally, the hypotheses under the third theme are: 
Table 1.3: Third hypotheses theme  
Hypotheses in relation to LBP quality and intensity 
H 8: In people with iSCI there is a significant correlation between quality of LBP and 
pain or LBP onset post iSCI. 
 H 9: In people with iSCI there is a significant correlation between intensity of LBP and 
pain or LBP onset post iSCI. 
H 10: In people with iSCI there is a significant correlation between QoL and quality of 
LBP.  
H 11: In people with iSCI there is a significant correlation between QoL and intensity of 
LBP.  
H 12: In people with iSCI there is a significant correlation between function and quality 
of LBP.  
H 13: In people with iSCI there is a significant correlation between function and 
intensity of LBP.  
Abbreviations: LBP, Low Back Pain; iSCI, Incomplete Spinal Cord Injury 
 
1.4 Statement of significance  
This study makes a significant contribution to the literature by producing a systematic 
literature review on chronic MSKP (CMSKP) and chronic LBP (CLBP), the first to be 
conducted in SCI, to this author’s knowledge. This could be used as a point of 
reference for people interested in the topic.  
A second significant contribution is the detailed examination of LBP in iSCI and its 
relation to QoL and function as reported by the respondents. This is important in 
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helping health professionals to understand better the needs of this patient group and 
direct research, assessment and treatment appropriately.  
One more novel contribution of this study is the translation into Greek of a functional 
independence measure, Spinal Cord Independence Measure v3 (SCIM III), for the first 
time. A preliminary validation is also conducted. In addition, for the first time this tool 
is used as a self-reported measure for both the English and the Greek versions. It is 
expected that researchers and therapists will benefit from these new ways to use SCIM 
III.  
A final original contribution is that for the first time QoL and function of people with 
iSCI from Greece are assessed. The findings of this part of the study will assist health 
professionals in Greece both in clinical and research settings which they can develop 
further.  
 
1.5 Route to thesis chapters  
This thesis is structured in the following way: 
Chapter 1 
The current chapter has offered an introduction to the background of this research and 
discussed the basis of this project in a general framework. The three thematic areas of 
the study have been presented along with their hypotheses. The significant 
contributions of the study have been summarised and these will be explored in detail 
in the chapters to follow. 
Chapter 2  
This chapter will review the literature related to the three major areas of interest. It 
will include an examination of understanding the experience of pain and will seek to 
present the current literature on how pain relates to QoL and function. The aim will be 
to describe in detail the current knowledge on the related topic and identify any gaps 
that need to be addressed.    
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Chapter 3 
Chapter 3 is a systematic literature review on CLBP and CMSKP in SCI. The approach 
and the results of this systematic review are presented step by step. LBP is the main 
category of pain examined in this project and a systematic literature review became 
essential and informative.  
Chapter 4 
Chapter 4 will explore the methodology required to translate into Greek the 
questionnaire used in the study. In the absence of specific guidelines when translating 
a standardised, validated tool into another language, it is argued that a combination of 
the best techniques used in other guidelines is appropriate. This approach has been 
followed and the suitability of the procedure and the methods used will be presented. 
Chapter 5 
Chapter 5 will describe the methods used to collect data for the current survey. The 
decisions to use these methods and their appropriateness will be explained. This 
chapter will discuss the statistical methods used for data analysis and explain their 
advantages and disadvantages.  
Chapters 6 – 9 
Chapters 6 to 9 will present the results of the statistical analysis performed. The first 
three chapters (6, 7, 8) will use the pooled data of all the respondents. Chapter six will 
present the profiles of the respondents and will answer the core question of the study.  
Chapter 7 will start by describing the overall reported QoL of the respondents and will 
then examine how this may differ based on the participants’ demographic profiles. 
Most importantly, an investigation of how the experience of the pain categories may 
relate to QoL will be carried out.  
Chapter 8 will set out the analysis related to the functional independence of the 
participants. Initially, the tests to validate the function measure translated and used in 
Greek will be presented, a procedure essential to ensure appropriate usage of the tool. 
Then this chapter will exhibit the analysis conducted in regard to function. The Greek 
group will be examined separately from the rest of the group for reasons that will be 
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explained in full. Chapter 8 will also examine the possible effect(s) of the experience of 
pain on function.  
Finally, chapter 9 will present the cross-national analysis focusing on answering the 
hypotheses examined in chapters 6, 7 and 8 using between and within national group 
analysis.  
Chapter 10 
Chapter 10 will discuss the findings of the study reflecting upon the aim, objectives and 
hypotheses. It will investigate current findings in relation to similar or dissimilar 
findings in the literature and it will seek to explain them.  
Chapter 11 
Chapter 11 will discuss the contributions of the project to the field of knowledge in SCI, 
in terms of importance for health professionals and patients. This chapter will critically 
appraise both the strengths and the limitations of the project and will propose future 
studies.  
 
1.6 General note on thesis presentation 
Footnotes exist throughout the thesis. They are numbered using the arithmetic system 
and they are referred in the text with a subscript number (e.g. 1). When a subscript 
number occurs, please see the relevant footnote for explanation. References are in an 
adapted Vancouver system, which is widely used for health-related documents in 
various peer-reviewed journals, and uses an arithmetic system which is referred in the 
text with a superscript number (e.g. 1). When a superscript number occurs, please 
refer to the reference list, which will be in alphabetic order. In data analysis the 
Bonferroni correction has been used which, as it will be explained in Chapter 5, 
reduces the alpha level of significance below p≤0.05. Each test that passes the 
Bonferroni correction (or Bonferroni post hoc) will be marked in bold colour. Each test 
that does not pass the Bonferroni correction but is p≤0.05 will be presented but not 
marked in bold. Finally, the thesis is followed by appendices which are divided into 
nine sections and references will be made as appropriate throughout the thesis.  
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2"In literature as in love, we are astonished at what 
is chosen by others." 
Andre Maurois (1885 – 1967) - French biographer, 
novelist and essayist 
                                                     
2
 Picture of the Rosetta Stone, taken from www.wikipedia.org The Rosetta Stone is attributed to the 
Ptolemaic Period, Egypt 196 BC. It has three scripts; Ancient Egyptian hieroglyphs, Demotic and Ancient 
Greek. 
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Part 1; Spinal Cord Injury and the experience of pain 
 
2.1.1 Introduction 
The previous chapter gave an overview of the three areas that will be examined in this 
study, pain, QoL and function, and presented the aim, objectives and hypotheses. This 
chapter will explore, in detail, the background information that is available on the 
topics of interest with the aim of identifying those areas that need further 
investigation.  
The chapter will be divided in two parts; the first will include an overview of cross-
national research and the general profiles of the three participating countries. It will 
then move on to describe SCI and conclude by looking at the experience of pain and 
what it involves. The second part will review both QoL and function examining what 
can influence them and what is known about them in people with SCI.  
 
2.1.2 Health and disability 
The World Health Organisation (WHO) defined health as “a state of complete physical, 
mental, and social well-being and not merely the absence of disease or infirmity”.499 
Disability is part of the human condition, it is complex, and almost everyone will be 
temporarily or permanently impaired at some point in their lives.499 The estimated 
prevalence of disability worldwide is 15% with 2.2% to 3.8% of the world’s population 
having severe disability.499 The number of people with disability is growing due to a 
number of factors including the ageing population and the global increase in chronic 
health conditions associated with disability.499 
People with disabilities have poorer health compared to the general population, 
depending on the type of disability and the setting they live in, they may be more 
vulnerable to secondary complications or co-morbidities, and they may be at higher 
risk due to poor diet and reduced physical activity.499 People with disabilities tend to 
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have reduced educational achievements as well as a reduction in their economic 
participation, as they have reduced employment rates and earn less money when 
employed.499 Consequently, higher rates of poverty are reported compared to non-
disabled people.499 In this study, emphasis will be given to one particular type of 
disability, SCI.   
 
2.1.3 Cross-national research 
Ross and Homer388 gave a brief summary of the history of cross-national research and 
what was known as “Galton’s problem in cross-national research”. They quoted a 
study published in 1889 by Edward Tylor on the relationship between marriage and 
descent patterns. That study used data from a cross-cultural sample which led to a 
critique paper by Sir Francis Galton who said that the correlation found by Tylor could 
have been due to contact between cultures and questioned if the cases were really 
independent.388 “Galton’s problem” and criticism resulted in researchers hesitating to 
conduct cross-cultural studies for the next 50 years.388 More recently, theories and 
“solutions” to Galton’s problem have begun to emerge.388 
A broad definition of cross-national research is “any research that transcends national 
boundaries. It is an explicitly comparative study that utilizes systematically 
comparative data from two or more nations”.245 According to Kohn,245 cross-national 
research is a type of comparative research that is more complex than other types of 
comparative research but benefits from being able to carry out a broader range of 
comparisons, thus not limiting comparisons to a single nation. It is a valuable type of 
research which enables generalisation of findings, validating interpretations from 
single-nation studies, forces revisions of interpretations by taking into account cross-
national differences that cannot be revealed via single-nation studies and raises 
questions about the generalisations made in single-nation studies.245 
Cross-national, cross-cultural or international research has increased rapidly over the 
last few decades possibly because of globalisation and the easiness of transportation 
between countries which, on the one hand, enables, but on the other hand requires 
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these types of research. Most recently more advanced technological developments 
and, in particular, the internet can facilitate completion of cross-national studies. 
Internet research will be discussed in detail in Chapter 5. 
Kohn245 referred to four types of explicit comparative cross-national research:  
1) Where a nation is the object of study; the interest is primarily on the 
countries studied and understanding of each country;245 
2) Where a nation is the context of a study; interest here is primarily on the 
generality of the findings and the interpretation of how social institutions and social 
structures can affect the people of a given nation;245 
3) Where a nation is a unit of analysis; in this case the country is not classified 
by name but from other socio-economic factors like national income, educational level 
etc. and the interest is in establishing relationships among the characteristics of 
nations;245  
4) Those which are transnational in character; in this case the country is part of 
a larger international system.245 
Kohn245 pointed out the difficulties often faced with differentiating between a study 
that uses a nation as object or as context, and also said that the differences between 
research that uses a nation as a unit and not as context are not sharp either.245  
There are two research strategies employed in cross-national studies; looking at 
similarities and differences.245 Finding similarities across nations are easier to interpret 
sociologically and their explanation should be focused on identifying the structural 
similarities between the countries.245 Finding differences among the examined nations 
is more difficult to interpret and the explanation may be due to historical, cultural, 
political or economic reasons.245   
The number of countries to be included in a cross-national research project should be 
small with the aim of conducting some systematic, intensive study.245 Cross-national 
research can be costly and requires the establishment of good collaborations. Thus the 
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reason for embarking on it should be either because the topic studied cannot be 
studied unless following this methodology or because it has been studied enough in 
one country and the next logical step is to study it in another, thus discussing 
generality.245 Pain in general and/or QoL in SCI have been studied mainly in single-
nation studies116,251,260,313,368,481 and, more recently, in some international studies.255,294 
Function has been investigated via single-nation studies252,353,331 and international 
studies65,222,266,495 in SCI. Often the studies that examined QoL subsequently looked 
into function because many QoL measures include items on function. However, at the 
time of designing this study the author was not aware of a cross-national study on SCI 
to investigate QoL and function together (using different assessment tools) and 
examine them in relation to pain. In addition, research on SCI in Greece is limited, thus, 
designing a cross-national research study was a promising research approach.  
Kuechler256 described some principles which aim to reduce validity problems 
encountered in cross-national research. The first is that people from the different 
countries should have similar experiences and exposure to surveys and, more general, 
the nations should not to be too distant with regard to their development and politico-
economic systems.256 Of course, the latter principle is not valid where the aim is to 
compare the different politico-economic systems between countries.256 The three 
countries participating in this study are similar in their politico-economic structures as 
it will be described in the following section. Validity problems with cross-national 
research can be minimised by applying similar sampling selection methodology for 
each country but some variation could exist if the needs or the possibilities for 
recruiting vary within the nations.256 Such a variation in the recruiting methodology for 
the current project was necessary and this will be explained in Chapter 5.   
One of the main problems in comparative research is “equivalence” which means 
identifying equivalent phenomena and analysing the relationships in an equivalent 
way.365 Equivalence, on the one hand, may not be a necessary concept in some 
countries but, on the other hand, it can be influenced by external phenomena which 
may be common to all countries but not equally relevant to them.365 Przeworski & 
Teune365 pointed out that complete equivalence is unlikely to happen but researchers 
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may attempt to measure equivalence. One way to do this is by examining 
homogeneity; i.e. if some indicators correlate in a within-nation analysis and they 
maintain their correlation in a pooled, cross-country analysis then this gives validity to 
the concept.365 Another way to examine equivalence is by analysing data relationships 
separately within each country and then compare across countries.365 In order to be 
able to confirm a hypothesis cross-nationally, the within-country relationships must 
not differ.365 The strength of the relationship may differ from country to country which 
may help identify which other variables could influence each country individually.365 
This study follows the second way to examine equivalence.  
 
2.1.4 General profile of countries 
As mentioned above, the general development and politico-economic profiles of the 
countries participating in a cross-national study should be similar256 and the number of 
participating countries should be small.245 Of course, politico-economic and 
developmental changes have occurred rapidly around the world over the last few 
years, affecting all three participating countries, a general profile of which is presented 
in brief below. The information that will be used to describe the countries will be 
based mainly on data related as closely as possible to the period of collecting data for 
this study (2008-2009).  
 
2.1.4.1 United States of America 
The USA has a democratic political system, has a population of around 310 million 
people, 50.8% of whom are females, with a life expectancy of 79.6 years.338 It is 
located in North America covering an area of 9.83million Km² and consists of 50 states 
and 1 district area.70 Its capital is Washington DC with a population of 4.4million 
people and migration is 4.18 migrants/1000 people.70  
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Overall, it has maintained a stable ranking of fourth place on the Human Development 
Index3 over the years 2005-2011.
218 Expected (compulsory) mean schooling years are 
15.7, which are the lowest among the three countries examined but attended mean 
schooling years are 12.4, which is the highest among the three countries. The country 
spent 7.3% of its Gross Domestic Product (GDP) on public expenditure on health (in 
2007) and 15.9% on public social expenditure (in 2005).335 Among the three countries 
the USA spends the most on public health but the least on social expenditure. The 
country spent 2.66% of its GDP on research and development (R&D) in 2007 which is 
the highest among the three countries.335 In 2005, the disability percentage was 18.7% 
(including all types of disabilities) and it was higher among females (20.1%) compared 
to males (17.3%). Fewer than half (46%) of people with disabilities aged 21-64 were 
employed.37 Among 10.2 million accidents there were 37,261 fatalities and 2,346,000 
injuries in 2008.338  
 
2.1.4.2 United Kingdom 
The UK has a population of 62.3 million people and a life expectancy of 79.8 years.456 
The UK consists of England, Wales, Scotland and Northern Ireland and comprises an 
area of 244,820km² and its capital is London.136 It has a constitutional monarchy and a 
parliamentary democracy and has been a member of the European Union (EU) since 
1973.136 The UK is the home of the industrial revolution and has produced many great 
scientists. It is also home to diverse immigrant communities that mainly come from its 
former colonies.136 
The UK is another very highly developed country which ranks from 22nd to 28th 
positions over the years 2005-2011 on the Human Development index.218 Expected 
                                                     
3
 The Human Development Index is an annual world report that examines the dimensions of health, 
education and income for each country. It refers to their economic growth but also includes many other 
related aspects like social progress, efficiency (including resource use and availability), equity, 
participation and freedom, sustainability (ecological, economic and social), human security, education, 
perception of individual’s well-being and health. The first 47 counties are labelled as having “very high 
human development”.
218
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mean schooling years are 15.9, but attended mean years are 9.5, the lowest among 
the three countries (in 2010).  Public expenditure on health was 6.9% of GDP (in 2007) 
and 21.3% on public social expenditure (in 2005).336 The country spent 1.82% of its 
GDP on R&D in 2007.336 The prevalence of disability in the UK is around 18% and 
people with a disability are twice as likely not to have a qualification and their 
employment rate is around 48%.208 In 2010, in Great Britain alone there were 1,850 
people killed in road traffic accidents (RTAs) (including pedestrians), 22,660 seriously 
injured and 184,138 slightly injured.105  
 
2.1.4.3 Greece 
Greece is the smallest of the three countries participating in this study; it has a 
population of around 11 million people, 50.8% of the population are females and life 
expectancy is 79.7 years.199 Greece forms a crossroad between Europe and Asia, 
located at the South-East end of the Balkan Peninsula. It covers a total area of 
131,957km² including more than 2000 islands.137 Its capital is Athens which has a 
population of nearly 4 million.199 The country consists of 13 regions, is a member of the 
EU since 1981 and is a member of the Eurozone.137 Greece is one of the most ancient 
civilisations with scholars who have contributed greatly to mathematics, philosophy, 
astronomy, politics and medicine. In the ancient world Greece consisted of city-states 
which pioneered the democratic system. Today, Greece is a republic with its current 
constitution since 1975.137 
Similar to the UK and USA, Greece ranks among the very highly developed countries of 
the world, ranking from 22nd to 29th positions during the years 2005-2011 on the 
Human Development index.218 Expected mean years of schooling are 16.5 which is the 
highest among the three countries, and attended mean years are 10.5. The country 
spent 5.8% of its GDP on public health expenditure (in 2007), which is the lowest 
among the three countries, and 20.5% on public social expenditure.337 The country 
spent the least among all three on R&D, 0.58% of its GDP in 2007.337 The prevalence of 
people with disabilities (all types) is 18.2%,482 which is very similar to that reported in 
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the USA and UK. In around 18,000 annual RTAs (including accidents to pedestrians) 
there were about 1,500 fatalities, 1,500 severely injured and 17,000 slightly injured (in 
2007),482 which is a large number for the size of the population.  
 
Summary 
In summary, all three countries are among the 30 most highly developed countries in 
the world and have maintained their positions with no great changes over the last six 
years. Among the three countries, the USA ranks highest, spends the most money on 
public health and the least on public social expenditure. Greece spent the least money 
on public health though the differences are not great. The disability rate is very similar 
across the countries. Finally, the USA invests a lot more on R&D than the other two 
countries, particularly Greece. This may reflect the reason why in the literature, as will 
be discovered in the sections to follow, the vast majority of the studies on SCI are 
conducted in the USA. This may also imply that people within these three countries 
have different exposure to participating in research and more than one method of 
recruiting participants may be essential as will be explained in Chapter 5. Despite some 
differences, the selected countries have similar politico-economic profiles thus their 
selection for this study is not expected to bias results due to major differences in their 
general profiles. 
 
2.1.5 Spinal Cord Injury; a brief historic overview 
Spinal Cord Injury is “an insult to the spinal cord resulting in a change, either temporary 
or permanent, in its normal motor, sensory, or autonomic function”.95 
Reports on SCI, its symptoms, including pain, and early treatment have been found in 
ancient Egyptian papyrus, in Homer’s Iliad  and spinal stabilisation techniques were 
described by Hippocrates (ca.460-ca.370 BC).173 The Egyptian papyrus, dating from 
3000 to 2500 BC describes an incomplete cervical SCI as “an ailment not to be treated 
(cured)”.134 In ancient Greece, Hippocrates described paraplegia and used traction 
methods for the treatment of SCI.134 In his book “Anatomy of the spine” he described 
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mechanisms in SCI that may be fatal (related to fall injuries) and he used the same 
treatment methods (like the extension bench) for both traumatic and non-traumatic 
SCI.134 Galen (131-201 AD), in ancient Rome, followed the Hippocratic methods and 
described, in more detail, the spinal cord anatomy.134 In the middle ages (700-1400 
AD) the treatment of SCI developed to include diet and hygiene.134 During the 
Renaissance period, the Hippocratic techniques were modified by various physicians. 
At that time, there was a gradual transition from the Greek and Latin languages to 
French and English and thus medicine started developing in Western Europe.134 In the 
17th and 18th centuries, anatomy dissection was allowed in Europe.134 In the 19th 
century, further descriptions of SCI lesions, like cauda equine and Brown-Sequard 
Syndrome, were made. Advances in treatment and rehabilitation also occurred, like 
the plastic jacket for postsurgical stabilisation by Burrell in 1887.134 Famous people, 
like Admiral Lord Nelson (battle of Trafalgar 1805), and James Garfield (President of 
USA 1881), sustained SCIs and died.124     
Death is the most serious consequence of SCI. At the beginning of the previous century 
mortality due to SCI was high reaching 65%.52 Death after SCI frequently occurred 
within one month, and up to 78% of people injured could die in the first five days.52 
Major advances in surgery and rehabilitation in SCI happened in the second half of the 
20th century.134 In 1944, Guttmann created a unit at Stoke Mandeville in UK, where a 
multidisciplinary approach to the rehabilitation of SCI was followed.134 In time, more 
SCI centres started opening around the modern world.134  
Nowadays, life expectancy after SCI, if injured at the age of 20, can vary from 33 to 44 
years.95 The survival rate of people with SCI has increased to as high as 85%.114 If 
injured at younger age than 25 years and sustaining an incomplete injury, individuals 
can have a survival rate as high as 95%.114 People with injuries at C1-C3 level can have 
more than six times higher mortality rate.114 Life expectancy still remains poor if injury 
occurs at the age of 50 years and above.114  Another factor, apart from age, 
determining life expectancy is severity of injury.53 Previously, the main causes of death 
were renal diseases but recently respiratory complications have become the leading 
cause.53 As life expectancy after SCI is on the increase, non-SCI related causes of death, 
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like cancer, are on the increase too.53 More recently, Strauss et al425 concluded that in 
the last 30 years the critical care provided in the first two years post injury has greatly 
progressed and survival rates and life expectancy have increased considerably. But the 
difference between the life expectancy for people who have survived the first two 
years of their SCI and the general population still remains increased.425  
 
2.1.6 Spinal Cord Injury; epidemiology  
2.1.6.1 Spinal Cord Injury; Incidence and prevalence  
Over the last 30 years the prevalence and incidence of SCI have not changed a lot but 
there is still a lack of registration of SCI cases.503 A review study aiming to estimate an 
international incidence and prevalence of SCI concluded that the incidence of SCI is 
between 10.4 and 83 per million inhabitants annually.503 The data however, came 
mainly from North America, Europe and Australia which, according to the authors, 
made up only 20% of the world’s population in 1999. In addition, in the vast majority 
of countries, people who died at the scene due to a SCI were not counted in the 
incidence total.503 
In the USA the estimated SCI cases that required hospital admission has been reported 
to range from 32-50 cases per million people.231,433 It is estimated that in the UK there 
are 900-1000 new SCI cases per year and about 40,000 people live with SCI.482 There 
are not many publications that have investigated incidence or prevalence of SCI in 
Greece, but recently some have examined regional epidemiology. Examining the 
incidence of traumatic SCI in the region of North Greece, Divanoglou et al122 found it to 
be 33.6 per million population per year (including people who survived one week post 
injury). In another study conducted on a Greek island, 38 cases were reported among a 
population of about 54,000 inhabitants.249 Prevalence has been more difficult to 
estimate as very few reports exist in the literature; an estimated figure is 223-755 per 
million inhabitants. However available data is insufficient.503  
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2.1.6.2 Spinal Cord Injury; Gender 
More men than women sustain SCIs and the  ratio is 4:1, but the difference between 
the two sexes is reducing332 and a ratio of 3:1 has been reported.490 In one Greek 
study, a 7:1 ratio was reported and the authors attributed this finding to cultural 
reasons.122  
 
2.1.6.3 Spinal Cord Injury; Age 
SCI occurs most frequently in young men followed by people aged between 55-74 
years.53 The average age at injury has risen over the past few years, but still 50% of 
people who sustain SCI are aged 16-30.332 Recent studies on Greek SCI groups reported 
a higher mean age at injury (above 40 years),122,249 but in the past a lower mean age at 
injury was reported.392  
 
2.1.6.4 Spinal Cord Injury; Causes 
The primary cause of SCI is road traffic accidents, followed by falls and then sports 
accidents.53 As the ageing population is increasing, it is believed that injuries related 
with spondylosis and caused by falls will increase.53 Some of the causes of SCI can be 
explained culturally and economically, for example, in economically developing 
countries road traffic accidents are more common while in other countries violent 
injuries are more frequent.53,122 Gender can also explain some of the causes of SCI as 
intentional violence is more common among men53 and the incidence of violence-
related SCI has been rising.332  
 
2.1.6.5 Spinal Cord Injury; Types and levels 
Injury occurs most frequently at the lower cervical and thoracolumbar regions and 
fractures at more than one level of the spine can occur.53 The different types of SCI are 
defined by the American Spinal Injury Association (ASIA) as follows: 
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Tetraplegia is caused by “the impairment or loss of the motor and/or sensory function 
in the cervical segments of the spinal cord due to damage of the neural elements within 
the spinal canal”.9  
Tetraplegia involves the loss of muscle strength in all extremities95 including the trunk 
and the pelvis but excluding brachial plexus lesions or injury to peripheral nerves.9     
Paraplegia is caused by “the impairment or loss of motor and/or sensory function in the 
thoracic, lumbar or sacral (but not cervical) segments of the spinal cord, secondary to 
damage of neural elements within the spinal canal”.9 
In paraplegia the arms maintain their function but depending on the level of the injury 
the trunk, legs and pelvis can be affected. Paraplegia may involve injury to the cauda 
equine and conus medullaris but not the lumbosacral plexus or injury to the peripheral 
nerves.9 
Complete SCI results in “loss of sensory and motor function below the level of lesion 
and the severity of the symptoms depend on the level of injury”.482  
Incomplete Spinal Cord Injury (iSCI) is “the partial preservation of the sensory and/or 
motor function below the neurological level and includes the lowest neurological sacral 
segments”.9 
If there is an iSCI at the onset of injury then some improvement may occur and 
recovery can go on for at least two years, however much of this improvement depends 
on the severity of the condition.53  
Using the ASIA Impairment Scale (AIS), SCI is further classified as shown in Table 2.1.1. 
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Table 2.1.1: ASIA classification of SCI9  
   
A Complete No sensory or motor function is preserved in 
the sacral segments S4-S5. 
B Incomplete Sensory Sensory but not motor function is preserved 
below the neurological level and includes the 
sacral segments S4-S5. 
C Incomplete Sensory & 
Motor 
Motor function is preserved below the 
neurological level, and more than half of the 
key muscles below the neurological level have a 
muscle grade less than 3. 
D Incomplete Sensory & 
Motor 
Motor function is preserved below the 
neurological level and at least half of key 
muscles below the neurological level have a 
muscle grade greater than or equal to 3.  
E Normal Sensory and motor function are normal 
Abbreviations: ASIA, American Spinal Injury Association; SCI, Spinal Cord Injury 
 
 
2.1.6.6 Spinal Cord Injury; Clinical Syndromes 
According to ASIA9, iSCI includes a number of clinical syndromes. 
Central Cord Syndrome is “a lesion occurring almost exclusively in the cervical region 
that produces sacral sensory sparing and greater weakness in the upper limbs than in 
the lower”.9 
Brown-Séquard Syndrome is “a lesion that produces relatively greater ipsilateral 
proprioceptive and motor loss and contralateral loss of sensitivity to pain and 
temperature”.9 
Anterior Cord Syndrome is “a lesion that produces variable loss of motor function and 
of sensibility to pain and temperature, while preserving proprioception”.9 
Conus Medullaris Syndrome is “an injury of the conus and lumbar nerve roots within 
the spinal canal, which usually remains in an areflexic bladder, bowel and lower limbs. 
Sacral segments may occasionally show preserved reflexes”.9 
Cauda Equina Syndrome is “an injury to the lumbosacral nerve roots within the neural 
canal resulting in areflexic bladder, bowel and lower limbs”.9 
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As seen in the literature presented above, spinal injuries vary widely in level and extent 
and, as a result, a variation in their consequences is expected. People with SCI will 
differ in their abilities, limitations or challenges depending on the severity of their 
injuries. The vast majority of the literature on SCI includes people with all types of 
injuries, pooling them together in the analysis and frequently no subgroup analysis is 
reported. Often, other studies focus on recruiting participants based on the cause of 
their injuries rather than the type. Undoubtedly, these studies have contributed 
valuable information to the SCI literature, but the current study will examine people 
based on the type of their injury, as the type of injury determines the level of 
functionality as per ASIA classification.9 This study will examine people with incomplete 
SCI. Looking back at Section 2.1.6.5, a complete injury results in motor and sensory loss 
below the level of injury482 which indicates that function but also the sensation (or 
presence) of pain can be different when compared to people with incomplete injuries. 
Of course, there is a variation of disability within the incomplete injuries, thus this 
study will carry out subgroup analysis as well.  
 
2.1.7 Spinal Cord Injury; secondary complications  
Secondary complications are common in SCI, more than 95% of people will have one 
and around 60% will have three or more.13 These complications are listed and 
described below:  
 
2.1.7.1 Spinal Cord Injury; secondary complications; neurogenic bladder and bowel 
Problems of the bladder due to SCI may require the use of long-term bladder drainage 
with the aim of avoiding kidney damage and preventing complications like repeated 
infections and stone formations.53 Bowel mobility is usually reduced and care, often 
with the use of laxatives and suppositories, is needed in order to limit the risk of 
incontinence.53 People with tetraplegia and people older than 60 years often have 
more abnormal renal tests, increased number of stones in the kidney and/or ureter, in 
particular, if they have complete tetraplegia.296 
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2.1.7.2 Spinal Cord Injury; secondary complications; cardiovascular, circulation and 
pulmonary problems 
After SCI there is an increased risk of deep venous thrombosis (DVT) (by 15-20%) and 
pulmonary embolism (by 5%).53 The risk is higher for people with complete injuries,53 
particularly during the first year compared to people with incomplete injuries.296 
Pulmonary function is reduced in most cases of SCI even for people with paraplegia 
and it is affected by increased duration of injury.267 Atelectasis or pneumonia can 
affect 3.5% of people during the first year and, overall, people older than 60 years 
develop pneumonia more often.296 
People with SCI tend to have lower than normal blood pressure, relative bradycardia, 
and they can suffer from postural hypotension which may result in symptoms as 
serious as the loss of consciousness.53 Autonomic dysreflexia may occur in severe SCI 
at levels T5 and above and its symptoms can include headache, paraesthesia, chest 
tightness, dyspnoea, occasionally cardiac arrhythmias or even myocardic failure.53 
 
2.1.7.3 Spinal Cord Injury; secondary complications; spasticity 
Spasticity is a common consequence of SCI and tolerance to it may vary.53 It may 
interfere with transfer abilities, causing falls, but on the other hand it may be 
beneficial by assisting in achieving transfers.53 
 
2.1.7.4 Spinal Cord Injury; secondary complications; pressure ulcer 
Pressure ulcers, which are lesions caused by pressure, usually over bony areas and 
which result in tissue damage, are common in SCI and are a lifelong complication.161 
Pressure ulcers have been noticed and recognised since ancient times; Egyptians 
applied topical remedies, Arabs used nutrition to promote healing and during the 
Renaissance good hygiene was proposed.134 In the last century, the use of antibiotics 
and surgery were developed.134 McKinley et al296 recorded pressure ulcers as the most 
frequent secondary medical complication present in 15% of people with SCI in the first 
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year and more people were affected in the following years. People with incomplete 
lesions are less likely to develop pressure sores or pressure ulcers and males and 
people with a violent onset of injury report them more often.296 
 
2.1.7.5 Spinal Cord Injury; secondary complications; spinal deformities 
Spinal and/or pelvic deformities may develop following SCI, affecting the person’s 
ability to maintain a correct sitting position.102 The following deformities may appear 
following injury or may pre-exist leading to SCI:  
2.1.7.5.1 Scoliosis 
There are many different types of scoliosis including idiopathic, congenital, 
degenerative and neuromuscular.287  The last two can be due to degeneration of the 
discs or arthritis of the joints of the spine and due to defects of the neuromuscular 
system and muscle forces that support the spine.287  
Scoliosis can follow trauma to the spine that results in tetraplegia or paraplegia,287 and 
it can affect up to 15% of people with SCI by the third year of their injury.230 The 
degree of the curve does not correlate with the completeness or the level of the SCI100 
but people with paraplegia and complete SCI have greater scoliosis.23 Interestingly, 
paralytic scoliotic deformity affects as many as 97% of pre-adolescent SCI patients and 
48% of mature SCI patients. The pre-adolescent curve can progress twice as fast as the 
adolescent curve and, in the majority of the cases, an operation is needed to stop 
progression.100 Muscles that are weakened due to an underlying neuromuscular 
condition in combination with the beginning of the growth of the scoliosis, can result 
in the worsening of the scoliotic curve287 which can then become a fixed deformity.320 
The paralysed muscles cannot support the spine leading to loss of sitting balance.287 
2.1.7.5.2 Kyphosis 
Both congenital kyphosis and kyphoscoliosis are less common than scoliosis but are 
more serious and occasionally lead to spinal cord compression and paraplegia.297  
McMaster and Singh298 found that 10% of people with kyphosis or kyphoscoliosis 
  Chapter 2: Literature review 
 
29 
developed a progressive spastic paraparesis of the lower limbs due to anterior 
compression of the spinal cord at the apex of the deformity.     
Around 90% of people with traumatic paraplegia were found to have developed a 
post-traumatic kyphosis of up to 65°.2 In wheelchair users with SCI kyphosis can extend 
to the lumbar spine.23 
2.1.7.5.3 Lordosis 
The causes of lordosis are unknown but it could be associated with poor posture, 
congenital problems of the vertebrae, neuromuscular problems, and back surgery or 
hip problems.334 People with SCI have been reported to have bigger lumbar angles 
compared to healthy controls209 and lordosis is reported to be greater in people with 
paraplegia and incomplete lesions.23 
2.1.7.5.4 Pelvic tilt and obliquity 
People with SCI have a more passive sitting position with a backward pelvic tilt, and 
their back leaning against the backrest for support.363 They may develop a c-shaped 
posture in an effort to compensate for their loss of balance.30 Patients with SCI were 
found to have posteriorly rotated pelvises401 and reduced pelvic angle by as much as 
15° compared to healthy people and pelvic obliquity of about 1.5°.209  
In the neuromuscular disorders the pelvic tilt is one part of a composite deformity, 
which includes the hip joints and the spine. The patient sits with uneven weight 
bearing which makes sitting painful and this sitting position creates an unstable base 
for the spine.287 Four different types of pelvic tilt in combination with spinal and hip 
deformities have been reported and one of them can be found in people with 
tetraplegia; type III (wind-blow-hip syndrome) in which there is scoliosis and pelvic tilt 
together with unilateral hip dislocation.159 People with SCI have been found to have 
pelvic deformities,401 pelvic tilt being greater in people with paraplegia and pelvic 
obliquity being present in as many as around 70% of the SCI population studied.23  
The treatment of neuromuscular spinal disorders follows the same philosophy as in 
non-neurological conditions. The aims are to improve balance and stop curve 
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progression,320 to prevent pain or offer pain relief,234,287 but even though  surgical 
correction can greatly correct the deformity, it cannot always completely stop the 
pain.479 
2.1.7.6 Spinal Cord Injury; secondary complications; ageing with SCI 
As life expectancy following SCI has been increasing over the last century, the 
consequences of living with SCI and the associated problems with ageing eventually 
become more apparent, and include other symptoms like increased shoulder and 
upper limb pain, added urinary management, constipation, an increase in pressure 
ulcers, fatigue, increased pain and spasticity.53 In addition, psychological 
consequences, for example, feelings of isolation may present, and all the above may 
lead to the loss of independence.53   
2.1.7.7 Spinal Cord Injury; secondary complications; pain 
Another secondary complication, following SCI, is pain. Both acute and chronic pain 
have been extensively studied in SCI. Pain is the focus of the current research 
therefore it will be discussed in detail later in this thesis.  
2.1.7.8 Spinal Cord Injury; secondary complications; other 
Fractures of the long bones of the lower extremities is another secondary complication 
post SCI, though not often seen but more common in people over 60 years and in 
women especially, as time post injury increases.296  
In summary, many secondary complications may follow SCI some of which are 
common in the general population like cardiovascular problems. The severity of the 
secondary complications can depend on the severity of the injury itself, but also SCI 
complications tend to become worse with age. Increasingly, the literature has been 
investigating these secondary complications, and this project will focus on one of 
them. Before going further, the experience of pain will be explored.  
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2.1.8 Understanding pain and the experience of pain  
2.1.8.1 A historic route to the definition of pain 
2.1.8.1.1 Pain in Ancient Greece 
Pain is experienced by all people and has been studied for centuries. Its description 
goes back to antiquity, for example, there are references to pain in Homer’s texts, in 
the 8th century BC.378  Various books from Ancient Greece include references to pain, 
often using words like “exhausting”, “sharp”, “consuming” or “shooting” to describe it. 
In addition, there were words like “kedos” (κῆδος) or “achos” (ἄχος) which describe 
emotions and feelings.378 In the 5th century BC, Hippocrates (ca 460 BC –ca. 370 BC) 
discussed pain in more detail, talked about the believed causes and treatment of the 
time.   
Hippocrates said “Pain arises from cold and from heat, and both from excessively great 
amounts and from too little. In persons that are cooled by nature out of their body 
towards their skin, pain arises from excessive heating, in those by nature hot, from 
cold, in those by nature dry, when they are moistened, and in those by nature moist, 
when they are dried. From each thing that is altered with suspect to its nature, and 
destroyed, pains arise. Pains are cured by opposites, and there is a specific thing for 
each disease: in persons by nature hot, and who are ill because of cooling, it is what 
heats, and so on according to this principle”.207   
Hippocrates’s ideas were spread to the Greek cities, then via Alexander the Great’s 
conquests to much of the rest of the known world and later the study of pain 
continued to expand via the Egyptians and the Romans.378 Herophilus, in Alexandria 
(3rd century BC), who experimented on live criminals (his work was then stopped on 
ethical grounds), described seven pairs of cranial nerves and identified the origins of 
the motor nerves in both the brain and the spinal cord.378 Erasistratus, during the same 
period, talked about two kinds of nerves; the sensory and the motor.378 
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2.1.8.1.2 Pain in the Roman period 
Another landmark in the study of pain was the Roman period, during the 1st century 
AD, when Aretaeus of Cappadocia talked about acute and chronic conditions like 
migraine pain.378 Galen, during the 2nd century AD, studied and combined medicine, 
philosophy, anatomy and physiology from the ancient years to his time and wrote 
many books. He developed his work on pain advancing the ancient theories about the 
nerves and senses. He focused on the analysis of the mechanism of pain and he set 
down the basis for its perception.  He identified three conditions necessary for the 
perception of pain; an organ to receive the stimulus, a connecting pathway, and a 
centre which would organise and transform the sensation into a perception. He 
attributed pain to the tactile sense.378 The theories of Galen were followed for many 
centuries but little progress was made during the middle ages.378 During the 
Renaissance years (14th – 17th Centuries), art and poetry described illnesses like the 
plague and the experience of pain due to famine. Christianity also affected beliefs 
about pain at this time.378 New work on anatomy started in the 15th Century AD, with 
text now been written in Latin and French by doctors like Vesalius and Paré.378 
2.1.8.1.3 Pain in the Classical Age 
The study of pain progressed during the Classical age. Descartes discussed the theory 
of sensation. He believed that pain was a mode of action, rather than a sensation, 
involving the nerve of touch. He did not believe pain was caused by opposites. Based 
on Harvey’s discovery of blood circulation, Descartes talked about the transmission of 
sensation.378 Willis discussed pain and reflex movements and he described involuntary 
actions as sensations which warn the organism of danger and produce automatic 
protective movements.378 In the so-called “Age of Enlightenment”, the 18th Century, 
physicians started thinking more spherically around the value and the usefulness of 
pain. They advised that attention should always be paid to reports of pain and tried to 
classify pain, using ancient knowledge, but in a more organised way. Dr. Renauldin 
used a four-category classification system and more systems were developed by other 
pioneers.378 
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2.1.8.1.4 Pain in the 19th Century 
The location of pain was studied in the 19th Century and research focused on tissue 
damage rather than the organ as the source of pain. Knowing how to evaluate pain, by 
questioning the patient became more important during the 19th Century. The difficulty 
faced was how to value patients’ complaints about their own pain.378 The concept of 
sensibility was studied further and the concept of the pain threshold developed.378 
During the 19th Century morphine was discovered, followed by great developments in 
anaesthesia.378 During that period further significant developments were made in the 
study of the nervous system. For example, an understanding of the ascending and 
descending pathways and of the nerve fibres,378 as well as the work of Brown-Séquard 
on the cross transmission taking place in the cord and the establishment of “pain 
points”.378  War was a constant feature that resulted in many people being injured due 
to trauma. There was uncertainty expressed as to whether the pain was “real” due to 
the trauma or due to the psychological effects of war.378 
2.1.8.1.5 Pain and current theories 
Clearly, over the centuries, pain, its causes, its origin, its transmission and its 
expression has generated debates as all of the above theories had both supporters and 
detractors.  Overall, the tendency was that there had to be a somatic reason which 
would activate the pain receptors in the periphery and the fibres would then transmit 
the messages up the spine to the brain in a pain centre. This was the theory of 
specificity developed by Descartes, three centuries earlier, which was challenged by 
the “pattern theory” which included a number of forms.306 Still, the pattern theory 
explained the role of the brain as a passive one.306 If there was pain without a physical 
cause this was attributed to a psychological illness. The debate on pain did not stop.  
2.1.8.1.6 The Gate Control Theory 
Melzack and Wall developed the Gate Control Theory of pain in 1965,310 which gave 
rise to a different approach to understanding pain. They said that the spinal cord is 
constantly bombarded with incoming impulses, even when there is no obvious 
stimulation, but small fibres are activated and they do not produce any pain.310 When 
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a stimulus is applied to the skin then larger fibres are activated that send messages to 
the brain. There exists a “central control trigger” which selects and activates particular 
processes in the brain that has control over the sensory input. According to their 
model, psychological factors, like previous experience, emotional influences, 
perception and so on, act on the gate control system.310 So, the gate control theory of 
pain gave more emphasis to the function of the brain in the processing of pain. Both 
Melzack306 and Wall476 had reported how astonished they were by the huge support or 
opposition with which their theory was received. In the light of new research, in 1978, 
Wall476 published a summary paper in which he stated that the function of the large 
fibres in their original gate control theory was over-estimated. Nevertheless, the gate 
control theory of pain was a landmark in understanding pain better, the mechanism of 
which is still largely unexplained.306 Melzack, meanwhile, studying types of pain, like 
phantom limb pain was realising that the gate control theory could not explain certain 
types of pain, including chronic pain, thus there must be greater participation by the 
brain in the production of pain.306,308,309 Melzack306 quoted the work of Loeser, of 1978, 
who studied people with paraplegia and pain in their paralysed areas and developed 
further on the gate control theory to propose a central “pattern generating 
mechanism” which existed in the brain.  
2.1.8.1.7 The theory of Neuromatrix 
Following further work, Melzack then proposed the theory of neuromatrix in 1996.306 
According to this theory, there is a widespread network of neurons in the brain with 
many loops that include many parts of the brain. The loops constantly perform cyclical 
processing and synthesis of nerve impulses. All inputs of the body go into the 
processing of the neuromatrix and some parts of the neuromatrix are specialised into 
processing information related to sensory events such as an injury.306,308,309 The 
neurosignature is a continuous outflow from the body-self neuromatrix, and is 
converted into awareness. It can also activate the appropriate networks to create 
movement.306,308,309 Melzack,306,308,309 concluded that chronic pain could be the 
cumulative effect of cortisol, which is released in injuries, on the muscles, bones and 
neural tissue. But he added that cortisol on its own is not sufficient to cause chronic 
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pain, but it is a contributing factor along with sex-related hormones, genetic 
predisposing factors and psychological stresses. In conclusion, the neuromatrix theory 
of pain is produced by genetic and sensory influences and by stressors of a physical or 
psychological nature that could explain chronic pain.306,308,309 
 
Summary of history of pain 
Thus, the latest theory of pain, mainly attributable to the work of Prof. Melzack, is that 
pain is a multidimensional experience produced by multiple influences in the brain 
neuromatrix which creates sensory, affective and cognitive dimensions of the 
experience of pain and the behaviour that accompanies it.308   
The historic route to the definition of pain has changed massively over the course of 
the centuries from Hippocrates’ theory of the opposites, to the current definition of 
“an unpleasant sensory and emotional experience associated with actual or potential 
tissue damage, or described in terms of such damage”.220  
 
2.1.8.2 Chronicity of pain and pain classification in Spinal Cord Injury 
In 2008 the International Spinal Cord Injury Pain Basic Data Set (ISCIPDS:B) was 
published as the result of the collaboration of four major organisations with an interest 
in SCI (ASIA, American Pain Society, International Spinal Cord Injury Society and 
International Association of the study of PAIN (IASP)).483 The aim of the basic data set 
is to facilitate collection and reporting of pain in people with SCI, assisting comparisons 
across the world.483 Prior to this collaborative work many pain classification systems 
had been reported in other studies but ISCIPDS:B proposed seven types of pain that 
include many previously described categories.483 
 
 
 
 
 
  Chapter 2: Literature review 
 
36 
Table 2.1.2: Pain classification in SCI according to the International Spinal Cord Injury 
Basic Data Set (ISCIPDS:B)483 
Type of pain Definition and description of pain  
MSKP (nociceptive) Refers to pain occurring in any region where there is at least some 
preserved sensation above, at or below the neurological level of 
injury and which is believed to  arise from musculoskeletal structures. 
The presence of this type of pain is suggested by pain descriptors 
such as dull or aching pain related to movement, tenderness of 
musculoskeletal structures on palpation, response to anti-
inflammatory medications and evidence of skeletal pathology 
on imaging consistent with the pain presentation. 
Visceral (nociceptive) Refers to pain usually located in the thorax or abdomen and believed 
to be generated in visceral structures. 
The presence of this type of pain is suggested by characteristics such 
as dull, aching or cramping and a relationship to visceral pathology or 
dysfunction, for example, infection or obstruction. 
Other (nociceptive) Refers to nociceptive pains that may be present but do not fall into 
the musculoskeletal or visceral categories. 
At-level (neuropathic) Refers to neuropathic pain presenting in a segmental pattern. It is 
perceived anywhere within the dermatome of the level of 
neurological injury and three dermatomes below this level. 
It is often characterised as burning, electric or shooting. Sensory 
changes such as allodynia or hyperalgesia within the pain distribution 
are often found. The pain may be unilateral or bilateral. 
Below-level 
(neuropathic) 
Refers to neuropathic pain present in the region more than three 
dermatomes below the neurological level of injury. 
It has typical characteristics such as burning, electric or shooting 
qualities and a diffuse, regional distribution. Sensory changes such as 
allodynia or hyperalgesia may be present. 
At- and below-level 
(neuropathic) 
Refers to the case when a person with below-level neuropathic pain 
also has neuropathic pain within the region three dermatomes at or 
below the neurological level of injury but is unable to distinguish two 
separate pain problems. 
Other  
(neuropathic) 
For a neuropathic pain to be classified as SCI-related pain, a lesion or 
disease affecting the spinal cord or nerve roots must be present and 
the pain must fall within an expected anatomical location for that 
lesioned or diseased spinal cord or nerve roots. Neuropathic pain that 
cannot be attributed to a lesion or disease affecting the spinal cord or 
nerve roots should be classified as ‘other’ (neuropathic). 
‘Unknown’ Should be used when it is not possible to classify the pain into one of 
the categories listed above. 
Abbreviation: MSKP, Musculoskeletal pain.  
 
2.1.8.3 Pain as a personal experience 
Earlier in Section 2.1.8.1, it was mentioned that during the 19th Century scientists 
started emphasising that attention to pain should be paid by listening to the patients’ 
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symptoms. Today this is the standard and according to IASP220 the patient’s report on 
pain, even in the absence of any tissue damage or pathophysiological cause, should be 
regarded as pain. 
A number of questionnaires have been developed aiming to capture the experience of 
pain. Though its mechanism still is not completely understood, it is known that the 
experience of pain is impacted by many personal, biological and psychological factors 
and its expression is a subjective matter. Pain has three psychological dimensions, 1) 
the sensory-discriminative, 2) the affective-motivational and 3) the cognitive-
evaluative.305  
 
2.1.8.4 The importance of pain quality and intensity 
Collecting information about the quality of pain, as shown in Section 2.1.8.1, has in 
reality been done since ancient times using verbal descriptors. The importance of 
collecting information on the quality of pain is now highlighted and recommended.483 
As seen in Table 2.1.2 above, verbal descriptors help to classify pain in SCI.404,406,407,483  
It is essential, together with quality, to measure the intensity of pain. Measuring these 
variables is a gold standard for measuring the effects of treatment46 and 
understanding what treatment needs to be applied.45 The information about the 
intensity of pain in SCI is mixed as, on the one hand, it is found to correlate with the 
cause of injury381 and, on the other hand, no such correlation is found.55,422 
Irrespective of age55,422 or gender50 or level or injury,457 people report similar intensity 
or severity of pain though in the adolescent general population girls report higher pain 
intensity219 and also in SCI women tend to report higher, but not statistically 
significant, pain intensity.57 In general, males are found to tolerate pain more than 
women and pain tolerance decreases with increasing age.497 Females are reported to 
have lower pain thresholds and thus report greater sensory pain than males.241 People 
with complete SCI report more intense pain,374,381 but a trend towards people with 
incomplete injuries to report higher sensory scores than those with complete 
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injuries451 has been found. Despite the similarities or differences in the characteristics 
of people in pain it can persist regardless of the use of medication.13  
 
2.1.8.5 The importance of pain extent  
Location of pain in SCI, and other conditions, has been recorded more regularly over 
the past few years and its relation with other variables like the quality,488 the 
duration,380 the intensity,457 and the type of pain484 that are sometimes reported help 
to gain a better understanding of the experience of pain in SCI. People with SCI may 
report a mean of 3.4 (±SD 1.8) areas with pain488 and only up to a third of participants 
have only a single-pain site.59,316 In people with chronic pain, including LBP, longer 
duration of pain and increased intensity of pain relates to an increase in pain 
extent.59,254 There is no such information for people with iSCI and this study will 
investigate the relation of the extent of pain with regard to a number of variables 
including LBP, QoL and function. It would appear reasonable to expect that dealing 
with more painful areas on the body would interfere with the experience of pain.  
Carnes et al59 mentioned that two-thirds of their sample had multi-site pain, which did 
not meet the definition of chronic widespread pain, and pointed out that the impact of 
multi-site pain on QoL, health care and mental health may be greater than widespread 
pain. This can have implications for work abilities as people with multi-site pain 
perceive themselves to have less work ability compared to those with single-site 
pain.316,329 A treatment aiming to target one single pain site, when the person suffers 
from multi-site pain, may fail to be effective if the other pain sites are not addressed, 
thus understanding multi-site pain is important.59 
 
2.1.8.6 The importance of pain onset  
It is well accepted that pain is an unpleasant experience therefore it is a logical 
assumption that an unpleasant experience that lasts a long time or starts early would 
create negative feelings and will affect various aspects of the life of the person living 
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with pain. Chronic pain is common in SCI and the onset of pain may be a factor that 
influences the experience of pain. The time of the onset of pain following SCI is often 
reported in studies but the extent to which this relates to the experience of pain or 
QoL and function is limited. It is known that in SCI the onset of pain post injury is at a 
similar time in both males and females,50 it can be early, within the first six months 
following injury12 for 50% or more of people.90,488 On other occasions onset may be 
slightly beyond one year post injury406 though for certain pain types, like MSKP,  may 
have an early onset, which  drops and then increases again.406 LBP in SCI has also been 
reported early post injury.371 Early pain onset is associated with higher pain 
intensity.488 Intensity of pain affects the experience of pain, therefore this study will 
record pain onset and explore its relation with the experience of pain but also with 
QoL and function.  
 
Summary of the experience of pain 
In summary, in order to understand some of the theory behind this thesis it was 
essential to do a historical précis to understand what brought us to the current 
knowledge of pain and look at what constitutes the experience of pain in general, and 
in SCI, in particular. As scientists themselves state, there is still a lot that is not known 
about the mechanism of pain. What is accepted is that pain is a multidimensional 
experience, subjectively reported by the individual and has many factors affecting it 
including psychological and cultural ones. The next step is to review how prevalent the 
pain experience is in the population of interest.   
 
2.1.9 Pain in Spinal Cord Injury 
2.1.9.1 Prevalence of pain and general characteristics 
The prevalence of pain in SCI has been reported to range from 26% to 
96%,12,13,58,115,240,317,331,380,381,427,446,451,470,489 with many studies placing it above 
70%58,317,331,380,381,451,489 similar to percentages reported by Burrell in the early 20th 
century.52  
  Chapter 2: Literature review 
 
40 
In SCI the main pain-related problems are caused by chronic pain482 and severe chronic 
pain affects 25-43% of people.53,489 The prevalence of chronic pain in the community 
has increased by around 10% in four years (1996 – 2000) and more than three-quarters 
of those with pain had persistent pain.133  
Gender is one of the factors that may affect the experience of pain, and females are 
reported to have lower pain thresholds and pain tolerance148,241 and they report pain 
more often115 and of higher severity.57 One mechanism to explain the sex differences is 
the “psychosocial” one in which the female role allows acknowledgement of pain 
whereas the male role discourages it.149 Biological and environmental mechanisms can 
exist and result in the behavioural responses of the sex roles with regard to pain 
perception.149 Hormones, particularly, oestrogens are suspected to be the modulators 
of pain even though it is not concluded if they worsen or alleviate pain, possibly doing 
both depending on the chronicity and the type of pain but also on the level of the 
oestrogen.87 Cognitive factors may affect pain differences among sexes, for example, 
coping strategies, catastrophising, depression, post-traumatic stress, and anxiety are 
all usually more common in females and relate to higher levels of pain.149,179 Other 
reports say that sex-related differences in MSKP are not explained by age, or even 
physical activity and catastrophising.491 Other factors that may affect gender-related 
pain differences, however with conflicting evidence, are age (reduced tolerance to pain 
with increasing age), physical activity, family history, genetic factors and social 
learning.147,149,491,497 In the general population some studies did not find any gender 
differences with regard to pain or back pain (BP).383,444 Women may use more words to 
describe their pain thus disclosing more information on their pain experience.426 Men 
and women describe their pain similarly with regard to the number of areas with pain, 
distribution, onset, intensity and pain influence on life satisfaction and no differences 
have been noted but women report significantly higher nociceptive pain.48 
Patients may feel severe pain at the time of their SCI or just when they regain 
consciousness and never be pain free or, on the other hand, pain onset can be years 
post SCI.33 Pain can be present in 25% of people with SCI by the first year of their injury 
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and increase to more than 40% by the third year.230 It has been reported that pain in 
general is high following the injury but then decreases over the first six months.407  
Regarding pain intensity people with complete paraplegia are reported to have more 
intense pain,381 but no relationship between cause of injury and pain intensity  is 
found.55,422 Pain can persist even when patients receive pain medication and pain 
associates with spasticity.13     
 
2.1.9.2 Brief causes, risk factors and consequences 
Among the general risk factors for pain in SCI can be race and education level as more 
non-whites and more people with lower levels of education are pain free.57  Older age 
at injury is another risk factor.422 Pain is a common symptom in post-traumatic spinal 
deformity which often follows SCI.47 Spasticity can cause pain and, in particular, 
MSKP.500 
Pain can be associated with anxiety, distress, stress, low self-esteem, lower self-
assessed health, fatigue, anger, family and social difficulties,12,22,90,381,422 
depression,55,240,489 suicidal tendencies,482 and negatively affects the person’s mood.406 
It can interfere with sleep90,381 lead to poor quality of life,12,103 interfere with 
activities427 and is related to spasticity,470 which, in turn, affects function.469 It has been 
reported that pain can interfere so much with the functional abilities of the person 
with SCI that it can take up to six months more to achieve independence in activities of 
daily living (ADL) compared to those with SCI who are pain free.435 
The experience of pain is affected by its intensity and increased intensity of pain 
reduces QoL in the general population and in people with health-related problems, for 
example, AIDS,387 as increased pain intensity relates to reduced well-being, increased 
depression and distress. Pain intensity interferes with daily activities and life control 
which then affects depression15 and it contributes to developing chronic pain15 via 
mechanisms probably explained by the neuromatrix model of Melzack (Section 
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2.1.8.1). Pain of higher intensity is related to catastrophising51 and pain catastrophising 
is considered a predictor for poorer QoL.257   
The relation between pain intensity and catastrophising has been shown in SCI too and 
greater catastrophising is related to greater psychological distress450 and to decreased 
ability to deal with the pain.488 As with other conditions similar to SCI, increased pain 
intensity has a negative impact on basic activities like sleep, mobility and self-care.228 
The pain with the highest intensity is the most disturbing145 and higher pain intensity 
correlates with pain interference and mental health problems.370  
The above findings illustrate the current beliefs about the complexity of pain and show 
the interaction of the psychological and the physiological effects on the pain 
experience. Widerström-Noga et al,486 studying  a group of people with SCI, concluded 
that even though increased severity of pain decreases life satisfaction its impact may 
be moderated by perceived social support. The social factor can vary in different 
cultures but is also affected by the health systems in place for each particular nation. 
The study by Widerström-Noga et al486 came from a single country (the USA), while the 
current study investigates pain in three different countries. Though social factors will 
not be directly analysed, interesting questions may arise.  
 
2.1.9.3 MSKP and LBP  
Doing an online search of the literature using the combined keywords of “pain” and 
“SCI” plenty of papers are available to be read. When examining the papers in more 
detail it becomes clear that the vast majority of them discuss neuropathic pain and 
information on nociceptive pain is a lot less studied and tends to focus on MSKP 
involving the upper extremities.7,92,196,322,459 Reference to MSKP is often made in 
papers discussing classification of pain in SCI.19,58,381,406 Upper limb pain is studied in SCI 
examining shoulder pain and QoL169,183,391 or function.391 Recently, a randomised 
control trial used shoulder exercise strengthening to investigate shoulder pain in 
relation to QoL.322,323 When location of pain is considered then LBP seems to be missed 
out. Whereas, when referring to “pain” in the general population, LBP is one of the 
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most commonly cited types of pain. This difference in the studying of LBP between the 
general population and the SCI population marks an obvious gap. In SCI it maybe that 
other types or locations of pain are of more importance, however the consequences of 
LBP will not be understood unless studied. Due to the difficulty in identifying related 
papers using a simple literature search, it was decided to address the question of LBP 
in SCI using a systematic literature search method. This will be presented in Chapter 3. 
Before presenting the results of the systematic literature search, it is essential to 
explain to the reader why LBP is an important location of pain and how it may relate to 
various aspects of patients’ lives. To do this, LBP in the general population examining 
the three participating countries will be reviewed.        
2.1.9.3.1 The problem of LBP 
LBP is one of the two most common causes of disability in Western society,238 
accounting for seven million GP visits in the UK (in 1992-93).11 Prevalence ranges from 
12% to 49%107,220,248,263 with one-year prevalence of 44%, point prevalence4 of 27% and 
CLBP5 of 21%.
358 The annual incidence is around 7%,88,107 but can reach as much as 
25%.477 LBP prevalence slightly declines with increasing age.358 Men and women are 
found to report similar percentages or women may report LBP slightly more 
frequently.358,491 The prevalence of LBP in the USA has been rising over the past few 
years (period 1992 – 2006) to more than double for reasons that could include an 
increase in obesity, depression, awareness of LBP and reporting of it.153 A rise in the 
one-year prevalence of LBP has been reported in the UK, from 36% to 49% with a 
consistent trend across ages, sexes, social classes and regions due possibly to 
awareness and willingness to report it.346 In Greece, point LBP prevalence among office 
workers was 33% and life-time prevalence was 62%.417  
 
 
                                                     
4
 Point prevalence mean prevalence at the current time. 
5
 CLBP is usually referred to as pain of at least three months duration.
220
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2.1.9.3.2 Location of pain 
In the literature “back pain” is often used to refer to LBP. Some papers specify upper 
and lower back but often this is not the case. Unless a clear explanation is given of 
where on the back the pain is located, then it can be misleading to assume that “back 
pain” means “low back pain”. In this thesis, the studies that report on “back pain” will 
be treated as a separate category of pain location to “low back pain”. Back pain has 
been increasing over the last 10 years (by around 13%) in the UK but its severity 
remains the same. Possible cultural changes that lead to more awareness and 
willingness to report back pain are believed to be the reason for this increase.346 Back 
pain can be the most common complaint in the general population (22.7%) rated first 
among men and second (after shoulder pain) among women and it is the most severe 
pain complaint in women.26 In the elderly general population back pain can be even 
more frequent (48%).496  
One of the questions that need to be answered when studying pain at any location is 
the type of pain. Treatment of pain relies to a great extent on the type of pain. In SCI 
two types of pain may arise; nociceptive and neuropathic as it was seen in Table 2.1.2. 
This study aims to focus on MSKP.  
A number of the studies that report on MSKP in the general population include LBP as 
one type of MSKP though LBP is a location rather than a type of pain. MSKP is a 
common type of pain for every subgroup of the general population358 making it an 
important type of pain to study. Over a period of 40 years, the prevalence of MSKP in 
the UK has increased again possibly due to people’s willingness to report this type of 
pain, increased psychological distress and increased awareness by patients and health 
professionals.192 In a Dutch population sample, the one-year MSKP prevalence was 
74.5%, point prevalence was 54% and chronic musculoskeletal pain (CMSKP) was 
44%.358  
2.1.9.3.3 LBP recurrence 
Unfortunately, LBP is a condition that often consists of more than one episode with 
recurrence percentages ranging from 34% to 42%.88,348 Recurrence tends to happen in 
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people with longer lasting LBP and a tendency for more persistent LBP.197 Even in 
adolescent schoolchildren recurrence can reach 59% and it is linked to impaired QoL 
and reduced physical fitness.193  
2.1.9.3.4 LBP cost 
Because LBP is common in the population it clearly has an economic impact on all 
societies. Indeed, the cost of LBP in the UK is estimated to be £1.4 billion in benefits, 
£480 million in health care and £3.8 billion in lost production totalling £5.68 billion.152 
These figures are rising as health care costs alone in 1998 were £1632 million280 and 
the cost of lost production in industry in 1999 was £5 billion.107  
2.1.9.3.5 LBP causes 
Among the known causes of LBP are disc herniations, spinal stenosis, spondylolysis, 
spondylolisthesis or narrowing of the canal,74,287,372,441,442 degenerative or congenital 
conditions, spine abnormalities like scoliosis, lordosis and kyphosis,63,326,372,441,446 
overuse syndromes,301 mechanical damage/injury caused by abnormal loading, 
increased age,248 imbalance of trunk muscle strength,261 reduced physical activity and 
poor sitting posture,301,326,441,442 and possibly changes in the CNS including changes in 
muscle tone and coordination and increased postural deviation.210 People with 
scoliosis can report back pain (23%)372 or LBP (30%).420 Among people with 
neurological findings, like tight hamstrings, up to 42% report BP372 and also lordosis 
(over 40°) is more commonly found in the LBP group.420 
Lord271 quoted Keegan (1953) saying that LBP can be a consequence of prolonged 
sitting possibly because of a decreased angle between the trunk and the thighs which 
results in flattening of the lumbar curve. Prolonged sitting with a poor posture is 
associated with the progress of LBP.369 There can be two forms of poor sitting position; 
the flexed and the lordotic.369 A flexed sitting position increases the pressure in the 
area and eventually leads to disc degeneration which can cause LBP155,369 and a 
lordotic sitting posture which is less tensious and less harmful.369 However, pain 
increases when there is lordosis of the lumbar spine and forward rotation of the 
pelvis.466 Thus, a poor relationship between lumbar lordosis and the pelvis can 
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contribute to the appearance of LBP.389 In addition, static posture aggravates pain.466 
Static sitting posture and prolonged sitting positions are experienced by wheelchair 
dependent people thus they often maintaining a poor relation between the pelvis and 
the lumbar area. Finally, it has already been mentioned that people with SCI may have 
secondary complications including scoliosis, lordosis, kyphosis or muscle imbalance 
(Section 2.1.7.5), thus contributing factors to the appearance of LBP can be vast.   
2.1.9.3.6 Recovery from LBP 
There is conflicting information regarding recovery from LBP. Some reports say that 
90% of patients feel better after 4-8 weeks441 or that 80-98% recover by 12 
weeks11,88,314 or even that the majority of the patients recover within 1-2 weeks.441,442 
Speed of recovery depends on factors like age, occupation11 and severity of disability.88 
The patient’s beliefs can influence recovery, for example, lack of confidence or the 
inability to cope with the problem may influence disability directly or indirectly.314  
2.1.9.3.7 LBP risk factors 
Factors that can influence recovery can also be features that could predict it, like 
factors prior to the onset of injury varying from psychological factors to work and 
physical activity or even physical appearance,277 short duration of symptoms or sudden 
onset of symptoms.277 It is important to be able to identify people who are at risk of 
developing chronic pain197 and a number of prognostic factors are consistent among 
the reviews in the literature, including older age, increased psychological or 
psychosocial stress and worse baseline functional ability.198 There seems to be a need 
to look wider and try to identify clusters of patients that fall under particular 
contributing factors that are overlooked like social and family support, benefits and 
health care availability.197 Identifying these risk factors is essential to help treat the 
patient by providing counselling, planning, management and monitoring.197 But also, 
as rightly stated “the ability to predict which individuals are susceptible to long-
standing LBP would be a major step ahead with regard to prevention”.460 Studying LBP 
in SCI will help us to understand if being an individual with SCI is a risk factor for 
developing LBP.   
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2.1.9.4 Cross-national research and pain 
Studies on pain, MSKP or LBP in the general population conducted in single countries 
have been regularly reported in the literature: in Sweden,11,132 Denmark,358,460 
UK/England,59,192,346,477 Canada,35 Germany,157 Singapore,504 USA,75,376,471 Australia475 
and Greece.417,424 However, the majority of single-nation studies discussing pain in 
people with SCI have been done in the USA,80,145,228,380,427,450,451,457,484,487 the UK,240,374 
Australia406,407 and, occasionally,  in other countries like Iran371 and Turkey.103 Studies 
looking into cross-cultural or cross-ethnic similarities or differences in pain, within one 
country have also been reported in the UK206,346,444 and the USA.130,379  
The number of studies discussing pain, MSKP or LBP either in the general population 
and more so in the SCI population using cross-national design, has been fewer. A study 
aiming to explore prevalence and severity of chronic pain, in the general population, in 
Europe included a random sample of around 50,000 people from 15 European 
countries plus Israel and found a chronic pain prevalence of 19%.38 People in Europe 
reported pain of moderate to severe intensity which affected their daily activities, 
social and working lives.38 They found some variations in the reported prevalence of 
pain between countries which they attributed to cultural differences within the 
countries and ways of managing chronic pain. Differences in the prevalence of chronic 
pain were observed among the countries; in the UK, 13% of people reported chronic 
pain and 24% depression, whereas in Norway, 30% reported pain and 28% 
depression.38 This is very interesting as people with pain in Norway seem to have 
mechanisms (cultural or social) that maintain depression at low levels. Breivik et al38 
also found similarities between the countries like a lack of assessing pain by using valid 
pain scales. This is also important because comparisons of the results among countries 
are better enabled when using valid pain scales. 
In another study conducted by WHO182 across 14 countries, including Greece and the 
UK, the prevalence of persistent pain in the general population, and its association 
with health perceptions and psychological distress was investigated. Persistent pain 
was a common problem across the countries and associated with psychological 
problems but inconsistencies in the relationship between persistent pain and disability 
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across the countries were noted.182 Greece was among the European centres that had 
relatively low prevalence rates and the UK was among the countries with persistent 
pain prevalence above 20%.182 Gureje et al182 found the back as the primary area with 
persistent pain. Persistence of pain is thus an important variable and it will be explored 
in the current study.   
Finally, another study on MSKP in the general population across eight European 
countries, one of which was the UK, concluded that despite some differences between 
countries, the impact of MSKP and the perception of its treatment were similar across 
the countries.498 This study showed that the prevalence of MSKP for people having 
constant/daily pain across the countries was similar (60-75%), and in all countries 
MSKP had a negative impact on QoL limiting the physical activities of daily living.498  
The author of this thesis is not aware of any cross-national study conducted 
simultaneously on SCI to discuss pain in detail. Divanoglou et al,121 in a cross-national 
study investigating medical complications following traumatic SCI in Greece and 
Sweden, reported on pain prevalence but did not expand further. They found no 
significant difference in the pain prevalence between the two countries.121    
In summary, it has been shown that pain is a very common consequence of SCI and it 
has been studied mostly in single-nation studies. A preliminary examination of the 
literature showed that LBP has not been extensively studied in the SCI population, and 
though studies on MSKP do exist they refer to pain in other body areas. To verify the 
extent to which LBP (and related MSKP) is examined in SCI, a systematic literature 
review is conducted and described in Chapter 3. The second part of the current 
chapter will explore two important aspects of the lives of people living with SCI that 
have already been mentioned; QoL and function.  
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Part 2; Quality of Life and function  
 
2.2.1 Introduction 
The first part of this chapter, described the condition of interest, SCI, looked at the 
subject of cross-national research and reviewed what is currently known about the 
experience of pain. The presence of pain in SCI was reviewed along with LBP in 
general.   
As mentioned previously, life expectancy following SCI has been rising in recent 
decades.53,71,114 Though there are different reports about how much life expectancy 
has increased, in general researchers agree that people with incomplete injuries have a 
better life expectancy,53,71,114 sometimes as high as 95%, if injured at a young age.114 
Consequently, improving the QoL of people with a disability like SCI, is essential. The 
direct consequence of SCI is a reduction of function and improving function is likely to 
improve QoL. This part of the literature will focus on these two important areas for the 
lives of people with SCI and will explore how they relate to the experience of pain.  
 
2.2.2 Quality of Life definition 
Skevington (1998)409 quoting the WHO stated that QoL is defined as the “individuals' 
perceptions of their position in life in the context of the culture and value systems in 
which they live and in relation to their goals, expectations, standards and concerns”. 
QoL can vary between individuals as their subjective evaluation of it can be affected by 
cultural, social and environmental factors.62  
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2.2.3 Factors affecting Quality of Life  
2.2.3.1 Personal expectations 
Health-related QoL (HRQoL) is the health expectation one person has based on their 
experiences. Thus, even if the clinical condition between two people is almost 
identical, if their expectations are different then they may perceive their QoL 
differently.62 Following a SCI though actual scoring on the QoL may not change a lot, 
people’s expectation from the QoL may change.354  
 
2.2.3.2 Time of measurement 
The time of the measurement can affect QoL; QoL is dynamic and if the individual’s 
health changes so does his/her QoL.62  
 
2.2.3.3 Psychological functioning 
QoL is reported to primarily be affected by psychological functioning and to a lesser 
extent by physical functioning.412 Anxiety is associated with poor QoL and disability, 
and when it co-exists with a physical condition then the impact on QoL could be worse 
than the impact of the physical condition alone.393  
 
2.2.3.4 Cultural background 
One of the major factors affecting QoL is cultural background. In some cultures 
satisfaction is obtained via fulfilling material needs, whereas in others it is achieved via 
reducing them.213 Hofstede developed six dimensions of national culture; 1) power 
distance, 2) individualism, 3) masculinity, 4) uncertainty avoidance, 5) long-term versus 
short-term orientations, and 6) indulgence versus restrain.213 He concluded that 
different countries have different hierarchical needs and this should be taken into 
account.213 These dimensions, though used extensively, have been heavily criticised as 
anthropologists and sociologists disagree with the equation of nation with culture and 
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they argue that within one nation there can be more than one culture.20 As Smith 
summarised in his review,413 Hofsdede argues that culture is deeply embedded and it 
is resistant to change. The belief by many that nation is not synonymous with culture 
has led to many people applying the Hofstede cultural dimensions at an individual level 
rather than at a national level125,212 something that Hofstede criticised.211 Another 
criticism of Hofstede’s cultural dimensions has been the fifth dimension which was 
based on Confucian values, which Western societies find too oriental in nature and not 
applicable to the West, while oriental and Chinese societies believe that it is 
philosophically flawed.144  
 Magala279 concludes that despite the criticism this framework it is the most widely 
acknowledged and used in studying cross-cultural differences. In this study, two out of 
the three (USA and UK) participating nations consist of more multicultural societies 
than the third (Greece). This study aims to describe differences and similarities 
between nations and will not examine sub-cultures within each nation. According to 
Hofstede’s theory, the nation is the culture, but concerns raised in the literature 
regarding this concept will be taken into account.  
 
2.2.3.5 Demographic characteristics 
A number of demographic characteristics have been reported to be associated with 
QoL.  
2.2.3.5.1 QoL; gender 
Gender differences in QoL are found in SCI as women have lower mental health, health 
care or health satisfaction and they report lower HRQoL252,349 despite being more 
comfortable with interpersonal relations.252 They report better life satisfaction116 
despite reporting higher depression252 across various races and ethnicities.254 For 
women, in general, bad health is related more to the emotional and psychological 
aspects of life.349  
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2.2.3.5.2 QoL; age 
Youth links with better QoL in general349 as well as in SCI, as ageing with SCI leads to 
physical health deterioration.260,438 However, no impact of age on life satisfaction has 
been reported116 but age is reported to be associated with a decline in self-perceived 
health.349 
2.2.3.5.3 QoL; level of injury 
More serious injuries are found to result in lower life satisfaction362 and people with 
tetraplegia report worse QoL.313 However, Tatel et al438 reviewing the literature found 
an inconsistency on the impact of the level of injury on QoL.  
2.2.3.5.4 QoL; time since of injury 
As the time since injury increases life satisfaction also increases116 and QoL increases481 
for people with SCI or no such result is found.362 
2.2.3.5.5 QoL; education 
Education is related to QoL in SCI as those with lower levels of education report lower 
life satisfaction116 which is similar to the general population.349 
2.2.3.5.6 QoL; employment 
The importance of employment resulting in better QoL is confirmed in people with SCI 
who report “occupation” as one of the three least satisfactory areas (along with sexual 
activity and pain relief).239 Employment over the preceding year results in better 
QoL260 and people who are employed report better life satisfaction.116 Lower income is 
related to lower QoL.349 
2.2.3.5.7 QoL; marital status 
Marriage is positively related with better QoL after SCI, which again is similar to the 
general population.438 Marriage is more vital in ageing with SCI.438 Co-habiting 
improves life satisfaction116,362 and single people report lower QoL.481 Widowed people 
report bad health which is related more to the emotional and psychosocial aspects of 
life.349 
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2.2.3.6 Experience of pain 
Despite pain alone not explaining variance in QoL,219 the impact of pain on QoL is well 
recognised in the literature and included in QoL assessment tools e.g. 
WHOQOL,226,409,410 EQ-5D139,341 and the SF 36. Examining pain in relation to QoL is 
important and one of the main reasons for doing so is to gain insight into how people 
prioritise pain in relation to other QoL aspects and to explore how different cultures or 
people within the same culture think of the importance of pain.409  
In the general population, pain and discomfort affect QoL by having an effect on a 
number of the components that constitute QoL.409 Skevington409 found seven such 
components, the most important of which were negative mood and satisfaction with 
and access to health and social care. Pain has been found to affect both mental health 
and physical functioning but the impact on mental health is greater.235 People with 
various types of pain, like females with chronic pelvic pain288 or pain due to Multiple 
Sclerosis,235 or MSKP across many European countries498 report lower general health12 
and HRQoL.481 It is not only the presence but also the severity of pain which strongly 
correlates with a reduction in social functioning and mental health.235 Gender 
differences on the impact of pain on QoL have been reported, as chronic pain is found 
to be related to anxiety and depression in females.235 Women, in particularly elderly, 
with MSKP report worse health-related QoL.26,69 Higher intensity of pain, more often 
reported by females, is also associated with lower QoL, especially in psychological 
functioning, in both genders.219  
In SCI pain can be associated with poor QoL,230,331 poor adjustment,230 worse life 
satisfaction49,362 and can cause distress in addition to that caused by the SCI itself.12 
Pain interference negatively influences self-reported life satisfaction, physical and 
mental health.366 Pain in combination with low self-efficacy reduces QoL even further 
than each one individually.331 
Earlier, when examining what constitutes the experience of pain (Section 2.1.8), it was 
pointed out extensively that pain is a subjective, personal experience which is affected 
by many factors. By definition (Section 2.2.2) QoL is also subjective and it is affected by 
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various factors including “concerns”. Since pain, when present, is usually a concern for 
the person in pain, it is understandable why pain negatively affects QoL. This explains 
the increasing interest in recent years for researchers to take the next step from just 
examining pain to investigating pain in relation to QoL. With this in mind, the current 
study will investigate the relationship between certain categories of pain in iSCI and 
their impact on QoL.  
 
2.2.3.7 Other factors affecting Quality of Life 
Other factors related to QoL but not requiring hospitalisation260 include co-existing 
problems like respiratory problems and pressure sores,362 problematic spasticity and 
bladder problems481 and low mood and social functioning.255 In the elderly population, 
it is reported that QoL depends, among other factors, on the physical functioning 
abilities of the individual386 and, similarly in SCI, reduction of function leads to 
reduction in QoL.446  
 
2.2.4 Cross-national research and quality of Life 
Tate et al,438 in reviewing the literature on SCI and QoL, concluded that the mixture of 
studies available from the USA, Canada and Western Europe enables interesting 
comparisons between the main groups  and there is a fair consistency in what is a good 
QoL. Another important conclusion they made was that although people with SCI 
reported lower QoL than the normal population, their QoL was in general not as low as 
expected.438 One point to take further from their study is that, at that time, most of 
the studies they reviewed came from developed countries where factors that 
positively affect good QoL, like education, social support and community integration, 
were improved compared to developing or underdeveloped countries. The studies 
reviewed in Tate et al438 were single-nation studies though comparisons across the 
countries were enabled.  
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In a cross-national study on QoL in SCI (groups from Australia and Sweden), the 
predictors for QoL were very similar; mood, physical and social functioning and 
problems related to the actual injury.255 Some differences within the system of each 
country may however affect the QoL of a person with a SCI. Kreuter et al255 attributed 
the reported depressive feelings to the lower educational level. Lower level of 
education is often related to more physically demanding jobs, then people with SCI 
may not be able to manage such jobs thus exacerbating depression.254 The author of 
this study is not aware of any study that discusses QoL in SCI in Greece thus the 
present research will provide interesting new information.  
 
2.2.5 Summary of QoL 
In summary, QoL is a very important aspect in the life of the individual. It is affected by 
personal, cultural and demographic characteristics but also by the experience of pain. 
The latter affects the QoL of all people with chronic disorders,395 including those with 
SCI,313,481 compared to the normal population. Interestingly though, often QoL in SCI is 
better than expected, though this usually depends on the severity of the SCI.361  In 
general, QoL measures include some functional assessment of the person as it is 
thought to be an important element for what constitutes QoL. As expected people 
with SCI report lower scores on the function scale of the QoL measures and on general 
health but mental health and emotional health-related QoL scores are not as low as 
anticipated.361 As problems with function are the principal direct consequences of SCI, 
the author of this thesis believes that when examining the experience of pain, function 
should be investigated in relation to pain and it should be examined using a tool 
specifically to assess function for this population, separate from a QoL tool, with the 
aim of addressing function in more detail.  
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2.2.6 Function and factors affecting it 
As expected, people with SCI have worse function and well-being compared to the 
general population481 and a number of factors may affect their function which will be 
reviewed below.  
 
2.2.6.1 Severity of injury 
Function in SCI is directly affected by the type, level and completeness of the injury as 
described in part 1, Table 2.1.1 of this chapter. Thus, functional recovery also depends 
on the level of impairment. People with an iSCI rate walking recovery as the most 
significant factor.397 Walking recovery is “the regained ability to walk independently in 
the community, with or without the use of devices and braces. It is also defined as 
functional walking”.397 According to this review paper, 33% of people with a B lesion 
on the ASIA classification6 may have motor recovery. People with incomplete motor 
injuries have a higher chance of walking recovery and up to 87% of people with 
paraplegia can recover two years post injury. People with iSCI syndromes, like Central 
Cord Syndrome and Brown-Sѐquard, also have good functional outcomes.397 
Thompson446 reported no differences in the level of injury in people with SCI who had 
a decline in function.  
Using the keywords “incomplete SCI”, “complete SCI” and just “SCI”, while conducting 
an online search, there was a huge difference in the number of the results found.  On 
one single search engine (the Google scholar©174) the number of papers returned 
when using the keywords “complete SCI” were about 10 times higher than those found 
when using the keywords “incomplete SCI”. Clearly the focus in SCI studies has been 
on either complete injuries or studies that include both complete and incomplete 
injuries and pooled data together in one single analysis. The type of injury is one of the 
                                                     
6
 A B lesion on the ASIA Classification system is an incomplete sensory lesion: Sensory but no motor 
function is preserved below the neurological level and includes the sacral segments S4-S5.
9
 For more 
details on all lesions see Table 2.1.1. 
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most significant factors to affect function, as mentioned above, and this study aims not 
to pool together data from people with complete and incomplete injuries but to focus 
solely on people with incomplete injury. The fact that people with incomplete injuries 
usually have better function must be taken into account when discussing, in later 
chapters, the results on function.  
 
2.2.6.2 Demographic characteristics 
In the general population, increasing age results in a reduction of the physical 
functioning and this reduction accelerates in older age groups,21,94,352 though some 
recovery in function may happen the extent of which depends on the individual.21 
Women have a consistently greater decline in function with age than men21,94 and are 
less likely to recover from a disability.21 Reduced education94,352 and non-marriage352 
are also related to reduced physical function in older people.  
Age can be a negative prognostic factor for functional walking in SCI.  However, people 
classified as having a C lesion on the ASIA classification system7 and who are younger 
than 50 years old can achieve up to 90% of functional walking recovery.397 Ageing with 
SCI leads to the need for more help with ADL activities, particularly in females.266 In 
addition, older age at the time of injury negatively affects function in SCI as functional 
decline starts earlier than those injured at a younger age.446 Finally, increased duration 
of injury is linked to worse physical function in SCI.446  
 
2.2.6.3 Psychological difficulties 
In the elderly, increased anxiety is found to relate to a reduction in functional 
status119,428 and depressive symptoms are predictive of physical performance 
                                                     
7
 A C lesion is an incomplete sensory and motor lesion: Motor function is preserved below the 
neurological level, and more than half of the key muscles below the neurological level have a muscle 
grade less than 3.
9
 For more details on all lesions see Table 2.1.1. 
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decline.94,119,352 Poor self-perception of health status is also reported to relate to a 
functional decline.119,428  
 
2.2.6.4 Physical activity 
In the elderly, lack of physical activity and exercise are found to be associated with 
increased risk of reduction in functional status94,428 and continued physical activity 
promotes physical function.386 The benefits of physical activity and exercise are known 
in the literature for the general population but also apply to people with disabilities.400  
 
2.2.6.5 Experience of pain 
In the general population, pain and, in particular, MSKP results in functional and 
psychological impairment.496,498 In the elderly population, those who report pain, 
including arthritis, joint pain and stiffness, also have reduced physical function.94  
People with SCI and pain are found to have worse functional health status (measured 
with the Sickness Impact Profile Scale) and, in particular, the psychological dimension 
of the scale scored as worse.362 In SCI people rate pain among the three top reasons 
for a reduction in their physical function.446 Women with SCI attribute their functional 
deterioration to their MSKP (which they consider as a secondary complication to 
wheelchair use and ageing) and their upper limb joint pain.353 Finally, people with pain 
and SCI require more assistance in achieving functional activities like dressing, bathing 
and shopping.446  
 
2.2.6.6 Other factors affecting function 
In the elderly, environmental problems like safety, lack of accessibility and problems 
with the neighbourhood including traffic, or inadequate lighting are related with a 
decline in physical functioning.17,94,119 The reasons why function under these 
conditions can be reduced are self-evident as people would tend to be restricted 
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within their own homes due to the above mentioned problems. These problems could 
be faced by people with a disability like SCI, who are among a more vulnerable 
category of the population and problems like lack of accessibility or increased 
criminality could result in them reducing or not taking part in functional activities 
outside the home. Different countries may have different problems or the same 
problems at different levels, for example, in one country criminality may be a severe 
problem and in another lack of accessibility outside the home could be the main 
problem but in both cases the result would be the same for a person with SCI; 
restricting functional “freedom”. Emotional support from a social network is found to 
predict better physical performance400 and access to social networks for people with 
SCI can vary from country to country.     
Among other problems relating to increased risk of a functional decline, there are also 
heavy alcohol consumption428 and smoking,428 while good nutrition status helps in 
promoting physical function.386 Some medical complications following SCI, including 
skin and GI track problems can negatively influence function.266 Finally, fatigue and 
weakness are among the three top problems leading to a reduced function in SCI446 
and women report increased fatigue and reduced energy levels more than men.353  
 
2.2.7 Cross-national research and function 
One large international study conducted in six countries, including the UK, examined 
function in people with SCI in order to evaluate the reliability and validity of a new 
version of a function scale (SCIM III) in a cross-cultural setting.64,171 Another cross-
national study conducted in Sweden and Greece, among others, looked at the function 
of people with traumatic SCI and found that people with a complete motor injury from 
Greece had inferior functional outcomes but no differences were noted for people 
with motor incomplete injuries.122 No other cross-national studies in SCI to examine 
function were identified in the literature. As mentioned earlier, in Section 2.2.4, 
function measurement is often included in the tools used to measure QoL. But even 
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those studies which examine QoL, which would include some functional assessment in 
cross-national designs, are minimal. 
 
2.2.8 Summary of function 
In summary, function is the first aspect of the life of a person with SCI to be directly 
affected by the injury. The reduction in function depends on a number of factors that 
include both physical and psychological but also social ones like lack of accessibility. 
The experience of pain is one of these factors to negatively affect function and 
reduced function is related to reduced QoL. Thus, it becomes very clear why these 
three areas of the lives of people with SCI benefit from being studied together to 
identify relations between them. The number of studies on QoL in SCI is increasing, but 
there remains a lack of information on the impact of certain types of pain on function 
and, in particular, in cross-national studies or in iSCI.  
 
2.2.9 Conclusion 
This chapter discussed the importance of cross-national research and described the 
condition to be studied and the profile characteristics of people living with it. Studying 
the experience of pain is the aim of this thesis, thus it was essential to describe the 
philosophy and the theory behind it with a précis of what is known so far and how 
theories have developed through the centuries. A noticeable gap following a first look 
at the literature was that certain types of pain (i.e. LBP and to an extent MSKP) are not 
as often studied in SCI as other types of pain (i.e. neuropathic) and a more systematic 
examination of the literature will be needed to identify the information available. In 
contrast, LBP is extensively studied in the general population. The next chapter is 
devoted to systematically reviewing the literature in order to investigate how great 
this gap is.  
The second part of this chapter explored two other areas of importance for the lives of 
people with SCI, function and QoL. The conclusion is that there is an increasing interest 
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by health professionals in studying QoL in SCI, but studies do not necessarily examine 
those three areas (pain, QoL and function) to establish relationships between them 
while using the same sample.     
Two issues that rose while studying the literature which may affect the results in SCI 
are as follows: first, there is a tendency for studies to pool together data from people 
with complete and incomplete injuries (who may differ functionally) and often no 
comparison between them is made. Second, though there are plenty of studies that 
carry out cross-cultural comparisons within a single nation (e.g. the USA), there are 
few studies, in general, that follow cross-national designs.  
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3.1 Introduction 
In Chapter 2 it was explained that most of the papers discussing pain in SCI refer to 
neuropathic pain or when discussing MSKP they mainly focus on pain in the upper 
extremities of pain classification. In order to identify the reported prevalence of 
chronic LBP in SCI, the need to conduct a systematic search of the literature became 
apparent. Back pain has been included in the systematic search because often authors 
used the term “back” to refer to the lower back. MSKP was included in the search as 
long as it fitted the criteria of the study which will be explained later in the chapter.  
Via a systematic review, the information available on a certain topic is identified, 
evaluated and interpreted by collecting primary studies in a secondary study.243 In a 
systematic review, a pre-determined plan is used to collect information which includes 
a pre-plan protocol.232 This protocol must include, for example, the study questions, 
inclusion criteria, search engines and data extraction.232  
The systematic literature search which is presented in this chapter was initially 
conducted at an earlier stage of the thesis (in 2008) and has recently (2011) been 
updated to include up-to-date publications. This chapter will present the final search 
(2011) in the format as submitted for publication in a peer-reviewed journal.  
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 This part of the chapter has been submitted, and it is currently under revision, for 
publication as follows:  
 Michailidou C, Marston L, DeSouza LH, Sutherland I.  A systematic review of the 
prevalence of musculoskeletal pain and back and low back pain in people with Spinal 
Cord Injury.    
3.2 Abstract 
Study design: A systematic literature review between 1990 and 2011 in English 
speaking journal.   
Objective: To review and summarise the prevalence of chronic back pain (CBP), 
chronic low back pain (CLBP) and chronic musculoskeletal pain (CMSKP) in people with 
spinal cord injury (SCI) and evaluate how pain is assessed. 
Setting: Twelve databases were searched including CINAHL, Cochrane, Embase, 
Pubmed, and Science direct.  
Method: One investigator reviewed the literature. Analysis was conducted using SPSS 
and Stata. Data were analysed using descriptive statistics and 95% Confidence Interval 
(CI). 
Results: Eight studies fulfilled the inclusion criteria. Four reported on CMSKP, four on 
CBP and only two on CLBP.  
Among people with SCI and pain the prevalence of CMSKP was 49% (95% CI 44%, 55%), 
CBP was 47% (95% CI 43%, 50%) and CLBP from two studies was 49% (95% CI 44%, 
55%). There were variations in both the pain classification systems used and the data 
collected. The type of pain reported in the back and low back areas could not be 
established due to insufficient evidence. 
Conclusion: The main finding is that the prevalence of CMSKP, and more particularly 
CBP and CLBP are not sufficiently reported in SCI literature. 
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3.3 Introduction 
Medical advances over the last century have helped to keep people who sustain a 
Spinal Cord Injury (SCI) alive and life expectancy after injury now ranges from 33 to 44 
years.95 One of the most common and extensively studied consequence of SCI is pain. 
Pain is found to interfere with everyday life causing distress, stress, anxiety,90,381,422 it 
negatively affects mood,240,406,489 it interfers with sleep,90,381 activities,34,427 and quality 
of life (QoL).230,331 Dijkers et al115 conducted a systematic review on the prevalence of 
chronic pain after traumatic SCI and found a range from 26% to 96%.  
The wide range of the prevalence of pain has often been attributed to the great variety 
of pain classifications used,43,44,404 which can result in placing the same type of pain in a 
different category (one such example is given in Bryce & Ragnarsson, 200144). This 
makes communication among researcher and clinicians difficult and comparison 
between studies impossible.44 Often studies discussing pain management do not 
specify the type of pain treated, something Teasell et al440 pointed out, highlighting the 
need for studies to examine the management of pain subtypes.     
We agree with recent recommendations proposed by the International SCI Basic Data 
Set (ISCPDS:B)483 that the location of pain needs to be assessed alongside the 
classification of pain. There has been a tendency for studies to discuss neuropathic 
pain or describe all types of pain together, and not report on pain location. When pain 
locations are reported they often refer to the shoulder or an upper limbs.7,92,196,322 
Chronic back pain (CBP) and, in particular, chronic low back pain (CLBP) are extensively 
studied in the general population and guidelines for treatment or 
prevention5,54,325,394,461 have been published. In SCI a 60% prevalence of back pain90 
and a 30% prevalence of low back pain (LBP)371 have been reported. People with SCI 
may expect to experience musculoskeletal pain (MSKP)221 and its prevalence is around 
60%.406  
The importance of combining location and type of pain can be significant for the 
treatment of pain. Heat for pain relief in SCI has been proposed,56 but guidelines for 
non-specific LBP tend to report that heat is not an effective treatment for LBP and do 
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not recommend it.5 Thus, though heat may be considered as a pain relief for MSKP in 
SCI56 it may be inappropriate when the pain is located at the lower back. 
This study aims to systematically review and analyse the reported prevalence of CBP, 
CLBP and chronic MSKP (CMSKP) in people with SCI. It will also examine the types of 
pain reported in the back and lower back and how assessment is made. Unlike the 
review by Dijkers at al,115 this review will examine studies that include people with any 
cause of spinal injury but will focus on specific pain locations (back pain (BP), and LBP) 
and pain type (MSKP). The research questions are:  
For individuals with SCI: 
1) What is the prevalence of CMSKP? 
2) What is the prevalence of CBP and CLBP? 
3) Is the reported CBP or CLBP neuropathic, nociceptive or both? 
4) How are CMSKP, CBP and CLBP assessed?  
 
3.4 Methods 
3.4.1 Search strategy  
A systematic search of the literature was carried out using the databases of the Centre 
for Reviews & Dissemination, CINAHL, the Cochrane Library, Embase (which includes 
Medline Ovid), Ingenta, metaRegister of Current Controlled Trials, OpenSINGLE, Pedro, 
PubMed, Science Direct, Scopus and Sport Discus.  
Combinations of the following keywords were used:  
 SCI, paraplegia, tetraplegia, and quadriplegia, CMKP, MSKP, CBP, BP, CLBP, LBP, 
back, low back, chronic lumbar pain, lumbar pain, pain site, site of pain, area of 
pain, and secondary conditions, prevalence, epidemiology, percentage, 
assessment, and measurement.   
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3.4.2 Inclusion Criteria 
Articles were included if published in English between 1990 and 2010. An automatic 
alert was set up with the search engines to inform us of new, related publications. No 
such alert was sent out for papers published in 2011. The articles should discuss 
CMSKP in general in SCI and, if focusing on specific areas of pain, to refer to back 
and/or lower back pain. The study design was not a limiting factor for inclusion. The 
abstracts of all articles found to match the keywords were read (first stage of search) 
and, if relevant, the full paper was checked for eligibility to enter the review (second 
stage of search).  
 
3.4.3 Criteria for allocation to research questions 
To answer the first research question the studies should discuss CMSKP (≥3months 
duration). This could be one of three ways: 1) clear statement of pain chronicity, 2) use 
of a pain classification, 3) use of chronic pain measurement. If this was not clear then 
contact with the author was made and clarification was sought. 
To answer the second and third research questions the studies should discuss CBP or 
CLBP (≥3 months duration). Finally, the selected papers should offer enough 
information to answer the fourth question about pain assessment.  Table 1 in 
Appendix 1 describes these criteria.         
 
3.4.4 Identification of studies 
Initially 1729 papers matched the first stage of the search. Sixty-five keyword 
combinations were used but ultimately only 18 publications fulfilled the inclusion 
criteria to enter the review (Figure 3.1). Some of these papers were multiple 
publications or follow-up articles of the same study. In these cases we used the most 
complete report with the longest follow-up and referenced each “group study” under 
one publication; i.e. the five publications (Widerström-Noga et al.,1999;489 
Widerström-Noga et al., 2001;488 Widerström-Noga, 2003;484 Widerström-Noga and 
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Turk, 2003;487 Cruz-Almeida et al., 200590) are treated as one study and referenced 
under the latest reference 90 (Cruz-Almeida et al., 200590). Another six publications 
(Jensen et al., 2005;228 Hanley et al., 2006;190  Raichle et al., 2007;370 Molton et al., 
2008;318 Ullrich et al., 2008457; Turner et al., 2001451) are also grouped together and 
referenced under the latest reference 457 (Ullrich et al., 2008457). The 18 publications 
were part of eight different studies and their characteristics are described in Appendix 
1: Table 2.    
One study, by Loubser and Atkman273 fitted the inclusion criteria, but was excluded as 
it can be argued that their sample was highly selective thus increasing the possibility of 
bias (people scheduled for intrathecal baclofen pump infusion for chronic pain for 
spasticity secondary to SCI).   
 
3.4.5 Data extraction and analysis 
A single investigator (CM) performed the literature search. Data extracted from the 
papers or given by authors was entered into the statistical package SPSS version 15.  
I² was used to assess heterogeneity using Stata version 11.204,418 We found that there 
was considerable heterogeneity in all prevalences considered; therefore, it was not 
possible to do meta-analyses. However, we calculated the mean prevalence and 95% 
confidence interval (CI) for the total number of participants by creating a “total-
sample” for each pain outcome, similar to the method of Dijkers et al.115  Doing so 
gives more weight to larger studies because there are more people contributing to the 
total than from smaller studies.205 We used the total sample percentages to describe 
the demographic profiles and injury characteristics of the participating subjects.  
 
3.4.6 Quality assessment  
The quality of the study was not an exclusion criterion; however, a study quality check 
was carried out. The Effective Public Health Practice Project (EPHPP) quality 
assessment tool131 was used but only for those aspects that were of interest; 1) 
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selection bias, 2) study design and 3) data collection method. In addition, we were 
interested in other aspects of the studies such as definitions and duration of pain, 
classifying pain according to types and dividing pain into location. 
 
Figure 3.1: Identification of selected publications.    
 
3.5 Results 
3.5.1 General characteristics of studies  
The studies were mainly surveys, either postal questionnaires or interviews, in many 
cases following a longitudinal methodology.90,189,381,382,406,457 Many publications had a 
return rate above 70%19,90,381,406,487 but others were below 50%.228,318,370,457,489 
Recruitment and random selection techniques were reported by some58,381,382,451 but 
not usually explained. Only one study228 compared the findings of their SCI sample to 
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national norms. According to EPHPP (selection bias),131 the recruitment methods were 
“somewhat likely” or “very likely” to identify people representative of the target 
population.         
There were no reports in these identified studies on the sample calculation or the 
profile characteristics of the people lost to follow-up. Only one study reported on 
missing data90 and another on non-respondents.489 Many studies lacked clear 
definition of pain chronicity and we had to either contact the authors or assume 
chronicity based on the assessment tools used. All studies reported on the main 
outcome measures and the statistical methods used. The tools used to collect data 
were in general both valid and reliable. The majority of the studies were well rated on 
the EPHPP, though the designs were rated as “moderate” or “weak”. While a survey 
design is considered as a weak design by the EPHPP, it is commoncly used for exploring 
questions of prevalence. 
 
3.5.2 Research question 1; What is the prevalence of CMSKP? 
Four studies19,58,381,406 discussed CMSKP. Table 3 in Appendix 1 presents the 
demographic profiles and injury characteristics of the participants for each individual 
study and for the “total-sample” created. Of the 453 participants19,58,381,406 76% (95% 
CI 72%, 80%) reported chronic pain and 38% (95% CI 33%, 42%) (172/453) reported 
CMSKP. Thus, among people with pain the prevalence of CMSKP increases to 49% (95% 
CI 44%, 55%) (172/344).  
There was not enough data to check for differences in CMSKP based on the 
completeness of injury. Two of the four studies conducted physical examinations,19,381 
one used interviews to identify pain characteristics406 and one58 used a postal survey. 
 
3.5.3 Research question 2; What is the prevalence of  CBP and CLBP? 
Under the study group referenced as Ullrich et al457 the main participants’ profile 
characteristics came from Turner et al451 but information about the areas of pain 
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mainly came from Ullrich et al.457 In the studies discussing CBP or CLBP90,371,380,381,457 
1312 people participated but information was not always available for all (Appendix 1: 
Table 3).  
3.5.3.1 Prevalence of CBP   
There was a total of 1045 participants and 79% of them reported pain in general (95% 
CI 77%, 82%). Overall, 388 people reported CBP, which is 37% (95% CI 34%, 40%) of the 
total sample and 47% (95% CI 43%, 50%) of people with pain only.   
3.5.3.2 Prevalence of CLBP      
In the group study referenced under Ullrich et al,457 LBP was discussed in two papers; 
Molton et al318 and Ullrich et al.457 Raissi et al371 also discussed LBP (Appendix 1: Table 
4). Of the 382 people with SCI (in the studies by Ullrich et al457) and Raissi et al,371 290 
reported pain and 143 reported LBP. Thus, 37% (95% CI 33%, 42%) of people with SCI 
have CLBP which increases to 49% (95% CI 44%, 55%) among people with pain only.  
The information available about the percentage of people reporting CLBP per level of 
injury could not be evaluated due to differences in data presentation in the studies. 
Ullrich et al457 reported the highest LBP presence in people with high cervical injuries 
(69%), followed by people with paraplegia (64%) and last, low cervical injuries (51%). 
Among the studies examining CBP and CLBP two included physical examinations,371,381 
one interviews380 and in the others postal surveys.90,457 
 
3.5.4 Research question 3; Is reported CBP or CLBP neuropathic, nociceptive or both? 
To answer this question the classification systems and verbal descriptors used in the 
studies90,380,381,457 (Appendix 1: Table 5) were examined. 
In the grouped studies referenced as Cruz-Almeida et al,90 64%488 of their sample 
described pain in the back area as “aching”, a term mainly used to describe MSKP, and 
61% reported “burning pain in the back”. “Aching” was found to be more common in 
people who marked the back (p≤0.01), or neck and shoulder (p≤0.001) on a pain 
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drawing. However, the authors confirmed that no distinction between pain types was 
made (i.e. neuropathic, MSKP) therefore conclusions about origin cannot be drawn. No 
information was given about LBP.   
Rintala et al381 used the Donovan pain classification system dividing pain into five 
categories and also dividing the body into five areas including the back, trunk and 
lower body. However, information about the type of pain in these areas was not 
provided.  Rintala et al380 and Raissi et al371 did not classify pain by type, therefore 
identifying the origin of pain was not possible. Rintala et al380 reported pain locations 
(which they categorised as above-, at-, below-level of injury) but they could not 
determine if pain was neuropathic or nociceptive.    
Ullrich et al457 discussed the finding that among people with BP, 67%451 said that pain 
was worse with activity and 72% reported worse pain according to position. This may 
indicate mechanical factors contribute to the appearance of BP in this population.451 
Raissi et al371 also found that BP was worse with activity and position and said that 
factors related to stability of the spine may cause or contribute to BP in SCI.   
In summary, of the five studies reporting on CBP and CLBP,90,371,380,381,457 only one used 
a specific classification system to describe the type of pain and this only discussed 
CBP.381 Therefore, we did not have enough data to answer the third research question.   
 
3.5.5 Research question 4; How are CMSKP, CBP and CLBP assessed? 
All the studies discussing CMSKP19,58,380,406 used a pain classification system (Appendix 
1: Table 5). Cruz-Almeida et al90 proposed a classification system in which MSKP was 
defined as mechanical spine pain (pain in the back or neck affected by activity and 
position) and overuse pain. Rintala et al381 used the Donovan classification and MSKP 
was defined as pain secondary to stimulation or irritation of nociceptors within bone, 
muscles, and soft tissues. Siddall et al406 used a classification system, which they had 
developed previously, that defined MSKP as “pain that was dull, aching, worse with 
movement or exercise, and that appeared to be arising from musculoskeletal 
structures”.  
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Intensity of MSKP was assessed by a Visual Analogue Scale (VAS)19,406 or a Numeric 
Rating Scale (NRS).19,381,406 Severity was assessed by the Verbal Rating Scale (VRS)10,406 
and location was assessed by a body diagram90,381 and a pain location checklist457 
(Appendix 1: Table 6).  
In the studies discussing LBP, the type of LBP could not be determined by the 
assessment conducted. To assess LBP severity, a list of adjective descriptors,90 the 
VAS58 and the NRS371 were used. Finally, the NRS was used457 to assess BP intensity 
(Appendix 1: Table 6).  
 
3.5.6 Other related information of interest 
Mean severity of MSKP was found to be 54 (SD 22) on a 0-100 NRS scale406 and mean 
maximal intensity 3.5 on a 0-5 NRS.381 No statistically significant difference in MSKP in 
people with complete and incomplete injury was found.406  Turner et al451 reported a 
trend towards more people with a C5-8 and T6-12 injury having BP and Ullrich et al457 
found slightly more people with high cervical injuries reporting LBP. BP was the second 
most common (58%) area of pain (after shoulder pain)228 and the most common area 
for persistent, bothersome pain (61%).451 As duration of pain increased, BP was found 
to be more common (p=0.036).380  Pain intensity (using NRS 0-10) for the back was 4.7 
(for C1-C4 injuries), 5.1 (for C5-T1 injuries) and 5.9 (for paraplegia).457  
 
3.6 Discussion  
The main finding of this review is that the presence of CMSKP and especially CBP and 
CLBP, have not been sufficiently investigated in the reported SCI literature. This review 
found that nearly half of the people with SCI who have pain report CMSKP, CBP and 
CLBP. This is slightly higher than that found in other populations like multiple sclerosis 
and stroke where MSKP is found to be around 31%.176,187,246  Since the lower back is an 
area included within the whole back area, it would have been expected that the 
prevalence of LBP found in the current review would be similar to or smaller than the 
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percentage of the total BP, which was not the case. This is due to the fact that the 
reviewed studies used different ways to collect data, often not differentiating between 
BP and LBP. 
The studies examined lacked homogeneity thus meta-analysis could not be conducted, 
The first difference between the studies was the definition of chronic pain, which 
varied from ≥ 3 to ≥ 6 months90,380,381 to not being reported at all and there was a need 
to seek clarification from the authors90 or to assume that pain was chronic because of 
the use of the Chronic Pain Grade Questionnaire (CPGQ).19,58,406,457 Lack of definition of 
pain chronicity resulted in the exclusion of six studies230,240,293,435,446 originally 
identified. Had definitions been clear, we may have identified additional information 
for the research questions. Some studies pooled together data on acute and chronic 
pain. Five studies that came under this category were excluded.124,158,407,466,469 Clear 
definitions of pain chronicity should be given.115 None of the studies we excluded for 
lack of pain definition or data pooling was published after the paper by Dijkers et al.115 
Since their study was recently published (2009) it may be that if a new systematic 
review will be conducted in a few years it may be able to identify further new studies 
that will have defined chronic pain including CBP and CLBP 
Another problem encountered was the pain classification systems used. Although 
accepted systems and other pain measures were used, the variety contributed to the 
lack of homogeneity. The different classification measures have been suspected of 
contributing to the wide variability in the reported prevalence of pain in the 
literature.22 Even though pain classification systems and often pain locations were 
reported, the type of pain in the back and low back could not be clearly established. 
While pain classification systems may seem accurate in categorising pain, they may not 
be accurate in assessing the type of pain at specific locations, at least where the lower 
back is concerned, particularly when physical examination is not conducted. Some 
studies described pain in the back to be most likely of musculoskeletal origin but did 
not report particularly on LBP.381,451 
The type and the level of the injury have been reported to relate to MSKP. Siddall et 
al406,407 found that despite differences not being statistically significant, people with 
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incomplete injuries report MSKP more often. MSKP is felt in areas that have preserved 
sensation,405,483 thus in complete injuries it is felt above the level of injury, and in 
incomplete injuries it can be felt above or  below the level of injury.56 This means that 
for LBP to be considered of MSKP origin the injury should be either incomplete or, if it 
is complete, it should be paraplegia below the lower back level. The studies included in 
this review did not provide sufficient information about the level or the completeness 
of the lesion, or location of pain to allow calculations to be done for the “total-sample” 
or to draw adequate conclusions about the type of pain. Ullrich et al457 reported a 
similar percentage of LBP for people with different levels of injury but did not clarify 
the type of pain. Cardenas et al58 proposed a classification system in which MSKP was 
divided to include mechanical spinal pain (pain in the back or neck affected by activity 
and position) and overuse pain. This is an effort to put musculoskeletal back pain into 
one classification category, however, it still lacks separation of upper and lower back. 
Studies need to report more detail on the injury characteristics of their participants in 
order for the readers to be able to form a clearer idea of the type of pain at certain 
locations.   
Lack of understanding of the type of pain in the lower back may have consequences for 
the treatment prescribed. Current published pain treatment in SCI is based on the 
broader pain categorisation and mainly dealt with using medication. Recently, authors 
have pointed to a need to improve pain treatment in SCI and that this should include 
other modes of therapy like strengthening exercises, massage or heat.56 But heat is not 
appropriate for use when the area is not innervated56 and a LBP strengthening 
programme may have to be adapted to take account of the non-innervated muscle 
groups. Recommendations for the treatment of MSKP in SCI have been reported405 and 
guidelines for the treatment of LBP in the general population exist.5,325,394 The lack of 
knowledge of the type of pain in the lower back may lead to non-effective treatment 
or maltreating the area. However, it should be mentioned that this review did not 
systematically examine the literature for studies offering treatment for CMSKP, CBP or 
CLBP in SCI. The collected data cannot conclude that these categories of pain are 
treated appropriately, or not, in clinical settings. The lack of reporting the type or 
presence of pain in the lower back may be an indication of a gap between what may 
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happen in a clinical setting and what is published. The best clinical decisions are taken 
from evidence-based information which is formed by the critical appraisal of the 
evidence.390 Thus, if there is lack of such evidence treatment may be affected. 
Despite BP being the second most common228 or the most common451 pain in SCI 
which increases, along with MSKP, at five years’ post injury,406,407 it has not received 
sufficient attention in the literature. On the basis of our results the prevalence of LBP is 
also infrequently studied. 
Another point worth bringing to attention is that the profiles of the participants vary in 
some studies; some only reported on males381 or people with pain only58,273 or special 
groups.273 Rintala et al380 recruited the second largest sample which consisted of 
veterans. They reported the highest (together with one other study406) prevalence of 
chronic pain (81%) but did not report on MSKP. Veterans are often affected by Gulf 
War Syndrome (GWS) or Post-Traumatic Stress Disorder (PTSD) and can be found to 
report pain as a consequence.18,480 Though most studies recruited people from the 
community, there was still variability in the participant profiles making generalisability 
more difficult. 
Three studies19,371,381 included physical examinations and the others relied on self-
reported information about pain. Physical and/or radiographic examination help 
understand pain better. If these are not done then researchers should use other tools 
(e.g. body chart and classification systems) that are able to capture all types and 
locations of pain and discuss the combined information collected by such tools. Using 
the ISCIPDS:B483 in new studies will help address such issues.  
The purpose of the papers reviewed was to study the specific population of SCI so no 
comparisons with the general population were made. Only Jensen et al228 compared 
SCI to national norms and found that people with SCI have significantly more severe 
pain which is an important finding.  A future study that compares people with SCI to 
healthy individuals who may maintain prolonged positions with fixed or altered 
postures, and focuses on BP and LBP characteristics, would add to the body of current 
knowledge.  
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Recently, research interest about the impact of pain on social functioning and the 
psychology of the person with SCI has increased. This has already been discussed in 
LBP in the general population.63,152,281,468 The benefit of the “insider” description of the 
experience of pain by using in-depth interviews has been pointed out.99 It is essential 
to include the patients’ knowledge and pain experience in their clinical management, 
as it can change with progression of their symptoms.151 It is possible that the 
combination of in-depth interviews with the ISCIPDS:B may assist further in identifying 
the most suitable treatment approach using traditional techniques as well as emerging 
biopsychological interventions to reduce pain.  
In conclusion, studies in the future should include investigation of the presence and 
aetiology of BP and LBP in SCI and long-term follow-ups would be useful. Enhanced 
pain assessment will improve pain management. The different mechanisms of pain can 
influence the response to treatment,487 thus it is important to know the mechanism. In 
addition, preventative approaches may not be implemented if health professionals are 
not aware of the likelihood of a person developing BP or LBP. For example, designing 
or improving appropriate devices and seating systems151 and educating patients and 
health professionals on pain prevention and management.  
One limitation of the review is that only publications in English were included. To our 
knowledge this is the first systematic review of CMSKP and, in particular, pain in the 
back and low back areas in SCI. In order to gain further evidence more studies are 
needed which will use standardised measures to examine the presence, intensity and 
origin of pain in the back and lower back and possibly compare SCI with other patient 
groups.
               Chapter 4: Translation into Greek; methodology and methods 
 
78 
78 
Chapter 4; Translation of the questionnaire 
 
 
 
 
 
 
 
 
 
 
 
 
 
How would one correctly translate the phrase:  
“It’s all Greek to me”  
in Greek to be used by Greeks who anyway master the Greek language and nothing “Is 
Greek to them”? 
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4.1 Introduction 
During the past few decades interest in cross-national and cross-cultural studies has 
increased and the availability and expansion of online surveys makes them easier and 
more approachable to conduct. As a result, the need for correct translations becomes 
crucial.  
In order to conduct cross-cultural studies the measurements that will be adopted have 
to be equivalent in both cultures.181 In this chapter, the theory of the translation 
procedure will be reviewed in brief and recommended guidelines will be discussed. 
The procedure followed to translate the two parts of the survey from English into 
Greek will be explained thoroughly.  
 
 4.2 Theory of translation 
Translation is defined as “written or spoken rendering of the meaning of a word or text 
in another language”.217 
Brislin et al40 argue that questionnaire wording and translation go “hand in hand”, 
therefore one of the requirements of a good translation is to have a well-written 
original document. The SCIM III, which was translated for the purpose of this study, 
has been standardised in English and its validity and reliability are therefore 
established. The English version of the socio-demographic questionnaire8 was first 
pilot tested and then translated into Greek.  
 
4.2.1 Types of document translation 
 In starting to explain the procedure of a translation, it may be helpful initially to 
discuss the features of a document to be translated as well as the characteristics of a 
translator.  
                                                     
8
 The English version of the full questionnaire can be found at Appendix 2.  
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Reiss377 categorised text that has to be translated into four different types: 
1.  Content-focused text; relates to “what” the author says. It must provide 
effective communication and accurate information. The information has to be 
explicitly given in the target language taking into account the usage of this 
language. Content-focused text is judged for its grammatical, stylistic and 
semantic characteristics.377 
2.  Form-focused text; is about the aesthetic and artistic nature of the form and is 
judged for its aesthetic, grammatical, stylistic and semantic characteristics. The 
translator does not adopt the forms of the source language but tries to identify 
analogous forms in the target language.377 
3.  Appeal-focused text; has to be presented in a particular and explicit way often 
involving non-linguistic results. The text maybe changed considerably to 
present this type of information effectively.377 
4.  Audio-medial text; can also be classified under the above types of text and the 
translated text must have the same effect as the original text on the hearer.377 
 
4.2.2 Characteristics of the translator 
Sofer415 listed a number of requisites for the translator, the most important of which 
are presented below; 
1. The translator needs to have a complete understanding of both languages 
(source and target);  
2. Must be familiar with the culture of the study undertaken;  
3. Must be up-to-date with linguistic developments and changes;  
4. An individual must translate from a language to their own native language 
because he/she will be more familiar with the native language. However, an 
exception can be made if the person has lived in more than one culture and 
speaks both languages fluently;  
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5. The translator should be effective in writing or speaking by using an easily  
understood vocabulary; 
6. A translator ought to have or develop research skills and be able to identify 
references. 
Reiss377 mentions the extra-linguistic determinants that can affect both the original 
and the translated version of a text. Among them are: 
1. The subject matter: the translator is required to be familiar with the field to a 
satisfactory level;  
2. The audience factor: the translator should understand the original author’s 
audience and make it possible for the target language audience to understand the 
text in same way, and  
3. The speaker factor; this can affect the language of the original author.  
As it will be noticed later many of the characteristics of the translator mentioned 
above, as well as the elements of the translation explained below, are closely linked 
with the methods of the translation used in the current study.  
 
4.2.3 Elements of a translation 
Prieto364 states a number of recommendations for the translation procedure including: 
1. Pay attention to using the best initial translation method (prefer bilingual) and 
use phrases common in both languages; 
2. Pay attention to the selection of the bilinguals; 
3. Criteria for the project should be established in advance of the translation; 
4. Combine pragmatic, ethnographic and linguistic principles for the translation 
rather than aesthetic-poetic; 
5. Use a proof-reader unfamiliar with the project who can identify possible 
differences;  
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6. Use criteria for quality control and compare for equivalency;  
7. Pilot test by seeking feedback on the translated questionnaire from members 
of the target population.  
 
4.3 Proposed translation methods and guidelines 
Among the first people to discuss translation procedures back in the early 1970s was 
Brislin39 who mentioned four different methods of translation: 
1. Back-translation refers to the translation when the researcher prepares the 
material in one language which is then translated by a bilingual into the target 
language. Then a second, independent translator back-translates into the 
source language and the researcher can judge the quality of the two original 
language forms;  
2. The bilingual technique where bilinguals take the same text or different groups 
take different halves of a text, in the two languages they know;  
3. The committee approach occurs when a group of bilinguals translate into the 
target language and then they discuss the mistakes and produce a single text;  
4. Pre-test procedure is done after the translation to ensure the accuracy of the 
text. 
Guillemin et al181 state that cross-cultural adaptation of a measurement relates to the 
quality of the translation. The adaptation follows two steps; the translation and then 
its adaptation which means combining the literal translation of the words and 
sentences and adapting them according to idiom, cultural context and lifestyle of the 
language translated into. They proposed translation guidelines following five steps: 1) 
forward translation, 2) back translation, 3) committee review of the translations and 
back-translations, 4) pre-testing for equivalence and 5) re-examination of the 
weighting of scores if relevant.   
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They recommend at least two independent translators to conduct the forward 
translation. The use of qualified translators is advised and they should preferably 
translate in their mother tongue.181    
Guillemin et al181 recommended having as many back-translations as forward 
translations. This step can help to identify gaps in the cultural target context and 
mistakes in the first translation. The back-translators should be translating in their 
mother language and preferably not be aware of the concept of the translation.  
The work of the committee, according to Guillemin et al,181 is to compare the original 
source and the final versions of the translation. It should consist of multidisciplinary 
members. Structured techniques to resolve inconsistencies should be used as well. The 
committee should ensure that the translation is comprehensive and should verify 
cross-cultural equivalence of source and final versions.  
Using multiple methods rather than a single method when translating is 
recommended.39,40,181 More recently, the WHO501 published a document on the 
process of translation and adaptation of measures of instruments which consists of 
four steps: 1) forward translation, 2) expert panel back-translation, 3) pre-testing and 
cognitive interviewing, and 4) final version. There are many similarities to the 
recommendations proposed by Guillemin et al181 mentioning that the forward 
translator should preferably be a health professional familiar with the terminology and 
pre-testing should be done on the target population. 
Along similar lines, the Medical Outcome Trust300 published minimal translation 
criteria using four steps of translation: 1) forward step, 2) quality control, 3) pre-test, 
4) international harmonisation. They emphasise the importance of seeking 
authorisation from the source author and gaining insight from the source author in the 
translation procedure. Also the pre-test can be done with either monolingual or 
bilingual panels.377     
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4.3.1 Equivalence 
There are some differences between the processes explained above but the major 
characteristics are similar. Checking for equivalency in translations is very important as 
it is the best way to know if any possible differences found between the subject groups 
are not due to differences in the items translated and discrepancies in the 
translations.39   
Brislin et al40 proposed five techniques by which equivalence of the translation to the 
original language may be checked:  
1. Comparisons of meaning between the original and back-translated forms; 
2. Comparisons of meaning, by bilinguals other than the translator, between the 
original and the translated form; 
3. Answering questions written about the content of the original version; the 
questions should be answered correctly by people who have read only the 
target version; 
4. Comparing performance to instructions written in the original and in the target 
language; 
5. Administering both versions of a test or questionnaire to a sample of bilinguals.  
If aiming for conceptual equivalence attention should be paid to: 1) semantic 
equivalence, which is the equivalence of the meaning of the words. Problems with it 
may mean problems with vocabulary and grammar, 2) idiomatic equivalence where 
equivalent expressions or items need to be found, 3) experiential equivalence where 
the situations of the source version should fit the cultural context in the target 
language, 4) conceptual equivalence.181 Both the WHO501 and the Medical Outcome 
Trust300 recommend a quality checking based on conceptual equivalence when 
translating health-related instruments.   
 
               Chapter 4: Translation into Greek; methodology and methods 
 
85 
85 
4.4 Methods of translation; general steps 
In the case of a standardised assessment tool, a manual or guidelines for its translation 
might exist. However, there were no specific translation guidelines or manual for the 
SCIM III measure. In this project a combination of techniques, as reported above, was 
used. The primary aim was to use effective techniques (e.g. use of bilinguals, back-
translation, a panel and professional or health-related translators) in combination with 
pragmatic factors including the resources available to the project, identification of 
collaborators and cost.  Existing literature on translated measures into the Greek 
language was reviewed looking into characteristics of the Greek population (e.g. SF-
MPQ166 and the EQ-5D505).  
General advice on the procedure was provided to all translators participating in any 
stage. Also they were advised to use the following aid tools: 1) English – Greek 
dictionary of medical terms,312 2) Greek- English dictionary of medical terms,508 3) 
Oxford English – Greek and Greek – English learners’ dictionary419,508 4) Babylon online 
Greek – English dictionary.16 
The forward translations were collected and checked by the PI9 who combined them 
into one document. If more than one word was given to describe the same word of the 
original English version but had the same meaning, then the word given by more 
translators or the one closest to the English original was chosen.  Where different 
translations occurred they were checked for errors based on: 1) if different words had 
same meaning, 2) if different words had different meanings. Also, the level of difficulty 
of translating the question was taken into account as well as the comments made by 
the translators. In cases where discrepancies could not be resolved as explained above, 
the PI met with the translators to discuss the differences as recommended in the 
literature to do in these cases.32 If there were still discrepancies in the translation and 
in order to enhance the accuracy of the translation an expert panel was used as 
recommended by WHO501 and a single complete version of the translation was finally 
produced.   
                                                     
9
 The PI (Principal Investigator) is the author of this thesis.  
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In other studies, for the back-translation either one professional translator166 or more 
than one volunteer health-related professional was used.32,505 However, the back-
translators used in the current study were not, in origin, of the targeted language 
(English), as recommended in the literature, thus an external panel to assist in the 
process was involved.   
All translators were asked to rate each question on a numeric rating scale 0-10 (0=very 
easy to translate – 10= most difficult to translate). Additionally, some information 
regarding their background was collected. Finally, all translations were pilot-tested by 
patients32,166 or lay persons.505 Further details of the translation methods are explained 
below.  
 
4.5 Methods of translation; translation of SCIM III into Greek    
The steps followed were: 
1. Gaining permission to translate the measure into Greek; 
2. Forward translation; 
3. Back-translation; 
4. Piloting of Greek version.   
 
4.5.1 Step 1; Permission to translate measure  
As suggested by the Medical Outcome Trust,300 permission for the translation of SCIM 
III into Greek was granted by Prof. A. Catz who is among the members of the team that 
developed SCIM I and produced the following versions. Prof. Catz recommended the 
translation of version III which had been published shortly before our contact. Prof. 
Catz confirmed that set guidelines for the translation of SCIM III did not exist and gave 
advice on which method to follow.   
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4.5.2 Step 2; Forward translation 
Lee et al261 found a high incidence of error while assessing their translated 
questionnaire and they said that this may have been due to the fact that they had not 
used a professional translator for the forward translation but a bilingual health-related 
scientist.   
To avoid such a problem, an independent, professional translator together with four 
volunteer health professionals, all of Greek origin, conducted a forward translation. 
Their personal characteristics and the reasons for choosing them were as following:  
A professional translator, of Greek origin, who specialised in health and medical 
related documents. This particular professional translator was chosen because of his 
specialist knowledge of medical documents.  
A surgeon urologist, of Greek origin, was chosen because of his specialist medical 
knowledge. The SCIM III contains elements related to the functioning of the person in 
the toilet, an area familiar to this translator.   
Two occupational therapists, PhD holders and university lecturers, both of Greek 
origin, were selected due to their research knowledge and their advanced skills in 
dealing with written documents.  
A physiotherapist and university lecturer with experience in neurological rehabilitation 
in clinical settings, of Greek origin, was selected because of his familiarity with the 
target population.  
All the above non-professional translators had the common characteristic of being 
exposed to the culture of both languages as they had been living and working in the UK 
for a number of years but were born and educated in Greece.  
The PI compared the similarities and differences of the translations and combined the 
five translations into one document. In cases where differences required discussion 
with the individual translator this was done on a one-to-one basis. A panel of two 
external health professionals was consulted if there were still discrepancies in the 
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forward translation. The panel consisted of two physiotherapists, of Greek origin, both 
MSc holders, living and working in the UK, one of whom was a PhD student. They were 
chosen for their professional skills and research knowledge.   
The final version in Greek was then proof-read for clarity by a separate lay person who 
was independent of the study and any necessary corrections were done. Details of the 
forward translation are presented in Figure 4.1.  
 
4.5.3 Step 3; Back-translation 
One of the benefits of using back-translation is the ability to utilise the technique of 
“decentring” which means, if necessary, making alternations to the original text in the 
source language in order to accommodate the text in the target language.39 This was 
not possible with the translation of SCIM III (because it was an already established, 
validated tool in the English language) but was an option for the translation of the 
socio-demographic part of the questionnaire. 
Guidelines recommend that translators should translate into their mother tongue but 
Sofer415 claims that an exception may be made if the person has lived in more than one 
culture and uses both languages frequently. This was the case with the two selected 
back-translators who, even though they were not of English origin, had been living in 
the UK for many years, obtained postgraduate degrees in the UK and worked in the 
country, therefore using the English language daily. One was a physiotherapist, of 
Greek origin, holder of a Master’s in Neurorehabilitation, and working in a hospital. 
This person was selected as he was found to be able to combine research knowledge 
and clinical skills and he had experience of working with people with a condition of 
neurological origin. The other was a lecturer in Biosciences, of Greek origin, holder of a 
PhD with an extensive knowledge of dealing with written texts.  To increase the quality 
of the translation both of the translators were independent of the study, not aware of 
the original English version or the purpose of the study. 
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Similar to the forward translation process, the PI checked the two translations and, in 
the cases of differences, the back-translators were consulted face-to-face. If there 
were still discrepancies, these were discussed with the external health professionals 
who were the same two people who participated in the forward translation.  
 
4.5.4 Step 4; Piloting of the Greek version 
The Greek version of SCIM III10 was piloted by five people all of Greek origin. This 
sample was a mixture of people with SCI and lay persons. They were asked to 
comment on items they found difficult, upsetting or confusing. All comments were 
reviewed by the PI and, as necessary, words were reviewed with the health 
professionals who participated in the previous steps of the process. Details of the 
back-translation and the pilot step are presented in Figure 4.2. 
 
4.5.5 The role of the developers of SCIM III 
The developers of SCIM were included in the translation process by giving advice/ 
clarification whenever needed. Collaborating with the team that developed an 
instrument is recommended by other scholars.283  
 
4.6 Methods of translation; translation of socio-demographic part   
The fourth part of the questionnaire consisted of questions collecting socio-
demographic and other information and will be described in detail in Chapter 5. Here 
the focus will be on the translation approach only.  
The steps followed in the design and translation of this part of the questionnaire were 
as follows: 
                                                     
10
 The Greek version of the full questionnaire can be found at Appendix 3.  
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1. Development of the questionnaire; 
2. Pilot of the English questionnaire; 
3. Forward translation into Greek;  
4. Back-translation into English; 
5. Pilot of the Greek questionnaire; 
6. Amendments and finalising of the questionnaire.  
The first two steps will be described in the next methodology chapter (Chapter 5). 
Similar to the SCIM III translation, the translators were asked to rate the level of 
difficulty of translating questions and were encouraged to provide comments. Figure 
4.3 describes the procedure followed for the development and translation of the socio-
demographic questionnaire. 
 
4.6.1 Step 3; Forward translation of the socio-demographic questionnaire  
Five professionals volunteered to conduct the forward translation and they were all 
different individuals to those participating in the SCIM III forward translation. One was 
an occupational therapy lecturer, of Greek origin, a PhD holder, who had lived and 
worked in the UK for many years. This person was chosen for her specialist skills in 
research and experience in dealing with written forms.  
The next translator was a physiotherapist, of Greek origin, holder of an MSc and, at 
that time, a PhD researcher. She was one of the two members of the external panel for 
the SCIM III translation and did not serve as a member of panel in this translation.  
One translator was a senior lecturer in Economics, of Greek origin, holder of a PhD, 
living and working in the UK for many years who was chosen for his extensive 
knowledge of dealing with and correcting documents.  
The next translator was a business analyst, of Greek origin, holder of a Master’s 
degree, who was chosen for his ability to look into the detail. This person was a 
               Chapter 4: Translation into Greek; methodology and methods 
 
91 
91 
proofreader in the translation of SCIM III and did not act as a proofreader in this 
translation.   
The final forward translator was holder of a BSc in business administration, of Greek 
origin, at the time completing her PhD in a UK university. This person was chosen 
because she had used cross-cultural, back-translation methodology in her research and 
was familiar with the procedure.  
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 Figure 4.1: Flow chart of forward translation into Greek of SCIM III                
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Figure 4.2: Flow chart of back-translation (into English) translation procedure of SCIM III        
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As with the procedure undertaken in SCIM III, all the above translators had the 
common characteristic of being exposed to the culture of both languages as they had 
been living and working in the UK for a number of years, and therefore used the 
language on a daily basis, but were born and educated in Greece.  
The completed translations were cross-checked by the PI and a single socio-
demographic questionnaire was formed. The decision of the final formulation of each 
question was taken based on the same general regulations that were pre-established 
and described in earlier pages. When it was necessary to discuss discrepancies with the 
forward translators this was done on an individual face-to-face basis and, if they were 
not resolved, the opinion of the external panel was sought. The external panel 
consisted of a physiotherapist, holder of a Master’s in neurorehabilitation, of Greek 
origin, and who served as member of panel in the translation of SCIM III. A single 
document in Greek was produced out of the five forward translations (Figure 4.3).  
 
4.6.2 Step 4; Back-translation of the socio-demographic questionnaire 
A professional translator was not used in the forward translation of the socio-
demographic questionnaire, but was used in its back-translation. She was an English 
teacher and translator, of Greek origin, who had been working as an English examiner, 
in the UK, for many years.  
One single back-translation (into English) was made which was then double checked by 
the PI for errors. When necessary a discussion between the back-translator and the PI 
took place. Because there was only one back-translation an external panel of 
monolinguals of English origin was consulted. This panel consisted of four members: a 
research nurse, an occupational therapist and two clinical psychologists, all of whom 
had been working for the NHS in funded research projects. They contributed to the use 
of the decentering technique11, assisted with any grammatical errors and decided on 
                                                     
11
 The “decentering” technique means  making alternations to the original text in the source language in 
order to accommodate the text in the target language, as necessary.
38
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“disputes” on word choices between the translators.   Figure 4.4 describes the back-
translation process.  
 
4.6.3 Step 5; Piloting of the Greek version 
A group of five people piloted the Greek version of the questionnaire. They were all of 
Greek origin and were asked to comment on items they found difficult, upsetting or 
confusing. All comments were reviewed by the PI and discussions were held with 
individual health professionals who participated in the previous steps of the process.  
 
4.7 Conclusion 
This chapter has presented and justified the method followed to translate the two 
parts of the survey that were not available in the Greek language, 1) SCIM III and 2) 
socio-demographic related questions. Details of the proposed methodology for 
translations were described by looking into the existing literature and proposed 
guidelines. Two separate translation procedures took place and a methodological, 
step-by-step, procedure was carried out which included a mixture of techniques. Using 
the approach of mixing methods enabled choosing techniques that were found to be 
more appropriate for this study taking into account the resources available combined 
with sound methodology.     
The next chapter will look into the methods employed to conduct the survey, will 
explain step-by-step the procedure followed and examine the related methodology.  
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       Figure 4.3: Preparation and forward translation of the socio-demographic part of the questionnaire 
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Figure 4.4: Back-translation of socio-demographic part of questionnai
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12“Every art and every science 
reduced to a teachable form, 
and in like manner every 
action and moral choice, aims, 
it is thought, at some good” 
Aristotle (384 BC – 322 BC) – 
Greek philosopher14 
                                                     
12
 Picture taken from http://asymptotia.com: The Antikythera Mechanism is believed to be the first 
ancient mechanical computer. It was used in astronomy. It may be linked to Archimede’s concepts. The 
mechanism was found in 1900 in the Antikythera shipwreck in Greece.  
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5.1 Introduction 
The need for health studies to become more cost-effective, more efficient and 
maintain the scientific evidence is well documented. To achieve these goals, the design 
and the methods of any study need to be well prepared, well structured and evidence 
based.  
The previous chapter described the methodology and the methods employed to 
conduct the necessary translations that were performed as part of the survey for this 
project. This chapter will describe the methods followed to conduct the survey while 
referring to the theory of survey methodology.  
The study was conducted in three countries and the survey was primarily completed 
electronically (web survey) but also via the post (mail survey). An extensive 
presentation of the web survey, its benefits and the difficulties of conducting it will be 
made. The description and justification for both the web and the mail survey will be 
done in parallel with presenting the web survey process described by Fan & Yan.143 The 
chosen method aimed to increase response rates and to reach the targeted sample 
size together with minimising, where possible, the sources of error. Finally, a 
methodology of the data analysis will be provided.  
 
5.2 Research design; General 
In order to make a research idea an actual plan, an understanding of research is 
required as various designs can be used to answer the same research questions, with 
various benefits. Therefore the best design is the one that is scientifically valid but also 
reconciles the goals and the resources available to this study.347,357 
This project is a quantitative, correlational research study using descriptive and 
analytic survey methodology based on a cross-sectional, cross-national retrospective 
design collecting data using mixed mode research techniques of self-completed 
questionnaires primarily collected online (web survey) or of paper format (mail 
survey). The survey methodology has been widely used in epidemiological studies and 
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other studies aiming to identify prevalence on variables of interest within specific 
groups of people. It has been used extensively to study all types of health issues 
including SCI. Furthermore, the survey is the method most commonly used in cross-
national research. Thus, selection of this type of method is in line with the general 
research methodology followed in the field. It also fulfils the aim of the current study. 
In the sections that follow this type of research is explained in detail and the reasons 
for its selection will be understood in more depth.  
 
5.3 Research design; Survey design 
A survey is a research approach used to collect information from a large number of 
people by using a questionnaire or an interview.203 It has the “ability to estimate, with 
precision, the distribution of a characteristic in a defined population” but can be 
subject to sources of error including coverage, sampling, measurement and non-
response.117 Survey errors will be discussed later in this chapter.   
A survey is descriptive or analytic where the descriptive answers the question “how 
many?” and the analytic the question “why?” A descriptive study looks at certain 
characteristics of the people studied, can test hypotheses and generate associations 
but cannot give evidence related to the cause. An analytic study uses inferential 
statistics to explore associations and test hypotheses, it is less orientated towards 
representativeness and more towards giving explanations and predictions.36,285,342,347 
The current survey will describe the participating group and will explore associations 
and hypotheses.  
A correlation analysis observes the characteristics of the sample but makes no 
inference from them and147 when the data is collected at one point in time, then this is 
a cross-sectional study.36 
In a retrospective design, the events of interest happened before the onset of the 
study347 but questions related to the current time can be included.36 This type of 
design is commonly used in surveys.  
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Over the last few years technology and, particularly, the internet are increasingly used 
for professional and/or personal use and for research purposes including both 
questionnaires and interview techniques. The interview method is beyond the scope of 
this project and will not be discussed further.  
 
5.3.1 Research design; Cross – national surveys 
In Chapter 2 cross-national research was described in detail and it will not be repeated 
here. What can be added is that this type of research can often only be done following 
a survey methodology and so far there is limited practical guidance on international 
research.195 Despite the disadvantages of being expensive, difficult, time-consuming 
and requiring good local collaborators it has the advantage of raising questions about 
the generalisations made in single-nation studies.245 Certain steps can be used to 
reduce errors which will be discussed later in this chapter.  
 
5.3.2 Research design; Mail survey 
The first documented mail survey took place in 1788 by Sir John Sinclair who mailed 
questionnaires, consisting of more than 100 questions, to 938 parishes of the Church 
of England, sent 23 reminders and achieved a 100% return rate.97 Sampling technique 
was first used in 1802 in France by Laplace.97 
Mail survey has continued to grow and it is extensively applied in this type of research. 
Among its advantages are targeting a large number of people, reaching people in 
remote areas and collecting data internationally (Table 5.1). Studies aim to collect data 
while reducing errors and increasing the response rate. Of course, this is the aim for all 
types of research.   
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5.2.3 Research design; Internet survey  
“The Internet is becoming the town square for the global village of tomorrow” 
Bill Gates (1955 -) – Non-executive Chairman, Microsoft 
 
An internet survey is “the administration of the surveys via the internet, including 
distribution by email or electronic mailing lists, or posting the survey on web page”.289 
Scientists had to respond to the development of the computer technology and shifted 
research methodology to use the means available262 and the Disk-By-Mail-survey13 was 
introduced.97 Technology is developing rapidly and methodologists are constantly 
trying to “catch up” with the innovations, the latest of which is the internet survey117 
which is a promising type of data collection offering great opportunities but imposing 
challenges.507  
There are two main categories: 1) the email and, 2) the web (based) survey and more 
than one technique can be used to collect data.402 The email survey is when the 
questionnaire is delivered to its targeted population via an email attachment, 
completed and returned via email. The web survey is when the questionnaire is placed 
on the web (HTML:HyperTextMark-up Language), accessed by the respondents 
through an internet connection and via a web browser, completed and submitted 
online.202 Often these techniques are pooled together in the literature under broad 
categories like “online survey”402 sometimes causing difficulties in distinguishing some 
of the methodological characteristics. A web survey was used for the purpose of this 
project.  
There are many advantages of the web survey. The growing number of people using 
the internet makes it an even greater tool to access large numbers of people including 
those of special interest396 and it makes international data collection easier,72 both of 
which were targets in the present study.  
                                                     
13
 Disk-By-Mail-survey is when a disc with the survey is mailed to the respondent who uploads it on the 
computer, completes it and returns the disc by mail.
95
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Another benefit is that cost is kept lower by reducing labour hours, paper, postage, 
printing, travel, faster recruiting.77,278,432 An average response time of six days for a 
web survey is reported77 and almost everyone replies within two weeks.185 The cost 
factor contributed to the decision to follow this type of methodology for the current 
project.  
Another benefit that applies to web surveys is maintenance of anonymity which can 
reduce the negative social effects of completing a survey.202 Social desirability and 
political correctness may result in the respondents giving insincere but “correct” 
answers and a tendency to be more honest when faced with a computer has been 
suggested.431 Using the tools of the internet survey immediate feedback on the return 
rate (RR) is provided233 which may result in taking action, if needed, to increase it, 
which is another benefit of this method.  
Improvements in technology enable all types of internet survey to be conducted via 
devices including mobile phones and Personal Digital Assistants (PDAs).464 Most web 
surveys have techniques for transferring data directly into statistical packages or 
spreadsheets for analysis, therefore data entry errors can be eliminated396 and data 
can be stored, used and re-used faster.262  
All research methods, including online surveys, have disadvantages including limited 
coverage of the population, reduced control over responses, reliance on software, 
security-related issues and skewed demographics.85,201,396,431,507 In later sections in this 
chapter the steps taken to minimise the disadvantages, eliminate errors and increase 
RR in the current project will be discussed. Table 5.1 summarises the advantages and 
disadvantages of surveys.   
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Table 5.1: Advantages and disadvantages of mail and internet surveys. 
 
 Mail survey                             Internet Survey 
  Email survey Web based survey 
A
d
va
n
ta
ge
s 
Can target large number of participants Compared to interview More than all methods More than postal & 
interview 
Can reach people in disperse areas and of special interest Compared to interview Compared to all methods Compared to all methods 
Easier collection of international data Compared to interview Compared to all methods Compared to all methods 
Can be sent to various types of devices (phone, pc, PDA)  Compared to all methods Compared to all methods 
Faster data collection  Compared to all methods Compared to all methods 
Use of better design to motivate respondents   Compared to all methods 
Can secure greater anonymity  Compared to postal Compared to all methods 
Respondents are believed to be more honest  Compared to postal Compared to postal 
Can be completed in respondents own time & privacy Compared to all 
methods 
Compared to all methods Compared to all methods 
Gives immediate feedback on response rate   Compared to all methods 
Less costly Compared to interview Compared to all methods Compared to all methods 
Requires reduced administration hours  More than postal & interview Compared to all methods 
Reduced data entry errors   Compared to all methods 
Can archive research in environmentally friendly way  Compared to all methods Compared to all methods 
D
is
ad
va
n
ta
ge
s 
Lower response rate Compared to interview Compared to postal & 
interview 
Compared to all methods 
Increased coverage error  Compared to all postal Compared to postal 
No control over drop out/incomplete questionnaires Compared to interview Compared to interview Compared to interview 
Increased risk of multiple responses from same person  Compared to postal Compared to postal 
Bias introduced due to software incompatibility  Compared to postal & 
interview 
Compared to postal & 
interview 
Evidence summarised from72,77,202,214,262,278,343,396,202,233,431,432,464,507  
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5.3.4 Research design; Internet survey; world internet usage 
It is clear from the previous sections that using web techniques in surveys has plenty of 
advantages. But the most important element for it to be successful is that people 
actually use the internet so the researcher can identify a group of people that can be 
representative of the population to be examined. This and the next sections aim to 
examine this matter.  
The internet has a very recent history. In 1969, the ARPANET, the first network, was 
developed, and the internet was invented. In 1971, the use of email was introduced 
and a year later email lists were found. In 1990, the World Wide Web (WWW) was first 
used.270 By 2010, nearly 29% of the world’s population had access or used the 
internet.315 North America has only the 5% of the world’s population but 13.5% of the 
world’s internet-user population. The percentage of internet users in Europe is 61.3% 
and in the European Union it is 71.5% (increased 6.5% in two years December 2009 - 
2011). The overall growth of internet users around the world is 528% between 2000 – 
2011.315 In 2009, Greece showed an increase of 16.8% on information and 
communication usage compared to the same period in the previous year and home 
internet connection increased by 75%.200 In the UK, 60% of internet users339 and 64.5% 
in Greece200 access the internet on a daily or almost daily basis with both countries 
showing an increase over previous years. Using the internet via a mobile device 
(mainly phone) increased to 45% (up by 5% in one year) in the UK. These figures show 
that among the three participating countries the number of users is high and growing 
fast.  
Among the profile characteristics of internet users is that in the UK and USA more 
people with higher qualifications tend to use it. However, this is not the case in Greece 
where the highest usage is by young people who have recently finished high school 
and the lowest by those who have a Master’s degree or above.123 Lower household or 
individual income is related to lower internet use in the UK200 but the reports for the 
USA are mixed.85,454 Internet users in the UK connect to social networks (43%) and, the 
older the age group, the lower the percentage of people using the internet (Table 
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5.2).339 This pattern is similar in the Greek population, however it is not similar in the 
USA population where the highest usage is by those aged 45-64 years.454  
With regard to gender differences, in both the UK and Greece more men use the 
internet but this difference has been reducing.200,339 Men are more likely to respond to  
web surveys292 however, women are more likely to go online.123 In the USA, slightly 
more women used the internet in 2009.454 Despite internet users in the three 
participating countries having some small differences in their demographic profile 
characteristics, they use the internet for the same order of activities (Table 5.2).   
A USA study found that those using the internet rate higher in self-rated health, 
memory and functional status.85 Some evidence suggests that there is no significant 
difference between postal surveys and web surveys in regard to gender, age, income, 
education and country of residence of respondents.150 Table 5.2 summarises the 
characteristics of internet users in the three countries of interest. 
 
5.3.5 Research design; Internet survey; usage by people with SCI 
So far it has been seen that internet usage is high in the general population. This study 
will recruit a group of people with a specific disability so it is essential to review 
internet usage by this particular group.  
In 2006, one-third of people with disabilities used a computer at home while only just 
over a quarter had access to the internet from home. This could be due to technical 
accessibility problems as adaptive technology, which is often required by people with 
disabilities, is difficult to learn, expensive, and its development is behind that of 
Information Technology (IT).123 However, different disabilities show different 
percentages of internet usage, therefore it is misleading to collapse all disabilities into 
one category.123 
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Table 5.2: General characteristics of internet users per country  
 Internet 
access/ 
usage 
(%) 
Internet use by 
areas of residence  
(%) 
Internet 
use by 
gender 
M/F (%) 
Internet use 
by marital 
status 
(%) 
Internet use by 
qualification  
(%) 
Internet 
use by age 
group 
(%) 
Internet use by 
income  
(%) 
Internet activities 
(%) 
UK* 77 Wales: 67 
London: 87 
84/79 Single: 92 
Married:81 
Widowed: 32 
Degree or higher: 97 
No qualification: 45 
16-24: 97 
25-44: 93 
45-54: 84 
55-65: 72 
65+: 32 
>£41,600: 98 
<£10,399: 69 
Email: 90 
General information: 75 
Online news: 51 
Social network: 43 
Health information: 39 
Looking for job: 26 
USA** 77 West: 70 
South: 65 
Arizona: 79 
Washington: 79 
68/69 Single: 26 
Married: 58.5 
Other: 15.5 
Degree or higher: 90 
< highschool: 25   
18-34: 69.1 
35-44: 40.7 
45-64: 76.9 
65+: 40.8 
<$50,000: 37¹ 
 >$150,000: 12¹ 
Email: 57 
General information: 50 
Online news: 38 
Social network: 27 
Looking for job: 29 
Greece³ 42 Greater Athens: 52 
North: 40 
58/49 Not reported Master’s & above: 4 
Degree: 30 
High school: 40 
Junior high school: 
12 
16-19: 90 
25-29: 72 
35-39: 54 
45-49: 40 
55-59: 17 
65-69: 3.3 
Not reported Email: 73 
General information: 55 
Online news: 50 
Social network: 42 
Health information: 19² 
 
Studies used for references: *339, **³,200,454;  ¹Figure taken from 2008 statistics; ²Figure taken from 2006 statistics 
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The percentage of internet and computer use by people with SCI is high. In the USA, in 
2004, it was found that 67% owned a computer, 65% had home internet access and 
65% used it daily.127 Only a few years later these figures increased to 69% computer 
ownership, 94% of them had home internet access and 69% daily internet usage.172 It 
is not only the percentage of people with SCI who use the internet that is essential but 
also their demographic profile characteristics. This examines if certain types or groups 
of people with SCI may be over- or under-represented.  An equal percentage of people 
use and do not use assistive devices to connect to the internet (94% v 94.2%).172 No 
significant differences were found for the use of the computer by gender or level of 
injury, but more males than females log on to use the internet.172 There was a 
decrease in the use of the internet as age increased and both computers and internet 
were used more by white than black people and internet use significantly increased 
with education level172 and income (higher income: more usage).127 Presence of pain 
affected internet access (the less the pain, the higher the internet access).127 People 
with SCI used the internet mainly for emailing followed by web surfing and 
chatting.172,216  
Some 65% of people with SCI, compared to 77% of people from the general 
population,454 use the internet. In addition, the level of injury does not affect internet 
use which means that people with tetraplegia and paraplegia would be expected to 
participate similarly in the survey. The fact that the presence of pain may negatively 
affect internet use was taken into account and actions were taken to make survey 
completion easier. The above provides a reasonable justification for the decision to 
use a web design to collect data from this population in the current project. Statistics 
about internet usage by people with SCI in the UK and Greece are not known, to the 
best of this author’s knowledge, and the results of this survey may help to provide 
some interesting comparisons on this topic.  
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5.3.6 Research design; Survey; mixed-mode 
It was mentioned earlier that the current survey uses a mixed mode method to collect 
data. This is when more than one method is used to collect data; for example, mixing 
internet with other types of survey. This approach gives an opportunity to compensate 
for the weaknesses of each mode but at an affordable cost.98 As a method, it emerged 
because of the problems found in the other types of data collection methods464 and it 
can help achieve a higher RR.98 The mixed-mode survey may be the most applicable 
solution to study different populations or subgroups in comparative studies where 
people have different survey traditions.98  
This last point was one of the main reasons for selecting mixed mode for this survey. 
Greece has lower internet usage, though increasing, (Section 5.3.4). Demousis et al104 
point out that reducing the gap in internet use between Greece and other EU 
countries may take some time. One indirect way to examine if people with disabilities 
in one country use the internet is to check how many disability-related websites exist 
and how many members they have. Only one such site was identified in Greece. This 
included people with all disabilities. It became obvious that additional methods had to 
be used to assist recruiting from Greece.  
 
5.3.7 Research design; Survey; sources of error 
In order to conduct a good study with reliable results, errors must be eliminated by 
addressing their sources in advance. The major sources of error in surveys result from 
1) coverage, 2) sampling, 3) non-response and 4) measurement.84 These errors will be 
described here but the steps taken to reduce them in this particular survey will be 
explained in the sections to follow.  
Coverage error is when members of the defined population do not have a non-zero 
probability of being included in the sample to be drawn,117 resulting in a mismatch 
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between the target14 and frame15 population.
84  If nearly all members of a population 
have internet access then coverage error becomes less of a problem.117 In theory, the 
second type of error, sampling error, can happen because not all the members of the 
frame population are accessed.84,117  
The next error, non-response, happens when people in the sample do not respond to 
the survey resulting in the possibility of them having given different answers if they 
had responded.117 Another type of non-response error is when participants return the 
questionnaires but have not completed them properly. This can take two forms: 1) unit 
non-response when the whole questionnaire is not completed, and 2) item non-
response when some questions are not answered.431 This results in missing data which 
may create problems for the data analysis.  
Although Sir John Sinclair in 1788 achieved a 100% RR following 28 reminders97 
(Section 5.3.2) this is a percentage that is hardly ever achievable.  A RR of 75% reduces 
bias347 but the RR can depend on the methods followed and the target population.289 
Online surveys have been found, on the one hand, to have lower RR than mail 
surveys402 and, on the other hand, to have similar RR289 or even higher.77 Not many 
reports on online surveys RR exist but some reviews or meta-analyses give an average 
of 32% for an internet survey185 and 40% for a web survey.81 Postal survey studies on 
people with SCI have had RRs between 50% - 85%.58,90,488,489 A few studies are available 
about internet usage by people with SCI however they did not follow an online (either 
email or web-based) recruiting approach, so the RR for this specific population for an 
online survey is not yet known.  
Finally, the last type of error, measurement error, can result from giving inaccurate 
responses for various reasons like poor question wording, survey mode effect, 
comprehension problems and lack of motivation,117 resulting in a deviation of the 
                                                     
14Target population is the set of people that the researcher wants to study or the population 
the researcher wants to make inferences about.82 In this study it is people with iSCI. 
15 Frame population is “a set of persons for whom enumeration can be made prior to the 
selection of the sample frame”.178 In this study these are the centres used to recruit 
participants.  
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answer from the true value of the measure.84 There are various techniques that can be 
used to reduce this type of error and those used in the current study will be addressed 
later.  
All the above sources of error can occur in all types of survey design including web, 
mail, mixed-mode and interview surveys.117  Ways of reducing them and increasing the 
RR are explored in detail using a model that describes each step of the process. Fan & 
Yan in 2010143 reviewed the survey process and systematically summarised the 
literature taking into account theories related to survey methods described previously, 
(e.g. the tailored design method described by Dillman in 2000117), and illustrated the 
factors that can increase the RR when conducting a web survey in a model comprised 
of four steps.  
 
5.4 Web survey process  
Fan and Yan143 identified a gap in the “theoretical model of the psychological process 
of web survey” and developed a model of the web process based on a conceptual 
framework. According to this model, the process of a survey in general, consists of 
three key elements; 1) the researchers, 2) the participants and 3) the tools. The 
process consists of four steps: 1) survey development, 2) survey delivery 3) survey 
completion and 4) survey return.143  
The authors, Fan & Yan, gave permission for their model (Figure 5.1) to be used for the 
purposes of this thesis to describe the steps followed in this survey (Table 5.3). The 
current survey used three more actions that were not enclosed in the Fan & Yan model 
and they will be described in addition to the model; 1) piloting 2) ethics, and 3) 
confidentiality, anonymity and consent. They will be described under the first step of 
the survey process.  
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 Figure 5.1: The web mail process as described by Fan & Yan.143  (Figure used with 
permission by authors)     
  
 
Table 5.3: Fan & Yan143 survey process together with additional actions done in the 
survey 
 
Key elements 
1) Survey researcher (surveyors) 
2) Survey participants (surveyees) 
3) Survey tools (also called survey modes, e.g. mail, telephone and 
web) 
Step 1; Survey 
development 
1) Content of questionnaire 
2) Presentation of questionnaire 
3) Pilot* 
4) Ethical Approval* 
5) Confidentiality, anonymity and consent* 
Step 2; (web) 
survey delivery 
1) Sampling method 
2) Contact delivery modes 
3) Design of invitations 
4) Use of pre-notifications and reminders 
5) Incentives 
Step 3; (web) 
survey completion 
1) Participation in surveys 
2) Participation decision 
Step 4; (web) 
survey return 
1) Survey software 
2) Data safety 
 * Not described in the Fan & Yan process143 but used in the current study. 
 
 
5.5 Survey key element 1; Survey researchers (adapted from Fan 
& Yan143) 
The survey researchers are the surveyors who design and develop the web survey and 
put it on the web which is similar to those who develop a mail survey, print it out and 
use it.143 This project had one main surveyor, the author of this thesis, who designed 
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the study. A number of collaborators participated in various stages of the project, 
including delivering of the survey (Table 5.4).  
 
Table 5.4: Key element 1; Survey collaborators/volunteers 
 
Overall project Principal investigator (author of this thesis) 
Two thesis supervisors 
Survey developing 
phase  
Pilot phase; 10 people taking part 
Translation phase; 14 collaborators 
Survey recruiting phase Five major collaborators (including online sites/organisations and 
hospital units)  
 
 
5.5.1 Survey collaborators/volunteers; UK arm   
The Spinal Injury Association (SIA) greatly assisted in the study.  Members of the SIA 
team participated by assisting in the development of the web-based survey, the pilot 
and the recruiting phases in the UK.  
 
5.5.2 Survey collaborators/volunteers; USA arm 
The National Spinal Cord Injury Association (NSCIA) approved of this study being 
advertised on their website. Members of the association placed the invitation for the 
study on the appropriate section of their website.  
 
5.5.3 Survey collaborators/volunteers; Greek arm 
The main collaborators in recruiting from Greece participated in the mail survey. There 
was one medical visitor who worked as a local co-ordinator assisting in the phases of 
piloting and recruiting by contacting other collaborators and distributing paper 
questionnaires either to them or directly to eligible participants. Two local hospitals 
and one medical centre were used for recruiting. They were the General Hospital of 
the city of Kavala, a medical centre in Chrysoupoli based in the city of Kavala and the 
General Hospital of Papageorgiou in the city of Thessaloniki.  
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Kavala is located in the East Macedonia region in Greece has a municipality population 
of 70,360 and a regional population of 124,480 making it the fifth largest city in Greece 
outside the Attiki region (which includes Athens).199 Thessaloniki is located in the area 
of Central Macedonia in Greece; it has a municipality population of 322,240 and a 
regional population of 1,104,460 making it the second largest city in Greece after 
Athens.199  
The team at the General Hospital in the city of Kavala was led by the director of the 
“Patient flow” office who assisted in obtaining the necessary hospital approval and 
identifying eligible participants via the central computer list. One medical doctor based 
at the Medical centre of Chrysoupoli was in close contact with the local co-ordinator of 
the study and distributed paper questionnaires to eligible participants who visited the 
centre. At the General Hospital of Papageorgiou in the city of Thessaloniki the study 
was approved and access to patients’ medical records and the computer for a 
Neurosurgery clinic was permitted. The local team was lead by one medical doctor 
who assisted in obtaining the necessary approvals and also discussed the eligibility of 
some participants whose available information was partial.  
 
5.6 Survey key element 2; Survey participants (adapted from Fan 
& Yan143) 
To take part in the study, participants had to meet the following criteria: 
Inclusion criteria 
1. Adults, above the age of 18 years, who live in the UK, USA, or Greece; 
2. They must have an incomplete spinal cord injury.  
Exclusion criteria 
1. People younger than 18 years of age; 
2. People who do not have SCI; 
3. People with complete SCI; 
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4. People who do not live in the UK, USA, or Greece; 
5. People who do not speak English or Greek. 
 
5.6.1 Sample size calculation 
A statistician, independent to the study, conducted the sample size calculation 
required for this project. Information from the paper by Kennedy et al,240 which 
reported 14% of pain in the lumbosacral area of the SCI sample, was used. The sample 
calculation assumed that the percentage of LBP was 14% and with 95% CI either side 
of the estimate (9%, 19%), a total of 185 participants for all three countries were 
needed to answer the questionnaire. 
 
5.7 Survey key element 3; Survey tools (adapted from Fan & 
Yan143) 
The third key element in a survey study, according to Fan & Yan143 is the tools used for 
a survey. Those used in the current study were postal mail and the web 
questionnaires.  
Eligible participants from all three study arms were offered the option of requesting a 
paper format questionnaire which they would return by post. Recruiting from Greece 
greatly depended on the mail survey and for this reason a return account using a pre-
paid envelope system was set up with the local post office. For web data collection 
SurveyMonkey©434 was used. This is a web-based online host which collects data 
centrally and access to it is by subscription. More details on how this tool was used are 
explained later.   
 
5.8 Survey steps; Step 1; Survey development (adapted from Fan 
& Yan143) 
The first step of the process is about developing the questionnaire and putting it on 
the web, and as the authors143 comment, it is a similar stage to creating and printing a 
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paper questionnaire. This step includes two elements known to affect RR: 1) content, 
and 2) presentation.143  
5.8.1 Survey steps; Survey development; content of questionnaire 
The content of the questionnaire is affected by three factors: 1) official sponsorship, 2) 
topic of study and 3) length of survey.143   
5.8.1.1 Official sponsorship 
Sponsorship can motivate eligible participants to complete a survey342 and affects both 
mail and web surveys.143 This particular study was sponsored by the School of Health 
Sciences and Social Care (SHSSC) at Brunel University, London, UK. In addition, the 
study was partially funded by the Engineering and Physical Sciences Research Council 
(EPSRC) (as part of further funding for the PhD) and a small grant from the Graduate 
School of Brunel University. Support for the study by some well known national 
associations or organisations in each country was obtained.      
5.8.1.2 Topic of survey  
If the topic of the project is of interest to the people surveyed then this has a positive 
effect on RR194 and even long and complex questionnaires can be completed.343 Aiming 
to identify groups of people who would be interested in the study, it was advertised on 
SCI-related websites.  
5.8.1.3 Length of questionnaire  
The last factor to affect content of the questionnaire is its length. It has been reported 
that long questionnaires can result in people dropping out of the survey before 
completing it.25 However, other studies conclude that the length of the questionnaire 
is not associated with a reduced RR,81,408 suggesting that maybe the negative effect of 
the length of the questionnaire on the RR has been overestimated.408  
The questionnaire for this project was 24 pages long in the paper format and the same 
number of questions was laid out over 20 pages on the web format, thus it was a long 
questionnaire. Taking into account the fact that the target population would have 
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possible physical problems which could limit the time they could spend completing the 
questionnaire, participants were encouraged to take breaks. The web survey was set 
up appropriately to enable continuation of completing the questionnaire if the 
participant had one or more breaks.   
 
5.8.2 Survey steps; Step 1; survey development; presentation of questionnaire 
The presentation of the questionnaire is the second element of step 1 and it is affected 
by 1) question writing, 2) question wording and 3) visual display.143  When a 
questionnaire is easy to understand, it motivates the respondents to fill it in and 
minimises errors.84 The questionnaire should aim to be conservative but pleasant, 
attractive, consistent and keeping open-ended questions to minimum.343  
Harzing194 conducted an international study in 22 countries sending questionnaires 
written in English. They found that English language capability negatively affected the 
RR and suggested that in cross-national studies the questionnaires should be 
translated for the non-English speaking respondents despite their level of English.  
They emphasised that translation may further motivate the respondent to complete 
the survey by appreciating the fact that the researcher translated the questionnaire.194  
Part of the survey development and related to the presentation of the questionnaire 
were the stages of piloting (or pretesting), obtaining ethical approval and securing 
confidentiality, anonymity and consent. These stages are not discussed in the Fan & 
Yan process143 however they are essential to a survey, and for this reason are 
presented here. As they were part of step 1 they will be discussed below before 
moving on to reviewing step 2.  
5.8.2.1 Question wording and ordering 
Question wording can affect responses and introduce bias especially when they are 
complex, leading, have double negatives or other difficulties.36 People may interpret 
words differently therefore use of short, simple, specific and familiar words is 
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advised.36 Complex questions should be broken up into shorter ones36 and long 
questions can cause comprehension difficulty.229  
Consideration given to the order of the questions is pointed out in the literature and 
the “funnel” approach, which starts off with broader questions and then narrows 
down to more specific ones, is quoted.343 Filter questions can be used to exclude 
people from questions that are irrelevant to them.343  
The current questionnaire included three validated measures where question wording 
and ordering is believed to have been taken into account when developing the 
measures. The final part of the questionnaire consisted of questions selected by the PI 
in order to collect demographic and other information of interest. Questions were 
ordered using the “funnel” approach when possible. Filter questions were used in 
many cases to help reduce time spent with non-applicable questions. 
5.8.2.2 Visual display  
The question of display may be more difficult to standardise in a web survey than in a 
printed survey as the format of the questions may be affected by different internet 
browsers and the screen of the device used.396 Usage of appropriate programmes may 
eliminate this problem.25,117 Visual display is improved by drop-down and scrolling 
questions117 though this has been debated.357 The size of the text can impact visual 
display and Arial 12 pt. font is recommended.25 
To decide on the visual display of the survey the above recommendations along with 
the guidelines of the Survey Monkey© software434 were taken into account. The survey 
was previewed on the major web browsers and using different versions of Windows to 
ensure the questionnaire looked the same on each browser.  
5.8.2.3 Language of questionnaire 
The last factor to affect presentation of the questionnaire is its language. The official 
language in the UK and USA is English, however, in Greece the official language is 
Greek and 99% of the country’s population report it as their native language.138 Half of 
the Greek population (48%) speak a good level of English, however the vast majority of 
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them (89%) do not use it daily.138 Taking into account the study of Harzing194 and the 
affect of language on RR (Section 5.8.2), it was decided that Greeks should receive the 
survey in Greek making it easier to understand and reduce errors. The translation 
procedure was explained in Chapter 4.  
 
5.8.3 Survey steps; Step 1; survey development; pilot phase 
Fan & Yan143 did not discuss piloting in detail but said that it is essential during the first 
step of survey development before the questionnaire is distributed to potential 
respondents. Piloting improves the wording and order of the questions343 and 
identifies questions that need to be eliminated or revised.430 The people who pilot the 
survey should have similar characteristics to those who will eventually respond to it.343 
The three standardised measures used in the survey were assumed to be pilot tested 
by their developers including those that had already been translated and validated into 
Greek. The final part of the current survey collecting socio-demographic information 
was piloted by both English and Greek speaking people. The complete questionnaire 
was also piloted to examine the time needed to complete it.  
The pilot procedure was divided into five stages (Table 5.5) including a pre-pilot and a 
translation stage. At stage 2, some of the people with SCI who piloted the survey were 
members of the SIA with experience of SCI studies and their feedback was of great 
importance. Stage 3 included translation into the Greek language (Chapter 4). At stage 
4, the Greek part of the questionnaire was piloted by people with SCI and lay members 
and appropriate corrections were made.  Finally, at stage 5, final corrections were 
made before sending the survey out to participants.  
 
 Chapter 5: Survey; research design, methodology and methods 
 
120 
Table 5.5: Stages of pilot of the survey  
 
Stage 1; Pre-pilot SHSSC Ethics Committee reviews study for approval and 
offers valuable suggestions on the survey design and 
questions. 
Stage 2; Pilot English version Survey is piloted online and on paper by a group of 
people with SCI, members of SIA, and by lay members. 
Discussions when appropriate followed.   
Stage 3; Translation Following corrections of the English version the survey is 
translated into Greek. 
Stage 4; Pilot of Greek 
version 
Survey is piloted online and on paper by a group of 
people with SCI and by lay members. Discussions when 
appropriate followed.   
Stage 5; Finalising The changes to the Greek version are translated into 
English. Both versions are discussed with lay members or 
health professionals of English and Greek origin. Changes 
are made as appropriate to surveys for each arm of the 
study. Researcher checks for typos and errors.  
Abbreviations: SHSSC, School of Health Science and Social Care; SCI, Spinal Cord Injury; SIA, 
Spinal Injury Association. 
 
 
5.8.4 Survey steps; Step 1; survey development; ethical approval 
Ethics has got its roots well back in ancient Greece. The Hippocratic Oath (written in 
the 5th century BC) says “do no harm or injustice to them” (the patients), and 
“whatever I see or hear in the lives of my patients...I will keep secret”.455 Aristotle (384 
BC – 322 BC) wrote over 20 books where he discussed the morality and ethics of social 
living.14 The modern form of ethical guidelines started by the Nuremberg code in 1949 
and the first official guidelines were introduced in mid 1970s.141  Online research could 
go beyond institutional borders and national boundaries of specific ethics 
requirements as people from any geographical area could log online.141 The 
Association of Internet Researchers (AoIR) developed some guidelines that help to 
conduct online research taking into account the diversity of cultures.135  
A number of ethical issues are raised in the planning of a study384 and the effectiveness 
of using the internet to conduct international studies may expose researchers to legal 
liabilities that are different to those of their own countries.72 Therefore it is essential 
for the study methodology to be reviewed by a team of experts. The methodology of 
this survey was reviewed by SHSSC Research Ethics Committee of Brunel University 
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and ethical approval was granted (Appendix 2). In addition, local approvals to conduct 
the study were given by the research and development bodies (hospital management 
board) of the hospitals which took part.  
 
5.8.5 Survey steps; Step 1; survey development; confidentiality, anonymity and 
consent 
The information reviewed (questionnaire data) must be treated with confidentiality 
which also increases the RR.343 Confidentiality and anonymity were secured in this 
study by implementing the following: 
1) Collaborations and approvals were secured prior to commencing recruiting;  
2) The questionnaires were anonymous, however the participants had the option 
to provide their name, address and contact details; 
3) In the case of the returned online questionnaires, the Internet Protocol (IP) 
address of the computer was de-activated. An IP address is the mark of each 
computer, which could lead to identifying the respondent and therefore it 
could be a potential violation to consent and anonymity if the respondent is 
not informed about it.233 By de-activating the IP address anonymity was 
secured. When entering data into the computer each participant was coded 
using a pin number;  
4) Paper data were kept in locked cabinets accessible only by the PI who withheld 
the right to show detailed data to the PhD supervisors. Computers used for this 
project were password protected; 
5) The local collaborators, who assisted in recruiting, were not aware of the 
participants’ details who returned the questionnaires as they used the prepaid 
addressed envelopes to return them directly to the PI or left the completed 
questionnaires in sealed envelopes for collection by the local co-ordinator. In 
the case of web questionnaires the collaborators had no access to the online 
database.  
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Eligible participants must be fully informed of the study, understand it and be able to 
consent.141,214 Guidelines about information sheets exist327 and they were read to help 
design the current information sheets. For online research permission of the site 
owner, posting the information sheet on the message board and reading the site’s 
regulations are recommended.214  
The participants in both the paper and the web version of the questionnaire were 
asked if they wanted to take part in the study. By providing completed questionnaires 
they automatically consented to participate. The participant should be given the right 
to withdraw from participation,289 and this option was given provided that their 
questionnaires were not returned anonymously.  
 
5.9 Questionnaire components 
Before moving on to describe step 2, which deals with survey delivery, a description of 
the measures and questions included in the questionnaire is provided. The 
questionnaire “package” was divided into four following parts.  
 
 5.9.1 Survey questionnaire; Part 1 - examining pain; The Short Form McGill pain 
questionnaire 
A number of pain assessment scales were looked at in order to decide which one was 
the most appropriate to use. Three were selected for consideration; 1) the 
multidimensional pain inventory (MPI), 2) the Chronic Pain Grade Questionnaire 
(CPGQ) and 3) the McGill Pain Questionnaire (MPQ).  
The reason for excluding the MPI was that despite it being a reasonable tool to 
measure the impact of pain in people with SCI, it has been suggested that due to the 
differences in activity based on the level of injury the MPI may not necessarily reflect 
impairment from pain.485  
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The CPGQ has been used in SCI58,406,451 and despite its good properties414,472 it was 
excluded because it has not been used as extensively as the MPQ. Another important 
reason for excluding it was that it did not exist in the Greek language.  
The MPQ provides quantitative measures of clinical pain and examines three 
dimensions of pain; 1) the affective, which is how the respondent feels at that 
moment, 2) the sensory, which is the sensations the person has at that moment and 3) 
the evaluative, which describes the subjective overall intensity of the total pain 
experience.305 It takes 15-20 minutes to administer.304 Four types of data can be 
acquired from it:  
1) Pain rating index based on the patient’s mean scale values (S-PRI), which is the 
sum total of the scale values of the chosen words in a category or all 
categories; 
2) Pain rating index based on the rank values of the words (P-PRI), where the 
values of the chosen words are added to give a total score for each or all 
categories; 
3) The number of words chosen; 
4) The present pain intensity (PPI), which is the number-word combination chosen 
that indicates the overall intensity at the time the questionnaire is 
administered.  
The MPQ was found to be too long and in 1987 Melzack303 developed a short-form (SF-
MPQ) consisting of 15 descriptors (11 sensory and 4 affective) rated on a scale 0 to 3 
(none to severe), includes the PPI and a VAS and provides information on the sensory, 
affective and overall intensity of pain and takes two minutes to complete.303  Both the 
MPQ and the SF-MPQ have been used in studies to assess self-reported pain in adults 
with SCI.31,58,380,381,451  
Concerns have been raised about the true number of dimensions included in the MPQ 
as some studies found four or more factors when using factor analysis.305 But, support 
for the original model was given and with the exception of the descriptor “gnawing”, 
the factorial validity of the English version of SF-MPQ was confirmed.502 The 
discriminant validity of the measure has been questioned as Turk et al448 found that 
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the inter-correlations in the PRI were too high thus not allowing adequate discriminant 
validity and proposed using the total score of the PRI. However, Melzack305 claimed 
that the high inter-correlations among the variables do not essentially mean that there 
is lack of discriminant abilities and the validity of the scale has been shown in other 
studies. Another difficulty with the MPQ is that high affect scores can reduce its 
discriminant abilities, however Melzack305 who does not doubt this problem, claims 
that MPQ still maintains good discriminant ability even in cases of high levels of 
anxiety. It has also been mentioned that the MPQ is less sensitive to clinical change 
compared to the VAS398 and also that using only verbal descriptors to distinguish pain 
types in SCI is limited.367  
The MPQ developers have not, though, claimed it to be the perfect tool in assessing 
pain305 but its psychometric properties have been studied by others.82,423,502 The SF-
MPQ has also been found to be a good tool as a predictor of the result.474 SF-MPQ has 
been translated into Greek by Georgoulis et al166 who studied people with chronic 
spinal and osteoarthritic MSKP.  The questionnaire was found to have an internal 
consistency of Cronbach’s Alpha α=0.71, to be reliable and sensitive to change 
following therapy for people with chronic pain including LBP165 or patients with 
cancer.324  
After the design and the onset of the current study an initial validation of a revised 
version of the SF-MPQ was developed. Its objective was to better assess and 
distinguish between neuropathic and non-neuropathic pain, it uses seven more verbal 
descriptors and it replaces the four-point rating scale to a 0-10 NRS.129 Thus, the 
revised version of SF-MPQ, if used in future studies may become a more appropriate 
tool for the assessment of pain.  
In addition to the SF-MPQ, the body chart, which is used in the full MPQ was used. A 
body chart or pain drawing or body map is used extensively in the literature90, 484,487,488 
or clinics and the respondents mark the location of their pain. The use of the body 
chart aims to collect information on the pain extent. 
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5.9.2 Survey questionnaire; Part 2 - examining quality of life; The EQ-5D 
questionnaire 
A number of measures have been developed aiming to measure QoL by summarising 
individuals’ judgements on their experiences of health and illness.62 These measures 
do not aim to measure the disease or conditions particularly but their impact on QoL.62 
Measuring HRQoL enables identifying such problems with the aim of improving them. 
Sometimes QoL is measured by health professionals but QoL is a subjective evaluation, 
thus measurement needs to be done by the person themselves. Slevin et al411 said that 
doctors did not adequately evaluate the patient’s QoL.  
The QoL scales that were considered for inclusion were 1) the WHO QoL – BREF 
(WHOQOL-BREF), 2) the SF-36 and SF-12, and the 3) EQ-5D. 
The WHOQOL-BREF has been used in studying people with SCI and has acceptable 
validity226 and the long version (WHOQOL-100) has been translated into Greek.170 
However, the WHOQOL-BREF could not be found in the Greek language, and even if it 
existed it consists of 26 questions which was too long for a single measure to be 
included in this study. The SF-36 and SF-12 are widely to assess for health-related QoL. 
However barriers had been reported when using them in SCI which led to some 
modifications of the SF-36 to enable use in SCI research with good construct validity.438 
Despite the original SF-36 being available in the Greek language, the measure was 
found to be much longer than the EQ-5D to be included in the survey.  
The EQ-5D is a widely used measure to assess health status41 with universal 
application.505 It measures mobility, self-care, usual activities, pain/discomfort and 
anxiety/depression.341 It is a simple, short and easy to administer, generic, self-
completed measure of health status that has been used in various studies,143 has no 
complicated tasks and has been used by people with SCI.294,302 The EQ-5D has been 
translated into Greek and returned good validity results when studied on the general 
population.247 When it is compared to another HRQoL measure on the Greek 
population it was found to be equally acceptable.506 The version selected for use in the 
current study was the 3-level one. A 5-level EQ-5D version has been created but it 
needs further development227,359 and thus not chosen for use here.   
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Suarez-Almazor et al429 evaluated the discriminant abilities over time for a number of 
health status measurements, including the EQ-5D, in patients with LBP. They found 
that even though the EQ-VAS, which is included in the EQ-5D, was one of the least 
stable measures it could discriminate better among those patients who improved and 
those who got worse than most of the SF-36 subscales.429 There have been some 
concerns in the literature about the ability of the mobility dimension of the EQ-5D to 
properly assess and discriminate individuals’ levels of disability, particularly in 
SCI.108,168 The mobility dimension refers to the difficulties with “walking about” which 
people with iSCI may be able to maintain, those with a complete injury probably would 
not.108 But, wheelchair users may consider “walking about” similar to “getting about” 
so this may not be such a great problem.168 In the present study only people with iSCI 
participated thus problems with the mobility dimension should not be expected (see 
Appendix 2 for this measure). 
The current study has been registered with the EuroQol Group140 who provided all 
relevant documentation for both the English and Greek versions.  
 
5.9.3 Survey questionnaire; Part 3 - examining function; The Spinal Cord 
Independence Measure (SCIM) questionnaire 
Among the scales used to examine function those that were considered for inclusion 
were 1) the functional independence measure (FIM) and, 2) the SCIM. The FIM has 
been used to assess function in many conditions including SCI,237 however it has been 
said that a total FIM score in the SCI population may be misleading as some of the 
domains (i.e. cognitive) have been reported to be inappropriate for SCI.184 In 
comparison with SCIM, the FIM was found to be less reliable to change for people with 
spinal cord lesions.68 FIM was not found in Greek either, similar to SCIM.    
SCIM is the only “comprehensive ability rating scale that has been designed specifically 
for patients with spinal cord lesions”.65 In SCI it is necessary to use a condition-specific 
measure even with adequate measurement properties.96 SCIM assesses function 
covering three principal areas:68 
 1) Self-care including tasks of feeding, bathing, dressing, and grooming;  
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2) Respiration and sphincter management including tasks of respiration, 
bladder & bowel management, and use of a toilet;  
3) Mobility, which is divided into tasks in a) room and toilet, and b) tasks 
indoors and outdoors (see Appendix 2 for SCIM).  
The original SCIM had high inter-rater agreement correlation coefficients ranging from 
0.91-0.9968 but it was revised (SCIM II) and the new version showed better correlation 
coefficients between the two raters in total scores (r=0.99).67 Compared to the original 
version it was more reliable in the category of self-care (80-99% vs 75-87%) making it a 
valid and highly reproducible measure of daily function for people with spinal cord 
lesions.67 A large population study using SCIM II confirmed its validity and reliability 
and concluded that despite some flaws it is suitable and recommended for use.224  
SCIM was designed as an observational measure and seems to show better properties 
when used for assessment by a multidisciplinary (MTD) team compared to a single 
rater.66  
Conducting a systematic review, Dawson et al96 noticed that the measures used to 
assess function in SCI rely on observation, thus on the assessor’s perspective and do 
not represent the patient’s perspective. The authors expanded on the debate about 
whether more accurate data is collected by observation (as claimed by Itzkovich et 
al223) or by self-report and mentioned that when SCIM was assessed by interview the 
differences between patients’ ratings and observers appeared insignificant.  
Indeed, SCIM was tested for assessment via interview223 where the interviewers had 
no specific training in using it and the correlation between the total scores of the 
interviewers was high (r=0.903). When comparing the results of the two interviewers 
with those of the observers the correlations were also high, ranging from r=0.69-
0.96.223 The only statistical difference was between one interviewer and the observers 
on the mobility subscale and the other interviewer and the observers on the self-care 
subscale.223 They concluded that SCIM could also be reliable by interview, however 
these findings might be less accurate than those with observation.  
Studies on SCIM led to the development of the SCIM III version which consists of three 
complementary subscales including 6, 4, and 9 items, respectively. Each item 
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represents a daily task and is graded on an increased difficulty therefore demanding a 
higher patient ability. Each item consists of 2-9 grades and the higher the grade the 
better the patient’s performance/independence. The scores range from 0-20 for “self-
care”, 0-40 for “respiration and sphincter management”, and 0-40 for “mobility”, 
totalling 0-100 for the three subscales. The mobility subscale has two subscales; “room 
and toilet” and “indoors and outdoors, on even surface”.65  
SCIM III has an intraclass correlation coefficient (ICC) of above 0.94 for the total SCIM 
and for all subscales. It has improved inter-rater reliability compared to version II, 
internal Cronbach’s α consistency for the overall SCIM III α=0.847 and α=0.849 (first 
and second raters). Validity of scale when compared to FIM was r=0.79. SCIM III was 
tested by observing more than 400 people in 13 centres in six countries and it showed 
good validity and better responsiveness to respiration and sphincter management for 
mobility indoors and outdoors subscales.65,222 SCIM III was suitable for cross-cultural 
research65,222 (Appendix 2).  
For pragmatic reasons and because of the methodology of the present study, it was 
impossible to use SCIM III by observation or interview. The only way to use it was by 
respondent self-report. Using SCIM III via this method should give information on how 
this assessment works under this condition.  
 
5.9.4 Survey questionnaire; Part 4 - socio-demographic profile and other related 
information 
The final part of the questionnaire consisted of 58 questions developed specifically for 
this study to collect socio-demographic data and other information of interest and was 
divided into four sections.  
The first section, labelled “Questions about you” consisted of 22 questions collecting 
demographic profile information. The second section labelled “Questions about your 
pain in general” consisted of 15 questions related to the respondent’s pain in general 
since the time of injury and type of treatment received. The third section, labelled 
“Questions about your LBP” consisted of 15 questions similar to the second section but 
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about LBP. The final section, labelled “Final questions about yourself” consisted of six 
questions investigating whether the respondents completed the questionnaire on their 
own (Appendix 2). 
This part of the questionnaire included factual questions starting with classification 
questions related to the general demographic characteristics of the population (e.g. 
age, sex and education).343 These were mainly closed questions which are easier and 
faster to complete but may be considered not as flexible which can lead to loss of 
rapport.343 To allow more flexibility, in many cases the closed questions were followed 
by an open-ended alternative (i.e. “other – please state” option) which provides a 
compromise118 and aims to collect additional information. The questions were on 
nominal, ordinal (including ranking) and continuous levels of measurement. Filter 
(skip) questions were added and respondents completing the paper version were 
directed to the appropriate skip question but those completing it online were 
automatically taken to the relevant questions. Omitting questions can produce 
problems with the questionnaire,396 therefore a logical technical solution was set up 
asking respondents to complete the questions regarded to be essential for the survey. 
This was a benefit of the web survey over the paper survey.  
 
5.10 Survey steps; Step 2; the survey delivery (adapted from Fan 
& Yan143) 
Moving on to the next step of the process (Table 5.3),143 the sampling method is 
decided, participants are contacted and the web survey is delivered to them, similar to 
the mail survey being distributed to the respondents.  The elements that can affect RR 
in this step are five; 1) sampling method, 2) contact delivery mode, 3) design of 
invitations, 4) use of pre-notifications and reminders and 5) incentives. Each of these 
elements is discussed below.   
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5.10.1 Survey steps; Step 2; survey delivery; sampling  
Population is the whole group for which generalisability results will be made431 and in 
this case the target population is adults with iSCI. The sampling frame is the list of units 
of the population from which the target sample is drawn36 and here these are the 
online and offline centres used to recruit participants.  
The most commonly used sampling recruiting technique on the internet is to post the 
study on websites or newsgroups asking people to participate.202 It is understood that 
this type of sampling creates problems with the RR as it cannot properly be 
measured,202 however as  there is currently no central registry as, for example, there is 
the telephone book which can be used for telephone research, this problem is more 
often encountered. Sending emails to the eligible participants may give an 
approximation to the sampling frame.202  
For the purpose of this study a combination of sampling recruiting techniques were 
used. Primarily, convenience sampling was used for the web survey. This means that 
the study was posted on communities, forums, online websites431 and people with iSCI 
were invited to participate. A second type of sampling used, which also falls into the 
category of convenience sampling, was judgement sampling. This is when the 
researcher selects the sample from the online community.156 This was done 
subjectively in two ways; 1) in cases where the website was generic and included 
people with all disabilities, then the SCI-related forums were identified and the study 
was posted on them and, 2) by looking at people’s registrations profiles (when freely 
available to other members to view) and those believed to match the study’s criteria 
were invited to participate via an email or a message. A third sampling technique used 
for online recruiting was the saturation method. This is when all the members of the 
frame have an email address and an email can be sent to them thus this technique has 
no coverage error.431 However, only one website was found to offer this option.  
Finally, the sampling frame for the mail survey was based on convenience. No register 
of people with SCI existed in Greece, online or offline, to the author’s knowledge, at 
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the time of recruiting. The hospitals and the medical centre were selected because the 
PI had access and collaborations that could be established.  
For each arm of the study, the sampling procedure is described below.  
5.10.1.1 Survey steps; Step 2; survey delivery; sampling; UK arm 
The study was published directly by the SIA on their electronic-clips bulletin, which had 
a membership list of 2,500 people and it was on the front page news for a few weeks. 
The study was also published in the Association’s “Forward” magazine and put on the 
message board. At that time there were 1,941 registered members online.  
Two further, UK-based online sites for people with SCI, were identified. Combining the 
sites at that time, there were more than 6,800 registered members. The study was 
advertised on some forums of these websites.  
5.10.1.2 Survey steps; Step 2; survey delivery; sampling; USA arm 
NSCIA had 1,060 subscribed members at the time on their online forum but more than 
24,000 members belonged to NSCIA. Nine further USA-based online sites were 
identified and posts were put on various forums. For six of them the given total 
number of registered members was more than 35,500, however one of the sites (with 
30,000 registered members) included people with various disabilities (some 425 were 
believed to possibly fit the study’s criteria).  
5.10.1.3 Survey steps; Step 2; survey delivery; sampling; Greek arm 
“Disability Now” is a non-profit, non-governmental organisation, mainly managed by 
people with severe disabilities. It was the only organisation related to disability to have 
an extensive online site consisting of discussion boards and forums. The site had more 
than 1,000 registered members with various disabilities at that time. An advert 
promoting the study was approved and placed on the forum.  
At the General Hospital of Kavala the general records of all patients that had been 
seen in the hospital since 01/05/1996 were available. A total of 34 keywords were 
used to search the hospital’s central computer and 615 results were returned. These 
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were screened in more detail and 122 people were found to have SCI. Only 14 cases 
were confirmed iSCI, however a total of 72 letters were sent out because the 
information available suggested some of these possibly had an iSCI. For the remainder, 
eligibility remained unclear. At the Medical centre in Chrysoupoli, Kavala, access to the 
records was not requested, therefore it is not known how many people were on the 
database of this centre.  
Finally, at the General Hospital of Papageorgiou, in Thessaloniki, access was given to 
the records of the clinic of Neurosurgery. The registration books of people entering the 
clinic were reviewed manually for the years 10/09/2002 – 03/12/200816. A total 
number of 5,491 people were seen at the clinic, of whom 128 were selected as eligible 
to participate and were further reviewed. There was a clear diagnosis of iSCI for only 7 
people reported in the medical registration books, however 28 letters were sent out to 
people considered to fit the study’s criteria. For the remainder, the diagnosis was not 
clear and they were excluded. 
Table 5.6 below presents an overview of the sampling frame, the contacts made and 
an estimation of the people identified in each arm of the study but, as previously 
mentioned, an accurate RR is not feasible for online research. One of the problems 
encountered in this study and which made determination of the RR difficult was that 
not all members registered with an online site had  SCI themselves but  were relatives 
or friends of a person with  SCI. They were sent an email and asked to forward the 
invitation to the person with SCI but it can only be assumed that this was indeed done.  
Another problem was that in many cases it was unclear if the SCI was complete or 
incomplete, however emails were sent anyway and people were asked to participate 
only if they had an incomplete injury. A third problem was that people could be 
registered with more than one site, thus not accurately reflecting the number of 
individuals with SCI. In those cases where people had no description on their profile at 
                                                     
16
 Excluded periods not registered in the books were: 25/12/02 - 02/01/03, 01/01/04, 01/01/05 - 
2/01/05, 31/12/05, 29/12/06 - 31/12/06. 
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all (which was very common) no invitation was sent and people with SCI may have 
been missed out.  
A further problem was that even if a site was based in the USA, for example, people 
from other countries could register, thus creating difficulties in estimating the number 
of people with SCI in a single country. Finally, in most cases no email address was 
available and contact was made by sending a private message. Private messages were 
held “online” by the web-creator (host site) and the account holders were 
automatically informed via the host site about the presence of a private message 
available to them online. They then had to log onto the site to read the message. 
There is no way of knowing how many emails were indeed delivered and how many 
people actually logged onto the site to read the private messages sent by the PI of this 
study.  
Screening people’s profiles for eligibility was more time-consuming. However, it 
probably enhanced the RR by targeting people who fitted the inclusion criteria and by 
sending personalised invitations.  
 
5.10.2 Survey steps; Step 2; survey delivery; contact delivery mode 
The next element in step 2 is the contact delivery mode (Table 5.3). This is a message 
or an email invitation sent to eligible respondents informing them of the imminent 
arrival of the survey or giving them the hyperlink to the survey.143 As discussed in 
Section 5.10.1, this was one of the recruiting techniques used.  
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Table 5.6: Overview of sampling frame, contacts, and responses per study arm 
 UK 
Arm/sites 
USA 
Arm/sites 
Greek 
Arm/sites 
Collaborators and 
hosts 
SIA and 2 online 
hosts 
NSCIA and 9 online 
hosts 
Disability Now online host, 
2 hospitals, 1 Medical 
centre  
Known number of 
registered 
members at the 
time  
Online: 4,441 
Registered with 
paper magazine: 
7,000 
Around 30,000 
registered with SCI 
sites only 
Online: Over 1,000 but 
with various disabilities 
Hospitals (people with 
probable SCI): 250. 
Information from medical 
centre not known. 
Profiles looked at 1,406 24,344 Online:1,000 
Names screened at 
computer/books:  
Confirmed 
incomplete SCI via 
self-report or  in 
hospital records 
60 living in UK and 
another 12 living in 
USA 
288 living in USA, 7 
in UK, 22 in Canada 
and 1 in Greece 
Online: 7 
Via hospitals: 21 
Information from medical 
centre not known. 
Total personalised 
emails sent out 
and letters posted 
112 (18 from USA & 
12 were confirmed 
relatives or partners 
of a person with SCI) 
1209 (including 25 
known relatives or 
partners of a person 
with SCI, 33 in UK, 
22 in Canada and 1 
in Greece 
Online: 29 (including 3 
relatives or partners of a 
person with SCI) 
Hospital: 100 
Given by Dr by hand: 40 
Number of people 
started survey 
online 
344 132 37 
Number of people 
completed survey 
online 
149 69 12 
% of online 
completeness of 
survey 
43.3% 52.3% 32.4% 
Number of 
returned paper 
questionnaires 
1 3 Via hospital: 8 
Via Medical Centre: 38 
 
 
5.10.4 Survey steps; Step 2; survey delivery; pre-notifications and reminders 
Using pre-notification slightly increases the RR.81 In the current survey a type of pre-
notification was made by posting an introduction and brief presentation of the study 
on the most popular forums of each online site.  
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Reminders are found to increase RR in surveys. 236,343 In this project, in general, no 
reminders or follow-ups were sent out. The only exception was the re-advertising of 
the study on the SIA front page. It is worth noting that of those people who viewed the 
three arms of the study online, the UK arm had the highest survey completeness rate 
and re-advertising may have influenced this. The reason for not sending reminders and 
follow-ups was pragmatic as the required sample size had been achieved.  
 
5.10.5 Survey steps; Step 2; survey delivery; incentives 
The final element in step 2 is incentives. These can be either monetary or non-
monetary. In this study no incentives were offered and therefore this will not be 
further discussed.   
 
5.11 Survey steps; Step 3; survey completion (adapted from Fan & 
Yan143) 
The third step for a web survey is when the respondents receive the invitation to 
participate, log into the study, complete it and submit it, similar to receiving the mail 
survey, completing it and posting it back. The factors that are important at this stage 
and may affect RR are 1) prior participation in the survey, and 2) decision to 
participate.143 One could claim that prior participation in surveys is directly linked to 
the decision to participate in a survey thus these factors are discussed together.  
 
5.11.1 Survey steps; Step 3; survey completion; prior participation in surveys and 
decision to participate 
The decision to participate in a survey can be affected by elements related to 1) the 
society, 2) the respondent and 3) the design of the survey.143  
People may decide to participate (or not) because they are interested in the topic,180 
they want to present themselves as helpful,431 for social reasons143 or they find the 
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topic sensitive.194 A society may suffer from questionnaire fatigue making potential 
participants less likely to respond compared to other societies where questionnaires 
are not so commonplace.143,194,195 Finally, the design of the survey can affect the 
decision to participate. Zhang507 noticed that, when given the option, 20% of people 
chose to complete a postal survey over the web format and proposed offering 
alternative ways of distributing and collecting a survey. In this survey, this option was 
offered, although not many people requested a paper survey.  
Another factor affecting the decision to participate is the geographical distance 
between the surveyor and the surveyed.142,143,194,195 One technique for overcoming 
cultural and geographical distance is to mail (postal) questionnaires from the countries 
to be posted to and to have local collaborators.194 Both these techniques were 
followed when possible in this survey.  
 
5.12 Survey steps; Step 4; survey return (adapted from Fan & 
Yan143) 
The final step in the survey process is the return of the questionnaire (Table 5.3) which 
for a web survey is when the researcher downloads the collected data from the 
website to the computer for analysis similar to the process of entering data from a 
mail survey into the computer.143 This process can be influenced by the 1) survey 
software and 2) data safety.  
 
5.12.1 Survey steps; Step 4; survey return; survey software 
Hundreds of survey software products are available in the market and a list can be 
found in http://www.websm.org.465 The advantages of having such a programme 
include 1) that data is stored in a central location, 2) the survey is always up-to-date 
and 3) a backup is usually available if needed.233  
For the current study a professional subscription with Survey Monkey©434 was taken 
out. This gave full access to the benefits of the software licence including unlimited 
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responses on the surveys and fast and helpful customer support. The questionnaire 
could be designed in both English and Greek, data could be downloaded in Excel 
spreadsheets and transferred into the statistical package SPSS.  
 
5.12.2 Survey steps; Step 4; survey return; data safety 
Even though data safety in web surveys is a concern, the risk may not be higher than in 
non web surveys and there are ways to reduce it.143 In the UK, 87% of internet users 
expressed strong or mild concern with abuse of personal information.339 Security is 
strengthened by having the appropriate anti-virus programmes and firewalls. Access to 
the computer should be via a password.289 Appropriate security measures were in 
place in this study.  
In conclusion, this chapter has so far explained in detail the methods used in this 
survey discussing, at the same time, the methodology behind them. The next sections 
of this chapter will discuss the methodology and methods employed to conduct the 
statistical analysis of the survey.  
 
5.13 Methodology of data analysis 
5.13.1 Data analysis; Preparation for analysis   
A “code book” was created which included rules of coding taking into account 
recommendations found in Leech et al.264 Data were entered into SPSS package, 
version 15 for Windows.  
 
5.13.2 Data analysis; Data screening  
Exploratory data analysis (EDA) was conducted. This involved doing some descriptive 
statistics in order to become familiar with the data and checking for problems, outliers, 
missing data, and data entry mistakes. In addition EDA helps in the analysis.264  
 Chapter 5: Survey; research design, methodology and methods 
 
138 
Mistakes were checked by cross-tabulation for impossible or unlikely combinations. 
For example, a person with a cervical level injury could not have paraplegia. For 
continuous data, scatterplots and boxplots were used to check for outliers17 and data 
errors.  When found, outliers were checked and, if appropriate, deleted from the 
specific part of the analysis.147 When an outlier is eliminated this is stated in the 
relevant tables. 
Missing responses existed in two forms; 1) when the participant had either forgotten 
or deliberately skipped a question, and 2) when data were missing because the 
response was not applicable to the respondent. The latter was noted a lot in the PRI 
section of the SF-MPQ. It was obvious that a large number of respondents only ticked 
those descriptors that applied to them and the missing cases were not “truly” missing. 
Therefore an explicit rule was created and the developer of SF-MPQ, Prof. Melzack was 
contacted for advice. Prof. Melzack agreed with the rule of how to treat missing data 
in this case (Appendix 4; Section 4.2.2). Returned questionnaires which had 50% or 
more missing data were excluded from the analysis.  
 
5.14 Data analysis; Statistical tests; general 
This section will explain the specific statistical tests selected for data analysis and the 
reasons for their selection. Quantitative methods were used for the analysis of the 
data which included descriptive statistics, comparisons between groups and 
correlation analysis. Tables and graphs were used throughout the results to describe 
groups and summarise findings. The statistical test chosen for comparisons or 
correlations depended on 1) the level of data, 2) the number of groups to be 
compared and 3) fulfilment of the assumptions of the test.  
                                                     
17
 An outlier is an observation that differs a lot from others and can bias statistics.
145
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5.14.1 Comparisons; Categorical data; two groups 
When two groups of the same variable were compared and data were categorical the 
chi-square goodness of fit test (χ²) was used which is the proportion of a population 
distribution within one variable.  
When there were two different variables examined with categorical data on a 2x2 
table then the Pearson’s chi-square test (χ²) was used. This is based on looking at the 
difference of expected and observed frequencies.  The assumption is that 80% of cells 
should have an expected frequency of at least five counts.147,285 Chi-square is a non-
parametric test, a category of tests believed to have less efficient characteristics than 
the parametric tests, however, having a large sample, as in the present study, makes 
non-parametric tests only a little less powerful than parametric tests.321 When the 
assumptions of the Chi-square were violated its alternative, Fisher exact test, was 
used.285  
 
5.14.2 Comparisons; Categorical data; more than two groups 
When data were categorical but more than two conditions were compared, (e.g. three 
groups with two or more categories) the extended chi square (χ²) was used. This test 
can only be based on a two-tailed hypothesis203 and, if found to be significant, two 
group comparisons, using a post hoc test, must be conducted in order to identify 
where the difference lies. Post hoc analysis is explained later in Section 5.18.  
 
5.14.3 Comparisons; Continuous data; two groups  
To compare differences between the means of two groups the independent t-test, 
which is a parametric test was used. Assumptions of the test are 1) a normal 
distribution, 2) homogeneity (equal variances), 3) different population in the different 
groups and 4) at least interval level data.147 T-test can be used when the data is 
continuous on one variable and dichotomous on the other.285 
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According to Peacock & Kerry350 even when there are deviations from the assumptions 
the t-test can still be used when the data:  
1) May not be normal but is symmetric; 
2) Is symmetric but have a digit preference; 
3) Is moderately skewed but the two groups are even in size; 
4) Is highly skewed but the groups are large (>50 in each group).  
In the cases where the assumptions of the t-test were not met, the Mann-Whitney U 
test was used, which is the equivalent non-parametric test. It can also be used for 
relationships between a continuous or ordered variable and a dichotomous variable.285  
 
5.14.4 Comparisons; Continuous data; more than two groups 
When comparing means of more than two groups the one-way ANOVA was used. This 
is an extension of the t-test and has three assumptions: 1) data are continuous, 2) data 
are normally distributed within groups and 3) equal variances.285,350  
It has been claimed that breaking the assumptions of ANOVA does not matter a lot but 
when the group sizes are not equal ANOVA is affected by skew and non-normality.147 If 
the assumption of equal variances is violated, when group sizes are not the same, then 
ANOVA can be affected.147 When assumptions were not met the non-parametric 
equivalent Kruskal-Wallis H test was used. This can be used for ordinal/continuous 
data.147 ANOVA can only indicate the existence of a difference between the groups but 
not where the difference lies.147 Therefore, when ANOVA was significant a post hoc 
test was done.   
 
5.15 Data analysis; Associations and correlations 
The relationship between two or more groups was often examined looking at 
associations and correlations. 
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5.15.1 Associations and correlations; Categorical data 
When data were nominal on a 2x2 table, the Phi (φ) test was used to test for the 
direction and strength of the correlations.147,264     
When data were ordinal285 or when one variable was interval/ratio and the other 
ordinal,203 Spearman’s rank correlation rho (ρ) was employed which uses the ranks of 
the data and not its values.351 All the above are non-parametric tests.   
 
5.15.2 Associations and correlations; Continuous data 
When data were continuous Pearson’s correlation (r) was used to measure the 
strength and the direction of the association between the two variables.285 The 
assumption of the test is that at least one of the variables is normally distributed.350 
Pearson’s correlation is a parametric test and when its assumptions were violated then 
its equivalent non-parametric, Spearman’s rank correlation rho (ρ) was used.  
 
5.16 Data analysis; Examination of interaction effect 
The interaction effect between the country of residence and another independent 
variable (IV) which changed every time (e.g. gender, type of injury etc) on the outcome 
(dependent variable- DV) which was the various categories of pain, was examine. The 
main purpose was to investigate the role of the “country of residence” on the outcome 
as a co-effect with another independent variable. When the DV, the category of pain, 
was on a nominal level binomial logistic regression was used. The purpose was not to 
identify general predictors via this type of regression but solely to check the two-way 
interaction under investigation which can be done using logistic regression.147 Thus, 
analysis focused only on the interaction effect. When data on the DV were continuous 
the interaction effect was examined using independent factorial design analysis.147 
This between-groups analysis uses two-way analysis of variance (ANOVA)18 to examine 
                                                     
18
 Two-way analysis of variance (ANOVA) means that there are two independent variables.
145,283
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the effect of one variable on all relationships previously analysed by a one-way 
analysis. For example, differences in pain intensity per gender are initially examined 
using one-way analysis and, using two-way ANOVA, the effect of country on the 
relation between pain intensity and gender is inspected. The assumptions for two-way 
ANOVA are: 1) normal distribution and 2) equal variances between groups 
(homogeneity).  
 
5.17 Data analysis; Checking for assumptions  
As seen above the parametric tests have assumptions that need to be met in order for 
the test to be used. Often these assumptions are similar. The procedure to check for 
these main assumptions is explained below.    
 
5.17.1 Checking for assumptions; Normal distribution 
All the parametric tests used have the assumption of a normal distribution. This is 
checked by looking at histograms and bell-shaped curves. Normal distribution is 
characterised by a bell-shaped curve and deviations from normality are; 1) lack of 
symmetry (skew) and, 2) pointiness (kurtosis). Both skewness and kurtosis should have 
a value of 0.147 Checking the normal distribution via a histogram when the sample is 
small is not very reliable and examining the normal Q-Q plot is a more reliable 
method.28 This plot shows the cumulative frequency distribution of the data against 
the cumulative frequency distribution for normal distribution.28 The closer the 
distribution of the data to the line of the normal distribution, the more normally 
distributed the data.  
Normal distribution can also be examined by the Kolmogorov-Smirnov (K-S) test which 
checks if the distribution deviates from a comparable normal.147 If K-S is significant 
(p≤0.05) then the distribution is not normal. When used with large samples a 
significant result may not necessarily mean a deviation from normality. In this case any 
decision should be based on looking at the data and the extent of non-normality.147 
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Decisions about normality of the distribution, for the current study, were based on a 
combination of examining all the above.  
5.17.2 Checking for assumptions; Equal variances 
To check for equal variances, Levene’s test was used. When the test is significant 
(p≤0.05) the assumption of homogeneity of variance is violated whereas, if not 
significant (p>0.05), then the variances are equal and homogeneity accepted.147  
 
5.17.3 Checking for assumptions; When assumptions are violated 
When assumptions are violated transformation can be used to correct problems with 
the distribution and enable the use of a parametric test. However, this is a complicated 
procedure147 and often the reader finds interpretation of the results difficult.350 With a 
large sample, as in the current study, using a non-parametric test is only a little less 
powerful than using a parametric test.321 It was decided not to do transformation of 
the data when assumptions of the distribution were violated but use a non-parametric 
test instead. In some cases, where assumptions slightly deviated from normality but 
could still be accepted both parametric and non-parametric tests were used in the 
analysis. Finally, in the case where both normal distribution and equal variances could 
not be assumed then the non-parametric test was applied.  
 
5.18 Data analysis; Post hoc analysis and multiple testing 
In the case where a statistical significance was found between more than two groups 
then, in order to identify between which groups the difference laid, a post hoc test 
was done.275 Post hoc analysis is only appropriate for a two-tailed hypothesis.147  
If multiple significance tests are applied to the variables then the possibility of a Type I 
error increases the risk that one in 20 of tests on the same sample may be found 
significant due to chance.28  A Type I error is when a genuine effect in the population is 
believed but, in reality, there is no such effect (i.e. wrongly supports the alternative 
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hypothesis).  A Type II error is when no effect in the population is believed but, in 
reality, there is one (i.e. wrongly supports the null hypothesis). As Type I error 
decreases, the probability of making a Type II error increases.147 It is essential that the 
post-hoc test corrects for Type I error. Often multiple tests are done for separate 
individual tests (maybe examining different hypotheses but using the same variables), 
so the variables, though appearing independent, may not be independent. In these 
cases, Bonferroni can also be used to reduce Type I error.28,351  
There are different methods of multiple testing. The Bonferroni correction corrects the 
cut-off point for multiple testing, controls very well for Type I error but it is found to be 
a conservative test.147,351 Bonferroni is easy to conduct as it is mainly a division of the 
alpha level to the number of comparisons: if α=0.05 and the number of comparisons 
10 then for the test to be significant it should be α=0.05/10=0.005. When the 
statistical test used is not parametric (e.g. chi square), then the most appropriate 
method to use is the Bonferroni correction.275 Because the test is conservative one can 
be selective about the number of two-group comparisons to be made147 which will 
result in a less conservative level of alpha value after Bonferroni correction.   
Apart from being used for post hoc analysis, Bonferroni correction has also been used 
while doing multiple correlations.4,91,344,436 Games-Howell is an accurate post-hoc test 
for controlling Type I error when the sample has unequal variances and also when 
sample sizes are unequal but it is too liberal when sample sizes are small. Field147 
recommends running Games-Howell in addition to any other selected post hoc test.  
In this study, the following were made in relation to multiple testing:  
1) When using multiple correction for many separate individual tests conducted; 
At the beginning of each result’s chapter (Chapters 6 – 9) the number of times 
a variable of interest is involved in individual tests is given. The alpha level for 
each variable is set accordingly using the Bonferroni correction;  
2) When using multiple correction for post hoc pair comparisons (done to identify 
where the significance is after one single test);  
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a. If a statistical significance was found after having used a non-parametric 
test then Bonferroni was used (by hand calculation); 
b. If a statistical significance was found after having used a parametric test 
then post hoc tests were provided as an option on the SPSS programme. 
If only a few pair-comparisons needed to be done then Bonferroni was 
calculated manually.  
3) Games-Howell was used, for cross – checking, in all cases as an additional post 
hoc. It will only be reported if there are discrepancies between the post hocs.  
 
5.19 Data analysis; Sample size 
A sample size calculation was conducted prior to the data collection for this study and 
185 people were identified to participate (Section 5.6.1). This number of participants 
was exceeded. When comparing between groups, the size of each group may be of 
importance for the selection of the statistical test to be used. Some people consider a 
group size to be large if more than 50 people are included,350 whereas others will do so 
if more than 30 are included.265 This study usually had a large number of people in 
each group (>50) when making comparisons or checking for relationships. On the 
occasions where group sizes were small or very small then non-parametric tests were 
used.  
 
5.20 Data analysis; Significant testing and alpha level 
There are three types of significance; the statistical, the practical and the clinical 
significance.445 A statistically significant test is used in order to explore the likelihood 
that a hypothesis about a group is true or not true.351 Usually the null hypothesis is 
tested and this is generally called Null Hypothesis Significance Testing (NHST).78 To 
measure the result of the NHST the p-value is used. The level of the p value is the 
alpha level (α-level) which is the probability of making a Type I error.147 Usually, the α-
level chosen is 0.05 which means that there is 5% probability of wrongly supporting 
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the alternative hypothesis.147 The alternative hypothesis can be two-tailed, which 
allows for the relationship between the variables examined either way. Or it can be 
one-tailed, which allows it only to be in one direction.351 One-sided hypotheses should 
be avoided unless there is clear justification for doing so.351  
Because statistical significance has been negatively criticised over the past few 
decades, practical and clinical significance have been proposed. Practical significance 
evaluates the relationships by explaining the practicality of the findings and it uses 
effect sizes to do so.445 Clinical significance indicates if an intervention makes a 
difference to people’s everyday lives.445  
As no intervention was applied in this study, clinical significance was not applicable. 
But, both the statistical and practical significance have been evaluated for all research 
hypotheses. For statistical significance the α-level chosen was set to p≤0.05. This, 
however, changed depending on the Bonferroni correction. As there was no prior 
evidence in the literature that could justify the use of one-tailed testing for most of the 
variables under examination in iSCI, all tests were two-tailed.   
 
5.21 Data analysis; Effect size  
The NHST has been criticised as not adequately answering the questions, leading to 
misinterpretation of findings and not properly evaluating the importance of the 
results.78,146,445,492 For a null hypothesis to be true the effect size (ES) should be 0 but 
this can never be really true because two random samples will always have some small 
difference in their means.78 Since the ES can never be 0 in reality the null hypothesis 
can never be true either. The p-value “accepts” or “rejects” the null hypothesis, which, 
then, can be misleading.78,147,492 A better explanation of the findings can be given if the 
ES and the confidence intervals (CI) are also reported.78  
The effect size gives information on the strength of a relationship between the IV and 
a DV.264 It is considered an “index of degree of departure from the null hypothesis”.79 
The larger the ES, the greater the power of the test and the smaller the size of the 
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group needed to identify a relationship.79 Generally, there are four major categories of 
ES146 but two are the most commonly used, the “r” and the “d” family. The “r” family 
expresses the ES in strength of association146,264 and the “d” family expresses the ES in 
terms of difference between two or more groups.79  
One of the following, ES, has been used for each research hypotheses in this study 
depending on the statistical test used: 
 From the “d” family the most commonly used is Cohen’s d which is used when 
data is categorical.146 It is recommended to use Kendall’s τ when data is 
ordinal;146   
 When conducting ANOVA the ES of choice should come from the “eta” (η) or 
“omega” (ω) categories.  SPSS by default only calculates the partial eta-squared 
when ANOVA is conducted, but this type of ES is considered to be 
inappropriate for use in ANOVA.340 In between group designs the Omega 
squared (ω²) should be the ES of choice.340 Unfortunately, this is not calculated 
in SPSS and it is complicated to do by hand. Eta squared (η²) can also be used 
with ANOVA, and although it may slightly overestimate the effect,340 it is much 
easier to do manually and for this reason was preferred; 
 When using Pearson’s correlation the ES used was the “r” and when using 
Spearman’s ρ correlation the ES used was the “ρ”. The value range for the “r” 
and “ρ” are identical;146  
 When chi-square goodness of fit or independent chi-square are used the most 
appropriate ES to use is the phi (φ).  When for a table greater than 2x2 then 
Cramer’s v is preferred;79,264 
 When the Mann-Whitney U test was used then the effect size was computed 
by converting the z to r using a given formula.147,264  
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5.22 Data analysis; Confidence interval (CI) 
When studying the mean of groups it is of interest to use the mean of the group as an 
estimate of the value in the population.147 The means of the groups can have different 
values and by calculating the boundaries within which the true value of the mean is 
believed to be then the accuracy of the mean is assessed.147 These boundaries are the 
confidence intervals (CI). Typically, a 95% CI is used which suggests that one can be 
95% confident that the true value of the mean of the population lies within the CI 
given.28,351 CI can take other limits like 99% or 90%.8,147,351 The CI can be used in the 
following ways: 
 The 95% CI is usually used for large groups (n>100 for total group);351  
 If the group size is smaller then the data need to be normally distributed and 
the t-distribution is used to calculate the CI.147,351 If data are skewed then the CI 
can be calculated by the median, which if done in small groups can be rather 
wide, but it is preferable to using the mean if data are skewed;8  
 In the case when CI is calculated for proportions then a large group size (to 
enable 95% CI) is when the number of responses with the condition (r) (e.g. 
people with pain) and the n-r (where n=total number of participants) are in 
both cases greater than 5;351   
 To calculate CI for correlation the r needs to be converted into a z value, using 
a formula to identify the CI limits which are then back converted in to r 
values.147 This formula was used to find the CI of all related correlations in the 
current study. The Fisher transformation can also be used to calculate the CI for 
Spearman’s correlation.  
When interpreting results the following need to be taken into account:  
 For the p value to be significant the CI must not include zero;8  
 When the CI of the mean is small then the mean of the group is a good 
representative of the true mean of the population.147 
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In this study, 95% CI were calculated for means, proportions and correlations for all 
hypotheses.  
 
5.23 Methods of analysis for translation and validation of SCIM III 
into the Greek language 
It is important that when translating and validating a measure in one language or 
validating it for use under different circumstances to evaluate its reliability and 
validity.  
 
5.23.1 Reliability 
There are five general types of reliability, 1) inter-rater, 2) test-retest, 3) parallel forms, 
4) internal consistency and 5) sensitivity to change. Inter-rater reliability is given by the 
result of agreement on one item between two or more raters.36 Test-retest reliability 
measures the ability of the test to remain stable over a period of time.36,447 Parallel 
forms reliability checks how consistent the results of two tests that are constructed in 
the same way from the same content, are.447 Internal consistency investigates the 
homogeneity by looking at the extent to which the questions (items) relate to a 
particular dimension (construct) in a measure.36,447 Finally, sensitivity to change is the 
ability of the measure to capture a change in the outcome of the people who complete 
the measure.36 
 In this study, inter-rater, test-retest and sensitivity to change reliability could not be 
performed due to the design of the project. Internal consistency was tested. There are 
various ways to test internal consistency; Cronbach’s alpha (α), multiple form, half 
split, item-item and item-total.36 The most commonly used is Cronbach’s α which 
produces an estimate of reliability using all possible correlations. The “rules of thumb” 
for Cronbach’s α are: >0.9 Excellent, >0.8 Good, >0.7 Acceptable, >0.6 Questionable, 
>0.5 Poor and <0.5 Unacceptable.164 In the case of research tools a satisfactory 
Cronbach’s α is between 0.7 and 0.8 but in the case of a clinical situation a higher 
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Cronbach’a α is recommended (minimum 0.90).27 For this study, a 0.7-0.8 level is 
satisfactory.   
Cronbach’s α can be affected by multidimensionality which affects its precision, thus it 
should be used when there is only one single common factor in order to measure the 
strength of this factor.83 Therefore unidimensionality should be established first by 
principal component analysis (PCA).83 PCA was used in the present study to confirm 
the unidimensionality of SCIM III for the Greek version before applying the Cronbach’s 
alpha to check for internal validity. The same was done for the English version despite 
the fact that the original version of SCIM III had established unidimensionality of the 
subscales by using factor analysis.65 This was done because in the current study SCIM 
III was used under different conditions (by self-reporting).  
PCA reveals the underlying structures in complex data sets and it identifies the 
importance of each dimension of the data.403 The assumptions for PCA are; 1) data is 
normal to the extent that skewness or outliers do not affect the observed correlations 
or the tests performed and 2) data should be correlated in a linear way.264 Linearity 
was checked via scatterplots. For conducting PCA two tests are taken into account; the 
Kaiser-Meyer-Olkin measure of sampling adequacy (KMO) test which tells if enough 
items are predicted in one factor. Its values range from 0 to 1, a value near 0 can 
indicate that factor analysis is inappropriate for the data and a value near 1 that the 
factors are reliable. Values below 0.5 should not be accepted, 0.7 - 0.8 are good and 
0.8 - 0.9 are excellent and above are superb.147 The second test conducted was the 
Bartlett’s test of sphericity which should be significant to indicate that the variables 
are correlated enough to give a reasonable basis for doing factor analysis.264  
 
5.23.2 Validity 
There are many types of validity but the main four are 1) criterion, 2) concurrent, 3) 
construct and 4) content validity. The first two can be grouped together. Criterion 
validity refers to how much the measure under examination correlates with another 
measure already accepted and validated. Concurrent validity, which is part of the 
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criterion validity, investigates if the measure actually measures what it intends to 
measure.36 In this study criterion/concurrent validity could be examined for two of the 
subscales of SCIM III which were similar to two of the subscales of EQ-5D; self-care and 
mobility.  
Construct validity is the degree to which conclusions from the study can be correctly 
drawn according to the theoretical constructs that they were based on.447 In other 
words, the test actually measures what it is designed to. Construct validity can be 
examined by checking if the expectations of the results have been achieved, by using 
correlation matrices and with factor analysis. When two tests are designed to measure 
the same construct a good correlation between them is predicted.89 In this study, this 
was examined via concurrent validity in which two of the subscales of SCIM III and EQ-
5D were tested for correlation. According to Cronbach and Meehl,89 another way to 
support construct validity is to examine the internal consistency and homogeneity of 
the measure. They claimed than even if correlations are low but they are consistent 
this can give support to the fact that the sample is describing a generalised tendency.89 
As explained earlier, internal consistency was determined by applying Cronbach’s α 
and homogeneity by applying PCA.   
Finally, content validity is the extent to which the content of the measure is logical 
enough to examine the characteristics or concept that it intends to examine. This is 
achieved by judgements from the panel who develop the measure.36 As SCIM III was 
previously developed and examined for its content validity this was not examined 
further in the current study.  
 
5.24 Additional note on presentation of results 
All results that pass the α-level ≤0.05 will be presented in the tables in the results 
chapters and in the appendices. Those, however, that pass the Bonferroni correction 
level will be in bold. These will be considered the statistically significant results for the 
study. In post hoc multiple comparison analysis the statistically significant level 
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calculated for the particular analysis will be given each time, and the results passing 
the significance level will also be marked in bold.     
 
5.25 Conclusion 
This chapter explored the methodological background and described in detail the 
methods followed in order to collect data appropriate to answer the aim, questions 
and hypotheses of this project. Cross-national research has been considered a valuable 
method of research for many years and internet research is now used more 
frequently. Both types have advantages and disadvantages which have been presented 
in this chapter focusing on the steps taken to reduce bias and increase RR. This chapter 
also presented the methodology of the statistical analysis followed including that for 
examining the psychometric properties of SCIM III.  
The next chapter is the first of four chapters to present the data analysis of the survey. 
This chapter will describe the socio-demographic profiles of the group and examine 
the experience of pain focusing on LBP.  
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Chapter 6; Results: Demographic profile and pain 
characteristics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
"Aw, people can come up with statistics to prove 
anything, Kent. Forty percent of all people know that." 
- Homer Simpson, from The Simpsons episode: "Homer 
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6.0 Introduction 
The previous chapter described in detail the methodological steps followed to achieve 
data collection. In addition, the selection of the specific standardised tools used was 
justified and a description of the methods employed for statistical analysis explained.  
This chapter is the first of a series of four to present results. Its main aim is to respond 
to the thesis’s primary research question “Do people with iSCI have LBP, and what is 
their present and usual pain experience?” The chapter divides in two parts; part 1 will 
perform the analysis of the translation of the socio-demographic profile section of 
the questionnaire and will continue with presenting the findings of the profiles of the 
respondents. The second part will focus on the characteristics of LBP in relation to 
its quality and intensity. In addition, pain location and extent on the body will be 
examined in this chapter. 
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Part 1; Translation and respondents’ profiles 
 
6.1.1 Translation and piloting of socio-demographic profile 
questions 
There were five forward translators19, who were given the original version of the 
questionnaire. They were of Greek origin, living in the UK for a mean of 7.7±5.2 
(mean±SD) years, thus having a good knowledge of the English language and culture. 
They needed 6.8±4.6 (mean±SD) hours to translate the questionnaire including time to 
give feedback.  For each question they were asked to rate the difficulty of translating it 
on a 0-10 NRS ranging from “very easy” to “the most difficult” to translate. The overall 
difficulty of translating the questionnaire was low (2.6±2.6, mean±SD) with the easiest 
questions rated as 0.4±0.5 (mean±SD) and only one rated as moderately difficult 
(4.6±3.0, mean±SD) to  translate (Appendix 5: Table 5.1.1). 
Feedback from the forward translators led to some format changes in the 
questionnaire. The back-translator20 was an English teacher of Greek origin, who had 
been living in the UK for 10 years. She spent 13 hours on the back-translation, rarely 
used the dictionary and rated the easiness of the translation as 4 (0-10 NRS). The pilot 
of the questionnaire led to minor reformatting. Some important changes following 
translation, feedback and piloting can be found at Appendix 4. Following the second 
pilot stage21, given to the Greek group, the most important changes can be found at 
Appendix 4. The final Greek questionnaire can be found at Appendix 3. 
                                                     
19
 Forward translation is the procedure for translating a document from its original language to the 
target language; in this case from English into Greek. For details see Chapter 5. 
20
 Back-translation is the procedure for translating the document from the target language back into the 
source language; in this case from Greek into English. For details see Chapter 5. 
21
 For details on the sequence of the pilot stages see Chapter 5. 
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6.1.2 Results; data cleaning 
During the first stage of data analysis, while conducting EDA22, the data were checked 
for responses that were not appropriate to enter in the analysis. In total 282 people 
returned the questionnaire either online or via the post but 219 entered the data 
analysis (Table 6.1.1). The initial plan of the study was to recruit participants from 
Canada as well, however collaboration with a Canadian association could not be 
established at the time and no Canadian online site was identified, thus making 
recruitment from this particular country inappropriate. Six Canadians completed the 
survey (via other websites) but it was a very small group and it was therefore decided 
to exclude them. Four further people from various countries were identified but 
excluded.   
A further 20 people (7.1% of initial group) were excluded because they had stated that 
they did not know the type of their injury. Their responses were double checked and 
the author believes that 16 of them could possibly have incomplete injuries (5.7% of 
initial group). Of these 20 people, 13 came from the USA (8.6% of USA initial group), 
five from Greece (8.6% of Greek initial group) and two from the UK (3% of UK initial 
group – 2/77). Three people (1.1%) completed less than 50% of their questionnaire 
and were excluded.   
Twenty eight people with a complete injury completed the survey but analysing their 
data were beyond the scope of the study, hence these questionnaires were excluded.  
Many people viewed the survey online but dropped out before completing it, in total 
there were 283 people from all three participating countries. Thirty six (36%) of them 
gave information about their pain presence: 34% had pain post their injury and 2% did 
not have pain. The remaining 64% of those who dropped out did not give any 
information about their pain status. The data from the dropped out respondents were 
not analysed further as it was beyond the scope of the study.  
                                                     
22
 For details about EDA see Chapter 5, Section 5.13.2 
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As explained in Chapter 4, there are difficulties with precisely calculating the return 
rate of questionnaires for surveys which follow an online methodology but a 
calculation of “complete rate” was made based on how many people viewed the 
survey online and how many completed it. The highest online completion rate was 
from the UK (52.3%) followed by the USA (43.3%) (Table 6.1.1). 
Table 6.1.1: Completed, returned and excluded questionnaires 
 
Arm 
country 
Web survey Mail 
questionnaires 
returned 
 
Excluded from study 
(both from e-survey 
and paper survey) Number of 
people who 
viewed all or 
part of the 
questionnaire 
Number of 
people who 
completed the 
questionnaire 
Complete 
rate (%) 
USA 344 149 43.3% 1 Complete injury n=28 
Type of injury not 
known n=20 
Other country n=10 
50% missing data n=3 
Non SCI n=2 
UK 132 69 52.3% 5 
Greece 37 12 32.4% 46 
Total  513 230 44.8% 52  
Total completed questionnaires: 282  
Excluded questionnaires: 63  
Total included in study: 219  
  USA n=122 
  UK n=52 
  GR n=45 
 
 
6.1.3 Bonferroni correction 
As explained in Chapter 5 (Section 5.18), Bonferroni was used in two ways; 1) for post 
hoc analysis and 2) when multiple independent tests were conducted using the same 
main variable of interest. In the current chapter, depending on the number of multiple 
tests done on the variable of interest the α-level of statistical significance set by 
Bonferroni ranged from p≤0.005 – 0.007 (Appendix 5: Table 5.2.1).   
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6.1.4 General results 
Two hundred and nineteen (219) respondents completed questionnaires which were 
included in the data set. They were mainly males (62.3%), with an average age of 
50.3±14.4 (mean±SD) years. Mean time since injury was 11.6±10.7 (mean±SD) years 
and mean age at injury was 38.6±16.2 (mean±SD) years. The majority were married 
(57%). Their education level varied from high school (24.1%) to college (21.8%) or 
university degree (21.8%). Most respondents were either employed (28%) or retired 
(24.2%), while many reported that they could not work due to their iSCI (25.1%). For 
those who worked, the mean working hours per week were 24.2 ±13.3 (mean±SD) 
(Table 6.1.2).   
Cause of injury was mainly traumatic (70.8%), with road traffic accidents accounting 
for half of the injuries and sport injuries for 21.4%. Falls were responsible for 9.6% of 
the injuries and happened in various places including work, home, stairs or due to a 
slippery surface. Among the non-traumatic causes of injury, degenerative conditions 
were the most common (21.9%) (mainly osteoporosis), followed by a vascular cause 
(18.8%) and then by a spinal deformity (12.6%). For 18.8% of the cases, more than one 
reason was the cause of the non-traumatic injury (Table 6.1.3). 52.9% of respondents 
had an incomplete paraplegia.  
 
6.1.5 Pain, MSKP and LBP prevalence  
The respondents were asked to report on their pain in general and other types of pain 
in particular including MSKP, LBP and BP. They could choose all types of pain that 
applied to them. A very high number of the respondents (91.3%) reported having pain 
in general. Eightly three participants reported having MSKP which was a prevalence of 
38.8%. Among people with pain only, the prevalence of MSKP rose to 42.6% (Table 
6.1.4). Some further information related to participants’ characteristics, not analysed 
in detail at present, can be found at Appendix 5, Table 5.3.1.  
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Table 6.1.2: General demographic profile of the survey respondents  
*Total sums to greater than 100% as respondents were allowed to choose more than one 
option. Abbreviation: SD, Standard Deviation.  
 
Variable  (n=number of responses)                                                                Mean ± SD, % or min-max 
Sex (M/F) (n=215) 62.3/37.7 
Age (years; mean ± SD; min-max) (n=211) 50.3 ± 14.4,   19.8-91.7                                                      
Time since injury (years, mean ± SD, min-max) (n=218) 11.7 ± 10.7,      0.3-44.2 
Age at injury (years, mean ± SD, min=max) (n=210) 38.6 ± 16.2,      0.0-78.3 
Ethnic group (%)  
    White – UK 
    White Greek 
    Other White or other European 
    White American (including American Indians, Spanish/Hispanic)   
    Other Asian 
    Black; Caribbean, African & other Black 
    Mixed – White & Asian/Other mixed  
 
22.4 
21.0 
38.3 
12.2 
1.4 
0.9 
3.3                   
Mother Tongue (%) (n=218) 
    English 
    Greek 
    Other 
 
75.7 
20.2 
4.1 
Marital status (%) (n=214) 
    Married 
    Living with partner 
    In a relationship 
    Separated/Divorced 
    Widowed 
    Single 
    Other 
 
57.0   
6.5      
2.8     
8.9 
6.5 
17.8 
 0.5 
Education (%) (n=216) 
     PhD or equivalent 
    Master’s 
    University Bachelor Degree 
    College or equivalent 
    High School 
    Other 
    No diploma/degree 
 
3.2 
13.9  
21.8 
21.8 
24.1 
4.2 
11.1 
Employment (%)* (n=219) 
    Employed 
    Self-employed 
    Voluntary work 
    Working from home 
    Receive health benefits 
    Looking for a job 
    Unemployed but was working before iSCI 
    Unable to work due to iSCI 
    Unemployed and never had a paid job 
    Homemaker 
    Retired 
    Student 
    Other 
    Working hours per week (mean ± SD, min-max) (n=53) 
 
27.9 
15.5 
11.0 
9.6 
19.2 
5.0 
16.0 
25.1 
0.9 
6.8 
24.2 
4.6 
5.0 
24.2±13.3   
Type of injury (%) 
 Incomplete tetraplegia (n=100) 
Other incomplete tetraplegia (n=3) 
Incomplete paraplegia (n=112) 
Other incomplete paraplegia (n=4) 
 
45.7 
1.4 
51.1 
1.8 
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Table 6.1.3: Cause of injury  
    Cause                                                                    %                                                                 Cause                                                                          %  
Cause of injury (n=219)  
    Traumatic (n=155)                                             70.8 
 
Non-Traumatic (n=64)                                                  29.2 
Cause of Traumatic Injury (n=154) 
    Road Traffic Accident                                             
        Bicycle Accident 
Car Accident 
Motorbike/ATV Accident 
Pedestrian Accident 
    Gunshot/other violence accident 
    Work Related Accident 
Falling off 
Ladder/Stair/scaffolding/other 
    Domestic Related Accident 
Falling down Stairs 
Falling out of Window 
Slippery Floor/trip over object on floor 
    Sport Accident 
Climbing 
Diving 
        Horse Riding 
Motorbike Racing 
Skydiving/paragliding 
Swimming/body surfing/scuba diving 
Skiing/snow boarding 
Other sport related 
Other Traumatic Cause of Injury 
 
50.0 
5.8 
30.5 
11.7 
1.9 
1.9 
2.6 
 
2.6 
7.1 
3.2 
0.6 
3.2 
21.4 
1.3 
5.2 
1.9 
2.6 
3.2 
1.8 
2.6 
2.5 
5.8 
Cause of Non-Traumatic Injury  (n=64) 
Vascular 
    Embolism 
    Epidural Haemorrhage 
    Other vascular 
Cancerous 
Inflammations & Infections 
    Sacroidosis 
    Transverse Myelitis 
Degenerative 
    Osteoarthritis 
    Osteoporosis 
    Rheumatoid Arthritis 
    Other degenerative 
Spinal Deformity 
    Kyphoscoliosis/Spinal Bifida 
    Spondylolisis/Spinal hernia/Spinal stenosis 
Other Neurological 
    Cerebral Palsy/Multiple Sclerosis 
Other not above 
More than one of the above reasons 
Medical mistake at surgery 
 
18.8 
6.3 
3.1 
9.4 
4.7 
7.5 
1.6 
4.7 
21.9 
3.1 
10.9 
6.3 
1.6 
12.6 
3.2 
9.4 
4.7 
4.7 
7.8 
18.8 
4.7 
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LBP could be established for four time periods; 1) occurrence of LBP at any time post 
iSCI (Life prevalence LBP post iSCI) which was reported at 73.5% for the total group 
(80.5% among people with pain only), 2) current LBP at the time of completing the 
questionnaire (Point prevalence LBP) which was reported as 67.9% (74.6% among 
people with pain only), 3) LBP over the last 1 month (1 month LBP prevalence) 
reported as 68.4% (75.1% among people with pain only) and 4) LBP over the last 3 
months (3 months LBP prevalence) reported 70.1% (77.1% among people with pain 
only) (Figure 6.1.1). Throughout this chapter, in most cases, all types of LBP time 
period prevalence were used in the analysis. However, analysis in the following 
chapters will only examine “current LBP prevalence”. The reason for selecting this LBP 
prevalence was twofold, first, because it does not raise issues related to memory bias 
and, second, because in general current prevalence is most commonly reported in the 
literature and thus comparisons to other studies may be feasible.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1.1: Percentage of people reporting pain categories examined. 
Abbreviations: LBP, Low back pain. 
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Significantly more people reported pain post their iSCI (n=200) than no pain (n=19), 
prevalence 91.3% (95% CI 86%, 94%, p≤0.001, χ²=149.5, goodness of fit chi-square,) 
and the effect of this difference was larger than typical (ES φ=0.82). Similarly, 
significantly more people reported having back pain (n=165) than those who did not 
(n=49), prevalence 77.1% (95% CI 71%, 82%, p≤0.001, χ²=62.87, goodness of fit chi-
square) representing a larger than typical effect (ES φ=0.54). 
The primary research question aimed to investigate if people with iSCI had LBP and 
what was their present and usual LBP. The primary hypothesis was:  
Hypothesis 0 (null): In people with iSCI there is no significant difference in the 
percentage of those with LBP and those without.  
Hypothesis 1: In people with iSCI there is a significant difference in the percentage of 
those with LBP and those without. 
More people reported having LBP since iSCI onset (n=161) compared to those who did 
not (n=58), prevalence 73.5% (95% CI 67%, 78%, p≤0.001, χ²=48.44, goodness of fit chi-
square, ES: φ=0.47). More people reported having current LBP (n=144) than those who 
did not (n=68), prevalence 67.9% (95% CI 61%, 73%, p≤0.001, χ²=27.24, goodness of fit 
chi-square, ES: φ=0.35). More people reported having LBP over the last month (n=145) 
than those who did not (n=67), prevalence 68.4% (95% CI 61%, 74%, p≤0.001, 
χ²=28.69, goodness of fit chi-square, ES: φ=0.36). Finally, more people reported having 
LBP over last 3 months (n=148) than those who did not (n=63), prevalence 70.1% (95% 
CI 63%, 75%, p≤0.001, χ²=34.24, goodness of fit chi-square, ES: φ=0.40,). In all cases 
the differences were statistically significant and the effect sizes were medium. The null 
hypothesis can be rejected. In the case of MSKP the opposite happened, significantly 
less people reported having MSKP (n=83) compared to those who did not have MSKP 
(n=131), prevalence 38.8% (95% CI 32%, 45%, p≤0.001, χ²=10.76, Chi-square goodness 
of fit) however, it had a small effect size (ES: φ=0.22).  
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6.1.6 Relationship between LBP and MSKP  
The type of pain felt in the lower back area was examined to see if it was related to 
MSKP. This hypothesis was not set at study onset but developed in the process. This 
was done by examining if a correlation between the two variables existed. The 
hypothesis was:   
 Hypothesis 0 (null): There is no significant association between LBP and MSKP in 
people with iSCI.  
Hypothesis new: There is a significant association between LBP and MSKP in people 
with iSCI.  
The Phi test (φ) was applied to a group of 213 people and a positive significant 
correlation of medium strength was found between LBP (lifetime) and MSKP, (p≤0.001, 
φ=0.331, 95%CI 0.23, 0.42), suggesting that the more people report LBP, the more 
people report MSKP. The same positive and statistically significant correlation was 
found between the other reported time periods of LBP and MSKP; between current 
LBP and MSKP: p≤0.001, (φ=0.33, 95%CI 0.23-0.45, n=207); between LBP over the last 
1 month and MSKP: p≤0.001, (φ=0.30, 95%CI 0.19, 0.39, n=210); and between LBP 
over the last 3 months and MSKP: p≤0.001, (φ=0.27, 95%CI 0.16, 0.37, n=207). The null 
hypothesis can be rejected as a positive correlation between MSKP and LBP has been 
shown.  
 
6.1.7 Pain, MSKP and LBP; relation to demographic profile 
characteristics 
People with and without the pain categories were compared for differences in their 
demographic profiles including sex, cause of injury, age, level of injury and time since 
injury. Two analyses were made; one included the total group of participants and one 
included only people with pain.  
Though women (n=76) reported MSKP and LBP significantly more often over the last 3 
months this failed to remain significant following the Bonferroni application (Table 
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6.1.4; Appendix 5: Table 5.4.1; Figure 5.4.1). Among people with pain only, no 
significant difference was found between males and females in their LBP presence over 
the last 3 months (Appendix 5: Table 5.4.2).  
The consensus report by IASP177 said that research hypotheses should be tested in 
both sexes. As seen in the paragraph above a difference between males and females in 
the MSKP and 3 months LBP was found but only pre-Bonferroni application. Therefore, 
further analysis will not be part of this main analysis. However, it was conducted in this 
case, and it is presented at Appendix 5. (Appendix 5: Table 5.4.3).  
Analysis showed that although some differences in the presence of the pain categories 
between people with traumatic and non-traumatic cause of injury were found, only 
one passed the Bonferroni level of significance (Table 6.1.4; Appendix 5: Figure 5.4.2 
and Tables 5.4.4, 5.4.5). A significantly higher proportion of people with non-traumatic 
cause of injury (78%) than those with a traumatic injury (64%) reported current LBP 
(p=0.003, χ2=4.37, Pearson’s chi-square) (Table 6.1.4).  
The only results strong enough to pass the Bonferroni significance when the level of 
injury was examined related to LBP presence. A significantly higher proportion of 
people with paraplegia reported LBP compared to people with tetraplegia; lifetime LBP 
post iSCI: 84% versus 62%, p≤0.001, (χ2=12.93, Pearson’s chi-square); current LBP: 77% 
versus 58%, p=0.003, (χ2=9.13, Pearson’s chi-square); LBP over the last 1 month: 78% 
versus 58% p=0.002, (χ2=10.06, Pearson’s chi-square); and LBP over the last 3 months: 
81% versus 58%, p≤0.001, (χ2=14.06, Pearson’s chi-square) (Table 6.1.4; Appendix 5: 
Table 5.4.6, Table 5.4.9; Figure 5.4.3).  
Neither age nor time since injury impacted significantly on pain as no statistical 
differences were found between people with and without the pain categories 
examined (Table 6.1.4). Time since injury was divided into groups to examine if the 
results in the present study would match the finding reported by Siddall et al406 that 
MSKP presents higher initially in the first 6 months post injury, then it drops and 
increases again at 5-years post injury. In the current study there were no participants 
who had sustained their injury  less than 3 months prior to the study, thus time since 
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injury was divided into groups of 3-6 months, 7-11 months, 1-5 years, 6-10 years, 11-
15 years, 16-20 years, 21-30 years and 30+ years. No significant difference was found 
in the mean time since injury between people with and without MSKP (χ²=4.34, 
p=0.73, df7, extended chi-square, n=212). Dividing the groups into fewer categories (3-
6 months, 7 months – 5 years, and 6 years and above), again no significant difference 
was found in the mean time since injury between people with and without MSKP 
(χ²=1.79, p=0.40, df2, extended chi-square, n=212).  
 
6.1.8 Pain and LBP; pain/LBP days, free periods, onset 
Among people with pain, nearly 62% said that they felt pain (in general) and 44% LBP 
on a daily basis over the last six months. These were followed by 14.4% feeling pain 
between 1-9 and 10-20 days per month and 26.3% feeling LBP 1-9 days per month 
(Figure 6.1.2; Appendix 5: Table 5.5.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1.2: Percentage of people reporting number of pain and LBP  
days felt per month. 
Abbreviations: LBP, Low back pain 
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Table 6.1.4: Summary results and statistics of categories of pain and demographic profile characteristics of the respondents   
 
¹People with this type of pain, **Significant at p≤0.01 level, ***Significant at p≤0.001 level; in bold: significant following application of the 
Bonferroni correction; ²not significant post Bonferroni correction 
Abbreviations: LBP, Low back pain.  
Statistical tests: χ², Chi-Square; t, independent t-test.  
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There was no question in this survey to specifically ask the number of MSKP days felt in 
a month. Looking at the differences in the number of pain days between people with 
and without MSKP provided some information on the impact of MSKP on the pain 
days. Out of the 195 people with pain, who replied to this question, people with (n=83) 
and without (n=112) MSKP did not differ on the number of pain days they reported per 
month (p=0.40, χ2=4.9, Pearson’s chi-square) (Appendix 5: Table 5.5.2). 
The participants were asked to indicate if since the start of their pain or LBP they had 
any pain/LBP-free week. An administrator error led to the possible loss of some 
responses related to the LBP-free week question, however the number of responses 
remained large (n=123). More than half of people who reported pain did not have any 
pain-free weeks and just below 10% reported being pain free most of the time.  Some 
40% of respondents said that their LBP was constant and only about 14% said they 
were LBP-free most of the time (Figure 6.1.3; Appendix 5: Table 5.5.3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1.3: Percentage of people reporting frequency of pain and LBP free weeks 
Abbreviations: LBP, Low back pain 
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Finally, people were asked to indicate the time of pain onset following their iSCI. Just 
under half of them (41.7%) said that pain started immediately after their injury; then, 
the new cases of pain dropped to just below 20% for the next 6 months. There was a 
low percentage of new pain cases between 6 months and 1 year, which slightly 
increased after 1 year (Figure 6.1.4; Appendix 5: Table 5.5.4). People were then asked 
particularly about their LBP onset which followed a similar pattern of onset during the 
first 6 months. LBP onset was common immediately after the injury (32.6%) and then it 
dropped to below 20% for the next few months. After 6 months post injury, the 
percentage of new LBP cases started increasing, particularly after 1 year.(Figure 6.1.4; 
Appendix 5: Table 5.5.4).  
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1.4: Percentage of people reporting time of pain and LBP onset post iSCI. 
Abbreviations: iSCI, Incomplete Spinal Cord Injury; LBP, Low Back Pain. 
 
As part of the second hypothesis theme it was hypothesised that: 
Hypothesis 0 (null): In people with iSCI there is no significant correlation between pain 
or LBP onset post iSCI and the number of pain or LBP days felt in a month. 
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Hypothesis 4a: In people with iSCI there is a significant correlation between pain onset 
post iSCI and the number of pain days felt in a month. 
Hypothesis 4b: In people with iSCI there is a significant correlation between LBP onset 
post iSCI and the number of LBP days felt in a month. 
The gamma test (γ) which assesses correlations between variables on an ordinal level 
was used. Among people with pain, the correlation between pain onset and pain days 
was negative and statistically significant, thus the earlier the onset of pain, the more 
the pain days felt in the month (γ=-0.27, p=0.003, n=186, gamma test). The same was 
found in the case of LBP onset post iSCI and LBP days felt in a month where the 
correlation was slightly stronger (γ=-0.29, p=0.002, n=137, gamma test). 
 
The only study in the literature to have discussed LBP onset post SCI371 found that 
87.5% of people with LBP reported LBP onset immediately post injury. In that study, 
people had a traumatic onset to their SCI and thus, to check if the findings of the 
current study would match the findings of Raissi et al,371 LBP onset was examined per 
cause of injury. Time of LBP onset post iSCI was divided into two groups: immediately 
after iSCI, and any other time. Only a 28.2% of people with a traumatic injury reported 
a LBP onset immediately post injury, which differs substantially from Raissi et al.371 A 
higher proportion of people with a non-traumatic injury (42.6%) reported an 
immediate LBP onset following iSCI (Table 6.1.5).  
 
 
Table 6.1.5: Time of LBP onset post iSCI reported by people divided into groups by 
cause of injury. Differences in reported time of LBP onset.  
 LBP onset 
immediately 
after iSCI 
Statistical 
Test 
LBP onset 
any time 
later 
Statistical Test 
Traumatic injury  28.4% n=27  
χ²=1.04 
p=0.30 
42.6% n=20  
χ²=17.69 
p≤0.001*** 
Non traumatic 
injury 
42.6% n=19 57.4% n=12 
***Significant at p≤0.001 level.  
Statistical tests: χ², Pearson’s Chi-Square. 
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Part 2; Pain extent and LBP experience 
 
6.2.1 Introduction 
The previous section of this chapter answered the first part of the study’s main 
research question about the presence of LBP in people with iSCI. This part of the 
chapter will explore the experience of pain focusing further on LBP. The experience of 
pain is divided in: 1) pain extent, 2) pain quality and 3) pain intensity. Quality and 
intensity of pain will focus on LBP.  
To remind the reader, data on LBP quality was collected via the PRI of the SF-MPQ. 
Data on LBP intensity was collected via the PPI of the SF-MPQ and a 0-10 NRS. Finally, 
data to examine pain extent was collected via the body chart.23 Of the 219 
respondents to this study, 200 reported having pain all of whom were asked to 
complete the body chart. Of the 200 people with pain, 161 reported having LBP and 
were asked to report on the quality and intensity of their LBP.   
 
6.2.2 Bonferroni correction 
In the current part of the analysis the number of multiple tests done on all the 
variables of interest was the same (n=13) thus the α-level of statistical significance set 
by Bonferroni was p≤0.0038 (Appendix 6: Table 6.1.1).   
 
6.2.3 Pain extent; general results 
The body chart was initially divided into 45 areas as discussed by Margolis et al.282 
Then these 45 areas were grouped into eight broader areas; 1) head, 2) neck and 
shoulders, 3) upper extremities, 4) front torso and genitals, 5) back, 6) buttocks, 7) 
thighs and 8) legs and feet. This grouping was reported in the study of Wideström-
                                                     
23
 For detail on the SF-MPQ see Chapter 5, Section 5.9.1 
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Noga et al488 and has been recommended by the ISCIPDS:B.483 According to 
ISCIPDS:B,483 further divisions to allow for more precise locations can be made, thus 
the back was divided into upper and lower area totalling 9 areas on the body chart 
(Figure 6.2.1).  
ISCIPDS:B483 encourages the division of some body areas, including the back, to right 
side, midline and left side. In this study the area of the back was divided into right side, 
left side and midline and the midline was defined as the line that included the spine 
and only a few centimetres around it. To ensure that this area was consistently 
measured in all respondents, data from the body charts were collected using a 
quadrille formatted screen. 
Using the instructions of the MPQ, respondents had to indicate if pain was “internal”, 
“external” or both. Some respondents failed to do this or they described pain using 
their own words. Notes were made accordingly. Of the 200 people who reported 
having pain, 10 did not complete the body chart at all leaving a group of 190 people 
suitable for analysis.  
There were occasions where the respondents had specified that they had pain in a 
particular area on their body but failed to mark this area on the body chart. This was 
corrected as appropriate whenever possible. 
The mean number of areas with pain based on the 45-area division (n=190) was 
7.82±7.03 (mean±SD) (Appendix 6, Figure 6.2.1). The mean number of areas with pain 
based on the 8-area division was 3.2±1.5 (mean±SD). Data from the 9-area division 
were used to examine differences or relationships between pain extent and other 
variables of interest. The mean number of areas with pain using the 9-area division 
was 3.3±1.7 (mean±SD). The most frequently reported area with pain was the lower 
back followed by the thighs and then the legs and feet (Table 6.2.1, Figure 6.2.2).  
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                     Head 
        Neck & shoulders 
       Upper Extremities 
       Front torso & genitals  
       Upper back 
                    Lower back   
                    Buttocks        
       Thighs 
       Legs   
  
 
Figure 6.2.1: Body chart divided into 9 areas (based on the 8 body-areas by Wideström 
-Noga et al488) 
 
A quarter of the respondents (24.7%) reported having two areas with pain on their 
bodies, closely followed by people with 3 pain areas (21.1%) (Appendix 6, Figure 6.2.2). 
In the upper back area, pain most commonly occurred at the left side (19%) and in the 
lower back area it mainly occurred in the midline (57.6%). When pain was at the 
buttocks, the midline area (defined as the area to include the anus) was the most 
common location for pain (34.7%) (Table 6.2.1). 
Finally, referring to the back area, pain was more frequently reported as “internal” 
followed by the combination of “both internal and external” pain. This was more the 
case for the midline area of the upper back and for all areas of lower back pain 
(Appendix 6, Table 6.2.1).  
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Figure 6.2.2: Percentage of people reporting pain per body areas. 
 
 
Table 6.2.1: Percentage of people reporting pain at the back and buttocks 
Pain on back area and buttocks¥ n 
(total 
n=190) 
Percentage of 
people with pain 
(%) (total n=190) 
Back area 
   Upper back right side  
    Upper back left side  
    Upper back midline  
    Lower back right side  
    Lower back left side  
    Lower back midline  
161 
21 
19 
34 
45¹ 
47¹ 
76¹ 
84.7 
11.0 
10.0 
18.0 
34.1 
35.5 
57.6 
Buttocks 
    Right buttock   
    Left buttock  
    Midline area buttock (including anus) 
107 
58 
59 
66 
56.3 
30.5 
31.0 
34.7 
¹Total responses in this case were n=132, ¥using 9-areas division 
 
 
6.2.4 Pain extent; relation to LBP and MSKP 
As expected, the mean number of areas with pain was larger for people with LBP 
compared to those without and a significant difference between the groups was found 
for all time points of LBP (Table 6.2.3). It was also found that among people with pain, 
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those with MSKP (n=83) reported significantly higher mean number of areas with pain 
than those without MSKP (n=112) (p≤0.001, Mann-Whitney U test).  
 
Table 6.2.3: Mean number of areas with pain in groups by pain presence. Differences 
between groups   
 Yes 
mean±SD, median, 
min-max, n 
No 
mean±SD, median, 
min-max, n 
Statistical test 
Lifetime LBP 
 
3.7±1.6  
4, 1-9 n=161 
1.9±0.9  
2, 1-5 n=39 
U=995.5 
p≤0.001*** 
Current LBP 3.7±1.7  
1-9 n=144 
2.3±1.3  
2, 1-6 n=49 
U=1672.5 
p≤0.001*** 
LBP over last 1 
month 
3.7±1.7  
4, 1-9 n=145 
2.2±1.3  
2, 1-6 n=48 
U=1595 
p≤0.001*** 
LBP over last 3 
months 
2.1±1.3  
4, 1-6 n=148 
3.7±1.7  
4, 1-9 n=44 
U=1390.5 
p≤0.001*** 
MSKP¹ 4.0±1.7 
4, 1-8, n=83 
2.8±1.3 
3, 1-7, n=112 
U=2546.5 
p≤0.001*** 
¹Three outliers eliminated; ***Significant at p≤0.001 level; in bold: significant following 
application of the Bonferroni correction.  
Abbreviations: LBP, Low Back Pain; MSKP, Musculoskeletal Pain.  
Statistical test: Mann-Whitney U test. 
 
6.2.5 Pain extent; relation to demographic profile characteristics 
People who completed the body chart were compared for differences or correlations 
in their demographic profile characteristics; sex, cause of injury, age, type of injury and 
time since injury. Females reported significantly more areas with pain than males: 
3.8±1.6 versus 2.9±2.4, p≤0.001, (t=-3.68, 95% CI -1.32, -0.40, independent t-test) 
(Table 6.2.4). No other significant differences or correlations were found between the 
number of areas with pain and the participants’ demographic profile characteristics 
(Table 6.2.4, Appendix 6: Table 6.3.1 and Figures 6.3.1-6.3.3).  
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Table 6.2.4: Mean number of areas with pain in groups by demographic profile 
characteristics. Differences and correlations between groups.  
Demographic Number areas of pain  
(range 1-9) mean±SD, n 
Statistical Tests 
Sex¹ 
  Male 
  Female 
 
2.9±2.4, n=118 
3.8±1.6, n=70 
t=-3.68 
p≤0.001*** 
95% CI -1.32, -0.40 
Cause of Injury² 
  Traumatic 
  Non-traumatic 
 
3.2±1.5, n=131 
3.3±1.5, n=59 
t=-0.43  
p=0.66 
95% CI -0.10, 0.24 
Age  r=-0.46 
p=0.54, n=211 
Type of injury 
  Tetraplegia 
  Paraplegia 
 
3.3±1.9, n=84 
3.4±1.5, n=106 
t=-0.57 
p=0.56 
95% CI -0.64, 0.35 
Time since injury  r=0.08 
p=0.22, n=218 
¹Three outliers were eliminated, ²Four outliers were eliminated; ***Significant at p≤0.001 
level; in bold: significant following application of the Bonferroni correction.  
Statistical tests: t, independent t-test; r, Pearson’s correlation. 
 
As it was found that females reported significantly more mean number of areas with 
pain than males gender was examined further. It was found that for both males but 
also females, people with LBP (all time periods) or MSKP reported more mean 
numbers of areas with pain compared to those without LBP maintaining significance 
post Bonferroni application in most cases (Table 6.2.5).  
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Table 6.2.5: Mean number of areas with pain in groups with or without LBP or MSKP 
 Males Females 
LBP or MSKP 
presence 
Yes 
mean±SD, 
median, min-
max, n 
No  
mean±SD, median, 
min-max, n 
Statistical Test Yes 
mean±SD, 
median, min-
max, n 
No  
mean±SD, 
median, min-
max, n 
Statistical Test 
Lifetime LBP 
 
3.5±1.6  
3, 1-9 n=90 
1.6±0.7  
1.5, 1-3 n=26 
U=334.0¹ 
p≤0.001*** 
4.1±1.6  
4, 1-8 n=59 
2.2±0.9  
2.5, 2-5 n=10 
t=-3.63, df67² 
p=0.01 
95% CI -2.94, -0.85 
U=92.5 
p≤0.001*** 
Current LBP 3.3±1.4  
3, 1-6 n=81 
1.7±0.8  
2, 1-6 n=29 
U=402.0³ 
p≤0.001*** 
4.1±1.6  
4, 1-8 n=54 
2.5±0.9  
4, 1-8 n=13 
t=-3.43, df654 
p=0.01 
95% CI -2.58, -0.68 
U=144.5 
p≤0.001*** 
LBP over last 
1 month 
3.5±1.6  
2, 1-6 n=82 
2.1±1.2  
2, 1-6 n=34 
U=646.0 
p≤0.001*** 
4.0±1.6  
4, 1-8 n=56 
2.3±1.0 
3, 1-4 n=11 
t=-3.31, df654 
p=0.025 
95% CI -2.70, -0.67 
LBP over last 
3 months 
3.3±1.4  
3, 1-6 n=82 
1.8±0.9  
2, 1-4 n=30 
U=489.0 
p≤0.001*** 
4.0±1.6  
4, 1-8 n=57 
2.2±0.9  
2.5, 1-3 n=10 
t=-3.55, df65¹ 
p≤0.015 
95% CI -2.92, -0.81 
MSKP 3.6±1.8  
3, 1- n=43 
2.8±1.4  
2, 1-91 n=74 
t=-2.9, df115 
p≤0.001*** 
95% CI -1.4, -0.2 
4.6±1.7  
3, 2-9 n=38 
3.0±1.4  
3, 1-7 n=31 
t=-4.05, df67 
p≤0.001*** 
95% CI -2.3, -0.7 
¹Two outliers eliminated, ²One outliers eliminated, ³Six outliers eliminated, 4Three outliers eliminated; ***Significant at p≤0.001 level,  
in bold: significant following application of the Bonferroni correction; 5not significant post Bonferroni correction 
Abbreviations: LBP, Low Back Pain; MSKP, Musculoskeletal Pain. Statistical tests: U, Mann-Whitney U test; t, independent t-test. 
 Chapter 6: Survey; results; demographic profile and pain characteristics 
 
177 
6.2.6 Pain extent; pain/LBP days, free periods, onset 
Analysis showed that the more areas with pain felt on the body, the more the days of 
pain or LBP felt per month (p≤0.01, ρ=0.33, n=182 and p=0.004, ρ=0.24, n=143, 
Spearman’s correlation) but these correlations were not significant following 
application of the Bonferroni correction, though for LBP days it was very near 
significance (Figure 6.2.4, Appendix 6: Table 6.4.1).  
In addition, it was found that the more the number of areas with pain, the less 
frequent the number of pain-free weeks (p≤0.001, ρ=0.25, n=170, Spearman’s 
correlation) (Figure 6.2.4; Appendix 6: Table 6.4.2). This similar positive correlation did 
not pass the Bonferroni α-level in the case of LBP free weeks (p=0.009, ρ=0.25, n=110, 
Spearman’s correlation) (Figure 6.2.5, Appendix 6: Table 6.4.2).  
 
 
Figure 6.2.4: Mean number of areas with pain in groups divided by pain/LBP  
days felt per month.  
Abbreviations: LBP, Low Back Pain. 
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Figure 6.2.5: Mean number of areas with pain in groups divided by frequency  
of pain/LBP free weeks.  
Abbreviations: LBP, Low Back Pain. 
 
As part of the second hypothesis theme, which related to the onset of pain/LBP, it was 
hypothesised that: 
Hypothesis 0 (null): In people with iSCI there is no significant correlation between the 
number of areas with pain and the onset of pain or LBP post iSCI.  
Hypothesis 5-pain: In people with iSCI there is a significant correlation between the 
number of areas with pain and the onset of pain post iSCI. 
Hypothesis 5-LBP: In people with iSCI there is a significant correlation between the 
number of areas with pain and the onset of LBP post iSCI. 
Following application of the Bonferroni correction, no significant correlation was found 
in the case of pain onset (p=0.042, ρ=-0.15, n=187, Spearman’s correlation, 95%CI         
-0.28, -0.02) (Figure 6.2.6; Appendix 6: Table 6.4.3) or LBP onset (p=0.34, ρ=-0.08, 
n=135, Spearman’s correlation, 95%CI -0.23, 0.07) (Figure 6.2.6; Appendix 6: Table 
6.4.3). The strength of the correlations was weak and the 95% CI wide. Consequently, 
the null hypothesis cannot be rejected. 
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Table 6.2.6: Mean number of areas with pain in groups divided by time of  
pain or LBP onset post iSCI.  
Abbreviations: LBP, Low Back Pain; iSCI, incomplete Spinal Cord Injury. 
 
 
6.2.7 LBP quality and intensity; general results 
The PRI, which measures quality, consists of 15 word descriptors that are given a 
numerical value on an ordinal scale 0-324.
303,304 The rank value of each person’s 
response was added to give the sum of the rank values for the person. Then the totals 
of all respondents were added to give the sum for PRI for the group. Three pain scores 
derive from the sum of the PRI of the rank values of the chosen words; 1) sensory (first 
11 descriptors), 2) affective (following 4 descriptors) and 3) total PRI (all descriptors)303 
(see also Chapter 5: Section 5.9.1).  
The second part of the SF-MPQ consisted of a 10cm long horizontal VAS with end 
points of “no pain” to “worst pain imaginable”. In the present study participants were 
asked to mark their intensity of current LBP as well as their usual LBP intensity over the 
                                                     
24
Each word is rated on an intensity scale 0=none, 1=mild, 2=moderate or 3=severe and this is the rank 
value of the word.  
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last 1 and last 3 months. Unpredicted technical difficulties at the time of designing the 
web format of the survey did not allow for the use of the VAS online. To solve this 
problem, it was decided that the web survey would include a NRS instead of the VAS. 
However, the paper version of the questionnaire was prepared and already included 
the VAS. The NRS was chosen because, like the VAS, it is a unidimensional scale and 
like the VAS it is extensively used in pain assessment.269 Also there is a good 
correlation between the NRS and the VAS.101,373 The NRS has been preferred to the 
VAS by some patients.493 Because the two survey formats were going to end up using 
two (similar in their psychometric qualities) different tools to measure LBP intensity, 
an effort was made to “match” the two scales as much as possible. The NRS was 
designed to be 10cm long and have the same end points as the VAS. The aim was to 
enable pooling of the data collected from the two tools together and analysing it.  
The last part of the SF-MPQ consisted of an overall PPI score measured on a 6-point 
verbal rating scale (VRS) (“no pain” to “ excruciating pain”) which were given numeric 
values (0 – 5).  
People used all 15 descriptors to portray the quality of their LBP. The less frequently 
used descriptor was “splitting” (29.9%) and the most frequently used was “aching” 
(76.2%) “Aching” was ranked mainly as of moderate intensity (by 36.4% of 
respondents), followed by “tiring-exhausting” (61.6%) which was also rated mainly as 
of moderate intensity (by 26.5% of respondents) (Table 6.2.6). The total PRI was 
13.6±10.8 (mean±SD), the sensory PRI was 10.2±7.8 (mean±SD) and the affective PRI 
was 3.4±3.5 (mean±SD) (Appendix 6, Table 6.5.1). The number of words chosen ranged 
from 1 to 15 and the mean was 7.05±4.1 (mean±SD). Some of the respondents (6.4%) 
used all 15 descriptors to describe their LBP. Among the 11 descriptors for the sensory 
dimension people chose a mean of 5.3±3.5 (mean±SD, range 0-11) and 0.9% did not 
choose any sensory descriptor but 8.2% used all of them. Finally, from the 4 possible 
descriptors for the affective dimension, people used a mean of 0.7±1.55 (mean±SD, 0-
4 range), 21.9% of respondents did not choose any affective descriptor and 15.6% used 
all of them.    
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Table 6.2.6: Percentage of people reporting each LBP descriptor 
Pain 
descriptors 
n Reported 
pain total 
None Mild Moderate Severe 
Throbbing 149 40.9 59.1 16.1 13.4 11.4 
Shooting 151 47 53 15.9 17.2 13.9 
Stabbing 149 45.6 54.4 10.1 16.1 19.5 
Sharp 150 54 46 14 21.3 18.7 
Cramping 150 47.3 52.7 22.7 18 6.7 
Gnawing 152 55.3 44.7 21.7 23.7 9.9 
Hot-burning 149 53.7 46.3 18.8 19.5 15.4 
Aching 151 76.2 23.8 18.5 36.4 21.2 
Heavy 150 44.7 55.3 16 18.7 10 
Tender 150 43.3 56.7 15.3 17.3 10.7 
Splitting 147 29.9 70.1 13.6 10.2 6.1 
Tiring-
exhausting 
151 61.6 38.4 13.9 26.5 21.2 
Sickening 150 35.3 64.7 15.3 10 10 
Fearful 151 31.1 68.9 13.9 9.9 7.3 
Punishing-cruel 152 46.7 53.3 17.8 16.4 12.5 
 
Data collected about the intensity of LBP via the NRS and the VAS were compared to 
ensure that data from both groups did not differ significantly thus could be pooled and 
analysed together. A significant difference was found in the mean intensity of LBP over 
the last 1 month (p=0.004, t=2.95, 95% CI 5.06, 25.43, independent t-test) and the last 
3 months (p=0.002, t=3.13, 95% CI 5.92, 26.06, independent t-test) between people 
using the NRS (n=122) and those using the VAS (n=31). The difference was not 
statistically significant for current LBP (p=0.07, t=1.8, 95% CI -0.90, 20.0, independent 
t-test). A minimum clinically significant difference (MCSD) for chronic LBP is said to be 
20mm when using the VAS and 2.5 points when using the NRS (or 25mm if a 0-100 NRS 
is used).345 Even though the MCSD is typically used in interventional studies to identify 
a meaningful change in the score, which is not the aim of this study, it was noticed that 
the difference in the mean intensity measured by NRS and VAS was greater than the 
recommended MCSD levels (47.0±2.7 for NRS versus 31.8±20.7 for VAS) (Table 6.2.7; 
Appendix 6, Section 6.2.1). 
A brief analysis to identify possible reasons for the observed differences in the mean 
scores of people using the NRS and the VAS showed some differences in the mean 
scores of the Greek group (using the VAS) to the UK and USA groups (using the NRS) 
for LBP intensity over the last 1 and 3 months. This finding implied that country of 
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residency could have been a factor affecting the results. The respondents who 
completed the VAS mainly had a non-traumatic cause to their injury but further 
analysis did not reveal that the cause of injury was the reason for the finding. This brief 
analysis did not clarify the reasons for the observed differences; therefore further 
analysis would have been needed to identify the exact factors to affect the results. But, 
this was beyond the aim of the study. It was decided that it would have been 
inappropriate to pool together and analyse the above data. Consequently only the 
data collected using the NRS, which was the larger of the two groups, were included in 
the analysis.” 
Table 6.2.7: Mean difference of LBP intensity between people using the NRS and the 
VAS measures 
 Mean±SD, min-max 
NRS (n=122), VAS (n=32) 
Statistical Tests 
PPI – current 
(range 0-100) 
NRS: 47.0±27.1, 0.0 – 100 
VAS: 31.8±20.7, 0.0 – 84.0 
t=1.8, df152 
p=0.07 
95% CI -0.90, 20.0 
PPI – over last 1 month 
(range 0-100) 
NRS: 47.1±27.1, 0.0 – 98.0 
VAS: 31.8±20.7, 1.25 – 78.5  
t=2.95, df152 
p=0.004** 
95% CI 5.06, 25.43 
PPI – over last 3 months 
(range 0-100) 
NRS¹: 47.9±26.9, 0.0 - 100  
VAS: 31.9±20.1, 1.0 – 81.5 
t=3.13, df151 
p=0.002** 
95% CI 5.92, 26.06 
¹In this case n=121, **Significant at p≤0.01 level.  
Abbreviations: PPI, Present Pain Intensity; NRS, Numeric Rating Scale; VAS, Visual Analogue 
Scale.  
Statistical tests: t, independent t-test. 
 
The mean intensity of current LBP was 42.6±28.3 (mean±SD), usual LBP intensity over 
the last month was 47.0±27.1 (mean±SD), and usual LBP intensity over the last 3 
months was 47.9±269 (mean±SD). Most people rated their evaluative overall intensity 
of LBP as discomforting (41.5%), followed by distressing (26.5%) and then mild (18.4%) 
(Figure 6.2.7). The mean intensity on the PPI was 2.4±1.0 (mean±SD).  
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Figure 6.2.7: Percentage of people reporting their evaluative overall  
intensity of LBP   
 
 
6.2.8 LBP quality and intensity; relation to demographic profile 
characteristics 
The quality and the intensity of LBP were examined for differences or correlations 
according to the respondents’ demographic profiles; sex, cause of injury, age, level of 
injury and time since injury.  
Men (n=88) and women (n=62) described their LBP very similarly for both sensory and 
affective dimension of the PRI and no significant differences were found in their quality 
scores (Appendix 6: Table 6.5.2). The intensity of LBP in men (n=76) was slightly higher 
than in women (n=46) for reported current LBP but not for LBP over the last 1 and 3 
months (Appendix 6: Table 6.5.2). The mean intensity was moderate for all three time 
periods and in no case statistically significant between the two sexes. Similarly, males 
(n=80) and females (n=59) reported the same evaluative PPI for their LBP and no 
significant difference existed between the two sexes (Appendix 6: Table 6.5.2). 
People with a traumatic (n=100) and non-traumatic (n=52) cause for their injury 
described the quality of their LBP similarly (Appendix 6: Table 6.5.3). People with a 
non-traumatic cause reported slightly higher mean intensity for current LBP, LBP over 
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the last 1 month , 3 months and evaluative PPI but not enough to reach a significant 
difference (Appendix 6: Table 6.5.3, Figures 6.5.4-6.5.6) 
Interestingly, it was found that as the age of the participants increased, their total PRI 
improved significantly (p≤0.001, r=-0.27, n=148, Pearson’s correlation). The correlation 
between age and sensory component had the same direction and was singificant 
(p=0.002, r=-0.25, Pearson’s correlation, n=148). The correlation between age and the 
affective component of PRI was weak and non-significant (r=-0.14, p=0.08, Pearson’s 
correlation). Age related weakly to LBP intensity and the correlations were not 
significant; with intensity for current LBP: p=0.60, (r=0.09, n=117, Pearson’s 
correlation); with LBP intensity over the last 1 month: p=0.41, (r=0.07, n=117, 
Pearson’s correlation); with LBP intensity over the last 3 months: p=0.56, (r=0.05, 
n=117, Pearson’s correlation); and with evaluative PPI of LBP: p=0.51, (r=-0.05, n=142, 
Pearson’s correlation).  
People with paraplegia (n=92) reported higher, therefore worse, quality for their LBP 
compared to people with tetraplegia (n=58) which was significant for the sensory and 
affective dimensions (Table 6.2.8). They also reported worse intensity of LBP (all time 
points) but the differences did not reach significant levels (Table 6.2.8). Further 
analysis on the three levels of injury showed that overall, people with a thoracic injury 
reported worse quality of LBP (PRI) while those with a lumbar injury reported worse 
intensity of LBP (Appendix 6: Tables 6.5.4, 6.5.5 and Figures 6.5.7–6.5.9).  
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Table 6.2.8: Mean LBP quality and intensity in groups divided by type of injury and 
between groups differences 
 Tetraplegia  
mean±SD, min-max 
Paraplegia 
mean±SD, min-max 
Statistical Tests 
S-PRI  
(range 0-33) 
7.24±5.4, 0-21, 
n=58¹ 
 
11.5±7.9, 1-30, n=92 
 
t=-3.6, df148 p≤0.001*** 
95% CI -6.6, 1.9 
U=1845, p≤0.001*** 
A-PRI  
(range 0-12) 
2.5±2.9, 0-11 
n=58¹ 
3.7±3.6, 0-12 
n=92 
t=-2.23, df148 p=0.02³ 
95% CI -2.4, 0.1 
PRI total 
(range 0-45) 
9.1±7.1, 1-29 
n=56² 
14.7±10.4, 1-39 
n=94 
t=-3.58, df144 p≤0.001*** 
95% CI -8.75, -2.5 
U=1741.5, p=0.002** 
Intensity for 
current LBP 
(range 0-100) 
37.8±25.6, n=60 
0-97 
42.3±28.7, n=94 
0-100 
t=-0.99, df152 
p=0.32, 95% CI -13.5, 4.5 
Intensity for 
LBP over last 
1 month 
(range 0-100) 
41.0±26.2 
0-98, n=60 
 
45.7±26.8 
0-95, n=94 
 
t=-1.09, df152 
p=0.27, 95% CI -13.5, 18.9 
Intensity for 
LBP over last 
3 months 
(range 0-100) 
40.2±27.1 
0-95, n=60 
 
47.4±25.7 
0-100, n=93 
 
t=-1.66, df151 
p=0.09, 95% CI =15.8, 1.4 
PPI evaluative 
for LBP¹ 
(range 0-5) 
2.2±1.0 
1-5, n=58 
2.4±0.8 
1-4, n=83 
t= -0.97, df139 
p=0.33, 95% CI -0.46, 0.15 
¹2 outliers were eliminated, ²3 outliers eliminated, **Significant at p≤0.01 level, 
***Significant at p≤0.001 level; in bold: significant following application of the Bonferroni 
correction; 3not significant post Bonferroni correction 
Abbreviations: PRI, Pain Rating Index; S-PRI, Sensory PRI; A-PRI, Affective PRI; PPI, Present Pain 
Intensity; LBP, Low Back Pain. Statistical tests: t, independent t-test; U, Mann-Whitney U test. 
 
The correlations between time since injury and quality of LBP were positive but weak 
and not significant; with the sensory dimension of PRI: p=0.078, (ρ=0.144, Spearman’s 
correlation, n=151); with the affective dimension of PRI: p=0.693, (ρ=0.031, 
Spearman’s correlation, n=151); and with the total PRI: p=0.078, (ρ=0.144, Spearman’s 
correlation, n=151). The same was found between time since injury and intensity of 
LBP; with intensity of current LBP: p=0.25, (r=0.10, Pearson’s correlation, n=121); with 
intensity of usual LBP over the last 1 month: p=0.34, (r=0.086, Pearson’s correlation, 
n=121); with intensity of last 3 months: p=0.34, (r=0.086, Pearson’s correlation, 
n=120); and with evaluative PPI: p=0.51, (r=0.054, Pearson’s correlation, n=146).  
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6.2.9 LBP quality and intensity; pain/LBP days, free period, onset 
As the reported number of LBP days felt per month increased, the quality of LBP got 
worse and in all cases the strength of the correlations were moderate and highly 
significant; between the number of LBP days and: the sensory dimension of PRI: 
p≤0.001, (ρ=0.44, Spearman’s correlation, n=147); for the affective dimension of PRI: 
p≤0.001, (ρ=0.33, n=146, Spearman’s correlation); for total PRI: p≤0.001, (ρ=0.39, 
Spearman’s correlation, n=144) (Table 6.2.9). The increase of pain days felt in a month 
did not correlate significantly with the quality of LBP though the direction of the 
correlations were the same but they were weak (Appendix 6: Table 6.6.1).  
Similarly, as the number of LBP days felt in the month increased so did the intensity of 
LBP and correlations were highly significant; for reported intensity of current LBP: 
p≤0.001, (ρ=0.59, Spearman’s correlation, n=119); for reported LBP intensity over the 
last month: p≤0.001, (ρ=0.55, Spearman’s correlation, n=117); for intensity over last 3 
months: p≤0.001, (ρ=0.45, Spearman’s correlation, n=116); and for evaluative PPI: 
p≤0.001, (ρ=0.45, Spearman’s correlation, n=136) (Table 6.2.9, Appendix 6: Figure 
6.6.1). The correlation between increasing number of pain days and intensity of LBP 
had the same positive direction, it was often of low moderate strength but not 
statistically significant (Appendix 6: Table 6.6.1).  
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Table 6.2.9: Mean LBP quality and intensity in groups by number of LBP days per month. Correlations between groups  
Number of 
LBP days 
per month 
S-PRI 
(range 0-33) 
mean±SD, 
min-max 
A-PRI 
(range 0-12) 
mean±SD, 
min-max 
Total PRI 
(range 0-45) 
mean±SD, 
min-max 
Intensity of 
current LBP 
(range 0-
100) 
mean±SD, 
min-max 
Intensity of 
LBP over last 
1 month 
(range 0-
100) 
mean±SD, 
min-max 
Intensity of 
LBP over last 
3 months 
(range 0-
100) 
mean±SD, 
min-max 
Evaluative 
overall 
intensity of 
LBP 
(range 0-5) 
mean±SD, 
min-max 
1-9 days  
 
6.2±4.7 
1-17, n=37¹ 
1.9±2.2 
0-7, n=36¹ 
8.8±7.3 
1-28, n=37 
19.2±20.2 
0-70, n=27 
21.3±20.4 
0-67, n=26 
25.0±22.5 
0-72, n=25 
1.7±0.7 
0-3, n=37 
10-20 days 
 
4.8±2.2 
2-10, n=22² 
1.8±2.1 
0-7, n=25 
6.1±4.1 
2-19³, n=25 
24.4±18.5 
0-65, n=15 
31.8±21.4 
2-75, n=15 
34.3±21.6 
2-85, n=15 
2.1±0.9 
1-4, n=25 
21-30 days 
 
9.9±6.1 
2-21, n=17 
4.4±4.3 
0-12, n=17 
14.3±9.6 
2-33, n=17 
49.8±25.0 
10-90, n=13 
52.3±18.9 
24-85, n=12 
53.0±20.3 
25-85, n=12 
2.6±0.6 
2-4, n=16 
Every day 
 
13.9±8.7 
0-33, n=68 
4.5±3.8 
0-12, n=68 
17.4±11.2 
2-41, n=65 
56.1±23.7 
1-100, n=64 
458.9±22.2 
5-98, n=64 
57.0±24.5 
7-100, n=64 
2.7±0.9 
1-5, n=58 
Statistical 
Test 
ρ=0.44 
n=147 
p≤0.001*** 
ρ=0.33 
n=146 
p≤0.001*** 
ρ=0.39 
n=144 
p≤0.001*** 
ρ=0.59 
n=119 
p≤0.001*** 
ρ=0.60 
n=117 
p≤0.001*** 
ρ=0.51 
n=116 
p≤0.001*** 
ρ=0.50 
n=136  
p≤0.001*** 
¹One outlier, ²Three outliers, ³Three outliers; ***Significant at p≤0.001 level, in bold: significant following application of the  
Bonferroni correction.  
Abbreviations: PRI, Pain Rating Index; S-PRI, Sensory PRI; A-PRI, Affective PRI; PPI, Present Pain Intensity; LBP, Low Back Pain.  
Statistical tests: ρ, Spearman’s rank correlation rho. 
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A reduction in the regularity of the LBP-free weeks related with significantly worse 
quality of LBP, noticed across all dimension of PRI; with the sensory dimension: 
p≤0.001, (ρ=0.41, Spearman’s correlation, n=116); with the affective dimension: 
p≤0.001, (ρ=0.31, Spearman’s correlation, n=119); and with total PRI: p≤0.001, 
(ρ=0.40, Spearman’s correlation, n=115) (Table 6.2.10). Similarly, the more infrequent 
the pain- free weeks, the worse the quality of LBP in correlations that were of 
moderate strength (Appendix 6: Table 6.6.1).   
The intensity of LBP was worse when pain was more persistent as the less frequent the 
pain-free weeks, the higher the intensity of LBP (Appendix 6: Table 6.6.1). This was 
similar when the LBP-free weeks were reduced and, in this case, the strength of the 
correlations was high; with intensity of current LBP: p≤0.001, (ρ=0.55, Spearman’s 
correlation, n=87); with intensity of reported LBP over the last 1 month: p≤0.001, 
(ρ=0.53, Spearman’s correlation, n=88); with intensity of LBP over the last 3 months: 
p≤0.001, (ρ=0.48, Spearman’s, n=88); and with evaluative PPI: p≤0.001, (ρ=0.47, 
Spearman’s correlation, n=111) (Table 6.2.10; Appendix 6: Figure 6.6.2). 
Part of the third hypothesis theme was to examine the relation between pain or LBP 
onset post iSCI and the quality or intensity of LBP. The hypothesis is:  
Hypothesis 0 – LBP quality (null): In people with iSCI there is no significant correlation 
between quality (sensory, affective or total PRI) of LBP and pain or LBP onset post iSCI. 
Hypothesis 8a – LBP quality: In people with iSCI there is a significant correlation 
between the sensory dimension of quality of LBP and pain or LBP onset post iSCI. 
Hypothesis 8b – LBP quality: In people with iSCI there is a significant correlation 
between the affective dimension of quality of LBP and pain or LBP onset post iSCI. 
Hypothesis 8c – LBP quality: In people with iSCI there is a significant correlation 
between the total quality of LBP and pain or LBP onset post iSCI. 
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Table 6.2.10: Mean LBP quality and intensity in groups by LBP-free weeks. Correlations between groups 
LBP free 
weeks 
S-PRI 
(range 0-33) 
mean±SD, 
min-max 
A-PRI 
(range 0-12) 
mean±SD, 
min-max 
Total PRI 
(range 0-45) 
mean±SD, 
min-max 
Intensity of 
current LBP 
(range 0-100) 
mean±SD, 
min-max 
Intensity of 
LBP over last 1 
month 
(range 0-100) 
mean±SD, 
min-max 
Intensity of 
LBP over last 3 
months 
(range 0-100) 
mean±SD, 
min-max 
Evaluative 
overall 
intensity of 
LBP 
(range 0-5) 
Yes, most of 
the time 
6.1±4.5 
2-17, n=13¹ 
1.9±2.2 
0-6, n=15 
7.7±6.2 
2-23, n=14¹ 
20.0±31.2 
0-100, n=9 
12.2±13.2 
0-35, n=9 
13.2±15.3 
0-40, n=8 
1.4±0.8 
0-3, n=13 
Yes, 
frequently 
6.6±4.9 
2-14, n=9 
3.3±3.1 
0-11, n=9 
9.9±8.2 
2-25, n=9 
11.5±16.3 
0-23, n=2 
66.0±1.4 
65-67, n=2 
60.0±7.1 
55-65, n=2 
1.9±0.3 
1-2, n=9 
Yes, 
sometimes 
6.5±4.1 
2-18, n=12¹ 
2.1±2.7 
0-7, n=13 
8.3±6.2 
3-25, n=12¹ 
30.0±21.5 
0-58, n=7 
34.1±23.4 
0-71, n=7 
31.6±20.8 
0-65, n=7 
2.4±1.0 
1-4, n=13 
Yes, not very 
often 
6.5±4.5 
1-15, n=11 
3.4±4.0 
0-11, n=11 
9.8±8.0 
1-24, n=11 
15.0±12.3 
0-25, n=4 
39.6±15.2 
25-65, n=5 
43.0±22.8 
25-80, n=5 
2.2±0.8 
1-3, n=10 
Yes, but 
rarely 
 
9.7±7.3 
1-24, n=23 
3.6±3.8 
0-12, n=23 
13.4±10.4 
1-34, n=23 
37.7±30.3 
0-90, n=22 
46.4±25.2 
0-88, n=22 
51.2±25.2 
0-85, n=22 
2.3±0.9 
1-4, n=22 
No, I always 
have pain 
13.9±8.1 
1-30, n=48 
4.8±3.6 
0-12, n=48 
17.8±10.7 
3-39, n=46 
58.9±20.5 
19-97,n=43 
61.6±20.0 
20-98, n=43 
62.1±21.1 
20-100, n=43 
2.9±1.0 
1-5, n=41 
Statistical 
Test 
ρ=0.41, 
n=116 
p≤0.001*** 
ρ=0.31, 
n=119 
p≤0.001*** 
ρ=0.40, 
n=115 
p≤0.001*** 
ρ=0.55, n=87 
p≤0.001*** 
ρ=0.53, n=88 
p≤0.001*** 
ρ=0.48, n=87 
p≤0.001*** 
ρ=0.47, 
n=111 
p≤0.001*** 
¹One outlier; ***Significant at p≤0.001 level, in bold: significant following application of the Bonferroni correction.  
Abbreviations: PRI, Pain Rating Index; S-PRI, Sensory PRI; A-PRI, Affective PRI; PPI, Present Pain Intensity; LBP, Low Back Pain.  
Statistical tests: ρ, Spearman’s rank correlation rho. 
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Earlier pain onset correlated with worse LBP quality (sensory, affective dimensions and 
total PRI) but the relations were not statistically significant and of small strength 
(Appendix 6: Table 6.6.1). Earlier onset of LBP post iSCI also related with worse quality 
of LBP (sensory, affecting dimensions and total PRI) and though relationships were 
stronger they failed to maintain their significance level post application of the 
Bonferroni correction (Table 6.2.11). Therefore, for both pain or LBP onset post iSCI 
and quality of LBP the null hypothesis cannot be rejected as statistical significance is 
not found. The practical significance needs to be considered in the case of LBP onset 
post iSCI.    
The next hypothesis was about the onset of pain or LBP and the intensity of LBP:  
Hypothesis 0 – LBP intensity (null): In people with iSCI there is no significant 
correlation between intensity of LBP (current, over the last 1, last 3 months, or 
evaluative PPI) and pain or LBP onset post iSCI. 
Hypothesis 9a – LBP intensity: In people with iSCI there is a significant correlation 
between intensity of current LBP and pain or LBP onset post iSCI. 
Hypothesis 9b – LBP intensity: In people with iSCI there is a significant correlation 
between intensity of LBP over the last 1 month and pain or LBP onset post iSCI. 
Hypothesis 9c – LBP intensity: In people with iSCI there is a significant correlation 
between intensity of LBP over the last 3 months and pain or LBP onset post iSCI. 
Hypothesis 9c - intensity: In people with iSCI there is a significant correlation between 
evaluative overall intensity of LBP and pain or LBP onset post iSCI. 
The earlier pain onset following iSCI had a weak and non-statistical correlation with 
LBP intensity (any time point or evaluative) (Appendix 6: Table 6.6.1). However, earlier 
onset of LBP following iSCI correlated with higher intensity of LBP and these relations 
were stronger; for reported current LBP intensity: p≤0.001, (ρ=-0.29, Spearman’s 
correlation, 95% CI -0.42, -0.14, n=105); for reported intensity of last 1 month LBP: 
p≤0.001, (ρ=-0.29, Spearman’s correlation, 95% CI -0.42, -0.14, n=104); and for LBP 
intensity over last 3 months: p≤0.001, (ρ=-0.29, Spearman’s correlation, 95% CI -0.42,   
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-0.14, n=104). However, the relationship was not statistically significant in the case of 
the evaluative PPI but it had the same direction (Table 6.2.11, Figures 6.2.8, 6.2.9, 
6.2.10). The null hypothesis can only be rejected for the relations between LBP onset 
and LBP intensity (excluding evaluative PPI).  
 
Figure 6.2.8: Mean LBP quality and intensity in groups by time of LBP onset  
post iSCI 
Abbreviations: PRI, Pain Rating Index; PPI, Present Pain Intensity; iSCI, incomplete  
Spinal Cord Injury. 
 
 
Figure 6.2.9: Mean LBP intensity in groups by time of LBP onset post iSCI 
Abbreviations: NRS, Numeric Rating Scale; iSCI, incomplete Spinal Cord Injury;  
LBP, Low Back Pain. 
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Table 6.2.11: Mean LBP quality and intensity in groups by time of LBP onset post iSCI. Correlations between groups 
 
¹Two outliers, ²One outlier, 3not significant post Bonferroni correction; *Significant at p≤0.05 level, **Significant at p≤0.01 level, ***Significant at 
p≤0.001 level, in bold: significant following application of the Bonferroni correction;  
Abbreviations: PRI, Pain Rating Index; S-PRI, Sensory PRI; A-PRI, Affective PRI; PPI, Present Pain Intensity; LBP, Low Back Pain.  
Statistical tests: ρ, Spearman’s rank correlation rho.
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Figure 6.2.10 Mean evaluative overall LBP intensity in groups by LBP onset  
post iSCI. 
Abbreviations: LBP, Low Back Pain; PPI, Present Pain Intensity; iSCI, incomplete  
Spinal Cord Injury. 
 
 
6.2.10 LBP quality and intensity; relation to pain extent 
The relation between pain extent and LBP quality or intensity was investigated using 
correlations. When the number of areas with pain increased people reported worse 
LBP quality in correlations that were of near moderate strength and of statistical 
significance; for the sensory dimension of PRI: p≤0.001, (ρ=0.26, Spearman’s 
correlation, n=143); for the affective dimension of PRI: p≤0.001, (ρ=0.28, Spearman’s 
correlation, n=146); and for total PRI: p=0.002, (ρ=0.25, Spearman’s correlation, 
n=144) (Table 6.2.12). 
The correlation was in the same direction and of similar strength between the number 
of areas with pain and the intensity of LBP but passed the Bonferroni α-level of 
significance for intensity of current pain: p≤0.001, (ρ=0.22, Spearman’s correlation, 
n=119); and evaluative PPI for LBP: p≤0.001, (ρ=0.27, n=140, Spearman’s correlation) 
(Table 6.2.12).  
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  Table 6.2.12: Mean LBP quality and intensity in groups by the number of areas with pain. Correlations between groups 
 S-PRI 
(range 0-33) 
mean±SD, 
min-max 
A-PRI 
(range 0-12) 
mean±SD, min-
max 
Total PRI 
(range 0-45) 
mean±SD, 
min-max 
Intensity of current 
LBP 
(range 0-100) 
mean±SD, min-max 
Intensity of LBP 
over last 1 month 
(range 0-100) 
mean±SD, min-max 
Intensity of LBP 
over last 3 months 
(range 0-100) 
mean±SD, min-max 
Evaluative overall 
intensity of LBP 
(range 0-5) 
1 area 6.3±0.6 
6-7, n=3¹ 
2.2±1.9 
0-5, n=5 
8.4±3.9 
3-14, n=5 
24.0±20.0 
0-45, n=4 
46.2±14.0 
35-65, n=4 
50.2±12.5 
35-61, n=4 
2.2±0.4 
2-3, n=6 
2 areas 8.6±7.1 
0-29, n=34 
2.0±2.6 
0-10, n=32² 
11.1±9.7 
2-36, n=34 
35.0±26.4 
0-90, n=29 
39.4±27.5 
0-85, n=29 
35.4±26.7 
0-90, n=29 
1.9±0.8 
1-4, n=34 
3 areas 7.2±4.5 
1-16, n=29¹ 
3.2±3.2 
0-12, n=31 
9.9±6.9 
1-26, n=29¹ 
44.3±29.2 
0-92, n=19 
44.3±29.3 
0-95, n=19 
46.5±27.8 
0-97, n=19 
2.3±1.4 
1-5, n=31 
4 areas 8.3±6.2 
1-23, n=32² 
2.6±3.0 
0-10, n=33 
11.6±9.2 
1-39, n=33 
43.0±29.2 
0-100,n=26 
44.7±26.6 
0-80, n=26 
49.8±25.4 
0-85, n=25 
2.3±0.9 
1-4, n=31 
5 areas 12.7±8.3 
2-29, n=27 
4.0±3.8 
0-12, n=27 
14.9±10.3 
3-34, n=25 
52.8±26.9 
0-90, n=25 
56.4±25.3 
0-92, n=25 
56.8±25.3 
3-100,n=25 
2.5±0.8 
1-4, n=23 
6 areas 12.9±8.2 
0-24, n=9 
6.3±3.5 
0-11, n=9 
19.1±10.7 
3-34, n=9 
43.4±35.3 
0-97, n=8 
48.6±35.0 
0-98, n=8 
48.1±34.5 
0-95, n=8 
2.9±1.5 
0-4, n=7 
7 areas 13.7±8.5 
2-21, n=4 
5.7±4.9 
0-12, n=4 
19.5±13.2 
2-33, n=4 
32.0±27.6 
10-63, n=3 
57.6±15.3 
40-67, n=3 
69.0±12.8 
55-80, n=3 
2.7±0.9 
2-4, n=4 
8 areas 13.5±13.4 
4-23, n=2 
3.0±2.8 
1-5, n=2 
16.5±16.3 
5-28, n=2 
54.5±27.6 
35-74, n=2 
65.5±28.9 
45-86, n=2 
64.5±27.6 
45-84, n=2 
3.0±1.4 
2-4, n=2 
9 areas 20.3±4.9 
17-26, n=3 
6.7±5.0 
2-12, n=3 
27.0±9.8 
19-38, n=3 
20.3±4.9 
17-26, n=3 
46.6±37.5 
10-85, n=3 
48.7±30.0 
16-75, n=3 
2.5±0.7 
2-3, n=2 
Statistical 
Test 
ρ=0.26  
p≤0.001*** 
n=143 
ρ=0.28, 
p≤0.001*** 
n=146 
ρ=0.25, 
p=0.002** 
n=144 
ρ=0.22  
p≤0.001*** 
n=119 
ρ=0.19  
p=0.03³ 
n=119 
ρ=0.25 
p=0.005³ 
n=118 
ρ=0.27 
p≤0.001*** 
n=140 
  ¹Two outliers, ²One outlier, 3not significant following application of the Bonferroni correction, **Significant at p≤0.01 level, ***Significant at p≤0.001 
level, in bold: significant following application of the Bonferroni correction.  
Abbreviations: PRI, Pain Rating Index; S-PRI, Sensory PRI; A-PRI, Affective PRI; PPI, Present Pain Intensity; LBP, Low Back Pain. Statistical tests: ρ, 
Spearman’s rank correlation rho. 
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6.2.11 Conclusion 
This chapter has confirmed that people with iSCI have pain which usually starts early 
following their injury, becomes chronic and tends to be continuous. It has also shown 
that people with iSCI have LBP of moderate intensity which increases when LBP 
becomes more regular. The onset of LBP is early after injury but LBP can also start after 
the first year following the injury. The demographic profile differences found to affect 
LBP presence and to pass the Bonferroni α-level of significance were the cause of 
injury and the level of injury. The level of injury significantly affected the quality of LBP 
as well.   
This chapter has demonstrated the high presence of both pain in general, MSKP, but 
also of pain at the location of the lower back area following iSCI. It has also shown how 
the experience of pain, focusing on LBP, can be affected by demographic profile 
characteristics. The next chapter will describe the QoL of the respondents and will 
examine how the experience of pain, focusing on LBP, relates to QoL.  
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Chapter 7; Results: Quality of Life 
 
 
 
 
 
 
 
 
 
 
 
 
 “The quality of life is determined by its activities.” 
Aristotle (384 BC – 322 BC) – Greek Philosopher 
(in Nicomachean Ethics14) 
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7.1 Introduction 
The previous chapter described the characteristics of the study participants and looked 
into the experience of pain. Extra emphasis was given to pain location, in particular at 
the lower back area.  
Over the past few decades, as survival for people with a SCI has significantly increased, 
it has become important to identify ways to improve their QoL. Researchers 
increasingly include the study of QoL in their work. Currently there is a need to 
understand the barriers and challenges to a good QoL with the aim of being able to put 
in place appropriate treatment as well as prevention management. This chapter 
initially aims to describe the QoL of people with iSCI. Then it will investigate the 
answers to the question “what is the relationship, and what are the characteristics, 
between QoL and LBP in people with iSCI?”  
The EQ-5D measurement was used to collect information about QoL. The results will 
be presented taking into account the user guide published by the EQ-5D,341 which are 
divided into three areas; 1) a description of the health status profile based on its 
dimensions, 2) the EQ-5D index which is a classification of health state and 3) EQ-VAS 
which is the self-rated health perception25.  
 
7.2 Bonferroni correction 
The main variables of interest involved in the analysis conducted for the present 
chapter were two; 1) the EQ-5D index, and 2) the EQ-VAS. Both were involved in 21 
tests thus the α-level of significance for Bonferroni correction was set at p≤0.002 
(Appendix 7: Table 7.1.1).  
 
                                                     
25
 For more details on EQ-5D refer back to Chapter 5, Section 5.9.2.  
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7.3 QoL characteristics, scoring and missing data 
The EQ-5D is a self-completed QoL measure which consists of a descriptive system and 
a VAS. The descriptive system includes five dimensions, in which the respondent self-
classifies him/herself on; 1) mobility, 2) self-care, 3) usual activities, 4) pain/discomfort 
and 5) anxiety/depression. Each dimension is scored on three levels ranked as none/no 
problem (1), some problems (2) to severe problems (3). The five dimensions of the EQ-
5D descriptive system can give a total of 243 possible health states (or profiles), and 
each state is referred to using a 5-digit code. For example, the state 11111 indicates 
that there are no health problems in any dimension. The state 12123 indicates that 
there are no problems with mobility, some problems with self-care, none with usual 
activities, some problems with pain/discomfort and severe problems with 
anxiety/depression. 
Responses to the five dimensions can be converted into a single summary index using 
set values. In this study the set values for the UK (UK-TTO) were used following the 
advice and guidelines of the EuroQuol group.341 The best health state possible (11111) 
is given a mean value of 1.00, therefore the closer the mean value of the profile is to 
1.00 the better the health state is. Finally, part of the EQ-5D is the EQ-VAS which is an 
overall self-rated health ranging from 0 to 100 and the higher the score the better the 
health status. Thus it measures the individual’s perception of their health status. 
There were some data missing in the dimensions in this study and responses ranged 
from 198 to 218.  In general, there can be two forms of missing data in the EQ-5D: 1) 
item non-response which is when a person does not replied to at least one question of 
the EQ-5D, and 2) unique non-response when the whole EQ-5D questionnaire is not 
answered. Handling missing data in the EQ-5D when one of the dimensions is missing 
is not adequate and in most cases results in rejecting the whole questionnaire unless 
the measures are repeated.250 The current survey had some item non-response related 
missing data and, since no repeated measures were made, all the EQ-5D was rejected 
when there were items missing. This left a total of 198 participants eligible to enter the 
analysis of QoL. The demographic profiles of the 21 people who were excluded were 
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compared with those of the 198 people included and no significant differences were 
found (Table 7.1).  
 
7.4 QoL; general results 
Overall, people described themselves as having some problems (level 2) for all 
dimensions. It was only for the “self-care” dimension that a few more people reported 
no problems (level 1) and more than one-fifth of people reported severe problems 
(level 3) for “pain/discomfort” (Figure 7.1). Following scoring of the dimensions, the 
mean index value was 0.4±0.3 (mean±SD) with a median of 0.51 (25 percentile at 0.06 
and 75 percentile of 0.66). The EQ-5D index had a distribution that was bimodal 
indicating a non-normal distribution of the data (Appendix 7: Figure 7.2.1). This can be 
a problem when a parametric test, requiring a normal distribution, is used. In the 
current study, because the sample was large, the t-test26 could be applied. However, 
the applicability of using a parametric test was checked throughout and, when not 
possible, a non-parametric test was used.  
 
 
Figure 7.1: Percentage of people reporting the levels 
 on each of the EQ-5D dimensions 
                                                     
26
 In highly skewed data to be able to apply t-test the groups need to be large (>50 in each group).
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Table 7.1: Differences in the demographic profile characteristics of people included and excluded in the 
analysis of the EQ-5D  
Demographic 
characteristics 
Excluded from 
analysis 
Included in 
analysis 
Statistical 
Test 
Demographic 
characteristics 
Excluded from 
analysis 
Included in 
analysis 
Statistical 
Test 
Gender¹ 
  Male 
  Female 
 
n=14 
n=6 
 
n=120 
n=75 
χ²=0.55 
p=0.45 
 
Age n=21 n=190 F=0.69 
p=0.40 
Cause of injury 
  Traumatic 
  Non-traumatic 
 
n=16 
n=5 
 
n=139 
n=59 
χ²=0.32 
p=0.56 
 
Age at injury n=21 n=189 F=0.35 
p=0.55 
Type of injury² 
  Tetraplegia 
  Paraplegia 
 
n=11 
n=9 
 
n=90 
n=107 
χ²=0.63 
p=0.42 
 
Time since injury n=21 n=197 F=0.08 
p=0.76 
Country  
  USA 
  UK 
  Greece 
 
n=9 
n=9 
n=3 
 
n=113 
n=43 
n=42 
χ²=4.7 
p=0.09 
extended 
χ² 
 
Education³ 
  None/compulsory 
  High school 
  College/University 
  Master/PhD 
 
n=2 
n=8 
n=7 
n=3 
 
n=22 
n=44 
n=96 
n=34 
χ²=0.55 
p=0.45 
 
    Employment 
  Employed  
  Unemployed 
  Retired 
 
n=14 
n=3 
n=4 
 
n=105 
n=106 
n=31 
χ²=0.55 
p=0.45 
 
¹One person failed to report gender, ²one persons failed to report type of injury, ³one person failed to report education level.  
Abbreviations: USA, United States of America; UK, United Kingdom; PhD, Doctor of Philosophy.  
Statistical tests: F, One way ANOVA; χ², Pearson’s or Extended Chi square. 
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Table 7.2, which ranks in decreasing order the mean index value, includes the first 20 
health profiles. From the 243 possible health profiles, the total groups reported 64 
health profiles. Table 7.2.1 in Appendix 7 presents all the health profiles. Table 7.2 
below and 7.2.1 in Appendix 7 also present the mean perceived health status (EQ-VAS) 
and how much this mean ranges within each health profile. Overall it is noticed that as 
the EQ-5D index, thus the health state classification, is reduced then the EQ-VAS, thus 
the self-rated perception of the health, is also reduced. However, this is not constant 
as often it is seen that people who classify their health lower (mean index) perceive 
their health status higher (EQ-VAS) or vice versa. This is seen more clearly in the 
Appendix 7: Table 7.2.1 where all the health profiles are presented.  Twenty people 
(10.1%) reported a profile with “some problems” for all five dimensions. Three (1.5%) 
reported severe problems (level 3) on all five dimensions and their perceived health 
state was very low (Appendix 7: Table 7.2.1).  
The mean self-rated perceived health (EQ-VAS) was 62.95±22.5 (mean±SD) (median 
68.5 and 25 percentile at 48.4 and 75 percentile of 80). The distribution of the data for 
the EQ-VAS in combination with the large group size was acceptable which allowed the 
use of parametric tests as required (Appendix 7: Figure 7.2).    
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Table 7.2: Frequency distribution of the first 20 reported health profiles with mean 
index and EQ-VAS values 
Rank 
order 
EQ-5D profile Count % Index value 
(UK TTO) 
Mean EQ-
VAS 
Range of 
mean EQ-
VAS 
1 11111 1 0.5 1.000 90.0 90 
2 11211 2 1.0 0.883 72.5 70-75 
3 21111 4 2.0 0.850 89.7 70-99 
4 11112 1 0.5 0.848 60.0 60 
5 21211 1 0.5 0.814 80.0 80 
6 11121 2 1.0 0.796 88.5 80-95 
7 11221 1 0.5 0.760 75.0 75 
8 22111 3 1.5 0.746 96.0 95-98 
9 21212 2 1.0 0.743 60.0 50-70 
10 21121 8 4.0 0.727 85.4 80-95 
11 11122 2 1.0 0.725 54.5 40-69 
12 22211 3 1.5 0.710 73.3 65-85 
13 21221 16 8.1 0.691 72.0 29-90 
14 11222 3 1.5 0.689 69.3 58-90 
15 21122 6 3.0 0.656 74.6 49.5-100 
16 22212 5 2.5 0.639 59.0 50-85 
17 21222 20 10.0 0.620 67.6 40-95 
18 22221 10 5.1 0.587 58.0 20-90 
19 22222 20 10.1 0.516 56.1 40-80 
20 23211 2 1.0 0.331 90.0 90 
The table is ranked in order of decreasing health according to the mean health index 
value; in bold are the 5 most frequently reported health profiles. 
Abbreviations: EQ-5D, Quality of Life; EQ-VAS, Quality of Life Visual Analogue Scale. 
 
7.5 QoL; relation to pain, MSKP and LBP 
Analysis involving LBP presence in this chapter included referrals to “current” LBP. This 
was explained in Chapter 6 (Section 6.1.5).  
In general, people with pain, LBP and MSKP replied similarly to the EQ-5D dimensions 
(Figure 7.4). People without MSKP or LBP still reported having some problems with 
“pain/discomfort” which indicated that they were referring to other types or locations 
of pain (Figure 7.5). More people without pain reported no or some problems with 
“self-care” (levels 1 and 2) and some problems with “usual activities” (level 2). Finally, 
people with pain, MSKP or LBP seemed to be more “anxious/depressed” than those 
without these pain categories (Figures 7.4, 7.5).  
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Figure 7.4: Percentage of people with pain, LBP and  MSKP reporting each  
EQ-5D dimension 
Abbreviations: LBP, Low Back Pain; MSKP, Musculoskeletal Pain. 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.5: Percentage of people without pain, LBP or MSKP reporting each  
EQ-5D dimension 
Abbreviations: LBP, Low Back Pain; MSKP, Musculoskeletal Pain. 
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Part of the first hypothesis theme was to investigate the differences in QoL between 
people with and without the pain categories of interest. The hypothesis (hypothesis 2) 
was threefold: 
Hypothesis 0 (null): In people with iSCI there is no significant difference in QoL (EQ-5D 
index or EQ-VAS) between those with pain, MSKP or LBP and those without.  
Hypothesis 2a: In people with iSCI there is a significant difference in QoL (EQ-5D index 
or EQ-VAS) between those with pain and those without. 
Hypothesis 2b: In people with iSCI there is a significant difference in QoL (EQ-5D index 
or EQ-VAS) between those with MSKP and those without. 
Hypothesis 2c: In people with iSCI there is a significant difference in QoL (EQ-5D index 
or EQ-VAS) between those with LBP and those without. 
Scoring of the EQ-5D showed that people with pain, MSKP or LBP reported worse on 
the index but no difference passed the Bonferroni α-level of significance; for pain: 
p≤0.01, (U=798, Mann-Whitney U test, ES: r=-0.23, n=198); for current LBP: p=0.004, 
(t=2.90, 95% CI 03.05, 0.26, independent t-test, ES: d=0.19, n=193); for MSKP: p=0.03, 
(t=2.13, 95% CI 0.008, 0.2, independent t-test, ES: d=0.008, n=194) (Table 7.3, Figure 
7.6). 
People with pain (n=181) perceived their health as slightly worse than people without 
pain (n=17) but this difference was of small effect and not significant (p=0.93, 95% CI -
5.95, 16.6, independent t-test, ES d=0.24). People with current LBP (n=133) perceived 
their self-rated health as significantly worse (58.0±22.3) than those without LBP with a 
much greater than typical effect size (p≤0.001, t=4.48, 95% CI 8.41, 21.6, ES d=0.71). 
Similarly, people with MSKP (n=77) perceived their self-rated health as significantly 
worse than people without MSKP (n=117) with a medium effect size (n=117) (p≤0.01, 
t=2.55, 95% CI 1.90, 14.82, ES d=0.37) (Table 7.4). These results indicate that when the 
type of pain is MSKP and when the location of pain is at the lower back then their 
impact on self-rated health perception is greater.  
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Figure 7.6: Mean EQ-5D index reported by people with and without  
pain, LBP or MSKP. 
Abbreviations: EQ-5D index, Quality of Life index; LBP, Low Back Pain;  
MSKP, Musculoskeletal Pain.  
 
 
Table 7.3: Characteristics of EQ-5D index in groups by pain presence (“Yes” and “No”). 
Differences in the EQ-5D between groups 
 Yes No Statistical tests 
Pain      n 
Mean±SD 
              Median 
              Percentile 25th  
              Percentile 75th  
             Skewness 
            Kurtosis 
181 
0.3±0.3 
0.5 
0.008 
0.65 
-0.5 
-0.9 
17 
0.6±0.3 
0.6 
0.3 
0.8 
-0.8 
-0.7 
U=798.0, 
ES: r=-0.23 
p≤0.01¹ 
Current  n 
LBP       Mean±SD 
              Median 
              Percentile 25th  
              Percentile 75th  
              Skewness 
            Kurtosis 
133 
0.3±0.3 
0.5 
-0.01 
0.6 
-0.4 
-1.1 
60 
0.5±0.3 
0.6 
0.1 
0.7 
-0.8 
0.04 
t=2.90, df189, 
ES: d=0.19 
p=0.004¹ 
95% CI 0.05, 0.26 
 
MSKP   n 
Mean±SD 
              Percentile 25th  
              Percentile 75th 
77 
0.3±0.3 
-0.05 
0.6 
117 
0.4±0.3 
0.1 
0.7 
t=2.13, df192, 
ES: d=0.008 
p=0.03¹ 
95% CI 0.008, 0.2 
3not significant post Bonferroni correction 
Abbreviations: LBP, Low Back Pain; MSKP, Musculoskeletal Pain.  
Statistical tests: U, Mann-Whitney U test; t, Independent t-test. 
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Table 7.4: Characteristics of EQ-VAS in groups by pain presence (“Yes” and “No”). 
Differences in the EQ-VAS between groups  
 Yes No Statistical Tests 
Pain     n  
             Mean±SD 
              Percentile 25th  
              Percentile 75th  
181 
62.5±22.7 
45 
80 
17 
67.8±20.9 
50 
85 
t=0.93, df196,  
ES: d=24 
p=0.93 
95% CI -5.95, 16.60 
LBP       n 
              Mean±SD 
              Percentile 25th  
              Percentile 75th  
133 
58.0±22.3 
60 
90 
60 
73.0±19.8 
60 
90 
t=4.48, df191,  
ES: d=0.71 
p≤0.001*** 
95% CI 8.41, 21.6 
MSKP   n 
              Mean±SD 
              Percentile 25th  
              Percentile 75th  
77 
57.8±20.8 
50 
85 
117 
66.0±23.3 
50 
85 
t=2.55, df192,  
ES: d=0.37 
p≤0.01¹ 
95% CI 1.90, 14.82 
3not significant post Bonferroni correction; ***Significant at p≤0.001 level, in bold: significant 
following application of the Bonferroni correction.  
Abbreviations: LBP, Low Back Pain; MSKP, Musculoskeletal Pain.  
Statistical tests: t, Independent t-test. 
 
 
7.6 QoL; relation to demographic profile characteristics 
Men (n=120) and women (n=76) responded similarly to the EQ-5D dimensions mainly 
reporting “some problems” with them. A small proportion (6%) of women, compared 
to men, reported having worse pain and discomfort. However, it appeared that 
women reported slightly more cases of “anxiety/depression” than men (Figure 7.7; 
Appendix 7: Table 7.3.1). Following scoring of the EQ-5D, the similarities between men 
(0.4±0.3, mean±SD) and women (0.3±0.3, mean±SD) were evident and there were no 
significant differences between the two sexes (p=0.13, t=1.48, 95% CI -0.02, 0.17, 
independent t-test) (Table 7.5; Appendix 7: Table 7.3.2). Despite males reporting 
slightly better self-rated health (64.0±23.9, mean±SD) compared to females 
(61.7±20.3, mean±SD) this was not a significant difference (p=0.5, t=0.67, 95% CI -4.33, 
8.79, independent t-test) (Appendix 7: Table 7.3.2). 
In Chapter 6 (Section 6.1.7) prior to application of the Bonferroni correction a higher 
proportion of females reported having MSKP. Taking into account the report by IASP177 
which advised to investigate pain-related variables by gender, the difference in mean 
EQ-5D index between those with and those without MSKP was tested with males and 
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females. However, this was not part of the main analysis and as such it is presented at 
Appendix 7, Table 7.3.3. 
  
Figure 7.7: Percentage of men and women reporting each EQ-5D dimension 
 
People with a traumatic cause of injury (n=139) reported fairly similar scores on the 
EQ-5D dimensions to people with a non-traumatic cause of injury (n=59). People from 
both groups reported having “some problems” on the dimensions. However, some 
individual differences emerged as people with a traumatic injury were less 
“anxious/depressed” and seemed to be more able to carry out their “usual activities” 
(Figure 7.8; Appendix 7: Table 7.3.1). After scoring the EQ-5D dimension, the 
similarities between people with traumatic (0.4±0.3, mean±SD) and non-traumatic 
injuries (0.3±0.4, mean±SD) were evident and no significant difference was found 
between them (p=0.07, U=3441.5, Mann-Whitney) (Table 7.5; Appendix 7: Table 
7.3.4). People with a non-traumatic cause perceived their health to be lower 
(53.8±19.5, mean±SD) than those with a traumatic cause (66.8±22.7, mean±SD), but 
this difference failed to pass the Bonferroni α-level of significance (p=0.006, t=-2.85, 
95% CI -43, -7.5, independent t-test, n=198) (Table 7.5; Appendix 7: Table 7.3.4).  
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Figure 7.8: Percentage of people reporting each EQ-5D dimension divided into 
 groups by cause of injury 
 
The mean age of people was very similar across all five dimensions ranging from a low 
of 46.0±15.8 (mean±SD, “mobility” subscale for level 3) to a high of 51.1±13.7 
(mean±SD, “self-care” subscale for level 2) (Appendix 7: Table 7.3.8). Following scoring 
of the dimensions, age did not correlate significantly with health state classification 
(p=0.78, r=0.02, Pearson’s correlation, n=190). However, older people perceived their 
health as significantly worse (p≤0.001, r=-0.36, Pearson’s correlation) (Table 7.5). 
Overall, people with tetraplegia (n=91) as well as people with paraplegia (n=107) 
reported some problems (level 2) on the EQ-5D dimensions. As expected, people with 
lower injuries reported better “self-care”. Interestingly, people with higher injuries 
(tetraplegia) seemed to be less “anxious/depressed” (Figure 7.9; Appendix 7: Table 
7.3.1). Scoring of EQ-5D dimensions confirmed that the differences between the two 
groups were not significant (p=0.81, U=4772, Mann-Whitney, n=198) (Table 7.5; 
Appendix 7: Table 7.3.5). Again of interest, people with tetraplegia perceived their self-
rated health as better than those with paraplegia but this difference did not pass the 
Bonferroni α-level of significance (p=0.017, t=2.41, 95% CI 1.4, 13.93) (Table 7.7; 
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Appendix 7: Table 7.3.5). Analysis per the three levels of injury is presented at 
Appendix 7: Figure 7.3.1 and Tables 7.3.6-7.3.7.  
 
Figure 7.9: Percentage of people reporting each EQ-5D dimension divided into groups 
 by level of injury 
Abbreviations: EQ-5D, Quality of Life 
 
 
People with a longer mean time since injury reported more severe problems on some 
dimensions (i.e. “mobility” and “pain/discomfort”) while, on other occasions people 
with a longer time since injury reported less or even no problems (i.e. “usual activities” 
and “anxiety/depression”) (Appendix 7: Table 7.3.11). Following scoring of the EQ-5D 
dimensions, it was found that time since injury did not correlate significantly with EQ-
5D either on the index (p=0.509, ρ=-0.04, Pearson’s correlation) or the perceived self-
rated health of the respondents (p=0.62, r=0.35, Pearson’s correlation). People 
perceived their self-rated health as better when the time since injury was longer in a 
correlation of moderate strength (Table 7.5).  
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Table 7.5: Summary results and statistical tests of EQ-5D and EQ-VAS reported by 
people divided into groups by demographic profile characteristics 
  EQ-5D Index EQ-VAS 
 n mean±SD Statistical 
Tests 
mean±SD Statistical Tests 
Gender 
  Male  
  Female  
 
120 
76 
 
0.4±0.3 
0.3±0.3 
t=1.48 
p=0.18 
95% CI -0.02, 
0.17 
 
64.0±23.9 
61.7±20.3 
t=0.67 
p=0.5 
95% CI -4.33, 
8.79 
Cause of Injury 
  Traumatic  
  Non-traumatic  
 
139 
59 
 
0.4±0.3 
0.3±0.4 
U=3441.5 
p=0.07 
 
 
66.8±22.7 
53.8±19.5 
t=-2.85 
p=0.006³ 
95% CI -43.0, -7.5 
Age  190  r=-0.46 
p=0.54 
 r=-0.36 
p≤0.001*** 
Level of injury 
  Tetraplegia  
  Paraplegia  
 
91 
59 
 
0.3±0.4 
0.3±0.4 
U=4772 
p=0.81 
 
67.1±23.9 
59.4±20.8 
t(df196)=2.41 
p=0.017³ 
95% CI 1.4, 13.9 
Time since injury  197  ρ=-0.04 
p=0.509 
 r=0.35 
p=0.62 
Marital status  
  Married/with partner 
Single/divorced/widow  
194  
0.4±0.3 
0.4±0.4 
t=0.02 
p=0.98 
95% CI -0.10, 
0.10 
 
61.9±22.6 
55.8±21.8 
t=-1017 
p=0.24 
95% CI -10.5,  2.6 
Education level 
  None or compulsory 
  High School 
  Colleg/Bachel/Assoc 
  Master’s/PhD 
196  
0.4±0.4 
0.3±0.4 
0.4±0.3 
0.4±0.3 
H=3.23 
p=0.35 
 
52.1±22.5 
61.8±24.1 
65.2±21.8 
65.3±21.2 
H=7.31 
p=0.06 
Employment status  
  Employed1 
  Unemployed2 
  Retired 
197  
0.5±0.3 
0.2±0.4 
0.4±0.3 
 
H=14.06 
p≤0.001*** 
  
1including people in paid job, voluntary job, working from home and students, 2including 
people unable to work, looking for a job and homemakers; 3not significant post Bonferroni 
correction; ***Significant at p≤0.001 level, in bold: significant following application of the 
Bonferroni correction.  
Abbreviations: EQ-5D index, Quality of Life index; EQ-VAS, Quality of Life Visual Analogue 
Scale; PhD, Doctor of Philosophy.  
Statistical tests: U, Mann-Whitney U test; t, Independent t-test; r, Pearson’s correlation; H, 
Kruskal-Wallis H test. 
 
 
Three additional variables that were found in the literature to relate to QoL (marital 
status, education level and employment) were examined as well. Marital status was 
collated into two categories 1) people married or living with a partner or in a 
relationship and 2) people single or separated/divorced or widowed. The majority of 
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people from both categories said that they had some problems (level 2) for all health 
status dimensions. They reported no problems with “self-care” and a greater 
percentage of single people seemed to be less “anxious/depressed” than those with a 
partner. After scoring of the dimensions, the similarities between the two groups were 
confirmed, as no significant differences were found on the classification or perception 
of health status according to marital status (Table 7.5). 
Education was grouped into four categories; 1) none or compulsory education, 2) high 
school, 3) college, associate degree or university bachelor degree and 4) master’s or 
PhD. Overall, the groups did not differ much, however people with higher levels of 
education seemed to be less severely “anxious/depressed” and reported more cases of 
no problems with “self-care” (Appendix 7: Table 7.3.9). Following scoring of the five 
dimensions, it was found that people with different education levels did not differ 
significantly in their classification of health state or perception of self-rated health 
(Table 7.5).  
Finally, in the case of employment status the categories were collated into three; 1) 
“employed” included people in a paid job, voluntary job, working from home and 
students, 2) “unemployed” included people unable to work, looking for a job and 
homemakers and 3) “retired”. It was decided to put students under the “employed” 
category, even though in some cases they were not paid, because it was believed that 
studying involves tasks that many paid office-based jobs would also require. People 
reported very similarly on the five dimensions of health status, although those who 
were employed reported none or less severe problems with “self-care” and fewer 
cases of severe problems with “anxiety/depression”. Scoring of the EQ-5D dimensions 
confirmed that there was a significant difference in the EQ-5D index by education level 
(p=0.001, H=14.06, Kruskal-Wallis H test, n=197). Two-group analysis showed that this 
difference was between employed and unemployed people, with employed people 
reporting a better mean index (p≤0.001, U=2111, Mann-Whitney U test, n=166, Table 
7.7).  
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Table 7.7: Two-group comparisons for EQ-5D between groups 
divided by employment status 
n, mean±SD,  
min-max 
Unemployed n=61, 
0.2±0.4, -0.6, 0.8 
Retired n=31, 
0.3±0.3, -0.2, 0.7 
Employed, n=105 
0.4±0.5, -0.3, 1 
U=2111 
p≤0.001*** 
U=1313.5 
p=0.10 
Unemployed   U=77.5 
p=0.16 
***Significant at p≤0.001 level; in bold: significant following application  
of post hoc Bonferroni correction.  
Statistical Test: U, Mann-Whitney U test. 
 
Similarly, people in employment perceived their health status as significantly better 
(p≤0.001, F=8.55, one-way ANOVA, n=197). Two-group comparisons using Bonferroni 
post hoc analysis showed that this difference was between employed and unemployed 
people as well as between retired and employed (Table 7.8). 
 
Table 7.8: Two-group comparisons for EQ-VAS between groups divided by 
employment status 
n, mean±SD,  
min-max 
Unemployed n=61, 
59.2±25.2, 0-100 
Retired n=31, 
51.9±21.7, 10-98 
Employed, n=105 
68.7±19.3, 5-100 
I-J=9.4, 95% CI 1.02, 
17.8, p=0.02** 
I-J=16.7, 95% CI 6.02, 27.4, 
p≤0.01** 
Unemployed  I-J=2.8, 95% CI -4.01, -18.5, 
p=0.28 
 **Significant at p≤0.01 level;  
in bold: significant following application of post hoc Bonferroni correction. 
 
 
7.7 QoL; relation to pain/LBP days, free periods, onset 
As the number of pain or LBP days felt per month increased people with pain or LBP 
reported higher percentages of some or severe problems with “mobility”. Between 
people divided into groups of varying pain/LBP days there were some differences in 
their reported problems, for example, more people who felt LBP daily reported 
moderate to extreme “anxiety/depression”, however these differences were not very 
high. It seemed that as the pain or LBP days felt per month increased so did 
“anxiety/depression” (Appendix 7, Table 7.5.1).  
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After scoring the EQ-5D dimensions, it was found that as the number of pain days felt 
in a month increased, the health status classification was significantly worse (p≤0.001, 
ρ=-0.24, Spearman’s correlations, n=176). The same was found when the LBP days felt 
per month increased (p≤0.001, ρ=-0.30, Spearman’s correlations, n=148) (Appendix 7: 
Table 7.4.1). When the number of pain/LBP days felt per month increased, the 
perceived self-rated health decreased; for pain days: p=0.03, (ρ=-0.16, Spearman’s) 
and for LBP days: p=0.003, (ρ=-0.35, Spearman’s) and though not passing the 
Bonferroni   α-level of significance, it was close, particularly in the case of the increase 
of LBP days (Appendix 7: Table 7.4.1).  
When the regularity of pain- or LBP-free weeks decreased, more people reported 
severe problems with all five EQ-5D dimensions (Appendix 7: Table 7.4.2). People with 
no LBP breaks reported severe problems slightly more often on the dimensions of QoL 
than those who reported having no breaks in their pain in general (Appendix 7: Table 
7.4.2). That may imply that when pain is general, maybe not located at the lower back, 
the problems with QoL are not as severe. Though the current data cannot confirm this 
(as in the “pain in general” group those with LBP are also included), it may be a 
possibility.    
After scoring the EQ-5D, it became apparent that as the frequency of pain-free weeks 
decreased so did the health status classification. The relationship between the EQ-5D 
index and the frequency of pain- or LBP-free weeks was significant; for pain free 
weeks: p≤0.001, (ρ=-0.30, Spearman’s correlation, n=166); for LBP-free weeks: 
p≤0.001, (ρ=-0.31, Spearman’s, n=112) (Appendix 7: Table 7.4.3). However, the 
regularity of the pain- or LBP-free weeks did not correlate significantly with how 
people perceived their self-rated health despite the direction of the correlation being 
similar to how people classified their health state (Appendix 7: Table 7.4.4).   
The relationship between QoL and the onset of pain/LBP was part of the second 
hypotheses theme (hypothesis 6). The following was hypothesised: 
Hypothesis 0 (null): In people with iSCI there is no significant correlation between QoL 
(EQ-5D index or EQ-VAS) and the onset of pain or LBP post iSCI. 
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Hypothesis 6a: In people with iSCI there is a significant correlation between QoL (EQ-
5D index or EQ-VAS) and the onset of pain post iSCI. 
Hypothesis 6b: In people with iSCI there is a significant correlation between QoL (EQ-
5D index or EQ-VAS) and the onset of LBP post iSCI. 
Slightly more people who had LBP onset immediately after their injury reported more 
problems with anxiety/depression in comparison with people with immediate pain 
onset following injury (Table 7.13). Following scoring of the EQ-5D dimensions it was 
seen that the correlation between EQ-5D index and pain onset was very weak and not 
significant (p=0.65, ρ=0.035, Spearman’s, 95%CI -0.10, 0.16, n=171) (Table 7.9). But the 
correlation between the EQ-5D index and LBP onset was slightly stronger although it 
did not pass the Bonferroni α-level of significance (p=0.02, ρ=0.19, Spearman’s 
correlation, 95%CI 0.04, 0.33, n=130) (Table 7.10).    
Overall, it was seen that the later the onset of pain or LBP, post iSCI, the better people 
perceived their self-rated health but these correlations failed to pass the Bonferroni α-
level of significance; for pain onset: p=0.017, (ρ=0.18, Spearman’s correlation, 95%CI 
0.05, 0.30, n=171) (Table 7.11, Figure 7.10); for LBP onset: p=0.01, (ρ=0.21, Spearman’s 
correlation, 95%CI 0.06, 0.35, n=130) (Table 7.12, Figure 7.10).  
 
Table 7.9: EQ-5D index in groups divided by time of pain onset post iSCI. Correlations 
between EQ-5D index and pain onset 
Pain onset Immediately 
after iSCI 
 
Within the 
1st month 
post iSCI 
Between 1-
6 months 
post iSCI 
Between 6 
months & 
1 year post 
iSCI 
After 1 
year 
post 
iSCI 
Statistical 
tests 
n 
Mean±SD 
Median            
Percentile 25th 
Percentile 75th 
Skewness 
Kyrtosis  
75 
0.3±0.3 
0.5 
-0.01 
0.6 
-0.3 
-1.1 
32 
0.4±0.3 
0.5 
0.1 
0.6 
-0.5 
-1.4 
34 
0.3±0.3 
0.5 
-0.05 
0.6 
-0.6 
-1.2 
10 
0.2±0.4 
0.2 
-0.05 
0.6 
-0.6 
-0.2 
20 
0.4±0.4 
0.6 
0.01 
0.7 
-0.9 
-0.4 
p=0.65 
ρ=0.035 
95%CI  
-0.10, 0.16, 
n=171 
Abbreviations: EQ-5D index, Quality of Life index; iSCI, incomplete Spinal Cord Injury,  
Statistical tests: ρ, Spearman’s pho correlation, CI: Confidence Interval. 
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Table 7.10: EQ-5D index in groups divided by time of LBP onset post iSCI. Correlation 
between EQ-5D index and LBP onset 
LBP onset Immediately 
after iSCI 
 
Within the 
1st month 
post iSCI 
Between 
1-6 
months 
post iSCI 
Between 6 
months & 
1 year post 
iSCI 
After 1 
year 
post 
iSCI 
Statistical 
tests 
n 
Mean±SD 
Median            
Percentile 25th 
Percentile 75th  
Skewness 
Kyrtosis 
45 
0.3±0.4 
0.2 
-0.03 
0.6 
0.03 
-0.9 
19 
0.3±0.3 
0.5 
-0.008 
0.6 
-0.6 
-1.2 
26 
0.3±0.3 
0.5 
-0.04 
0.7 
-0.4 
-1.4 
 
0.3±0.4 
0.6 
-0.1 
0.6 
-0.6 
-1.6 
27¹ 
0.5±0.3 
0.6 
0.3 
0.7 
-1.3 
0.3 
p=0.02² 
ρ=0.19 
95%CI 0.04, 
0.33, n=130 
¹One outlier eliminated from analysis, 2not significant post Bonferroni correction 
Abbreviations: EQ-5D index, Quality of Life index; EQ-VAS, Quality of Life Visual Analogue 
Scale; LBP, Low Back Pain; iSCI, incomplete Spinal Cord Injury;  
Statistical tests: ρ, Spearman’s pho correlation; CI, Confidence Interval 
 
 
Table 7.11: EQ-VAS in groups divided by time of pain onset post iSCI. Correlation 
between EQ-VAS and pain onset 
 Immediately 
after iSCI 
 
Within the 
1st month 
post iSCI 
Between 
1-6 
months 
post iSCI 
Between 6 
months & 
1 year post 
iSCI 
After 1 
year post 
iSCI 
Statistical 
tests 
n 
Mean±SD 
Median            
Percentile 25th 
Percentile 75th  
Skewness 
Kyrtosis 
75 
57.3±23.5 
55 
40 
77 
-0.2 
-0.8 
32 
64.4±19.7 
66 
46.2 
82 
-0.3 
-1.3 
34 
66.8±19.4 
68.5 
50 
81.2 
-0.5 
-0.6 
10 
51.4±30.7 
54.7 
28.7 
80 
-0.5 
-0.8 
20 
72.2±23.9 
75.5 
53.7 
95 
-0.8 
-0.4 
p=0.0171 
ρ=0.18 
95%CI 
0.05, 
0.30, 
n=171 
1not significant post Bonferroni correction;  
Abbreviations: EQ-VAS, Quality of Life Visual Analogue Scale; iSCI, incomplete Spinal Cord 
Injury;  Statistical tests: ρ, Spearman’s pho correlation; CI, Confidence Interval 
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Table 7.12: Descriptive of EQ-VAS for LBP onset following iSCI 
 Immediately 
after iSCI 
 
Within the 
1st month 
post iSCI 
Between 
1-6 
months 
post iSCI 
Between 6 
months & 
1 year 
post iSCI 
After 1 
year post 
iSCI 
Statistical 
tests 
n 
Mean±SD 
Median            
Percentile 25th 
Percentile 75th  
Skewness 
Kyrtosis 
45 
53.4±24.6 
55 
34.5 
76 
-0.3 
-1.0 
19 
55.1±18.1 
55 
40 
75 
-0.05 
-1.5 
26 
60.6±21.1 
65 
43.7 
76.2 
0.1 
-0.8 
13 
63.6±18.1 
60 
49.7 
82.5 
0.2 
-1.4 
27¹ 
68.8±22.2 
71 
60 
85 
-0.7 
-0.2 
p=0.012 
ρ=0.21 
95%CI 0.06, 
0.35, n=130 
¹One outlier eliminated from analysis; 2not significant post Bonferroni correction 
Abbreviations: EQ-VAS, Quality of Life Visual Analogue Scale; iSCI, incomplete Spinal Cord 
Injury;  Statistical tests: ρ, Spearman’s pho correlation; CI, Confidence Interval 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.10:  Mean EQ-VAS reported by groups of people divided per pain/LBP  
onset post iSCI. 
Abbreviations: EQ-VAS, Quality of Life Visual Analogue Scale; iSCI, incomplete  
Spinal Cord Injury; LBP, Low Back Pain. 
 
7.8 QoL; relation to pain extent 
Data analysis showed that as the number of areas with pain on the body increased, the 
mean EQ-5D index significantly decreased thus people classified their health state 
lower. Though of nearly moderate strength it did not pass the Bonferroni α-level of 
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significance (p=0.01, r=-0.25, n=174, Pearson’s correlation). The same was found 
between the perception of self-rated health and the number of areas with pain 
(p=0.05, r=-0.21, n=174, Pearson’s correlation).  
In Chapter 6, females were found to report significantly more areas with pain on the 
body (Section 6.2.5) thus, the relationship between QoL and number of areas with pain 
was investigated by gender. When the number of areas with pain increased in males, 
the EQ-5D index decreased with a correlation of moderate strength (p=0.02, r=-0.21, 
Pearson’s correlation, n=107). The same was found with females (p=0.04, r=-0.25, 
Pearson’s correlation, n=65). Finally, with males, the increased number of areas with 
pain correlated with a decreased perception of self-rated health (EQ-VAS) (p≤0.01,          
r=-0.10, Pearson’s correlation, n=107) but this correlation was very weak among 
females (p=0.42, r=-0.10, Pearson’s correlation, n=65). None of the above correlations 
were significant following application of the Bonferroni correction.  
 
7.9 QoL; relation to LBP quality and intensity  
The third hypothesis theme examined the relationship of LBP quality and intensity with 
a number of variables including QoL. Earlier analysis found no gender differences in 
quality and intensity of LBP or any other EQ-5D reports. Therefore, there was no need 
to examine the relationship between QoL and LBP quality or intensity by gender.  
Data showed that as quality of LBP (PRI) became worse (increased), more people 
reported severe levels on the EQ-5D dimensions. This was more obvious for the 
dimensions of “usual activities”, “pain/discomfort” and “anxiety/depression” (Table 
7.15 and Figure 7.11).  
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Table 7.13: Percentage of people reporting the EQ-5D dimensions divided in groups by time of pain and LBP onset post iSCI 
 Pain onset after iSCI % 
n=171¹ 
LBP onset after iSCI % 
n=131¹ 
Immediately 
after iSCI 
Within 1
st
 
month 
1-6 
months 
6 months 
– 1 year 
After 1 
year 
Immediately 
after iSCI 
Within 1
st
 
month 
1-6 
months 
6 months 
– 1 year 
After 1 
year 
Mobility Level 1 6.7 6.3 5.9 0 5 6.7 15.8 3.8 0 3.6 
Level 2 82.7 78.1 85.3 70 65 82.2 73.7 80.8 92.3 82.1 
Level 3 10.7 15.6 8.8 30 30 11.1 10.5 15.4 7.7 14.3 
Self-Care Level 1 45.3 50.0 44.1 30 50 44.4 42.1 42.3 46.2 57.1 
Level 2 48 34.4 41.2 60 30 51.1 47.4 53.8 38.5 32.1 
Level 3 6.7 15.6 14.7 10 20 4.4 10.5 3.8 15.4 10.7 
Usual 
Activities 
Level 1 13.3 21.9 11.8 20 30 15.6 15.8 11.5 15.4 21.4 
Level 2 65.3 68.8 70.6 50 55 60.0 68.4 69.2 69.2 71.4 
Level 3 21.3 9.4 17.6 30 15 24.4 15.8 19.2 15.4 7.1 
Pain / 
Discomfort 
Level 1 6.7 0 2.9 0 15 2.2 5.3 11.5 0 7.1 
Level 2 64.0 81.3 70.6 70 75 57.8 68.4 65.4 69.2 78.6 
Level 3 29.3 18.8 26.5 30 10 40.0 26.3 23.1 30.8 14.3 
Anxiety / 
Depression 
Level 1 40.0 28.1 38.2 20 50 33.3 21.1 30.8 38.5 46.4 
Level 2 44.0 68.8 50.0 60 40 51.1 63.2 57.7 53.8 46.4 
Level 3 16.0 3.1 11.8 20 10 15.6 15.8 11.5 7.7 7.1 
¹Including only people with pain/LBP and excluding those who did not recall when the onset of their pain/LBP was.  
Abbreviations: EQ-5D, Quality of Life; LBP, Low Back Pain; iSCI, incomplete Spinal Cord Injury 
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Figure 7.11: Mean LBP quality and intensity in groups by EQ-5D dimensions 
Abbreviations: PRI, Present Rating Index; LBP, Low Back Pain 
 
 
A correlation between QoL and quality of LBP had been hypothesised as follows:  
Hypothesis 0 (null): In people with iSCI there is no significant correlation between QoL 
(EQ-5D index or EQ-VAS) and quality (sensory, affective or total PRI) of LBP.  
Hypothesis 10a: In people with iSCI there is a significant correlation between QoL (EQ-
5D index or EQ-VAS) and the sensory dimension of LBP. 
Hypothesis 10b: In people with iSCI there is a significant correlation between QoL (EQ-
5D index or EQ-VAS) and the affective dimension of LBP. 
Hypothesis 10c: In people with iSCI there is a significant correlation between QoL (EQ-
5D index or EQ-VAS) and the total PRI of LBP. 
Analysis verified that as sensory dimension became worse (increased), the health state 
classification significantly decreased (p≤0.001, r=-0.29, Pearson’s correlation, 95%CI      
-0.42, -0.14, n=141). The same significant correlation was verified for the affective 
 Chapter 7: Survey; results; quality of life 
 
220 
dimension (p≤0.001, r=-0.32, Pearson’s correlation, 95%CI -0.45, -0.18, n=141) and for 
total PRI (p≤0.001, r=-0.26, Pearson’s correlation, 95%CI -0.39, -0.11).  
People perceived their self-rated health to be worse when the quality of LBP became 
worse but these correlations were not statistically significant and overall they were 
less strong; for the affective dimension: p≤0.01, (r=-0.27, Pearson’s correlation, 95%CI -
0.40, -0.11, n=141); for the sensory dimension: p=0.21, (r=-0.19, Pearson’s correlation, 
95%CI -0.33, -0.04, n=141) and for the total PRI: p=0.24, (r=-0.10, Pearson’s 
correlation, 95%CI -0.25, 0.05). Thus the above null hypothesis cannot be rejected 
when reference is made to the classification of health state and quality of LBP.   
In Chapter 6, it was seen that the intensity of LBP is important in the experience of 
pain for people with iSCI. Here it can be seen that when the mean intensity of the 
current LBP increases, more people report severe problems with the health status 
dimensions (Figure 7.12). In particular people with severe “pain/discomfort” and 
“anxiety/depression” (level 3) also reported the highest mean intensity of current LBP 
(61.3±28.1 and 59.4±23.9, mean±SD, respectively) (Tables 7.15, 7.16). This is a clear 
suggestion that experiencing a higher intensity of pain at this location affects QoL.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.12: Mean intensity of current LBP reported by people divided into  
groups by EQ-5D dimensions 
Abbreviations: VAS, Visual Analogue Scale. 
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A correlation between QoL and LBP intensity was hypothesised (hypothesis 11) as 
follows:  
Hypothesis 0 (null): In people with iSCI there is no significant correlation between QoL 
(EQ-5D index or EQ-VAS) and intensity of LBP.  
Hypothesis 11a: In people with iSCI there is a significant correlation between QoL   
(EQ-5D index or EQ-VAS) and current intensity of LBP. 
Hypothesis 11b: In people with iSCI there is a significant correlation between QoL   
(EQ-5D index or EQ-VAS) and intensity of LBP over the last 1 month. 
Hypothesis 11c: In people with iSCI there is a significant correlation between QoL   
(EQ-5D index or EQ-VAS) and intensity of LBP over the last 3 months. 
Hypothesis 11d: In people with iSCI there is a significant correlation between QoL   
(EQ-5D index or EQ-VAS) and evaluative overall intensity of LBP (PPI). 
Following scoring of the EQ-5D index and applying correlations it was confirmed that 
worse intensity significantly correlated with worse health state classification. All 
correlations were of high strength (Table 7.14). The same was found about the 
perception of self-rated health which significantly dropped when intensity of LBP (all 
time periods) increased. 95% CI were also not wide; as a result, the null hypothesis can 
be rejected (Table 7.14).  
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Table 7.14: Correlations between intensity of LBP and quality of life 
 Intensity of 
Current LBP  
n=115 
Intensity of LBP 
over last 1 month 
n=113 
Intensity of LBP 
over last 3 
months n=112 
Evaluative LBP 
intensity  
n=130 
EQ-5D index r=-0.47 
p≤0.001*** 
95%CI, -0.59,  
-0.33 
r=-0.39 
p≤0.001*** 
95%CI, -0.52,  
-0.24 
r=-0.31 
p≤0.001*** 
95%CI, -0.46,  
-0.15 
r=-0.39 
p≤0.001*** 
95%CI, -0.51,  
-0.26 
EQ-VAS r=-0.43 
p≤0.001*** 
95%CI, -0.79,  
-0.28 
r=-0.45 
p≤0.001*** 
95%CI, -0.57,  
-0.30 
r=-0.39 
p≤0.001*** 
95%CI, -0.62,  
-0.24 
r=-0.38 
p≤0.001*** 
95%CI, -0.50,  
-0.25 
***Significant at p≤0.001 level, in bold: significant following application of the  
Bonferroni correction.  
Abbreviations: EQ-5D index, Quality of Life index; EQ-VAS, Quality of Life Visual Analogue 
Scale; LBP, Low Back Pain.  
Statistical Tests: r, Pearson’s correlation; CI, Confidence Interval 
 
 
7.10 Conclusion 
This chapter analysed the data collected about QoL and showed that people with iSCI 
report reduced QoL. All the dimensions that were measured as part of health status 
were affected. The findings confirm that the presence of pain in iSCI negatively affects 
QoL.  A new finding is that LBP presence also negatively affects health status in people 
with iSCI. The more persistent pain or LBP are, the worse the health status. When the 
quality of LBP gets worse people classify their health status as worse but they do not 
perceive their health status as worse. However, when the intensity of LBP gets worse, 
then people perceive their health status as worse too. This confirms the importance of 
the intensity of this type of pain experience on QoL.  
The next chapter will describe the functional independence of the respondents and 
will examine the impact of pain, MSKP and, in particular, LBP on it.   
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Table 7.15: Mean LBP quality and intensity in groups divided by EQ-5D dimensions   
 
¹One outlier eliminated, ²Two outliers eliminated.  
Abbreviations: PRI, Present Rating Index; S-PRI, Sensory PRI; A-PRI, Affective PRI; NRS, Numeric Rating Scale; LBP, Low Back Pain. 
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Table 7.16: Mean evaluative overall intensity of LBP (PPI) in groups divided by EQ-5D dimensions 
 Evaluative PPI for LBP      
 Total  
mean±SD, min-
max, median 
No pain 
% 
n=2 
Mild 
% 
n=25 
Discomforting 
% 
n=56 
Distressing 
% 
n=36 
Horrible 
% 
n=14 
Excruciating 
% 
n=10 
Mobility Level 1  1.9±0.8, 1-3, 2 0 12 5.4 5.6 0 0 
Level 2  2.4±0.9³, 1-5, 2 100 68 85.7 77.8 85.7 80 
Level 3 2.4±1.2, 1-5, 2 0 28 8.9 16.7 14.3 20 
Self-Care Level 1 2.2±1.1, 0-5, 2 100 60 46.4 38.9 28.6 40 
Level 2  2.5±1.0¹, 1-4, 2 0 32 46.4 50 71.4 40 
Level 3  2.9±0.8, 1-3, 2 0 8 7.1 11.1 0 20 
Usual 
Activities 
Level 1  2.1±0.8, 1-4, 2 0 20 19.6 13.9 7.1 0 
Level 2  2.9±0.9², 0-5, 2 100 72 67.9 66.7 50 50 
Level 3  2.9±0.9, 1-5, 3  0 8 12.5 19.4 42.9 50 
Pain / 
Discomfort 
Level 1  1.8±0.8¹, 1-3, 2 0 8 3.6 2.8 0 0 
Level 2  2.1±0.8, 1-4, 2 100 80 87.5 58.3 42.9 0 
Level 3  3.4±0.9³, 2-5, 3 0 12 8.9 38.9 57.1 100 
Anxiety / 
Depression 
Level 1  1.9±0.7², 1-3, 2 0 68 41.1 27.8 14.3 10 
Level 2  2.4±0.8³, 1-4, 2 100 32 55.4 50 50 60 
Level 3  3.3±0.8¹, 2-5, 3 0 0 3.6 22.2 35.7 30 
¹One outlier eliminated, ²Two outliers eliminated, ³Three outliers eliminated.  
Abbreviations: PPI, Present Pain Intensity; LBP, Low Back Pain. 
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Chapter 8; Results: Function 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A language does not become fixed. The 
human intellect is always on the march, 
or, if you prefer, in movement, and 
languages with it.           
Victor Hugo (1802 – 1885) – French 
writer  
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8.1 Introduction 
The analysis conducted so far has shown a high presence of pain and LBP in people 
with iSCI and demonstrated how pain can affect the QoL of people living in pain. This 
chapter aims to answer the primary question “What is the relationship and what are 
the characteristics between function and LBP in people with iSCI?” 
It has been explained previously (Chapter 5) that to collect data about function the 
SCIM III measurement was used. This measurement was translated into Greek. A 
preliminary validation of the Greek version of SCIM III was conducted. Data from this 
group was analysed separately from the rest of the group for reasons explained 
previously. The first part of this chapter will present this preliminary validation and the 
results of the Greek group. The second part of this chapter will present the results of 
the remaining group. The psychometric properties of the English version of SCIM III 
have also been examined and will be presented in the second half of the current 
chapter.  
 
8.2 Bonferroni correction 
For both the Greek group and the rest of the group in the current chapter the main 
variables of interest were used in 23 different tests thus the α-level of statistical 
significance set by Bonferroni was p≤0.002 (Appendix 8: Table 8.2.1).   
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Part 1 ; Translation and preliminary validation of       
GR-SCIM III 
 
8.1.3 Preliminary validation of GR-SCIM III 
8.1.3.1 Translation of GR-SCIM III 
The methodology followed to translate SCIM III and the justification of the methods 
pursued was explained in detail in Chapters 4 and 5. A forward and back-translation27 
was conducted and all translators were health-related professionals of Greek origin. In 
addition a professional translator, with health-related experience was involved in the 
procedure. The difficulty of translating each question was rated on a 0-10 NRS (0=very 
easy to translate to 10=the most difficult translation). All translators were residents of 
the UK for a mean 6.8±2.0 (mean±SD) years thus having a good knowledge of the 
English language and culture (Appendix 8: Table 8.1.1).  
In the forward translation words, usually verbs, were translated from the third person 
(e.g. “requires”) into the passive voice, which is commonly used in Greek (e.g. 
“απαιτείται”). In general, this was accepted as part of the Greek language culture, and 
as long as the meaning of the text was not altered it was followed throughout the 
questionnaire unless it was grammatically wrong to do so. Another change, which was 
done for both the Greek and English versions of SCIM III, was that verbs in general 
were changed, where appropriate, from the third person to the first person. This was 
done because SCIM III was going to be completed by the respondents themselves and 
it would have been grammatically inappropriate and confusing to self-complete a 
questionnaire which uses third person language. The major changes that occurred 
during the translation of SCIM III can be found at Appendix 4. The mean hours required 
to translate the questionnaire was 4.3±3.1 (mean±SD) and the most difficult questions 
to translate (mean 6.3 and 6.0 on the 0-10 NRS) were related to “sphincter 
management” (Table 8.2.1).  
                                                     
27
 For details on forward and back-translation refer to Chapter 4. 
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There were two volunteer back-translators, who had not participated in the forward 
translation, both of Greek origin. One translator provided information about the 
difficulty of translating the questionnaire rated as 6 (0-10 NRS) and needed 4.5 hours 
to complete the translation. The dictionary was used rarely, and the most difficult 
question to translate was related to “bladder management”. The process of the 
translation was described in Chapter 4, Figures 4.1, 4.2. The Greek version of SCIM III is 
at Appendix 3. 
 
8.1.3.2 GR-SCIM III; validity; Principal Component Analysis (PCA) 
The original developers of SCIM III tested the unidimensionality of the measure’s 
subscales using factor analysis. Only a negligible fraction of the scale score variance 
was not explained by ability measurements and this could be due to randomness and 
not due to any extraneous hidden variable.65 Unidimensionality was also supported for 
the UK group when their data were tested in the same study.171  
In this study, the first step taken was to check the data collected for normality by using 
matrix scatterplots for each subgroup separately and for the sum variables of the total 
of the subgroups. The relationship between the variables was checked via a correlation 
matrix.  
PCA was conducted to check for unidimensionality. Table 8.2.2 summarises the main 
results of PCA including the KMO and Bartlett’s tests.28  None of the KMO test results 
were below acceptance value (<0.50), though the “respiration” item in the “respiration 
and sphincter management” subscale was rather low but still acceptable. This means 
that the data were appropriate for factor analysis. The Bartlett test was significant in 
all cases meaning that the variables were correlated enough to justify factor analysis. 
Finally, only one factor was extracted each time confirming the unidimensionality of 
each of the subscales of the GR-SCIM III.  
 
                                                     
28
 For details on the theory on PCA, KMO test and Bartlett’s test refer back to Chapter 5, Section 5.23. 
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Table 8.2.2: Principal Component Analysis for GR-SCIM III 
Subscales KMO test¹ KMO values 
for 
individual 
items  
Bartlett’s 
test² 
Number of 
factors 
extracted 
Self-care  
(6 items) 
KMO=0.78 >0.66 χ2 (15)=178.32 
p≤0.001*** 
1 
Respiration & sphincter 
management 
(4 items) 
KMO=0.55 >0.55³ χ2 (6)=33.36 
p≤0.001*** 
1 
Mobility in room & toilet 
(3 items) 
KMO=0.67 >0.60 χ2 (3)=137.07 
p≤0.001*** 
1 
Mobility indoors & 
outdoors 
(6 items) 
KMO=0.89 >0.85 χ2 (15)=319.72 
p≤0.001*** 
1 
Sum of all 4 subscales 
(4 items) 
KMO=0.80 >0.77 χ2 (6)=92.16 
p≤0.001*** 
1 
¹Values for KMO are: <0.5 not accepted, 0.7 – 0.8 good, 0.8 – 0.9 excellent, >0.9 superb, 
²Bartlett’s test needs to be <0.05, ³The item of “respiration” was <0.55 (0.42),  
in bold: ***Significant at p≤0.001 level.  
Statistical Tests: χ², Bartlett’s Chi square; KMO, Kaiser-Meyer-Olkin 
 
 
8.1.3.3 GR-SCIM III; criterion/concurrent validity 
Criterion/concurrent validity was examined for two of the subscales of SCIM (self-care 
and mobility) by correlating them with the same two subscales of EQ-5D (self-care and 
mobility). The two tests are scored in opposite directions, i.e. in EQ-5D the higher the 
score the worse the health outcome whereas in SCIM the higher the score the better 
the outcome. Therefore the two measures should be inversely (negatively) related to 
indicate a good concurrent validity and the closer this relationship to -1 the better the 
relationship.  
Applying Spearman’s ρ correlation29, on the data of 45 people who responded to the 
two subscales of both the measures, the correlation between the self-care subscales 
was found to be strong ρ=-0.78 and between the mobility subscales it was moderate 
ρ=-0.58. In both occasions these correlations were statistically significant at p≤0.01 
level.  
                                                     
29
 Spearman’s ρ was used because one variable was on a continuous and one on an ordinal level of 
measurement. 
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8.1.3.4 GR-SCIM III; reliability; internal consistency  
Since the unidimensionality of the subscales of GR-SCIM III were established, internal 
consistency was tested which would help to examine reliability. Cronbach’s α30 was 
used for each subscale and for the sum of the subscales.  
In particular, for the “self-care” subscale, Cronbach’s α was found to be α=0.90, which 
is “excellent”. The item of “feeding” within this subscale was the weakest item 
(α=0.54) and if this item was to be deleted then Cronbach’s α for the subscale would 
increase to α=0.91 (Table 8.2.3). For the “respiration and sphincter management” 
subscale, Cronbach’s α was found to be α=0.59, which is a “poor” correlation. Within 
this subscale two items had below acceptable level correlations; “respiration” (α=0.17) 
and “bowel management” (α=0.39) and if deleted then Cronbach’s α would increase to 
α=0.65 and α=0.51. For the “mobility in the room and toilet” subscale, Cronbach’s α 
was α=0.83, which was a “good” correlation. The item of “mobility in bed” in this 
subscale had the lowest correlation (α=0.73) and if deleted then Cronbach’s α would 
increase to α=0.98. For the “mobility indoors and outdoors” subscale, Cronbach’s α 
was α=0.91, which was “excellent”. The item “transfer ground-wheelchair” within this 
subscale was the lowest (α=0.77) and, if deleted, Cronbach’s α would increase to 
α=0.92. Overall, Cronbach’s α for the GR-SCI III was α=0.78 which is “acceptable”. The 
subscale of “respiratory & sphincter management” was the weakest subscale within 
the total GR-SCIM III which rated as “poor” (α=0.57) and if deleted Cronbach’s α of the 
total scale would increase to α=0.74. Finally, the subscales of “self-care” and “mobility 
indoors & outdoors”, were the strongest subscales and, if deleted, the α for the total 
scale would drop (Table 8.2.3).   
Examining the results, ceiling effects31 were noticed. Of the 19 items included in the 
four subscales 11 had a ceiling effect (57.9%). Of the four subscales one had a ceiling 
effect of 20%. The subscale with the highest ceiling effect was the “mobility in room 
and toilet” (100%) followed by “respiration & sphincter management” (75%), “self-
                                                     
30
 For a reminder on the theory of Cronbach’s α refer back to Chapter 5, Section 5.23.1. 
31
 Ceiling and floor effect is the percentage of the sample achieving the highest and lowest possible 
scores, respectively.
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care” (66%) and finally “mobility indoors & outdoors” (16.7%) (Table 8.2.4). Floor 
effect was 0%.  
To summarise the above, PCA verified the unidimensionality of the GR-SCIM III which is 
in line with the unidimensionality of the original English version of SCIM III.64 
Criterion/concurrent validity was tested by examining two subscales of SCIM III with 
two subscales of EQ-5D and it was found to be strong for “self-care” (ρ=-0.78) and 
moderate for the “mobility” subscale (ρ=-0.58). Finally, in GR-SCIM III all items 
correlated well with the subscales they were under and the tool had acceptable 
internal consistency, α=0.78, with the subscales ranging from 0.59 – 0.91.   
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Table 8.2.3: Cronbach’s alpha for GR-SCIM III 
Item Item total correlation¹ Cronbach’s alpha if item 
deleted2 
Self-care subscale  
α=0.90 
  
  Feeding 0.54 0.91 
  Bathing upper body 0.77 0.88 
  Bathing lower body 0.86 0.86 
  Dressing upper body 0.86 0.86 
  Dressing lower body 0.80 0.88 
  Grooming 0.73 0.88 
Respiration & sphincter 
management  
α=0.59 
  
  Respiration 0.17 0.65 
  Bladder management 0.51 0.44 
  Bowel management 0.39 0.51 
  Use of toilet 0.65 0.38 
Mobility in room & toilet 
α=0.83 
  
Mobility in bed 0.73 0.98 
Transfer bed-wheelchair 0.86 0.70 
Transfer wheelchair-toilet-
tub 
0.84 0.72 
Mobility indoors & outdoors 
α=0.91 
  
Mobility indoors 0.94 0.86 
Mobility moderate distances 0.96 0.86 
Mobility outdoors 0.92 0.87 
Stair management 0.90 0.88 
Transfer wheelchair-car 0.79 0.91 
Transfer ground-wheelchair 0.77 0.92 
Sums of subscales 
α=0.78 
  
Self-care 0.73 0.69 
Respiration & sphincter 
management 
0.57 0.74 
Mobility room & toilet 0.76 0.78 
Mobility indoors & outdoors 0.77 0.68 
¹Item total correlation is the correlation between each item and the total score or the subscale. 
 2This is how much the value of alpha would change if the particular item was deleted from the 
analysis. No items have been deleted in GR-SCIM III.  
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Table 8.2.4: Description of items and subscales of GR-SCIM III  
Task n Mean SD Median Min - Max 
Feeding  45 2.8 0.5 3 1 -3 
Bathing upper body 41 2.2 0.9 2 0 – 3 
Bathing lower body 45 2.0 1.0 2 0 – 3 
Dressing upper body 45 2.3 1.3 3 0 – 4 
Dressing lower body 45 2.6 1.5 3 0 – 4 
Grooming 44 2.7 1.4 3 0 – 3 
Total self-care¹  45 14.5 5.1 16 2 – 20 
Respiration 45 10.0 0.3 10 8 – 10 
Sphincter management - bladder 43 13.6 3.5 15 0 – 15 
Sphincter management – bowel 44 7.9 2.9 8 0 – 10 
Use toilet 43 3.8 1.8 5 0 – 5 
Total respiration & sphincter 
management² 
45 34.3 7.5 38 11 – 40 
Mobility in bed 45 5.2 1.4 6 0 – 6 
Transfer bed – wheelchair 40 1.6 0.7 2 0 – 2 
Transfer wheelchair – toilet – tub 43 1.6 0.6 2 0 – 2 
Total Mobility in room & toilet3 45 8.2 2.5 10 0 – 10 
Mobility indoors 45 5.6 2.6 6 0 – 8 
Mobility moderate distance 43 5.2 2.7 6 0 – 8 
Mobility outdoors 44 4.7 2.6 6 0 – 8 
Stair management 44 1.8 1.3 2 0 – 3 
Transfer wheelchair - car 44 1.6 0.7 2 0 – 3 
Transfer ground – wheelchair 44 0.7 0.5 1 0 – 1 
Total mobility indoors & outdoors4 45 19.0 9.9 23 0 – 30 
Total SCIM5 45 76.1 21.3 82 28 - 100 
¹Score can range from 0-20, ²Score can range from 0-40, ³Score can range from 0-10, 4Score 
can range from 0-30, 5Score can range from 0-100.  
Abbreviation: SCIM, Spinal Cord Independence Measure. 
 
8.1.4 GR-SCIM III; general results 
The possible range of scores for each SCIM subscale is different thus, to understand on 
which subscale people reported better function, the percentage of the group mean 
score for each subscale in relation to its maximum score for the subscale was 
calculated. The group scored better on the “respiration and sphincter management” 
subgroup, followed by the “mobility” subscale and last the “self-care” subscale. Within 
the mobility subscale the group scored better on the “mobility in room and toilet” 
subscale followed by the “mobility indoors and outdoors”.  
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GR-SCIM III was completed by 45 people, more than half were males (56.1%), 25% of 
people had finished high school education in Greece (12 years of education), 31.5% 
had finished the third level of education (University or Technological Educational 
Institution (TEI)) and nearly 7% had completed postgraduate studies. Mean age of 
respondents was 60.9±17.4 (mean±SD) years and mean time since injury was 11.0±8.6 
(mean±SD) years. Two-thirds of the respondents (66.7%) had paraplegia, primarily had 
suffered a non-traumatic iSCI (60%), and more than half were married or in a 
relationship (Table 8.2.5). 
 
8.1.5 GR-SCIM III; relation to demographic profile characteristics 
Overall, females (n=18) reported slightly higher (better) SCIM scores than males (n=23) 
for all subscales apart from “mobility in room and toilet”. Following testing for 
differences, no statistically significant results were found between the two sexes and 
their total function (Table 8.2.6; Appendix 8: Table 8.3.1). People with a non-traumatic 
cause of injury (n=27) had slightly better function than people with a traumatic injury 
(n=18), but the differences were not significant (Table 8.2.6; Appendix 8, Table 8.3.3).  
Data showed that the correlation between age and SCIM was positive, of small to 
moderate strength for all subscales, but not statistically significant (Table 8.2.6; 
Appendix 8: Figure 8.3.1). The correlation between time since injury and total SCIM or 
its subscales was negative and weak (the longer the time since injury the better the 
function) but not significant (Table 8.2.6). Because older age correlated with time since 
injury (p=0.005, r=0.41, Pearson’s correlation) the correlation between age and 
function was tested controlling for time since injury using partial correlation. The 
strength of the correlations became slightly stronger and in the case of “mobility in 
room and toilet” the result passed the Bonferroni α-level of significance (Table 8.2.6). 
 
 Chapter 8: Survey; results; function 
 
235 
Table 8.2.5: Demographics of the Greek group  
Variable    Mean ± SD, % or min-max          
Sex (M/F) (%) (n=41) 56.1/43.9 
Age (years, mean ± SD, min-max) (n=45) 60.9 ± 17.4, 26.5-91.7                                                      
Age groups (%) (n=45) 
18 - 29 
30 – 39 
40 – 49 
50 – 59 
60 – 69 
70+ 
4.4 
11.1 
8.9 
20.0 
17.8 
37.8 
Time since injury (years, mean ± SD, min-max) (n=45) 11.0 ± 8.6,     1.4- 34.3 
Age at injury (years, mean ± SD, min-max) (n=45) 50.9 ± 15.9,  20.8-78.3 
Type of injury (%) (n=45) 
Incomplete Tetraplegia  
Incomplete Paraplegia 
 
33.3 
66.7 
Level of injury (%) (n=45) 
Cervical 
Thoracic 
Lumbar 
 
33.3 
35.6 
31.1 
Cause of Injury (%) (n=45) 
  Traumatic  
  Non-Traumatic 
 
40 
60 
Ethnic group (%) (n=45) 
    White – Greek 
100          
Mother Tongue (%) (n=45) 
    Greek 
    English 
97.8 
2.2 
Marital status (%) (n=43) 
    Married 
    Living with partner 
    In a relationship 
    Widowed 
    Single 
 
53.5   
9.3      
4.7     
20.9 
11.6 
Education (%) (n=44) 
    Master’s 
    University Bachelor Degree 
    College or equivalent 
    High School 
    No diploma/degree 
6.8  
31.8 
2.3 
25.0 
34.1 
Employment (%)¹ (n=45) 
    Employed 
    Self-employed 
    Voluntary work 
    Receive health benefits 
    Unable to work due to iSCI 
    Homemaker 
    Retired 
    Other 
    Working hours per week  (n=1) 
 
15.5 
22.2 
2.2 
4.4 
8.9 
2.0 
23.0 
2.2 
40.0     
¹Total sums greater than 100% because respondents were allowed to choose more than one 
option.  
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Overall, it was noticed that people with paraplegia (n=30) reported a better mean 
function for all subscales and total SCIM than people with tetraplegia (n=15) but the 
differences were not significant (Table 8.2.6; Appendix 8: Table 8.3.4). This was also 
confirmed when the three different levels of injury (cervical, thoracic and lumbar) 
were examined (Table 8.2.6; Appendix 8: Table 8.3.5).  
Time since injury did not correlate significantly with any of the function subscales 
(Table 8.2.6). When the correlations between function and time since injury were re-
calculated while controlling for age, it was noticed that the relationships became 
stronger but still not statistically significant (Table 8.2.6).  
 
8.1.6 GR-SCIM III; relation to pain, MSKP and LBP 
Part of the first hypothesis theme was to examine the relation between the presence 
of the categories of pain and function: 
Hypothesis 0 (null): In people with iSCI there is no significant difference in function 
(total SCIM or subscales) between those with and without pain, MSKP or LBP.  
Hypothesis 3a: In people with iSCI there is a significant difference in function (total 
SCIM or subscales) between those with and without pain. 
Hypothesis 3b: In people with iSCI there is a significant difference in function (total 
SCIM or subscales) between those with and without current LBP. 
Hypothesis 3c: In people with iSCI there is a significant difference in function (total 
SCIM or subscales) between those with and without MSKP. 
People without pain (n=10) and without MSKP (n=25) reported slightly higher mean 
total SCIM (better function) than people with pain (n=35) or MSKP (n=17) (Table 8.2.7). 
However, interestingly, people with LBP (n=30) reported slightly better total function 
than those without LBP (n=13) but the difference was not significant (p=0.67, t=-0.42, 
95% CI -17.5, 11.5, ES: d=0.14, Table 8.2.7, Figure 8.2.1; Appendix 8: Table 8.4.1).  
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Table 8.2.6: Summary of statistics between GR-SCIM III and demographic profile 
characteristics 
 Self-care 
subscale 
Respiration & 
sphincter 
management 
Mobility room 
& toilet 
 
Mobility 
indoors & 
outdoors 
Total SCIM 
 
Gender 
 
t=-0.51, df172 
 p=0.60 
95% CI -2.23, 
1.30 
t=1.75, df171  
p=0.08 
95% CI -0.24, 
4.23 
t=-1019, df172 
p=0.23 
95% CI -1.61, 
0.39 
t=0.74, df172 
p=0.45 
95% CI -1.65, 
3.65 
t=0.69, df171  
p=0.48 
95% CI -4.07, 
8.50 
Cause of 
injury 
 
U=2103.5 
p=0.10 
t=-0.25, df170 
p=0.79 
95% CI -2.99, 
2.30 
U=2497.5 
p=0.88 
 
t=0.05, df172 
p=0.95 
95% CI -3.03, 
3.21 
U=2411.5  
p=0.89 
Age  r=0.23  
p=0.12 
r=0.18 
p=0.23 
r=0.29 
p=0.04¹ 
r=0.37 
p≤0.01¹ 
r=0.33 
p=0.02¹ 
Age (after 
controlling for 
time since 
injury)  
r=0.28 
p=0.06 
n=42 
r=0.32 
p=0.02¹ 
r=0.36 
p=0.016¹ 
r=0.45 
p=0.002** 
r=0.43 
p=0.003¹ 
Type of injury 
 
U=152 
p=0.07 
U=166.5 
p=0.26 
U=194.5 
p=0.41 
U=185 
p=0.33 
U=144.5 
p=0.09 
Time since 
injury  
ρ=-0.05 
p=0.71 
r=-0.25  
p=0.08 
ρ=-0.05  
p=0.72 
ρ=-0.06  
p=0.06 
r=-0.14  
p=0.33 
Time since 
injury (after 
controlling for 
age)  
r=-0.17 
p=0.25 
n=42 
r=-0.37 
p=0.013¹ 
r=-0.22 
p=0.14 
r=-0.28 
p=0.06 
r=-0.33 
p=0.02¹ 
1not significant post Bonferroni correction; **Significant at p≤0.01 level, in bold: significant 
following application of the Bonferroni correction.  
Abbreviation: SCIM, Spinal Cord Independence Measure.  
Statistical tests: t, Independent t-test; U, Mann-Whitney U test; r, Pearson’s correlation; ρ, 
Spearman’s rank correlation rho. 
 
 
In Chapter 6 (Section 6.1.7), prior to application of the Bonferroni correction a higher 
proportion of females reported having MSKP. Taking into account the report by IASP177 
to investigate pain-related variables by gender the difference in function in people 
who feel and those who do not feel MSKP was tested in males and females. This was 
not part of the main analysis and as such it is presented at Appendix 8, Table 8.3.2. 
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Figure 8.2.1: Mean SCIM scores reported by people with and without pain, LBP and 
MSKP. 
Abbreviation: SCIM, Spinal Cord Independence Measure; LBP, Low Back Pain; MSKP, 
Musculoskeletal Pain. 
 
 
Table 8.2.7: Statistical differences on function scores between people with and 
without pain, MSKP or LBP 
  Self-care 
subscale 
 
Respiration & 
sphincter 
management 
Mobility room 
& toilet 
 
Mobility 
indoors & 
outdoors 
Total SCIM 
 
Pain  t=-0.09, df43  
p=0.92 
95%CI -3.9, 3.6 
ES: d=0.04 
U=163.5  
p=0.75  
ES: r=0.09 
t=0.72, df43  
p=0.47 
ES: d=0.26 
95%CI -1.1, 2.4 
U=157.5, p=0.59 
t=0.63, df43  
p=0.53 
ES: d=0.24 
95%CI -4.9, 9.4 
U=162, p=0.72 
U=169  
p=0.87  
ES: r=0.02 
Current 
LBP 
t=-0.85, df41  
p=0.39 
95% CI -5.0, 
2.0 
ES: d=0.29 
U=122.5  
p=0.28  
ES: r=0.18 
t=-0.58, df41  
p=0.55 
95%CI -2.1, 1.15 
ES: d=0.19 
U=184.5, p=0.75 
t=-1.8, df41  
p=0.85 
95%CI -7.1, 5.9 
ES: d=0.06 
U=184, p=0.77 
t=-0.42, df41  
p=0.67 
95%CI -17.5, 
11.5 
ES: d=0.14 
MSKP t=0.71, df39  
p=0.48 
95% CI -1.9, 
4.0 
ES: d=0.22 
U=208  
p=0.90 
ES: r=0.02 
t=-0.04, df40  
p=0.96 
95%CI -1.4, 1.3 
ES: d=0.04 
U=206, p=0.85 
U=210  
p=0.94  
ES: r=0.009 
t=0.61, df44  
p=0.54 
95%CI -9.2, 
17.2 
ES: d=0.18 
Abbreviations: SCIM, Spinal Cord Independence Measure, LBP, Low Back Pain; MSKP, 
Musculoskeletal Pain.   
Statistical tests: t, Independent t-test; U, Mann-Whitney U test; r, Pearson’s correlation; ρ, 
Spearman’s rank correlation rho. 
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8.1.7 GR-SCIM III; relation to pain/LBP days, free weeks, onset  
When people were divided into groups based on the number of days they felt pain/LBP 
some groups contained only a few respondents. In order to increase the reliability of 
the statistical tests to be used, the groups were collated into two larger sized 
categories: 1) 1-20 days of pain/LBP days felt per month and 2) 21 – every day 
pain/LBP felt per month.  Analysis showed that an increasing number of pain or LBP 
days did not correlate significantly with function. However, the strength of all the 
correlations were strong and had strong effect sizes, thus failure to find statistical 
results may have been due to the small number of respondents even in these groups 
(Appendix 8: Tables 8.5.1 and 8.5.2).  
The group of people divided according to the frequency of pain/LBP-free breaks were 
also collated into larger categories: 1) have pain/LBP-free break most of the time, 
frequently or sometimes, and 2) do not often have a pain/LBP-free break, rarely and 
always in pain (Appendix 8: Table 8.5.3). Following analysis no statistical correlations 
were found between the frequency of pain or LBP breaks and function. However, the 
effect sizes were mostly large indicating a possible practical significance (Appendix 8: 
Table 8.5.4). 
The second hypothesis theme examined the relation between pain/LBP onset and 
function:  
Hypothesis 0 (null): In people with iSCI there is no significant correlation between 
function (total SCIM or subscales) and the onset of pain or LBP post iSCI. 
Hypothesis 7a: In people with iSCI there is a significant correlation between function 
(total SCIM or subscale) and the onset of pain post iSCI. 
Hypothesis 7b: In people with iSCI there is a significant correlation between function 
(total SCIM or subscale) and the onset of LBP post iSCI 
To avoid having very small groups, time of pain/LBP onset were collated into two 
larger categories; a) pain/LBP onset immediately after or within one month post iSCI 
and b) pain/LBP onset after one month post injury. Overall, it seemed that people with 
 Chapter 8: Survey; results; function 
 
240 
pain (n=19) or LBP (n=20) onset after six months post iSCI had slightly better function 
on SCIM than people who had pain (n=14) or LBP (n=13) onset within the first month 
post iSCI (Tables 8.2.8 and 8.2.9). The correlations were not statistically significant but 
all were strong. Consequently, if only the statistical significance is taken into account 
then this would lead to the acceptance of the null hypothesis (with the exception of 
LBP onset and “mobility indoors and outdoors”). However, the strength of the 
correlations must be considered too. In the case of “mobility in room & toilet” those 
people whose LBP onset was more than one month post iSCI had better scores than 
those with onset within the first month post iSCI (p≤0.001, φ=0.75, Phi Test) (Table 
8.2.9). 
 
Table 8.2.8: Mean function scores based on the onset of pain and LBP following iSCI 
 Pain onset LBP onset 
 Immediately 
after and up to 1 
month post iSCI 
(n=14) 
mean±SD, 
median, min-max 
After 1 month 
post iSCI 
(n=19) 
mean±SD, 
median, min-
max 
Immediately 
after and up to 1 
month post iSCI 
(n=13) 
mean±SD, 
median, min-max 
After 1 month 
post iSCI 
 (n=18) 
mean±SD, 
median, min-
max 
Self-care 
subscale 
Range 0-20 
13.6±6.5  
16.5, 2-20 
15.4±726.0 
17, 4-20 
14.4±5.9 
17, 4-20 
15.3±5.2 
17, 2-20 
Respiration & 
sphincter 
management 
Range 0-40 
35.8±6.1¹  
38, 18-40 
32.7±9.5  
38, 11-40 
35.8±6.3¹  
38, 18-40 
35.4±7.1 
38, 15-40 
Mobility room & 
toilet 
Range 0-10 
7.7±2.3  
8, 4-10 
8.4±2.8  
10, 0-10 
8.0±2.2  
8, 4-10 
9.4±1.4² 
10, 6-10 
Mobility indoors 
& outdoors 
Range 0-30 
17.6±11.3  
23, 0-30 
20.5±9.3  
26, 4-30 
18.5±11.2  
23, 0-30 
21.2±9.0 
26, 5-30 
Total SCIM 
Range 0-100 
74.1±23.3  
82.5, 28-100 
77.0±24.2  
90, 34-99 
76.0±21.1  
83.5, 27-98 
80.0±21.33 
89, 28-100 
Table excludes people with no pain or who did not recall onset of pain, ¹1 outlier eliminated, 
²Two outliers eliminated, 3Three outliers eliminated.  
Abbreviations: SCIM, Spinal Cord Independence Measure, LBP, Low Back Pain.  
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Table 8.2.9: Statistical correlations between function and time of pain/LBP onset  
 Self-care 
subscale 
 
Respiration & 
sphincter 
management 
Mobility room 
& toilet 
Mobility 
indoor & 
outdoor 
Total SCIM 
 
Pain  
n=33  
φ=0.79 
p=0.64  
φ=0.85 
p=0.46  
φ=0.40 
p=0.71  
φ=1.02 
p=0.25 
φ=1.23 
p=0.38  
LBP  
n=31 
φ=0.713 
p=0.20  
φ=0.51 
p=0.62  
φ=0.75 
p≤0.001*** 
n=29  
φ=0.65 
p=0.50  
φ=0.84 
p=0.50  
***Significant at p≤0.001 level; In bold: significant following application of Bonferroni 
correction.  
Abbreviations: SCIM, Spinal Cord Independence Measure, LBP, Low Back Pain.  
Statistical test: φ test. 
 
8.1.8 GR-SCIM III; relation to pain extent 
The number of areas with pain of the body did not correlate significantly with total 
function or any of its subscales (n=30) (Appendix 8: Table 8.6.1).  
 
8.1.9 GR-SCIM III; relation to quality and intensity of LBP  
The third hypothesis theme included the investigation of the relationship between the 
quality and intensity of LBP with function. It had been hypothesised that:  
Hypothesis 0a (null): In people with iSCI there is no significant correlation between 
function (total SCIM or subscales) and quality (sensory, affective or total PRI) of LBP.  
Hypothesis 12a: In people with iSCI there is a significant correlation between function 
(total SCIM or subscales) and sensory PRI of LBP. 
Hypothesis 12b: In people with iSCI there is a significant correlation between function 
(total SCIM or subscales) and affective PRI of LBP. 
Hypothesis 12c: In people with iSCI there is a significant correlation between function 
(total SCIM or subscale) and total PRI of LBP. 
All correlations were found to be very weak, negative and none was statistically 
significant (Table 8.2.10). The null hypothesis was accepted.  
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Table 8.2.10: Correlations between quality of LBP (PRI) and function (SCIM) 
 Self-care 
subscale 
 
Respiration & 
sphincter 
management 
Mobility room 
& toilet 
Mobility 
indoors & 
outdoors 
Total SCIM 
 
S-PRI 
n=30 
r=-0.11,p=0.50 
95%CI -0.18, 
0.51 
r=-0.06,p=0.72 
95%CI -0.26, 
0.45 
r=-0.13,p=0.47 
95%CI -0.36, 
0.36 
r=-0.06,p=0.74 
95%CI -0.11, 
0.56 
r=-0.09,p=0.61 
95%CI -0.17, 
0.52 
A-PRI 
n=31 
r=-0.07,p=0.70 
95%CI -0.19, 
0.47 
r=0.19,p=0.28 
95%CI 0.05, 
0.64 
r=0.04,p=0.80 
95%CI -0.16, 
0.50 
r=0.06,p=0.71 
95%CI -0.02, 
0.59 
r=0.08, p=0.65 
95%CI 0.00, 
0.61 
Total PRI 
n=31 
r=-0.11,p=0.55 
95%CI -0.16, 
0.50 
r=0.03,p=0.84 
95%CI -0.11, 
0.53 
r=-0.07,p=0.71 
95%CI -0.41, 
0.27 
r=-0.01,p=0.94 
95%CI -0.03, 
0.59 
r=-0.02,p=0.88 
95%CI -0.07, 
0.56 
One outlier had been eliminated.  
Abbreviations: SCIM, Spinal Cord Independence Measure; S-PRI, Sensory Pain Rating Index; A-
PRI, Affective PRI.  
Statistical test: r, Pearson’s correlation.  
 
The relationship between intensity of LBP and function was also hypothesised: 
Hypothesis 0 (null): In people with iSCI there is no significant correlation between 
function (total SCIM or subscales) and intensity of LBP.  
Hypothesis 13a: In people with iSCI there is a significant correlation between function 
(total SCIM or subscales) and intensity of current LBP.  
Hypothesis 13b: In people with iSCI there is a significant correlation between function 
(total SCIM or subscales) and intensity of LBP over last one month. 
Hypothesis 13c: In people with iSCI there is a significant correlation between function 
(total SCIM or subscales) and intensity of LBP over last three months. 
Hypothesis 13d: In people with iSCI there is a significant correlation between function 
(total SCIM or subscales) and evaluative LBP intensity. 
When intensity of LBP (all time periods) increased the mean function (total and all its 
subscales) decreased, thus became worse. These correlations were strong and 
significant in one case; however, the numbers of responses in the groups were 
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extremely small32. This reduces the reliability of the results of this particular analysis. 
But intensity of LBP could be examined via the evaluative PPI for which data were 
more complete (Table 8.2.11). 
Analysis showed that as the evaluative dimension of LBP increased, function (SCIM and 
its subscales) mean score decreased. These correlations were moderate and for “self-
care”, “mobility indoors and outdoors” and total SCIM did not pass the Bonferroni      
α-level of significance (Table 8.2.11). 
 
Table 8.2.11: Correlations between LBP intensity and function  
 Self-care 
subscale 
 
Respiration & 
sphincter 
management 
Mobility room 
& toilet 
Mobility 
indoors & 
outdoors 
Total SCIM 
 
Intensity of 
current LBP 
n=3¹ 
r=-0.45 
p=0.009¹ 
r=-0.36 
p=0.04¹ 
r=-0.34 
p=0.05 
r=-0.67 
p≤0.001*** 
r=-0.58 
p≤0.01¹ 
Intensity of LBP 
last 1 month 
n=3¹ 
ρ=-0.81 
p=0.39 
ρ=-0.81 
p=0.39 
ρ=-0.04 
p=0.96 
ρ=-0.50 
p=0.65 
ρ=-0.04 
p=0.96 
Intensity of LBP 
last 3 months 
n=3¹ 
ρ=-0.71 
p=0.49 
ρ=-0.89 
p=0.29 
ρ=0.20 
p=0.87 
ρ=-0.50 
p=0.66 
ρ=-0.50 
p=0.66 
Evaluative PPI  
n=29 
r=-0.41 
p=0.02¹ 
95%CI  
-0.71,  
-0.15 
r=-0.12 
p=0.51 
95%CI -0.46,  
0.25 
r=-0.13 
p=0.47 
95%CI -0.24,  
0.24 
r=-0.23 
p=0.22 
95%CI -0.54,  
0.14 
r=-0.41 
p=0.02¹ 
95%CI  
-0.71,  
-0.15 
 1not significant post Bonferroni correction; ***Significant at p≤0.001 level; in bold: significant 
following application of the Bonferroni correction; Confidence Interval cannot be calculated as 
the group size is very small.  
Abbreviations: SCIM, Spinal Cord Independence Measure; LBP, Low Back Pain; PPI, Present 
Pain Intensity.  
Statistical tests: r, Pearson’s correlation; ρ, Spearman’s rank correlation rho. 
 
 
8.1.10 GR-SCIM III; relation to QoL  
Statistical analysis showed that as function increased (improved), the health 
classification also improved. These correlations were moderate or strong and they 
were all statistically significant (Table 8.2.12; Appendix 8: Figure 8.7.1). When function 
                                                     
32
 For an explanation as to why there were few responses from the Greek group refer back to Chapter 6, 
Section 6.2.7. 
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improved people also perceived their health status as better. However, it was only 
when “mobility indoors and outdoors” improved that improvements in the perception 
of the health status reached a statistically significant level (Table 8.2.12; Appendix 8: 
Figure 8.7.2). 
 
Table 8.2.12: Correlations between function and QoL 
 Self-care 
subscale 
 
Respiration & 
sphincter 
management 
Mobility room 
& toilet 
 
Mobility 
indoors & 
outdoors 
Total SCIM 
 
EQ-5D Index  
n=44 
ρ=0.66 
p≤0.001*** 
ρ=0.45 
p=0.002** 
ρ=0.60 
p≤0.001*** 
ρ=0.57 
p≤0.001*** 
ρ=0.62 
p≤0.001*** 
EQ-VAS  
n=43 
r=0.40 
p=0.008¹ 
r=0.11 
p=0.46 
r=0.18 
p=0.22 
r=0.46 
p=0.002** 
r=0.37 
p≤0.01¹ 
1not significant post Bonferroni correction; **Significant at p≤0.01 level, ***Significant at 
p≤0.001 level; in bold: significant following application of the Bonferroni correction.  
Abbreviations: SCIM, Spinal Cord Independence Measure; EQ-5D, Quality of life; EQ-VAS, 
Quality of Life Visual Analogue Scale.    
Statistical tests: r, Pearson’s correlation; ρ, Spearman’s rank correlation rho. 
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Part 2; Results: SCIM III, function 
 
8.2.1 Introduction 
The first part of this chapter dealt with the analysis and preliminary validation of SCIM 
III. It presented the demographic results of the group as well as examined the relations 
with the variables of interest. This second part will examine the psychometric 
properties of SCIM III and examine the functional profile of the group that used the 
English version of SCIM III. The same question examined in the first part of this chapter 
will be examined here, too; “What is the relationship and what are the characteristics 
between function and LBP in people with incomplete SCI?” The Bonferroni α-level of 
significance is set at p≤0.002.   
 
8.2.2 Validation of SCIM III; for use by self-completion 
8.2.2.1 SCIM III; validity; Principal Component Analysis (PCA) 
The English version of SCIM III used in this study was also examined for its validity and 
reliability because it was used under different conditions than those for which it was 
originally developed (by self-completion). PCA was done to examine the 
unidimensionality of the English version of SCIM III which was confirmed as only one 
factor was extracted each time (Table 8.2.2.1). All KMO test results were above 
acceptance value (>0.50) indicating that data were appropriate for factor analysis. 
Variables were also correlated enough to justify factor analysis (Table 8.2.2.1).  
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Table 8.2.2.1: Principal Component Analysis of the English version of SCIM III 
Subscales KMO test¹ KMO values 
for 
individual 
items  
Bartlett’s 
test² 
Number of 
factors 
extracted 
Self-care  
(6 items) 
KMO=0.89 >0.86 χ2=897.7 
p≤0.001*** 
1 
Respiration & sphincter 
management 
(4 items) 
KMO=0.60 >0.58 χ2=48.6 
p≤0.001*** 
1 
Mobility in room & toilet 
(3 items) 
KMO=0.73 >0.67 χ2=441.3 
p≤0.001*** 
1 
Mobility indoors & 
outdoors 
(6 items) 
KMO=0.85 >0.79 χ2=794.6 
p≤0.001*** 
1 
Sum of all 4 subscales 
(4 items) 
KMO=0.75 >0.68 χ2=375.9 
p≤0.001*** 
1 
¹Values for KMO are: <0.5 not accepted, 0.7 – 0.8 good, 0.8 – 0.9 excellent, >0.9 superb, 
²Bartlett’s test needs to be <0.05, in bold: ***Significant at p≤0.001 level  
Statistical Test: KMO, Kairer Meyer Olkin test; χ², Bartlett’s Chi square 
 
8.2.2.2 SCIM III; criterion/concurrent validity 
Criterion concurrent validity was examined by checking the correlations between two 
of the subscales of SCIM (“self-care” and “mobility”) with two similar of the subscales 
of EQ-5D (“self-care” and “mobility”). The two tests are scored in opposite directions 
thus they should be inversely (negatively) correlated to indicate a good concurrent 
validity (the closer to -1 the better). Applying Spearman’s ρ33 the correlations were 
found to be highly significant and of moderate to large strength; between the “self-
care” subscales the correlation was strong: ρ=-0.75, p≤0.001, n=156, and between the 
“mobility” subscales it was moderate: ρ=-0.45, p≤0.001, n=156.  
 
8.2.2.3 SCIM III; reliability; internal consistency 
Similar to the procedure followed for the GR-SCIM, Cronbach’s α was used to examine 
internal consistency as part of testing for reliability.  
                                                     
33
 Spearman’s ρ was used because one variable was on a continuous and the other on an ordinal level of 
measurement.  
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Overall, Cronbach’s α for the English version of SCIM III was very similar to the one 
found for the Greek version (α=0.79). Some differences were noted in the α of the 
subscales (see Table 8.2.3). The “self-care” subscale was α=0.92, which was marked as 
“excellent” and was slightly higher than that found for GR-SCIM III. The item of 
“feeding” was the weakest within the subscale, similar to GR-SCIM III, but it was not as 
low as in GR-SCIM III. The “respiration and sphincter management” subscale had an α 
which was below an acceptable level (α=0.40 and the non-acceptable level is <0.50164). 
“Bowel management” was the weakest item within the subscale (α=0.19) which, if 
deleted, would increase α to α=0.39 which was still not above acceptable level.  The 
subscale of “mobility in room and toilet” was acceptable α=0.77, with no item falling 
below acceptable levels. The subscale of “mobility indoors and outdoors” had a slightly 
smaller α compared to GR-SCIM III, which was still good α=0.87. The weakest item in 
the subscale was “transfer ground – wheelchair”, which was just above acceptable 
level (α=0.52) and was the weakest item in GR-SCIM III but with a higher Cronbach’s 
(α=0.77). Finally, when examining the sum of the subscales, two out of the four 
subscales had Cronbach’s α of acceptable levels and two of poor levels (Table 8.2.2.2).  
Ceiling effects were noticed in the results; of the 19 items included in the four 
subscales, seven had a ceiling effect (36.8%) which was lower than that found in the 
case of the Greek group. Of the four subscales, one had a ceiling effect of 20%. “Self-
care” and “mobility in room and toilet” were the subscales with the highest ceiling 
effects (66.6%), followed by “mobility indoors and outdoors” (16.6%). No ceiling effect 
was noticed for “respiration and sphincter management” and no floor effects were 
noticed for any item (Table 8.2.2.3).  
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Table 8.2.2.2: Cronbach’s alpha for the English version of SCIM III 
Item Item total correlation¹ Cronbach’s alpha if item 
deleted2 
Self-care subscale  
α=0.92 
  
  Feeding 0.68 0.92 
  Bathing upper body 0.84 0.90 
  Bathing lower body 0.86 0.89 
  Dressing upper body 0.88 0.89 
  Dressing lower body 0.87 0.90 
  Grooming 0.76 0.91 
Respiration & sphincter 
management  
α=0.40 
  
  Respiration 0.28 0.37 
  Bladder management 0.26 0.38 
  Bowel management 0.19 0.37 
  Use of toilet 0.42 0.25 
Mobility in room & toilet 
α=0.77 
  
Mobility in bed 0.78 0.94 
Transfer bed-wheelchair 0.84 0.66 
Transfer wheelchair-toilet-
tub 
0.83 0.65 
Mobility indoors & outdoors 
α=0.87 
  
Mobility indoors 0.87 0.81 
Mobility moderate distances 0.90 0.80 
Mobility outdoors 0.75 0.83 
Stair management 0.86 0.84 
Transfer wheelchair-car 0.61 0.87 
Transfer ground-wheelchair 0.52 0.88 
Sums of subscales 
α=0.79 
  
Self-care 0.73 0.68 
Respiration & sphincter 
management 
0.59 0.75 
Mobility room & toilet 0.77 0.75 
Mobility indoors & outdoors 0.59 0.78 
¹Item total correlation is the correlation between each item and the total score of the subscale. 
 2This is how much the value of alpha would change if the particular item was deleted from the 
analysis.  
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Table 8.2.2.3: Descriptive characteristics of SCIM subscales and items 
Task N Mean SD Median Min – Max 
of group 
Feeding  174 2.6 0.6 3 0 -3 
Bathing upper body 172 2.1 0.9 2 0 – 3 
Bathing lower body 169 2.0 1.0 2 0 – 3 
Dressing upper body 173 3.0 1.4 4 0 – 4 
Dressing lower body 170 2.9 1.5 4 0 – 4 
Grooming 174 2.5 0.9 3 0 – 3 
Total self-care¹  174 15.1 5.7 18 0 – 20 
Respiration 174 9.9 1.2 10 0 – 19 
Sphincter management - bladder 172 9.9 4.9 11 0 – 15 
Sphincter management – bowel 173 6.0 3.4 8 0 – 10 
Use of toilet 173 3.5 1.8 4 0 – 6 
Total respiration & sphincter 
management² 
174 29.1 7.5 30 0 – 40 
Mobility in bed 174 4.9 2.0 6 0 – 6 
Transfer bed – wheelchair 172 1.6 0.7 2 0 – 2 
Transfer wheelchair – toilet – tub 174 1.5 0.7 2 0 – 2 
Total Mobility room & toilet³ 174 7.9 3.2 10 0 – 10 
Mobility indoors 173 3.9 2.5 2 0 – 8 
Mobility moderate distance 173 3.6 2.5 2 0 – 8 
Mobility outdoors 173 2.9 2.3 2 0 – 8 
Stair management 173 1.2 1.1 2 0 – 3 
Transfer wheelchair - car 173 1.4 0.7 2 0 – 2 
Transfer ground – wheelchair 173 0.6 0.6 1 0 – 6 
Total mobility indoors & outdoors4 174 13.5 8.5 11 0 – 30 
Total mobility5 174 21.4 10.7 21 0 – 40 
Total SCIM6 174 65.5 20.6 68 3 – 100 
¹Score can range from 0-20, ²Score can range from 0-40, ³Score can range from 0-10, 4Score 
can range from 0-30, 5Score can range from 0-40, 6Score can range from 0-100 
 
8.2.3 SCIM III; general results 
A total of 174 people completed the English version of SCIM III and the mean score of 
total SCIM was 65.5±20.6 (mean±SD).  To understand on which subscale people 
reported better function the percentage of the group for each subscale in relation to 
its maximum mean for the subscale was calculated. The group scored better on “self-
care”, followed by “respiration and sphincter management” and least well on the 
“mobility” subscale. Within the mobility subscale, the group scored higher on the 
“mobility in room and toilet” subscale followed by “mobility indoors and outdoors”.  
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8.2.4 SCIM III; relation to demographic profile characteristics 
SCIM III (English version) was completed by 111 males and 63 females and despite 
males reporting slightly better function than females no significant differences were 
found (Table 8.2.4.1; Appendix 8: Table 8.8.1). This finding concurs with the finding for 
the Greek respondents that no significant differences were found, although, in the 
Greek group, females reported slightly better function. 
People with a non-traumatic injury (n=37) reported better function scores than people 
with a traumatic injury (n=137) but differences were not significant as in the Greek 
group (Table 8.2.4.1; Appendix 8: Table 8.8.3).  
Overall, people with paraplegia (n=116) reported better function than people with 
tetraplegia (n=103) and this difference was significant for “self-care” (p≤0.001, t=-592, 
independent t-test), “mobility room and toilet” (p≤0.001, t=-5.35), and total SCIM 
(p≤0.001, t=-3.97) (Table 8.2.4.1; Appendix 8: Table 8.8.4). Analysis was done for the 
three levels of injury (cervical, thoracic and lumbar), which showed significantly better 
“self-care” for people with thoracic and lumbar injuries compared with those with 
cervical injuries (Appendix 8: Tables 8.8.5 and 8.8.6). 
It was seen that as age increased, function slightly improved but results did not pass 
the Bonferroni α-level of significance (Table 8.2.4.1). Though the relationships were 
not significant, the strength was often moderate and in the case of “mobility in room 
and toilet” it was large (r=0.99). As there is a significant correlation between time since 
injury and age (p≤0.01, r=0.20, n=173) the relation between age and function was 
checked again while controlling for time since injury. It was found that the correlations 
remained non-statistically significant, the strength of the correlations became very 
small and the direction of the correlations changed. When controlling for the time 
since injury, ageing correlated with a decline in function but not strongly.  
Time since injury had a weak, non-significant, negative correlation with function, 
including all its subscales. This did not change when the age of the participants was 
controlled for (Table 8.2.4.1).  
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Table 8.2.4.1: Statistical differences and correlations between function and 
demographic profile characteristics 
 
1not significant post Bonferroni correction;***Significant at p≤0.001 level; in bold: significant 
following application of the Bonferroni correction.  
Abbreviations: SCIM, Spinal Cord Independence Measure.  
Statistical tests: r, Pearson’s correlation; ρ, Spearman’s rank correlation rho; t, independent t-
test. 
 
8.2.5 SCIM III; relation to pain, LBP and MSKP 
At the onset of the study it had been hypothesised that people with and without the 
categories of pain would differ on their functional independence scores:  
Hypothesis 0 (null): In people with iSCI there is no significant difference in function 
(total SCIM or subscales) between those with and without pain, MSKP or current LBP.  
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Hypothesis 3a: In people with iSCI there is a significant difference in function (total 
SCIM or subscales) between those with and without pain. 
Hypothesis 3b: In people with iSCI there is a significant difference in function (total 
SCIM or subscales) between those with and without MSKP. 
Hypothesis 3c: In people with iSCI there is a significant difference in function (total 
SCIM or subscales) between those with and without current LBP. 
In all comparisons conducted people without pain, or current LBP or MSKP reported 
worse function than people with pain, MSKP or LBP (Figure 8.2.5.1). The correlations 
did not pass the Bonferroni α-level of significance. In general the effect sizes were 
small thus not indicating a practical significance either (Table 8.2.5.1; Appendix 8:  
Table 8.9.1). Consequently, the null hypothesis cannot be rejected.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.2.5.1: Mean SCIM scores reported by people with and without pain,  
LBP and MSKP 
Abbreviations: SCIM, Spinal Cord Independence Measure; LBP, Low Back Pain; MSKP, 
Musculoskeletal Pain. 
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Table 8.2.5.1: Differences in function between groups with and without pain, LBP, or 
MSKP  
  Self-care 
subscale 
 
Respiration & 
sphincter 
management 
Mobility room 
& toilet 
Mobility 
indoors & 
outdoors 
Total SCIM 
 
Pain 
n=165  
U=508.0 
p=0.15  
ES: r=0.10 
U=487.5 
p=0.86  
ES: r=0.13 
U=546.5  
p=0.14  
ES: r=0.11 
U=556.5 
p=0.20  
ES: r=0.09 
U=506.0  
p=0.11  
ES: r=0.11 
Current 
LBP 
n=168 
t=-1.39, 
df161  
p=0.16 
95%CI -3.49, 
0.62  
ES: d=0.12 
t=-0.69, df171  
p=0.48 
95%CI -3.22, 
1.53  
ES: d=0.12 
t=-2.96, df159  
p=0.019¹ 
95%CI -2.56,  
-0.24  
ES: d=0.41 
t=-1.19, df165  
p=0.23 
95%CI -4.40, 
1.09  
ES: d=0.16 
t=-1.25, df165  
p=0.26 
95%CI -3.70,  
-11.5  
ES: d=0.19 
MSKP 
n=172 
t=-0.50, 
df164  
p=0.61 
95%CI -2.04, 
1.20  
ES: d=0.09 
t=-0.18, df169  
p=0.85 
95%CI -2.46, 
2.05 
ES d=0.02 
t=-3.06, df162  
p=0.003¹ 
95%CI -2.20,  
-0.47  
ES: d=0.16 
t=-1.05, df170  
p=0.29 
95%CI -4.02, 
1.22  
ES: d=0.16 
t=-1.06, df168  
p=0.29 
95%CI -9.56, 
2.87  
ES: d=0.16 
1not significant post Bonferroni correction.  
Abbreviations: SCIM, Spinal Cord Independence Measure; LBP, Low Back Pain; MSKP, 
Musculoskeletal Pain.  
Statistical tests: U, Mann-Whitney U test; t, Independent t-test. 
 
8.2.6 SCIM III; relation to number of pain/LBP days, free weeks, 
onset 
It appeared that people who reported having pain or LBP for more days in the month 
reported a lower mean on the SCIM subscales and total SCIM (Appendix 8: Tables 
8.10.1 and 8.10.2). However, the strength of the correlations was weak and not 
significant (Appendix 8: Table 8.10.3).  
People who reported constant pain also reported worse function (all subscales) 
compared to people who were pain free most of the time (Appendix 8: Table 8.10.4). 
The frequency of pain or LBP-free weeks did not correlate significantly with function 
but the direction of the correlation indicated that the less infrequent the pain/LBP 
breaks, the worse the function (Table 8.2.6.1; Appendix 8: Table 8.10.5).  
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Table 8.2.6.1: Correlations between pain- or LBP-free weeks and function scores 
 Self-care 
subscale 
 
Respiration & 
sphincter 
management 
Mobility 
room & 
toilet 
Mobility 
indoors & 
outdoors 
Total SCIM 
 
Pain-free 
weeks  
ρ=-0.12 
p=0.13 
ρ=-0.15 
p=0.05 
ρ=-0.10 
p=0.21 
ρ=0.04 
p=0.59 
ρ=-0.09 
p=0.26 
LBP-free 
weeks 
ρ=-0.24 
p≤0.01¹ 
ρ=-0.13 
p=0.18 
ρ=-0.26 
p≤0.01¹ 
ρ=-0.01 
p=0.88 
ρ=-0.16 
p=0.11 
1not significant post Bonferroni correction; in bold: significant following application of  
the Bonferroni correction.  
Abbreviations: SCIM, Spinal Cord Independence Measure; LBP, Low Back Pain.  
Statistical test: ρ, Spearman’s rank correlation rho. 
 
 
The second hypothesis theme included examination of the relationship between onset 
of pain or LBP and functional independence of the participants. Therefore,  
Hypothesis 0 (null): In people with iSCI there is no significant correlation between 
function (total SCIM or subscales) and onset of pain and LBP post iSCI. 
Hypothesis 7a: In people with iSCI there is a significant correlation between function 
(total SCIM or subscales) and onset of pain post iSCI. 
Hypothesis 7b: In people with iSCI there is a significant correlation between function 
(total SCIM or subscales) and onset of LBP post iSCI 
Examination of the data of 154 people with pain who reported the onset of their pain 
following iSCI showed that, overall, the earlier the onset of pain post iSCI the slightly 
better their function. But relationships were small in strength and not statistically 
significant. The correlation in the cases of “mobility in room and toilet”, “mobility 
indoors and outdoors” and total SCIM were slightly stronger (Tables 8.2.6.2, 8.2.6.3, 
8.2.6.4).  Similarly, the correlation between LBP onset post iSCI and function was 
negative, weak and not significant (Tables 8.2.6.2, 8.2.6.3, 8.3.6.4).  
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Table 8.2.6.2: Function mean scores for groups based on onset of pain post iSCI 
Pain onset post 
iSCI  
Immediately 
after iSCI 
(n=69) 
mean±SD, 
median, 
min-max 
Within the 1
st
 
month post 
iSCI (n=31) 
mean±SD, 
median, min-
max 
Between 1-6 
months post 
iSCI (n=25) 
mean±SD, 
median, min-
max 
Between 6 
months & 1 year 
post iSCI 
(n=9) 
mean±SD, 
median, min-max 
After 1 year 
post iSCI 
(n=20) 
mean±SD, 
median, 
min-max 
Self-care 
subscale 
Range 0-20 
15.6±4.9  
18, 1-20 
15.4±5.3  
18, 0-20 
15.5±5.5 
18, 2-20 
14.2±5.6 
16, 4-18 
12.2±7.4 
15.5, 0-20 
Respiration & 
sphincter 
management 
Range 0-40 
29.6±7.3  
30, 11-40 
30.4±8.5  
32, 0-40 
29.8±7.1  
30, 12-40 
26.0±5.9 
28, 15-33 
27.1±7.1 
28.5, 15-36 
Mobility room & 
toilet 
Range 0-10 
8.5±2.6  
10, 0-10 
8.3±2.9  
10, 0-10 
8.2±2.8  
10, 0-10 
6.1±3.7 
8, 0-10 
6.2±4.4 
8.5, 0-10 
Mobility indoors 
& outdoors 
Range 0-30 
14.7±8.1  
14, 0-30 
14.9±8.5  
15, 3-30 
13.6±9.4  
8, 3-30 
8.8±6.7 
7, 3-23 
9.3±7.0 
7, 3-25 
Total SCIM 
Range 0-100 
68.4±17.9  
70, 21-100 
69.1±20.8  
74, 3-100 
67.0±20.9  
67, 26-100 
55.1±18.1 
63, 25-75 
54.8±22.3 
62.5, 18-86 
Table excludes people with no pain or who did not recall the onset of their pain.  
Abbreviations: SCIM, Spinal Cord Independence Measure; iSCI, incomplete Spinal Cord Injury. 
 
Table 8.2.6.3: Function mean scores for groups based on onset of LBP post iSCI 
LBP onset post SCI  Immediately 
after iSCI 
(n=39) 
mean±SD, 
median, 
min-max 
Within the 1
st
 
month post 
iSCI (n=17) 
mean±SD, 
median, min-
max 
Between 1-6 
months post 
iSCI (n=18) 
mean±SD, 
median, min-
max 
Between 6 
months & 1 year 
post iSCI 
(n=8) 
mean±SD, 
median, min-max 
After 1 year 
post iSCI 
(n=29) 
mean±SD, 
median, min-
max 
Self-care 
subscale 
Range 0-20 
16.0±4.8  
18, 2-20 
15.1±5.4  
16, 0-20 
15.7±3.6 
16, 6-20 
16.2±3.7 
18, 8-20 
14.6±6.0 
18, 1-20 
Respiration & 
sphincter 
management 
Range 0-40 
30.0±5.5  
30, 15-40 
26.8±10.3  
29, 0-40 
30.7±7.1  
31.5, 12-40 
32.2±8.1 
34, 15-40 
29.1±7.2 
31, 15-40 
Mobility room & 
toilet 
Range 0-10 
8.6±2.6  
10, 0-10 
8.2±3.0  
10, 0-10 
7.9±2.4  
8.5, 3-10 
9.5±1.1  
10, 7-10 
8.0±3.3 
10, 0-10 
Mobility indoors 
& outdoors 
Range 0-30 
15.2±7.78  
15, 3-30 
16.0±8.1  
16, 3-30 
14.2±8.8  
12, 4-30 
15.7±8.9 
18.5, 3-28 
11.6±7.7 
9, 0-30 
Total SCIM 
Range 0-100 
69.8±15.4  
73, 35-98 
66.1±22.4  
73, 3-98 
68.5±17.3  
66, 32-100 
73.7±19.4 
80.5, 33-91 
63.3±20.6 
68, 21-100 
Table excludes people with no LBP or who did not recall the onset of their LBP.  
Abbreviations: iSCI, incomplete Spinal Cord Injury; SCIM, Spinal Cord Independence Measure; 
LBP, Low Back Pain. 
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Table 8.2.6.4: Correlations between onset of pain or LBP post iSCI and function scores 
 Self-care 
subscale 
 
Respiration & 
sphincter 
management 
Mobility room 
& toilet 
Mobility 
indoors & 
outdoors 
Total SCIM 
 
Pain onset 
post iSCI 
n=154  
ρ=-0.10 
p=0.17, 95%CI 
-0.25, 0.05 
ρ=-0.10 
p=0.19, 95%CI  
-0.25, 0.05 
ρ=-0.17 
p=0.02¹ 
 95%CI -0.31, 
 -0.02 
ρ=-0.23 
p=0.004¹ 
95%CI -0.08,  
-0.46 
ρ=-0.18 
p=0.02¹ 
95%CI -0.32, 
-0.03 
LBP onset 
post iSCI 
n=111 
ρ=-0.07 
p=0.41, 95%CI 
-0.24, 0.10 
ρ=0.01 
p=0.83, 95%CI  
-0.16, 0.18 
ρ=-0.09 
p=0.30, 95%CI  
-0.20, 0.08 
ρ=-0.16 
p=0.08, 
95%CI -0.32, 
0.01 
ρ=-0.08 
p=0.37, 
95%CI -0.25, 
0.09 
1not significant post Bonferroni correction. 
 Abbreviations: iSCI, incomplete Spinal Cord Injury; SCIM, Spinal Cord Independence Measure; 
LBP, Low Back Pain.  
Statistical test: ρ, Spearman’s rank correlation rho. 
 
8.2.7 SCIM III; relation to pain extent 
Analysis showed that no correlation existed between the number of areas with pain on 
the body and SCIM subscales or total SCIM (n=180) (Appendix 8: Table 8.11.1). This is 
the same finding as that found for the Greek group earlier in this chapter.  
 
8.2.8 SCIM III; relation to quality and intensity of LBP 
The third theme hypothesis examined the relationship between the quality or intensity 
of LBP with function. It was hypothesised that:  
Hypothesis 0 (null): In people with iSCI there is no significant correlation between 
function (total SCIM or subscales) and the quality (sensory, affective or total PRI) of 
LBP.  
Hypothesis 12a: In people with iSCI there is a significant correlation between function 
(total SCIM or subscales) and sensory PRI of LBP.  
Hypothesis 12b: In people with iSCI there is a significant correlation between function 
(total SCIM or subscales) and affective of LBP.  
Hypothesis 12c: In people with iSCI there is a significant correlation between function 
(total SCIM or subscales) and total PRI of LBP.  
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All correlations examined were weak, negative and not statistically significant (Table 
8.2.8.1). Though a decrease in the quality of LBP correlated with a decrease in function 
these relationships were weak, thus the null hypothesis cannot be rejected. This is 
similar to the findings for the Greek group examined earlier.  
 
Table 8.2.8.1: Correlations between quality of LBP (PRI) and function (SCIM) 
 Self-care 
subscale 
 
Respiration & 
sphincter 
management 
Mobility room 
& toilet 
Mobility 
indoors & 
outdoors 
Total SCIM 
 
S-PRI 
n=121 
ρ=-0.10, p=0.24 
r=-0.12, p=0.54 
95%CI -0.29, 
0.05 
r=-0.09 
p=0.28 
95%CI -0.26, 
0.08 
ρ=-0.08, 
p=0.36 
r=-0.01, 
p=0.90 
95%CI -0.25, 
0.09 
ρ=-0.09, 
p=0.31 
r=-0.7, 
p=0.44 
95%CI -0.26, 
0.08 
r=-0.08 
p=0.34 
95%CI -0.25, 
0.09 
A-PRI 
n=121 
ρ=-0.12, p=0.16 
r=-0.08, p=0.33 
95%CI -0.29, 
0.05 
r=-0.09 
p=0.28 
95%CI -0.26, 
0.08 
ρ=-0.11, 
p=0.21 
r=-0.06, 
p=0.50 
95%CI -0.23, 
0.11 
ρ=-0.02, 
p=0.79 
r=0.009, 
p=0.92 
95%CI -0.17, 
0.17 
r=-0.06 
p=0.45 
95%CI -0.22, 
0.11 
Total PRI 
n=118 
ρ=-0.11, p=0.21 
r=-0.07, p=0.44 
95%CI -0.28, 
0.06 
r=-0.10 
p=0.25 
95%CI -0.27, 
0.07 
ρ=-0.10, 
p=0.27 
r=-0.02, 
p=0.76 
95%CI -0.19, 
0.15 
ρ=-0.07, 
p=0.41 
r=-0.04, 
p=0.60 
95%CI -0.21, 
0.13 
r=-0.08 
p=0.35 
95%CI -0.25, 
0.09 
Abbreviations: SCIM, Spinal Cord Independence Measure; PRI, Present Rating Index; S-PRI, 
Sensory PRI; A-PRI, Affective PRI.  
Statistical test: ρ, Spearman’s rank correlation rho; r, Pearson’s correlation.  
 
For the relationship between LBP intensity and function it was hypothesised that: 
Hypothesis 0 (null): In people with iSCI there is no significant correlation between 
function (total SCIM or subscales) and intensity (on the NRS or evaluative) of LBP.  
Hypothesis 13a: In people with iSCI there is a significant correlation between function 
(total SCIM or subscales) and intensity of current LBP.  
Hypothesis 13b: In people with iSCI there is a significant correlation between function 
(total SCIM or subscales) and intensity of LBP over last one month.  
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Hypothesis 13c: In people with iSCI there is a significant correlation between function 
(total SCIM or subscales) and intensity of LBP over three months.  
Hypothesis 13d: In people with iSCI there is a significant correlation between function 
(total SCIM or subscales) and evaluative PPI of LBP.  
Total SCIM and most of its subscales were found to have a statistically significant 
negative correlation with the intensity of LBP, in particular for intensity of current LBP 
but none remained significant following Bonferroni correction (Table 8.2.8.2). The 
correlations between the evaluative dimension of LBP and function were also negative, 
slightly weaker and non-statistically significant (Table 8.2.8.2). 
 
8.2.9 SCIM III; relation to QoL  
Finally, the relationship between function and QoL was investigated using correlation 
analysis. This part of the analysis aimed to examine if reports in the literature that 
decreased function affects QoL (Chapter 2) could be confirmed in this particular group 
of participants. Analysis confirmed that when function was worse, then people 
classified their health as worse (Table 8.2.9.1). This correlation was strong and 
statistically significant. Though people also perceived their health status as worse 
when functional independence was reduced, this correlation was not strong enough to 
reach significance. Consequently, reduction of functional independence had a negative 
effect on health classification but not so much on health perception (Table 8.2.9.1). 
Overall, these results were similar to those found for the Greek group.   
 
 Chapter 8: Survey; results; function 
 
259 
Table 8.2.8.2: Correlations between intensity of LBP and function (SCIM) 
 Self-care 
subscale 
 
Respiration & 
sphincter 
management 
Mobility 
room & 
toilet 
Mobility 
indoors & 
outdoors 
Total SCIM 
 
Current LBP 
intensity 
n=121 
r=-0.19 
p=0.02¹ 
95%CI -0.35, 
 -0.02 
r=-0.23 
p=0.009¹ 
95%CI -0.38, 
 -0.06 
r=-0.23 
p≤0.01¹ 
95%CI -0.38, 
 -0.06 
r=-0.13 
p=0.13 
95%CI -0.30, 
 0.04 
r=-0.23 
p=0.008¹ 
95%CI -0.38, 
 -0.06 
LBP intensity 
over last 1 
month 
n=119 
r=-0.13 
p=0.013¹ 
95%CI -0.03, 
 -0.09 
r=-0.19 
p=0.03¹ 
95%CI -0.30, 
 -0.02 
r=-0.17 
p=0.051 
95%CI -0.33, 
 0.00 
r=-0.07 
p=0.43 
95%CI -0.24, 
 0.10 
r=-0.17 
p=0.051 
95%CI -0.33, 
 0.00 
LBP intensity 
last 3 months 
n=118 
r=-0.05 
p=0.54 
95%CI -0.22, 
 0.12 
r=-0.12 
p=0.18 
95%CI -0.29, 
 0.05 
r=-0.06 
p=0.49 
95%CI -0.23, 
 0.11 
r=-0.02 
p=0.79 
95%CI -0.19, 
 0.15 
r=-0.06 
p=0.49 
95%CI -0.23, 
 0.11 
Evaluative PPI  
n=111 
ρ=-0.10, 
p=0.24 
r=-
0.12,p=0.54 
95%CI -0.29, 
 0.05 
r=-0.27 
p=0.12 
95%CI -0.42, 
 -0.10 
ρ=-0.10, 
p=0.24 
r=-0.12, 
p=0.54 
95%CI -0.29, 
 0.05 
ρ=-0.10, 
p=0.24 
r=-
0.12,p=0.54 
95%CI -0.29, 
 0.05 
r=-0.12 
p=0.54 
95%CI -0.29, 
 0.05 
1not significant post Bonferroni correction. 
 Abbreviations: SCIM, Spinal Cord Independence Measure; LBP, Low Back Pain; PPI, Present 
Pain Intensity.  
Statistical tests: ρ, Spearman’s rank correlation rho; r, Pearson’s correlation.  
 
 
Table 8.2.9.1: Correlation between function and QoL  
 Self-care 
subscale 
 
Respiration & 
sphincter 
management 
Mobility 
room & 
toilet 
Mobility 
indoors & 
outdoors 
Total SCIM 
 
EQ-5D Index  
n=156 
r=0.47, 
p≤0.001*** 
r=0.37 
p≤0.001*** 
r=0.40, 
p≤0.001*** 
r=0.31, 
p≤0.001*** 
r=0.41 
p≤0.001*** 
EQ VAS  
n=156 
ρ=0.07, p=0.33 
r=-0.02, 
p=0.78 
r=0.03 
p=0.66 
ρ=0.02, 
p=0.77 
r=-0.06, 
p=0.41 
ρ=-0.11, 
p=0.12 
r=-0.002, 
p=0.97 
ρ=0.009 
p=0.90 
***Significant at p≤0.001 level, in bold: significant following application of the Bonferroni 
correction.  
Abbreviations: SCIM, Spinal Cord Independence Measure; EQ-5D, Quality of Life, EQ-VAS, 
Quality of Life Visual Analogue Scale.  
Statistical tests: ρ, Spearman’s rank correlation rho; r, Pearson’s correlation.  
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8.3 Conclusion 
This chapter confirmed the unidimensionality of the subscales of both GR-SCIM III and 
SCIM III. Internal consistency for the two versions was almost equal and 
criterion/concurrent validity accepted. Ceiling effects were noticed for both SCIM III 
versions. 
When the demographic profile characteristics were examined for the Greek group, age 
seemed to have a negative impact on function. For the rest of the group the type of 
injury seemed to affect function. The presence of any pain category examined did not 
affect function significantly either for the Greek or the rest of the group. Worse LBP 
quality correlated with worse function for both groups but the correlations were not 
very strong. The correlation was stronger in the case of increased intensity of LBP for 
both groups but still not statistically significant. Finally, overall reduction of functional 
independence related to a significantly lower health classification but not significantly 
lower perception of health status.  
The next chapter is the final chapter to examine results of the data analysis conducted 
in this survey. It will examine the hypotheses themes discussed in the three previous 
chapters of analysis and will compare the groups within and between nations. Thus, 
the next chapter will deal with the cross-national analysis of the data. 
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Chapter 9; Results: Cross-national analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
There is no such thing as a little country. The greatness of 
people is no more determined by their numbers than the 
greatness of a man is by his height.  
Victor Hugo (1802 – 1885) - French Writer 
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Part 1; Participants’ demographic characteristics and 
pain presence across the countries 
 
9.1.1 Introduction 
The previous three chapters of the results described in detail the profiles of the total 
group of people participating in the current survey. They explored the experience of 
pain and investigated how it related to function and QoL.  
This chapter will examine the same relationships and seek to answer the same 
questions, however, this time within and between the three participating countries 
and will investigate the effect of the country of residence on the main variables under 
investigation. The aim is to analyse similarities and differences between the groups 
from the three participating countries which will answer the objective of the study 
related to the cross-national analysis. The importance and contribution to knowledge 
of cross-national research was explored in detail in Chapter 2.  
The format of the chapter will be similar to the previous chapters starting by 
presenting the demographic profiles of people from each nation followed by exploring 
their experience of pain. Then QoL and function will be investigated. The statistical 
tests used tend to be non-parametric, in particular, for the UK and Greek groups where 
the group sizes are often smaller than 50 people in each sub-group.  
 
9.1.2 Bonferroni correction 
In the current part of the analysis the number of multiple tests done on the variables 
of interest were either six or seven thus, the α-level of statistical significance set by 
Bonferroni was p≤0.008 or p≤0.007 depending on the variable examined (Appendix 9: 
Table 9.a.1.1).   
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9.1.3 Across nations; general results 
In total there were 122 people from the USA, 52 from the UK and 45 from Greece. 
There were some significant differences noticed in the profile and injury characteristics 
of people from the three participating countries. These are presented below.  
A significant difference in the mean age of people from the three participating 
countries was found (p≤0.001, H=34, Kruskall-Wallis H test, n=217). Further two-group 
analysis showed that Greeks were significantly older than those from the USA 
(p<0.001, U=1106.5, Mann-Whitney U test) and the UK (p≤0.001, U=608, Mann-
Whitney U test). In addition, people from the UK were significantly older than those 
from the USA (p=0.009, U=2153, Mann-Whitney U test) (Appendix 9, Table 9.a.2.1). 
Similarly, a significant age difference at the time of the injury was found between 
people from the three participating countries (p≤0.001, F=20.15, one-way ANOVA). 
The Greek group was significantly older at the time of the injury than both the UK 
(p≤0.001, I-J=-13.9, Bonferroni post hoc) and the USA groups (p≤0.001, I-J=-13.9, 
Bonferroni post hoc) (Appendix 9, Table 9.a.2.1).  
Another difference between people across countries was the cause of injury (p≤0.001, 
x²=26.08, extended chi-square). Two-group analysis showed that significantly more 
Greeks had a non-traumatic cause of injury compared to people from the UK (p≤0.001, 
χ²=16.9, Pearson’s chi-square) and USA (p≤0.001, χ²=21.5, Pearson’s chi-square) 
(Appendix 9, Table 9.a.2.2). Finally, some differences were found in the level of 
education and the marital status of participants. People with the highest level of 
education (above high school) were from the UK and their education level was 
significantly higher than those from the USA (p=0.006, χ²=7.43, Pearson’s chi-square) 
(Appendix 9, Table 9.a.2.2). Tables in Appendix 9, 9.a.2.1-9.a.2.6 include all examined 
demographic profile characteristics between people from the three countries.
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9.1.4 Across nations; pain, MSKP and LBP  
People from Greece reported the lowest cases of pain presence among all participants. 
Indeed, there was a significant difference in the pain presence between the three 
countries (χ2=13.282, df2, p≤0.001, extended chi-square). Two-group comparisons 
confirmed that Greeks reported significantly less cases of pain presence than people 
from the USA (p=0.04, Fishers exact) and the UK (p=0.006, χ2=7.514, chi-square) 
(Tables 9.1.1 and 9.1.2). Differences in reported back pain between people from the 
three countries were not significant. The presence of MSKP did not differ between 
people from the three countries and it was only within the USA that there was a 
significant difference between those with and without MSKP (Tables 9.1.1 and 9.1.2) 
 
Table 9.1.1: Prevalence of pain categories per national group 
Category of 
pain 
Pain prevalence % 
( among all participants) 
Pain prevalence % 
(among people with pain only) 
 USA UK GR USA UK GR 
Pain in 
general  
94.3 n=122 
95% CI 
88%, 97% 
96.2 n=52 
95% CI 
87%, 98% 
77.8 n=45 
95% CI 
63%, 87% 
n/a n/a n/a 
Musculoske-
letal pain 
36.7 n=120 
95% CI 
28%, 45% 
42.3 n=52 
95% CI 
30%, 56% 
37.8 n=42 
95% CI 
27%, 55% 
38.9 
n=113 
44  
n=50 
53.1 
n=32 
Back pain 72.1 n=120 
95% CI 
69%, 84% 
75 n=52 
95% CI 
63%, 86% 
76.2 n=42 
95% CI 
61%, 86% 
77.9 
n=113 
78  
n=50 
100  
n=32 
LBP life 
prevalence 
73 n=122 
95% CI 
64%, 80% 
75 n=52 
95% CI 
80%, 97% 
73.3 n=45 
95% CI 
58%, 84% 
77.4 
n=115 
78  
n=50 
94.3 
n=35 
LBP point 
prevalence 
65.8 n=117 
95% CI 
57%, 74% 
70.6 n=51 
95% CI 
57%, 81% 
69.8 n=43 
95% CI 
54%, 81% 
70 
n=110 
73.5 
n=79 
90.9 
n=33 
LBP over the 
last 1 month 
prevalence 
65.3 n=118 
95% CI 
56%, 73% 
72.5 n=51 
95% CI 
59%, 82% 
72.1 n=43 
95% CI 
57%, 83% 
69.4 
n=111 
75.5 
n=49 
93.9 
n=33 
LBP over the 
last 3 
months 
prevalence 
68.4 n=117 
95% CI 
58%, 75% 
72.5 n=51 
95% CI 
59%, 82% 
72.1 n=43 
95% CI 
57%, 83% 
72.7 
n=110 
75.5 
n=49 
93.9 
n=33 
Abbreviations: MSKP, Musculoskeletal Pain; LBP, Low Back Pain. 
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In Chapter 6, Section 6.1.5, it was found that a high proportion of people reported LBP 
(all time periods) (hypothesis 1). Here these findings are examined across the nations.  
Hypothesis 0 (null): In people with iSCI there is no significant difference in the 
percentage of those with LBP and those without for each national group. 
Hypothesis 1: In people with iSCI there is a significant difference in the percentage of 
those with LBP and those without for each national group. 
For each individual country the same result as for the total group of participants was 
found; more people reported having LBP than not having LBP at all time periods. All 
results were statistically significant for the USA group following application of the 
Bonferroni correction. Though not many findings passed the Bonferroni correction for 
the other two countries the effect sizes were strong, thus, the practical significance 
must be considered (Table 9.1.2).  
 
9.1.5 Across nations; relationship between LBP and MSKP 
In Chapter 6, Section 6.1.6, it was found that when LBP prevalence (all time periods) 
increased so did MSKP prevalence. This correlation is examined across the countries. 
Therefore the added hypothesis in the study is: 
Hypothesis 0 (null): In people with iSCI there is no significant correlation between LBP 
and MSKP for each national group. 
Hypothesis new: In people with iSCI there is a significant correlation between LBP and 
MSKP for each national group. 
Using Phi test (φ) for correlation, the original finding of the positive correlation 
between LBP and MSKP presence was supported within each individual country group. 
The strength of the correlations was moderate, but for people from the UK it was 
stronger and passed the Bonferroni α-level of significance (Table 9.1.3).    
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Table 9.1.2: Differences in pain presence within and between national groups 
Category of pain Within countries 
Statistical Test 
Between countries 
Statistical Test 
 USA UK GR  
Pain in general  
 
 
 
 
χ²=95.6, df1 
p≤0.001*** 
φ=0.88, n=122 
 
χ²=44.3, df1 
p≤0.001*** 
φ=0.92, n=52 
 
χ²=13.8, df1 
p≤0.001*** 
φ=0.55, n=45 
 
χ²=13.2, df2 
p≤0.001*** 
People from Greece 
reported less pain 
presence than 
people from USA 
(p=0.04) and UK 
(p=0.006) 
Back pain  χ²=36.3, df1 
p≤0.001*** 
φ=0.54, n=120 
χ²=15.0, df1 
p≤0.001*** 
φ=0.53, n=52 
χ²=11.5, df1 
p≤0.01¹ 
φ=0.50, n=42 
χ²=0.03, df2 p=0.98 
Musculoskeletal 
pain 
χ²=8.5, df1 
p=0.003** 
φ=0.26, n=120 
χ²=0.9, df1 
p=0.32 
φ=0.13, n=52 
χ²=1.5, df1 
p=0.21 
φ=0.18, n=42 
χ²=0.68, df2 p=0.71 
LBP life 
prevalence 
χ²=25.7, df1 
p≤0.001*** 
φ=0.45, n=122 
χ²=13.0, df1 
p≤0.001*** 
φ=0.50, n=52 
χ²=9.8, df1 
p=0.02¹ 
φ=0.46, n=42 
χ²=0.08, df2 p=0.96 
LBP point 
prevalence 
χ²=12.4, df1 
p≤0.001*** 
φ=0.31, n=117 
χ²=8.6, df1 
p=0.03¹ 
φ=0.40, n=51 
χ²6.72=, df1 
p≤0.01¹ 
φ=0.39, n=43 
χ²=0.35, df2 p=0.83 
LBP over the last 
1 month 
prevalence 
χ²=10.9, df1 
p≤0.001*** 
φ=0.29, 118 
χ²=10.3, df1 
p=0.01¹ 
φ=0.44, n=51 
χ²=8.3, df1 
p=0.04¹ 
φ=0.42, n=43 
χ²=1.21, df2 p=0.54 
LBP over the last 
3 months 
prevalence 
χ²=14.6, df1 
p≤0.001*** 
φ=0.34, n=117 
χ²=10.3, df1 
p≤0.001*** 
φ=0.44, n=51 
χ²=8.3, df1 
p=0.004** 
φ=0.42, n=43 
χ²=0.50, df2 p=0.77 
1not significant post Bonferroni correction; ***Significant at p≤0.001 level, in bold: significant 
following application of the Bonferroni correction or Bonferroni post hoc; 1not significant post 
Bonferroni correction  
Abbreviations: MSKP, Musculoskeletal Pain; LBP, Low Back Pain 
Statistical tests: χ², Goodness of fit Chi square or extended chi-square; φ, Phi test for effect size 
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Table 9.1.3: Correlation between LBP and MSKP presence across the national groups 
 USA UK Greece 
LBP lifetime with 
MSKP 
φ=0.23 
p≤0.01¹, n=120 
95%CI 0.08, 0.37 
φ=0.50 
p≤0.001*** n=51 
95%CI 0.37, 0.60 
φ=0.38 
p≤0.01¹, n=42 
95%CI 0.18, 0.55 
LBP current with 
MSKP 
φ=0.23 
p=0.02¹, n=116 
95%CI 0.07, 0.37 
φ=0.55 
p≤0.001*** n=50 
95%CI 0.43, 0.64 
φ=0.33 
p=0.04¹, n=41 
95%CI 0.08, 0.52 
LBP over last 1 
month with MSKP 
φ=0.22 
p≤0.01¹, n=118 
95%CI 0.06, 0.37 
φ=0.44 
p=0.002** n=50 
95%CI 0.28, 0.58 
φ=0.38 
p≤0.01¹, n=42 
95%CI 0.19, 0.55 
LBP over last 3 
months with 
MSKP 
φ=0.18 
p=0.058 n=115 
95%CI 0.01, 0.34 
φ=0.44 
p=0.002** n=50 
95%CI 0.28, 0.58 
φ=0.38 
p≤0.01¹ n=42 
95%CI 0.15, 0.57 
1not significant post Bonferroni correction; **Significant at p≤0.01 level, ***Significant at 
p≤0.001 level, in bold: significant following application of the Bonferroni correction; 1not 
significant post Bonferroni correction;  
Abbreviations: MSKP, Musculoskeletal Pain; LBP, Low Back Pain.  
Statistical test: φ, Phi test. 
 
 
9.1.6 Pain, MSKP and LBP across nations; relation to demographic 
profile characteristics 
Earlier, in Chapter 6, using the pooled group only two significant differences were 
found for the categories of pain under examination in combination with the 
demographic profile characteristics of the participants; 1) people with paraplegia 
reported significantly more cases of LBP presence (all time periods) than people with 
tetraplegia, and 2) people with non-traumatic injury reported significantly more cases 
of current LBP than those with a traumatic injury (Chapter 6, Section 6.1.7). In 
addition, earlier in this chapter some differences in the demographic profile 
characteristics of people from the three countries were found (Section 9.1.3).  
 
9.1.6.1 Gender across nations 
The interaction effect of gender and country of residence on each category of pain34 
was examined but in no case was this effect statistically significant (Table 9.1.4). 
                                                     
34
 For an explanation on the interaction effect methods see Chapter 5, Section 5.16 
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Examining each group of the three participating countries no significant differences 
were found in the presence of pain or MSKP between males and females when the chi-
square or Fisher exact tests were applied (Table 9.1.5; Appendix 9: Table 9.a.3.1). The 
proportion of pain presence for some groups, however, seemed to be rather different 
and they were examined further in two-group analysis. This revealed that males from 
Greece reported pain significantly less often than males from both the USA (p≤0.01, 
Fisher’s exact, n=104) and the UK (p≤0.01, Fisher’s exact, n=53). This was not found 
within the female groups (Appendix 9: Table 9.a.3.4). Women within all groups of the 
three countries reported more cases of LBP presence (all time periods) than males, but 
these differences did not reach significant levels (Table 9.1.5), which was similar to the 
pooled data examined in Chapter 6.  
 
9.1.6.2 Cause of injury across nations 
The interaction effect of cause of injury and country of residence did not have a 
statistically significant impact (therefore could not efficiently predict) the presence of 
any of the pain categories examined with one exception that of pain in general 
(p=0.007, χ²=9.5, Likelihood ratio Chi-square, n=219). However, exactly what the effect 
was could not be identified as none of the individual estimates (two-group 
comparisons between the variables) were found to be significant. Possibly, larger 
group sizes were needed to identify the specific effects (Table 9.1.4).  
Within each national group people with a non-traumatic injury reported the presence 
of the pain categories examined more often than people with a traumatic injury. 
People from the USA with a non-traumatic injury reported a higher proportion of pain 
presence than those from the other two countries (Appendix 9: Table 9.a.3.2). No 
differences passed the Bonferroni alpha level of significance (Table 9.1.5). Two-group 
comparisons were conducted between those groups whose proportion of pain reports 
seemed to differ a lot and it was found that Greeks with either traumatic or non-
traumatic cause of injury reported significantly less proportion of pain presence than 
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people with traumatic or non-traumatic (respectively) injuries from both the USA and 
UK (Appendix 9: Table 9.a.3.5). 
9.1.6.3 Level of injury across nations 
Logistic regression analysis showed that the interaction effect between the level of 
injury and the country of residence was significant on some of the pain categories 
examined (Table 9.1.4). On two occasions (the effect on lifetime LBP and LBP over the 
last month) the significance did not pass the Bonferroni α-level thus it cannot be 
accepted here, but could be considered in future studies. The interaction between the 
level of injury and country of residence could possibly predict the presence of pain in 
general as the effect was statistically significant (p≤0.001, χ²=23.82, Likelihood ratio, 
n=217) but it could not be identified exactly where the effect was as the individual 
estimates were not found to be significant. Finally, the interaction effect between level 
of injury and country of residence significantly affected the presence of LBP over the 
last three months (p=0.005, χ²=16.53, likelihood chi-square, n=207). Further analysis 
showed that people with tetraplegia from both the USA and the UK were less likely to 
report pain; interaction effect of USA and tetraplegia on pain presence: p=0.04, (b=-
1.07, OR=0.34); interaction effect of UK and tetraplegia on pain presence: p=0.04,   
(b=-1.24, OR=0.28) (Table 9.1.4).  
Looking at the level of injury for each individual group from the three countries, people 
with paraplegia reported a higher proportion of all categories of pain examined 
(Appendix 9: Table 9.a.3.3). However, these differences were not significant with the 
exception of the USA group for the presence of lifetime LBP (p=0.006, x²=7.4, chi-
square test). Two-group comparisons were conducted among groups which seemed to 
differ in their reported percentages and showed that Greeks with paraplegia reported 
pain in general significantly less often than people with paraplegia from the USA 
(p≤0.001, Fisher’s exact, n=88) and the UK groups (p=0.024, Fisher’s exact, n=58) 
(Appendix 9: Table 9.a.3.6). The level of injury was divided in cervical, thoracic, and 
lumbar, as in earlier analysis, and the related analysis is presented at Appendix 9, 
Tables 9.a.3.7, 9.a.3.8. No other significant differences were found when the level of 
injury was examined within or between the groups of people from the three countries.  
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Table 9.1.4: Interaction effects between country of residence and demographic/injury characteristics on the presence of the pain 
categories 
 Pain in general LBP lifetime LBP current LBP last 1 month LBP last 3 months MSKP 
Gender 
(Male – Female) 
p=0.09 
R²=0.10, n=215 
χ²=9.50, df5 
p=0.38 
R²=0.03, n=215 
χ²=5.22, df5 
p=0.54 
R²=0.02, n=206 
χ²=4.03, df5 
p=0.23 
R²=0.04, n=208 
χ²=6.81, df5 
p=0.26 
R²=0.04, n=205 
χ²=6.41, df5 
p=0.26 
R²=0.04, n=209 
χ²=6.43, df5 
Cause of injury 
(Traumatic - 
Non-traumatic) 
p=0.007**¹ 
R²=0.15, n=219 
χ²=15.9, df5 
p=0.17 
R²=0.05, n=219 
χ²=7.60, df5 
p=0.26 
R²=0.04, n=210 
χ²=6.40, df5 
p=0.22 
R²=0.04, n=212 
χ²=6.93, df5 
p=0.22 
R²=0.04, n=209 
χ²=6.89, df5 
p=0.16 
R²=0.04, n=213 
χ²=7.28, df5 
Level of injury 
(tetraplegia – 
paraplegia) 
p≤0.001***¹ 
R²=0.23, n=217 
χ²=23.82, df5 
p=0.01² 
R²=0.09, n=217 
χ²=14.26, df5 
p=0.06 
R²=0.06, n=208 
χ²=10.32, df5 
p=0.02² 
R²=0.08, n=210 
χ²=12.84, df5 
p=0.005** R²=0.10, n=207 
χ²=16.53, df5 
USA*Tetraplegia: p=0.04*, 
df1, b=-1.07, SE=0.52, 
Wald=4.16, OR=0.34  
95% CI for OR 0.12, 0.95 
UK*Tetraplegia: p=0.04, df1, 
b=-1.24, SE=0.63, 
Wald=3.88, OR=0.28,  
95% CI for OR 0.08, 0.9  
p=0.38 
R²=0.03, n=211 
χ²=5.30, df5 
Age p=0.01² 
R²=0.11, n=210 
χ²=10.73, df3 
p=0.90 
R²=0.004, n=219 
χ²=0.56, df3 
p=0.93 
R²=0.003, n=219 
χ²=0.42, df3 
p=0.73 
R²=0.009, n=203 
χ²=1.29, df3 
p=0.79 
R²=0.007, n=219 
χ²=1.03, df3 
p=0.88 
R²=0.004, n=204 
χ²=0.65, df3 
Time since injury p=0.09 
R²=0.10, n=215 
χ²=9.50, df5 
p=0.98 
R²=0.001, n=218 
χ²=0.14, df3 
p=0.93 
R²=0.003, n=209 
χ²=0.43, df3 
p=0.81 
R²=0.006, n=211 
χ²=0.94, df3 
p=0.44 
R²=0.01, n=208 
χ²=2.66, df3 
p=0.50 
R²=0.01, n=212 
χ²=2.32, df3 
**Significant at p≤0.01 level, ***Significant at p≤0.001 level, in bold: significant following application of the Bonferroni correction; ¹Significant but 
analysis could not identify what the exact effect was; ²not significant post Bonferroni correction, Abbreviations: MSKP, Musculoskeletal Pain; LBP, 
Low Back Pain; SE, Standard Error; OR, Odd Ratio; Statistical tests: χ², Likelihood ration Chi-square; Wald test chi-square distribution; R², Nagelkerke R 
square (pseudo-R). 
 Chapter 9: Survey; results; cross-national analysis 
 
271 
Table 9.1.5: Summary results of statistical differences in pain presence within each national group divided by demographic profile 
characteristics 
  Total groups of respondents Groups include people with pain only 
  USA UK GR USA UK GR 
Sex  
(Male – 
Female) 
Pain in general χ²=0.08, p=0.77 χ²=0.05, p=0.82 χ²=1.44, p=0.23 n/a n/a n/a 
Back pain χ²=0.13, p=0.71 χ²=0.51, p=0.47 χ²=1.59, p=0.20 χ²=0.08, p=0.77 χ²=0.73, p=0.39 constant 
MSKP χ²=2.23, p=0.13 χ²=0.92, p=0.33 χ²=2.33, p=0.12 χ²=2.18, p=0.14 χ²=1.03, p=0.31 χ²=1.2, p=0.27 
LBP lifetime χ²=0.81, p=0.36 χ²=0.94, p=0.31 χ²=3.06, p=0.08 χ²=0.73, p=0.39 χ²=1.25, p=0.26 χ²=2.0, p=0.15 
LBP current χ²=0.17, p=0.68 χ²=0.83, p=0.36 Fisher’s, p=0.28 χ²=0.12, p=0.72 χ²=1.05, p=0.30 Fisher’s, p=1.0 
LBP 1 month χ²=0.24, p=0.61 χ²=1.66, p=0.19 Fisher’s, p=0.14 χ²=0.2, p=0.65 χ²=2.06, p=0.15 Fisher’s, p=0.48 
LBP 3 months χ²=0.52, p=0.46 χ²=1.66, p=0.19 Fisher’s, p=0.14 χ²=0.50, p=0.74 χ²=0.20, p=0.15 Fisher’s, p=0.48 
Cause of 
injury 
(Traumatic 
- 
Non 
traumatic) 
Pain in general Fisher’s, p=0.34 Fisher’s, p=0.10 Fisher’s, p=0.48 n/a n/a n/a 
Back pain χ²=4.5, p=0.03¹ Fisher’s, p=0.67 Fisher’s, p=0.45 Fisher’s, p=0.15 Fisher’s, p=0.39 constant 
MSKP χ²=5.35, p=0.02¹ Fisher’s, p=1.0 χ²=1.84, p=0.17 χ²=4.1,p=0.04¹ Fisher’s, p=1.0 Fisher’s, p=0.45 
LBP lifetime χ²=4.46, p=0.03¹ Fisher’s, p=0.69 Fisher’s, p=0.17 χ²=2.66, p=0.10 Fisher’s, p=0.67 Fisher’s, p=0.13 
LBP current χ²=3.83, p=0.05¹ Fisher’s, p=1.0 Fisher’s, p=0.17 χ²=2.24, p=0.13 Fisher’s, p=1.0 Fisher’s, p=0.25 
LBP 1 month χ²=2.4, p=0.12 Fisher’s, p=1.0 Fisher’s, p=0.09 χ²=1.18, p=0.27 Fisher’s, p=0.69 Fisher’s, p=0.1 
χ²=4.2,p=0.03¹ 
LBP 3 months χ²=2.7, p=0.09 Fisher’s, p=1.0 Fisher’s, p=0.09 χ²=1.38, p=0.24 Fisher’s, p=0.69 Fisher’s, p=1.0 
χ²=4.2,p=0.03¹ 
Level of 
injury 
(tetraplegia 
– 
paraplegia) 
Pain in general Fisher’s, p=0.01¹ Fisher’s, p=0.20 Fisher’s, p=0.71 n/a n/a n/a 
Back pain χ²=6.5, p=0.01¹ χ²=5.2,p=0.02¹ Fisher’s, p=0.69 χ²=2.3, p=0.12 Fisher’s, p=0.08 constant 
MSKP χ²=2.41, p=0.12 χ²=1.47, p=0.22 χ²=0.25, p=0.61 χ²=1.17, p=0.27 χ²=0.93, p=0.33 Fisher’s, p=0.44 
LBP lifetime χ²=7.4,p=0.006** χ²=3.7,p=0.054 Fisher’s, p=0.17 χ²=3.36, p=0.06 Fisher’s, p=0.17 Fisher’s, p=0.09 
χ²=4.62,p=0.03¹ 
LBP current χ²=5.74,p=0.01¹ χ²=1.9, p=0.16 Fisher’s, p=0.29 χ²=1.5, p=0.11 χ²=0.87, p=0.35 Fisher’s, p=0.21 
LBP 1 month χ²=2.97, p=0.08 χ²=5.4,p=0.02¹ Fisher’s, p=0.16 χ²=0.78, p=0.37 χ²=3.6,p=0.055 Fisher’s, p=0.08 
χ²=4.8,p=0.02¹ 
LBP 3 months χ²=6.48,p=0.01¹ χ²=5.4,p=0.02¹ Fisher’s, p=0.16 χ²=2.93, p=0.08 χ²=3.6,p=0.055 Fisher’s, p=0.08 
χ²=4.8,p=0.02¹ 
1not significant post Bonferroni correction; **Significant at p≤0.01 level; in bold: significant following application of the Bonferroni correction. 
Abbreviations: MSKP, Musculoskeletal Pain; LBP, Low Back Pain. Statistical tests: χ², Pearson’s chi-square; Fisher’s exact.  
 
 Chapter 9: Survey; results; cross-national analysis 
 
272 
Table 9.1.6: Summary results of statistical differences in pain presence within each national group divided by age and time since injury 
 
1not significant post Bonferroni correction; **Significant at p≤0.01 level, in bold: significant following application of the Bonferroni correction; 
Abbreviations: MSKP, Musculoskeletal Pain; LBP, Low Back Pain. Statistical test: t, Independent t-test. 
 Chapter 9: Survey; results; cross-national analysis 
 
273 
9.1.6.4 Age across nations 
For the pooled data examined in Chapter 6, age did not differ significantly between 
people with and without the pain categories tested. The interaction between the 
country of residence and age did not have a significant effect on any of the pain 
categories examined. This means that the presence of pain (all types) could not be 
predicted by age in combination with where they lived (Table 9.1.4). Examining the 
groups of the three countries separately the finding that age did not differ, in general, 
between people with and without the pain categories was maintained. However, 
within the UK group, people without MSKP were significantly older than those with 
MSKP (p≤0.004, t=3.05, 95% CI 3.5, 16.98, independent t-test, n=114) (Table 9.1.6; 
Appendix 9: Table 9.a.3.9). It has already been established that the Greeks were 
significantly older than people from the USA and the UK (Section 9.1.3). For this 
reason, two-group comparisons were conducted to investigate if age differed among 
people from different nations with and without pain. It was found that the Greeks with 
any type of pain were significantly older than those with any type of pain from both 
the USA and the UK, which was not found among people without pain (Table 9.1.7). 
Earlier analysis had shown that people from the UK were significantly older than those 
from the USA. Two-group comparisons between them did not reveal any age 
differences in people with pain and in people without pain (all categories) (Table 
9.1.7). These results show the impact of age on the presence of the pain categories is 
greater at later age stages.  
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Table 9.1.7: Differences in mean age of people across national groups 
  Yes (pain category) No (pain category) 
  Greece 
USA Pain in 
general 
t=-6.69,df142, n=150, p≤0.001*** 
95% CI -21.7, -11.8 
t=-2.8, df46, n= 17, p=0.06¹ 
95% CI -20.2, -3.54 
 Back pain t=-7.9, df118, n=125, p≤0.001*** 
95% CI -24.9, -14.9 
t=-2.6, df34, n=37, p≤0.01¹ 
95% CI 22.5, -2.7 
 MSKP t=-7.34, df57, n=61, p≤0.001*** 
95% CI -31.7, -18.1 
t=-4.7, df95, n=145, p≤0.001*** 
95% CI -19.2, -7.9 
 LBP 
lifetime 
t=-6.7,df115, n=122, p≤0.001*** 
95% CI -23.3, -12.7 
t=-2.7, df42, n=145, p≤0.01¹ 
95% CI -20.4, -2.9 
 LBP 
current 
t=-6.9, df101, n=107, p≤0.001*** 
95% CI -24.4, -13.6 
t=-3.6, df49, n=52, p≤0.001*** 
95% CI -22.6, -6.4 
 LBP last 1 
month 
t=-7.23,df103, n=104, p≤0.001*** 
95% CI -24.7, -14.1 
t=-3.1, df48, n=53, p=0.03¹ 
95% CI -21.0, -4.6 
 LBP last 3 
months 
t=-7.6, df103, n=109, p≤0.001*** 
95% CI -25.5, -15.0 
t=-2.8, df46, n=49, p=0.006** 
95% CI -20.2, -3.5 
UK Pain in 
general 
t=-3.4, df81, n= 85, p≤0.001*** 
95% CI -18.6, -5.0 
t=-0.4, df10, n=12, p=0.67 
95% CI -32.0, 21.5 
 Back pain t=-4.4, df70, n=72, p≤0.001*** 
95% CI -22.3, -8.4 
t=-0.8, df18, n=22, p=0.42 
95% CI -17.6, 7.8 
 MSKP t=-4.4, df70, n=39, p≤0.001*** 
95% CI -22.3, -8.4 
t=-8.1, df18, n=54, p=0.42 
95% CI -17.6, 7.8 
 LBP 
lifetime 
t=-3.6, df70, n=72, p≤0.001*** 
95% CI -21.1, -6.2 
t=-0.49, df21, n=25, p=0.62 
95% CI -14.1, 8.7 
 LBP 
current 
t=-3.6, df70, n=66, p≤0.001*** 
95% CI -21.1, -6.2 
t=-0.49, df21, n=28, p=0.62 
95% CI -14.1, 8.7 
 LBP last 1 
month 
t=-4.4, df66, n=68, p≤0.001*** 
95% CI -23.4, -8.8 
t=-0.51, df22, n=26, p=0.61 
95% CI -13.5, 8.1 
 LBP last 3 
months 
t=-4.4, df66, n=68, p≤0.001*** 
95% CI -23.4, -8.3 
t=-0.51, df22, n=26, p=0.61 
95% CI 13.5, 8.1 
  UK 
USA Pain in 
general 
t=-2.48, df155, n=157, p≤0.01¹ 
95% CI -8.9, -1.0  
U=3.00, p=0.24 n=9 
 Back pain t=-2.09, df126, n=128, p=0.03¹ 
95% CI -8.8, -0.2  
t=-1.76, df34, n=36, p=0.08 
95% CI -16.7, 1.18  
 MSKP t=0.2, df62, n=64, p=0.82 
95% CI -5.2, 6.5  
t=-4.3, df97, n=99, p≤0.001*** 
95% CI -15.5, -5.7  
 LBP 
lifetime 
t=-1.96, df121, n=123, p=0.051 
95% CI -8.7, 0.02  
t=-2.21, df41, n=43, p=0.03¹ 
95% CI -17.2, -0.7  
 LBP 
current 
t=-1.39, df107, n=109, p=0.16 
95% CI -8.05, 1.4  
t=-2.7, df48, n=50, p=0.008¹ 
95% CI -17.2, -2.7  
 LBP last 1 
month 
t=-1.3, df109, n=111, p=0.16 
95% CI -7.9, 1.1  
t=-2.74, df48, n=50. p=0.008¹ 
95% CI -17.5, -2.7  
 LBP last 3 
months 
t=-1.3, df109, n=111, p=0.16 
95% CI -7.9, 1.3  
t=-02.74, df48, n=50, p=0.008¹ 
95% CI -17.5, -2.7  
1not significant post Bonferroni correction; **Significant at p≤0.01 level, ***Significant at 
p≤0.001 level, in bold: significant following application of the Bonferroni correction. 
Abbreviations: MSKP, Musculoskeletal Pain; LBP, Low Back Pain.  
Statistical test: t, Independent t-test. 
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9.1.7 Pain and LBP across nations; relation to pain/LBP days, pain 
free periods, onset 
The USA and UK groups had very similar reports on the number of pain and LBP days 
felt each month which was similar to that reported by the pooled group examined in 
Chapter 6. For both countries the vast majority of respondents felt pain or LBP daily. 
However, the reports by Greeks were different as just over 20% of Greeks reported 
daily pain and an even lower percentage reported daily LBP. Greeks mainly felt pain or 
LBP between 1-9 and 10-20 days per month (Figures 9.1.1, 9.1.2; Appendix 9: Table 
9.a.4.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.1.1: Percentage of people reporting the number of days they feel  
pain per month across nation.  People with no pain or who could not  
remember were excluded. 
 
 
Earlier, using the pooled data (Chapter 6), it was found that people with and without 
MSKP feel pain in general for a similar number of days throughout the month. This 
result was maintained within each individual national group (Appendix 9: Table 
9.a.4.2).  
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The USA and the UK groups were very similar in how often they had a break from pain 
in general or LBP in particular; pain was constant for most participants. For Greeks, the 
frequency of pain and LBP breaks was more regular (Figures 9.1.3 and 9.1.4; Appendix 
9: Table 9.a.4.3). 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9.1.2: Percentage of people reporting the number of days they  
feel LBP per month across nations. People with no pain or who could  
not remember were excluded. 
 
 
Overall, the same pain and LBP onset times post iSCI were noticed within each 
individual country group as for the pooled group which was examined earlier (Chapter 
6, Section 6.1.8). Though Greeks reported a higher proportion of pain/LBP onset at 
between 1-6 months post iSCI rather than immediately post iSCI as the USA and UK 
groups did (Figure 9.1.5, 9.1.6; Appendix 9: Table 9.a.4.4).  
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Figure 9.1.3: Percentage of people reporting the frequency of their  
pain-free weeks across nations   
 
 
 
Figure 9.1.4: Percentage of people reporting the frequency of their  
LBP-free weeks across nations   
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In Chapter 6 (Section 6.1.8) LBP onset was examined between people with different 
causes of injury. This was done to check for similarities with the only other study which 
reported on LBP onset post SCI in the literature.371 The findings in this study for the 
pooled data differed to that of Raissi et al.371 The group examined by Raissi et al371 was 
from Iran. Examining each individual group from the three participating countries 
looking at people with a traumatic onset to their injury (as in Raissi et al371), LBP onset 
immediately after iSCI was much lower than in Raissi et al.371 Differences in the onset 
of LBP between people with traumatic and non-traumatic injury is presented in 
Appendix 9: Table 9.a.4.5.  
 
 
 
Figure 9.1.5: Percentage of people reporting the onset of their pain post  
iSCI across nations  
Abbreviations: iSCI, incomplete Spinal Cord Injury. 
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Figure 9.1.6: Percentage of people reporting the onset of their LBP post iSCI  
across nations 
Abbreviations: iSCI, incomplete Spinal Cord Injury. 
 
Part of the second hypothesis theme has been the examination of the correlation 
between the onset of pain/LBP post iSCI and the number of pain/LBP days 
(respectively) felt per month. In Chapter 6, for the pooled group, it was found that the 
earlier the onset of pain or LBP, the significantly more the painful days. The correlation 
for LBP was stronger. The same correlation was examined per country as follows:  
Hypothesis 0 (null): In people with iSCI there is no significant correlation between pain 
or LBP onset post iSCI and the number of pain or LBP days felt in a month for each 
national group. 
Hypothesis 4a: In people with iSCI there is a significant correlation between pain onset 
post iSCI and the number of pain days felt in a month for each national group. 
Hypothesis 4b: In people with iSCI there is a significant correlation between LBP onset 
post iSCI and the number of LBP days felt in a month for each national group. 
Among people with pain, the correlation between pain onset and pain days within 
each country group was negative, thus the earlier the onset of pain, the more the pain 
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days felt in the month, but in no case was this statistically significant. The strength of 
the correlation for the UK group was moderate making it the strongest correlation 
(Table 9.1.8). In the case of LBP onset post iSCI, the earlier the onset, the more LBP 
days felt in the month for Greeks and for people from the USA. For the latter, the 
strength of the correlation was strong and statistically significant.  
For each individual group from the three countries there was no significant correlation 
between the onset of pain post iSCI and the number of pain days (Table 9.1.8), despite 
the fact that when the total number of respondents were previously pooled together 
(Chapter 6) this correlation was statistically significant (p=0.04). In the case of a 
correlation between LBP onset post iSCI and LBP days for the USA and UK, the earlier 
the LBP onset, the more LBP days were felt per month (p≤0.001, Table 9.1.8). This was 
not found for the Greek group.  
 
Table 9.1.8: Correlation between pain/LBP onset post iSCI and pain/LBP days  
per each national group 
Correlations USA 
Statistical test 
UK 
Statistical test 
Greece 
Statistical test 
Pain onset post 
iSCI and pain 
days 
p=0.054 
γ=-0.25, n=108 
p=0.06 
γ=-0.49, n=46 
p=0.97 
γ=0.007, n=32 
LBP onset post 
iSCI and LBP 
days 
p≤0.001*** 
γ=-0.51, n=74 
p=0.41 
γ=-0.20, n=32 
p=0.43 
γ=-0.17, n=31 
***Significant at p≤0.001 level; in bold: significant following application of the  
Bonferroni correction 
Abbreviations: iSCI, incomplete Spinal Cord Injury; LBP, Low Back Pain.  
Statistical test: γ, Gamma test. 
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Part 2; Pain extent and LBP experience across the 
countries 
9.2.1 Introduction 
So far this chapter has described the demographic profile characteristics of the 
respondents from the three participating countries. It has explored the pain presence 
for each individual group and compared for differences or similarities within and 
between the country groups. This second part of the chapter will investigate the 
quality and intensity of LBP, and the pain extent that people within each country group 
report. Comparisons with the results from the pooled data examined in the previous 
chapters will be made.  
 
9.2.2 Bonferroni Correction 
In the current part of the analysis the number of multiple tests done on the variables 
of interest was n=14 thus the α-level of statistical significance set by Bonferroni was 
p≤0.0035 (Appendix 9: Table 9.b.1.1).   
 
9.2.3 Pain extent across nations; general results 
As explained in Chapter 6 (Section 6.2.3), the body chart used was divided into nine 
areas. The groups from the three countries showed very similar results in their mean 
number of painful areas and no significant differences between the groups were found 
(p=0.13, H=4.07, Kruskal-Wallis, n=190) (Appendix 9: Table 9.b.2.1). 
For respondents for all three countries, the lower back midline area was the most 
common area with pain in the back similar to the pooled data (Chapter 6). One 
difference was that people from the UK reported less cases of upper back pain, mainly 
at the right and left side compared to the other two countries (Table 9.2.1). Pain at the 
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buttocks was highly reported by people from all countries, mostly however by the UK 
group.  
 
Table 9.2.1: Distribution of pain presence for the back and buttocks across nations  
Pain on back area and buttocks USA (%, n) 
Total n=110 
UK (%, n) 
Total n=50 
GR (%, n) 
Total n=43 
Back area 
Upper back right side  
Upper back left side  
Upper back midline  
Lower back right side  
Lower back left side  
Lower back midline  
81.8 (n=90) 
13.6 (n=15) 
10.9 (n=12) 
17.3 (n=19) 
17.3 (n=19) 
20.0 (n=22) 
35.5 (n=39) 
81.0 (n=39) 
4.2   (n=2) 
4.2   (n=2) 
8.3   (n=4) 
27.1 (n=13) 
22.9 (n=11) 
41.2 (n=20) 
100  (n=32) 
12.5 (n=4) 
15.6 (n=5) 
25.0 (n=8) 
40.6 (n=13) 
43.7 (n=14) 
53.1 (n=17) 
Buttocks 
Right buttock   
Left buttock  
Midline area buttock (including 
anus) 
54.5 (n=60) 
30.0 (n=33) 
27.3 (n=30) 
33.6 (n=37) 
62.5 (n=30) 
35.4 (n=17) 
37.5 (n=18) 
43.7 (n=21) 
53.1 (n=17) 
25.0 (n=8) 
34.4 (n=11) 
25.0 (n=8) 
The 9-areas body chart division was used in this analysis  
 
People from all countries described their pain at the back area in fairly similar ways, 
mainly as an internal pain and, in particular, this was the description for the lower back 
midline area (Appendix 9: Figure 9.b.2.1). Pain at the buttocks slightly varied across the 
countries (Appendix 9: Figure 9.b.2.2). 
 
9.2.4 Pain extent across nations; relation to LBP and MSKP 
Using data from the pooled group it was found that people with LBP (any time period) 
and people with MSKP reported a significantly higher mean number of areas with pain 
compared to people without these types of pain (Chapter 6, Section 6.2.4). The same 
relation was examined per country and it was found that the results from the USA 
were significant (Table 9.2.2; Appendix 9: Table 9.b.3.1).  
 
 Chapter 9: Survey; results; cross-national analysis 
 
283 
Table 9.2.2: Differences in the mean number of areas with pain in groups with and 
without LBP or MSKP within each national group  
 USA UK Greece 
 Statistical Test Statistical Test Statistical Test 
Lifetime LBP 
 
U=225.5, n=110 
p≤0.001*** 
U=108, n=48 
p=0.03¹ 
U=15.5, n=32 
p=0.12 
Current LBP U=422.5, n=107 
p≤0.001*** 
U=130, n=47 
p=0.04¹ 
U=28.5, n=32 
p=0.29 
LBP presence over 
last 1 month 
U=516, n=109 
p≤0.001*** 
U=14.5, n=47 
p≤0.03¹ 
U=15.5, n=32 
p=0.24 
LBP presence over 
last 3 months 
U=410.5, n=106 
p≤0.001*** 
U=114.5, n=47 
p≤0.03¹ 
U=15.5, n=32 
p=0.25 
MSKP U=799, n=110 
p≤0.001*** 
U=178.5, n=47 
p=0.03¹ 
U=76.5, n=31 
p=0.25 
1not significant post Bonferroni correction; ***Statistically significant at p≤0.001 level;  
in bold: significant following application of the Bonferroni correction.  
Abbreviations: LBP, Low Back Pain; MSKP, Musculoskeletal Pain 
Statistical test: U, Mann-Whitney U test 
 
 
9.2.5 Pain extent across nations; relation to demographic profile 
characteristics 
When examining pain extent in relation to the demographic profile characteristics 
using the pooled data, the only significant difference found was between males and 
females (Chapter 6, Section 6.2.5). Investigating each national group separately, no 
difference passed the Bonferroni α-level of significance, including the gender 
difference. This indicates that a larger group may be needed in order to identify any 
such differences for pain extent (Appendix 9: Tables 9.b.4.1 and 9.b.4.2).  
Because pre-Bonferroni application a difference in sex and the number of areas with 
pain was noticed this was examined further and it is presented at Appendix 9: Tables 
9.b.4.3 and 9.b.4.4.  
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9.2.6 Pain extent across nations; relation to pain/LBP days, free 
periods, onset 
Earlier analysis showed that for the pooled group, those who reported more areas 
with pain also reported significantly more pain days felt in the month (Chapter 6, 
Section 6.2.6). For the USA group, more areas with pain correlated significantly with 
increased pain days (p≤0.001, ρ=0.31, Spearman’s, n=110) but not LBP days. No such 
significant correlation was found for the other two countries although they had the 
same direction (Appendix 9: Table 9.b.5.1).  
For the pooled group (Chapter 6, Section 6.2.6), it was also found that the more the 
areas with pain, the less frequent the pain-free weeks. However, no such correlation 
was found for any individual country (Appendix 9: Table 9.b.5.2). 
As part of the second hypothesis theme for the total respondents group, it was found 
that the earlier the onset of pain or LBP post iSCI, the more the number of areas with 
pain but the correlation was not statistically significant (Chapter 6, Section 6.2.6). This 
hypothesis (hypothesis 6) was examined individually for each group from the three 
countries. 
Hypothesis 0 (null): In people with iSCI there is no significant correlation between the 
number of areas with pain and the onset of pain or LBP post iSCI for each national 
group.  
Hypothesis 6: In people with iSCI there is a significant correlation between the number 
of areas with pain and the onset of pain or LBP post iSCI for each national group. 
 Spearman’s correlation was applied on the data and no significant results were found. 
The direction of the correlations were negative, thus the earlier the pain or LBP onset 
post iSCI, the more the painful areas (Tables 9.2.3 and 9.2.4). 
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Table 9.2.3: Mean number of areas with pain in groups divided by the time of pain 
onset post iSCI. Correlations between the number of areas with pain and pain onset 
within each national group 
 USA UK Greece 
 Mean, 
median, 
min-max 
Statistical 
Test 
Mean, 
median, 
min-max 
Statistical 
Test 
Mean, 
median, 
min-max 
Statistical 
Test 
Immediately 
after iSCI 
3.7±2.1 
3.5, 1-9 
n=48 
ρ=-0.15 
p=0.11 
n=105 
95%CI 
 -0.31, 0.02 
3.9±1.4  
4, 1-6 
n=18 
ρ=-0.11 
p=0.46 
n=44 
95%CI  
-0.38, 0.18 
3.9±2.4, 3 
1-9, n=9 
ρ=-0.13 
p=0.45 
n=32 
95%CI  
-0.11, 0.22 
Within 1 
month post 
iSCI 
3.0±1.7 
3.0, 1-8 
n=21 
3.8±1.3  
4, 2-6 
n=10 
2.8±1.3, 2 
2-5, n=5 
Between 1-6 
months post 
iSCI 
2.8±1.5 
2, 1-6 
n=19 
3.7±1.9 
3.5, 2-7 
n=6 
3.1±1.0, 3 
1-5, n=12 
Between 6 
months & 1 
year post 
iSCI 
3.4±1.3 
4, 2-5 
n=5 
2.7±0.5  
3,2, 1-3 
n=4 
3.0±1.7, 3 
1-4, n=3 
After 1 years 
post iSCI 
2.8±1.6, 
2, 1-6, 
n=12 
4.2±2.1,  
4, 2-7,  
n=6 
2.3±1.2, 
3, 1-3, 
n=3 
Abbreviations: iSCI, incomplete Spinal Cord Injury.  
Statistical test: ρ, Spearman’s rank correlation rho. 
 
Table 9.2.4: Number of areas with pain in groups divided by LBP onset post iSCI. 
Correlations between the number of areas with pain and LBP onset within each 
national group 
 
¹One outlier eliminated from analysis.  
Abbreviations: iSCI, incomplete Spinal Cord Injury.  
Statistical test: ρ, Spearman’s rank correlation rho. 
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9.2.7 LBP quality and intensity across nations; general results 
During the pooled group analysis it was shown that respondents used all verbal 
descriptors to describe their pain; primarily using “aching” which ranked as of 
moderate intensity (Chapter 6, Section 6.2.7). Examining the groups by country 
(Appendix 9, Tables 9.b.7.1, 9.b.7.2),  it was noted that all three countries reported all 
verbal descriptors to some extent; “splitting” being less reported by the Greek group 
(19.4%), while “aching” was very frequently and similarly reported by both the USA 
and UK groups (86.5% and 84.3%, respectively). For the USA group “aching” was 
mainly a moderate pain (48.2%) but for the UK group it was mainly a severe pain 
(40.5%).  People from Greece reported “gnawing” as the most frequent type of pain 
(64.5%), which was mainly a mild pain (41.9%). The mean number of words chosen 
was also looked at and people from the UK used the most words to describe their LBP 
quality (Table 9.b.7.3). 
People from Greece reported a lower mean quality of LBP for all dimensions (sensory, 
affective and total PRI) particularly for the S-PRI and total PRI but the differences did 
not pass the Bonferroni α-level of significance (Table 9.2.5).  
 
Table 9.2.5: Mean LBP quality in groups across nations. Differences between national 
groups 
 USA 
mean±SD, n 
UK 
mean±SD, n 
Greece 
mean±SD, n 
Between counties 
Statistical Tests 
S-PRI 10.3±7.1 
n=83 
12.5±9.3 
n=38 
6.7±5.5 
n=29 
F=5.44, df2, p=0.005¹ 
 
A-PRI 3.4±3.4 
n=83 
3.9±3.8 
n=38 
2.5±3.6 
n=29 
F=1.2, df2 
p=0.3 
Total PRI 13.7±10.0 
n=82 
14.9±11.3 
n=36 
9.2±8.2 
n=31 
F=3.07, df2 
p=0.04¹ 
1not significant post Bonferroni correction.  
Abbreviations: PRI, Pain Rating Index.  
Statistical test: F, One-way ANOVA. 
 
 
Investigating LBP intensity per group, the UK was the group with the highest intensity 
for LBP time periods (current, usual over last one month, usual over last three months) 
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but the mean differences between the countries were not large. One-way ANOVA 
confirmed the similarities between the three groups on LBP intensity (Table 9.2.6).   
The Greek group only had three responses35 to this question so reliability in this case is 
limited.  
 
Table 9.2.6: Mean LBP intensity in national groups 
 USA 
mean±SD, n 
UK 
mean±SD, n 
Greece 
mean±SD, n 
Statistical Test 
Current LBP 
intensity  
(0-100 NRS) 
41.3±27.9 
n=85 
46.7±29.5 
n=36 
45.0±31.2 
n=3 
F=0.46, df2 
p=0.62, n=124 
Intensity LBP last 
1 month  
(0-100 NRS) 
45.2±27.3 
n=85 
51.8±26.5 
n=34 
47.0±33.9 
n=3 
F=0.71, df2 
p=0.49, n=122 
Intensity LBP last 
3 months  
(0-100 NRS) 
46.2±26.4 
n=84 
53.0±27.7 
n=34 
40.0±32.8 
n=3 
F=0.90, df2 
p=0.40, n=121 
Abbreviations: LBP, Low Back Pain; NRS, Numeric Rating Scale.  
Statistical test: F, One-way ANOVA. 
 
In the case of overall evaluative intensity of LBP (PPI), people from each country 
individually reported similar results, however a higher proportion of people from the 
UK felt discomforting LBP (Figure 9.2.1). Converting the evaluative intensity scale into a 
mean score it was clear that people from the three nations reported similar means; 
USA 2.4±0.9, UK 2.3±1.0 and GR 2.1±0.8 which did not differ statistically (p=0.52, 
F=0.64, n=141).   
 
 
 
 
                                                     
35
 For an explanation of why the NRS responses for Greece are so limited see Chapter 6, Section 6.2.7. 
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Figure 9.2.1: Percentage of people reporting their evaluative overall LBP  
intensity within each national group 
 
 
9.2.8 LBP quality and intensity across nations; relation to 
demographic profile characteristics 
The interaction effect between the country and another IV which changed every time 
(e.g. sex, type of injury etc) on the outcome of interest (DV) which also changed was 
examined using two-way ANOVA. The aim remained to investigate the role of the 
country of residence on the outcome as a co-effect.   
 
9.2.8.1 Gender across nations 
No significant interaction effect between country of residence and gender on sensory, 
affective or total quality of LBP (PRI) was found   (Appendix 9: Table 9.b.6.1). Similarly, 
there was no interaction effect of these two variables on LBP intensity (all time 
periods) (Appendix 9: Table 9.b.6.1). Overall, examining the groups between the three 
countries, males from the UK reported the worst quality of LBP. Also it was noticed 
that males from Greece reported the most severe LBP intensity, but as this group was 
very small results may not be reliable.  Within the groups from each country males and 
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females did not differ significantly in their mean reports either for the quality or the 
intensity of their LBP which was similar to the results found earlier for the pooled 
group (Appendix 9: Table 9.b.6.1). Further two-group comparisons were conducted 
between groups that could possibly differ but did not reveal any significant differences 
(Appendix 9: Table 9.b.6.2).  
 
9.2.8.2 Cause of injury across nations 
Analysis showed that there was no significant interaction effect between cause of 
injury and country on the quality or the intensity of LBP  and the effect sizes (η²)36  
were small (Appendix 9: Table 9.b.6.4). People from Greece reported the best quality 
for their LBP and people from the UK the worst. Two-group comparisons were made 
between groups that seemed to have distant means and some significant differences 
were found (Appendix 9: Table 9.b.6.4). Finally, within the groups from all three 
countries, people with traumatic and non-traumatic cause for their injury did not differ 
significantly in the quality of LBP and usually those with a non-traumatic cause had a 
slightly worse total mean score (Appendix 9: Table 9.b.6.4).  
 
9.2.8.3 Level of injury across nations 
The interaction effect between country of residence and level of injury was not 
significant on the quality or the intensity of LBP (Table 9.2.7). Earlier analysis in 
Chapter 6, Section 6.2.8 showed that people with paraplegia reported significantly 
worse LBP quality (sensory and affective dimension) and intensity of LBP was higher 
but not significantly different compared to people with tetraplegia. Between the 
groups from the three countries people from Greece reported the best quality of LBP. 
Additional two-group comparisons identified differences between the subgroups of 
the compared national groups (Appendix 9: Table 9.b.6.5). Separate, within country 
group analysis showed that only within the USA group people with paraplegia reported 
                                                     
36
 For details on the effect sizes refer back Chapter 5, Section 5.21. 
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significantly worse LBP quality and LBP intensity compared to people with paraplegia 
(Table 9.2.7).  
 
Table 9.2.7: Differences in LBP quality or intensity between groups divided by level of 
injury (paraplegia and tetraplegia), within each national group. Interaction effect of 
country of residence and level of injury on LBP intensity and quality 
 Comparisons within each country Effect of level of 
injury *country 
on DV  
 USA UK GR 
S-PRI U=445 
p≤0.001*** 
t=-1.00, df36, p=0.32 
95% CI -9.4, 3.1 
U=769.5 
p=0.58 
F=2.68, p=0.07,  
η²=0.0109 
n=152 
A-PRI U=551.5 
p=0.008¹ 
U=152.5 
p=0.63 
U=78.5 
p=0.91 
F=1.59, p=0.20,  
η²=0.0108 
n=150 
Total PRI U=433.5 
p≤0.001*** 
t=-1.17, df34, p=0.24 
95% CI -12.5, 3.3 
U=68.5 
p=0.55 
F=2.12, p=0.12,  
η²=0.0098 
n=148 
Intensity of 
current LBP 
t=-2.23, df83, 
p=0.02¹ 
95% CI -25.1, 1.4 
t=-0.09, df34, p=0.92 
95% CI -22.4, 20.4 
n/a F=1.94, p=0.14,  
η²=0.0095 
n=122 
Intensity of LBP 
over last 1 
month 
t=-2.90, df83, 
p=0.005¹ 
95% CI -20.0, 6.1 
t=0.18, df32, p=0.85 
95% CI -17.8, 21.4 
n/a F=2.96, p=0.055  
η²=0.0117 
n=120 
Intensity of LBP 
over last 3 
months 
t=-3.54, df82, 
p≤0.001*** 
95% CI -30.0, 8.4 
t=0.05, df32, p=0.95 
95% CI -19.9, 21.1 
n/a F=3.011, 
p=0.053,  
η²=0.01109 
n=119 
Evaluative PPI of 
LBP 
t=-2.66, df76, 
p=0.009¹ 
95% CI -0.9, 0.1 
t=0.28, df29, p=0.78 
95% CI -0.5, 0.6 
U=76.5 
p=0.83 
F=1.87, p=0.15,  
η²=0.00335 
n=139 
1not significant post Bonferroni correction; in bold: significant following application of the 
Bonferroni correction.  
Abbreviations: PRI, Pain Rating Index; S-PRI, Sensory PRI; A-PRI, Affective PRI; LBP, Low Back 
Pain; PPI, Present Pain Intensity.  
Statistical tests: U, Mann-Whitney U test; t, Independent t-test; F, Two-way ANOVA.  
 
9.2.8.4 Age across nations 
Previous analysis for the pooled group found that as age increased the total PRI 
improved and age did not correlate with the intensity of LBP (Chapter 6, Section 6.2.8). 
Using regression analysis to examine the interaction effect of age and country of 
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residence on quality and intensity of LBP for two cases, it was found statistically 
significant but failed to pass the Bonferroni α-level of significance (Table 9.2.8). Age did 
not correlate significantly with quality of LBP within any national groups although an 
increase in age correlated with an improvement in LBP quality but the correlations 
were of small strength. Also, the correlation between age and LBP intensity was weak 
and not significant though it was stronger for the UK group (Appendix 9: Table 9.b.6.6).  
 
9.2.8.5 Time since injury across nations  
Examining the pooled data earlier, no significant correlations between the time since 
injury and quality or intensity of LBP were found (Chapter 6, Section 6.2.8). Using 
regression, no effects were found between the time since injury and the country of 
residence on either the quality or the intensity of LBP that passed the Bonferroni        
α-level of significance. Finally, no significant correlations were found between time 
since injury and quality or intensity of LBP for any group per each individual nation 
(Appendix 9: Table 9.b.6.6).  
 
9.2.9 LBP quality and intensity across nations; pain/LBP days, free 
periods, onset 
Earlier analysis showed that as the number of LBP days felt in a month increased, the 
quality of LBP decreased (Chapter 6, Section 6.2.9). Using two-way ANOVA to examine 
the interaction effect of the country of residence and the number of LBP days felt in a 
month on any of the PRI dimensions of LBP, no significant results were found (Table 
9.2.8). Looking at the data from individual groups, however, it was found that within 
the USA group worse LBP quality correlated significantly with earlier LBP onset but not 
earlier pain onset (Appendix 9: Table 9.b.8.1). The significant relationship found 
previously that the more the LBP days, the higher the intensity of LBP maintained its 
significance within both the USA and UK groups (Appendix 9: Table 9.b.8.1). Though an 
increased number of pain days correlated with LBP intensity, the correlation was not 
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significant but there were occasions where the correlation had moderate strength 
(Appendix 9: Table 9.b.8.1).  
 
Table 9.2.8: Interaction effects of country of residence and age or time since 
 injury on LBP quality and intensity 
 Effect of age *country on 
DV  
Effect of time since injury 
*country on DV  
S-PRI p=0.005¹ df3, n=148 
Wald χ²=12.72, Likelihood 
ratio χ²=12.2 p=0.007¹  
p=0.01¹ df3, n=151 
Wald χ²=11.09, Likelihood 
ratio χ²=10.7, p=0.01¹ 
A-PRI p=0.26, df3, n=148 
Wald χ²=3.91, Likelihood 
ratio χ²=3.92 p=0.26 
p=0.28, df3, n=151 
Wald χ²=3.80, Likelihood ratio 
χ²=3.75 p=0.28 
Total PRI p=0.02¹ df3, n=145 
Wald χ²=9.25, Likelihood 
ratio χ²=8.97 p=0.03¹ 
p=0.01¹ df3, n=148 
Wald χ²=10.25, Likelihood 
ratio χ²=9.91, p=0.01¹ 
Intensity of 
current LBP¥ 
p=0.62, df3, n=116 
Wald χ²=0.74, Likelihood 
ratio χ²=0.73 p=0.69 
p=0.21, df3, n=120 
Wald χ²=3.07, Likelihood ratio 
χ²=3.03, p=0.21 
Intensity of LBP 
over last 1 
month¥ 
p=0.61, df3 
Wald χ²=0.97, Likelihood 
ratio χ²=0.96 p=0.61 
p=0.01¹ df3, n=118 
Wald χ²=6.94, Likelihood ratio 
χ²=6.75, p=0.03¹ 
Intensity of LBP 
over last 3 
months¥ 
p=0.66, df3, n=114 
Wald χ²=0.81, Likelihood 
ratio χ²=0.81 p=0.66 
p=0.01¹ df3, n=117 
Wald χ²=8.83, Likelihood ratio 
χ²=8.51, p=0.01¹ 
Evaluative PPI of 
LBP 
p=0.23, df12 
Likelihood ratio χ²=15.13, 
Nagelkerke R²=0.11 
p=0.11, df12 
Likelihood ratio χ²=17.89, 
Nagelkerke R²=0.11 
¥The Greek group was excluded due to insufficient data; ¹not significant post  
Bonferroni correction.  
Abbreviations: MSKP, Musculoskeletal Pain; LBP, Low Back Pain; SE, Standard Error; OR, Odd 
Ratio;  
Statistical tests: χ², Likelihood ration Chi-square; Wald test chi-square distribution; R², 
Nagelkerke R square (pseudo-R). 
 
The frequency of having pain- or LBP-free weeks was examined aiming to investigate if 
that would lead to less severe LBP. No significant interaction effect between pain- or 
LBP-free weeks and the country of residence was found on either the quality (any 
dimensions) or the intensity of LBP (Table 9.2.8).  In addition, within each country 
group the frequency of pain-free weeks did not correlate with the quality of LBP and 
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though the correlation was stronger for LBP-free weeks, they also did not pass the 
Bonferroni α-level of significance (Appendix 9: Table 9.b.8.2). The impact of the 
persistence of pain and LBP was greater on the intensity of LBP, particularly for the 
USA and UK groups, where the correlations were strong and statistically significant 
(Appendix 9: Table 9.b.8.2).  
Using the pooled data in earlier analysis it was found that worse LBP quality and 
intensity correlated significantly with earlier LBP onset following iSCI but not with 
earlier pain (in general) onset (Chapter 6, Section 6.2.9). Using two-way ANOVA to 
examine the interaction effect of the country of residence and the onset of LBP on 
either the PRI dimensions of LBP or its intensity, no results passed the Bonferroni        
α-level of significance (Table 9.2.8). In the case of the interaction effect of these 
variables on the affective dimension, the results were not far from the Bonferroni 
significance (p=0.005, F=2.96, Two-way ANOVA, n=135). Figure 9.2.2 shows this 
interaction as the lines representing each variable cross with each other. But as the 
significance did not pass the Bonferroni level it is not accepted here as a significant 
interaction effect but it may be considered for future studies. More interaction effect 
results are in Table 9.2.9. 
Figure 9.2.2: 
Graph showing 
the significant 
interaction effect 
between country 
of residence and 
LBP onset post 
iSCI on affective 
dimension 
(n=135). 
Abbreviations; PRI, 
Pain Rating Index; 
LBP, Low Back 
Pain; iSCI, 
incomplete Spinal 
Cord Injury. 
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Table 9.2.9: Interaction effects of country of residence and another variable  
 on LBP quality and intensity  
 Effect of number 
of LBP days 
*country on DV  
Effect of number 
of LBP free 
weeks *country 
on DV  
Effect of number of 
LBP onset post iSCI 
*country on DV  
S-PRI F=0.78, p=0.58,  
η²=0.0101 
n=142 
F=0.42, p=0.91,  
η²=0.0100 
n=119 
F=1.88, p=0.068,  
η²=0.0342 
n=135 
A-PRI F=3.81, p=0.10,  
η²=0.00348 
n=142 
F=0.90, p=0.52,  
η²=0.0317 
n=119 
F=2.96, p=0.005¹  
η²=0.0752 
n=135 
Total PRI F=0.80, p=0.56,  
η²=0.0114 
n=139 
F=0.58, p=0.81,  
η²=0.0146 
n=117 
F=1.98, p=0.055,  
η²=0.0377 
n=132 
Intensity of 
current LBP 
F=1.02, p=0.38,  
η²=0.0059 
n=114 
F=1.96, p=0.44,  
η²=0.0111 
n=90 
F=2.33, p=0.04¹  
η²=0.0294 
n=107 
Intensity of LBP 
over last 1 
month 
F=0.59, p=0.062  
η²=0.0027 
n=112 
F=0.80, p=0.542  
η²=0.0063 
n=91 
F=1.76, p=0.12,  
η²=0.0178 
n=105 
Intensity of LBP 
over last 3 
months 
F=0.32, p=0.80,  
η²=0.0015 
n=111 
F=1.40, p=0.23,  
η²=0.0111 
n=90 
F=3.24, p=0.01¹ 
η²=0.0285 
n=104 
Evaluative PPI of 
LBP 
F=0.83, p=0.54,  
η²=0.0041 
n=134 
F=1.40, p=0.19,  
η²=0.011 
n=111 
F=1.48, p=0.17,  
η²=0.0132 
n=126 
1not significant post Bonferroni correction.  
Abbreviations: PRI, Pain Rating Index; S-PRI, Sensory-PRI; A-PRI, Affective-PRI;  
LBP, Low Back Pain; PPI, Present Pain Intensity.   
Statistical test: F, Two-way ANOVA. 
 
 
It has been hypothesised (hypotheses 8 and 9) that:  
Hypothesis 0 (null): In people with iSCI there is no significant correlation between the 
quality (sensory, affective or total PRI) of LBP and pain or LBP onset post iSCI for each 
national group. 
Hypothesis 8a: In people with iSCI there is a significant correlation between the 
sensory dimension of quality of LBP and pain or LBP onset post iSCI for each national 
group. 
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Hypothesis 8b: In people with iSCI there is a significant correlation between the 
affective dimension of quality of LBP and pain or LBP onset post iSCI for each national 
group. 
Hypothesis 8c: In people with iSCI there is a significant correlation between the total 
PRI of LBP and pain or LBP onset post iSCI for each national group. 
Hypothesis 0 (null): In people with iSCI there is no significant correlation between the 
intensity of LBP (current, over last 1, last 3 month or evaluative PPI) and pain or LBP 
onset post iSCI for each national group. 
Hypothesis 9a: In people with iSCI there is a significant correlation between intensity 
of current LBP and pain or LBP onset for each national group. 
Hypothesis 9b: In people with iSCI there is a significant correlation between intensity 
of LBP over the last 1 month and pain or LBP onset for each national group. 
Hypothesis 9c: In people with iSCI there is a significant correlation between intensity 
of LBP over last 3 months and pain or LBP onset for each national group. 
Hypothesis 9d: In people with iSCI there is a significant correlation between the 
evaluative overall LBP intensity and pain or LBP onset for each national group. 
Neither earlier pain or LBP onset correlated significantly with the quality of LBP within 
the USA and Greek groups the strength of the correlations were moderately strong 
and negative (Table 9.2.10). The correlation between LBP onset post iSC and LBP 
intensity had the same negative direction and was significant within the USA group 
where the strength of the relation was slightly stronger than the pain onset for this 
group (Table 9.2.10). 
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Table 9.2.10: Correlations between pain or LBP onset and quality or intensity of LBP 
within each national group 
 Pain onset LBP onset 
 USA UK Greece USA UK Greece 
S-PRI ρ=-0.23 
p=0.03¹ 
 n=79 
ρ=0.09 
p=0.59 
 n=37 
ρ=-0.14 
p=0.42 
 n=31 
ρ=-0.33 
p=0.005¹ 
 n=71 
ρ=-0.01 
p=0.95 
 n=34 
ρ=-0.27 
p=0.14 
 n=30 
A-PRI ρ=-0.28 
p≤0.01¹ 
 n=79 
ρ=0.11 
p=0.49 
 n=37 
ρ=-0.46 
p=0.009¹ 
 n=31 
ρ=-0.30 
p≤0.01¹ 
 n=71 
ρ=0.07 
p=0.68 
 n=34 
ρ=-0.48 
p=0.007¹ 
 n=30 
Total PRI  ρ=-0.24 
p=0.03¹ 
 n=78 
ρ=0.10 
p=0.54 
 n=35 
ρ=-0.23 
p=0.21 
 n=31 
ρ=-0.33 
p=0.005¹ 
n=70 
ρ=-0.01 
p=0.90 
 n=32 
ρ=-0.37 
p=0.44 
 n=30 
Intensity of 
current LBP 
ρ=-0.18 
p=0.09 
 n=81 
ρ=0.01 
p=0.93 
 n=35 
ρ=-0.5 
p=0.66 
 n=3 
ρ=-0.42 
p≤0.001*** 
 n=73 
ρ=-0.02 
p=0.90 
 n=32 
n/a 
Intensity of 
LBP over 
last 1 
month 
ρ=-0.16 
p=0.15 
 n=81 
ρ=0.09 
p=0.61 
 n=33 
ρ=-0.5 
p=0.66 
 n=3 
ρ=-0.41 
p≤0.001*** 
 n=73 
ρ=-0.10 
p=0.57 
 n=30 
n/a 
Intensity of 
LBP over 
last 3 
months 
ρ=-0.26 
p=0.02¹ 
 n=80 
ρ=0.15 
p=0.38 
 n=33 
ρ=-0.50 
p=0.66 
 n=3 
ρ=-0.51 
p≤0.001*** 
 n=72 
ρ=-0.01 
p=0.92 
 n=30 
n/a 
Evaluative 
PPI of LBP 
ρ=-0.20 
p=0.07 
 n=74 
ρ=0.36 
p=0.04¹ 
 n=32 
ρ=0.08 
p=0.67 
 n=30 
ρ=-0.27 
p=0.02¹ 
 n=68 
ρ=0.22 
p=0.25 
 n=29 
ρ=-0.07 
p=0.71 
 n=29 
n/a: Data from the Greek group on the intensity of LBP was only given by three respondents 
thus will not be examined37. Data for the evaluative PPI intensity was used normally, 
1not 
significant post Bonferroni correction; ***Significant at p≤0.001 level, in bold: significant 
following application of the Bonferroni correction.  
Abbreviations: PRI, Pain Rating Index; LBP, Low Back Pain; PPI, Present Pain Intensity.  
Statistical tests: ρ, Spearman’s rank correlation rho. 
 
9.2.10 LBP quality and intensity across nations; relation to body 
chart 
It was found earlier for the pooled group that as the number of painful areas on the 
body increased, the quality of LBP became worse and LBP intensity increased (Chapter 
6, Section 6.2.10). These correlations were not significant when examining the groups 
from the three countries. The only exception was for the US group where there was a 
                                                     
37
 For an explanation of why there are only three respondents from Greece answering this question 
refer back to Chapter 6, Section 6.2.7. 
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correlation between the number of areas with pain and evaluative intensity of LBP. 
Despite correlations not being statistically significant they were often of moderate 
strength especially for the quality of LBP (Appendix 9: Table 9.b.8.3).  
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Part 3; EQ-5D: Pain and quality of life within and across 
nations 
 
9.3.1 Introduction 
So far this chapter has examined the demographic profiles of the respondents per 
country and their pain and LBP experiences. This part of the chapter will present the 
QoL for each group per individual country and will examine how QoL relates to the 
experience of pain and LBP.  
 
9.3.2 Bonferroni Correction 
The main variables of interest included in the analysis here were two; 1) the EQ-5D 
index, and 2) the EQ-VAS. Both were involved in 26 individual tests thus the α-level of 
significance for Bonferroni correction was set at p≤0.002 (Appendix 9; Table 9.c.1.1).  
 
9.3.3 QoL across nations; general results 
Looking at people from each country they all reported some problems with the EQ-5D 
dimensions38. People from the USA seemed to have less “self-care” problems and were 
less anxious/depressed compared to those from the other countries. At the same time, 
more people from the UK reported severe levels of pain (Figure 9.3.1). Scoring of the 
EQ-5D dimensions confirmed that the differences between the groups from the three 
countries were not great as no statistically significant differences were found (p=0.75, 
F=0.20, One-way ANOVA, n=198).  However, a significant difference was found in the 
perception of self-rated health (p≤0.001, F=9.73, One-way ANOVA, n=198) and 
Bonferroni post hoc showed that people from Greece reported significantly worse 
                                                     
38
 For an explanation of the characteristics of the EQ-5D measure see Chapters 5 and 7. 
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perceived health status (EQ-VAS) than those from the USA (p≤0.001, Bonferroni Post 
Hoc I-J=16.89, 95% CI 7.4, 26.3, Table 9.3.1). 
 
 
 
Figure 9.3.1: Percentage of people, within each national group, reporting  
their health status dimensions 
 
 
 
Table 9.3.1: Mean QoL of people within each national group. Differences in the  
mean QoL between national groups 
 USA UK GR Statistical Tests 
EQ-5D Index 
   mean±SD 
    
 
0.37±0.34 
 
 
0.33±0.35 
 
 
0.39±0.37 
 
F=0.20 
p=0.75 
n=198 
EQ-VAS 
   mean±SD 
    
 
 
68.2±21.4 
 
 
60.4±24.5 
 
 
51.3±18.8 
 
F=9.73 
p≤0.001*** 
USA-GR (I-J) 16.89, 
p≤0.001***, 95%CI 
7.4, 26.3, n=198 
***Significant at p≤0.001 level, in bold: significant following application of the  
Bonferroni correction or post hoc.  
Abbreviations: EQ-5D, Quality of Life, EQ-VAS, Quality of Life Visual Analogue Scale.  
Statistical test: F, One-way ANOVA. 
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9.3.4 QoL across nations; relation to pain, MSKP and LBP 
People with pain, MSKP and LBP from all three countries replied similarly on the EQ-5D 
dimensions with most reporting some problems. Irrespective of the type of pain, 
people from the USA seemed to have fewer problems with “self-care” (Figure 9.3.2, 
9.3.3, 9.3.4). One thing noted throughout the groups when people did not have pain, 
MSKP or LBP was that anxiety/depression levels dropped (Appendix 9: Figures 9.c.2.1-
9.c.2.3).  
In Chapter 5 it was found that among the total group, people without pain, MSKP or 
LBP had a better, though not statistically significant, QoL. Here the interaction effect 
between the country of residence and the presence of the categories of pain of 
interest on QoL was examined but no significant results were found (Table 9.3.2).   
To investigate the relation of the presence of the pain categories with QoL (hypothesis 
2) within each national group the following was hypothesised:  
Hypothesis 0 (null): In people with iSCI there is no significant difference in QoL (EQ-5D 
index or EQ-VAS) between people with pain, LBP or MSKP and those without for each 
national group. 
Hypothesis 2a: In people with iSCI there is a significant difference in QoL (EQ-5D index 
or EQ-VAS) between people with pain and those without for each national group. 
Hypothesis 2b: In people with iSCI there is a significant difference in QoL (EQ-5D index 
or EQ-VAS) between people with MSKP and those without for each national group. 
Hypothesis 2c: In people with iSCI there is a significant difference in QoL (EQ-5D index 
or EQ-VAS) between people with LBP and those without for each national group. 
The same significant differences, as per the pooled group, were confirmed within the 
USA group and the Greek group but not for the UK group (Table 9.3.3; Appendix 9: 
Table 9.c.2.4). Earlier in Chapter 7, among the pooled group, people with MSKP or LBP 
perceived their self-rated health as worse than those without. Examining the data 
cross-nationally, it was found that the presence of any of the pain categories did not 
 Chapter 9: Survey; results; cross-national analysis 
 
301 
affect classification or perception of health status for the Greeks or people from the 
UK, however the effect sizes were, on occasion, moderate implying a practical 
significance (Table 9.3.3). The presence of the pain categories had a stronger impact on 
the health status for people from the USA, particularly those with LBP who classified 
and perceived their health status as worse that those without LBP (Table 9.3.3).  
 
 
Figure 9.3.2: Percentage of people with pain in general, within each national  
group, reporting their health status dimensions 
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Figure 9.3.3: Percentage of people with MSKP, within each national group,  
reporting their health status dimensions 
 
 
 
 
Figure 9.3.4: Percentage of people with LBP, within each natinal group, reporting  
their health status dimensions 
 
 
 Chapter 9: Survey; results; cross-national analysis 
 
303 
Table 9.3.2: Interaction effects of country of residence and presence  
of pain/MSKP/LBP on health status 
 Effect of 
presence of pain 
*country on DV  
Effect of presence of 
MSKP *country on DV  
Effect of presence of 
LBP *country on DV  
EQ-5D index F=0.42, p=0.065  
η²=0.0020 
n=198 
F=3.31, p=0.03¹ 
η²=0.0161 
n=193 
F=2.09, p=0.12  
η²=0.0101 
n=191 
EQ-VAS F=1.93, p=0.14  
η²=0.0019 
n=198 
F=1.76, p=0.17  
η²=0.0018 
n=193 
F=0.63, p=0.52  
η²=0.00064 
n=191 
1not significant post Bonferroni correction;  
Abbreviations: EQ-5D, Quality of Life, EQ-VAS, Quality of Life Visual Analogue Scale.  
Statistical test: F, Two-way ANOVA. 
 
 
 Table 9.3.3: Comparisons within countries for EQ-5D Index or EQ-VAS  
and pain categories (between people with and without pain categories) 
EQ-5D USA UK GR 
Pain in 
general 
U=148, n=113 
ES: r=-0.24 
p=0.008¹ 
U=18, n=43 
ES: r=-0.03 
p=0.80 
U=81,n=42 
 ES: r=-0.31 
p=0.03¹ 
Current LBP t=3.31, df105, 
n=107  
ES: d=0.66 
p≤0.001*** 
95%CI 0.08, 0.3 
U=162.5, n=43  
ES: r=-0.01 
p=0.92 
U=126, n=41 
ES: r=-0.21 
p=0.16 
MSKP t=2.55, df109, 
n=111, ES: d=0.48 
p≤0.01¹ 
95%CI 0.03, 0.3 
t=-1.24, df40,  
n=42, ES: d=0.28 
p=0.21 
95%CI -0.3, 0.08 
U=91, n=40 
 ES: r=-0.31 
p≤0.01¹ 
EQ-VAS USA UK GR 
Pain in 
general 
U=212,n=113 
ES:  r=-0.17 
p=0.058 
U=0.0, n=43  
ES: r=-0.25 
p=0.08 
U=115, n=41 
ES: r=-0.02 
p=0.057 
Current LBP t=3.81, df105, 
n=107, ES: d=0.81 
p≤0.001*** 
95%CI 7.4, 23.6 
t=1.87, df41,  
n=43, ES: d=0.64 
p=0.06 
95%CI -1.24, 33.4 
t=1.76, df38,  
n=41, ES: d=0.36 
p=0.008¹ 
95%CI -1.4, 21.1 
MSKP t=2.60, df109,  
n=111, ES: d=0.51 
p≤0.01¹ 
95%CI 2.5, 19.0 
U=52, n=42 
ES: r=-0.01 
p=0.003¹ 
t=1.03, df39,  
n=40, ES: d=0.36 
p=0.30 
95%CI -6.3, 19.6 
1not significant post Bonferroni correction; ***Significant at p≤0.001 level,  
in bold: significant following application of the Bonferroni correction;  
Abbreviations: LBP, Low Back Pain; MSKP, Musculoskeletal Pain; EQ-5D, Quality of Life; 
 EQ-VAS, Quality of Life Visual Analogue Scale.  
Statistical tests: U, Mann-Whitney U test; t, Independent t-test. 
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9.3.5 QoL across nations; relation to demographic profile 
characteristics 
9.3.5.1 Gender across nations 
The interaction effect of the country of residence and gender was not significant on 
the QoL which means that where people lived in combination with whether they were 
males or females did not predict how their QoL would be. Between the three national 
groups men from the USA seemed to be less anxious than all other respondents. On 
the other hand, women from Greece reported the most severe anxiety/depression 
problems despite their pain problems not being as severe as females or males from the 
other countries. Problems with mobility were similar across all countries for men and 
women (Figures 9.3.5, 9.3.6; Appendix 9: Table 9.c.3.1). Scoring of the EQ-D5 
dimensions confirmed the similarities of the sexes within the country groups and 
therefore the original finding, when using the pooled group, of no gender differences 
in the EQ-5D index was maintained (Appendix: Table 9.c.3.6).  
A difference in MSKP between males and females was found pre-application of the 
Bonferroni correction in Chapter 6. Some further analysis on MSKP and QoL by gender 
was conducted and is presented at Appendix 9: Table 9.c.3.2 as it was not part of the 
main analysis.  
 
Figure 9.3.5: Percentage of males, within each national group, reporting  
their health status dimensions 
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Figure 9.3.6: Percentage of females, within each national groups, reporting  
their health status dimensions 
 
 
9.3.5.2 Cause of injury across nations 
The country of residence in combination with the cause of injury could not predict the 
health status of the participants as no significant interaction effect was found either on 
the classification of health state or the perception of self-reported heath; interaction 
effect between cause of injury and country of residence on the EQ-5D index: p=0.66, 
(F=0.41, η²=0.0033, two-way ANOVA, n=131);  interaction effect between the cause of 
injury and the country of residence on the EQ-VAS: p≤0.01, (F=4.57, η²=0.0081, two-
way ANOVA, n=131). People with traumatic injuries from the different countries 
reported fairly similarly on the EQ-5D dimensions. However, people with a traumatic 
injury from the UK seemed to suffer more with pain/discomfort than people in the 
other countries. Conversely, among people with a non-traumatic injury the least 
anxious/depressed came from the UK, despite reporting the more severe levels of 
pain/discomfort (Figures 9.3.7, 9.3.8; Appendix 9: Table 9.c.3.3). Scoring of the EQ-5D 
dimensions within each group confirmed the similarities between people with 
traumatic and non-traumatic injury as no significant differences were found (Appendix 
9: Table 9.c.3.6). In the case of perceived self-rated health, within the USA group 
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people with non-traumatic injuries reported a significantly lower mean than those with 
a traumatic injury (p≤0.001, t=4.25, 95%CI 10.1, 27.6, independent t-test).  
 
Figure 9.3.7: Percentage of people with traumatic injury, within each national  
groups, reporting their health status dimensions 
 
 
 
Figure 9.3.8: Percentage of people with non-traumatic injury, within each  
national group, reporting their health status dimensions 
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9.3.5.3 Level of injury across nations 
In earlier analysis of the pooled data (Chapter 7, Section 7.6), it was found that people 
with tetraplegia perceived their health status as better than people with paraplegia. 
Here, the country of residence in combination with the level of injury did not predict 
the QoL as no interaction effects were significant; interaction effect between level of 
injury and country of residence on the EQ-5D index: p=0.11, (F=1.91, η²=0.0300, two-
way ANOVA, n=131); interaction effect between level of injury and country of 
residence on the EQ-VAS: p=0.16, (F=1.64, η²=0.0059, two-way ANOVA, n=131). 
Between the groups from the three countries, those with tetraplegia from the UK 
seemed to be less anxious/depressed despite reporting the most severe levels of 
pain/discomfort. People with paraplegia were, within all groups, better with their “self-
care” and their “usual activities” compared to people with tetraplegia (Figures 9.3.9, 
9.3.10; Appendix 9: Table 9.c.3.4). Scoring of the EQ-5D dimensions showed that 
people with tetraplegia and paraplegia did not differ significantly within each group 
from country to country (Appendix 9: Tables 9.c.3.5). People with tetraplegia perceived 
their self-rated health as better compared to people with paraplegia, similar to the 
pooled group, but the difference was not significant which could be due to having  
smaller sized groups (Appendix 9: Table 9.c.3.6).  
 
Figure 9.3.9: Percentage of people with tetraplegia injury, within each  
national group, reporting their health status dimensions 
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Figure 9.3.10: Percentage of people with paraplegia injury, within each  
national group, reporting their health status dimensions 
 
 
9.3.5.4 Age across nations 
Originally, in the pooled group (Chapter 7, Section 7.6), it was found that age did not 
correlate with the EQ-5D index and the direction of the correlation was positive but 
very weak showing that increasing age slightly correlated with worse health status 
classification. Within each separate group from the three countries the correlation 
remained the same in terms of not being significant, the direction of the correlations 
was weak and positive for the USA and Greece but negative for the UK (Appendix 9: 
Table 9.c.3.7, Figure 9.c.3.1, Table 9.c.3.8). The country of residence in combination 
with age could not predict the EQ-5D index as the interaction effect was not significant 
(Table 9.3.3). Though age did not significantly correlate with perception of self-rated 
health within any group, the direction of the relation indicated that increasing age 
negatively related with health perception for people from all nations (Appendix 9: 
Table 9.c.3.7). However, the interaction effect of the country of residence and age on 
self-rated health perception was significant (p≤0.001, Wald χ²=33.84, df3, n=190). In 
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particular, as age increases, people from the USA, the UK or Greece are more likely to 
perceive their self-rated health as deteriorating (Table 9.3.3).  
Earlier it was found that time since injury does not correlate significantly with QoL, but 
people classified their health status as slightly worse and perceived it as better 
(Chapter 7, Section 7.6). When time since injury was examined within each group from 
the participating countries, those from the UK with longer time since injury seemed to 
report severe problems with “self-care” and “pain/discomfort”. Those with less time 
since injury reported severe problems with “anxiety/depression” but for the Greeks, 
those with the longest time since injury reported more problems with 
“anxiety/depression” (Appendix 9: Figure 9.c.3.2, Table 9.c.3.10). Those from the USA 
with a short time since injury reported severe problems with their usual activities. 
However, this changed as time since injury increases and more people reported no 
problems with usual activities. Scoring of the EQ-5D index did not reveal any significant 
correlation between time since injury and classification of health status (Appendix 9: 
Table 9.c.3.9). In addition, the interaction effect between the country of residence and 
time since injury was not significant on the health status classification (Table 9.3.3). 
The perception of the respondents about their self-rated health decreased with the 
passing of time for Greeks and people from the UK but increased for people from the 
USA. However, none was significant (Appendix 9: Table 9.c.3.9). But the country of 
residence in combination with the time since injury affected the self-rated health 
perception (p≤0.001, Wald χ²=33.84, df3, n=190). In particular, as time since injury 
increased, people from the USA were more likely to perceive their self-rated health as 
better while Greeks were more likely to perceive it as worse (Table 9.3.3).   
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Table 9.3.3: Interaction effects of residence and age or time since injury on health 
status 
 Effect of age or time since 
injury and country on EQ-
5D  
Effect of age or time since injury 
and country on EQ-VAS  
Age p=0.65 df3, n=190 
Wald χ²=1.60, Likelihood 
ratio χ²=1.60 p=0.65  
p≤0.001***, df3, n=190 
Wald χ²=33.84, Likelihood ratio 
χ²=31.14, p≤0.001*** 
USA*age: p=0.005**, b=-0.38, 
SE=0.13, Wald χ²=7.8, df3, 95% CI 
for Wald -0.66, -0.11 
UK*age: p=0.001***, b=-0.53, 
SE=0.13, Wald χ²=15.25, df3, 95% 
CI for Wald -0.53, -0.11 
Greece*age: p≤0.001***, b=-0.52, 
SE=0.10, Wald χ²=24.49, df3,  
95% CI for Wald -0.72, -0.31 
Time since 
injury 
p=0.65, df3, n=197 
Wald χ²=1.611, Likelihood 
ratio χ²=1.61, p=0.65 
p≤0.001***, df3, n=197 
Wald χ²=21.5, Likelihood ratio 
χ²=20.41, p≤0.001*** 
USA*age: p=0.02*, b=0.39, 
SE=0.16, Wald χ²=5.44, df3,  
95% CI for Wald -0.06, -0.72 
Greece*age: p=0.002**, b=-0.83, 
SE=0.27, Wald χ²=9.46, df3,  
95% CI for Wald -1.37, -0.30 
¥The Greek group was excluded due to insufficient data; **Significant at p≤0.01  
level, ***Significant at p≤0.001 level, in bold: significant following application  
of the Bonferroni correction;  
Abbreviations: MSKP, Musculoskeletal Pain; LBP, Low Back Pain; SE, Standard Error;  
Statistical tests: χ², Likelihood ratio Chi-square; Wald test chi-square distribution;  
 
9.3.5.5 Marital status across nations 
In Chapter 7, Section 7.6 the variables of marital status, education and employment 
were examined for their possible impact on QoL as in the literature they have been 
found to have an effect on QoL (Chapter 2). For the pooled group no difference was 
found in the QoL between people who were married or in a relationship and those 
who were single/divorced/widowed. Similarly, they did not perceive their self-rated 
health differently. The interaction effect between the country of residence in 
combination with marital status did not predict QoL; effect on the EQ-5D index: 
p=0.51, (F=0.66, η²=0.0033, two-way ANOVA, n=194); effect on the EQ-VAS: p=0.55, 
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(F=0.57, η²=6.073, two-way ANOVA, n=194). Within the groups from each country, 
people within and without a relationship replied very similarly on all five health status 
dimensions and no major differences were noticed (Appendix 9: Table 9.c.3.11). 
Indeed, scoring of the EQ-5D dimensions confirmed that within each group from the 
three countries people in or not in a relationship did not differ on their QoL reports 
either on the classification of their health status or on their self-rated perception of 
their health (Appendix 9: Table 9.c.3.14).  
 
9.3.5.6 Level of education across nations 
Previously examining the pooled group it was found that people with better education 
differed in their QoL compared to people with lower levels of education (Chapter 7, 
Section 7.6). The interaction effect between the level of education and country of 
residence was found to be significant but did not to pass the Bonferroni α-level of 
correction; effect on EQ-5D index: p=0.006, (F=3.16, η²=0.0434, Two-way ANOVA, 
n=196); effect on the EQ-VAS: p=0.04, (F=2.23, η²=0.00694, Two-way ANOVA, n=196. 
Within each group from the three countries but also between the countries, those 
with higher levels of education did not seem to differ on the five health status 
dimensions from those with lower levels of education. However, for the UK group, it 
seemed that less people with increased severity of mobility would get a good level of 
education compared to people from the USA (Appendix 9: Table 9.c.3.12). Scoring of 
the EQ-5D dimensions showed that people with different education levels did not 
differ in their EQ-5D index either in their health status classification or their perception 
within any national group. Education level did not significantly affect perception of 
self-rated health for people from any of the three groups (Appendix 9: Table 9.c.3.15).  
 
9.3.5.7 Employment across nations 
Earlier, in the analysis of the pooled group, it was found that employed people 
classified and perceived their health status as significantly better than unemployed and 
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retired people (Chapter 7, Section 7.6). The country in which respondents lived in 
combination with their employment status did not affect their QoL; interaction effect 
on EQ-5D index: p=0.78, (F=0.43, η²=0.0040, Two-way ANOVA, n=197); interaction 
effect on EQ-VAS: p=0.17, (F=0.16, η²=0.0031, Two-way ANOVA, n=197). Within all 
three groups from the individual countries, people employed, unemployed and retired 
reported some problems with mobility. It was noticed that within the UK group all 
people with severe mobility issues were unemployed, which was not the case for the 
other two countries. In the USA group, more people who were employed reported not 
having any problems with “anxiety/depression” (Appendix 9: Table 9.c.3.13). Scoring of 
the EQ-5D dimensions showed that though people in employment scored better on 
their QoL, the differences were not significant. When people reported on how they 
perceived their self-rated health no significant differences were found between people 
employed, unemployed or retired. However, employed Greeks seem to have a much 
better perceived self-rated health than retired people.  
 
9.3.6 QoL across nations; relation to pain/LBP days, free weeks, 
onset 
The earlier analysis of the pooled group showed that the more LBP days felt in the 
month the worse the QoL (Chapter 7, Section 7.7). Though there were differences in 
the EQ-5D dimensions within the groups from the three countries, as a rule those who 
had LBP for more days reported more severe problems with the dimensions (Appendix 
9: Table 9.c.4.1). Another earlier finding for the pooled group was that as the 
frequency of LBP-free weeks decreased so did health status (Chapter 7, Section 7.7). 
The country of residence in combination with LBP days did not affect health status; 
interaction effect between LBP days felt per month and country of residence on the 
EQ-5D index: p=0.99, (F=0.10, η²=0.0021, two-way ANOVA, n=139); on EQ-VAS: p=0.40, 
(F=1.03, η²=0.0051, two-way ANOVA, n=127). Similarly, the interaction effect between 
the number of pain days felt per month and country on QoL was not significant; on EQ-
5D index: p=0.71, (F=0.61, η²=0.0101, two-way ANOVA, n=177); on EQ-VAS: p=0.99, 
(F=0.42, η²=0.0033, two-way ANOVA, n=177). Within each national group none of the 
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correlations were statistically significant but they were all negative and moderate to 
strong particularly in relation to the perception of health (Table 9.3.4). The correlation 
between pain days and health status gave similar findings (Table 9.3.4).  
The frequency of pain (in general) breaks (Appendix 9: Table 9.c.4.2) also had a 
moderate to strong correlation with QoL and, in the case of the UK group, it was highly 
statistically significant for perception of self-rated health (p≤0.001, ρ=-0.53, 
Spearman’s ρ, n=40) (Table 9.3.4). The country of residence in combination with the 
frequency of the LBP-free weeks did not impact on QoL; interaction effect between 
LBP-free weeks and country of residence on the EQ-5D: p=0.54, (F=0.88, η²=0.0355, 
two-way ANOVA, n=116); interaction on perceived self-rated health: p=0.54, (F=0.88, 
η²=0.0348, two-way ANOVA, n=116). The same was found for the pain-free week; 
interaction between pain-free weeks and country of residence on the EQ-5D: p=0.51, 
(F=0.92, η²=0.026, two-way ANOVA, n=166); interaction on EQ-VAS: p=0.52, (F=0.84, 
η²=0.0051, two-way ANOVA, n=166) (see also Appendix 9: Tables 9.c.4.3 and 9.c.4.4. 
Finally, earlier analysis done as part of the second hypothesis theme showed that the 
earlier the LBP onset after iSCI, the worse the health status classification and the self-
rated health perception. Here no significant interaction effect was found between LBP 
onset and country of residence on the EQ-5D index: p=0.69, (F=0.69, η²=0.0225, two-
way ANOVA, n=131); or EQ-VAS: p=0.46, (F=0.96, η²=0.0071, two-way ANOVA, n=131). 
There was also no significant interaction effect between pain onset and country of 
residence on the EQ-5D index: p=0.64, (F=0.74, η²=0.0037, two-way ANOVA, n=171); 
or the EQ-VAS: p=0.35, (F=1.1, η²=0.057, two-way ANOVA, n=171) (see also Appendix 
9: Tables 9.c.4.5-9.c.4.7).  
Hypothesis five has now been made as: 
Hypothesis 0 (null): In people with iSCI there is no significant correlation between QoL 
(EQ-5D index or EQ-VAS) and the onset of pain or LBP post iSCI for each national group. 
Hypothesis 5a: In people with iSCI there is a significant correlation between QoL (EQ-
5D index or EQ-VAS) and the onset of pain post iSCI for each national group. 
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Hypothesis 5b: In people with iSCI there is a significant correlation between QoL (EQ-
5D index or EQ-VAS) and the onset of LBP post iSCI for each national group. 
Examining each country group separately no significant correlations either between 
pain or LBP onset post iSCI and the EQ-5D index were found and the strength of the 
correlations were small. Relationships were stronger between pain or LBP onset, post 
iSCI, and perceived self-rated health within all groups, and for the USA group it 
reached a significant level in the case of LBP onset (Table 9.3.4).  
Table 9.3.4: Correlations between pain or LBP days or free weeks or onset (post iSCI) 
and health status within each national group 
 
1not significant post Bonferroni correction; *Significant at p≤0.05 level, **Significant at p≤0.01 
level, ***Significant at p≤0.001 level, in bold: significant following application of the 
Bonferroni correction;  
Abbreviations: EQ-5D, Quality of Life, EQ-VAS, Quality of Life Visual Analogue Scale; iSCI, 
incomplete Spinal Cord Injury; LBP, Low Back Pain.  
Statistical tests: ρ, Spearman’s rank correlation rho. 
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9.3.7 QoL  across nations; relation to pain extent 
Previous analysis (Chapter 7, Section 7.8) found a decrease in the QoL (both EQ-5D and 
EQ-VAS) when the number of painful areas on the body increased but not significantly. 
The interaction effect between the number of areas with pain and country of 
residence on either EQ-5D or EQ-VAS was not significant; on EQ-5D: p=0.19, (F=1.34, 
η²=0.0453, two-way ANOVA, n=174); on EQ-VAS: p=0.24, (F=1.27, η²=0.0093, two-way 
ANOVA, n=174). Examining each group from the individual countries, it was found that 
the correlation was significant for the USA group for EQ-5D index: p≤0.001, (r=-0.31, 
Pearson’s correlation, n=101) (Table 9.3.5; Appendix 9: Table 9.c.5.1).  
 
Table 9.3.5: Correlations between the number of areas with pain and EQ-5D  
or EQ-VAS within each national group 
 USA UK GR 
EQ-5D Index  r=-0.31 
p≤0.001***, n=101 
r=-0.07 
p=0.63, n=41 
ρ=-0.05 
p=0.75, n=32 
EQ-VAS r=-0.28 
p=0.004¹, n=101 
r=0.03 
p=0.83, n=41 
r=-0.33 
p=0.06, n=32 
1not significant post Bonferroni correction; ***Significant at p≤0.001 level,  
in bold: significant following application of the Bonferroni correction;  
Abbreviations: EQ-5D, Quality of Life, EQ-VAS, Quality of Life Visual Analogue Scale.  
Statistical tests: r, Pearson’s correlation; ρ, Spearman’s rank correlation rho. 
 
 
9.3.8 QoL across nations; relation to quality and intensity of LBP 
Part of the third hypothesis theme was to examine the relationship between LBP 
quality and intensity and QoL, which here was examined within and between the 
groups from each country. It was noticed that as the quality of LBP became worse so 
did the level of severity of the health status dimensions. “Anxiety/depression” seemed 
to increase a lot for the UK group when the affective dimension of LBP became worse. 
For the same group mobility also became more severe when the total PRI of LBP 
became worse (Figures 9.3.11-9.3.13).  
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Figure 9.3.11: Mean sensory dimension of LBP reported by people, divided 
 in groups by country, for each level of the EQ-5D dimensions 
 
 
 
Figure 9.3.12: Mean affective dimension of LBP reported by people, divided  
in groups by country, for each level of the EQ-5D dimensions  
Abbreviations: EQ-5D, Quality of Life; PRI, Present Rating Index 
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Figure 9.3.13: Mean total PRI of LBP reported by people, divided in groups  
by country, for each level of the EQ-5D dimensions 
Abbreviations: EQ-5D, Quality of Life; PRI, Present Rating Index. 
 
 
The relationship between QoL and LBP quality and intensity was hypothesised 
(hypotheses 10 & 11) as following:  
Hypothesis 0 (null): In people with iSCI there is no significant correlation between QoL 
(EQ-5D index or EQ-VAS) and quality (sensory, affective or total PRI) of LBP for each 
national group.  
Hypothesis 10a: In people with iSCI there is a significant correlation between QoL (EQ-
5D index or EQ-VAS) and sensory dimension of LBP for each national group.  
Hypothesis 10b: In people with iSCI there is a significant correlation between QoL (EQ-
5D index or EQ-VAS) and affective dimension of LBP for each national group.  
Hypothesis 10c: In people with iSCI there is a significant correlation between QoL (EQ-
5D index or EQ-VAS) and total PRI of LBP for each national group.  
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Hypothesis 0 (null): In people with iSCI there is no significant correlation between QoL 
(EQ-5D index or EQ-VAS) and intensity of LBP (on the NRS or evaluative) for each 
national group. 
Hypothesis 11a: In people with iSCI there is a significant correlation between QoL (EQ-
5D index or EQ-VAS) and intensity of current LBP for each national group. 
Hypothesis 11b: In people with iSCI there is a significant correlation between QoL (EQ-
5D index or EQ-VAS) and intensity of LBP over the last one month for each national 
group. 
Hypothesis 11c: In people with iSCI there is a significant correlation between QoL (EQ-
5D index or EQ-VAS) and intensity of LBP over the last three months for each national 
group. 
Hypothesis 11d: In people with iSCI there is a significant correlation between QoL (EQ-
5D index or EQ-VAS) and overall evaluative intensity of LBP (PPI) for each national 
group. 
It was confirmed that as the mean quality (sensory, affective and total PRI) of LBP 
became worse, people from the USA classified their health status as worse but it was 
only in the  affective dimension that the correlation passed the Bonferroni α-level of 
significance (Table 9.3.6). Within the same group, when the affective dimension of LBP 
became worse, people perceived their self-rated health as highly significantly worse 
too (Table 9.3.6).  
Analysis of the pooled data (Chapter 7, Section 7.9) showed that when intensity of LBP 
increases then QoL becomes worse. Here, it was found that the worse the intensity of 
LBP (intensity of current, of last one and three months and evaluative LBP), the worse 
the QoL for each individual national group. All correlations within each group 
confirmed that when the intensity of LBP increases then people classify and perceive 
their health status as worse. The strengths of the correlations were moderate to 
strong, despite on some occasions not being statistically significant (Table 9.3.7, Figure 
9.3.16). Finally, no significant interaction effect between country and evaluative PPI of 
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LBP on either the EQ-5D index or EQ-VAS was found; for EQ-5D: p=0.29, (F=1.22, 
η²=0.0228, two-way ANOVA, n=130); for EQ-VAS: p=0.19, (F=1.45, η²=0.0055, two-way 
ANOVA, n=130). 
 
Table 9.3.6: Correlations between quality of LBP and health status within each national 
group 
  USA UK GR 
EQ-5D Index  S-PRI r=-0.26, n=76 
p=0.02¹  
95%CI -0.44, -0.05 
r=-0.40, n=35 
p≤0.01¹  
95%CI -0.64, -0.09 
ρ=-0.20, n=30 
p=0.26, 95%CI  
-0.52, 0.17 
A-PRI r=-0.38, n=76 
p≤0.001*** 
95%CI -0.55, -0.19 
r=-0.25, n=35 
p=0.14, 95%CI  
-0.52, -0.08 
ρ=0.05, n=30 
p=0.77, 95%CI  
-0.31, 0.40 
Total PRI r=-0.29 , n=75 
p=0.009¹ 95%CI -
0.46, -0.08 
r=-0.20, n=33 
p=0.25, 95%CI  
-0.51, 0.15 
ρ=-0.21, n=30 
p=0.25, 95%CI  
-0.52, 0.17 
EQ-VAS S-PRI r=-0.23, n=76 
p=0.03¹  
95%CI -0.42, -0.02 
r=-0.27, n=35 
p=0.10, 95%CI  
-0.54, 0.06 
r=-0.18, n=30  
p=0.33, 95%CI  
-0.50, 0.19 
A-PRI r=-0.37, n=76 
p≤0.001*** 
95%CI -0.53, -0.17 
r=-0.21, n=35 
p=0.22, 95%CI  
-0.50, 0.12 
r=-0.17, n=30 
p=0.36, 95%CI  
-0.50, 0.20 
Total PRI r=-0.19, n=75 
p=0.09, 95%CI  
-0.38, 0.02 
r=-0.02, n=33 
p=0.88, 95%CI  
-0.36, 0.32 
ρ=-0.18, n=30 
p=0.32, 95%CI  
-0.50, 0.19 
1not significant post Bonferroni correction; in bold: significant following application of the 
Bonferroni correction;    
Abbreviations: EQ-5D, Quality of Life; EQ-VAS, Quality of Life Visual Analogue Scale; 
PRI, Present Rating Index; S-PRI, Sensory PRI; A-PRI, Affective PRI;  
Statistical tests: r, Pearson’s correlation; ρ, Spearman’s rank correlation rho. 
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Table 9.3.7: Correlations between intensity of LBP and health status within  
each national group 
Correlations between USA 
n=78 
UK 
n=32 
GR 
n=3 
Current LBP  With EQ-5D 
index 
r=-0.39, 
p≤0.001*** 
95%CI  
-0.55, -0.20 
r=-0.70, 
p≤0.001*** 
95%CI  
-0.83, -0.47 
n/a 
With EQ-VAS r=-0.38, 
p≤0.001*** 
95%CI  
-0.55, -0.19 
r=-0.49, p=0.003¹ 
95%CI  
-0.71, -0.18 
n/a 
LBP intensity 
last 1 month 
With EQ-5D 
index 
r=-0.35, 
p≤0.001*** 
95%CI  
-0.52, -0.15 
r=-0.58, 
p≤0.001*** 
95%CI  
-0.76, -0.30 
n/a 
With EQ-VAS r=-0.47, 
p≤0.001*** 
95%CI  
-0.46, -0.08 
r=-0.32, p=0.07 
95%CI  
-0.71, 0.18 
n/a 
LBP intensity 
last 3 months 
With EQ-5D 
index 
r=-0.29, 
p≤0.01¹ 
95%CI  
-0.56, -0.21 
r=-0.49, p=0.004¹ 
95%CI  
-0.57, 0.06 
n/a 
With EQ-VAS r=-0.40, 
p≤0.001*** 
r=-0.29, p=0.09 n/a 
Evaluative LBP 
intensity 
With EQ-5D 
index 
r=-0.37, n=71 
p≤0.001*** 
95%CI  
-0.55, -0.15 
r=-0.37, n=30 
p=0.03¹ 
95%CI  
-0.64, -0.01 
r=-0.39, 
n=29 
p≤0.001*** 
95%CI  
-0.64, -0.02 
 With EQ-VAS r=-0.47, n=71 
p≤0.001*** 
95%CI  
-0.63, -0.28 
r=-0.37, n=30 
p=0.04¹ 
95%CI  
-0.64, -0.01 
r=-0.34, 
n=29 
p=0.06 
95%CI  
-0.62, 0.02 
n/a: Data from the Greek group on the intensity of LBP was only given by three respondents 
thus will not be examined39. Data for the evaluative PPI intensity was used normally; 
1not 
significant post Bonferroni correction; **significant at p≤0.01; in bold: significant following 
application of the Bonferroni correction; Abbreviations: EQ-5D, Quality of Life; EQ-VAS, Quality 
of Life Visual Analogue Scale; LBP, Low Back Pain; PRI, Present Rating Index.  
Statistical tests: r, Pearson’s correlation. 
 
                                                     
39
 For an explanation of why there are only three respondents from Greece answering this question 
refer back to Chapter 6, Section 6.2.7. 
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Figure 9.3.14: Mean intensity score of current LBP reported by people,  
divided in groups per country, for each level of the EQ-5D dimensions. In the  
Greek group only 1 respondent reported being on level 1 or 2 and thus no mean  
score can be given for these two levels.  
Abbreviations: EQ-5D, Quality of Life; EQ-VAS, Quality of Life Visual Analogue Scale; PRI, 
Present Rating Index. 
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Part 4; SCIM III: Pain and function within and across 
nations 
 
9.4.1 Introduction 
This is the final section of this chapter which aims to explore the functional 
independence of the respondents within each of the three participating countries. This 
chapter will explore the relations between the experience of pain and function.  
In Chapter 8 as part of the procedure followed to validate the translation of GR-SCIM 
III, data from the Greek group was analysed separately to the rest of the data. To avoid 
duplicating information the Greek group will not be re-analysed here unless new data 
is examined. Referencing back to the previous chapter will be made as appropriate.  
 
9.4.2 Bonferroni correction 
For all three groups from the participating countries the main variables of interest 
were used in 25 different tests in the cross-national analysis thus the α-level of 
statistical significance set by Bonferroni was p≤0.002 (Appendix 9: Table 9.d.1.1).   
 
9.4.3 Function across nations; general results 
Among the three participating countries people from Greece reported the best 
functional independence (mean±SD 76.1±21.3) followed by people from the USA 
(67.4±20.5) and then the UK (61.1±20.4) (Figure 9.4.1; Table 9.4.1; Appendix 9: Table 
9.d.2.1). Greeks reported the best function score for all subscales apart from “self-
care” in which people from the USA scored better than all others (Table 9.4.1). The 
groups from the three participating countries differed significantly in three of the five 
function subscales; for “respiration and sphincter management”: p≤0.001, (F=10.7, 
One-way ANOVA, n=219); for “mobility indoors and outdoors”: p≤0.001, (F=7.26, One-
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way ANOVA, n=219); and for total SCIM: p=0.002, (F=6.35, One-way ANOVA, n=219). 
Post hoc analysis using Bonferroni showed that for the first two subscales people from 
Greece scored significantly better than people from both the USA and the UK and for 
the third subscale people from the USA scored better than from people the UK (Table 
9.4.1).  
 
 
 
 
 
 
 
 
 
 
Figure 9.4.1: Mean function scores and statistical differences in function  
between national group 
Abbreviation: SCIM, Spinal Cord Independence Measure.  
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Table 9.4.1: Characteristic of SCIM per country and differences between countries 
 USA UK Greece Between national groups  
Statistical Tests 
Self-care   
(range 0-20) 
15.7±5.2 13.4±5.7 14.5±5.1 p=0.03¹, F=3.36, n=219 
Respiration & 
sphincter 
management  
(range 0-40) 
29.8±7.4 27.4±7.7 34.3±7.5 p≤0.001***, F=10.7, n=219 
USAvsGR: I-J=-6.9, p≤0.001*** 
95%CI-10.6, -3.2 
UKvsGR: I-J=-6.9, p≤0.001*** 
95%CI-10.6, -3.2 
Mobility room 
and toilet  
(range 0-10) 
8.1±3.1 7.6±3.4 8.2±2.5 p=0.58, F=0.54, n=219 
 
Mobility indoors 
& outdoors  
(range 0-30) 
13.8±8.6 12.8±8.2 19.0±9.9 p≤0.001***, F=7.26, n=219 
USAvsGR: I-J=-5.1, p=0.03, 
95%CI-8.9, -1.4 
UKvsGR: I-J=-6.27, p=0.02* 
95%CI-810.6, -1.9 
Total SCIM  
(range 0-100) 
67.4±20.5 61.1±20.4 76.1±21.3 p=0.002**, F=6.36, n=219 
USAvsUK: I-J=-8.7, p=0.04* 
 95%CI-17.4, 14.5 
UKvsGR: I-J=-14.9, p≤0.01** 
95%CI-25.1, -4.8 
1not significant post Bonferroni correction; *Significant at p≤0.05 level, **Significant at p≤0.01 
level, ***Significant at p≤0.001 level, in bold: significant following application of the 
Bonferroni correction or Bonferroni post hoc;  
Abbreviation: SCIM, Spinal Cord Independence Measure.  
Statistical test: F, One-way ANOVA, I-J, Bonferroni Post hoc 
 
9.4.4 Function across nations; relation to demographic profile 
characteristics 
9.4.4.1 Gender across nations 
Earlier analysis (Chapter 8, Sections 8.1.5 and 8.2.4) found no gender differences for 
any of the subscales or the total SCIM for the Greek group or the combined data from 
the rest of the respondents. Using two-way ANOVA the country of residence in 
combination with gender could not predict function (Appendix 9: Table 9.d.3.6). 
Examining the data between groups from each country separately, females, overall, 
reported better function than males within the US and Greek groups and males better 
than females in the UK group. The group with the lowest total SCIM score was females 
from UK (57±19.8) (Appendix 8: Table 8.3.1; Appendix 9: Table 9.d.3.1). Within each 
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group from the three countries separately, females and males reported very similar 
function on the SCIM subscales (Appendix 9: Table 9.d.3.2). When function was 
examined based on the presence of MSKP within each gender no significant 
differences were found (Appendix 9. Table: 9.d.3.8, 9.d.3.9).  
 
9.4.4.2 Cause of injury across nations 
Earlier, no significant differences were found between people with traumatic and non- 
traumatic injury from Greece or the rest of the group on SCIM or its subscales (Chapter 
8, Sections 8.1.5 and 8.2.4). No significant interaction effect between cause of injury 
and country of residence on function was found (Appendix 9: Table 9.d.3.6). Within 
each national group separately, generally those with a non-traumatic injury had a 
better function. No group or subscale for people with traumatic and non-traumatic 
injury differed significantly in their mean function reports (Appendix 9: Table 9.d.3.2). 
Between countries, people from Greece with a non-traumatic injury reported better 
SCIM and its subscales (Appendix 9: Table 9.d.3.4).  
 
9.4.4.3 Level of injury 
Within each group, separately, those with paraplegia reported better function than 
those with tetraplegia (Appendix 9: Table 9.d.3.5) which matched earlier findings from 
the pooled data (Chapter 8, Sections 8.1.5 and 8.2.4). However, these differences 
reached significant levels only within the USA group (Table 9.4.2) in the case of 
“mobility in room and toilet”. For this subscale a significant difference was found for 
the pooled group. Between the groups from the three countries, people with 
paraplegia from Greece reported the best function of all respondents (total SCIM 
83.3±13.6) and people with tetraplegia from the UK the worst (total SCIM 55.6±25.6) 
(Appendix 9: Table 9.d.3.5). Finally, no significant interaction effect between the type 
of injury and country of residence on any of the subscales and the total SCIM was 
found (Appendix 9: Table 9.d.3.6). 
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Table 9.4.2: Differences on function between people with tetraplegia and paraplegia 
within each national group 
 Self-care   Respiration & 
sphincter 
management  
Mobility room 
and toilet  
Mobility 
indoors & 
outdoors  
Total SCIM  
USA 
n=122 
U=170.5 
p=0.07 
t=0.15, df119 
p=0.87 
95% CI -2.3, 2.6 
t=-3.71, df120 
p≤0.001*** 
95% CI -3.0, 0.9 
t=-0.59, df120 
p=0.55 
95% CI -4.0, 
2.1 
t=-2.14, df120 
p=0.03¹ 
95% CI -15.1,   
-0.6 
UK 
n=50 
U=195 
p=0.021 
 
t=-1.08, df46 
p=0.18 
95% CI -6.4, 1.9 
t=-2.65, df48 
p≤0.01¹ 
95% CI -4.2, 0.5 
U=1370.5 
p=0.005¹ 
t=-0.98, df48 
p=0.32 
95% CI -6.9, 
2.3 
t=-1.77, df48 
p=0.08 
95% CI -21.6, 
1.3 
Greece Refer back to Chapter 8, Table 8.2.6 
 1not significant post Bonferroni correction; ***Significant at p≤0.001 level; in bold: significant 
following application of the Bonferroni correction;  
Abbreviation: SCIM, Spinal Cord Independence Measure.  
Statistical tests: t, Independent t-test. 
 
 
9.4.4.4 Age and time since injury across nations 
Earlier it was found that either age or time since injury did not correlate significantly 
with function or its subscales (Chapter 8, Sections 8.1.5 and 8.2.4). Examining each 
group separately from all three countries also showed no significant correlation 
between age and total function or its subscales though, again, the direction of the 
correlations tended to show a decrease in function with an increase in age but the 
relation, was of small strength  (Appendix 9: Table 9.d.3.7). Increase in the time since 
injury correlated with an overall decrease in function which in no case was statistically 
significant and usually it was of small strength (Appendix 9: Table 9.d.3.7). However, 
the interaction effect between age and country of residence was significant on the 
total function score (p=0.001, Wald χ²=16.42, df3, n=211). In particular, the effect was 
that with increasing age, people from Greece were more likely to report better 
function (p=0.04. b=0.20, SE=0.09, Wald χ²=4.1, df1, n=50). Finally, the interaction 
effect between time since injury and country of residence on the total function score 
was not significant past the Bonferroni α-level (p=0.009, Wald χ²=11.60, df3, n=218). 
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9.4.5 Function across nations; relation to pain, LBP and MSKP 
Examining the interaction effect of pain, LBP or MSKP presence and living in one of the 
three participating countries on function was not significant (Table 9.4.3). Part of the 
first hypothesis theme was to investigate differences in function based on the 
presence or not of the pain categories under examination (hypothesis 3). 
The hypothesis was examined per group from each of the three countries:  
Hypothesis 0 (null): In people with iSCI there is no significant difference in the function 
(total SCIM or subscales) between those with pain, MSKP or LBP and those without, for 
each national group.  
Hypothesis 3a: In people with iSCI there is no significant difference in the function 
(total SCIM or subscales) between those with pain and those without, for each national 
group.  
Hypothesis 3b: In people with iSCI there is no significant difference in the function 
(total SCIM or subscales) between those with MSKP and those without, for each 
national group.  
Hypothesis 3c: In people with iSCI there is no significant difference in the function 
(total SCIM or subscales) between those with LBP and those without, for each national 
group.  
 Looking at the data for pain in general, interestingly, people with pain particularly 
from the USA and the UK scored better on total function and its subscales than people 
without pain (Appendix 9: Table 9.d.4.1, Appendix 8: Table 8.4.1) though the 
differences were not statistically significant (Table 9.4.4; Chapter 8: Table 8.2.7). 
Between the three groups, people with the best total function were those with no pain 
from Greece (Appendix 9: Table 9.d.4.1, Appendix 8: Table 8.4.1). Within each group, 
people without MSKP seemed to have better function overall than those with MSKP 
for the UK and Greek groups. However, in no case did those with and without MSKP 
differ significantly on their SCIM or subscale mean scores (Table 9.4.4; Chapter 8: Table 
8.2.7; Appendix 9: Tables 9.d.4.1; Appendix 8: Table 8.4.1). Finally, in the case of LBP, it 
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was noticed that in all three groups, people with LBP reported better function than 
those without LBP. However, this difference was again not significant within any 
country (Table 9.4.4; Chapter 8: Table 8.2.7; Appendix 9: Tables 9.d.4.1, Appendix 8: 
Table 8.4.1).  
 
Table 9.4.3: Interaction effect between country of residence and pain  
presence on function 
 Interaction effect 
of pain *country 
on DV  
Interaction effect 
of MSKP 
*country on DV  
Interaction effect 
of LBP *country on 
DV  
Self-care   F=3.27, p=0.04¹  
η²=0.0034 
n=219 
F=0.44, p=0.63  
η²=0.0005 
n=213 
F=0.05, p=0.95  
η²=0.00005 
n=210 
Respiration & 
sphincter 
management  
F=4.37, p≤0.01¹  
η²=0.0022 
n=219 
F=1.02, p=0.36  
η²=0.00056 
n=213 
F=0.41, p=0.66  
η²=0.00020 
n=210 
Mobility room 
and toilet  
F=6.24, p=0.02¹  
η²=0.0070 
n=219 
F=0.37, p=0.69  
η²=0.0004 
n=213 
F=0.95, p=0.38  
η²=0.0011 
n=210 
Mobility indoors 
& outdoors 
F=1.66, p=0.19  
η²=0.0039 
n=219 
F=0.57, p=0.56  
η²=0.0013 
n=213 
F=0.07, p=0.92  
η²=0.00017 
n=210 
Total SCIM  F=4.65, p≤0.01¹  
η²=0.0034 
n=219 
F=0.76, p=0.46  
η²=0.0005 
n=212 
F=0.01, p=0.99  
η²=0.000007 
n=210 
1not significant post Bonferroni correction;  
Abbreviation: SCIM, Spinal Cord Independence Measure.  
Statistical test: F, Two-way ANOVA. 
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Table 9.4.4: Differences in function between groups with and without pain, LBP, or 
MSKP per country   
 Self-care 
subscale 
 
Respiration & 
sphincter 
management 
Mobility room 
& toilet 
Mobility 
indoors & 
outdoors 
Total SCIM 
 
USA      
Pain 
n=122  
U=370.5 
p=0.71  
ES: r=0.03 
U=323.5 
p=0.38  
ES: r=0.07 
U=364.5  
p=0.63  
ES: r=0.04 
U=379 
p=0.79  
ES: r=0.02 
U=348  
p=0.54  
ES: r=0.05 
Current 
LBP 
n=166 
U=1397.5  
p=0.53  
ES: r=0.07 
t=-1.03, df114  
p=0.30 
95%CI -4.0, 1.2 
ES: d=0.20 
U=1460.5  
p=0.78  
ES: r=0.02 
t=-0.98, df114  
p=0.32 
95%CI -5.0, 1.6 
ES: d=0.18 
t=-1.38, df113  
p=0.16 
95%CI -12.7, 
2.2, ES: d=0.25 
MSKP 
n=120 
t=-1.18, df118  
p=0.24 
95%CI -3.3, 0.8 
ES: d=0.22 
t=-0.8, df117  
p=0.41 
95%CI -3.7, 1.5 
ES: d=0.14 
t=-1.52, df118  
p=0.13 
95%CI -2.0, 0.2 
ES: d=0.30 
t=-1.16, df118  
p=0.24 
95%CI -5.1, 1.3 
ES: d=0.22 
t=-1.24, df117  
p=0.21 
95%CI -12.1, 
2.7, ES: d=0.24 
UK      
Pain 
n=52  
U=5.5 
p=0.03¹  
ES: r=0.29 
U=6.5 
p=0.03¹  
ES: r=0.28 
U=4.0  
p=0.02¹ 
ES: r=0.32 
U=4.0 
p=0.02¹  
ES: r=0.30 
U=1.5  
p=0.02¹  
ES: r=0.31 
Current 
LBP 
n=52 
U=270 
p=0.10  
ES: r=0.01 
t=0.40, df49  
p=0.68 
95%CI -3.8, 5.8 
ES: d=0.12 
U=212.5  
p=0.20,  
ES: r=0.17 
t=-0.74, df49 
p=0.46 
95%CI -7.0, 3.2 
ES: d=0.21 
t=-0.66, df49  
p=0.51 
95%CI -16.9, 
8.5, ES: d=0.17 
MSKP 
n=51 
t=-0.04, df49  
p=0.96 
95%CI -3.3, 3.2 
ES: d=0.01 
t=0.50, df49  
p=0.61 
95%CI -3.3, 5.5 
ES: d=0.15 
U=302.5 
p=0.74  
ES: r=0.04 
t=-0.22, df49  
p=0.82 
95%CI -5.2, 4.2 
ES: d=0.05 
U=314 
p=0.92  
ES: r=0.01 
Greece Refer back to Chapter 8, Section 8.2.8 
 1not significant post Bonferroni correction;  
Abbreviation: SCIM, Spinal Cord Independence Measure; LBP, Low Back Pain; MSKP, 
Musculoskeletal Pain.  
Statistical tests: U, Mann-Whitney U test; t, Independent t-test. 
 
9.4.6 Function across nations; relation to pain/LBP days, free 
weeks, onset 
Previous analysis did not find any statistically significant changes in function when 
there was an increase in the number of pain or LBP days felt in a month for the Greek 
or the pooled group (Chapter 8, Sections 8.1.7 and 8.2.6). Analysis for each national 
group separately confirmed that an increase in the number of LBP days felt in the 
month did not correlate significantly with a change in function score (Table 9.4.5). 
People who had more pain days were more likely to report worse function scores but 
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the correlations were not statistically significant although,  occasionally, correlations 
were of moderate strength and for the Greek group they were of high strength (Table 
9.4.5; Appendix 8: Table 8.5.2). In addition, no significant interaction effects were 
found between the country of residency and the number of LBP days or the frequency 
of LBP breaks on the total function score or any of its subscales (Table 9.4.6). 
Overall, for each individual country, the frequency of LBP-free weeks did not correlate 
significantly with changes in function. The only significant correlation was within the 
UK group in the case of “self-care” (p=0.002, ρ=-0.55, Spearman’s ρ, n=27) (Table 
9.4.5). Correlations for the UK and the Greek group, despite not being statistically 
significant, were often strong and this should be taken into account for the practical 
significance.  
Examining function in relation to pain or LBP onset post iSCI the country of residence in 
combination with pain or LBP onset did not affect the total function or any of its 
subscales (Tables 9.4.6 and 9.4.7). Finally, the relationship between pain or LBP onset, 
post iSCI, and function was part of the second hypotheses theme (hypothesis 7) and is 
here tested per each group from the individual countries.  
Hypothesis 0 (null): In people with iSCI there is no significant correlation between 
function (total SCIM and subscales) and the onset of pain or LBP, post iSCI, for each 
national group. 
Hypothesis 7a: In people with iSCI there is a significant correlation between function 
(total SCIM and subscales) and the onset of pain, post iSCI, for each national group. 
Hypothesis 7a: In people with iSCI there is a significant correlation between function 
(total SCIM and subscales) and the onset of LBP, post iSCI, for each national group. 
Three things were noticed during the analysis of these correlations. First, only one 
correlation was statistically significant and this was within the Greek group between 
LBP onset and “mobility in room and toilet” (p≤0.001, φ=0.75, Phi correlation, n=29). 
Second, within the USA and the UK groups the strength of the correlations were weak, 
particularly within the UK group, whereas within the Greek group the strength of the 
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correlations was very high. Finally, within the USA and UK groups the direction of the 
correlations was negative, which meant that the earlier the pain or LBP onset the 
better the function of the respondent, possibly showing a functional adjustment to the 
presence of pain or LBP. However, the opposite was found within the Greek group 
where the direction of the correlations was positive, thus the earlier the pain or LBP 
onset, post iSCI, the worse the function (Table 9.4.5).  
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Table 9.4.5: Correlations between function and pain/LBP onset port iSCI or pain/LBP days felt per month or frequency  
of pain/LBP free weeks within each national group   
 
1not significant post Bonferroni correction; **Significant at p≤0.01 level; in bold: significant following application of the Bonferroni correction;  
Abbreviation: SCIM, Spinal Cord Independence Measure; LBP, Low Back Pain.  
Statistical tests: ρ, Spearman’s rank correlation rho
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Table 9.4.6: Interaction effects between country of residence and LBP days or  
LBP-free weeks or LBP onset post iSCI on function 
 Interaction effect 
of LBP days 
*country on DV  
Interaction effect 
of LBP free weeks 
*country on DV  
Interaction effect of 
LBP onset post iSCI 
*country on DV  
Self-care   F=0.54, p=0.77  
η²=0.0020 
n=151 
F=0.91, p=0.51  
η²=0.00593 
n=123 
F=0.38, p=0.92  
η²=0.00223 
n=142 
Respiration & 
sphincter 
management  
F=0.37, p=0.89  
η²=0.0008 
n=151 
F=0.33, p=0.96  
η²=0.00136 
n=123 
F=0.90, p=0.51  
η²=0.00259 
n=142 
Mobility room 
and toilet  
F=0.48, p=0.82  
η²=0.00169 
n=151 
F=0.30, p=0.97  
η²=0.00192 
n=123 
F=0.54, p=0.81  
η²=0.0029 
n=142 
Mobility indoors 
& outdoors  
F=1.87, p=0.09  
η²=0.01628 
n=151 
F=2.08, p=0.03¹  
η²=0.0301 
n=123 
F=1.66, p=0.19  
η²=0.0039 
n=142 
Total SCIM  F=0.88, p=0.50  
η²=0.00243 
n=151 
F=0.81, p=0.60  
η²=0.00385 
n=123 
F=0.48, p=0.86  
η²=0.0019 
n=142 
1not significant post Bonferroni correction;  
Abbreviation: SCIM, Spinal Cord Independence Measure.  
Statistical test: F, Two-way ANOVA. 
 
9.4.7 Function across nations; relation to pain extent 
Previous analysis (Chapter 8, Sections 8.1.8 and 8.2.7) found no significant relationship 
between the number of painful areas on the body and function. This was confirmed when 
examining data within the groups from each country (Appendix 9: Table 9.d.5.1). In 
addition, using two-way ANOVA the interaction effect between the number of areas with 
pain and the country of residence on total function or its subscales was not found to be 
significant (Appendix 9: Table 9.d.5.1).  
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Table 9.4.7: Interaction effects between country of residence and pain days  
or pain-free weeks or pain onset post iSCI on function 
 Interaction 
effect of pain 
days *country 
on DV - Two-
way ANOVA  
Interaction effect 
of pain free weeks 
*country on DV - 
Two-way ANOVA  
Interaction effect of 
pain onset post iSCI 
*country on DV - 
Two-way ANOVA  
Self-care   F=1.98, p=0.18  
η²=0.0004 
n=163 
F=0.15, p=0.97  
η²=0.0006 
n=152 
F=1.31, p=0.26  
η²=0.0036 
n=154 
Respiration & 
sphincter 
management  
F=0.82, p=0.48  
η²=0.0008 
n=163 
F=0.25, p=0.93  
η²=0.0005 
n=152 
F=0.47, p=0.75  
η²=0.0007 
n=154 
Mobility room 
and toilet  
F=1.93, p=0.12  
η²=0.0044 
n=163 
F=0.27, p=0.92  
η²=0.0012 
n=152 
F=0.74, p=0.56  
η²=0.0024 
n=154 
Mobility indoors 
& outdoors  
F=0.36, p=0.77  
η²=0.0018 
n=163 
F=0.68, p=0.63  
η²=0.0064 
n=152 
F=2.04, p=0.09  
η²=0.0013 
n=154 
Total SCIM  F=1.28, p=0.28  
η²=0.0019 
n=163 
F=0.11, p=0.98  
η²=0.0003 
n=152 
F=1.65, p=0.16  
η²=0.0003 
n=154 
Abbreviation: SCIM, Spinal Cord Independence Measure.  
Statistical test: F, Two-way ANOVA. 
 
9.4.8 Function across nations; relation to quality and intensity of 
LBP 
Part of the third hypothesis theme was an examination of the relationships between 
quality and intensity of LBP and function (hypotheses 12 & 13). Previous analysis found no 
significant correlations between quality or intensity of LBP and function when the pooled 
group was examined though the correlation with increased intensity was stronger and 
always negative (Chapter 8: Tables 8.2.10, 8.2.11, 8.2.8.1 and 8.2.8.2). The combination of 
total function and where respondents resided did not have a significant effect on either 
the quality or the intensity of LBP (Table 9.4.8). 
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Table 9.4.8: Interaction effects of country of residence and total  
function on quality or intensity of LBP 
 Interaction effect of total SCIM  *country on DV  
S-PRI   p=0.01¹, n=152, Wald χ²=10.62, df3,  
Likelihood ration χ²=10.26, df3, p=0.016¹ 
A-PRI  p=0.01¹, n=152, Wald χ²=10.62, df3,  
Likelihood ration χ²=10.26, df3, p=0.016¹ 
Total PRI p=0.01¹, n=152, Wald χ²=10.62, df3,  
Likelihood ration χ²=10.26, df3, p=0.016¹ 
Intensity 
current LBP  
p=0.01¹, n=152, Wald χ²=10.62, df3,  
Likelihood ration χ²=10.26, df3, p=0.016¹ 
Intensity LBP 
over 1 month  
p=0.01¹, n=152, Wald χ²=10.62, df3,  
Likelihood ration χ²=10.26, df3, p=0.016¹ 
Intensity LBP 
over 3 months 
p=0.01¹, n=152, Wald χ²=10.62, df3,  
Likelihood ration χ²=10.26, df3, p=0.016¹ 
Evaluative PPI 
intensity of LBP 
p=0.01¹, n=152, Wald χ²=10.62, df3,  
Likelihood ration χ²=10.26, df3, p=0.016¹ 
¥The Greek group was excluded due to insufficient data;  
¹not significant post Bonferroni correction,  
Abbreviations: MSKP, Musculoskeletal Pain; LBP, Low Back Pain; SE, Standard Error;  
Statistical tests: χ², Likelihood ratio Chi-square; Wald test chi-square distribution;  
 
The hypotheses across nations were:  
Hypothesis 0 (null): In people with iSCI there is no significant correlation between 
function (total SCIM and subscales) and quality (sensory, affective or total PRI) of LBP, for 
each national group.  
Hypothesis 12a: In people with iSCI there is a significant correlation between function 
(total SCIM and subscales) and sensory dimension of LBP, for each national group.  
Hypothesis 12b: In people with iSCI there is a significant correlation between function 
(total SCIM and subscales) and affective dimension of LBP, for each national group.  
Hypothesis 12a: In people with iSCI there is a significant correlation between function 
(total SCIM and subscales) and total PRI of LBP, for each national group.  
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Hypothesis 0 (null): In people with iSCI there is no significant correlation between 
function (total SCIM and subscales) and intensity of LBP, for each national group.  
Hypothesis 13a: In people with iSCI there is a significant correlation between function 
(total SCIM and subscales) and intensity of current LBP, for each national group.  
Hypothesis 13b: In people with iSCI there is a significant correlation between function 
(total SCIM and subscales) and intensity LBP over the last one month, for each national 
group.  
Hypothesis 13c: In people with iSCI there is a significant correlation between function 
(total SCIM and subscales) and intensity LBP over the last three months, for each national 
group.  
Hypothesis 13d: In people with iSCI there is a significant correlation between function 
(total SCIM and subscales) and evaluative PPI of LBP, for each national group.  
All correlations maintained a negative direction, thus the worse the quality or intensity of 
LBP, the worse the function. This was true across all three national groups (Table 9.4.9, 
Chapter 8: Tables 8.2.10 and 8.2.11). Overall correlations between function and quality of 
LBP remained not significant and weak. The correlation between LBP intensity and 
function was stronger within each group, as found for the total group, and within the UK 
and the Greek groups statistically significant too, on some occasions involving the 
subscales of “self-care”, “mobility” and total function (Table 9.4.9).  
In each country, people who reported higher LBP intensity (current or over the last one or 
three months) also reported significantly lower total function and most of the SCIM 
subscales (Table 9.4.10). This was not though, the result found in the case of the 
evaluative overall PPI of LBP as for the USA group no correlation between function and PPI 
was found, and for the UK group it was found only for the “mobility in room & toilet” 
subscale (Table 9.4.10) but for the Greek group it was significant for “self-care”, “mobility 
indoors & outdoors” and total SCIM.  
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Table 9.4.9: Correlations between function and quality of LBP within each national group  
  Self-care 
subscale 
 
Respiration & 
sphincter 
management 
Mobility 
room & 
toilet 
Mobility 
indoors & 
outdoors 
Total SCIM 
 
       
S-PRI USA 
n=60 
r=0.07 
p=0.56 
95%CI -0.18,  
0.31 
r=-0.08 
p=0.49 
95%CI -0.32,  
0.17 
r=0.02 
p=0.83 
95%CI -0.23,  
0.27 
r=-0.01 
p=0.92 
95%CI -0.20,  
0.24 
r=-0.01 
p=0.89 
95%CI -0.20,  
0.24 
UK 
n=29 
r=-0.39 
p=0.03¹  
95%CI -0.65,  
-0.04 
r=-0.15 
p=0.43 
95%CI -0.48,  
0.21 
r=-0.27 
p=0.15 
95%CI -0.57,  
0.10 
r=-0.31 
p=0.09 
95%CI -0.60,  
0.05 
r=-0.37 
p=0.03¹ 
95%CI -0.64,  
-0.01 
Greece Refer to Chapter 8, Table 8.2.10   
A-PRI USA 
n=60 
r=-0.08 
p=0.50 
95%CI -0.32,  
0.17 
r=-0.12 
p=0.32 
95%CI -0.36,  
0.13 
r=-0.12 
p=0.34 
95%CI -0.36,  
0.13 
r=0.02 
p=0.84 
95%CI -0.23,  
0.27 
r=-0.07 
p=0.54 
95%CI -0.18,  
0.31 
UK 
n=29 
r=-0.36 
p=0.052 
95%CI -0.63,  
0.00 
r=-0.10 
p=0.58 
95%CI -0.44,  
0.27 
r=-0.24 
p=0.20 
95%CI -0.55,  
0.13 
r=-0.27 
p=0.18 
95%CI -0.57,  
0.10 
r=-0.31 
p=0.10 
95%CI -0.60,  
0.05 
Greece Refer to Chapter 8, Table 8.2.10   
Total 
PRI 
USA 
n=59 
r=0.02 
p=0.84 
95%CI -0.23,  
0.27 
r=-0.16 
p=0.20 
95%CI -0.39,  
0.09 
r=-0.04 
p=0.73 
95%CI -0.29,  
0.21 
r=-0.02 
p=0.87 
95%CI -0.23,  
0.27 
r=-0.07 
p=0.56 
95%CI -0.31,  
0.18 
UK 
n=28 
r=-0.35 
p=0.06 
95%CI -0.64,  
0.03 
r=0.005 
p=0.98 
95%CI -0.36,  
0.36 
r=-0.26 
p=0.16 
95%CI -0.57,  
0.13 
r=-0.28 
p=0.14 
95%CI -0.59,  
0.11 
r=-0.28 
p=0.14 
95%CI -0.59,  
0.11 
Greece Refer to Chapter 8, Table 8.2.10   
¹not significant post Bonferroni correction;  
Abbreviation: SCIM, Spinal Cord Independence Measure; PRI, Present Rating Scale.  
Statistical tests: r, Pearson’s correlation. 
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Table 9.4.10: Correlations between function and intensity of LBP within each national 
group  
  Self-care 
subscale 
 
Respiration & 
sphincter 
management 
Mobility 
room & 
toilet 
Mobility 
indoors & 
outdoors 
Total SCIM 
 
       
Current 
LBP 
Intensity 
USA 
n=61 
r=-0.23 
p=0.74 
r=-0.29 
p=0.02¹ 
r=-0.28 
p=0.02¹ 
r=-0.16 
p=0.19 
r=-0.28 
p=0.02¹ 
UK 
n=27 
r=-0.54 
p=0.03¹ 
ρ=0.5 
p=0.008¹  
r=-0.22 
p=0.25 
ρ=-0.22 
p=0.26  
r=-0.43 
p=0.002** 
ρ=-0.58 
p≤0.001*** 
r=-0.45 
p≤0.01¹ 
ρ=-0.46 
p=0.01¹ 
r=-0.53 
p=0.004¹ 
ρ=-0.59 
p≤0.001 *** 
Greece Refer to Chapter 8, Table 8.2.11   
LBP 
intensity 
last 1 
month 
USA 
n=61 
r=-0.17 
p=0.17 
r=-0.24 
p=0.057 
r=-0.19 
p=0.13 
r=-0.01 
p=0.91 
r=-0.17 
p=0.17 
UK 
n=25 
r=-0.55 
p=0.004*** 
r=-0.08 
p=0.68 
r=-0.46 
p≤0.01¹ 
r=-0.40 
p=0.04¹ 
r=-0.47 
p≤0.01¹ 
Greece Refer to Chapter 8, Table 8.2.11   
LBP 
intensity 
last 3 
month 
USA 
n=60 
r=-0.07 
p=0.58 
r=-0.22 
p=0.08 
r=-0.06 
p=0.63 
r=0.10 
p=0.43 
r=-0.07 
p=0.58 
UK 
n=25 
r=-0.43 
p=0.002** 
r=-0.006 
p=0.97 
r=-0.46 
p=0.02¹ 
r=-0.39 
p=0.051 
r=-0.40 
p=0.04¹ 
Greece Refer to Chapter 8, Table 8.2.11   
Evaluativ
e PPI of 
LBP 
USA 
n=54 
r=-0.09 
p=0.49 
r=-0.22 
p=0.10 
r=-0.08 
p=0.55 
r=0.13 
p=0.34 
r=-0.06 
p=0.63 
 UK 
n=25 
r=-0.36 
p=0.07 
r=-0.12 
p=0.54 
r=-0.49 
p≤0.01¹ 
r=-0.28 
p=0.16 
r=-0.35 
p=0.07 
 Greece Refer to Chapter 8, Table 8.2.11   
1not significant post Bonferroni correction; in bold: significant following application of the 
Bonferroni correction;  
Abbreviation: SCIM, Spinal Cord Independence Measure; LBP, Low Back Pain; PPI, Present Pain 
Intensity.  
Statistical test: r, Pearson’s correlation. 
 
9.4.9 Function across nations; relation to QoL  
Previous analysis found that the correlation between function and QoL was positive, 
strong and highly statistically significant for the EQ-5D index; people who reported worse 
function also reported worse health status classification (Chapter 8: Table 8.2.12). Here, 
examining the US and UK groups and previously the Greek group (Chapter 8, Table 8.2.12) 
separately, it was found that in all cases the correlations were positive, moderate or 
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strong and highly statistically significant for classification of health status (Table 9.4.11). In 
the case of perception of health status, as function got worse, people also perceived their 
scored health status as worse but not significantly and the correlations were of small 
strength (Table 9.4.11). Consequently, the original results between function and QoL are 
maintained within each individual group from the three participating countries. Finally, 
when examining interaction effects some significant differences were found (Table 
9.4.12). It was found that as function improves, people from the USA, the UK and Greece 
were more likely to classify themselves as better on health status (Table 9.4.12). Also, it 
was found that as function improves people from the USA were more likely to perceive 
their health status as better(Table 9.4.12).  
 
Table 9.4.11: Correlations between health status and function within each national group 
  Self-care 
subscale 
 
Respiration 
& sphincter 
management 
Mobility 
room & 
toilet 
Mobility 
indoors & 
outdoors 
Total SCIM 
 
USA 
n=113 
 
EQ-5D 
Index  
 
r=0.46 
p≤0.001*** 
r=0.36 
p≤0.001*** 
r=0.48 
p≤0.001*** 
r=0.31, 
p≤0.001*** 
r=0.45 
p≤0.001*** 
EQ 
VAS  
r=0.06 
p=0.50 
r=0.15 
p=0.11 
r=0.06 
p=0.51 
r=-0.05 
p=0.57 
r=0.05 
p=0.52 
UK 
n=43 
EQ-5D 
Index  
r=0.46 
p=0.002** 
ρ=0.47 
p≤0.001*** 
r=0.39 
p≤0.01¹ 
r=0.37 
p≤0.01¹ 
ρ=0.39 
p=0.009¹ 
r=0.32 
p=0.03¹ 
r=0.48 
p≤0.001*** 
EQ 
VAS  
r=0.13 
p=0.39 
ρ=0.20 
p=0.18 
r=0.07 
p=0.63 
r=-0.007 
p=0.96 
ρ=0.12 
p=0.42 
r=-0.09 
p=0.56 
r=0.03 
p=0.84 
Greece Refer back to Chapter 8, Table 8.2.12    
1not significant post Bonferroni correction; **Significant at p≤0.01 level, ***Significant at p≤0.001 
level; in bold: significant following application of the Bonferroni correction;  
Abbreviation: SCIM, Spinal Cord Independence Measure; EQ-5D, Quality of Life, EQ-VAS, Quality of 
Life Visual Analogue Scale;  
Statistical tests: r, Pearson’s correlation. 
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Table 9.4.12: Interaction effect between country of residence and  
function (total SCIM) on health status 
 Interaction effect of total SCIM  *country on DV  
EQ-5D   p≤0.001***, n=198, Wald χ²=75.53, df3,  
Likelihood ration χ²=63.98, df3, p≤0.001*** 
USA*SCIM: b=0.009, SE=0.001, Wald χ²=69.3, df1, 
95% CI for Wald 0.007, 0.01, p≤0.001*** 
UK*SCIM: b=0.009, SE=0.001, Wald χ²=51.23, df1, 
95% CI for Wald 0.007, 0.01, p≤0.001*** 
GR*SCIM: b=0.009, SE=0.001, Wald χ²=64.82, df1, 
95% CI for Wald 0.007, 0.01, p≤0.001*** 
EQ-VAS  p≤0.001***, n=198, Wald χ²=17.27, df3,  
Likelihood ration χ²=16.56, df3, p≤0.01¹ 
USA*SCIM: b=0.17, SE=0.07, Wald χ²=4.91, df1, 
95% CI for Wald 0.02, 0.32, p≤0.02¹ 
1not significant post Bonferroni correction; ***Significant at p≤0.001 level,  
in bold: significant following application of the Bonferroni correction;  
Abbreviations: MSKP, Musculoskeletal Pain; LBP, Low Back Pain; SE, Standard Error;  
Statistical tests: χ², Likelihood ratio Chi-square; Wald test chi-square distribution;  
 
 
9.5. Conclusion 
The aim of this chapter has been to examine the same objectives to those examined in the 
three previous chapters which presented results, but looking at differences and 
correlations between and within the groups from the three participating countries. In 
addition, the interaction effect of the country of residence with another independent 
variable of interest (e.g. LBP presence, LBP quality etc.) on the main outcome looked at, 
was examined.  
The main findings of this chapter were that Greeks differed in their type of injury and their 
mean age from respondents from the other countries. They reported the lowest 
percentage of pain but equal LBP. The quality of LBP was worse for people from the UK 
who also reported the worst function and classified their QoL lower. Greeks perceived 
their self-reported health as worse. The country of residence in combination with the 
demographic or injury-related characteristics could not predict the presence of the 
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categories of pain. It was found that as age increases people from the USA, UK and Greece 
are more likely to perceive their health status as worse. And, as time since injury 
increases, people from the USA are more likely to perceive their health status as better 
but Greeks, on the other hand, are more likely to perceive it as worse. Finally, it was found 
that as function improves people from the USA, the UK and Greece are more likely to 
report a better health state and people from the USA are more likely to also perceive a 
better self-rated health.  
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“The aim of argument, or of discussion, 
should not be victory, but progress” 
Joseph Joubert (1754 – 1824) - French Essayist 
and moralist 
 
Chapter Brief Table of Contents 
 
10.1 Introduction……………………………………………………………………………………………………….343 
10.2 Summary of results…………………………………………………………………………………………….343 
10.3 Discussion of thesis procedure and findings……………………………………………………….345 
10.4 Summary of major issues related to pain in iSCI…………………………………………………366 
Chapter 10; Discussion of findings 
 
343 
10.1 Introduction 
This work was motivated by the need to explore pain at a specific body location in a 
group of people who are known to suffer very frequently from pain. People with SCI 
who are in pain can differ from other people in pain because certain features or 
consequences of the injury itself, alone or in interaction with the dimensions of pain, 
may precipitate or perpetuate their pain experience causing limitations to their daily 
lives by affecting function and QoL.  
Using methods and tools, some for the first time, the original aim to describe the 
experience of pain and also to investigate its relationship with QoL and function in 
people with iSCI were fulfilled.  Some results supported the literature, others 
contrasted with previous findings and, finally, new results emerged. This chapter will 
begin with a summary of the results followed by a discussion of the findings while 
reflecting upon the objectives of the study. A more in-depth discussion about the 
future implications of the results will be made in the next chapter.  
 
10.2 Summary of results 
The current study found a number of results, the most important of which are 
presented in a bullet point summary below. 
The systematic literature search in people with SCI found that: 
 There is insufficient evidence in the literature about CMSKP, CBP and CLBP 
presence in SCI; 
 Prevalence of CMSKP is 38% (95% CI 33%, 42%) (among people with pain, this 
increases to 49% (95% CI 44%, 55%)); 
 Prevalence of CBP is 37% (95% CI 34%, 40%) (among people with pain, this 
increases to 47% (95% CI 43%, 50%)); 
 Prevalence of CLBP is 37% (95% CI 33%, 42%) (among people with pain, this 
increases to 49% (95% CI 44%, 55%)). 
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In addition, the general literature review showed that:  
 Some evidence about pain and QoL in SCI exists. However, the impact of the 
experience of specific types of pain, like LBP, on QoL is not examined; 
 Functional reduction due to pain presence in SCI has been looked at, often by 
using assessment scales that were not specific to function in SCI; 
 Many studies select participants based on the cause of injury and not the 
completeness of injury;  
 The onset of pain post SCI has been given little attention, in particular, its 
relation to function and QoL;  
 Cross-national studies in SCI, which simultaneously collect and analyse data, are 
inadequate.  
The self-completed survey conducted in the study produced the following results: 
 GR-SCIM III and SCIM III have internal consistency of α=0.78. Concurrent 
validity for “self-care” between GR-SCIM III and EQ-5D is ρ=-0.78 and SCIM III 
and EQ-5D is ρ=-0.75. Concurrent validity for “mobility” between GR-SCIM III 
and EQ-5D is ρ=-0.58 and SCIM III and EQ-5D is ρ=-0.45;   
 Lifetime prevalence of pain post iSCI is 91.3% (95% CI 86%, 94%). Prevalence of 
current LBP is 67.9% (95% CI 61%, 73%). Lifetime prevalence of LBP post iSCI is 
73.5% (95% CI 68%, 78%). Prevalence of MSKP post iSCI is 38.8% (95% CI 32%, 
45%). There is no significant difference in the prevalence of LBP post iSCI 
between the national groups; 
 The mean health index (classification of health status) is 0.4±0.3 and there is no 
significant difference between the countries. The mean perceived health status 
is 62.9±22.5. Greeks perceive their health status to be significantly lower than 
those from the USA; 
 The mean functional independence score is 65.5±20.6 and there are no 
significant differences between the three national groups;  
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 The impact of MSKP is greater in women than men. More people with 
paraplegia report LBP than those with tetraplegia. They also report worse LBP 
quality;  
 There is a strong positive correlation between MSKP and LBP;    
 LBP onset is most common immediately after the injury or within the first year. 
The earlier the LBP onset, the more persistent LBP is;  
 LBP is mainly described as “aching” followed by “tiring-exhausting”; 
 Quality of LBP is of moderate severity; 
 Intensity of LBP is at a moderate level; 
 LBP has a stronger negative relationship with QoL compared to MSKP or pain in 
general;  
 The presence of all examined pain categories affects people’s perception of 
their health status more than their classification of their health status;   
 Worse quality and increased intensity of LBP correlate with worse QoL; 
 Correlations between the pain categories and function are, in general, weak.  
 
10.3 Discussion of thesis procedure and findings 
The study had one core aim and seven objectives. Some of these objectives were 
answered via the literature review and others using data collected from the survey. 
The statistical analysis tested 13 hypotheses which were part of three themes. These 
hypotheses were tested for the whole group and across nations.  
 
10.3.1 Literature background  
An examination of the literature, as in any research, is the first step taken in order to 
explore the information available which guides researchers through the development 
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of their own work. This was the route followed in the current project. The literature 
was examined for pain, QoL and function.  
10.3.1.1 Literature on pain 
Looking back at the history of pain it was observed that the need to understand pain 
has been expressed for many centuries conveying the necessity of identifying effective 
ways to combat this unpleasant feeling. Studying the experience of pain has been a 
challenge for researchers but progress, though slow at times, has been made. The 
presence of pain is a major problem for health care systems around the world with 
very substantial direct and indirect costs.107,152,280 Pain is a subjective experience 
affected by many factors and the most efficient way to study it is to look at a specific 
condition each time and also to focus on pain location and examine influences that 
may come from other factors like cultural background. Though this idea is not new, it is 
not often followed.  
The purpose of this study was to look particularly at MSKP and pain in the area of the 
lower back and thus the literature was examined for this reason. 
10.3.1.2 Literature on MSKP and LBP 
When exploring the literature it was found that despite a wealth of information about 
pain in general in SCI, information about the specific pain categories examined was 
very limited. To properly identify the available literature on MSKP and/or LBP in SCI a 
systematic literature search was conducted. This was the logical step to follow in order 
to identify the information needed. The advantage of a systematic search is that it uses 
specific steps and processes that identify and analyse studies published in the 
literature that may not have been identified with a simple literature search.  
10.3.1.3 Systematic review on CMSKP, CBP and CLBP in SCI 
An important finding of the systematic review was the lack of evidence on the specific 
categories of pain examined. The lack of homogeneity among the studies identified 
made a meta-analysis unreliable and therefore this was not conducted. Dijkers et al115 
could also not conduct a meta-analysis for the same reason. The findings of the 
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systematic review contribute to knowledge by identifying the mean prevalence and 
95% CI for CMSKP, CBP and CLBP reported in the reviewed studies which were high. 
This review brings to attention the problem of the location of pain in the lower back, 
something that health professionals are aware of, but it is not studied sufficiently in 
the published literature. There are increasing calls to improve assessment and conduct 
subgroup comparisons and the lower back is an area that necessitates further 
attention. 
10.3.1.4 Literature on quality of life and function 
Inspection of the literature to explore how QoL and function may be affected when 
living with SCI, verified the fact that medical and technological advances have changed 
the lives of people by maintaining life, improving function, if this is impaired, and 
assisting ADL. In general, recent studies show increased interest in improving QoL in 
people with SCI often by emphasising the need to reduce pain and improve function in 
order to achieve this. But examination of the literature did not identify any studies that 
discussed the impact of LBP on QoL or function in SCI. A clear gap in the literature was 
noticed.   
 
 Brief summary 
Drawing upon the theoretical background and the findings of the systematic review, 
and having examined the first objective of the study, which showed that significant 
steps forward have been made but more need to be made, the survey design was 
developed.   
 
10.3.2 The presence of pain, MSKP and LBP  
Following the selection of the most appropriate research methods and assessment 
tools, the most suitable way to conduct the survey was decided. The second objective 
of the study focused on describing the presence of the categories of pain examined for 
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the whole group and for each national group and comparing them for differences and 
similarities. 
10.3.2.1 Presence of pain for the whole group 
This study found that a very high proportion of people report pain after iSCI (lifetime 
prevalence 91.3% (95% CI 86%, 94%)). Though this study found a very high prevalence 
of pain, reports of high prevalence have been made previously,58,371,380,381,451,489 
confirming once more the significance of this problem. One reason why so many 
people felt pain could be because only people with incomplete injuries participated in 
this study. People with incomplete SCI have been found to have pain more often than 
people with complete injuries.103,317 Another reason could be that more people with 
pain decided to complete the questionnaire because they felt they had a personal 
interest in this study. This, of course, can be an issue in any survey study. It is known 
from the collected non-respondent (drop-out) data that among the 36% of people who 
dropped out, 34% had pain and only 1.7% did not have pain. But the pain presence for 
the remaining 64% of people who dropped out of the study is not known.  
10.3.2.2 Presence of LBP for the whole group 
This study found that there was a high proportion of people with iSCI reporting LBP at 
any given time point: lifetime post iSCI 73.5% (95%CI 67%, 78%), current 67.9% (95%CI 
61%, 73%), last one month 68.4% (95%CI 61%, 74%) and last three months 70.1% 
(95%CI 63%, 75%).  These proportions were higher than expected based on the 
available literature identified in the systematic review. One could argue that LBP 
prevalence was higher here than in other reports because more people with pain in 
general participated, resulting in more of them experiencing LBP as well. However, 
Raissi et al371 found a higher percentage of pain in general but a lower percentage of 
LBP compared to this study. Thus, the above assumption is in doubt.   
One other factor, which may have contributed to the higher LBP prevalence, as 
mentioned previously, could be that only people with incomplete SCI participated. 
There are no previous reports about people with incomplete injuries reporting LBP 
more often than those with complete injuries, thus this remains an assumption. 
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Previous studies reporting on LBP in SCI318,371,457 reported lower LBP prevalence in their 
groups but pooled data from people with complete and incomplete injuries when 
reporting LBP. Other factors, not examined in this study, that require physical 
assessment or imaging (X-ray or MRI), like the presence of lordosis, which is found in 
people with incomplete SCI23 and is known to contribute to the appearance of LBP may 
have affected the results of the current study. Consequently, the assumption that 
more people with incomplete SCI could develop LBP needs to be considered further in 
future investigations. This information could be of importance for health professionals 
when planning treatment and setting targets for rehabilitation.  
 Finally, it is not possible to exclude the fact that the recruiting methods followed here, 
(i.e. no use of random selection approaches) did not result in more people with LBP 
and iSCI completing the survey because of special interest. Having said this, not many 
studies in the SCI and pain literature have used random selection techniques to 
identify their survey participants.   
Pain is a subjective experience and despite this current study not being able to or 
intended to discuss causality of LBP, it can confirm its high presence. The fact that the 
reported LBP prevalence in the current group is higher than that found in the general 
population220,248,263,346 could be because there is greater risk of developing LBP in iSCI.  
10.3.2.3 Presence of MSKP for the whole group 
The next finding of this study related to the presence of MSKP which was equally high 
(39%)  as revealed in the studies reviewed in the systematic search, where 
three19,381,406 of the four studies19,58,381,406 under review used physical examination or 
explained the questions to the participants over the telephone in contrast to the 
current survey in which MSKP presence relied solely on self-report.  
10.3.2.4 Presence of the pain categories for each national group and group differences 
Among the three participating countries, the Greeks reported pain significantly less 
often. One reason for this could be differences in the characteristics of the injury itself, 
as more Greeks suffered from a non-traumatic injury. In another study conducted in 
Greece121 pain prevalence was also lower than in the USA380,451 or UK.374  Greeks did 
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not report a different percentage of LBP or MSKP than people from the USA or the UK 
in this study; therefore, it could be due to cultural factors that Greeks report less 
general pain. It may be that unless the type of pain is specified (like MSKP or LBP), 
some Greeks may not consider they are in pain or, alternatively, they do not seek help 
or report their pain. This may reflect, on the one hand, reduced report of pain by the 
Greek patients themselves or, on the other hand, reduced assessment of general pain 
by health professionals. As both these factors could become barriers to the 
rehabilitation of the patient, these issues need to be examined further.  
Another factor which may need to be taken into consideration, when trying to explain 
pain differences within the national groups, is the possible climatic effect on pain and 
the different prevailing climatic conditions between the three countries. Some studies 
have indicated that the weather may affect pain sensitivity or pain perception175,225, 
though the belief that pain is improved when living in a better climate has proved 
inconclusive.225 The first population-based epidemiological study to examine the 
relationship between pain and weather in the UK found that people reported 
significantly less pain (any pain and chronic widespread pain) on days when the 
temperature and the sunshine were highest.276 Similarly, the SCI population living in a 
hotter and sunnier country, like Greece, may suffer less from pain in general. Further 
analysis will be needed to address this assumption. Understanding how much and in 
what ways the environment can affect the experience of pain will also help us 
understand the dimensions of pain better. 
Despite some differences in the demographic profiles and injury characteristics of the 
groups from the three nations, particularly the Greek group, LBP presence is a 
significant problem, equally high, for all people in the countries investigated. Similarly, 
all three national groups reported no significantly different prevalence of MSKP, 
people from the UK reporting it slightly more often.  Often when results were not of 
statistical significance, particularly in the within- and between-groups analysis, they 
were of practical significance. The inability to identify statistical significance at times 
may have been due to the small-sized groups, thus practical significance was used 
allowing comparisons and enabling discussion of results which would have been 
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dismissed if statistical significance only was taken into consideration. The similarities in 
the presence of LBP and MSKP across nations show that international guidelines to 
address this problem can be implemented but consideration to the effect sizes must 
given. 
 In the literature, LBP has often been attributed to be musculoskeletal in nature and 
this study has tried to examine this via examining the correlation between LBP and 
MSKP. 
10.3.2.5 The association between LBP and MSKP 
A positive highly significant correlation between LBP and MSKP pain was found. Taking 
into account the literature which shows that people with SCI have conditions that can 
be risk factors for mechanical LBP,23,100,159,209,287,401  this may be an indication that pain 
in the lower back is of MSKP origin. However, it cannot be claimed as a causal effect. 
This association is important both for the clinician and for the patient as it affects 
treatment of pain56 or response to treatment487 which can differ if pain is of 
neuropathic or nociceptive origin. Therefore there is a need for a multi-professional 
approach to diagnosis and treatment. People from different professions, including 
doctors, radiologists, physiotherapists, psychologists and others, may be required to 
do a holistic diagnosis of LBP. As such, the treatment of LBP may need to involve more 
than one health professional to deal with the multiplicity of factors that are involved in 
the continuation of pain. Doctors may have to address pain via medication or other 
means, but pain specialists or CBT therapists may have to address the cognitive 
dimension of pain. In addition, physiotherapists will have to work with the patient on, 
for example, strengthening of the area. A multi-professional team will aim to 
rehabilitate LBP more efficiently and possibly faster, educating the patient on long-
term pain control.    
10.3.2.6 Presence of the pain categories and group profile characteristics 
This study found that only a few of the demographic or injury profile characteristics 
affected the presence of pain.  
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Differences in the presence of the pain categories by gender 
Males and females were compared because it is recommended to conduct such 
comparisons when examining pain.177 This study failed to find any significant 
differences for the prevalence of pain, MSKP or LBP between men and women for the 
whole group. However, one interesting finding was that males from Greece reported 
significantly less frequent pain than males from the other two countries, which was 
not the case among females. This may be due to the social role expectations believed 
to affect men, which may be more prominent within the Greek male population. 
However, such a difference was not noticed in the case of LBP presence. This could be 
because LBP is a more disabling type of pain that affects people equally and gender 
may be irrelevant when reporting this type of pain in iSCI. In addition, as mentioned 
earlier, people may pay more attention when pain becomes specific. This study cannot 
support the claim by Greenspan et al177 about examining pain separately in men and 
women when the presence of pain, MSKP or LBP is considered but in cross national 
designs it may be an interesting variable to study. In addition the number of areas with 
pain (pain extent) is worth studying separately in men and women. 
Differences in the presence of the pain categories by cause of injury 
This study showed that the proportion of people with a non-traumatic iSCI reporting 
LBP was higher than those with a traumatic injury. Often the literature that focuses on 
examining SCI includes only participants with a traumatic injury which may lead to 
insufficient study of the pain categories that may be more common in non-traumatic 
SCI. Those individuals with a non-traumatic injury are a significant proportion of the 
SCI population.296 Therefore, it is essential that they are included in studies and 
analysed as a subgroup.  
Differences in the presence of the pain categories by level of injury 
A third significant finding from subgroup analysis, showed that people with paraplegia 
report LBP and pain in general more often than people with tetraplegia. The presence 
of pain by the level of injury has been a matter of debate in the literature as, on the 
one hand, people with lower-level injuries have an increased risk of pain317 but, on the 
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other hand, no such differences have been found.12,374,407,451 However, there is no 
previous information about the presence of LBP by the level of injury in iSCI alone. 
Both the cause and the level of injury could be part of a multifactorial model analysis 
aiming to determine the characteristics of people with iSCI who may develop LBP. This 
will be discussed in the next chapter. This study did not find any differences in the 
presence of LBP, pain or MSKP based on age, or time since injury for the whole group 
or within the national groups though a tendency for increased MSKP following longer 
time since injury was noticed. It should be noted that the literature often attributes 
the variations found for the presence of pain to the variation in the pain classifications 
used.  
10.3.2.7 Classification of pain 
The current study did not use a specific classification system to categorise pain. 
However, information was collected for the categories of neuropathic pain above-, at-, 
and below-level of injury, MSKP, upper limb pain and back pain. The presence of 
visceral pain (pain usually located at the thorax or the abdomen483) was not directly 
asked but the information collected via the body chart may suggest its presence. But 
physical examination, or at least an interview, would have been required to accurately 
classify pain. Although at the time of designing this study, there were many 
classification systems available, most did not include pain in the lower back within 
their categories. The ISCIPDS:B483 which was published after the start of this study 
recommends assessing pain location when collecting data clinically. An extended 
ISCIPDS:E version which will be used in research,483 but is not yet available, may help 
researchers resolve some of the problems faced in data collection methods followed in 
surveys.  
10.3.2.8 Persistence and onset of pain or LBP post iSCI  
The onset and the persistence of pain and LBP were examined in detail because it has 
been suspected that they may play an important role in the experience of pain and 
consequently QoL and function. Indeed it was found that both pain and LBP appeared 
early after iSCI and their early onset correlated with more persistent pain or LBP. The 
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current findings agree with reports on the persistence of pain in SCI90,484,488 or early 
pain onset19,240,317,374,484 and add that this is no different in the case of LBP. It is 
important for clinicians to know that LBP may start early post iSCI in order to assess it 
early, consider LBP prevention and management techniques including patient 
education. In this study, no questions were asked about the onset of pain in other 
areas like the hip or the upper back or the time of the onset of psychosocial factors like 
anxiety and depression. Future studies should include the examination of the potential 
risk factors for the onset of LBP or pain following iSCI.  
 
 Brief summary 
The information gathered to answer the second objective of the study has filled in 
some of the gaps identified in the literature search, by providing more evidence on LBP 
and MSKP. Awareness of the problem of LBP in iSCI and acknowledging its significance, 
will lead therapists to include it in their routine assessments and provide appropriate 
therapy in a timely manner.   
 
10.3.3 Quality and intensity of LBP 
This study is the first to investigate the quality and intensity of LBP in iSCI using the   
SF-MPQ. Using methods to overcome the technical problems encountered, the third 
objective of the study was investigated.  
10.3.3.1 Intensity and quality of LBP for the whole group 
Participants reported a moderate intensity of LBP which remained relatively stable 
over time (three months) and was characterised as “discomforting”. This finding 
confirms the single previous report on LBP intensity in SCI which was of a slightly 
higher moderate level.457 For people with paraplegia the intensity of LBP was higher, 
though not significantly so, which is in agreement with Ullrich et al.457 It is important to 
study the intensity of pain as it helps health professionals understand what type of 
treatment may be needed and if it is effective.43 Though there is no other study that 
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describes LBP quality in iSCI, the mean PRI did not differ a lot from that found by 
Cardenas et al58 for mechanical spinal pain40 in SCI. Likewise, it did not differ from the 
LBP description in the general population.333 Participants in the current study primarily 
used the word “aching”, a sensory descriptor, followed by “tiring-exhausting”, an 
affective descriptor. These are the most frequently used descriptors for mechanical 
spinal pain.58 Using verbal descriptors helps classify pain and “aching” is often used 
when describing back pain90 or MSKP406,483 in SCI or LBP in the general population.29 
Thus, the current description of LBP may be another indication of the musculoskeletal 
origin of the pain felt in the lower back area, bearing in mind that verbal descriptors 
and the positive relationship between LBP and MSKP presence (discussed earlier) 
alone are not enough to classify pain and assessment should include additional forms 
of examination.  
10.3.3.2 Intensity and quality of LBP for each national group and group differences 
Overall, people from all three countries described the quality and intensity of their LBP 
similarly. This shows that LBP as an experience in iSCI affects people similarly despite 
any sociocultural differences; thus similar clinical pathways for rehabilitation could be 
implemented across nations. However, two differences may be worth noting; 
respondents from the UK reported worse LBP quality and intensity, and Greeks used 
fewer words to describe a similar LBP quality. The latter may be affected by cultural 
influences as Greeks were found elsewhere to use fewer descriptors to portray their 
pain.324 People from the UK who reported worse quality and intensity of LBP were 
found to report the highest prevalence of all pain categories. This may be an indication 
that these people have worse QoL or function as will be discussed later.  
10.3.3.3 The impact of pain extent on LBP quality and intensity 
This study looked at pain extent and found that when pain was more widespread, 
people reported worse quality and intensity of LBP. Higher pain intensity, including 
LBP, has been reported to relate to pain extent59,254 and this study confirms that this is 
                                                     
40
 Mechanical spinal pain has been referred as one of the two types of MSKP (the other one is overuse 
pain) which is pain in the back or neck areas affected by activity and position.
56
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no different in LBP in iSCI. Widespread pain and higher pain intensity in SCI interferes 
with various aspects of the life of the patient, which will be discussed later in this 
chapter. Although the difference was not statistically significant, the mean areas of 
pain for the UK group was higher than the other two groups which could partially 
explain why people from the UK experience worse LBP. These research results agree 
with the recommendations of Carnes et al59 who emphasised the importance of paying 
more attention to the impact of multi-site pain on various factors including 
psychological ones and improving the current self-reported measures of multi-site pain 
assessment.   
Subgroup analysis showed that the lower level of injury, the earlier onset of LBP post 
iSCI and the increased persistence of LBP all related significantly with worse quality 
and intensity of LBP. These possible predictors of poorer QoL and function need 
further investigation. 
 
Brief summary 
This study has, until now, provided the information that a high proportion of people 
with iSCI have LBP, which can have an early onset post injury, be of moderate intensity 
and often be persistent with no regular breaks. These results justify the intention to 
investigate this location of pain further, as well as how it affects other aspects of 
patients’ lives. The focus of the remaining objectives was to investigate some of these 
relationships.  
 
10.3.4 Quality of life in people with incomplete spinal cord injury 
Examination of the literature clearly demonstrated the increasing interest by health 
researchers on the factors that affect QoL, particularly as life expectancy is increasing 
following conditions such as SCI, with the aim of improving QoL. Using the EQ-5D 
assessment measure, data were collected and analysed without difficulty and this is 
discussed below.  
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10.3.4.1 Quality of life for the whole group 
As anticipated, people with iSCI have problems with various aspects of their QoL. This 
study found a higher proportion of people reported problems with 
“anxiety/depression” compared to reports in the literature.126,188,253 One reason that 
could explain this is the presence of the Greek group which has not been included in 
other reports in the SCI literature and which, in the current study, reported more cases 
of “anxiety/depression” than the other two national groups. For the whole group the 
mean index for classification of health state was 0.4±0.3 (mean±SD) and the mean 
score for perceived self-rated health was 62.9±22.5 (mean±SD). Both these scores 
show what appears to be a moderately good level of QoL, despite the presence of the 
disability, reported by the respondents. Although this may seem strange, this has been 
reported previously.6  
This study found no significant differences in the reported QoL between men and 
women and no correlation between time since injury and QoL. It also found that age 
associates with a decline in the perception of self-rated health. All these findings have 
been previously reported.313,349,362 Finally, this study cannot confirm previous reports 
that people with paraplegia have significantly better QoL that those with tetraplegia.313 
A future study to analyse data solely from people with iSCI will be needed in order to 
further validate the findings of the current study.  
10.3.4.2 Quality of life for each national group and group differences 
It was mentioned above that Greeks reported more cases of “anxiety/depression”. 
Greeks have been found to report higher anxiety prevalence than people from the 
UK290 and older Greeks to have higher levels of depression than younger ones.467 The 
Greek group in this study was significantly older than the other two groups which may 
explain this finding. Another finding is that Greeks also perceived their self-rated 
health as worse than people from the other countries despite their health state 
classification not being significantly worse. This finding cannot be attributed to gender, 
sometimes reported to affect QoL, as the proportion of males and females between 
the countries did not differ. However, age could have affected this result as the Greeks 
were older and increased age relates to a decline in perceived health.349 Yet, people 
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from the UK, who were significantly older than people from the USA, did not report 
worse levels of “anxiety/depression” or QoL. What could have affected this result is 
the fact that the non-Greek groups replied mainly online and people using the internet 
are found to have better self-rated health.85 Nonetheless, studies on QoL of the 
general population do not report great differences between a Greek group247 and a 
USA group,274 but when people with a health problem were looked at, Greeks 
perceived their health status as worse.319 Therefore, it is possible that the impact of 
culture on health perception is greater when health is disturbed. Alternatively, the 
health service provided differs affecting perception of health status, but these factors 
alone do not explain why the health index remains the same.  
In Greece, in 2001, new legislation was published aiming to implement integrated 
primary health care (PHC) but this is yet to be achieved.268 While community health 
centres could be suitable in the current Greek setting,268 the medically-orientated 
Greek health system, though being specialist orientated, may still be too “inflexible” to 
accept changes essential for long-term rehabilitation. There is a lack of SCI units in 
Greece leading, to people being admitted to general hospitals after their injury,120,356 
with possible negative consequences for the complications that can follow SCI in the 
later stages,120,356 thus increasing the level of anxiety patients feel and their perception 
of QoL. There is a need to examine the impact of the health care system on the QoL of 
people with SCI living in Greece and compare it with Greeks living abroad under 
different health care systems. The findings may have implications both for the 
rehabilitation of Greeks living in Greece but also for those outside, for if the perception 
of QoL is more affected by culture, then health professionals in the UK and USA, where 
large Greek communities live, will need to consider this in their treatment plans. Over 
the last few years private rehabilitation centres have opened in Greece and people 
with SCI may (or may not) receive public funds to attend them. Outcomes from such 
centres need to be included in future studies.  
Finally, two findings emerged when health status was examined by the demographic 
and injury profiles of the respondents. The first was that a significant interaction effect 
between gender and country of residence on the health index existed but two-way 
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ANOVA did not reveal which groups differed. The inability to identify the exact effect 
may be because the difference was too small to be detected or that larger-sized 
groups were needed to detect differences. Another finding was that the cause of injury 
and the country of residence interact significantly with perceived health status. These 
two findings will need to be tested further as both are helpful in understanding what 
SCI and demographic features may affect QoL cross-nationally.  
 
10.3.5 Function in people with incomplete spinal cord injury 
A reduction in function is the primary complication following SCI and a number of 
factors that influence function have been examined in the literature.  Using SCIM III, 
data were collected with no difficulties. This study is the first to have translated SCIM 
III into Greek and the first to have used SCIM III as a self-completed measure. The 
implications of this will be discussed in the next chapter. The fifth objective was to 
describe the function of the group.   
10.3.5.1 Function for the whole group 
As expected, the participants had reduced function but overall they maintained a good 
level of functional independence possibly more than reported in other studies in the 
SCI literature. This is probably explained by the fact that only people with incomplete 
injuries were included.  
10.3.5.2 Function for each national group and group differences 
This study found that Greeks scored the best mean function of the three groups and 
people from the UK reported significantly lower mean function than both the other 
groups. Earlier, it was seen that people from the UK have the worst experience of pain 
and report a worse health status. In addition, they also report worse function. It can be 
seen that there are connections between these three areas but no causal effects can 
be assumed. 
 The subgroup analysis examining the demographic and injury profile characteristics 
revealed a finding that was not expected; for Greeks, older age (when time since injury 
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was controlled for) correlated with better function and, on one occasion, it reached 
significance level. This contrast with both the direction of the correlations found for 
the rest of the group and also reports in the literature.266,446 Factors including more or 
less family support or different expectations from functional abilities with increasing 
age may have contributed to this finding. This area needs further investigation. 
 
Brief summary 
Objectives four and five have described both QoL and function in iSCI. Some of the 
findings confirmed previously known information while others have added new. Three 
major areas of concern for a person living with an iSCI;  pain, QoL and function have so 
far been described and the next logical step was to investigate how they interact with 
each other. The final two objectives were set to do so.  
 
10.3.6 The impact of the presence of pain on quality of life and function 
No significant difficulties were noticed when the measures to collect data were cross-
analysed. To this author’s knowledge, this is the first study to report on the possible 
impact of LBP on QoL and function in iSCI and the first to discuss the impact of any 
type of pain on QoL and function in iSCI in Greece. The findings are discussed below.     
10.3.6.1 Pain presence and quality of life for the whole group 
This study found that a high proportion of people with iSCI and pain, MSKP or LBP were 
“anxious/depressed”. This was a result to be expected as the literature supports this 
finding. What is of importance to note is the conclusion that LBP has a greater negative 
effect than MSKP or pain in general on what people perceive as being a good health 
status. Lack of research into LBP in SCI may mirror a lack of attention to this problem 
and a possible lack of early management, perhaps resulting in people perceiving it as a 
greater challenge for a good QoL. Putting these variables into a multiple regression 
model will help to understand further the importance of each type of pain on QoL. The 
negative impact of LBP on health status was also confirmed as the more LBP days felt 
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in a month, the lower the health status, confirming once more the need to understand 
why and when LBP may become chronic and more persistent.   
10.3.6.2 Pain presence and quality of life for each national group and group differences 
It was found that although the QoL of people from all three groups was similar, for 
those from the USA, QoL was worse when LBP worsened further and when its 
persistence increased in comparison to the other two national groups. In addition, the 
later the LBP onset, post iSCI, the better the health status for the same group. It may 
have been that the Greek and UK groups were not large enough in number to capture 
a significant result as the direction of the correlation was the same for these groups 
too, although in most cases the strength of the correlation was not as strong. 
However, this may be a consequence of a societal belief in America  that pain is bad 
and needs to be quickly eliminated,328 which may result in perceiving worsening of 
pain as a greater “threat” to QoL. This belief may be less important in non-American 
societies, though it should be noted that the three countries examined share many 
similarities.  
The experience of pain, overall, affects the health status of people with iSCI very 
similarly, irrespective of differences in injury and demographic characteristics. Again, 
what seems to be of more importance is the type of pain which has a different impact 
on health. In this case some gender-related differences were found as women who 
suffered from MSKP perceived their health to be worse than those who did not suffer 
from this type of pain. This was not noticeable in males. In contrast to the above 
findings, the impact of MSKP on health for the UK group was larger for males than 
females and though there were no significant differences, the effect sizes were larger 
indicating the practical significance of the result. In addition, for the Greek group, 
within males those with MSKP classified their health state as worse than those without 
MSKP, but their perception of their self-rated health did not seem to be as affected. 
This was not the case among Greek females. The conflicting findings with regard to 
pain differences between males and females have been reported in the literature 
along with reports that the intensity of pain can affect QoL. This study did not examine 
intensity of MSKP and how this may affect QoL differently between men and women. 
Chapter 10; Discussion of findings 
 
362 
Taking into account the question posed by Greenspan et al177 as to whether 
assessment measures should include gender-specific questions when examining 
people, and in light of the evidence found here this may be the case for MSKP. In 
particular, the ISCIPDS:B41 uses some items from the MPI42 to examine pain 
interference including interference with mood. Among the types of pain examined in 
the data set is MSKP. It may be helpful to add a question related to health status 
perception as this may differ between and within genders in a single nation or across 
nations. This may be particularly useful for clinicians in multicultural societies who may 
need to differentiate treatment options for their patients.         
10.3.6.3 Pain presence and function for the whole group, each national group and 
group differences 
This study found that the proportion of people reporting worse function when the 
categories of pain were present was, surprisingly, not large. On the contrary, people 
with pain, MSKP or LBP reported slightly better function than people without these 
categories of pain though the differences were not statistically significant. This was 
noticed within each national group too. This finding contrasts with other findings in the 
literature both from the SCI population362 and the general population, including the 
elderly.94,496,498 Function was not greatly affected by increased persistence of pain/LBP 
or earlier pain/LBP onset post iSCI, though the latter had a stronger correlation and 
was of an opposite direction within the Greek group. Future studies could examine if 
older age is a factor affecting this result.  
Though many of the features investigated in this study have not been investigated in a 
similar way in previous studies, it was unexpected to find that a number of variables 
did not relate with worse function when they have already been found to relate with 
worse QoL. A number of reasons may have contributed to this result. First, the type of 
injury the participants had. Had the study pooled together people with complete and 
incomplete injuries, as often happens in published studies, the result may have been 
different.   
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 International Spinal Cord Injury Pain Basic Data Set.
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 Multidimensional Pain Inventory. 
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Another reason could be that people become more ’determined’ to be functionally 
independent irrespective of the presence of pain. Also, for some people the need to 
’get rid of’ the pain may become a motivation itself and they use activity to do so. 
These may contradict the theory of pain-fear avoidance which is based on avoiding, 
due to fear, movements or activities that may increase pain or cause (re)injury and 
result in functional reduction.51,468 The impact of chronic pain on everyday physical 
activity may be relatively small458 and Hammell186 argued that people with an 
impairment, like SCI, are reported to change their perception of ’self-worth’ and try to 
find things they can do.186 A number of other factors that have not been examined in 
this study could have contributed to this finding, for example, SCI self-efficacy which 
has a positive association with function,331 behavioural and social factors such as the 
level of family support when the person with iSCI is in pain. As the experience of SCI is 
a continuous learning process,61,109 people in pain may intentionally seek to be more 
physically active in order to maintain good health. Having an incomplete injury may 
help them to achieve this goal more easily than those with a complete injury. 
Conclusions cannot be drawn as these issues were not examined in the current study 
but they are interesting phenomena. 
To summarise, this study showed that people function relatively well across countries 
despite their pain. Future studies and clinicians need to consider what the reasons are 
for the increased motivation towards functional independence for people with iSCI. 
Identifying such motives for positive behaviour is more likely to enhance therapeutic 
outcomes. It is widely recommended in various guidelines5,54,325,461 that remaining 
active is one of the most promising approaches to treat non-specific LBP especially in 
early stages and thus decrease the likelihood of its chronicity. The combination of 
physical and psychological treatment programmes with the inclusion of CBT 
approaches is also encouraged.325 The CBT model is based on the assumption that pain 
and disability are influenced by somatic and psychosocial factors, and uses methods to 
change cognition and thus minimise negative behaviour.360,462 Finally, further studies 
will need to use SCIM III and GR-SCIM III, under the same or similar conditions as used 
here, to ensure that the findings are not attributable to the psychogenic properties of 
the measure.  
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10.3.7 The impact of low back pain quality and intensity on quality of life and 
function 
The final objective of the study was to examine how QoL and function relate to the 
quality and intensity of LBP. The main findings are discussed below. 
10.3.7.1 Low back pain quality and intensity in relation to quality of life 
This study showed that poor quality and high intensity of LBP negatively relate to QoL 
and that the relationship is stronger when LBP intensity is involved. This is the first 
study to confirm this in iSCI. It is known from the literature that increased pain 
intensity negatively affects QoL in SCI313 and in other situations including cancer,478 
adolescence219 and women with LBP.439 It is important to understand that LBP, which is 
commonly reported in iSCI as shown here, interferes with health and this is a 
characteristic noticed across each national group examined. When LBP becomes more 
constant and the LBP-free periods are reduced, LBP intensity increases, thus therapists 
need to consider earlier interventions to avoid LBP becoming chronic and constant 
which eventually will affect QoL.  
10.3.7.2 Low back pain quality and intensity in relation to function 
Earlier it was discussed that the presence of LBP does not significantly affect function; 
however, increased LBP intensity negatively relates to function, which is significant 
particularly for “mobility indoors and outdoors”. This was noticed across the three 
countries, particularly for people from the UK for whom the experience of pain is more 
severe. People with SCI who report higher pain intensity levels also report greater 
catastrophising, psychological distress and pain interference.450 Therefore, it is 
important to assess intensity of LBP as this may be the characteristic of LBP which 
interferes more with worsening of function. Since increased LBP intensity is a limiting 
factor particularly for “mobility indoors and outdoors”, it is likely to impact negatively 
on socialising, social participation, employment and even life satisfaction, which are all 
necessary for a good QoL. Reflecting back on the existing guidelines for treating LBP, it 
is important that multi-approach rehabilitation programmes promoting function start 
early.  
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10.4 Summary of major issues related to pain in iSCI 
The issues found in this study to relate to pain in iSCI can be grouped into three areas; 
1) SCI features, 2) demographic profile characteristics, and 3) category of pain. The first 
and the last groups are found to be of more importance to the experience of pain.  
The completeness of injury is one of the SCI features that needs to be considered when 
studying pain in SCI. Incomplete injury may be the reason that explains the high 
prevalence of pain in this present group, making people with iSCI more vulnerable to 
developing and reporting pain. This may be more significant in the case of LBP. The 
cause of injury is another SCI feature of importance to be examined when addressing 
LBP in SCI, as this study showed that people with non-traumatic injury report LBP more 
often than those with a traumatic injury. In addition, the cause of injury in combination 
with the completeness of injury may explain or predict earlier onset of LBP.  Finally, 
the level of injury is the last SCI-related feature that needs to be taken into 
consideration when studying presence and intensity of LBP. This study does not 
confirm previous reports that people with lower level injuries enjoy a better QoL. It 
actually found that people with tetraplegia perceive their health status as better 
compared to those with paraplegia though the difference was not statistically 
significant. This is another indication that the completeness of the injury is of great 
significance in determining how the experience of living with SCI may be affected. Of 
course, incomplete injury cannot solely account for better QoL as multiple 
psychosocial factors may affect it. Finally, the level of injury was a feature determining 
better function. As the SCI-related features are in general known from the start of the 
injury the clinicians can pay early attention to those found to affect the experience of 
SCI and pain. 
This study found that the demographic profile characteristics of people with iSCI may 
not be particularly important in the presentation and experience of pain, though 
factors related to MSKP do seem to differ for males and females.   
The final issue to be considered in relation to pain in iSCI is the type of pain. This study 
found that LBP in iSCI is a more disabling category of pain. Future studies need to 
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address if LBP can be so disabling that it leads people to overcome their cultural 
influences, in some cultures, or whether it is because of sociocultural reasons that LBP 
is reported more often. The results of this investigation may indicate different 
treatment approaches. Disabling LBP may need medical or physiotherapy techniques 
to be used, but increased reporting due to sociocultural reasons may need to be 
focused on social and cognitive approaches. 
 When LBP is present, it is important to assess how patients’ sensory, affective and 
cognitive dimensions are affected, given that LBP can have such a negative effect on 
people’s perception of QoL.  The similarities across nations in sensory, affective and 
cognitive dimensions may be an indication that there is a biological or biopsychological 
mechanism177 of LBP in iSCI that needs further research and investigation.  
Having discussed the increased likelihood that a person with SCI may report more than 
one site of pain, which is linked here with increased severity of LBP, it  is essential to 
use tools like the SF-MPQ to assess more than one type of pain. In non-clinical 
research settings it is often difficult to assess each single pain site, thus asking the 
patient to focus on the most important ones can be preferable. In clinical and 
rehabilitation settings it may be easier to assess more pain sites while the patient is 
present.    
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11.1 Introduction 
The previous chapter focused on a discussion of the results in relation to the study’s 
objectives while reflecting back to the literature. This chapter will focus on a more in-
depth discussion about the future implications of the results and how they fit in with 
current models of rehabilitation or assessment. This discussion will progress via reflecting 
upon the original contributions, strengths and limitations of the study and will propose 
changes that could be applied in light of the evidence.  
This chapter will start with a discussion of the radical changes that have occurred over the 
past few decades which have led to the development of different treatment approaches 
that have shifted rehabilitation in both pain management and SCI from a doctor-centred 
approach to the active involvement of the patient in the planning of programmes.  It will 
then finish with future recommendations.  
 
11.2 Pain, disability and related models 
Our current knowledge of the experience of pain, namely, the complex theory of 
neuromatrix, which puts the unidimensional beliefs and knowledge of previous pain 
theories under one multidimensional “umbrella”, has led to the development of new 
treatment models and pathways. Today, the biopsychosocial model of chronic pain is the 
most widely accepted model of understanding and treating pain.163 This model pays great 
attention to both disease and illness with the second being the subjective experience of 
the symptoms of the first.163 Building upon the theories of Melzack for the body-self 
neuromatrix which integrates the sensory-discriminative, motivational-affective and 
cognitive-evaluative components in the experience of pain, researchers have been trying 
to explain the “bio” part of the biopsychosocial model by using modern technology (e.g. 
genetics, electrophysiology and brain imaging).163 The interaction of the dimensions of 
pain has driven the need to search for further answers in the “psychosocial” part of the 
biopsychosocial model. The affective component of pain interacts widely with the 
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emotions that it creates which tend to be negative.163 The most extensively studied 
emotions have been depression and anxiety, often included in scales to measure QoL like 
the EQ-5D scale used in this study. There are other such emotions that have received less 
attention, for example, anger and emotional distress which can be directed towards the 
health service, the health professional, or family members and generate hostility and 
resentment.163 Patients have expressed frustration towards health professionals for their 
lack of understanding of the secondary complications of SCI.109 Considering LPB as a 
possible complication following SCI, early discussion about it could help patients and their 
families to be more prepared. All these emotions interact with each other over time and 
they interact with how the person in pain perceives it cognitively.163 A number of such 
cognitions have been studied including appraisal and beliefs, catastrophising and fear-
avoidance, perceived control, self-efficacy, vulnerability and resilience.163 Gatcher et al163 
correctly point out that though these negative factors, which can be predisposing and 
perpetuating factors for the experience of pain, have been extensively studied lately, 
there is little evidence on the protective factors of pain and disability. Such factors can 
include hope and optimism.163 Patients themselves express the need for more focus on 
their abilities and strengths109 and they use cognitive and behavioural strategies to 
increase their motivation to promote physical activity.242  
This huge interaction of factors in the experience of pain and disability, some of which 
have been mentioned in this thesis, have led to the need for an interdisciplinary pain 
management approach which should include a complete assessment and treatment of the 
dimensions of pain with the aim of making treatment more effective.162,163 Recent 
treatment approaches include tailored treatments such as the graded exposure to fear-
avoidance beliefs, patient education and CBT. Such interdisciplinary models of treatment 
illustrate the clear need for more active participation of the patient in his/her care. As 
such the “patient-centred” and the “expert patient” models have been developing rapidly.  
In SCI, the philosophy of research has been changing from “cure” to “care” over the past 
few decades, mostly due to the work of the SCI model systems (SCIMS) introduced in the 
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1970s in the USA.258,437 Treatment is now directed towards preserving the functions of the 
body that are necessary to preserve the independence of the individual.437 To achieve this 
there have been technological advances (assistive technology) but also methods to 
improve psychosocial outcomes.437 The WHO has developed the International 
Classification of Impairment and Disability (ICF) that takes account of environmental and 
personal constructs.73,437 Recently, the “ICF core sets for people with SCI in the long-term 
context” were developed, and back pain is one of the constructs that can limit function 
and health in SCI.73 Clearly the purpose of the current study to examine LBP in more detail 
is justifiable. Although the ICF core sets in SCI explain what should be examined they do 
not explain how, something the ISCIDS could work on.73  
The achievement of independence is done via rehabilitation. The necessity for health 
professionals to see SCI from the perspective of the patient and understand that 
rehabilitation is a dynamic learning experience that entails long-term adjustment 
strategies has been pointed out.61 Carpenter61 said that patients themselves want health 
professionals to overcome stereotypes and assumptions about a person’s injury and 
involve the patient, who eventually becomes the most experienced in their new condition, 
in their treatment planning. Clearly, what emerges from this report is that continuing 
education of both patients and health professionals is essential. Similar opinions on this 
matter have also been summarised more recently in the review by Gatchell et al163 who 
said that some health professionals may have beliefs themselves about fear-avoidance 
which may affect how they devise and recommend treatment.  
These voices that have been raised over the past few years led to the development of the 
Stanford Chronic Disease Self-Management Program (CDSMP), which was a lay-led self-
management course created in the USA back in the 1970s.178,494 This programme has been 
adopted and adapted in the UK as the “expert patient” programme, which has been 
promoted by the DoH since 2001.106,191,453 The model of the “expert patient” is based on 
the concept that, in the UK, the predominant disease pattern is chronic rather than 
acute.106 Having as its primary aim the improvement of the patient’s QoL by modes of 
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reducing the severity of the disease, decreasing the speed of deterioration, decreasing 
pain, while increasing self-esteem and keeping patients stable, this creates a partnership 
between the patient and the health professional where decisions about the management 
of the disease are shared.106,191 In this model the health professional maintains the 
medical knowledge, conducts diagnosis and prescribes accurately, while the patient is 
offered more access to information in order to make informed decisions.104,189,455 This 
empowerment of the patient results in an increase in their confidence, and motivates 
them while giving them choice, voice and control.106,191,453 In addition, health professionals 
become more reflective and understand better the expectations that patients may 
have.106,191 This model, which is generally well accepted, though it is criticised too,452 links 
well to earlier calls to think of the long-term rehabilitation of the patients as Carpenter61  
pointed out. Studies from CDSMP and the “expert patient” programmes have found them 
to reduce health distress and outpatient visits,272 while those with lower self-esteem and 
HRQoL improved more.375  
The ICF, which promotes the patient-centred goal setting model,259 includes the concept 
of “participation” which means being involved, being accepted and having access to 
resources.60 As already mentioned, people with SCI say that it is important to them to be 
physically active60 and, studies and guidelines suggest that keeping active reduces 
pain.5,325,394,461 Therefore, it is essential that functional independence and activity are 
promoted and patient participation encouraged. As physical health tends to deteriorate 
when ageing with SCI,260,438 it becomes important that rehabilitation in the community 
continues in the long-term enabling patients to adjust to the changes in their physical 
health.   
 
11.3 Relevance of original contributions to current concepts 
The findings of the current study fit with some of the features of the above models which 
are considered desirable for the future of patient care. Though this study has not 
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analysed, and does not intend to claim findings related to the rehabilitation and 
socioeconomic factors that interact with the experience of pain or SCI, it can inform the 
formulation of proposals for the future.  
 
11.3.1 Implications of the systematic review 
The importance of continuing education of health professionals and access to information 
by patients are central requirements of the new models. The original systematic review on 
CLBP, CBP and CMSKP in SCI, conducted here, brings the insufficient investigation on these 
topics to the attention of a wider range of health professionals and directs them to seek 
out more research on them. The findings of the systematic review can also be accessed by 
patients themselves (as they will be published) enhancing awareness of both parties of 
the partnership in the “expert patient” model of rehabilitation. 
 
11.3.2 Positive implications for Greek therapists and researchers 
Another contribution of the current study is the translation of the GR-SCIM III into Greek 
for the first time. This development method used both published protocols for 
translation40,300,377,501 and the advice of the original authors of the SCIM III (personal 
communication). The forward and back-translations were not problematic. The advantage 
of the method was that all translators were bilingual and had educational achievements to 
at least tertiary level. The advantage of the back-translation ensured the integrity of the 
items and, together with the use of an external panel, acted as a check for the 
preservation of face validity. Due to the small sample size of the Greek respondent group, 
it was not possible to carry out a full study of validity and reliability. However, the results 
reported on validity and reliability should be regarded as initial testing of the 
psychometric properties of GR-SCIM III.  
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The availability of this measure will have positive implications in the future for the 
assessment of functional independence for people with SCI in Greece. Systematically 
collecting, analysing and interpreting data from standardised tools can be done in the 
clinical setting and become evidence that the rehabilitation followed is effective.154 Now 
Greek health professionals can use this function measure in clinical settings, and also 
policy makers in Greece could include it in their recommendations. Using a standardised 
assessment tool will also allow comparisons between Greek groups and other groups who 
have used the English version of SCIM III, enhancing research and assisting therapists to 
compare their group(s) with other groups in order to follow the best treatment 
approaches suggested in the wider literature. Explaining to the patient the value of using a 
widely used and accepted measure could also have a positive impact on the relationship 
between therapist and patient as the latter could feel that he/she is more accurately 
assessed and significant attention is paid to treatment planning.     
 
11.3.3 The value of self-report 
The next original contribution of this study is the use of SCIM III and GR-SCIM III as self-
completed measures for the first time. The validity and reliability of the English version 
were examined using a large enough sample, similar to or larger than other studies in 
which other measures were translated and validated.165,166,244,311,443 Unidimensionality was 
confirmed and reliability was acceptable for both the English and the Greek versions. 
Validity was better for the Greek version.  
While this study does not imply replacing the function assessment done by the health 
professional via observation, it provides new and positive implications for the care of the 
patient in two ways. First of all, it builds on the call made by Dawson et al96 for the need of 
a new self-reported measure to assess function in SCI which would represent the patient’s 
perspective. Self-assessment of function may help patients who, according to May et al,291 
want to become self-aware and take responsibility for problem solving. The FIM self-
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report measure developed recently provides a measure of perceived functional 
independence.286 Although SCIM III, as used here, is not a new self-reported measure but 
an adaptation of a current measure, it is the first attempt to present the patients’ 
perspective about their function rating while using a SCI-specific measure. The fact that 
participants in this study managed to complete the scale without problems indicates that 
function in SCI can be assessed via self-reporting. Future studies may need to include new 
items in this particular scale, aiming to capture the cognitive aspects of the functional 
challenges and the behavioural outcomes as perceived by the patient.  
The second positive implication of using this self-reported measure links to a realistic 
structure around long-term rehabilitation. Patients request improvement in long-term 
rehabilitation,61 the “expert patient” and CDSMP models promote empowering of the 
patients, teaching them skill while seeking to reduce the socioeconomic cost of injury and 
rehabilitation.106,191,453 The continuous process of rehabilitation requires constant 
identification of problems that need to be addressed,421 and patients want to know 
practical information like for their “bladder & bowel” problems,291 thus the patients’ self-
assessment of their function will help them to “keep an eye” on any changes while 
growing older with SCI. Consequently, they will be able to feed back to their individual 
therapists or their rehabilitation group with the aim of responding quickly and in an 
appropriate manner to the changes noticed. While there are numerous course places 
currently in the UK on “expert patient” programmes, there are no such programmes in 
Greece. Thus, Greeks may have to rely more on their own individual self-assessment and 
report to their private health professional if they have one.           
 
11.3.4 The significance of cross-national reports 
This study provides some findings that are new to what it is known so far in regard with 
living with SCI. First, using a single study to compare groups of people from these 
particular three nations has not been conducted before. The information collected adds to 
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the minimal information known about SCI in Greece and, in particular, about the 
perception of the patient of their own experience where pain, QoL and function are 
concerned. The next step will be to ask patients with SCI in Greece in more detail about 
the experience of living with SCI. This could be done via in-depth interviews which give 
better “insider” information99 or structured face-to-face or telephone 
interviews.61,86,109,230,242 
Where LBP in iSCI is concerned, an examination of it in such detail has not been done 
before. The relevance of LBP by level of injury is a new report, and the quality and 
intensity of LBP by examining the three dimensions of LBP, as described by Melzack, is 
carried out for the first time. Linking this information with QoL and function enables a 
better understanding of the biopsychosocial model of LBP in this population. The findings 
show that the experience of LBP may be worse than that of pain in general in iSCI and 
concludes that the importance of LBP in SCI may have been underestimated. This ought to 
be examined and reported more in the literature and more studies are needed to confirm 
it. People with SCI who are in pain may be more prone to being caught in a vicious cycle of 
increased pain, social isolation, inaccessibility and reduced QoL because they may have to 
overcome more hurdles compared to people with pain but without SCI. Disabling LBP 
needs to be considered when pain is discussed in SCI.       
Finally, another original result of importance is the conclusion that Greeks with iSCI report 
lower QoL compared to their equivalents from the other two nations. Possible reasons for 
this finding were discussed in the previous chapter and will not be repeated here. This 
study provides the first reference document for Greeks with iSCI in regard to their LBP, 
QoL and function, which health professionals can use and take the research forward. 
Research in Greece now needs to be tailored towards understanding why Greeks may 
differ from other groups from countries that developmentally are not dissimilar. The 
question they need to ask is “how much this effect is a result of the health care system or 
is it a cultural issue?” 
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11.4 Strengths of the study and the significance of the findings 
This study has a number of advantages that derive from its methodological approach and 
shows positive implications for the future research directions in SCI. 
 
11.4.1 The power of modern data collection methods 
This study is the first to recruit participants and collect data on SCI online while 
simultaneously studying three countries. The use of modern technology in research and 
also in clinical patient assessment had been steadily increasing over the past few years. 
Previously, there have been single-nation studies which used electronic tools (i.e. pain 
diaries, 2- or 3-D drawings) to collect data from subjects including people with 
SCI.167,355,385,463 It may be considered that people with functional difficulties may be limited 
or even unable to use a computer to complete an online survey; however, there is no 
strong evidence to support this. On the contrary, computer usage by people with SCI is 
high172 (USA statistics). Consequently, the decision to use this method of data collection 
with this specific group of participants is defensible. Although this methodology still has 
challenges and limitations, techniques can be used to adjust to the needs of the study. 
This enables online surveying, which is a tool with immense potential, to be deployed 
when cross-national designs or large group sizes are desired. Indeed, at the time when this 
study was recruiting participants, the team of Turk D, Dworkin R and colleagues129,449 
started publishing their work which included a web survey  studying pain and they 
recruited a much larger sample than the one for this study (nearly 1000 participants).129 
Following personal communication with the author (Dworkin R on 13/01/2012), it was 
reported that some people with SCI were likely to have participated in their web study, 
however analysis did not reveal this distinct group of patients. Thus, participation and the 
number of people with SCI completing their web survey129,449 is not given.  
The current study demonstrates that surveying people with a physical disability like SCI 
can be achieved using online methods. This has multiple implications that can affect the 
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future of both research and rehabilitation in SCI. First, researchers will benefit as they can 
design and run studies in SCI with reduced costs and faster data collection, making 
international studies easier to conduct and facilitating the understanding of the 
experience of pain in SCI. Moreover, patients across countries can participate in research 
which empowers them to have their “say” by including them in the process of making 
general decisions about care and future directions in SCI. Though these benefits for 
patients participating in research are not unique to online studies, the additional benefit 
of online research is that this opportunity can be given to a greater number of people 
many of whom could not participate in a paper survey for various reasons.  
Another benefit of an online survey seems to be the possibility of collecting some data on 
“non-returned” (drop-out) questionnaires as the database holds information on the 
system for any questionnaire that has been started but not submitted. In this way, the 
researcher may be able to start exploring the reasons why some people decided not to 
complete and return the survey. A postal paper survey is unlikely to offer this information 
unless the researcher has access to some of the non-respondents profile characteristics 
(e.g. demographic information) which would be difficult if the survey is anonymous. In the 
current survey there were “non-returned” questionnaires (n=136) in which the people 
who dropped out completed some questions related to pain. These have not been 
analysed further, as this was not within the aims of the current project, but they could be 
considered for possible later analysis. 
Usage of online tools can be beneficial for patients’ rehabilitation as well. Tele-
rehabilitation is a recently suggested method of rehabilitation in SCI, with encouraging 
early results, where patients give feedback electronically and are monitored via 
videophone sessions.93,160 Assessment of function was done using the SCIM by 
observation before discharge from the SCI unit and again at six months. A home exercise 
programme was conducted and function for one group improved. Some functional tasks 
were assessed during the videophone sessions via interview.93,160 The use of SCIM III by 
self-reporting, as suggested in the current study, may add to the future benefits of tele-
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rehabilitation. In Greece, a similar programme of telemedicine-assisted home support was 
used for people with pulmonary problems and a decrease in hospitalisations and use of 
health services was found.473 As patients have expressed the desire to have a 
multidisciplinary outreach team to help them adjust in the community,86 the future of 
smooth transitions from SCI units or general hospitals (in the case of lack of specialist 
units) to the community and the monitoring of patients’ progress could fall within the 
remit of online technology. This could potentially help bring health care costs down, which 
is an ever-present goal of health departments, while maintaining contact with the patient.    
 
11.4.2 Statistical analysis 
Another strength of the study that should be mentioned here relates to some of the 
methods used in the statistical analysis. The study aimed to be descriptive both when 
presenting differences and correlations between groups. The only exceptions were testing 
of SCIM III and GR-SCIM III and investigation of the effect of the “country of residence” 
where methods of factor analysis were used. The chosen analysis was suitable for the 
purpose of the study but did not rely solely on NHST43. Correcting for multiple testing, 
finding the 95% CI and the effect sizes, which are increasingly a requirement in published 
literature, enhance the reliability of the results. Often descriptive studies in the literature 
fail to report these statistical components. Application of the Bonferroni correction 
resulted in losing some statistically significant results but strengthened those found. A less 
conservative test, like the Sheffé, could have been used which may have allowed more 
statistically significant results to have passed the alpha level but these tests are less 
accurate on reducing Type I error than Bonferroni. Descriptive studies that seek to explore 
new areas for research need to include in their analysis at least these statistical 
components.  
                                                     
43
 Null Hypothesis Statistical Testing. 
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11.5 Reflection upon the study limitations  
This study has a number of original contributions and strengths but there are limitations 
as well, that are often unavoidable in research and some may be out of the control of the 
researcher. However, they should be acknowledged and discussed, as future researchers 
may find them informative for their own research purposes.   
 
11.5.1 Length of the questionnaire 
It is possible that the length of the questionnaire was a limitation of the study. Though 
opinions about the importance of the length of the questionnaire differ, it may be true 
that some people dropped out of the study because of it. Indeed, a number of people 
started the questionnaire and did not complete it, but they could have done so for a 
number of reasons other than the length of it. Around 6% of respondents commented on 
the presentation of the questionnaire and the length of the questionnaire was not among 
their concerns. The current survey shows that designing a lengthy and possibly 
complicated online questionnaire, but applying additional measures to outweigh its 
length, can be enough to give completion rates very similar to postal surveys. This is 
encouraging, and shows that as both researchers and participants gain more experience in 
this methodology, completion rates will probably rise.   
 
11.5.2 Non-probability sampling 
Non-probability sampling, as used here, can be a limitation in the discussion of 
generalisability. Furthermore, the fact that not all people with SCI have access to the 
internet limits generalisability of the results even if random selection sample methods 
were applied. Though both are acknowledged limitations of the study, they are problems 
not solely encountered in internet surveys, as a telephone survey may suffer from the 
same problem because not everyone, for example, is registered in the phone book. Health 
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professionals in both clinical and research settings should encourage people with SCI to 
use the internet, which is likely to benefit them as individuals, but also help promote 
online research. The wider use of the internet is more likely to reduce barriers in the 
discussion of generalisability.  
 
11.5.3 Generalisability 
By comparing the profile characteristics of the participants to those of other studies the 
discussion of generalisability can be promoted. The current study used community 
samples which are extensively used in non-online surveys.  
While more women participated compared to the majority of non-online studies, this 
need not be attributed to the online methods because this has been noticed in non-online 
studies too. It may be that more women with SCI are starting to participate in studies.  
The current study found that its participants were injured at a slightly older age and mean 
age at study was at the upper range of that commonly reported in non-internet studies. 
But since age at injury is rising,332 this difference should not be attributed to the online 
methods.  
Participants in the present study had a higher level of education than in other non-online 
studies112,299 which may be a result of following online methodology and could possibly 
contribute to the low missing data found in the completed questionnaires. The 
participants may not have had difficulty understanding the questions including SCIM III, 
which uses a terminology that non-health professionals may consider difficult. Then again, 
the knowledge of SCI-related terminology by people with SCI should not be 
underestimated. Accessibility and exposure to new technologies could help reduce the 
educational gap between people who respond to online and non-online studies.  
The final difference noticed between the current group and those in previous non-online 
studies, was the percentage of people who were married which was higher in this study. 
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This may not necessarily be attributable to the online method but it could be due to other 
factors such as the presence of more women in the group, the higher level of education of 
the sample or the incomplete injury, all of which can contribute to a reduced divorce rate 
in SCI.42,110 Bearing in mind the differences in the level of education and marital status, the 
current group has the characteristics of people with SCI who live in the community, thus 
generalisability of the results may be considered, but with caution. 
When considering generalisability of the results from Greece, age may be a limitation. The 
Greeks were older both at the time of the study and the time of their injury compared to 
people from the other national groups or studies in the literature. The Greeks were found 
to be of older age at injury249 compared to other non-Greek studies but not as old as in 
the current study. There are not many studies conducted in Greece, either 
epidemiological or recruited via the community, and the lack of any central SCI 
registration restricts conclusions as to whether the current Greek group is similar to the 
general community SCI population in Greece. While it cannot be conclusive which factor 
affected this finding, generalisability of the results when discussing iSCI in Greece alone 
cannot be assumed. This constitutes another reason why further investigation of SCI in 
Greece is necessary as, in order to implement clinical pathways for assessment and 
rehabilitation that are found to be effective in other countries, an understanding of the 
differences or similarities in the profile characteristics of the groups must be established.  
 
11.5.4 Self-completed questionnaires 
The self-completed questionnaire is a very common technique used in survey methods 
but it imposes a number of limitations. One of them is that it cannot be guaranteed that 
the questionnaires were indeed completed by people with SCI even though there is no 
reason to believe otherwise. While only a small percentage of people did not know the 
completeness of their injury, the lack of a physical examination or access to medical 
records to confirm the ASIA level of injury may be another limitation of the study. While 
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there are limitations to self-completion, it needs to be emphasised that self-report 
enables people to express their own experience of pain and SCI, which is essential for 
patient-centred goal setting, allowing researchers to have a better insight into the 
perception of the dimensions of pain. For these reasons, research using self-completion 
measures should be encouraged.  
 
11.5.5 SCIM III 
Another limitation may arise from the psychometric properties of SCIM III. The subscale of 
“respiration and sphincter management” had the lowest internal consistency, particularly 
in the English version. This may be attributable to a number of factors. The translation into 
Greek may need improving as the translators found two of the four items in this specific 
subscale to be the most difficult to translate. But, the internal consistency for this subscale 
in the English version, which was not translated, was lower than the Greek version. This 
implies that the difficulty of the subscale was not because of the translation. It could be 
that the respondents may have had difficulty understanding the meaning of the questions 
and gave an approximate answer thus reflecting a potential difficulty with the wording of 
the subscale itself. This particular subscale had the lowest reliability in the original English 
version of SCIM III222 which could indeed indicate difficulties with the wording of the 
subscale. Thus, some of the wording of SCIM III may need to be simplified without 
changing what the function intended to be measured.  
Consideration also needs to be given to the type of the injury of the participants which 
may have affected the results of SCIM III which was originally tested for use with pooled 
groups with both complete and incomplete injuries.64,222 When a measure is used under 
different conditions from that originally intended, its characteristics may be different.96 
Future researchers need to examine SCIM III in incomplete SCI only to investigate this 
concern. If similar findings emerge, then adaptations to the SCIM III may be required in 
order to take account the completeness of the injury of the respondent.     
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The high level of ceiling and floor effects, which were beyond the recommendations for a 
good health measure,295 need to be reflected upon. There have been other studies in the 
literature to report similarly high ceiling effects of measurements295 including the SF-361 
and the SCIM III3 or SCIM II,495 which may  flag up concerns about the suitability of a tool 
for usage with certain patient groups. The high percentage of ceiling effects found here 
could be attributed to the fact that the respondents were less impaired as they all had 
incomplete SCI. Ackerman et al3 used SCIM III to study people with complete SCI and 
found a higher percentage of ceiling effects among people with less impairment, which is 
in line with the findings of the current study. Both the studies of Ackerman et al3 and 
Wirth et al495 found SCIM to respond to change. They included people with complete 
injury and within the first year of their injury. This means that overall function may have 
been at lower levels, thus improvements in function could be picked up easily by the 
SCIM.  But, the ability of SCIM III to discriminate progress in function for a group of people 
with incomplete injury and after a long time since injury may be limited, as people may 
have adapted to their new functional needs and limitations thus scoring higher on SCIM at 
baseline. However, as time since injury progresses and the person with SCI is ageing, SCIM 
III maybe more capable of discerning a reduction of function in incomplete SCI. Direct 
comparisons for response to change cannot be made with the two above-mentioned 
studies and the author can only speculate on these assumptions because SCIM III was not 
used to asses functional changes in a before-and-after study design. The author 
recommends future investigation for SCIM III to examine the above mentioned concerns.  
 
11.5.6 Pain onset 
This study asked respondents to state the onset of their pain categories following injury 
and there is no reason to believe that the respondents did not refer to pain acquired after 
their injury. However, the pain experience prior to injury and how this may have affected 
the experience of pain following injury was not examined. In short, whether there were 
any pain risk factors prior to iSCI was not investigated. It may be important that future 
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studies include some questions which examine predisposing or precipitating factors for 
the onset of pain post injury.  
 
11.5.7 Technical difficulties 
The final limitation arose from technical problems during the data collection. The way the 
body chart was presented to the respondents may have created difficulties in completing 
it, thus not capturing the extent of pain efficiently. The second technical problem related 
to the difficulty, at the time, of designing a VAS for online usage as was originally intended 
when the questionnaire was designed, resulting in using the NRS instead. To resolve this 
problem, responses given using the VAS were excluded due to differences found in the 
results. As most of these responses came from the Greek group, comparisons with this 
country when referring to intensity of LBP are of limited value. It is therefore 
recommended that studies use the same scale (i.e. NRS or VAS) to collect data.  
 
11.6 Suggestions for future studies 
While this study has successfully filled in some of the gaps identified during the literature 
search and has achieved its purpose of describing the experience of LBP in iSCI, it has also 
detected a number of areas for further research, many of which have already being 
addressed. They are presented together below.   
 
11.6.1 Regression analysis 
The first area for further research is to expand on the current analysis conducted and 
identify predictors either in a future secondary analysis of the current data or as an 
independent study. Multifactorial models could be designed using stepwise (backward) 
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multiple regression analysis to identify predictors for 1) LBP presence, 2) reduction in QoL, 
and 3) reduction in function in iSCI.  
For the first model, it is suggested that logistic regression analysis could be used to predict 
LBP presence and could include the following factors: 
  
1. Level of injury  2. Age 
3. Cause of injury 4. Gender 
5. Presence of MSKP 6. Number of areas with pain 
7. Country of residency 8. Anxiety/depression 
 
For the second model, it is suggested that multiple regression analysis could be used to 
predict QoL and could include the following factors: 
  
1. Employment  2. Age 
3. Cause of injury 4. Level of injury 
5. Presence of pain in general 6. Presence of MSKP 
7. Presence of LBP 8. Number of areas with pain 
9. Number of pain days felt 
per month 
10. Country of residency 
11. Pain onset post injury 12. LBP onset post injury 
13. Quality of LBP 14. Intensity of LBP 
15. Anxiety/depression  
 
Finally, for the last model, it is suggested that multiple regression analysis could be used 
to predict function and could include the following factors: 
  
1. Age 2. Level of injury 
3. Presence of pain in general 4. Presence of MSKP 
5. Presence of LBP 6. Pain onset post injury 
7. Quality of LBP 8. Intensity of LBP 
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In a regression model used to predict outcome the variables to be included should be 
found significant in bivariate analysis351 which was the case with most of the variables 
proposed in the above three models. However, in cases where some variables are not 
significant in bivariate analysis, but past experience indicates that they are important, they 
could also be included in the model.351 Such variables have been proposed for inclusion in 
the above models, for example, gender and age as predictors of LBP or the various pain 
categories and age as predictors of function. Future researchers may want to include 
other psychosocial variables which may predict LBP presence or changes in QoL and 
function.  
 
11.6.2 Further validation of GR-SCIM III and SCIM III 
As already mentioned, the psychometric properties of SCIM III and GR-SCIM III should be 
further explored in future studies. These studies should include people with both 
complete and incomplete SCI. They could compare usage of the measure by self-
completion and observation and use a before-and-after design to enable examination of 
sensitivity to change. Further attention will need to be given to the subscale of 
“respiration and sphincter management” for both the SCIM III and GR-SCIM III as they 
were found here to have low internal validity. The wording of the subscale may require 
simplification. 
 
11.6.3 Further cultural analysis 
Although this study looked at differences and similarities in the variables of interest 
between and within the groups from the three participating countries, it cannot claim that 
it directly looked into cultural impact. The three countries have similar development 
profiles, which may be affected by social structures and health systems, but probably have 
different cultural and possibly religious structures. Global migration is more extensive in 
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the USA and UK compared to Greece. In addition, Greeks tend to register under one single 
religion and, among the three countries, it is probably the country with the most unified 
culture. A future study may look into cultural influences including variables like religion, 
race/ethnicity, cultural expectations and their impact on the categories of pain, QoL and 
function in iSCI. There is also a need to examine the impact of health care systems on the 
experience of living with iSCI and pain, particularly in Greece. An in-depth interview study 
design would provide essential information. 
 
11.6.4 MSKP, gender and assessment scales 
A future study could seek to examine in more detail the differences of the impact of MSKP 
on QoL and function between genders. Assessment scales or the ISCIDS may consider 
adding some items about the perception of QoL between genders when MSKP is 
investigated. A pain measure adapted differently for men and women, particularly to 
examine MSKP, could be a proposition.  
 
11.6.5 Standardised measures for web-surveys 
As pointed out beforehand, internet research is an area with great potential. The use of 
technological advances to survey people will benefit research as it will strengthen results 
by enabling large-scale studies to be conducted more easily. The SF-MPQ, and other self-
completed measures, could be designed for online completion by people with physical 
disabilities. It is known from Dworkin et al129 that the new version of SF-MPQ (SF-MPQ-2) 
was used online for initial validation testing. The use of SF-MPQ online will be a very 
valuable tool for research in the field of pain.  
2-D body charts have been used for years in clinical settings or in postal surveys and 
advancing technology has transferred the body chart or pain questionnaires into hand-
held devices.82,355,385 More recently, pain drawings have been made into 3-D forms in PDAs 
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and have been used to assess pain in studies including people with SCI or back pain167,416 
with very promising results in the study of pain. The online format of the body chart used 
in the current study presented some technical difficulties thus updating the body chart for 
such use would be a useful tool in future pain research.  
 
11.6.6 Post-thesis secondary analysis 
A post-thesis secondary analysis, or an analysis of data not currently presented as they 
were not part of the objectives of this project, could also be undertaken. This analysis 
could include; 1) more detailed examination of the body chart focusing on areas other 
than the back, 2) analysis of the data from respondents who had a complete injury (and 
were excluded from the current analysis), 3) analysis of the available data from people 
who dropped out and 4) treatment, accessibility to treatment and social support available 
to respondents. This post-thesis analysis may identify further significant or important 
variables that could be included in the three prediction multifactorial models proposed 
above.  
Finally, a future study could build on and adapt the purpose of an intervention study 
originally designed, but not conducted (see postscript), prior to this study which planned 
to use a 3-dimensional movement therapy to treat pain. 
 
11.6.7 Repeating the study 
The design and methodology of this study could be repeated in a new project which could 
use the following comparison groups; 1) people with complete SCI, and 2) people with LBP 
from the general population. The aim would be to enable direct comparisons between 
these groups in order to seek to answer, with more precision, questions about “if” and 
“how” these groups differ and “if” and “how” these differences affect the experience of 
pain.  
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11.7 Reflection upon personal experience 
Planning, conducting and writing up this study has been a journey full of challenges, as 
well as the acquisition of new knowledge and skills. Throughout the PhD journey, 
reflection has helped to identify both strengths and weaknesses related to the project but 
also to me personally. These learning skills can now be transferred to my future research 
environment.  
The current project was developed following a critical moment in my PhD studies, which 
necessitated taking a crucial decision to make a radical change in the direction of the PhD 
and terminate a randomised controlled trial (RCT) and to design the current study instead. 
RCTs are considered to be the “gold standard” in research methodology203  and, at the 
time, it felt difficult to accept a changed methodology and study design. However, 
combining knowledge gained from the original project, together with guidance from the 
literature and a personal desire to design a survey which would use techniques that would 
make it a “good” survey, the current project emerged. As the project developed, it 
became more interesting and more stimulating. With the phrase of Winston Churchill in 
mind “There is nothing wrong with change, if it is in the right direction”,399 this particular 
learning experience is one of the most valuable I take with me from this PhD.  
On being given the opportunity to create a study that could involve more than one 
country, the desire to include my native country and the wish to contribute to the 
knowledge in the field of SCI in Greece was great. This personal desire was also an 
important field of research as such studies in Greece are scarce. In addition, the 
assessment tool translated into Greek could then be used by Greek therapists in clinical 
practice or by researchers in future projects.   
During the period of conducting the study further challenges emerged. Running the study 
in three different countries was one of the major challenges. This management was most 
challenging in Greece where data collection involved more than one method and there 
was a need to organise and set up appropriate links in order for the data collection to be 
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effective. Organising a team of people to work on the translations of the Greek version of 
the questionnaire was another challenge, but I was fortunate enough to identify people 
who were willing to volunteer to assist in the study. Another challenge was to gain 
sufficient understanding of research methods, such that it became clear how and which 
methods were appropriate for this transnational study and then learn how to conduct the 
appropriate statistical analysis. Finally, and as life can never truly be put on hold in order 
to do a PhD, learning to manage some serious personal issues and their consequences at 
the same time was a valuable lifelong skill learned during this process.  
As a physiotherapist, at the onset of my PhD, I had hoped to accomplish a thesis that 
would involve therapy for patients. The journey through this PhD taught me some of the 
challenges that may have to be faced while conducting research and the ability to take 
crucial decisions when necessary. But above all, it taught me that changes can be 
successfully accomplished if we develop the appropriate skills to manage them.  
 
11.8 Summary of key messages and their contributions 
This study influences the field of SCI by providing key messages that are anticipated to 
contribute to all the participating stakeholder groups; 1) researchers, 2) practitioners, 3) 
patients and 4) policy makers. 
Researchers are expected to benefit on various aspects:  
 First of all, the systematic literature review brings into attention the lack of 
research on CMSKP and more particularly on CBP and CLBP. This can become a 
point of reference for the researchers who are now encouraged to conduct further 
studies to confirm the findings of the high prevalence of LBP, and its greater 
interference with QoL and function (compared with pain in general) as shown in 
this research.  
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 This study showed that patients can self-report on their function with no particular 
problems. Undoubtedly, further testing needs to be conducted to confirm this and 
it is anticipated that researchers now will act upon this message. This study advises 
researchers to consider that SCIM III may need to be adapted when examining 
people with iSCI only. 
 Another key finding expected to have a positive impact for people who work in the 
field of SCI in Greece is the availability of the first scale to assess functional 
independence.  Greek researchers can now conduct studies to examine further the 
psychogenic properties of GR-SCIM III and compare it with other studies using the 
English, or other, versions.  
 This research showed that the presence of pain or LBP does not negatively affect 
function in iSCI, on the contrary it may assist it slightly. However, worse intensity of 
LBP does affect function negatively. Researchers are encouraged to look into the 
reasons for increased motivation towards functional independence in iSCI despite 
the pain presence.  
 This investigation confirms that gender needs to be separately examined when 
considering MSKP particularly in relation to QoL and function. Researchers of the 
ISCIDS can consider adding some items related with the perception of QoL 
between genders when MSKP is investigated.   
 This study confirms that surveying people with a physical disability like SCI can be 
achieved. Researchers are highly encouraged to design more studies using the 
same techniques of data collection which will reduce the cost of the research, 
recruit larger samples and enable international studies all of which will facilitate 
the understanding of the experience of pain in SCI.  
 
Practitioners are expected to benefit from this study in many ways too: 
 This study raises awareness about the problem of LBP in SCI. Clinicians are urged to 
include regular and repeated assessment of this category of pain in their clinical 
practise. As the characteristics of LBP interfere with QoL and function it is essential 
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that clinicians work early on addressing these possible consequences of SCI and 
educate patients about them.  
 Self-assessment of function will benefit clinicians as it will allow them to have an 
insight to the patient’s perspective about their function. Practitioners will be able 
to better implement long term rehabilitation in the community in two ways: 1) 
using tele-rehabilitation to follow up and assess patients, 2) patients can assess 
themselves at various point times and feedback to their clinicians. As a 
consequence therapy outcome is likely to improve by the promoted clinician – 
patient therapy alliance.   
 Clinicians in Greece can now use the GR-SCIM III to systematically collect, analyse, 
interpreter and compare their data, using a SCI related measure, which will help 
them to ensure that the most effective rehabilitation is followed.  
 The confirmation that people with SCI can complete a survey online also benefits 
clinicians who can encourage their patients to use the internet and the computer 
to provide fast and regular feedback when living in the community. Usage of the 
computer can also promote QoL.    
 
Patients are expected to benefit in several ways from the findings of this study: 
 Awareness about the problem of LBP is promoted for patients, who work alongside 
clinicians on the “expert patient” model of rehabilitation.  
 Self-assessment of function, which builds on calls to examine function by the 
patients’ perspective (Dawson et al 2008), actively empowers patients in their 
rehabilitation plan which is essential in the “patient centred” model. Patients are 
expected to benefit cognitively by this empowerment as they can feel that their 
perception is taken into account and assessed by using a valid measure. Also, they 
can benefit physically as by regular self-assessment they can monitor changes in 
their function and act appropriately in manner time.  
 The message of this study on the applicability of the internet to survey people with 
iSCI has a positive implication to the patients themselves. More people can be 
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identified from around the world who have their “say” and include them in the 
process of making general decisions about care and future directions in SCI.  
 
11.9 Conclusion 
In conclusion, the main research question of the project “Do people with iSCI have LBP 
and what is their present and usual pain experience?” was answered by examining the 
experience of pain including examination of the extent, intensity and quality of pain 
focusing on the area of LBP. In addition, the effect of pain, concentrating more on LBP, 
QoL and function were investigated as further goals of the study.  
This study demonstrated that people with iSCI have a high chance of suffering from LBP 
which may be of musculoskeletal origin. Usually LBP appears in the first six months 
following injury, is of moderate intensity and remains stable over time. It is described as 
“aching” and “tiring-exhausting” and is perceived as a “discomforting” experience. The 
presence and the worsening of the quality and intensity of LBP are related to a worse QoL. 
The presence of LBP does not relate significantly to function but increased intensity of LBP 
relates to worse “indoors and outdoors” function.  
Among the three participating countries some differences in the results were noted 
though, overall, these were not major. The Greeks differed from the other two groups in 
both the cause of injury and the age of the participants which may have affected the 
results found. Greeks reported significantly less pain in general but not LBP.  Their LBP was 
less constant and of slightly better quality. The group had more cases of 
“anxiety/depression” and Greeks perceived their health status as worse compared to 
people from the other countries. Finally, they reported the best functional independence 
compared to the other participants. But if pain or LBP was persistent, this had a more 
negative effect on their function compared to respondents from the other countries. 
Hence, overall, Greeks reported a less severe experience of pain, they functioned better 
than others but believed that their health status was worse. As pain reports can be 
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affected by culture or personality,76 this area needs to be further explored. Beliefs about 
pain, such as catastrophising, may have a worse impact on QoL than pain intensity;257 
thus, it may be that such aspects of the LBP experience in the Greek group may lack the 
necessary attention. In Greece, back pain clinics or SCI units are minimal especially in 
provincial areas. Greeks may lack the appropriate understanding provided by their health 
carers of how to deal with the cognitive aspect of pain. If these are concerns in the Greek 
population with iSCI then the Greek health professionals need to pay more attention to 
such perceptions and include therapy options, like CBT to assist in dealing with them. 
The UK group differed from the other two groups in that they reported the highest (but 
not statistically significant) prevalence of all the pain categories examined. They reported 
the worst (but not statistically significant) quality and intensity of LBP. They used the most 
descriptors to describe their LBP and more people, compared to the other countries, 
perceived it as “discomforting”. They reported the worst (but not significantly different) 
health index and significantly worse total function. When the quality of LBP became 
worse, it had a more negative correlation with QoL than occurred when the same 
happened to respondents from the other countries. The presence of pain related to 
stronger, negative correlations with functional reduction compared to the other two 
groups. Consequently, people from the UK were more severely affected by the experience 
of pain, which then correlated with their health status classification and their function.  
The USA group was the biggest group and often statistically significant results found for 
the pooled group maintained their significance only within the USA group in the cross-
national analysis. The fact that this group was larger in size may have contributed to this. 
Respondents from the USA were the youngest among the participants and their LBP was 
of moderate severity. Their overall pain experience was not as severe as that of people 
from the UK. Similarly, as already mentioned, their QoL was slightly better and their 
function was significantly better than for people from the UK.  
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The findings of this study provide new information and propose directions for research, 
clinical assessment and rehabilitation. The study brings to the surface a topic given little 
attention in the literature, as shown by the systematic review, but one of significance to 
the patient, as found in the survey conducted. It shows that the presence of pain can be 
disabling but there may be other factors, not examined here, possibly psychosocial, that 
may motivate people with iSCI to overcome it and remain active. The findings conclude 
that self-assessment of function in iSCI can be reliable which will help in the long-term 
rehabilitation goals of the patients. Empowering patients and motivating them to become 
active participants in their own rehabilitation plans, offering them self-assessment tools to 
do so, will undoubtedly have a positive impact on them, their families and carers.  Early 
management of pain and LBP could lead to a reduction in recurrence of pain, chronicity of 
pain, hospital visits, keep health costs down and, above all, increase the QoL of the 
patient.  
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1. Original study plan 
The original plan of this thesis was to conduct a single-blind, experimental, randomised 
controlled trial using two types of participants: people with iSCI and children with cerebral 
palsy (CP). The aim was to investigate the therapeutic effect of 3-dimensional movement, 
via using the Brunel Active Balance Saddle (BABS) which is a horse simulator, on pain 
(including LBP), balance and posture.  
 
2. Study methodology 
Preliminary information was collected for the study by developing two questionnaires and 
sending them to two different samples; 1) physiotherapists working in the National Health 
Service (NHS) with people with neurological conditions including SCI and 2) therapists 
providing horse riding treatment. The aim was to ask the therapists directly about pain 
(including LBP), balance and posture problems among their patients, reasons for 
developing these problems and to identify therapies used to treat them, including horse 
riding.  
The NHS sample was selected using simple random sampling technique via information 
available on the NHS website. Thirty-nine physiotherapy units entered the final sampling 
frame. As this survey was done for exploratory reasons, 25 participants were believed to 
be sufficient to provide the information needed to design the next stage of the project. 
Twenty-six questionnaires were returned.  
To identify eligible participants for the second sample, the Association of Chartered 
Physiotherapists in Therapeutic Riding (ACPTR) members’ list was used and questionnaires 
mailed to randomly selected people from the list. Twenty-seven questionnaires were 
collected.  
The second stage of the study involved the main trial. Using information gathered from 
the questionnaires and by reviewing the literature, the study was designed. The 
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assessment tools to be used were selected, volunteer physiotherapists to participate in 
the study had been identified and a lab at the School of Health Sciences and Social care 
hosted BABS and was ready to host the trial.  
 
3. Ethical approval and research and development (R&D) approvals  
The proposal for the study was submitted to a Multicentre Research Ethics Committee 
(MREC). Following corrections and amendments ethical approval to conduct the trial was 
granted nearly one year post original submission of the proposal to the Ethics Committee. 
The next step involved gaining research and development (R&D) approvals via Primary 
Care Trusts (PCT) and hospitals. More than one year after the MREC ethical approval, only 
two R&D approvals were given, five were pending and others had declined. Twenty-five 
eligible participants (people who expressed interest in the study) were identified but 
access to their medical records was not yet granted. The time-consuming procedures to 
obtain approvals led to insufficient recruitment in the time frame available and, as a 
result, the study was terminated.       
 
4. Moving on 
Not completing the PhD was not an option for me. Following reflection upon the 
information gathered thus far, a different approach and a new project was designed. The 
vast majority of the physiotherapists, who returned the questionnaire sent to them as 
part of the original project, and who worked in the NHS, said that up to half of their 
patients with neurological disabilities had LBP. They also said that their patients would 
only complain about their pain when it interfered with everyday activities, when pain was 
acute and when asked. It was interesting to note that more than one-fifth of the 
therapists said that their patients would report their pain only when asked. This implies 
that pain is present but not necessarily recorded. This was one of the main reasons that 
led to the development of the current project of this thesis, which has been described in 
Chapters 1-11, and which directly asked people to report on their pain.   
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Table 1: Criteria for allocating studies to research questions  
Article Source of 
sample 
Chronic Pain 
definition started (≥3 
months) 
Chronic pain 
definition provided 
by author 
Tool assessing 
chronic pain 
(≥3 months) 
Report on 
musculoskeletal 
pain 
Report 
on back 
pain 
Report on 
LBP 
Rintala et.al381   community lasted or recurred 
over at least 6 months 
 
______ 
None used Yes Yes Yes 
Barrett et.al19  secondary NR ______ CPGQ Yes No No 
Cardenas et.al58  community NR ______ CPGQ Yes No No 
Siddall et.al406  community NR ______ CPGQ Yes No No 
Cruz-Almeida et.al90  community NR ≥3 months None used No Yes No 
Rintala et.al382                     community continuous or 
intermittent for at 
least 6 months 
______ None used No Yes No 
Ullrich et.al457 community NR ______ CPGQ No Yes Yes 
Raissi et al371 community 
centres 
NR ______ Not known No No Yes 
Abbreviations: NR, Not Reported; CPGQ, Chronic Pain Grade Questionnaire; LBP, Low Back Pain  
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Table 2: Description of the selected papers under review 
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Table 2 continued: Description of the selected papers under review 
Paper or paper 
groups selected 
Description Design 
Rintala et al
380
 Aim to find prevalence and characteristics of chronic pain in SCI/dysaesthesia in a group of veterans recruited 
via a SCI veterans’ centre. Response rate 66% and some additional information about the number of 
participants with complete/incomplete paraplegia/tetraplegia, and the exact number of people reporting pain 
at each area of the body was provided to us.    
Cross-sectional 
telephone 
interview 
Multiple studies 
Turner et al
451 
Jensen et al
36 
 
 
Overall comment 1 
 
 
 
 
 
Raichle et al
370 
Molton et al
318  
Ullrich et al
457 
 
Hanley et al
190 
 
 
Overall comment 2 
 
University led study. Aim to study pain in SCI. Return rate 64%. CPGQ was used.  
Surveyed people who had participated in two previous studies, one of which was Turner et al. (Turner et al., 
2001)
 
Aim to assess severity of pain in SCI and change of pain prevalence and intensity at specific sites. The 
results were compared to national norms. Return rate 49%. 
Further publications were identified
38, 39, 40, 44 
and differences in the reported sample size for each paper were 
noted. Following personal communication with the authors it was explained that the publications were products 
of the longitudinal study by Jensen et al (2005)
36 
but
 
surveys were mailed out in waves therefore resulting in 
additional participants. It was also confirmed that the participants largely came from the study by Turner et al 
(2001)
43 
and also that each sub-study included subjects from the previous (Jensen et al., 2005)
 36
but only 
reported on people who had provided complete data for the variables investigated in the particular study.  
Examined the biopsychosocial model in order to understand and treat pain in SCI. Return rate 50%. 
Another publication from same study related to “Motivational model of pain self-management”. 
Used data only from people who had reported current pain aiming to check the characteristics of pain location, 
intensity and interference and also to examine the areas of the body with more intense pain.  
Is a six months follow-up study of Jensen et al. (2005).
36
 Due to an administrative error, the whole sample was 
not surveyed. Aim to examine how coping, cognitive and social environment associate with psychological 
functioning and pain interference at six months follow-up.  
Even though the subjects of each of the sub-studies
 
did not overlap 100% of the time, the subjects mainly came 
from the same group, therefore it was decided to group all these publications as one study, starting from Turner 
et al. (2001).
43 
None of the papers made particular reference to MSKP in general but they referred to BP or LBP.  
Postal survey  
Raissi et al
371
 Studied people who sustained a SCI following an earthquake in Iran aiming to investigate pain among other 
things. They worked on the earthquake site immediately after the event (for three months) and they returned 
for evaluations at eight months. Physical examination was conducted. They report on LBP.  
Physical 
examination at 
patients location 
(residence or 
treatment centres) 
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Table 3: Description of participants as reported in the studies  
 
¹ Only the demographic characteristics of the 163 (out of the 215) patients (who reported pain) were described, ²No information given to the specific causes of the 
traumatic injury, ³Demographic and SCI characteristics are from Wideström-Noga (1999),
492
;  
4
Demographic and SCI characteristics are from Turner et al.
451
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Table 3 continued: Description of participants as calculated in the super-sample  
Super-
sample 
N of 
participants 
Gender Ratio 
(M:F) 
Cause of Injury Level/Completeness of 
Injury 
N of participants 
Time since Injury 
(years) 
mean±SD, min-max 
Age of participants 
mean±SD, min-max 
Studies 
discussing 
CMSKP 
n=453 n=277;  
144 (52%) motor accident,  
55 (20%) fall,  
22 (8%) diving/water 
accident,  
14 (5%) gunshot,  
17 (6%) sport accident,  
25 (9%) other  
n=399;  
211 (53%) tetraplegia 
188 (47%) paraplegia 
n=73;  
28 (38%) complete 
45 (62%) incomplete 
Range 3 – 51 years Range 40 – 48 years 
Studies 
discussing 
CBP or CLBP 
n=1312;   
M=823 (63%) 
F=489 (37%) 
n=1311;  
558 (42.6%) motor 
accident,  
166 (12.6%) fall,  
238 (18%),  
82 (6.3%) diving/water 
accident,  
80 (6.1%) gunshot,  
78 (6%) sport accident,  
62 (4.7%) violence,  
53 (4%) earthquake 
n=1302;  
654 (50.2%) tetraplegia, 
648 (49.8%) paraplegia             
n=1154;  
473 (41%) complete,  
681 (59%) incomplete 
Range 8 months – 17 
years 
Range 29 – 55 years 
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Table 4: Percentage of chronic pain per body areas    
Article key 
Number 
Trunk Back Upper Back Lower back Buttocks 
Rintala et al381 
 
1% (a.a.p) 
1.4% (a.p.p) 
(n=8) 
34.4% (a.a.p) 
47.1% (a.p.p) 
(n=13) 
NR NR NR 
Cruz-Almeida et 
al90  
NR 60% (a.p.p) 
(n=130) 
NR NR 52.8% (a.p.p) 
(n=115) 
Rintala et al380 
 
14.1% (a.a.p) 
16.1% (a.p.p) 
(n=49) 
13.5% (a.a.p) 
17.7% (a.p.p) 
(n=47) 
NR NR NR 
Ullrich et al457  
 
NR 46.3% (a.a.p) 
58.6% (a.p.p) 
(n=178) 
29.6% (a.a.p) 
40.8% (a.p.p) 
(n=97) 
42.7% (a.a.p) 
58.8% (a.p.p) 
(n=140) 
32.9% (a.a.p) 
45.4% (a.p.p) 
(n=127) 
Raissi et al371  
 
NR NR NR 29.6% (a.a.p) 
30.7% (a.p.p) 
(n=54) 
NR 
¹Under the group publications referenced as90 are the characteristics as presented in Widerström-Noga 2003484  
Abbreviations: a.a.p, Among all participants; a.p.p, Among participants with pain; NR, Not Reported.  
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Table 5: Description of chronic pain participants as described in the studies 
 
Results in italics are after this review’s calculations, NR: not reported, ¹Under the group study referenced as Cruz-Almeida et al., 2005
90
 characteristics of 
participants taken from study Widerstrom-Noga et al., 2001,
488
;  ²Information taken from Turner et al.
451
 Appendix 1 
 
46 
Table 6: Characteristics of CMSKP, CBP and CLBP      
Article key 
Number 
Assessment 
tool used 
Onset of pain Pain severity or description Pain intensity 
mean±SD 
Pain related 
disability 
Rintala et al381  
 
SF-MPQ¹ 
NRS² 
Body 
diagram 
NR NR 3.5  
Barrett et al19  
 
NRS 
VRS³ 
CPGQ 
18.02±11.4 years 77% mild/moderate 
23% severe/excruciating 
57.4±26.7 Reported for all 
pain 
Cardenas et al58 
 
SF-MPQ 
VAS4 
CPGQ 
NR 
 
Mechanical spine pain  
93.5% aching 
76.1% tiring-exhausting 
69.6% sharp, 58.7% tender 
56.5% stabbing, 54.3% shooting 
52.2% throbbing 
76.1% nagging¥, 71.7% tight¥ 
Mechanical spine pain 
18.02±11.4 years§ 
53.7 (±21.2) 
Overuse pain 
53.6 (±19)§ 
54.8 (±19.8)^^ 
32.8% Grade I 
21.3% Grade II 
19.75 Grade III 
26.2% Grade IV 
Cruz-Almeida et 
al90 
 58.5% <6 months (n=72) 
36.6%>6 months (n=45) 
35% <1 year (at level) 
28% 1-10 years (below level) 
37%>10 years (at & below 
level) 
   
Raissi et al371  
 
NRS 87.5% of those with LBP 
started after injury 
 46.3% scored 10 (0-10 
scale) 
64.8% scored >5 (0-10 
scale) 
 
¹SF-McGill Pain Questionnaire, ²1-5 scale,³Verbal Rating Scale; using mild, moderate, severe and excruciating, 4VAS 0-100, ¥Descriptor from original 
MPQ, §Mean for worst pain, ^^Mean for second worst pain, CPGQ; Reported for worst MSKP on the CPGQ; Grade I: “low pain intensity-low pain-
related disability”, Grade II: “high pain intensity and low pain-related disability”, Grade III: “moderate pain-related disability” and Grade IV: “severe 
pain-related disability 
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Participant information sheet for adults with Spinal Cord Injury 
      
 
Dear Sir/Madam,  
 
Study Title: “The study of pain experience, its intensity and its effect on the lives of 
people with Spinal Cord Injury (SCI) in United States of America (USA), the United 
Kingdom (UK) and Greece”.  
 
Invitation paragraph 
You are invited to take part in a research study. Before you decide it is 
important that you understand why the research is being done and what it will 
involve.  Please, read the information below carefully and discuss it with others if 
you wish. 
 Part 1 tells you the purpose of this study and what will happen to you if you take 
part.   
 Part 2 gives you more detailed information about the conduct of the study.  
Ask me if there is anything that is not clear or if you would like further information.  
Take time to decide whether or not you wish to take part. 
 
What is the aim of the study? 
The aim of the study is to look into pain in general and Low Back Pain (LBP) 
in particular in people with Spinal Cord Injury (SCI). The experience of pain and 
how it may affect quality of life and function will be explored. Finally, different 
health service systems and cultural influences that may affect pain will be 
discussed as the study is taking place in the USA, the UK and Greece.   
Why have I been identified? 
You have been identified because you have SCI and you may fit the 
inclusion criteria of this study. A minimum of 185 people with SCI living in the USA, 
UK and Greece will participate. 
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How was I identified? 
You accessed information about this study via the Spinal Injury Association 
(SIA). Due to the Data Protection Act I can not have direct access to your contact 
details. For this reason SIA was approached and asked to participate in this study. 
They have approved of this study and a local collaborator was identified and 
agreed to post this questionnaire on line or send it to you via email.  
 
 Do I have to take part? 
 No, it is up to you to decide whether or not to take part. If you decide to take 
part you have the option of replying anonymously. If you decide to give us your 
name we assure you that all personal information will be treated with strict 
confidentiality. A decision not to take part will not affect the standard of care you 
receive.  
 
What kind of study is it? 
This study is part of a larger PhD project that investigates pain in general 
and LBP in particular in adults with SCI and children with Cerebral Palsy. One of 
the aims of the complete PhD project is to investigate how a specific therapy based 
on 3-dimension movement could benefit LBP, posture, balance, function, and 
quality of life in these populations.  
This current part of the project, in which you are invited to participate, 
consists of a self-completed questionnaire, which is included in this letter, aiming to 
be answered by people with SCI only. In the second part of this letter you will find 
detailed information on how to fill in the questionnaire booklet.  
    
What are the possible benefits of taking part? 
 Pain has been found to be part of the everyday life of people with SCI and in 
many cases it may cause stress and anxiety and affect quality of life and interfere 
with every day activities. However, pain experience overall and LBP in particular 
have not been well studied in people with SCI. 
 
  It is expected that you will gain indirect benefits as the results of this survey 
will investigate questions related to pain and may contribute to raising awareness 
and provoking further studies aiming to improve pain symptoms, quality of life and 
function in people with SCI and pain.  
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 What will happen to me if I take part? 
All you will have to do is answer the enclosed questionnaire booklet and 
return it to me.  
 
Will I have to pay anything? 
No, you will not have to pay for anything. We provide you with a stamped 
addressed envelope for you to put in the completed questionnaire booklet and 
return it to me.  
Are there any risks involved?  
There are no potential risks expected as a result of your agreement to 
complete the questionnaire.   
 
What if I do not have any LBP or any pain? 
 It is very important that you reply to this questionnaire even if you do not 
have any LBP or other pain. This will provide us with valuable information 
regarding the prevalence of pain and LBP in SCI and enable us to do statistical 
comparisons between the people who have and those who do not have LBP and 
pain. In the questionnaire booklet you will find instructions on which questions to 
answer if you do not have pain or LBP.  
 
What if there is a problem? 
No problem is expected, however if this is the case it will be fully discussed 
with you.  
 
Will my taking part be kept confidential? 
Yes. Any information about you that has your name and address is removed 
so that you cannot be recognised from it. All data will be kept in locked cabinets, 
located in the University building, and accessed only by me.   
 
 
Thank you for reading so far – if you are still interested please, go to Part 2 
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Part 2 
 
What will happen if I do not want to carry on with the survey? 
If you decide to take part you are free to withdraw at any time and without 
giving a reason. A decision to withdraw will not affect the standard of care you 
receive. However, it will be impossible to withdraw questionnaires that have been 
returned anonymously as it will not be able to allocate a name to an anonymous 
questionnaire.  
 
What if I want to complain about anything? 
If you have a concern about any aspect of this study, you should ask to 
speak with the researchers who will do their best to answer your questions. You 
can contact me. If you remain unhappy and wish to complain formally, you can 
contact the supervisors of this study. Their telephone numbers are at the end of 
this information sheet.  
 
Will my doctor be informed? 
No, your doctor will not be informed about your decision to complete this 
questionnaire. However, if at any stage during the study it will be found necessary 
to inform your doctor then your consent will be asked in advance.  
 
What will happen to the results of the study? 
The results will be included in my PhD thesis within the next two years. 
Additionally, they will be published during the years after the PhD completion. If 
you wish, you could contact me and I can send you a report of the results or you 
can find them directly in the journals once published. Under no circumstances will 
your name be identified in any report or publication.  
 
Who is organising and funding the research? 
This study is sponsored by the School of Health Sciences and Social Care 
of Brunel University of West London and partially funded by the Engineering and 
Physical Sciences Research Council (EPSRC) and the Brunel University Graduate 
School. The supervisors of the study are Professor Lorraine DeSouza and 
Professor Ian Sutherland. 
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Who has reviewed the study? 
Before any research can go ahead it has to be checked and approved by an 
Ethics Committee. They make sure that the research is ready to run. This study 
has been checked and approved by the School of Health Science and Social Care 
Research Ethics Committee. SIA has also reviewed the study and approved of the 
collaboration.  
 
How long will it take me to complete the questionnaire and what does 
it consist of ?  
 It will take you approximately 1 hour to complete the questionnaire. We 
understand that this questionnaire may be long to complete but as it examines 
areas that have not previously been looked into such depth the data collected will 
be of great interest. You may wish to complete this questionnaire into stages.   
The first part consists of three standardized questionnaires. They are the 
Short form McGill Pain Questionnaire, the EQ-5D and the Spinal Cord 
Independence measure.  
The Short form McGill questionnaire examines pain and its dimensions. A 
body pain diagram where you can mark the area on your body with pain has been 
included. Pain intensity is measured on the Visual Analogue Scale (VAS). There is 
also a list of word descriptors that provide sensory, affective and evaluative 
information about your pain.  
The EQ-5D questionnaire measures the quality of life and gives information 
about mobility, self-care, usual activities, pain/discomfort and anxiety/depression.  
The SCIM provides information about function. It investigates the areas of 
self-care, respiration and sphincter management and indoors and outdoors 
mobility.  
The second part of the questionnaire booklet consists of socio-demographic 
data aiming to collect information about your SCI history and treatment and to find 
how they may interact with the presence or not of pain and LBP. This part of the 
questionnaire may also help identify best treatment options.   
 
I want to take part; What do I do now? 
If you agree to take part but you wish to remain anonymous, please 
complete and return only the questionnaire booklet without writing your name 
anywhere in it. If you wish to give us your personal contact details, please, do so 
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when asked. The completed questionnaire booklet should be directly returned to 
me, the chief investigator of the study. If you are sending the questionnaire by 
postal mail please use the address provided below. If you are returning the 
questionnaire online it will automatically be returned to the chief investigator.  
 
I want to take part but can not complete the questionnaire on my own 
 If you are having difficulties reading or completing this questionnaire on your 
own, please ask for the help of a member of your family or a friend. However, 
please make sure that you are answering the questions and they are helping you 
by writing them down in the paper questionnaire or ticking them on the electronic 
version questionnaire. When completing the VAS and the body pain drawing, 
please point to them as accurately as possible where your answer is.  
If you need any further assistant, please do not hesitate to contact me. 
 
Can I do it later? 
Yes. We will be accepting returned questionnaires for at least one month.  
 
I don’t want to take part; What do I do now? 
If you do not want to take part then please, ignore this letter. You may 
automatically receive a reminder letter in the near future. If you still do not wish to 
participate, then please ignore that reminder letter too. However, any information 
you provide us with will be most helpful.  
Thank you very much for taking the time to read this information sheet. If 
you have any further questions please, feel free to contact me. If you wish to 
remain anonymous to me but require further information please contact SIA via 
email or telephone.  
Additionally, if you need further information about your pain please refer to 
the SIA webpage. The link is: http://www.spinal.co.uk/b-04.aspx  
 
Yours Sincerely,  
 
Christina Michailidou, MSc, BSc in Physiotherapy 
Study Chief Investigator 
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Email: christina.michailidou@brunel.ac.uk 
Tel: 01895 268807 
Mob: 07900 930605 
Postal address: School of Health Science and Social Care 
      Mary Seacole Building, Brunel University 
      UB8 3PH, Uxbridge, Middlesex, 
      London, United Kingdom 
 
Study Supervisors: 
Professor Lorraine DeSouza  
Head of School of Health Sciences and Social Care 
Email: lorraine.desouza@brunel.ac.uk 
Tel: 01895 268755 
Professor Ian Sutherland  
Director of Brunel Institute for Bioengineering 
Email: ian.sutherland@brunel.ac.uk 
Tel: 01895 271206 
 
 
 
Thank you very much for reading the information sheet
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 For office use: 
 
 
         : 
 
 
 
 
 
 
 
 
 
 
 
 
 
We are very grateful for your help in completing these questions. The 
information provided helps us to understand more about spinal cord injury and 
the symptoms around it.  Analysis of the results may help us develop future 
treatment options aiming to improve pain and quality of life for people with 
Spinal Cord Injury. 
 
There are no right or wrong answers to these questions.  We are most 
interested in your own personal views rather than those of your family 
or the people who are treating you.  
 We would like you to answer the questions as honestly and as 
quickly as possible. 
 
 If you find it hard to keep your mind on the statements, take a 
short break. The questionnaire may be completed over a day or 
two.  
 
 Some questions are marked with an asterisk (*), at the 
beginning of them, which indicates that an answer is needed. 
Please, answer these questions if applicable to you.  
  
 Based on your answers you may skip some questions. Please, 
follow the instructions of the questions as appropriate.  
 
Thank you very much  
 
Date Completed 
 
 
 
Date analysed 
 
 
 
Questionnaire PIN Number 
 
 
 
Centre Pin Number 
 
 
 
Participant Pin number 
 
 
 
Country 
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Abbreviations: Spinal Cord Injury (SCI), Low Back Pain (LBP), Visual analogue Scale (VAS), 
Pain Rating Scale (PRS), Present Pain Intensity (PPI), *answer the question if applicable to you 
Short-Form McGill Pain Questionnaire 
 
*This picture is a body drawing to help you indicate the areas where you feel 
pain. 
 Please, mark on the above drawing the areas where you feel pain. Put E if 
external, or I if internal, or EI if both external and internal pain is present near 
the areas you mark.   
  
59 
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Abbreviations: Spinal Cord Injury (SCI), Low Back Pain (LBP), Visual analogue Scale (VAS), 
Pain Rating Scale (PRS), Present Pain Intensity (PPI), *answer the question if applicable to you 
1) *Since you got your SCI have you ever felt low back pain (LBP)? 
  Yes   (please, continue with questions below) 
         No   (please, go to EQ-5D, page 5) 
 
I. Pain Rating Index (PRI). 
 
 The words below describe average pain. Place a check mark () in the 
column that represents the degree to which you feel that type of pain. Please, 
limit yourself to a description of the pain in your lower back (lumbar) area only. 
None Mild Moderate Severe
Throbbing
Shooting
Stabbing
Sharp
Cramping
Gnawing
Hot-Burning
Aching
Heavy
Tender
Splitting
Tiring-exhausting
Sickening
Fearful
Punishing-Cruel  
II. *Present Pain Intensity (PPI) - Visual Analogue Scale (VAS).  
      Place a “x” mark along the line to indicate your present low back pain 
(LBP).  
No pain __________________________________________ Worst pain imaginablee 
 
 *Usual Pain Intensity – last 3 months.  
      Please, place a “x” mark along the line to indicate your usual LBP over 
the last 3 months 
 
No pain __________________________________________ Worst pain imaginable 
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Abbreviations: Spinal Cord Injury (SCI), Low Back Pain (LBP), Visual analogue Scale (VAS), Pain 
 Rating Scale (PRS), Present Pain Intensity (PPI), *answer the question if applicable to you 
 
 
 *Usual Pain Intensity – last 1 month.  
      Please, place a “x” mark along the line to indicate your usual LBP over 
the last 1 month 
 
No pain __________________________________________ Worst pain imaginable 
 
 
III. *Evaluative overall intensity of total pain experience.  
     Please, limit yourself to a description of the pain in your lower back 
(lumbar) area only. Place a check mark () in the appropriate column  
 
 
Evaluative 
No Pain  
Mild  
Discomforting  
Distressing  
Horrible  
Excruciating  
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Health Questionnaire 
By placing a tick () in one box in each group below, please indicate 
which statements best describe your own health state today. 
 
Mobility 
I have no problems in walking about  
I have some problems in walking about  
I am confined to bed  
 
 
Self-Care 
I have no problems with self-care  
I have some problems washing or dressing myself  
I am unable to wash or dress myself  
 
 
Usual Activities (e.g. work, study, housework, family or 
leisure activities) 
I have no problems with performing my usual activities  
I have some problems with performing my usual activities  
I am unable to perform my usual activities  
 
 
Pain/Discomfort 
I have no pain or discomfort  
I have moderate pain or discomfort  
I have extreme pain or discomfort  
 
 
Anxiety/Depression 
I am not anxious or depressed  
I am moderately anxious or depressed  
I am extremely anxious or depressed  
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*To help people say how good or bad a 
health state is, we have drawn a scale (rather 
like a thermometer) on which the best state 
you can imagine is marked 100 and the worst 
state you can imagine is marked 0. 
 
We would like you to indicate on this scale 
how good or bad your own health is today, 
in your opinion. Please do this by drawing a 
line from the box below to whichever point 
on the scale indicates how good or bad your 
health state is today. 
9 0 
8 0 
7 0 
6 0 
5 0 
4 0 
3 0 
2 0 
1 0 
100 
Worst 
imaginable 
health state 
0 
Best  
imaginable 
health state 
Your own 
health state 
today 
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Abbreviations: Tracheal Tube (TT), Intermittent Assisted Ventilation (IAV), Residual Urine 
Catheter (RUV) 
SCIM – SPINAL CORD INDEPENDENCE MEASURE Version III 
Self –Care 
1. Feeding (cutting, opening containers, pouring, bringing food to mouth, 
holding cup with fluid) 
0. Need parenteral, gastrostomy or fully assisted oral feeding 
1. Need partial assistance for eating and/or drinking, or for wearing 
adaptive devices.  
2. Eat independently; needs adaptive devices or assistance only for 
cutting food and/or pouring and/or opening containers.  
3. Eat and drink independently; do not require assistance or adaptive 
devices.  
 
2. Bathing (soaping, washing, drying body and head, manipulating water 
tap). 
           A-Upper Body 
     0. Require total assistance 
1. Require partial assistance 
2. Wash independently with adaptive devices or in a specific setting (e.g. 
bars, chair) 
3. Wash independently; do not require adaptive devices or a specific 
setting  
 
             B-Lower Body 
          0. Require total assistance 
1. Require partial assistance 
2. Wash independently with adaptive devices or in a specific setting  
3. Wash independently; do not require adaptive devices or a specific 
setting 
 
     3. Dressing (clothes, shoes, permanent orthoses: dressing, wearing,   
          undressing).  
              A-Upper Body 
     0. Require total assistance 
1. Require partial assistance with clothes without buttons, zippers or 
laces  
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2. Independent with clothes without buttons, zippers or laces; require 
adaptive devices and/or specific setting  
3. Independent with clothes without buttons, zippers or laces; do not 
require adaptive devices and/or specific setting; need assistance or 
adaptive devices and/or specific setting only for buttons, zippers or 
laces   
4. Dress (any clothes) independently; do not require adaptive devices or 
specific setting.  
 
              B-Lower Body 
          0. Require total assistance 
1. Require partial assistance with clothes without buttons, zippers or 
laces  
2. Independent with clothes without buttons, zippers or laces; require 
adaptive devices and/or specific setting  
3. Independent with cwobzl; do not require clothes without buttons, 
zippers or laces; need assistance or clothes without buttons, zippers 
or laces only for buttons, zippers or laces   
4. Dress (any clothes) independently; do not require adaptive devices or 
specific setting.  
 
4.  Grooming (Washing hands and face, brushing teeth, combing hair, shaving, 
applying makeup) 
0. Require total assistance 
1. Require partial assistance 
2. Groom independently with adaptive devices 
3. Groom independently without adaptive devices 
 
Respiration and Sphincter Management 
1. Respiration 
0. Require tracheal tube (TT) and permanent or intermittent assisted 
ventilation (IAV) 
2. Breath independently with TT; require oxygen, much assistance in 
coughing or TT management  
4. Breath independently with TT; require little assistance in coughing or 
TT  management 
6. Breath independently without TT; require oxygen much assistance in 
coughing or TT management 
8. Breath without TT; require little assistance or stimulation for  coughing  
10.  Breath independently without assistance or device 
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Abbreviations: Tracheal Tube (TT), Intermittent Assisted Ventilation (IAV), Residual Urine 
Catheter (RUV) 
 
6. Sphincter Management – Bladder  
0. Indwelling catheter 
          3.  Residual urine volume (RUV) >100cc; no regular catheterization or     
               assisted intermittent catheterization 
          6.  RUV<100cc or intermittent self-catheterization; need assistance for   
   applying drainage instrument 
         9.  Intermittent self-catheterization; use external drainage instrument;  
              do not need assistance for applying   
11. Intermittent self-catheterization; continent between catheterization; do 
not use external drainage instrument  
13. RUV<100cc; need only external urine drainage; no assistance is 
required for drainage 
15. RUV <100cc; do not use external drainage instrument 
 
7. Sphincter Management - Bowel 
0.  Irregular timing or very low frequency (less than once in 3 days) of 
bowel movements  
5.  Regular timing, but require assistance (e.g. for applying   
suppository); rare accidents (less than once a month) 
     8.  Regular bowel movements, without assistance; rare accidents (less  
          than once a month) 
    10. Regular bowel movements, without assistance; no accidents 
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Abbreviations: Tracheal Tube (TT), Intermittent Assisted Ventilation (IAV), Residual 
Urine Catheter (RUV) 
 
8. Use of Toilet (perineal hygiene, adjustment of clothes before/after, use of 
napkins or diapers)  
0. Require total assistance 
1. Require partial assistance; do not clean self 
2. Require partial assistance; clean self independently  
4.   Use toilet independently in all tasks but need adaptive devices or   
      special setting (e.g. bars) 
5. Use toilet independently; do not require adaptive devices or special 
setting  
 
Mobility (room and toilet)  
9. Mobility in Bed and Action to Prevent Pressure Sores 
0. Need assistance in all activities; turning upper body in bed; turning 
lower body in bed, sitting up in bed, doing push-ups in wheelchair, with 
or without adaptive devices, but not with electric aides 
          2.  Perform one of the activities without assistance  
          4.  Perform two or three of the activities without assistance 
          6.  Perform all the bed mobility and pressure release activities     
               independently 
 
10. Transfers: bed-wheelchair (locking wheelchair, lifting footrests, removing 
and adjusting arm rest, transferring, lifting feet) 
0. Require total assistance 
1. Need partial assistance and/or supervision, and/or adaptive devices 
(e.g. sliding board) 
2. Independent (or do not require wheelchair) 
 
11. Transfers: wheelchair – toilet – tub (if use toilet wheelchair: transfer to 
and from; if use regular wheelchair: locking wheelchair, lifting footrests, 
removing and adjusting armrests, transferring, lifting feet) 
0. Require total assistance 
1. Need partial assistance and/or supervision, and/or adaptive device 
(e.g. grab-bars) 
2. Independent (or do not require wheelchair) 
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Abbreviations: Tracheal Tube (TT), Intermittent Assisted Ventilation (IAV), Residual Urine 
Catheter (RUV) 
 
Mobility (indoors and outdoors, or even surface) 
12. Mobility Indoors 
0. Require total assistance 
1. Need electric wheelchair or partial assistance to operate manual 
wheelchair 
2. Move independently in manual wheelchair 
3. Require supervision while walking (with or without devices) 
4. Walk with a walking frame or crutches (swing) 
5. Walk with crutches or two canes (reciprocal walking) 
6. Walk with one cane 
7. Need leg orthosis only 
8. Walk without walking aids 
 
13. Mobility for Moderate Distances (10 – 100 metres) 
0. Require total assistance 
1. Need electric wheelchair or partial assistance to operate manual 
wheelchair 
2. Move independently in manual wheelchair 
3. Require supervision while walking (with or without devices) 
4. Walk with a walking frame or crutches (swing) 
5. Walk with crutches or two canes (reciprocal walking) 
6. Walk with one cane 
7. Need leg orthosis only 
8. Walk without aids 
 
14. Mobility Outdoors (more than 100 metres) 
0. Require total assistance 
1. Need electric wheelchair or partial assistance to operate manual 
wheelchair 
2. Move independently in manual wheelchair 
3. Require supervision while walking (with or without devices) 
4. Walk with a walking frame or crutches (swing) 
5. Walk with crutches or two canes (reciprocal walking) 
6. Walk with one cane 
7. Need leg orthosis only 
8. Walk without aids 
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Abbreviations: Tracheal Tube (TT), Intermittent Assisted Ventilation (IAV), Residual 
Urine Catheter (RUV) 
 
15. Stair Management 
0. Unable to ascend or descend stairs 
1. Ascend and descent at least 3 steps with support or supervision of 
another person 
2. Ascend and descent at least 3 steps with support of handrail and/or 
crutch or cane 
3. Ascend and descend at least 3 steps without any support or 
supervision 
 
16. Transfers: Wheelchair – car (approaching car, locking wheelchair, 
removing arm- and footrests, transferring to and from car, bringing wheelchair 
into and out of car) 
0. Require total assistance 
1. Need partial assistance and/or supervision and/or adaptive devices 
2. Transfer independent; do not require adaptive devices (or do not 
require wheelchair) 
 
17. Transfer: ground – wheelchair 
         0.   Require assistance 
         1.   Transfer independent with or without adaptive devices (or do not  
               require wheelchair)  
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Abbreviation: Spinal Cord Injury (SCI), National Health System (NHS), Transcutaneous 
Electrical Nerve Stimulation (TENS), *answer the question if applicable to you 
 
Socio-demographic Information 
This is the final part of the questionnaire booklet. This part contains three 
sections; the first section asks questions about yourself, at the beginning and 
the end of the questionnaire, the second about your pain in general and the 
third about your LBP. Please, answer the questions as accurately as possible.  
 
Questions about yourself 
1) What is your sex?  
       Male              Female   
 
 
2) What is your date of birth _______/______/_______   
                             day     month     year 
 
3) What is your mother tongue? 
     English      French    Spanish      Arabic       Greek   
        Other  (please state)__________________________________  
 
4) What is your ethnic group? 
              White                                                      Asian  
               United Kingdom (UK)                               Turkish  
        West European – non UK                            Pakistani  
                        North European                                 Indian  
                                        Greek                              Chinese    
  
70 
70 
     East European – non Greek                           Japanese          
      Mediterranean – non Greek                        Other Asian                     
           Other white                         
                               
            Mixed                                                       Black  
     White and Black Caribbean                             Caribbean  
          White and Black African                                  African  
                      White and Asian                           Other Black  
                             Other Mixed         
    
5) What is the highest diploma/ degree you have earned? 
                             High school                                  Masters  
              College or equivalent                  PhD or equivalent        
     University Bachelor degree     
                                       I have not earned any diploma/ degree  
                   Other  (please state)__________________________________ 
 
 
6) What is your marital status? 
            Single              Living with partner                 Married              
         Widowed         Separated/ Divorced    In a relationship  
Other (please state)_________________________________________ 
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Abbreviation: Spinal Cord Injury (SCI), National Health System (NHS), Transcutaneous 
Electrical Nerve Stimulation (TENS), *answer the question if applicable to you 
 
7) *Which of the following best describes your main activity? 
                                                    Self-employed      
                                                           Employed  
    Voluntary work   
                                            Working from home  
                                      Receive health benefits  
  Unemployed but was working before my SCI   
    Unemployed and have never had a paid job   
                           Unable to work due to my SCI  
                                               Looking for a job    
                                                     A homemaker   
                                                               Retired  
                                                              Student   
                              Other   (please state)____________________________ 
 
8) Where do you live? 
    City/ town or village_____________   County_______________________ 
 
9) What is the mile distance between your house and the nearest of the 
following. Please, if you do not know, please leave blank.  
                                       Hospital__________Mile(s)  
            SCI Rehabilitation Centre__________Mile(s)  
   SCI Outpatients’ Specialist Unit__________Mile(s)  
              NHS Physiotherapy Unit__________Mile(s)  
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                  Private Physiotherapy__________Mile(s)  
                                     Pain clinic__________Mile(s)  
Therapeutic Horse Riding Centre __________Mile(s)  
           Other centre of my interest__________Mile(s)  
If “other centre”, please state what type of centre 
_____________________________________________________________ 
 
 
10) *When did you have your SCI?    _______/______/_______  
                        day     month    year 
 
 
11) *What was the cause of your SCI? 
                 Traumatic (please, continue with questions below ) 
                  Non-traumatic  (please, go to question 13, page 15) 
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Abbreviation: Spinal Cord Injury (SCI), National Health System (NHS), Transcutaneous 
Electrical Nerve Stimulation (TENS), *answer the question if applicable to you 
12) *The cause of my traumatic SCI was  
            Road Traffic Accident         
     Bicycle Accident                                       
Assault   
Car Road Traffic Accident                         
Gunshot   
Motorbike Road Traffic Accident                 
Knife attack   
Pedestrian                                 
Other   
                                             Other   
                                                Violence Accident  
              Work related accident                      Domestic related accident 
                Falling of ladders/stairs                            Falling of stairs  
                     Falling of scaffolding             Falling out of the window  
                                Slippery floor                               Slippery floor  
   Tripping over object on the floor  Tripping over object on the floor  
                                            Other                                            Other  
                                                  Sport accident  
        Car racing                                  Horse riding  
          Climbing            Motorbike racing   
            Cycling                                Rugby   
              Diving                         Swimming   
           Football                            Other   
 
If “other” please state_______________________________________ 
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Abbreviation: Spinal Cord Injury (SCI), National Health System (NHS), Transcutaneous 
Electrical Nerve Stimulation (TENS), *answer the question if applicable to you 
13) *The cause of my non-traumatic SCI was  
                                     Vascular         
           Atherosclerosis leading to loss of blood supply  
                                                                     Embolism  
                                                Epidural Haemorrhage  
    Severe hypotension leading to loss of blood supply  
                                                                            Other  
                                    Cancerous (Neoplastic)  
Cancer of the in and around spinal structures, e.g. meningioma, glioma etc  
                  Cancer spread from another site, e.g. lung, breast, prostate etc   
                                                                                                             Other     
Inflammation and infections                             Degenerative 
                     Epidural abscess    Osteoarthritis  
                   Sarcoidosis                   Osteoporosis  
                Transverse myelitis       Paget’s Disease  
                           Tuberculosis          Rheumatoid Arthritis  
                                        Other            Spondylolisis  
                                                      Other  
          Spinal deformity     Other neurological 
                         Kyphosis           Cerebral Palsy  
                    Kypholordosis               Friedreich’s ataxia  
                  Kyphoscoliosis                          Multiple Sclerosis  
                             Lordosis                               Other  
                           Scoliosis  
                       Spinal bifida  
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Abbreviations: Tracheal Tube (TT), Intermittent Assisted Ventilation (IAV), Residual Urine 
Catheter (RUV) 
 
                                 Other  
If “other” please state_______________________________________ 
 
14) *What is the level of your injury? (Please, state the number of vertebra) 
       Cervical are the first 7 vertebrae of the spine; known as C1 to C7 
       Thoracic (upper back) are the next 12 vertebrae; known as T1 to T12 
        Lumbar (lower back) are the next 5 vertebrae; know as L1 to L5 
 
    The level of my injury is 
     Cervical_________      Thoracic_________        Lumbar__________ 
  
 
15) *What is the type of your SCI? 
      Complete paraplegia            Complete tetraplegia   
    Incomplete paraplegia          Incomplete tetraplegia   
                    I don’t know  
                               Other   (please state)____________________________ 
 
16) What type of health insurance do you have? 
          NHS                         Private                  Both  
    Other (please state)_______________________________________    
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Abbreviations: Tracheal Tube (TT), Intermittent Assisted Ventilation (IAV), Residual Urine 
Catheter (RUV) 
 
17) Which insurance have you mainly used for your various SCI related 
treatments?  
           NHS                         Private                  Both  
    Other (please state)_______________________________________    
 
 
18) Where were you first treated for your SCI? 
                          NHS hospital             Private rehabilitation centre  
                       Private hospital                               NHS SCI centre  
        NHS rehabilitation centre                            Private SCI centre  
 
     Other (please state)_______________________________________ 
 
 
19) In which country were you first treated for your SCI? 
              UK              
          Other  (please state)__________________________________ 
 
 
20) How long did you stay in the above hospital/ centre after your SCI?  
If you were then transferred to another unit (e.g. SCI centre) please also   
state how long you stayed there.  
(Please, state if months or weeks) 
Initial hospital/centre for ___________________________________ 
      Transferred to other unit for_________________________________  
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Abbreviations: Tracheal Tube (TT), Intermittent Assisted Ventilation (IAV), Residual Urine 
Catheter (RUV) 
 
21) Have you had any surgery after your SCI? 
              No  
            Yes    (please, state what surgery you have had)        
 
    I have had_________________________________________________ 
    __________________________________________________________ 
 
22) Do your friends and family support you with your SCI? 
                                         Yes                 I don’t want their support        
                                          No                I don’t need their support  
          Not as much as I need                     I don’t want to say  
 
    Other (please state)________________________________________ 
 
Questions about your pain in general 
 
23) *Since you got your SCI have you ever felt any pain? 
        Yes   (please, continue with questions below)         
         No  (please go to question 39, page 21) 
 
24) *How long after your SCI did your pain start? 
       Immediately after the SCI          Between 2 weeks and 1 month  
                           The next day                         Between 1 - 3 months         
                             After 3 days                    Between 3 - 6 months  
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Abbreviation: Spinal Cord Injury (SCI), National Health System (NHS), Transcutaneous 
Electrical Nerve Stimulation (TENS), *answer the question if applicable to you 
 
                            After 1 week            Between 6 months and 1 year                        
                          After 2 weeks                                         After 1 year  
    Other  (please state)__________________________________________ 
 
25) *On average over the last 6 months how many days of each month did you 
feel pain?  
                           1 - 4 days                   21 - 25 days   
                           5 - 9 days                   26 - 30 days              
                        10 -15 days                      Every day   
   16 - 20 days     
 
      If pain first appeared less than 6 months ago, please state how long  ago it 
appeared                                
      _________________________________________________________ 
 
26) *What type of pain do you suffer from? Please, tick all that apply. 
    Neuropathic above level of injury                    Upper limb                                          
           Neuropathic at level of injury                     Musculoskeletal      
     Neuropathic below level of injury         Back pain  
  I don’t know   
     Other  (please state)_________________________________________ 
 
27) *Do you take any medication for your pain? 
            Yes   (please, continue with questions below)           
              No   (please, go to question 30 below) 
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Abbreviation: Spinal Cord Injury (SCI), National Health System (NHS), Transcutaneous 
Electrical Nerve Stimulation (TENS), *answer the question if applicable to you 
 
28) How often do you take pain medication? 
                   Every day                              Whenever I have pain  
      On a regular basis             
                          Other  (please 
state)_______________________________ 
 
29) When you take pain medication, how many hours does it usually take 
before the pain returns? 
                        1 hour                               4 hours  
                       2 hours                                 5-12 hours                                                                                             
                       3 hours                             More than 12 hours      
                                            Pain medication does not help  
 
30) *While in the hospital/ centre, were you assessed by the health 
professionals for your pain? Please, tick all that apply. 
  Yes, I was assessed by a doctor immediately   
                                            Yes, I was assessed by a nurse immediately   
                              Yes, I was assessed by a physiotherapist immediately  
           I was assessed by a doctor but only after I complained of my pain  
            I was assessed by a nurse but only after I complained of my pain    
  I was assessed by a physiotherapist but only after I complained of my pain   
                                          I was assessed long time after my pain started  
                                           No, I was not assessed by anyone for my pain  
                                     I did not feel any pain while in the hospital/centre   
Other  (please state)____________________________________________                                        
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 Abbreviation: Spinal Cord Injury (SCI), National Health System (NHS), Transcutaneous 
Electrical Nerve Stimulation (TENS), *answer the question if applicable to you 
 
31) *While in the hospital what pain treatment did you have? Please, state all 
that apply. 
 
    Pain  medication                       Acupuncture                 
       Physiotherapy                               Kinesiotherapy                                                                     
      Cold Therapy                            Massage         
         Heat Therapy               Strengthening exercises    
                      TENS    I did not feel any pain while in the hospital/centre       
Relaxation techniques       I felt pain but I was not offered any therapy         
        Electrotherapy                                                     I don’t remember         
              Other    (please state)______________________________ 
 
32) While in the hospital/centre, how often did you have pain treatment?  
 
               Not applicable  
Pain medication__________________________________           
                  Physiotherapy__________________________________                                                                  
                   Cold Therapy__________________________________    
                   Heat Therapy__________________________________                                          
                               TENS__________________________________   
  Relaxation techniques_______________________________     
              Electrotherapy_______________________________     
               Acupuncture________________________________     
          Kinesiotherapy ________________________________    
                          Massage__________________________________ 
  Strengthening exercises__________________________________ 
         Other (please state)__________________________________ 
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Abbreviations: Spinal Cord Injury (SCI), Low Back Pain (LBP), National Health System 
(NHS), Transcutaneous Electrical Nerve Stimulation (TENS), *answer the question if 
applicable to you 
 
33) *Since you have left the hospital/centre have you had any pain 
treatment? Please, state all treatments that you have had.  
 
            Pain medication                                  Acupuncture                   
              Physiotherapy                        Kinesiotherapy                                                                     
                 Cold Therapy                                          Massage         
                Heat Therapy                     Strengthening exercises    
        TENS                               Therapeutic horse riding  
       Relaxation techniques                                           I don’t remember         
                   Electrotherapy                                    I did not feel any pain          
                                                I felt pain but I was not offered any therapy                                         
              Other    (please state)______________________________ 
 
34) Since you have left the hospital/centre, how often did you have pain 
treatment?   
                  Not applicable  
Pain medication__________________________________           
        Physiotherapy__________________________________                                                                  
                   Cold Therapy__________________________________    
                   Heat Therapy__________________________________                                          
                               TENS__________________________________   
  Relaxation techniques________________________________    
              Electrotherapy________________________________    
            Acupuncture__________________________________     
                 Kinesiotherapy __________________________________    
                          Massage__________________________________ 
  Strengthening exercises__________________________________ 
  Therapeutic horse riding__________________________________ 
         Other (please state)__________________________________ 
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Abbreviation: Spinal Cord Injury (SCI), National Health System (NHS), Transcutaneous 
Electrical Nerve Stimulation (TENS), *answer the question if applicable to you 
 
35) *If you had any pain treatment which one do you believe has most helped 
you? If more than one, please rank them in order of effectiveness.  
 
                  Not applicable  
Pain medication__________________________________           
         Physiotherapy__________________________________                                                                  
                   Cold Therapy__________________________________    
                   Heat Therapy__________________________________                                          
                               TENS__________________________________   
     Relaxation techniques__________________________________     
         Electrotherapy__________________________________     
            Acupuncture__________________________________     
        Kinesiotherapy __________________________________    
                          Massage__________________________________ 
  Strengthening exercises__________________________________ 
  Therapeutic horse riding__________________________________ 
         Other (please state)__________________________________ 
 
 
36) On average, since you have left the hospital/centre, how long were you on 
a waiting list to receive your pain treatment?  
 Treatment started immediately                                4 months                                           
                               1 – 2 weeks                                5 months  
                                     1 month                                6 months  
                                   2 months               More than 6 months  
                                   3 months       I was not on a waiting list  
Other (please state)______________________________________________ 
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Abbreviations: Spinal Cord Injury (SCI), Low Back Pain (LBP), National Health System 
(NHS), Transcutaneous Electrical Nerve Stimulation (TENS), *answer the question if 
applicable to you 
 
37)  *Have you had pain free period of 1 week or more since your pain first 
started? 
           Yes, most of the time                             Yes, but rarely  
                    Yes, frequently         No, I always have had pain  
                   Yes, sometimes                              I do not remember                 
       Yes, but not very often  
 
38) *Do you feel any pain right now?  
        No  
     Yes  (please, describe it in a few words) 
_______________________________________________________________
_______________________________________________________________
_______________________________________________________________
_______________________________________________________________
__________________________________________________________ 
 
Questions about your LBP 
39) Since you got your SCI have you ever felt Low Back Pain (LBP)?  
            Yes  (please, continue with questions below)          
              No   (please, go to question 53, page 24) 
 
40) *How long after your SCI did your LBP start? 
   Immediately after the SCI      Between 2 weeks and one month  
                       The next day                         Between 1 - 3 months         
                         After 3 days                  Between 3 - 6 months  
                        After 1 week            Between 6 months and 1 year                        
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Abbreviations: Spinal Cord Injury (SCI), Low Back Pain (LBP), National Health System 
(NHS), Transcutaneous Electrical Nerve Stimulation (TENS), *answer the question if 
applicable to you 
 
                   After two weeks                                         After 1 year  
                                   Other  (please state)_______________________ 
 
41) *On average over the last 6 months how many days of each month did you 
feel LBP?                         
                          1 - 4 days                  21 - 25 days   
                          5 - 9 days                   26 - 30 days              
                       10 - 15 days                      Every day     
                       16 - 20 days    
 
  If LBP first appeared less than 6 months ago, please state how long ago it 
appeared.  
   ____________________________________________________________                         
 
42) *Do you take any medication for your LBP? 
             Yes   (please, continue with questions below)           
              No   (please, go to question 45, page 22) 
 
43) *How often do you take LBP medication? 
                      Every day              Whenever I have pain  
        On a regular basis             
                             Other  (please state)____________________________ 
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Abbreviations: Spinal Cord Injury (SCI), Low Back Pain (LBP), National Health System 
(NHS), Transcutaneous Electrical Nerve Stimulation (TENS), *answer the question if 
applicable to you 
 
44) When you take medication for your LBP, how many hours does it usually 
take before the LBP returns? 
                    1 hour                                            4 hours  
                  2 hours                                       5-12 hours                                                                                             
                  3 hours                         More than 12 hours     
                                          Pain medication does not help  
 
45) *While in the hospital/centre, were you assessed by the health 
professionals for your LBP? Please, tick all that apply. 
  Yes, I was assessed by a doctor immediately   
                                            Yes, I was assessed by a nurse immediately   
                              Yes, I was assessed by a physiotherapist immediately  
           I was assessed by a doctor but only after I complained of my pain  
            I was assessed by a nurse but only after I complained of my pain    
  I was assessed by a physiotherapist but only after I complained of my pain   
                                          I was assessed long time after my pain started  
                                           No, I was not assessed by anyone for my pain  
                                     I did not feel any LBP while in the hospital/centre   
 
Other  (please state)____________________________________________                                        
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Abbreviations: Spinal Cord Injury (SCI), Low Back Pain (LBP), National Health System (NHS), 
Transcutaneous Electrical Nerve Stimulation (TENS), *answer the question if applicable to you 
 
46) *While in the hospital what LBP treatment did you have? (please, state all 
that apply) 
 
    Pain  medication                  Acupuncture                 
        Physiotherapy                   Kinisiotherapy                                                                     
      Cold Therapy                Massage         
         Heat Therapy       Strengthening exercises    
                   TENS    I did not feel any LBP while in the hospital/centre        
Relaxation techniques     I felt LBP but I was not offered any therapy         
        Electrotherapy                                                   I don’t remember         
             Other    (please state)______________________________
              
      
 
47) While in the hospital/centre, how often did you have LBP treatment?  
                  Not applicable  
Pain medication__________________________________           
          Physiotherapy__________________________________                                                                  
                   Cold Therapy__________________________________    
                   Heat Therapy__________________________________                                          
                              TENS__________________________________   
     Relaxation techniques__________________________________     
           Electrotherapy_________________________________     
                      Acupuncture__________________________________     
                  Kenisiotherapy __________________________________    
                          Massage__________________________________ 
  Strengthening exercises__________________________________ 
         Other (please state)__________________________________ 
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Abbreviations: Spinal Cord Injury (SCI), Low Back Pain (LBP), National Health System (NHS), 
Transcutaneous Electrical Nerve Stimulation (TENS), *answer the question if applicable to you 
 
48) *Since you have left the hospital/centre have you had any LPB 
treatment? Please, state all the treatments that you have had.  
 
    Pain  medication                   Acupuncture                 
        Physiotherapy                  Kinesiotherapy                                                                     
      Cold Therapy               Massage         
         Heat Therapy     Strengthening exercises    
                      TENS      Therapeutic horse riding   
Relaxation techniques I have not felt any LBP while in the hospital/centre       
       Electrotherapy   I have felt LBP but I was not offered any therapy        
     I don’t remember         
        Other    (please state)______________________________ 
 
49) Since you have left the hospital/centre, how often did you have LBP 
treatment?   
                  Not applicable  
Pain medication__________________________________           
          Physiotherapy__________________________________                                                                  
                   Cold Therapy__________________________________    
                   Heat Therapy__________________________________                                          
                              TENS__________________________________   
     Relaxation techniques__________________________________     
        Electrotherapy__________________________________     
           Acupuncture__________________________________     
       Kinesiotherapy __________________________________    
                          Massage__________________________________ 
  Strengthening exercises__________________________________ 
  Therapeutic horse riding__________________________________ 
         Other (please state)__________________________________ 
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Abbreviations: Spinal Cord Injury (SCI), Low Back Pain (LBP), *answer the question if 
applicable to you 
50) *If you had any LBP treatment which one do you believe has most helped 
you? If more than one, please rank them in order of effectiveness.  
Pain medication__________________________________           
                   Physiotherapy__________________________________                                                                  
                   Cold Therapy__________________________________    
                   Heat Therapy__________________________________                                          
                              TENS__________________________________   
      Relaxation techniques__________________________________     
          Electrotherapy__________________________________     
                      Acupuncture__________________________________     
          Kinesiotherapy _________________________________    
                          Massage__________________________________ 
  Strengthening exercises__________________________________ 
  Therapeutic horse riding__________________________________ 
         Other (please state)__________________________________ 
 
51) On average, since you have left the hospital/centre, how long were you on 
a waiting list to receive your LBP treatment?  
     Treatment started immediately                              4 months                                            
                                   1 – 2 weeks                              5 months   
                                         1 month                              6 months   
                                       2 months             More than 6 months   
                                       3 months     I was not on a waiting list   
Other (please state)____________________________________________ 
 
52)  *Have you had LBP free period of 1 week or more since your LBP 
started? 
          Yes, most of the time                           Yes, but rarely  
                    Yes, frequently       No, I always have had pain  
                   Yes, sometimes                     I do not remember  
         Yes, but not very often  
  
89 
89 
Abbreviations: Spinal Cord Injury (SCI), Low Back Pain (LBP), *answer the question if 
applicable to you 
 
Final questions about yourself 
53) Do you have any visual problems? 
      Yes               No     
If “yes”, please state what type___________________________________ 
 
 
54) Did you read the information sheet and questionnaire booklet on your own?  
      Yes               No     
If “no”, who helped you with the reading? 
Please state____________________________________________________ 
 
55) Do you have any problems with writing? 
     Yes               No     
If “yes”, please state what type_____________________________________ 
 
56) *Did you manually fill in the questionnaire on your own, without the help of 
anyone else?  
Yes      (please, go to question 58 below)       
 No      (please, continue with question 57 below)   
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Abbreviations: Spinal Cord Injury (SCI), Low Back Pain (LBP), *answer the question if 
applicable to you 
 
57) *If someone else helped you with filling in the questionnaire, how did they 
help you?  
 
I was answering all the questions but someone else was manually filling them in 
for me  
 
I was answering the questions but someone else manually filled in for me both 
the VAS and the body pain drawing  
 
I was answering the questions but someone else manually filled in for me only 
the VAS  
 
I was answering the questions but someone else manually filled in for me only 
the body pain drawing  
 
Other, please state_______________________________________________ 
 
 
58) *Please, give the date when you completed this questionnaire 
          ___/___/200___ 
 
 
 
 
Thank you very much for taking the time to complete this questionnaire
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Return slip (optional) 
 
 
Please, give us your name and address so we can identify your returned 
questionnaire in case you need us to do so, or contact you regarding this or 
future studies if agreed by you.   
 
Name______________________________________________________ 
Address____________________________________________________ 
Post Code__________________________________________________ 
Contact number______________________________________________ 
Email address (if applicable)____________________________________ 
 
 
 
In the future, would you like to be contacted and informed about our study 
programs and research?  
 
      Yes            No   
 
 
 
 
 
 
Thank you very much for taking the time to complete this questionnaire 
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Appendix 3; Questionnaire 
in Greek 
Supplement to Chapters 4 and 5
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Πληροφορίες προς συμμετέχοντες ενήλικες με Κάκωση Νωτιαίου Μυελού 
 
 
Αγαπητέ Κύριε/ Κυρία 
 
 
Τίτλος έρευνας: “Η μελέτης της εμπειρίας του πόνου, η ένταση και η επίδρασή 
της στις ζωές των ατόμων με Κάκωση Νωτιαίου Μυελού (ΚΝΜ) στις Ηνωμένες 
Πολιτείες Αμερικής (ΗΠΑ), στο Ηνωμένο Βασίλειο (ΗΒ) και την Ελλάδα”.  
 
 
Πρόσκληση 
Σας προσκαλούμε να πάρετε μέρος σε μία ερευνητική μελέτη. Πριν 
αποφασίσετε είναι απαραίτητο να καταλάβετε γιατί γίνεται αυτή η έρευνα και τι 
θα συμπεριλάβει. Παρακαλώ, διαβάστε τις παρακάτω πληροφορίες προσεχτικά 
και συζητήστε το με άλλους εάν το θέλετε.  
 
 Το πρώτο μέρος σας λέει για την μελέτη και τι θα γίνει σε εσάς εάν 
πάρετε μέρος. 
 Το δεύτερο μέρος σας δίνει περισσότερες λεπτομέρειες για την μελέτη.  
 
Ρωτήστε με εάν κάτι δεν είναι ξεκάθαρο ή εάν θα θέλατε περισσότερες 
πλήροφορίες. Πάρτε το χρόνο σας για να αποφασίσετε εάν θέλετε να 
συμμετάσχετε.  
 
Ποιός είναι ο σκοπός της έρευνας;  
Ο σκοπός της έρευνας είναι να μελετήσει τον πόνο γενικά και τον πόνο 
στη μέση (οσφυαλγία) ειδικά σε άτομα με Κακωση Νωτιαίου Μυελού (ΚΝΜ). Θα 
διερευνηθεί η εμπειρία του πόνου και πως αυτή μπορεί να επηρεάσει την 
ποιότητα ζωής και την λειτουργικότητα. Τελός, θα μελετηθούν τα διαφορετικά 
συστήματα υγείας και οι πολιτισμικές επιρροές  και πως αυτά μπορούν να 
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επηρεάσουν τον πόνο καθώς η έρευνα θα διεξαχθεί στη Ελλάδα, στις ΗΠΑ και 
στο Ηνωμένο Βασίλειο.  
 
Γιατί Επιλέχθηκα; 
Επιλεχθήκατε γιατί έχετε ΚΝΜ και μπορεί να εκπληρώνετε τα κριτήρια 
συμμετοχής αυτής της έρευνας. Συνολικά τουλάχιστον 185 άτομα με ΚΝΜ που 
ζούνε στις ΗΠΑ, στο Ηνωμένο Βασίλειο και την Ελλάδα θα συμμετάσχουν σε 
αυτή την έρευνα.  
 
Πώς αναγωρίστηκα; 
Αναγνωριστήκατε μέσω του “Αναπηρία Τώρα”. Λόγο της προστασίας των 
προσωπικών δεδομένων δεν μπορώ να έχω άμεση πρόσβαση στα προσωπικά 
σας στοιχεία για να επικοινωνήσω μαζί σας. Για τον λόγο αυτό το “Αναπηρία 
Τώρα” προσκλήθηκε να συμμετάσχει στην μελέτη αυτή. Το “Αναπηρία Τώρα” 
ενέκρινε την μελέτη και ένας τοπικός συνεργάτης ορίστηκε και συμφώνησε να 
προωθήσει αυτό το ερωτηματολόγιο σε εσάς στον διαδύκτιο ή μέσω email.  
 
Πρέπει να πάρω μέρος;  
Όχι, εξαρτάται από εσάς αν θα αποφασίσετε να πάρετε μέρος ή όχι. Εάν 
αποφασίσετε να πάρετε μέρος έχετε την επιλογή να απαντήσετε στο 
ερωτηματολόγιο ανώνυμα. Εάν αποφασίσετε να μας δώσετε το όνομα σας, σας 
βεβαιώνουμε ότι όλες οι προσωπικές σας πληροφορίες θα χειρισθούν με 
απόλυτη εμπιστευτικότητα. Η απόφαση σας να μην συμμετάσχετε δεν θα 
επηρεάσει καθόλου την θεραπεία που λαμβάνετε.     
 
Τι είδος μελέτης είναι;  
Αυτή η μελέτη είναι μέρος ενός μεγαλύτερου διδακτορικού προγράματος 
το οποίο μελετάει τον πόνο γενικότερα και την οσφυαλγία ειδικότερα σε ενήλικες 
με ΚΝΜ και παιδιά με Εγκεφαλική Παράλυση. Ένας από τους σκοπούς του 
συνολικού διδακτορικού είναι να μελετήσει πως μία συγκεκριμένη θεραπεία που 
βασίζεται στην τρισδιάστατη κίνηση μπορεί να οφελήσει την οσφυαλγία, στάση, 
ισορροπία, λειτουργικότητα, και την ποιότητα ζωής σε αυτούς τους 
πληθυσμούς.  
 
 Το παρόν μέρος του σχεδίου, στο οποίο προσκαλείστε να συμμετάσχετε, 
αποτελείται από ένα αυτο-συμπληρώμενο ερωτηματολόγιο, το οποίο 
εσωκλείεται σε αυτό το γράμμα, με στόχο να συμπληρωθεί μόνο από άτομα με 
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ΚΝΜ. Στο δεύτερο μέρος αυτού του γράμματος θα βρείτε λεπτομέρειες ως προς 
το πως να συμπληρώσετε το ερωτηματολόγιο.  
 
Ποια είναι τα πιθανά ωφέλη από την συμμετοχή μου;  
Ο πόνος έχει βρεθεί να είναι μέρος της καθημερινής ζωής σε άτομα με 
ΚΝΜ και σε αρκετές καταστάσεις μπορεί να προκαλέσει στρες και ανησυχία, να 
επηρεάσει την ποιότητα ζωής και να παρέμβει στις δραστηριότητες καθημερινής 
ζωής. Παρ’ όλα αυτά, η εμπειρία του πόνου γενικά και η οσφυαλγία 
συγκεκριμένα δεν έχουν μελετηθεί αρκετά σε άτομα με ΚΝΜ. 
 Αναμένεται ότι θα έχετε έμμεσα κέρδη από την συμμετοχή σας διότι τα 
αποτελέσματα της έρευνας αυτής θα χρησιμοποιηθούν για την ανάλυση 
ερωτήσεων σχετικές με τον πόνο που μπορούν να συμβάλουν στον να εγείρουν 
ενημερότητα και να προκαλέσουν περαιτέρω μελέτες με σκοπό την βελτίωση 
των συμπτωμάτων πόνου, της ποιότητας ζωής και της λειτουργικότητας σε 
άτομα με ΚΝΜ και πόνο.  
 
Τι θα μου συμβεί εάν αποφασίσω να πάρω μέρος;  
Το μόνο που έχετε να κάνετε είναι να απαντήσετε στο ένθετο 
ερωτηματολόγιο και να το επιστρέψετε σε εμένα.         
 
Θα χρειαστεί να πληρώσω κάτι;  
Όχι, δεν θα χρειαστεί να πληρώσετε τίποτα.  
 
Υπάρχουν κάποια ρίσκα;  
Δεν υπάρχουν ενδεχόμενα ρίσκα ως αποτέλεσμα της συμφωνίας σας να 
συμπληρώσετε το ερωτηματολόγιο.  
 
Τι συμβαίνει εάν δεν έχω οσφυαλγία ή άλλο πόνο;  
Είναι πολύ σημαντικό να απαντήσετε στο ερωτηματολόγιο ακόμα και εάν 
δεν έχετε οσφυαλγία ή άλλο πόνο. Θα μας δώσετε έτσι πολύτιμες πληροφορίες 
σχετικά με το ποσοστό του πόνου και της οσφυαλγίας σε ΚΝΜ και θα μας 
βοηθήσετε στην στατιστική σύγκριση μεταξύ ατόμων που έχουν με αυτούς που 
δεν έχουν οσφυαλγία και πόνο. Ανάλογα με τις απαντήσεις που θα επιλέξετε θα 
κατευθυνθήτε και στις ανάλογες ερωτήσεις.  
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Τι θα γίνει εάν υπάρξει κάποιο πρόβλημα; 
Κανένα πρόβλημα δεν αναμένεται να υπάρξει, παρόλα αυτά εάν αυτό 
συμβεί, θα συζητηθεί μαζί σας.  
 
Η συμμετοχή μου θα παραμείνει εμπιστευτική; 
Ναι. Το όνομα και η διεύθυνσή σας θα αφαιρεθούν από κάθε δεδομένο 
και δεν θα μπορείτε να αναγνωριστήτε από αυτό. Όλα τα δεδομένα θα 
κρατούνται σε κλειδωμένο ντουλάπι, που βρίσκεται στο Πανεπιστήμιο, και μόνο 
εγώ θα έχω πρόσβαση σε αυτά.  
 
 
 
 
Σας ευχαριστούμε που διαβάσατε μέχρι εδώ – εάν εξακολουθείτε να 
ενδιαφέρεστε, παρακαλώ πηγαίνετε στο δεύτερο μέρος.  
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Μέρος δεύτερο 
 
Τι θα συμβεί αν δε θέλω να συνεχίσω με την έρευνα; 
Αν αποφασίσετε να πάρετε μέρος, μπορείτε να αποχωρήσετε 
οποιαδήποτε στιγμή, και χωρίς να αιτιολογηθείτε. Η απόφαση να αποσυρθείτε 
δε θα επηρεάσει την φροντίδα που λαμβάνετε. Ωστόσο, θα είναι αδύνατον να 
αποσυρθούν ερωτηματολόγια τα οποία έχουν επιστραφεί ανώνυμα αφού δεν 
θα είναι δυνατόν να αναγνωριστεί από ποιον έχουν συμπληρωθεί.  
 
Τι θα συμβεί αν θέλω να παραπονεθώ για κάτι; 
Αν έχετε κάποια αμφιβολία για κάποιο τμήμα της έρευνας, θα πρέπει να 
ζητήσετε να μιλήσετε με τους ερευνητές οι οποίοι θα προσπαθήσουν να 
απαντήσουν στις ερωτήσεις σας όσο το δυνατόν καλύτερα. Μπορείτε να 
επικοινωνήσετε μαζί μου. Αν παραμένετε ανικανοποίητος/-η και επιθυμείτε να 
παραπονεθείτε επίσημα, μπορείτε να αποτανθείτε στους υπεύθυνους αυτής της 
έρευνας. Τα τηλέφωνά τους βρίσκονται στο τέλος αυτού του φυλλαδίου. 
 
Θα ενημερωθεί ο γιατρός μου; 
Όχι, ο γιατρός σας δεν θα ενημερωθεί. Ωστόσο, αν κατά τη διάρκεια της 
έρευνας κριθεί σκόπιμο να ενημερωθεί ο γιατρός σας θα ζητηθεί η συγκατάθεσή 
σας εκ των προτέρων γι’αυτό. 
 
Τι θα συμβεί με τα αποτελέσματα αυτής της έρευνας; 
Τα αποτελέσματα αυτής της έρευνας θα συμπεριληφθούν στο 
διδακτορικό μου μέσα στα επόμενα δύο χρόνια. Επιπρόσθετα, θα 
δημοσιευθούν κατά τα χρόνια που θα ακολουθήσουν την ολοκλήρωση του 
διδακτορικού. Εάν επιθυμείτε, θα μπορούσα να σας στείλω μία αναφορά με τα 
αποτελέσματα ή θα μπορούσατε να τα βρείτε απευθείας απο τα επιστημονικά 
περιοδικά  όταν θα έχουν δημοσιευθεί. Σε καμμία περίπτωση το όνομά σας δεν 
πρόκειται να δημοσιευθεί σε κάποια αναφορά ή δημοσίευση. 
 
Ποιος οργανώνει και χρηματοδοτεί την έρευνα; 
Η έρευνα υποστηρίζεται από τη Σχολή Επιστημών Υγείας και Κοινωνικής 
Πρόνοιας (ΣΕΥΠ) του Πανεπιστημίου Μπρουνέλ του Δυτικού Λονδίνου, και 
χρηματοδοτείται μερικώς από το Ερευνητικό Συμβούλιο Μηχανικών και 
Φυσικών Επιστημών και τη Σχολή αποφοίτων του Μπρουνέλ. Προϊστάμενοι σε 
αυτή την έρευνα είναι οι καθηγητές κ.κ. Lorraine DeSouza και Ian Sutherland. 
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Ποιος έχει επιθεωρήσει την έρευνα; 
Προτού οποιαδήποτε έρευνα μπορέσει να προχωρήσει πρέπει να 
επιθεωρηθεί και να εγκριθεί από μία Επιτροπή Ηθικής Δεοντολογίας. Ο σκοπός 
είναι η επιβεβαίωση ότι η έρευνα είναι έτοιμη να ξεκινήσει. Η συγκεκριμένη 
έρευνα έχει μελετηθεί και εγκριθεί από την Επιτροπή Ηθικής Δεοντολογίας της 
ΣΕΥΠ του Πανεπιστημίου Μπρουνέλ. Το “Αναπηρία τώρα” έχει επίσης 
μελετήσει την έρευνα και εγκρίνει την συνεργασία.  
 
Πόσο χρόνο θα μου πάρει να συμπληρώσω το ερωτηματολόγιο και 
από τι αποτελείται αυτό; 
   Θα σας πάρει περίπου 1 ώρα για να συμπληρώσετε το ερωτηματολόγιο. 
Αντιλαμβανόμαστε ότι αυτό το ερωτηματολόγιο ίσως χρειάζετε χρόνο για να 
συμπληρωθεί αλλά εξετάζει δεδομένα τα οποία στο παρελθόν δεν εξετάστηκαν 
σε τέτοιο βάθος και οι πληροφορίες που θα συλλεχθούν θα παρουσιάσουν 
ιδιαίτερο ενδιαφέρον. Εάν θέλετε συμπληρώσετε το ερωτηματολόγιο τμηματικά. 
Το πρώτο μέρος αποτελείται από 3 σταθμισμένα ερωτηματολόγια. Αυτά 
είναι η σύντομη μορφή ερωτηματολογίου του πόνου του ΜακΓκίλλ, το EQ-5D  
και το Μ.Α.Νω.Μυ.  
Η σύντομη μορφή του ερωτηματολογίου του ΜακΓκίλλ εξετάζει τον πόνο 
και τις διαστάσεις του. Έχει συμπεριληφθεί και ένα διάγραμμα σωματικού πόνου 
πάνω στο οποίο μπορείτε να σημειώσετε τις περιοχές στο σώμα σας που 
νοιώθετε πόνο. Η ένταση του πόνου υπολογίζεται με την οπτική αναλογική 
κλίμακα (ΟΑΚ). Επίσης, υπάρχει μία λίστα από περιγραφικές λέξεις που 
παρέχει αισθητήριες, συναισθηματικές και πληροφορίες αποτίμησης για τον 
πόνο σας.  
Το ερωτηματολόγιο EQ-5D μετράει την ποιότητα ζωής και παρέχει 
πληροφορίες σχετικά με την κινητικότητα, αυτοεξηπηρέτηση, συνήθεις 
δραστηριότητες, πόνο/ δυσφορία και άγχος/θλίψη.  
Το Μ.Α.Νω.Μυ παρέχει πληροφορίες σχετικά με την λειτουργικότητα. 
Μελετάει την αυτοεξυπηρέτηση, το αναπνευστικό, τον έλεγχο του σφιγκτήρα και 
την κινητικότητα σε εσωτερικό και εξωτερικό χώρο.  
Το δεύτερο μέρος του ερωτηματολογίου αποτελείται από κοινωνικο-
δημογραφικές ερωτήσεις με σκοπό να συλλέξει πληροφορίες σχετικές με το 
ιστορικό και την θεραπεία της ΚΝΜ σας, και αν και πως αυτά σχετίζονται με την 
παρουσία ή όχι  πόνου και οσφυαλγίας. Αυτό το μέρος του ερωτηματολογίου 
μπορεί να βοηθήσει να προσδιορίσουμε τις καλύτερες θεραπευτικές επιλογές.    
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Θέλω να συμμετάσχω. Τι κάνω τώρα; 
Εάν συμφωνήσετε να συμμετάσχετε αλλά επιθυμείτε να παραμείνετε 
ανώνυμος/-η, παρακαλώ συμπληρώστε και επιστρέψτε το ερωτηματολόγιο 
χωρίς να γράψετε το όνομα σας πουθενά. Το συμπληρωμένο ερωτηματολόγιο 
θα επιστραφεί κατευθείαν σε εμένα, την κύρια ερευνήτρια της μελέτης. 
Παρακαλώ χρησιμοποιήστε τον φάκκελο επιστροφής που σας έχουμε 
συμπεριλάβει σε αυτό το γράμμα.  
 
Θέλω να συμμετάσχω αλλά δεν μπορώ να συμπληρώσω μόνος/η 
το ερωτηματολόγιο.  
 Αν αντιμετωπίζετε δυσκολίες στην ανάγνωση ή συμπλήρωση αυτού του 
ερωτηματολογίου, παρακαλώ ζητήστε βοήθεια από κάποιο μέλος της 
οικογένειας σας ή φίλο. Όμως, παρακαλώ επιβεβαιώστε ότι εσείς απαντάτε στις 
ερωτήσεις και ότι σας βοηθούν με το να τις γράψουν στο γραπτό 
ερωτηματολόγιο. Όταν συμπληρώνετε την ΟΑΚ και το διάγραμμα σωματικού 
πόνου, παρακαλώ δείξτε τους με όσο το δυνατόν μεγαλύτερη ακρίβεια που 
ακριβώς είναι η απάντηση σας.   
Εάν χρειάζεστε επιπλέον βοήθεια, παρακαλώ επικοινωνήστε μαζί μου.  
 
Μπορώ να το κάνω αργότερα; 
Ναι. Το ερωτηματολόγιο θα παραμείνει στο διαδίκτυο για τουλάχιστον 
 ένα μήνα. 
 
Δεν θέλω να συμμετάσχω. Τι κάνω τώρα; 
Εάν δεν θέλετε να συμμετάσχετε, παρακαλώ αγνοήστε αυτό το γράμμα. 
Υπάρχει η πιθανότητα να παραλάβετε ένα αυτόματο γράμμα υπενθύμησης στο 
μέλλον. Εάν και τότε εξακολουθείτε να μην θέλετε να συμμετάσχετε παρακαλώ 
αγνοήστε και εκείνο το γράμμα. Όμως κάθε πληροφορία που μας παρέχετε θα 
είναι ιδιαίτερα χρήσιμη.  
 
Σας ευχαριστούμε πάρα πολύ για τον χρόνο που διαθέσατε να διαβάσετε 
αυτό το ενημερωτικό. Εάν έχετε περαιτέρω ερωτήσεις, παρακαλώ 
επικοινωνήστε μαζί μου ελεύθερα. Εάν θέλετε να παραμείνετε ανώνυμος/-η σε 
εμένα αλλά θα θέλατε περαιτέρω πληροφορίες παρακαλώ επικοινωνήστε με το 
“Αναπηρία Τώρα”. 
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Εάν θέλετε να μάθετε περισσότερα σχετικά με πόνο στην ΚΝΜ 
παρακαλώ πηγαίνετε στην ιστοσελίδα του "Αναπηρία Τώρα". Η ιστοσελίδα 
είναι: www.DISABLED.GR 
 
Με εκτίμηση 
 
Χριστίνα Μιχαηλίδου  
Υποψήφια Διδακτορικού, Μάστερ, Πτυχιούχος Φυσικοθεραπείας   
Κύρια Ερευνήτρια 
Email: christina.michailidou@brunel.ac.uk 
Τηλ: 0044(0)1895 268807 
Κινητό: 0044(0)7900 930605 
Ταχυδρομική Διεύθυνση: Christina Michailidou  
        School of Health Science and Social Care 
                     Mary Seacole Building, Brunel University 
            UB8 3PH, Uxbridge, Middlesex, 
                     London, United Kingdom 
 
Επιτηρητές Μελέτης:  
Καθηγήτρια: Lorraine DeSouza  
Διευθύντρια της Σχολής Επιστημών Υγείας και Κοινωνικής Πρόνοιας  
Email: lorraine.desouza@brunel.ac.uk 
Τηλ: 0044(0)1895 268755 
Καθηγητής Ian Sutherland, 
Διευθυντής Ινστιτούτου Βιομηχανολόγων Μπρουνέλ  
Email: ian.sutherland@brunel.ac.uk 
Τηλ: 0044(0)1895 271206 
Σας ευχαριστούμε πάρα πολύ που διαβάσατε το ενημερωτικό γράμμ
   
 101 
     Για χρήση γραφείου μόνο: 
 
 
         : 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Σας είμαστε ευγνώμων για την βοήθεια σας στην συμπλήρωση των παρακάτω 
ερωτήσεων. Οι πληροφορίες που θα μας δώσετε θα μας βοηθήσουν να 
καταλάβουμε περισσότερα πράγματα για την κάκωση νωτιαίου μυελού και τα 
συμπτώματα γύρω από αυτήν. Η ανάλυση των αποτελεσμάτων μπορεί να μας 
βοηθήσει στην ανάπτυξη μελλοντικών θεραπειών με στόχο την καλυτέρευση 
του πόνου και της ποιότητας ζωής σε άτομα με κάκωση νωτιαίου μυελού.  
 
   Δεν υπάρχουν σωστές ή λάθος απαντήσεις στις ερωτήσεις αυτές. Μας  
ενδιαφέρουν οι προσωπικές απόψεις και όχι αυτές της οικογένειας σας 
ή των θεραπευτών σας.   
 Θα θέλαμε να απαντήσετε στις ερωτήσεις όσο πιο ειλικρινά και 
γρήγορα γίνετε. 
 Εάν δυσκολεύεστε να συγκεντρωθήτε στις ερωτήσεις κάντε ένα 
διάλειμμα. Μπορείτε να συμπληρώσετε το ερωτηματολόγιο 
μέσα σε μια με δύο μέρες.   
 Μερικές ερωτήσεις έχουν έναν αστερίσκο (*) στην αρχή τους, ο 
οποίος ενδεικνύει ότι η απάντηση είναι απαραίτητη. Παρακαλώ, 
απαντήστε σε αυτές τις ερωτήσεις εάν είναι εφαρμόσιμες σ’ 
εσάς.  
 Με βάση τις απαντήσεις σας μπορεί να παρακάμψετε κάποιες 
ερωτήσεις. Παρακαλώ, ακολουθήστε τις οδηγίες των ερωτήσεων.  
 
Σας ευχαριστούμε πολύ 
 
Ημερομηνία συμπλήρωσης 
ερωτηματολογίου 
 
 
 
Ημερομηνία ανάλυσης 
ερωτηματολογίου 
 
 
 
Κωδικός αναγνώρισης  
ερωτηματολογίου 
 
 
 
Κωδικός αναγνώρισης κέντρου 
 
 
 
Κωδικός αναγνώρισης 
συμμετέχοντα 
 
 
 
Χώρα προέλευσης 
 
 
    
   
 102 
Συντομογραφίες: Κάκωση Νωτιαίου Μυελού (ΚΝΜ), Οπτική Αναλογική κλίμακα (ΟΑΚ), *απαντήστε 
στην ερώτηση εάν σας αφορά 
 
ΕΡΩΤΗΜΑΤΟΛΟΓΙΟ ΑΞΙΟΛΟΓΗΣΗΣ ΠΟΝΟΥ 
 
*Η παρακάτω φωτογραφία είναι το διάγραμμα σωματικού πόνου το οποίο θα σας 
βοηθήσει να προσδιορίσετε τις περιοχές στις οποίες νοιώθετε πόνο 
 
Παρακαλώ, σημειώστε στο παραπάνω σχεδιάγραμμα που στο σώμα σας 
αισθάνεστε πόνο. Τοποθετήστε Ε αν ο πόνος είναι εξωτερικός, ή Μ αν είναι 
εσωτερικός, ή ΕΜ αν εξωτερικός και εσωτερικός πόνος υπάρχει στις περιοχές που 
σημειώνετε.  
Δεξιά Δεξιά Αριστερά Αριστερά 
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Συντομογραφίες: Κάκωση Νωτιαίου Μυελού (ΚΝΜ), Οπτική Αναλογική Κλίμακα (ΟΑΚ), 
Δείκτης Διαβάθμισης Πόνου (ΔΔΠ),  Ένταση Παρόντος Πόνου (ΕΠΠ), *απαντήστε στην 
ερώτηση εάν σας αφορά 
1) *Από τότε που αποκτήσατε την ΚΝΜ σας έχετε νοιώσει πόνο στην μέση 
(οσφυαλγία) 
 Ναι  (παρακαλώ, συνεχίστε στην παρακάτω ερώτηση) 
 Όχι  (παρακαλώ, πάτε στο EQ-5D, σελίδα 5) 
 
           Ι. Δείκτης Διαβάθμισης Πόνου (ΔΔΠ)  
 Οι παρακάτω λέξεις περιγράφουν τον κατά μέσο όρο πόνο. Βάλτε ένα 
σημάδι () στην στήλη η οποία αντιπροσωπεύει τον βαθμό στον οποίο 
αισθάνεστε τον τύπο αυτό πόνου. Παρακαλώ, περιοριστείτε στην 
περιγραφή του πόνου στην περιοχή της μέση σας μόνο (οσφυϊκός 
πόνος).  
 
 
 
ΙΙ.  *Ένταση Παρόντος Πόνου (ΕΠΠ) – Οπτική Αναλογική Κλίμακα (ΟΑΚ). 
Βάλτε ένα σημάδι “x” κατά μήκος της γραμμής για να υποδείξετε τον πόνο που 
νοιώθετε τώρα στην μέση σας (οσφυϊκός πόνος). 
Καθόλου πόνος __________________________________________ Ο χειρότερος   
πόνος που έχετε 
νοιώσει ποτέ 
Καθόλου 
πόνος Ήπιος Μέτριος Έντονος
Παλμικός-ρυθμικός
Σαν να 'περπατάει'
Σαν ΄μαχαιριά'
Οξύς
Σαν 'κραμπα'
Σαν να 'δαγκώνει'
Καυστικός-ζεστός
Γενικός-διαρκής
Αίσθημα βάρους
Ευαίσθητος
Διαμελιστικός-σαν να 
σε 'σκίζει'
Κουραστικός
Αηδιαστικός-
νοσηρός
Τρομακτικός
Βασανιστικός-
σκληρός
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Συντομογραφίες: Κάκωση Νωτιαίου Μυελού (ΚΝΜ), Οπτική Αναλογική Κλίμακα (ΟΑΚ), Δείκτης 
Διαβάθμισης Πόνου (ΔΔΠ),  Ένταση Παρόντος Πόνου (ΕΠΠ), *απαντήστε στην ερώτηση εάν σας 
αφορά 
 
 *Ένταση Συνήθη Πόνου – τελευταίους 3 μήνες.  
Βάλτε ένα σημάδι “x” κατά μήκος της γραμμής για να υποδείξετε τον   πόνο 
που συνήθως νοιώθετε στην μέση σας (οσφυϊκός πόνος) τους τελευταίους 3 
μήνες. 
 
Καθόλου πόνος __________________________________________ Ο χειρότερος   
πόνος που έχετε 
νοιώσει ποτέ 
 *Ένταση Συνήθη Πόνου – τελευταίος μήνας.  
   Βάλτε ένα σημάδι “x” κατά μήκος της γραμμής για να υποδείξετε τον   πόνο 
που συνήθως νοιώθετε στην μέση σας (οσφυϊκός πόνος) τον τελευταίο 1 
μήνα. 
 
Καθόλου πόνος __________________________________________ Ο χειρότερος   
πόνος που έχετε 
νοιώσει ποτέ 
 
ΙΙΙ. *Εκτιμόμενη συνολική ένταση ολικής εμπειρίας του πόνου.  
Παρακαλώ, περιοριστείτε στην περιγραφή του πόνου στην περιοχή της 
μέση σας μόνο (οσφυϊκός πόνος). Βάλτε ένα σημάδι () στην κατάλληλη 
στήλη.  
 
Εκτίμηση 
Καθόλου πόνος  
Ήπιος  
Ενοχλητικός  
Οδυνηρός  
Φρικτός  
Αφόρητος  
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Ερωτηματολόγιο για την Υγεία 
 
Βάζοντας ένα  σε ένα κουτάκι κάθε ομάδας παρακάτω, παρακαλούμε 
σημειώστε ποιές δηλώσεις περιγράφουν καλύτερα την κατάσταση της 
υγείας σας σήμερα. 
 
Κινητικότητα 
Δεν έχω κανένα πρόβλημα στο περπάτημα  
Έχω μερικά προβλήματα στο περπάτημα  
Είμαι καθηλωμένος/η στο κρεβάτι  
 
 
Αυτοεξυπηρέτηση 
Δεν έχω κανένα πρόβλημα με την αυτοεξυπηρέτησή μου  
Έχω μερικά προβλήματα στο να πλένομαι και να ντύνομαι  
Είμαι ανίκανος/η να πλυθώ ή να ντυθώ  
 
 
Συνηθισμένες Δραστηριότητες (π.χ. δουλειά, μελέτη, νοικοκυριό,  
οικογενειακές δραστηριότητες ή δραστηριότητες ελεύθερου χρόνου)  
Δεν έχω κανένα πρόβλημα στο να εκτελώ τις συνηθισμένες  
δραστηριότητές μου  
Έχω μερικά προβλήματα στο να εκτελώ τις συνηθισμένες 
δραστηριότητές μου  
Είμαι ανίκανος/η να εκτελώ τις συνηθισμένες 
δραστηριότητές μου  
 
 
Πόνος/Δυσφορία 
Δεν έχω καθόλου πόνο ή δυσφορία  
Έχω μέτριο πόνο ή δυσφορία  
Έχω υπερβολικό πόνο ή δυσφορία  
 
 
Άγχος /Θλίψη 
Δεν έχω άγχος ή θλίψη  
Έχω μέτριο άγχος ή θλίψη   
Έχω υπερβολικό άγχος ή θλίψη  
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*Για να βοηθήσουμε κάποιον να πει πόσο 
καλή ή κακή είναι μια κατάσταση υγείας, 
ζωγραφίσαμε μια κλίμακα (σαν ένα 
θερμόμετρο) πάνω στην οποία η καλύτερη 
κατάσταση που μπορείτε να φανταστείτε 
έχει βαθμό 100 και η χειρότερη κατάσταση 
που μπορείτε να φανταστείτε έχει βαθμό 0. 
 
Θα θέλαμε να σημειώσετε πάνω σε αυτήν 
την κλίμακα πόσο καλή ή κακή είναι η υγεία 
σας σήμερα, κατά τη γνώμη σας. 
Παρακαλούμε κάντε το αυτό, τραβώντας 
μια γραμμή από το παρακάτω τετράγωνο 
προς οποιοδήποτε σημείο της κλίμακας 
δείχνει πόσο καλή ή κακή είναι η 
κατάσταση της υγείας σας σήμερα. 
 
 
 
 
 
 
 
 
 
 
 
  
Η κατάσταση της 
δικής σας υγείας 
σήμερα 
9 0 
8 0 
7 0 
6 0 
5 0 
4 0 
3 0 
2 0 
1 0 
100 
Η χειρότερη 
κατάσταση υγείας 
που μπορείτε να 
φανταστείτε 
0 
Η καλύτερη 
κατάσταση υγείας 
που μπορείτε να 
φανταστείτε 
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Συντομογραφίες: Τραχειακός σωλήνας (ΤΣ), Διαλείποντας υποβοηθούμενος αερισμός (ΔΥΑ), 
Υπολοιπόμενος όγκος ούρων (ΥΟΟ) 
 
GR- SCIM III - Spinal Cord Independence Measure – Έκδοση ΙΙΙ  
 Αυτοεξυπηρέτηση 
3. Σίτιση (κόψιμο τροφής, άνοιγμα δοχείων, σερβίρισμα υγρού, μεταφορά 
τροφής στο στόμα, κράτημα φλυτζανιού με υγρό) 
0. Χρειάζεται παρεντερική, γαστροστόμια ή πλήρως υποβοηθούμενη 
σίτηση από το στόμα 
1. Χρειάζεται μερική βοήθεια για τη σίτιση και/ή την πόση ή για να 
φορέσει προσαροστικά βοηθήματα   
2. Τρώω ανεξάρτητα. Χρειάζονται προσαρμοστικά βοηθήματα ή βοήθεια 
μόνο για το κόψιμο της τροφής και/ή  το σερβίρισμα υγρού και/ή το 
άνοιγμα δοχείων 
3. Τρώω και πίνω ανεξάρτητα. Δεν απαιτείται βοήθεια ή προσαρμοστικά 
βοηθήματα  
 
 
4. Μπάνιο (σαπούνισμα, πλύσιμο, στέγνωμα σώματος και κεφαλής, χειρισμός 
βρύσης).  
A - Άνω μέρος σώματος  
     0.  Απαιτείται πλήρης βοήθεια 
6. Απαιτείται μερική βοήθεια  
7. Πλένομαι ανεξάρτητα χρησιμοποιώντας προσαρμοστικά βοηθήματα  ή 
σε ειδικά προσαρμοσμένο περιβάλλον (π.χ. μπάρες στήριξης, 
καρέκλα) 
8. Πλένομαι ανεξάρτητα. Δεν απαιτείται χρήση προσαρμοστικών 
βοηθημάτων ή ειδικά προσαρμοσμένο περιβάλλον  
B - Κάτω μέρος σώματος 
     0.  Απαιτείται πλήρης βοήθεια 
1. Απαιτείται μερική βοήθεια  
2. Πλένομαι ανεξάρτητα χρησιμοποιώντας προσαρμοστικά βοηθήματα ή 
σε ειδικά προσαρμοσμένο περιβάλλον  
3. Πλένομαι ανεξάρτητα. Δεν απαιτείται χρήση προσαρμοστικών 
βοηθημάτων ή ειδικά προσαρμοσμένο περιβάλλον  
 
 
 
    
   
 108 
Συντομογραφίες: Τραχειακός σωλήνας (ΤΣ), Διαλείποντας υποβοηθούμενος αερισμός (ΔΥΑ), 
Υπολοιπόμενος όγκος ούρων (ΥΟΟ) 
 
5. Ντύσιμο (ρούχα, παπούτσια, μόνιμες ορθώσεις, ντύσιμο, γδύσιμο).      
     Α - Άνω μέρος σώματος  
     0.  Απαιτείται πλήρης βοήθεια 
5. Απαιτείται μερική βοήθεια με ρούχα χωρίς κουμπιά, φερμουάρ ή 
κορδόνια  
6. Ανεξάρτητος/-η με ρούχα χωρίς κουμπιά, φερμουάρ ή κορδόνια. 
Aπαιτείται χρήση προσαρμοστικών βοηθημάτων ή ειδικά 
προσαρμοσμένο περιβάλλον  
7. Ανεξάρτητος/-η με ρούχα χωρίς κουμπιά, φερμουάρ ή κορδόνια. Δεν 
απαιτούνται προσαρμοστικά βοηθημάτα ή ειδικά προσαρμοσμένο 
περιβάλλον. Χρειάζεται βοήθεια ή προσαρμοστικά βοηθημάτα ή ειδικά  
8. προσαρμοσμένο περιβάλλον μόνο για κουμπιά, φερμουάρ ή κορδόνια   
9. Ντύνομαι ανεξάρτητα (όλα τα ρούχα). Δεν απαιτούνται 
προσαρμοστικά βοηθήματα ή ειδικά προσαρμοσμένο περιβάλλον  
          
 B - Κάτω μέρος σώματος 
     0.  Απαιτείται πλήρης βοήθεια 
1. Απαιτείται μερική βοήθεια με ρούχα χωρίς κουμπιά, φερμουάρ ή 
κορδόνια  
2. Ανεξάρτητος/-η με ρούχα χωρίς κουμπιά, φερμουάρ ή κορδόνια. 
Απαιτείται χρήση προσαρμοστικών βοηθημάτων ή ειδικά 
προσαρμοσμένο περιβάλλον  
3. Ανεξάρτητος/-η με ρούχα χωρίς κουμπιά, φερμουάρ ή κορδόνια. Δεν 
απαιτούνται προσαρμοστικά βοηθημάτα ή ειδικά προσαρμοσμένο 
περιβάλλον. Χρειάζεται βοήθεια ή προσαρμοστικά βοηθημάτα ή ειδικά 
προσαρμοσμένο περιβάλλον μόνο για κουμπιά, φερμουάρ ή κορδόνια   
4. Ντύνομαι ανεξάρτητα (όλα τα ρούχα). Δεν απαιτούνται 
προσαρμοστικά βοηθήματα ή ειδικά προσαρμοσμένο περιβάλλον  
 
4.  Περιποίηση (Πλύσιμο χεριών και προσώπου, βούρτσισμα δοντιών, 
χτένισμα μαλλιών, ξύρισμα, μακιγιάρισμα) 
0. Απαιτείται πλήρης βοήθεια 
1. Απαιτείται μερική βοήθεια  
2. Ανεξάρτητη περιποίηση χρησιμοποιώντας προσαρμοστικά 
βοηθήματα  
3. Ανεξάρτητη περιποίηση χωρίς προσαρμοστικά βοηθήματα  
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Αναπνοή και διαχείρηση σφιγκτήρα  
1. Αναπνοή 
1. Απαιτείται τραχειακός σωλήνας (ΤΣ) και μόνιμος ή διαλείποντας 
υποβοηθούμενος αερισμός (ΔΥΑ)   
2. Ανεξάρτητη αναπνοή με ΤΣ. Απαιτείται οξυγόνο, πολλή βοήθεια στο 
βήξιμο ή στην διαχείρηση του ΤΣ 
        4.    Ανεξάρτητη αναπνοή με ΤΣ. Απαιτείται λίγη βοήθεια στο βήξιμο  ή στη 
διαχείριση του ΤΣ 
        6.    Ανεξάρτητη αναπνοή χωρίς ΤΣ. Απαιτείται οξυγόνο, πολλή βοήθεια    
               στο βήξιμο ή στην διαχείρηση του ΤΣ 
8. Αναπνοή χωρίς ΤΣ. Απαιτείται λίγη βοήθεια ή διέγερση για βήξιμο 
       10.   Ανεξάρτητη αναπνοή χωρίς βοήθεια ή βοηθήματα 
    
        
6. Διαχείρηση σφιγκτήρα – Ουροδόχος κύστη   
         0.   Εμφυτευμένος καθετήρας 
         3.   Υπολοιπόμενος όγκος ούρων (ΥΟΟ) > 100 κυβικά εκατοστά.   
               Κανένας τακτικός καθετηριασμός ή υποβοηθούμενος διαλείποντας                                                              
               καθετηριασμός 
6. ΥΟΟ < 100 κυβικά εκατοστά ή διαλείπων αυτοκαθετηριασμός.   
               Χρειάζομαι βοήθεια για την εφαρμογή συσκευής παροχέτευσης 
9. Διαλείποντας αυτοκαθετηριασμός. Χρήση εξωτερικής  
συσκευής παροχέτευσης. Δεν χρειάζομαι βοήθεια για την εφαρμογή 
       11.  Διαλείποντας αυτοκαθετηριασμός. Εγκράτεια μεταξύ καθετηριασμών.  
      Δεν χρησιμοποιείται εξωτερική συσκευή παροχέτευσης  
13.    ΥΟΟ < 100 κυβικά εκατοστά. Χρειάζεται μόνο εξωτερική ουρική      
   παροχέτευση. Δεν απαιτείται βοήθεια για παροχέτευση 
     15.  Υ.Ο.Ο <100 κυβικά εκατοστά. Δεν χρησιμοποιείται εξωτερική συσκευή   
     παροχέτευσης 
 
7. Διαχείριση σφιγκτήρα - Έντερο 
        0.  Αφόδευση με ακανόνιστο χρονισμό ή πολύ μικρής συχνότητας  
            (λιγότερο απο μία  φορά σε 3 ημέρες)  
        5.  Κανονικός χρονισμός, αλλά απαιτείται βοήθεια (π.χ. για τοποθέτηση  
             υποθέτου). Σπάνια ατυχήματα (λιγότερο από μια φορά το μήνα) 
       8.   Κανονική αφόδευση, χωρίς βοήθεια. Σπάνια ατυχήματα (λιγότερο από    
             μια φορά το μήνα)  
      10.   Κανονική αφόδευση, χωρίς βοήθεια, χωρίς ατυχήματα 
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8. Χρήση τουαλέτας (Υγιεινή περίνεου, τακτοποίηση ρούχων πριν/μετά, χρήση 
πάνας) 
3. Απαιτείται πλήρης βοήθεια 
4. Απαιτείται μερική βοήθεια. Δεν καθαρίζομαιι μόνος/-η  
5. Απαιτείται μερική βοήθεια. Καθαρίζομαι μόνος/-η 
         4.  Ανεξάρτητος/-η σε όλες τις δραστηριότητες τουαλέτας αλλά   
              χρειάζονται προσαρμοστικά βοηθήματα ή ειδικά 
              προσαρμοσμένο περιβάλλον (π.χ. μπάρες) 
5. Ανεξάρτητος/-η στην τουαλέτα. Δεν απαιτούνται προσαρμοστικά 
βοηθήματα ή ειδικά προσαρμοσμένο περιβάλλον  
 
 
Κινητικότητα (δωμάτιο και τουαλέτα) 
9. Κινητικότητα στο κρεβάτι και μέτρα για την αποφυγή κατακλίσεων  
0. Χρειάζομαι βοήθεια σε όλες τις δραστηριότητες. Γυρίζω το άνω μέρος 
του σώματος στο κρεβάτι, γυρίζω το κάτω μέρος του σώματος στο 
κρεβάτι, ανακάθομαι στο κρεβάτι. Kάνω ανασήκωμα στο αναπηρικό 
αμαξίδιο, με ή χωρίς προσαρμοστικά βοηθήματα αλλά όχι με ηλεκτρικά 
βοηθήματα 
2.  Εκτελώ μία από τις δραστηριότητες χωρίς βοήθεια 
         4.  Εκτελώ δύο ή τρεις από τις δραστηριότητες χωρίς βοήθεια 
6. Εκτελώ ανεξάρτητα όλες τις δραστηριότητες στο κρεβάτι και όλες τις 
δραστηριότητες απελευθέρωσης πίεσης 
 
 
10. Μεταφορές: κρεβάτι - αναπηρικό αμαξίδιο (κλείδωμα αμαξιδίου, 
ανασήκωση υποποδίων, αφαίρεση και προσαρμογή του βραχίονα, μεταφορά, 
ανασήκωμα ποδιών) 
3. Απαιτείται πλήρης βοήθεια 
4. Χρειάζεται μερική βοήθεια και/ή επίβλεψη, και/ή προσαρμοστικά 
βοηθήματα (π.χ. σανίδα μεταφοράς) 
5. Ανεξάρτητος/-η (ή δεν απαιτείται αναπηρικό αμαξίδιο) 
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11. Μεταφορές: αναπηρικό αμαξίδιο - τουαλέτα - νιπτήρας (εάν 
χρησιμοποιείται αναπηρικό αμαξιδίο τουαλέτας): μεταφορές προς και από; εάν 
χρησιμοποιείται κανονικό αναπηρικό αμαξιδίο: κλείδωμα αμαξιδίου, ανασήκωση 
υποποδίων, αφαίρεση και προσαρμογή του βραχίονα, μεταφορά, ανασήκωμα 
ποδιών) 
0. Απαιτείται πλήρης βοήθεια 
1. Χρειάζεται μερική βοήθεια και/ή επίβλεψη, και/ή προσαρμοστικά 
βοηθήματα (π.χ. μπάρες στήριξης) 
2. Ανεξάρτητος/-η (ή δεν απαιτείται αναπηρικό αμαξίδιο) 
 
 
Κινητικότητα (σε εσωτερικούς και εξωτερικούς χώρους, ή επίπεδη επιφάνεια) 
12. Κινητικότητα σε εσωτερικούς χώρους 
9. Απαιτείται πλήρης βοήθεια 
10. Χρειάζεται ηλεκτρικό αναπηρικό αμαξίδιο ή μερική βοήθεια για το 
χειρισμό χειροκίνητου αναπηρικού αμαξιδίου 
11. Aνεξάρτητη κινητικότητα με χειροκίνητο αναπηρικό αμαξιδίο  
12. Απαιτείται επίβλεψη κατά τη βάδιση (με ή χωρίς βοηθήματα)  
13. Βάδιση με πλαισίο βάδισης “Π” ή πατερίτσες (αιώρηση)  
14. Βάδιση με πατερίτσες ή δύο μπαστούνια (αμφοτερόπλευρη βάδιση)  
15. Βάδιση με ένα μπαστούνι  
16. Χρειάζεται μηροκνημοποδικός κηδεμόνας 
17. Βάδιση χωρίς βοηθήματα 
 
13. Κινητικότητα για μέτριες αποστάσεις (10-100 μέτρα) 
0. Απαιτείται πλήρης βοήθεια 
1. Χρειάζεται ηλεκτρικό αναπηρικό αμαξίδιο ή μερική βοήθεια για το 
χειρισμό χειροκίνητου αναπηρικού αμαξιδίου 
2. Aνεξάρτητη κινητικότητα με χειροκίνητο αναπηρικό αμαξιδίο  
3. Απαιτείται επίβλεψη κατά τη βάδιση (με ή χωρίς βοηθήματα)  
4. Βάδιση με πλαισίο βάδισης “Π” ή πατερίτσες (αιώρηση)  
5. Βάδιση με πατερίτσες ή δύο μπαστούνια (αμφοτερόπλευρη βάδιση)  
6. Βάδιση με ένα μπαστούνι  
7. Χρειάζεται μηροκνημοποδικός κηδεμόνας  
8. Βάδιση χωρίς βοηθήματα 
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14. Κινητικότητα σε εξωτερικό χώρο (άνω των 100 μέτρων) 
0. Απαιτείται πλήρης βοήθεια 
1. Χρειάζεται ηλεκτρικό αναπηρικό αμαξίδιο ή μερική βοήθεια για το 
χειρισμό χειροκίνητου αναπηρικού αμαξιδίου 
2. Aνεξάρτητη κινητικότητα με χειροκίνητο αναπηρικό αμαξιδίο  
3. Απαιτείται επίβλεψη κατά τη βάδιση (με ή χωρίς βοηθήματα)  
4. Βάδιση με πλαισίο βάδισης “Π” ή πατερίτσες (αιώρηση)  
5. Βάδιση με πατερίτσες ή δύο μπαστούνια (αμφοτερόπλευρη βάδιση)  
6. Βάδιση με ένα μπαστούνι  
7. Χρειάζεται μηροκνημοποδικός κηδεμόνας  
8. Βάδιση χωρίς βοηθήματα 
 
15. Κινητικότητα σε σκάλα 
4. Στερούμαι ικανότητας για ανέβασμα ή κατέβασμα σκάλας 
5. Ανεβαίνω και κατεβαίνω τουλάχιστον 3 σκαλοπάτια με στήριξη ή   
επίβλεψη άλλου ατόμου 
6. Ανεβαίνω και κατεβαίνω τουλάχιστον 3 σκαλοπάτια με στήριξη στο 
κάγκελο της σκάλας και/ή πατερίτσα ή μπαστούνι. 
7. Ανεβαίνω και κατεβαίνω τουλάχιστον 3 σκαλοπάτια χωρίς στήριξη ή  
επίβλεψη 
16. Μεταφορές: Αναπηρικό αμαξίδιο – αυτοκίνητο (προσέγγιση 
αυτοκινήτου, κλείδωμα αμαξιδίου, αφαίρεση βραχιόνων και υποποδίων, 
μεταφορά πρός και από το αυτοκίνητο, μεταφορά αμαξιδίου μέσα και έξω από 
το αυτοκίνητο) 
0. Απαιτείται πλήρης βοήθεια 
         1. Χρειάζεται μερική βοήθεια και/ή επίβλεψη και/ή προσαρμοστικά  
             βοηθήματα 
         2. Ανεξάρτητη μεταφορά. Δεν απαιτούνται προσαμοστικά βοηθήματα  (ή   
             δεν απαιτείται αναπηρικό αμαξίδιο) 
 
17. Μεταφορές: έδαφος - αναπηρικό αμαξίδιο 
0.  Απαιτείται βοήθεια 
1. Ανεξάρτητη μεταφορά με ή χωρίς προσαρμοστικά βοηθήματα (ή δεν 
απαιτείται αναπηρικό αμαξιδίο)  
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Κοινωνικο-δημογραφικές Πληροφορίες 
 
Αυτό είναι το τελευταίο μέρος του ερωτηματολογίου. Αυτό το μέρος περιέχει 
τρεις ενότητες, η πρώτη ενότητα περιέχει ερωτήσεις για τον εαυτό σας, στην 
αρχή και στο τέλος του ερωτηματολογίου, η δεύτερη για τον πόνο σας 
γενικότερα και η τρίτη για την οσφυαλγία σας. Παρακαλώ, απαντήσετε στις 
ερωτήσεις με όσο το δυνατόν μεγαλύτερη ακρίβεια. 
 
Ερωτήσεις για τον εαυτό σας 
1)  Ποιό είναι το φύλο σας;  
       Άνδρας              Γυναίκα   
 
2) Ποιά είναι η ημερομηνία γέννησής σας  _____/_____/______  
                                             ημέρα   μήνας   έτος 
 
3) Ποια είναι η μητρική σας γλώσσα; 
     Αγγλικά      Γαλλικά    Ισπανικά      Αραβικά       Ελληνικά   
     Άλλη (παρακαλώ δηλώστε)__________________________ 
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4) Ποια είναι η εθνικότητα σας; 
              Λευκή                                                      Ασιατική  
                                            Ελληνική                 Τουρκική        
Ανατολική Ευρωπαϊκή – μη Ελληνική             Πακιστανική                    
              Μεσογειακή – μη Ελληνική                       Ινδική                         
                   Ηνωμένο Βασίλειο (ΗΒ)                   Κινεζική                       
               Δυτική Ευρωπαϊκή – μη ΗΒ                  Ιαπωνική                   
                             Βόρεια Ευρωπαϊκή          Άλλη Ασιατική                          
                                        Άλλη Λευκή           
 
            Μικτή                                                       Μαύρη  
        Λευκή και Μαύρη Καραϊβική                            Καραϊβική  
      Λευκή και Μαύρη Αφρικανική                          Αφρικανική  
                       Λευκή και Ασιατική                        Άλλη Μαύρη  
        Άλλη μικτή  
 
Εάν είπατε “άλλη” σε κάποιο από τα παραπάνω, παρακαλώ δηλώστε 
______________________________________________________ 
______________________________________________________ 
 
 
5) Ποιο είναι το ανώτερο δίπλωμα/πτυχίο που έχετε αποκτήσει; 
                                   Λύκειο           Μεταπτυχιακό (μαστερ)  
           Κολλέγιο ή αντίστοιχο         Διδακτορικό ή αντίστοιχο        
                        Πανεπιστήμιο     
                             Δεν έχω αποκτήσει κανένα δίπλωμα/πτυχίο  
Άλλο (παρακαλώ δηλώστε)__________________________________ 
 
6) Ποια είναι η οικογενειακή σας κατάσταση; 
           Ελεύθερος                     Συζώ με σύντροφο        Παντρεμένος              
             Χήρος/α       Σε διάσταση/ Διαζευμένος/η              Σε σχέση  
Άλλο (παρακαλώ δηλώστε)__________________________________  
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7) *Ποιo από τα παρακάτω περιγράφει καλύτερα την κύρια δραστηριότητά σας; 
                                                                       Ελεύθερος/-η επαγγελματίας      
   Υπάλληλος  
  Εθελοντική εργασία  
                                                                               Εργάζομαι από το σπίτι  
 Λαμβάνω επιδόματα υγείας  
                                  Άνεργος/-η αλλά εργαζόμουν πριν από τη ΚΝΜ μου  
                                   Δεν εργάζομαι χωρίς πότε να είχα έμμισθη εργασία  
                                             Μη ικανός/-ή να εργαστώ λόγω της ΚΝΜ μου  
                                                                               Σε αναζήτηση εργασίας   
                                                                                                        Οικιακά   
                                                                                               Συνταξιούχος  
                                                     Φοιτητής/-τρια, μαθητής/-τρια   
      Άλλο   (παρακαλώ δηλώστε)__________________________________ 
 
8) Ποιος είναι ο τόπος διαμονής σας; 
    Πόλη ή χωριό_____________   Επαρχία_______________________ 
 
9) Ποια είναι η χιλιομετρική απόσταση μεταξύ της κατοικίας σας και του 
πλησιέστερου από τα ακόλουθα. Αν δε γνωρίζετε, παρακαλώ, αφήστε κενό. 
                                                         Νοσοκομείο__________Χμ   
                             Κέντρο Αποκατάστασης ΚΝΜ__________Χμ   
              Εξειδικευμένα Εξωτερικά Ιατρεία KNM __________Χμ  
                           Μονάδα Φυσιοθεραπείας ΕΣΥ__________Χμ   
                            Ιδιωτικό Φυσικοθεραπευτήριο__________Χμ  
                         Κέντρο Θεραπευτικής Ιππασίας__________Χμ 
 
10) *Πότε αποκτήσατε την ΚΝΜ σας; 
    ______/______/_______  
    ημέρα   μήνας    έτος 
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11) *Ποια ήταν η ατία για την ΚΝΜ σας; 
 Τραυματική      (παρακαλώ συνεχίστε με τις παρακάτω ερωτήσεις)
 Μη-τραυματική   (παρακαλώ, πηγαίνετε στην ερώτηση 13, σελίδα 15) 
 
12) *Η αιτία της τραυματικής ΚΝΜ μου ήταν 
 
 
         Τροχαίο Ατύχημα                                  Ατύχημα λόγω άσκησης βίας 
   Ατύχημα με Αυτοκίνητο                     Βίαιη επίθεση  
           Ατύχημα με Μοτοσυκλέτα                         Επίθεση με μαχαίρι  
          Ατύχημα ως πεζός                    Πυροβολισμός  
    Ατύχημα με Ποδήλατο               Άλλη  
                         Άλλη  
 
                   Εργατικό ατύχημα    Ατύχημα σε οικία 
                       Ολισθηρό έδαφος                           Ολισθηρό έδαφος  
          Πτώση από σκάλα/σκαλιά                       Πτώση από σκαλιά  
                Πτώση από σκαλωσιά                   Πτώση από παράθυρο  
                   Χάσιμο ισορροπίας από                     Χάσιμο ισορροπίας από 
               αντικείμενο στο έδαφος                   αντικείμενο στο έδαφος   
                                           Άλλη                                                Άλλη      
 
                                Ατύχημα λόγω αθλήματος 
      Αγώνες ταχύτητας με αυτοκίνητο            Ορειβασία  
    Αγώνες ταχύτητας με μοτοσυκλέτα            Ποδηλασία  
                 Ιππασία   
Ποδόσφαιρο            Καταδύσεις  
 Ράγκμπυ     Κολύμβηση             
Άλλη          
 
Εάν “άλλη”, παρακαλώ δηλωστε_____________________________________ 
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Συντομογραφίες: Κάκωση Νωτιαίου Μυελού (ΚΝΜ), Εθνικό Σύστημα Υγείας (ΕΣΥ), Διαδερμική 
Ηλεκτρική Διέγερση Νεύρων (ΤΕΝΣ), Σπονδυλική στήλη (ΣΣ), *απαντήστε στην ερώτηση εάν σας 
αφορά 
 
13) *Η αιτία της μη-τραυματικής ΚΝΜ μου ήταν 
Αγγειακή 
       Αρτηριοσκλήρωση που οδηγεί σε απώλεια ανεφοδιασμού αίματος  
    Εμβολή  
     Επισκληρίδιος αιμορραγία  
   Σοβαρή υπόταση που οδηγεί σε απώλεια ανεφοδιασμού αίματος  
  Άλλη  
 
Καρκινογενής (Νεοπλασία) 
Καρκίνος μέσα και γύρω από τις δομές του νωτιαίου μυελού 
         π.χ. μηνιγγίωμα, γλοίωμα κτλ  
Μεταστατικός καρκίνος από άλλη περιοχή  
                            π.χ. πνεύμονας, στήθος, προστάτης κτλ  
Άλλη    
 
    Φλεγμονές και μολύνσεις                Εκφυλιστική 
    Εγκάρσια μυελίτιδα    Νόσος Paget των οστών  
  Επισκληρίδιο απόστημα       Οστεοαρθρίτιδα  
 Σαρκοείδωση         Οστεοπόρωση  
    Φυματίωση      Ρευματοειδής αρθρίτιδα  
  Άλλη         Σπονδυλόλυση  
            Άλλη  
 
    Παραμόρφωση Σ.Σ.   Άλλη νευρολογική 
     Δισχιδής ράχη                   Αταξία Friedreich's  
  Κύφωση       Εγκεφαλική παράλυση  
   Κυφωλόρδωση    Σκλήρυνση κατα πλάκας  
   Κυφωσκολίωση        Άλλη  
Λόρδωση  
Σκολίωση  
  Άλλη  
Εάν “άλλη”, παρακαλώ δηλωστε_____________________________________ 
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Συντομογραφίες: Κάκωση Νωτιαίου Μυελού (ΚΝΜ), Εθνικό Σύστημα Υγείας (ΕΣΥ), Διαδερμική 
Ηλεκτρική Διέγερση Νεύρων (ΤΕΝΣ), *απαντήστε στην ερώτηση εάν σας αφορά 
 
14) *Ποιο είναι το επίπεδο της κάκωσης σας; Παρακαλώ δηλώστε τον αριθμό 
του σπονδύλου. 
    Αυχενικοί είναι οι πρώτοι 7 σπόνδυλοι της Σ.Σ, γνωστοί ως Α1 έως Α7 
    Θωρακικοί (άνω πλάτη) είναι οι επόμενοι 12 σπόνδυλοι, γνωστοί ως Θ1 έως Θ12 
     Οσφυικοί (κατώτερη πλάτη) είναι οι επόμενοι 5 σπόνδυλοι, γνωστοί ως Ο1 έως Ο5 
    
Το επίπεδο της κάκωσης μου είναι 
Αυχενικός_________      Θωρακικός_________      Οσφυϊκός__________ 
 
15) *Ποιος είναι ο τύπος της ΚΝΜ σας; 
           Πλήρης παραπληγία                Πλήρης τετραπληγία   
            Μερική παραπληγία                 Μερική τετραπληγία   
                      Δεν γνωρίζω      
                                 ΄Αλλος   (παρακαλώ δηλώστε)_____________________ 
 
 
16) Ποιο είναι το είδος της ασφάλειας υγείας που έχετε; 
          ΕΣΥ                         Ιδιωτική            Και οι δύο  
Άλλο (παρακαλώ δηλώστε)_________________________________________ 
 
 
17) Ποιά απο τις παραπάνω ασφάλειες έχετε κυρίως χρησιμοποιήσει για τις 
διάφορες θεραπείες για την ΚΝΜ σας; 
                ΕΣΥ             Και τις δυο  
          Ιδιωτική        Καμμία  
              Άλλη  (παρακαλώ δηλώστε)____________________________ 
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Συντομογραφίες: Κάκωση Νωτιαίου Μυελού (ΚΝΜ), Εθνικό Σύστημα Υγείας (ΕΣΥ), Διαδερμική 
Ηλεκτρική Διέγερση Νεύρων (ΤΕΝΣ), *απαντήστε στην ερώτηση εάν σας αφορά 
 
18) Που λάβατε την πρώτη σας θεραπεία για την ΚΝΜ σας; 
                   Νοσοκομείο του ΕΣΥ           Ιδιωτικό κέντρο αποκατάστασης  
                    Ιδιωτικό Νοσοκομείο                            Δημόσιο κέντρο ΚΝΜ  
 Δημόσιο κέντρο αποκατάστασης                    Ιδιωτικό κέντρο ΚΝΜ  
  Άλλο (παρακαλώ δηλώστε)________________________________________ 
 
 
19) Σε ποια χώρα λάβατε την πρώτη σας θεραπεία για την ΚΝΜ σας; 
                 Ελλάδα           
                     Άλλη   (παρακαλώ δηλώστε)____________________________ 
 
20) Πόσο καιρό παραμείνατε στο παραπάνω νοσοκομείο/κέντρο μετά από την   
 ΚΝΜ σας; 
Αν στη συνέχεια μεταφερθήκατε σε άλλη μονάδα (π.χ. κέντρο ΚΝΜ) 
παρακαλώ αναφέρετε πόσο καιρό επιπλέον μείνατε εκεί.  
(Παρακαλώ, δηλώστε αν μήνες ή εβδομάδες) 
      Αρχικό νοσοκομείο/κέντρο για____________________________________ 
      Μεταφέρθηκα σε άλλη μονάδα για_________________________________ 
 
21) Έχετε υποβληθεί σε χειρουργική επέμβαση μετά τη ΚΝΜ σας; 
       Όχι   
  Ναι   (παρακαλώ δηλώστε σε τι χειρουργικής επέμβασης υποβληθήκατε) 
    Υποβλήθηκα σε________________________________________________ 
    _____________________________________________________________ 
_______________________________________________________________ 
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Συντομογραφίες: Κάκωση Νωτιαίου Μυελού (ΚΝΜ), Εθνικό Σύστημα Υγείας (ΕΣΥ), Διαδερμική 
Ηλεκτρική Διέγερση Νεύρων (ΤΕΝΣ), *απαντήστε στην ερώτηση εάν σας αφορά 
 
22) Οι φίλοι και η οικογένειά σας σάς υποστηρίζουν στην ΚΝΜ σας; 
                                  Ναι              Δεν θέλω την υποστήριξή τους                    
                                  Όχι     Δεν χρειάζομαι την υποστήριξή τους          
         Όχι όση χρειάζομαι              Δεν θέλω να αναφέρω  
 
Άλλο (παρακαλώ δηλώστε)_________________________________________ 
 
 
Ερωτήσεις για τον πόνο σας γενικότερα 
 
23) *Aπό τότε που αποκτήσατε την ΚΝΜ σας έχετε νοιώσει πόνο; 
            Ναι   (παρακαλώ, συνεχίστε με τις παρακάτω ερωτήσεις)         
Όχι   (παρακαλώ πηγαίνετε στην ερώτηση 34, σελίδα 20) 
 
24) *Πόσο καιρό μετά από την ΚΝΜ σας ξεκίνησε ο πόνος; 
        Αμέσως μετά από την ΚΝΜ    Μεταξύ 2 εβδομάδων και ενός μήνα  
                     Την επόμενη ημέρα                              Μεταξύ 1 - 3 μηνών         
                      Μετά από 3 ημέρες                       Μεταξύ 3 - 6 μηνών   
                 Μετά από 1 εβδομάδα               Μεταξύ 6 μήνες και 1 χρόνου                        
                Μετά από 2 εβδομάδες                                Μετά από 1 χρόνο  
          
Άλλο (παρακαλώ δηλώστε)__________________________________ 
 
25) *Κατά μέσο όρο τους τελευταίους 6 μήνες πόσες ημέρες το μήνα νοιώθετε 
πόνο;  
                       1 - 4 ημέρες               21 - 25 ημέρες      
                       5 - 9 ημέρες                 26 - 30 ημέρες        
                    10 -15 ημέρες                       Κάθε μέρα      
          16 - 20 ημέρες    
 
   Αν ξεκινήσετε να πονάτε σε διάστημα μικρότερο από 6 μήνες, παρακαλώ   
   δηλώσετε πόσο καιρό πρίν 
_______________________________________________________________ 
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Συντομογραφίες: Κάκωση Νωτιαίου Μυελού (ΚΝΜ), Εθνικό Σύστημα Υγείας (ΕΣΥ), Διαδερμική 
Ηλεκτρική Διέγερση Νεύρων (ΤΕΝΣ), *απαντήστε στην ερώτηση εάν σας αφορά 
 
26) *Από τι είδος πόνου υποφέρετε; Παρακαλώ, σημειώστε όλα όσα 
σχετίζονται. 
 
                     Νευροπαθητικό πάνω από το επίπεδο της κάκωσης      
                      Νευροπαθητικό κάτω από το επίπεδο της κάκωσης      
                                     Νευροπαθητικό στο επίπεδο της κάκωσης      
                                                                                       Άνω Άκρα       
                                                                        Μυοσκελετικό                  
                                                                          Πόνο στην πλάτη  
                         Δεν γνωρίζω  
  Άλλο  (παρακαλώ δηλώστε)______________________________________ 
 
 
27) *Λαμβάνετε φαρμακευτική αγωγή για τον πόνο σας; 
         Ναι     (παρακαλώ, συνεχίστε με τις ερωτήσεις παρακάτω)           
         Όχι    (παρακαλώ πηγαίνετε στην ερώτηση 30, σελίδα 18) 
 
28) Πόσο συχνά λαμβάνετε φαρμακευτική αγωγή για τον πόνο; 
                Καθημερινά                 Όποτε νοιώθω πόνο  
         Σε τακτική βάση             
                           Άλλο  (παρακαλώ δηλώστε)__________________________ 
 
29) Όταν λαμβάνετε φαρμακευτική αγωγή για τον πόνο, πόσες ώρες περνάνε  
συνήθως για να επιστρέψει ο πόνος; 
                  1 ώρα                                                  4 ώρες  
                 2 ώρες                                             5-12 ώρες                                                                                             
                 3 ώρες                               Πάνω από 12 ώρες     
                 Η φαρμακευτική αγωγή για τον πόνο δε βοηθάει    
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Συντομογραφίες: Κάκωση Νωτιαίου Μυελού (ΚΝΜ), Εθνικό Σύστημα Υγείας (ΕΣΥ), 
Διαδερμική Ηλεκτρική Διέγερση Νεύρων (ΤΕΝΣ), *απαντήστε στην ερώτηση εάν σας 
αφορά 
 
30) *Κατά την παραμονής σας στο νοσοκομείο/κέντρο αξιολογηθήκατε από 
επαγγελματίες υγείας για τον πόνο σας; (Παρακαλώ, σημειώστε όλα όσα 
σχετίζονται) 
 
                                                             Ναι, αξιολογήθηκα αμέσως από το γιατρό  
                                               Ναι, αξιολογήθηκα αμέσως από το νοσηλευτή/τρια  
                                   Ναι, αξιολογήθηκα αμέσως από το φυσικοθεραπευτή/τρια  
             Αξιολογήθηκα από το γιατρό, αλλά μόνο αφού παραπονέθηκα για πόνο 
   Αξιολογήθηκα από νοσηλευτή/τρια, αλλά μόνο αφού παραπονέθηκα για πόνο 
Αξιολογήθηκα από φυσιοθεραπευτή/τρια, αλλά μόνο αφού παραπονέθηκα για πόνο  
                                  Αξιολογήθηκα πολύ καιρό μετά την έναρξη του πόνος μου 
                                           Όχι, δεν αξιολογήθηκα από κανένα για τον πόνο μου 
Άλλο  (παρακαλώ δηλώστε)_______________________________________ 
 
 
31) *Κατά την παραμονή σας στο νοσοκομείο/κέντρο, τι είδος θεραπείας 
για τον πόνο λάβατε; Παρακαλώ, δηλώστε όλα όσα σχετίζονται. 
 
Φαρμακευτική αγωγή πόνου               Τεχνικές Χαλάρωσης            
                    Φυσικοθεραπεία                     Ηλεκτροθεραπεία     
                       Κρυοθεραπεία                Βελονισμός            
                      Θερμοθεραπεία                       Κινησιοθεραπεία            
 ΤΕΝΣ            Ασκήσεις ενδυνάμωσης                              
  Δεν ένοιωθα κάποιο πόνο όσο ήμουν στο νοσοκομείο/κέντρο   
       Ένοιωθα πόνο αλλά δε μου προσφέρθηκε καμία θεραπεία  
  Δεν θυμάμαι  
                                       Άλλο  (παρακαλώ 
δηλώστε)____________________ 
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Συντομογραφίες: Κάκωση Νωτιαίου Μυελού (ΚΝΜ), Εθνικό Σύστημα Υγείας (ΕΣΥ), Διαδερμική 
Ηλεκτρική Διέγερση Νεύρων (ΤΕΝΣ), *απαντήστε στην ερώτηση εάν σας αφορά 
32) Κατά την παραμονή σας στο νοσοκομείο/κέντρο, πόσο συχνά 
λαμβάνατε θεραπεία για τον πόνο; 
 
                            Μη ισχύων  
Φαρμακευτική αγωγή πόνου_________________________________ 
                   Φυσικοθεραπεία_________________________________ 
                      Κρυοθεραπεία_________________________________ 
                    Θερμοθεραπεία_________________________________ 
                                    ΤΕΝΣ_________________________________ 
            Τεχνικές χαλάρωσης_________________________________ 
                 Ηλεκτροθεραπεία_________________________________ 
                           Βελονισμός_________________________________ 
                   Κινησιοθεραπεία_________________________________ 
                                   Μασάζ_________________________________ 
 
*απαντήστε στην ερώτηση εάν σας αφορά                                    
 
       Ασκήσεις ενδυνάμωσεις_________________________________ 
  Άλλο (παρακαλώ δηλώστε) _________________________________ 
 
33) *Από τότε που φύγατε από το νοσοκομείο/κέντρο έχετε λάβει θεραπεία 
για τον πόνο; Παρακαλώ, δηλώστε όλα τα είδη θεραπειών που είχατε. 
 
Φαρμακευτική αγωγή πόνου                  Βελονισμός  
             Φυσικοθεραπεία                   Κινησιοθεραπεία  
                Κρυοθεραπεία                          Μασάζ  
              Θερμοθεραπεία        Ασκήσεις ενδυνάμωσεις  
                              ΤΕΝΣ                      Θεραπευτική ιππασία  
      Τεχνικές χαλάρωσης                Δεν ένοιωθα καθόλου πόνο  
                  Ηλεκτροθεραπεία         
        Ένοιωθα πόνο αλλά δεν έλαβα καμία θεραπεία για τον πόνο 
   Δεν θυμάμε  
       Άλλο (παρακαλώ δηλώστε)   ___________________________________
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Συντομογραφίες: Κάκωση Νωτιαίου Μυελού (ΚΝΜ), Εθνικό Σύστημα Υγείας (ΕΣΥ), 
Διαδερμική Ηλεκτρική Διέγερση Νεύρων (ΤΕΝΣ),  
 
34) Απο τότε που φύγατε απο το νοσοκομείο/κέντρο, πόσο συχνά λαμβάνετε 
θεραπεία για τον πόνο; 
                            Μη ισχύων  
Φαρμακευτική αγωγή πόνου_________________________________ 
                   Φυσικοθεραπεία_________________________________ 
                      Κρυοθεραπεία_________________________________ 
                    Θερμοθεραπεία_________________________________ 
                                    ΤΕΝΣ_________________________________ 
            Τεχνικές χαλάρωσης_________________________________ 
                 Ηλεκτροθεραπεία_________________________________ 
                           Βελονισμός_________________________________ 
                   Κινησιοθεραπεία_________________________________ 
                                   Μασάζ_________________________________ 
       Ασκήσεις ενδυνάμωσεις_________________________________ 
           Θεραπευτική ιππασία_________________________________ 
  Άλλο (παρακαλώ δηλώστε) _________________________________ 
 
35) *Εάν είχατε θεραπεία για τον πόνο ποια πιστεύετε ότι σας βοήθησε 
περισσότερο; Εάν είναι περισσότερες από μία, παρακαλώ δηλώστε τις με σειρά 
αποτελεσματικότητας. 
    Μη ισχύων  
Φαρμακευτική αγωγή πόνου_________________________________ 
                   Φυσικοθεραπεία_________________________________ 
                      Κρυοθεραπεία_________________________________ 
                    Θερμοθεραπεία_________________________________ 
                                    ΤΕΝΣ_________________________________ 
            Τεχνικές χαλάρωσης_________________________________ 
                 Ηλεκτροθεραπεία_________________________________ 
                           Βελονισμός_________________________________ 
                   Κινησιοθεραπεία_________________________________ 
                                   Μασάζ_________________________________ 
       Ασκήσεις ενδυνάμωσεις_________________________________ 
           Θεραπευτική ιππασία_________________________________ 
  Άλλο (παρακαλώ δηλώστε) _________________________________ 
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Συντομογραφίες: Κάκωση Νωτιαίου Μυελού (ΚΝΜ), Εθνικό Σύστημα Υγείας (ΕΣΥ), 
Διαδερμική Ηλεκτρική Διέγερση Νεύρων (ΤΕΝΣ), *απαντήστε στην ερώτηση εάν σας 
 
36) Κατά μέσο όρο, από τότε που φύγατε από το νοσοκομείο/κέντρο,πόσο 
καιρό ήσασταν σε λίστα αναμονής για να λάβετε θεραπεία για τον πόνο σας;  
    Η θεραπεία ξεκίνησε αμέσως                                        4 μήνες                                           
                        1 – 2 εβδομάδες                                        5 μήνες  
                                       1 μήνα                                       6 μήνες   
                                      2 μήνες                      Πάνω από 6 μήνες  
                                      3 μήνες     Δεν ήμουν σε λίστα αναμονής  
Άλλο (παρακαλώ δηλώστε)__________________________________ 
 
37) *Από τότε που πρωτοεμφανίστηκε ο πόνος σας, υπήρξε περίοδο μίας 
εβδομάδας ή περισσότερο χωρίς πόνο; 
 
        Ναι, τον περισσότερο καιρό                      Ναι, αλλά σπάνια  
                                  Ναι, συχνά         Όχι, πάντα ένοιωθα πόνο  
                      Ναι, μερικές φορές                    Δεv θυμάμαι                      
           Ναι, αλλά όχι πολύ συχνά     
 
38) *Νοιώθετε τώρα κάποιο πόνο; 
       Όχι  
                          Ναι  (παρακαλώ, περιγράψτε τον με λίγα λόγια) 
_______________________________________________________________
_______________________________________________________________
_______________________________________________________________
_______________________________________________________________
_______________________________________________________________ 
 
Ερωτήσεις για την οσφυαλγία σας 
 
39)  Από τότε που αποκτήσατε την ΚΝΜ σας έχετε νοιώσει οσφυαλγία; 
             Ναι   (παρακαλώ, συνεχίστε με τις παρακάτω ερωτήσεις)         
 Όχι   (παρακαλώ, πηγαίνετε στην ερώτηση 53, σελίδα 25) 
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Συντομογραφίες: Κάκωση Νωτιαίου Μυελού (ΚΝΜ), Εθνικό Σύστημα Υγείας (ΕΣΥ), Διαδερμική 
Ηλεκτρική Διέγερση Νεύρων (ΤΕΝΣ), *απαντήστε στην ερώτηση εάν σας 
 
40) *Πόσο καιρό μετά από την ΚΝΜ σας ξεκίνησε η οσφυαλγία σας; 
  Αμέσως μετά από την ΚΝΜ     Μεταξύ 2 εβδομάδων και ενός μήνα  
              Την επόμενη ημέρα                              Μεταξύ 1 - 3 μηνών         
               Μετά από 3 ημέρες                        Μεταξύ 3 - 6 μηνών  
          Μετά από 1 εβδομάδα               Μεταξύ 6 μήνες και 1 χρόνου                        
        Μετά από 2 εβδομάδες                                Μετά από 1 χρόνο   
                                Άλλο  (παρακαλώ δηλώστε)_________________ 
 
 
41) *Κατά μέσο όρο τους τελευταίους 6 μήνες πόσες ημέρες το μήνα νοιώθετε 
οσφυαλγία;  
                       1 - 4 ημέρες               21 - 25 ημέρες       
                       5 - 9 ημέρες                26 - 30 ημέρες           
                    10 -15 ημέρες                    Κάθε ημέρα         
                   16 - 20 ημέρες    
 
 Αν η οσφυαλγία πρωτοεμφανίστηκε πριν από διάστημα μικρότερο από 6 μήνες, 
παρακαλώ δηλώστε πρίν πόσο καιρό εμφανίστηκε. 
_______________________________________________________________ 
 
42) *Λαμβάνετε φαρμακευτική αγωγή για την οσφυαλγία σας; 
            Ναι   (παρακαλώ, συνεχίστε με τις παρακάτω ερωτήσεις)            
Όχι   (παρακαλώ, πηγαίνετε στην ερώτηση 45, σελίδα 22) 
 
 
43) *Πόσο συχνά λαμβάνετε φαρμακευτική αγωγή για την οσφυαλγία; 
              Καθημερινά                   Όποτε νοιώθω πόνο  
        Σε τακτική βάση             
 Άλλο  (παρακαλώ 
δηλώστε)__________________________ 
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Συντομογραφίες: Κάκωση Νωτιαίου Μυελού (ΚΝΜ), Εθνικό Σύστημα Υγείας (ΕΣΥ), 
Διαδερμική Ηλεκτρική Διέγερση Νεύρων (ΤΕΝΣ), *απαντήστε στην ερώτηση εάν σας 
 
44) Όταν λαμβάνετε φαρμακευτική αγωγή για την οσφυαλγία, πόσες ώρες 
περνάνε  συνήθως για να επιστρέψει η οσφυαλγία; 
                  1 ώρα                                                         4 ώρες  
                 2 ώρες                                                   5-12 ώρες                                                                                             
                 3 ώρες                                    Πάνω από 12 ώρες     
              Η φαρμακευτική αγωγή για την οσφυαλγία δε βοηθάει    
 
 
45) *Κατά την παραμονής σας στο νοσοκομείο/κέντρο αξιολογηθήκατε από 
επαγγελματίες υγείας για την οσφυαλγία σας; (Παρακαλώ, σημειώστε όλα όσα 
σχετίζονται) 
 
                                                             Ναι, αξιολογήθηκα αμέσως από το γιατρό  
                                               Ναι, αξιολογήθηκα αμέσως από το νοσηλευτή/τρια  
                                    Ναι, αξιολογήθηκα αμέσως από το φυσικοθεραπευτή/τρια  
             Αξιολογήθηκα από το γιατρό, αλλά μόνο αφού παραπονέθηκα για πόνο 
    Αξιολογήθηκα από νοσηλευτή/τρια, αλλά μόνο αφού παραπονέθηκα για πόνο  
Αξιολογήθηκα από φυσιοθεραπευτή/τρια, αλλά μόνο αφού παραπονέθηκα για πόνο  
                                   Αξιολογήθηκα πολύ καιρό μετά την έναρξη του πόνος μου 
                                           Όχι, δεν αξιολογήθηκα από κανένα για τον πόνο μου 
Άλλο  (παρακαλώ δηλώστε)_______________________________________ 
 
 
46) *Κατά την παραμονή σας στο νοσοκομείο/κέντρο, τι είδος θεραπείας 
για την οσφυαλγία σας λάβατε; (Παρακαλώ, δηλώστε όλα όσα σχετίζονται) 
 
Φαρμακευτική αγωγή πόνου               Τεχνικές Χαλάρωσης            
                    Φυσικοθεραπεία                     Ηλεκτροθεραπεία     
                       Κρυοθεραπεία                Βελονισμός            
                      Θερμοθεραπεία                       Κινησιοθεραπεία            
 ΤΕΝΣ            Ασκήσεις ενδυνάμωσης                              
  Δεν ένοιωθα κάποιο πόνο όσο ήμουν στο νοσοκομείο/κέντρο   
       Ένοιωθα πόνο αλλά δε μου προσφέρθηκε καμία θεραπεία  
                                                                                Δεν θυμάμαι  
                                      Άλλο  (παρακαλώ δηλώστε)_________________ 
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Συντομογραφίες: Κάκωση Νωτιαίου Μυελού (ΚΝΜ), Εθνικό Σύστημα Υγείας (ΕΣΥ), Διαδερμική 
Ηλεκτρική Διέγερση Νεύρων (ΤΕΝΣ), *απαντήστε στην ερώτηση εάν σας 
 
47) Κατά την παραμονή σας στο νοσοκομείο/κέντρο, πόσο συχνά 
λαμβάνατε θεραπεία για την οσφυαλγία; 
                            Μη ισχύων  
Φαρμακευτική αγωγή πόνου_________________________________ 
                   Φυσικοθεραπεία_________________________________ 
                      Κρυοθεραπεία_________________________________ 
                    Θερμοθεραπεία_________________________________ 
                                    ΤΕΝΣ_________________________________ 
            Τεχνικές χαλάρωσης_________________________________ 
                 Ηλεκτροθεραπεία_________________________________ 
                           Βελονισμός_________________________________ 
                   Κινησιοθεραπεία_________________________________ 
                                   Μασάζ_________________________________ 
       Ασκήσεις ενδυνάμωσεις_________________________________ 
               Άλλο (παρακαλώ δηλώστε)_________________________________ 
 
 
48) *Από τότε που φύγατε από το νοσοκομείο/κέντρο, τι είδος θεραπείας 
για την οσφυαλγία λαμβάνετε; Παρακαλώ, δηλώστε όλες τις θεραπείες που 
έχετε λάβει. 
 Φαρμακευτική αγωγή πόνου                 Βελονισμός  
             Φυσικοθεραπεία                  Κινησιοθεραπεία  
                Κρυοθεραπεία                        Μασάζ  
              Θερμοθεραπεία        Ασκήσεις ενδυνάμωσεις  
                              ΤΕΝΣ                      Θεραπευτική ιππασία  
      Τεχνικές χαλάρωσης                Δεν ένοιωθα καθόλου πόνο  
                  Ηλεκτροθεραπεία          
          Ένοιωθα πόνο αλλά δεν έλαβα καμία θεραπεία για τον πόνο 
            Δεν θυμάμε  
   Άλλο (παρακαλώ δηλώστε) ___________________________________ 
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Συντομογραφίες: Κάκωση Νωτιαίου Μυελού (ΚΝΜ), Εθνικό Σύστημα Υγείας (ΕΣΥ), Διαδερμική 
Ηλεκτρική Διέγερση Νεύρων (ΤΕΝΣ), *απαντήστε στην ερώτηση εάν σας 
 
49) Απο τότε που φύγατε απο το νοσοκομείο/κέντρο, πόσο συχνά λαμβάνετε 
θεραπεία για την οσφυαλγία σας; 
                            Μη ισχύων  
Φαρμακευτική αγωγή πόνου_________________________________ 
                   Φυσικοθεραπεία_________________________________ 
                      Κρυοθεραπεία_________________________________ 
                    Θερμοθεραπεία_________________________________ 
                                    ΤΕΝΣ_________________________________ 
                    Τεχνικές χαλάρωσης_________________________________ 
                               Ηλεκτροθεραπεία_________________________________ 
                                         Βελονισμός_________________________________ 
                                Κινησιοθεραπεία_________________________________ 
                                                Μασάζ_________________________________ 
                    Ασκήσεις ενδυνάμωσεις_________________________________ 
                        Θεραπευτική ιππασία_________________________________ 
              Άλλο (παρακαλώ δηλώστε) _________________________________ 
 
 
50) *Εάν είχατε θεραπεία για την οσφυαλγία ποια πιστεύετε ότι σας βοήθησε 
περισσότερο; Εάν είναι περισσότερες από μία, παρακαλώ δηλώστε τις με σειρά 
αποτελεσματικότητας. 
    Μη ισχύων  
Φαρμακευτική αγωγή πόνου_________________________________ 
                   Φυσικοθεραπεία_________________________________ 
                      Κρυοθεραπεία_________________________________ 
                    Θερμοθεραπεία_________________________________ 
                                    ΤΕΝΣ_________________________________ 
            Τεχνικές χαλάρωσης_________________________________ 
                 Ηλεκτροθεραπεία_________________________________ 
                           Βελονισμός_________________________________ 
                   Κινησιοθεραπεία_________________________________ 
                                   Μασάζ_________________________________ 
       Ασκήσεις ενδυνάμωσεις_________________________________ 
           Θεραπευτική ιππασία_________________________________ 
  Άλλο (παρακαλώ δηλώστε) _________________________________ 
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Συντομογραφίες: Κάκωση Νωτιαίου Μυελού (ΚΝΜ), Εθνικό Σύστημα Υγείας (ΕΣΥ), 
Διαδερμική Ηλεκτρική Διέγερση Νεύρων (ΤΕΝΣ), *απαντήστε στην ερώτηση εάν σας 
 
51) Κατά μέσο όρο, από τότε που φύγατε από το νοσοκομείο/κέντρο,πόσο 
καιρό ήσασταν σε λίστα αναμονής για να λάβετε θεραπεία για την οσφυαλγία 
σας;  
    Η θεραπεία ξεκίνησε αμέσως                                        4 μήνες                                           
                        1 – 2 εβδομάδες                                        5 μήνες  
                                       1 μήνα                                       6 μήνες   
                                      2 μήνες                      Πάνω από 6 μήνες  
                                      3 μήνες     Δεν ήμουν σε λίστα αναμονής  
Άλλο (παρακαλώ δηλώστε)__________________________________ 
 
52) *Από τότε που πρωτοεμφανίστηκε η οσφυαλγία σας, υπήρξε περίοδο μίας 
εβδομάδας ή περισσότερο χωρίς οσφυαλγία; 
 
        Ναι, τον περισσότερο καιρό                      Ναι, αλλά σπάνια  
                                  Ναι, συχνά         Όχι, πάντα ένοιωθα πόνο  
                      Ναι, μερικές φορές                             Δεv θυμάμαι                      
          Ναι, αλλά όχι πολύ συχνά                                                      
 
 
Τελικές ερωτήσεις για τον εαυτό σας 
53) Έχετε κάποιο πρόβλημα όρασης; 
      Ναι               Όχι     
Εαν “ναι” παρακαλώ δηλώστε τι είδους_____________________________ 
 
54)  Διαβάσατε μόνος/-η σας το δελτίο πληροφοριών και το ερωτηματολόγιο;  
      Ναι               Όχι     
Εαν “όχι”, ποιος/-α σας βοήθησε με την ανάγνωση; 
Παρακαλώ δηλώστε____________________________________________
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Συντομογραφίες: Κάκωση Νωτιαίου Μυελού (ΚΝΜ), Εθνικό Σύστημα Υγείας (ΕΣΥ), Διαδερμική 
Ηλεκτρική Διέγερση Νεύρων (ΤΕΝΣ), *απαντήστε στην ερώτηση εάν σας 
 
55) Έχετε κάποιο πρόβλημα με το γράψιμο; 
      Ναι               Όχι     
Εάν “ναι”, παρακαλώ δηλώστε τι είδους_____________________________ 
 
56) Συμπληρώσατε το ερωτηματολόγιο μόνος/-η σας, χωρίς τη βοήθεια κάποιου 
άλλου;  
Ναι    (παρακαλώ, πηγαίνετε στην ερώτηση 58, σελίδα 26)       
Όχι    (παρακαλώ, συνεχίστε με την ερώτηση 57 παρακάτω)       
 
57) *Εάν κάποιος/-α άλλος/-η σας βοήθησε με τη συμπλήρωση του 
ερωτηματολογίου, πως σας βοήθησε;  
Απαντούσα όλες τις ερωτήσεις αλλά κάποιος/-α άλλος/-η τις συμπλήρωνε 
χειρόγραφα για μένα  
Απαντούσα όλες τις ερωτήσεις αλλά κάποιος/-α άλλος/-η συμπλήρωσε 
χειρόγραφα για μένα την οπτική αναλογική κλίμακα (ΟΑΚ) και το διάγραμμα 
σωματικού πόνου  
Απαντούσα όλες τις ερωτήσεις αλλά κάποιος/-α άλλος/-η συμπλήρωσε 
χειρόγραφα για μένα μόνο την οπτική αναλογική κλίμακα (ΟΑΚ)  
Απαντούσα όλες τις ερωτήσεις αλλά κάποιος/-α άλλος/-η συμπλήρωσε 
χειρόγραφα για μένα μόνο το διάγραμμα σωματικού πόνου  
Άλλο (παρακαλώ δηλώστε)_______________________________ 
 
58) *Παρακαλώ, δηλώστε την ημερομηνία που συμπληρώσατε αυτό το 
ερωτηματολόγιο 
              ___/___/200___ 
Σας ευχαριστούμε πολύ για το χρόνο που διαθέσατε για την συμπλήρωση 
αυτού του ερωτηματολόγιο
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Δελτίο Επιστροφής (προαιρετικό) 
 
Παρακαλώ, δώστε μας το όνομα και τη διεύθυνσή σας για να μπορέσουμε να 
αναγνωρίσουμε το ερωτηματολόγιο σας σε περίπτωση που μας το ζητήσετε, ή 
να επικοινωνήσουμε μαζί σας για μελλοντικες έρευνες εάν συμφωνείτε.   
 
 
Ονοματεπώνυμο________________________________________________ 
Διεύθυνση_____________________________________________________ 
Ταχυδρομικός Κωδικός___________________________________________ 
Τηλέφωνα Επικοινωνίας__________________________________________ 
Ηλεκτρονική Διεύθυνση (εάν υπάρχει)________________________________ 
 
 
 
Στο μέλλον, θα θέλατε να επικοινωνήσουμε μαζί σας και να σας 
πληροφορήσουμε για τα προγράμματα ερευνών μας;  
 
      Ναι            Όχι   
 
 
 
Σας ευχαριστούμε πολύ για το χρόνο που διαθέσατε για την συμπλήρωση 
αυτού του ερωτηματολόγιου 
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4.1 Feedback and changes during translations and pilot stage 
Table 4.1.1: List of major words or phrases from SCIM III, in Greek, that underwent 
review and changes during the translation process 
Word in English Options under consideration (in Greek) 
of the same word 
Final chosen word in 
Greek 
(cutting) food (Κόψιμο) “τροφής” (Κόψιμο) “τροφής” 
(holding) cup (Κράτημα) “ποτηριού” (Κράτημα) “φλυτζανιού” 
(Sphincter) 
management 
“Διαχείρηση” or “έλεγχος” 
(σφυκτήρων) 
“διαχείρηση σφιγκτήρα” 
; (symbol of 
semicolon)  
“:” or “.” (because in Greek the symbol of semicolon is used the 
symbol of the question mark 
adjustment of 
clothes 
“προσαρμογή” or “Τακτοποίηση” 
(ρούχων) 
“τακτοποίηση ρούχων” 
applying drainage 
instrument 
“εφαρμογή παροχετευτικής συσκευής” “εφαρμογή συσκευής 
παροχέτευσης” 
arm rest “μπράτσο” or “Βραχίονας” “Βραχίονας” 
bathing “Πλύσιμο” or “Λούσιμο” “Μπάνιο” 
devices “βοηθημάτα “ or “συσκευές” “Βοηθήματα”   
Dressing  “Ντύσιμο” or “ένδυση” “Ντύσιμο” 
external drainage 
instrument 
“εξωτερική παροχετευτική συσκευή” “εξωτερική συσκευή 
παροχέτευσης” 
fully assisted oral 
feeding 
“στοματική σίτιση με πλήρη βοήθεια” “πλήρως 
υποβοηθούμενη σίτηση 
από το στόμα” 
grooming “Ατομική Περιποίηση” “Περιποίηση” 
handrail “Κουπαστή” or “κιγκλίδωμα” or 
“χερούλι σκάλας” or “κάγκελο σκάλας” 
“κάγκελο της σκάλας” 
intermittent “διαλείπων” or “Περιοδικός” “Διαλείποντας” 
leg  orthosis “Κηδεμόνας” or “ορθωτήρας ποδιού”  “μηροκνημοποδικός 
κηδεμόνας” 
push-ups (in 
wheelchair) 
“Ανακάθισμα” (στο αναπηρικό 
αμαξίδιο) 
“Ανασήκωμα” (στο 
αναπηρικό αμαξίδιο) 
specific setting “ειδικά (προσαρμοσμένο) περιβάλλον” 
or  
“ειδική διαρύθμιση χώρου” 
“ειδικά προσαρμοσμένο 
περιβάλλον” 
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Table 4.1.1 (continued): List of major words or phrases from SCIM III, in Greek, that 
underwent review and changes during the translation process 
Word in English Options under consideration (in Greek) 
of the same word 
Final chosen word in 
Greek 
toilet wheelchair (SCIM developers confirmed that a 
“tiolet wheelchair” is “a wheelchair 
specially designed to access the toilet 
room”)  
“ενσωματωμένη τουαλέτα” or  
“καρότσι τουαλέτα” 
“αναπηρικό αμαξιδίο 
τουαλέτας” 
unable "ανικανότητα" or "δεν μπορεί" or 
"στερείται ικανότητας" 
“Στερούμαι ικανότητας” 
Upper Body” “Άνω μέρος σώματος” or  “άνω 
κορμός” 
“Άνω μέρος σώματος” 
Wash 
independently 
“Πλένεται ανεξάρτητα”  or 
“ανεξάρτητος/-η με πλύσιμο” 
“Πλένομαι ανεξάρτητα” 
Washing (body) “Πλύσιμο” or “ξέβγαλμα” “πλύσιμο” 
wearing It was agreed with SCIM developers that the word “wearing” was 
not different to the word “dressing” (also used in the same 
sentence) therefore only the word “dressing” was translated 
With (meaning with 
the use of) 
“με τη χρήση”  or “χρησιμοποιώντας” “Χρησιμοποιώντας” 
 
 
Table 4.1.2 Feedback provided by the forward translators led to the following changes: 
Changes made following translator’s feedback 
 Greeks may refer themselves as “Greeks” and “Mediterranean” and “East Europeans” 
and “Balkanians”, therefore question 4 was changed so as not to have overlapping 
categories. 
 In Greece only the metric system is used to measure distance and therefore the 
“miles” option was deleted (quest 9).   
 The word “centre” was added in the “therapeutic horse riding” (quest 9).  
 “Manual physiotherapy” was changed to “physiotherapy” to include the broader term 
of physiotherapy. Additionally, “exercises in the physiotherapy gym” was changed to 
“kinisiotherapy” to include any movement physiotherapy (quest 31).  
 Abbreviations were added at the beginning of the questionnaire and on the header of 
each page to assist reading of the questions.  
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Table 4.1.3 Changes to the questionnaire following the UK pilot stage 
 
 As the respondents were asked (quest 9) to state the distance of the therapeutic horse 
riding the option “Other centre of my interest” was added as some may have other 
therapy of their choice. 
 Explanation on where the spinal segments are is added (quest 14). 
 The option of “rehabilitations centre” does not necessarily mean that this is a SCI 
centre. Therefore the option “SCI centre” was added (quest 18). 
 There may be a case where the respondent was initially treated in on hospital/centre 
and then transferred to another. For this reason all respondents are asked to give their 
total hospitalisation period (quest 20).  
 Question 21 was simplified to be more users friendly.  
 The option “every day” (quest 25) was added.  
 The option “I did not feel pain while in hospital/centre was added (quest 20). 
 The option “therapeutic horse riding” was removed from in hospital period treatments 
as no hospital offers such treatment.  
 The formatting of questions 34 and 35 significantly changes to make the questions 
more users friendly.   
 The author decided to include the distance from “pain clinic” (quest 9).  
 
 
Table 4.1.4 Most important changes after the second pilot stage, given to the Greek 
group 
 
 The language options “Spanish” and “French” were taken out and “Albanian” was put 
in as it is a more common language to speak in Greece (quest 2). 
 As the Greek Higher Education System consists of both Universities and Technological 
Institutions, an option for the latest was added (quest 5). 
 Question 7 was commented on a number of times and changes were made on the 
suggested working hours, the easiness to read and the number choices the respondent 
can choose.  
 The format of question 9 was changed to make it more users friendly.  
 The cause of injury was further expanded to include more options. 
 Question 21 was further simplified. The respondents are now asked to state any 
surgery they may have had post their SCI related or not to their SCI.  
 Question 23 was re-formatted to avoid being a double question.  
 Question 25 was long to read and was therefore simplified.  
 Where necessary the option “I don’t remember” was added.  
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4.2 Rules and codes 
4.2.1 Rules and codes; Socio-demographic questionnaire 
4.2.1.1 Rules and codes; Socio-demographic questionnaire; design 
In summary, the following rules found to assist questionnaire completion342 were 
taken into account during the development of the survey:  
1) Abbreviations on each current page were explained on the header of each paper or 
web page so the respondent did not have to look for them;  
2) Double-barrelled questions were avoided; 
3) No proverbs, negatives or leading questions were used; 
4) Questions on sensitive topics were avoided, however some may claim that q2244 
could be a sensitive topic. For this reason the “do not want to say” option was added 
to give more flexibility to the respondent;  
5) Instructions how to fill in the questionnaire were included throughout.  
4.2.1.2 Rules and codes; Socio-demographic questionnaire; general 
The most important rules formed for data entry and analysis for the socio-
demographic part of the questionnaire were 
1) If a respondent reported a range of working hours, then the mean of these 
hours was calculated to (e.g. 10-15 hours of work per week is 12.5 hours of 
work); 
2) If a respondent reported “other type of injury” and explained this to be Cauda 
Equina or Brown Sequard Syndrome, then the type of injury was marked as an 
incomplete SCI as per ASIA International SCI classification9; 
3) If a respondent failed to report the date of completing the questionnaire, which 
was used in order to calculate the age of the participant and time since injury, 
this information was collected via the SurveyMonkey® functions which enables 
                                                     
44
 This question asked about friends and family support. See Appendix 2. 
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identification of this information. This option was applicable only for the online 
completed questionnaires.  
 
4.2.2 Rules and codes; SF-MPQ and PRI  
When a respondent did not tick all of the responses in the PRI of the SF-MPQ the 
following was taken into the account in order to decide if the lack of response should 
be marked as “truly” missing data or not: 
1) If the respondent has not replied to all the descriptors and to those that s/he has 
replied the descriptor "none" was never selected (the respondent has only marked 
descriptors as "mild", "moderate", or "severe") this will indicate that s/he had only 
chosen to reply to the pain descriptor that s/he felt pain for. In this case this will not be 
treated as missing data and for the descriptors that s/he has not replied it will be 
assumed that no pain existed and the "none" response will be entered (by the 
researcher) and calculated as such. 
2) If the respondent has replied to all/most of the variables but missed out some of 
them this will be considered as true missing data and calculated as such. If the 
respondent has selected the option "none" as a reply to some of the descriptors then 
this will be a stronger indication that s/he has understood that when a pain is not felt 
then the "none" option should be selected therefore failing to answer was due to lack 
of attention. " 
3) If the respondent did not reply to the PRI at all (not a single descriptor was given a 
response) then this is considered to be true missing data and no response will be 
added by the researcher.  
Prof. Melzack, developer of the McGill scale was consulted and his response was “I 
agree with your distinction.  It is very reasonable.  It is rarely expressed so explicitly and 
clearly”  (Personal communication, 04/03/2010). 
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Appendix 5; Transalation 
and respondents’ profiles 
Supplement to Chapter 6; part 1  
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5.1: Translations 
Table 5.1.1: Demographic profiles of forward translators used for the  
socio-demographic part of the questionnaire  
Profiles Responses Mean±SD 
Occupation n=1 Occupational Therapist 
n=1 Physiotherapist 
n=1 Lecturer in Economics 
n=1 Business analyst 
n=1 Business PhD student 
 
Years living in the UK  7.7±5.2 
Hours needed to complete the 
translation of the questionnaire 
 6.8±4.8 
Use of dictionary n=1 “yes, sometimes” 
n=3 “yes, but rarely” 
n=1 “no, it was easy to 
translate” 
 
Overall difficulty to translate  2.6±2.6* 
Easiest question to translate Questions 10, 16, 17, 24, and 51 0.4±0.5* 
The most difficult question to 
translate 
Question 29 4.6±3.0* 
*On a NRS ranging from 0= very easy to translate to 10= the most difficult translation. 
Abbreviation: SD, Standard Deviation; NRS, Numeric Rating Scale.  
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5.2.Bonferroni correction  
Table 5.2.1: Main variables used in analysis of socio-demographic profile of 
respondents and alpha value set following Bonferroni correction.  
Main Variable Tests with following variables Alpha value 
following 
Bonferroni 
correction 
Pain (in general) With itself             5)  Type of injury           
Gender                   6) Time since injury 
 Cause of injury     7) (3) levels of injury 
Age                          
0.05/7=0.007 
p≤0.007 
Back pain With itself             5)  Type of injury           
Gender                  6) Time since injury 
 Cause of injury   7) (3) levels of injury 
Age                          
0.05/7=0.007 
p≤0.007 
Current LBP With itself             5) Age     
With MSKP           6)  Type of injury           
Gender                  7) Time since injury 
 Cause of injury   8) (3) levels of injury      
0.05/8=0.006 
p≤0.006 
Lifetime LBP (post 
iSCI) 
With itself             5) Age     
With MSKP           6)  Type of injury           
Gender                  7) Time since injury 
 Cause of injury   8) (3) levels of injury      
0.05/8=0.006 
p≤0.006 
LBP over last 1 
month 
With itself             5) Age     
With MSKP            6)  Type of injury           
Gender                   7) Time since injury 
 Cause of injury     8) (3) levels of injury      
0.05/8=0.006 
p≤0.006 
LBP over last 3 
months 
With itself            6)  Cause of injury    
With MSKP           7) Age     
Gender                   8)  Type of injury           
With males           9) Time since injury 
With females      10) (3) levels of injury                      
0.05/10=0.005 
p≤0.005 
MSKP  With itself             6) Age 
 Gender                 7) Type of injury  
 With males           8) Time since injury           
With females        9) (3) levels of injury  
Cause of injury   10) With pain days 
0.05/10=0.05 
p≤0.005 
Abbreviations: MSKP, Musculoskeletal pain; LBP, Low back pain 
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5.3: Pain, MSKP and LBP prevalence  
Table 5.3.1: Demographic profile characteristics  
 Number of 
responses 
% 
Neuropathic pain 
Above level of injury  
  Yes 
  No 
At-level of injury 
  Yes 
  No 
Below-level of injury 
  Yes 
  No 
 
 
19 
176 
 
64 
131 
 
121 
74 
 
 
9.7 
90.3 
 
32.8 
67.2 
 
62.1 
37.9 
Upper limb pain 
  Yes 
  No 
 
 40 
155 
 
79.5 
20.5 
Had a surgery following SCI 
Yes 
No 
 
139 
79 
 
63.8 
36.2 
Family and friends supportive 
Yes  
No 
Not as much as I need 
I do not want their support 
I do not need their support 
I do not want to say 
Other 
 
166 
6 
36 
1 
6 
2 
1 
 
76.1 
2.8 
16.5 
0.5 
2.6 
0.9 
0.5 
Insurance used for SCI treatment 
  National/ State/ Public 
  Private 
  Both national/state/public and  private 
  None 
  Medicare 
  Other 
 
92 
71 
22 
6 
19 
8 
 
42.2 
32.6 
10.1 
2.8 
8.7 
3.7 
First treated after SCI in a: 
National/ State/ Public hospital 
Private hospital 
National/State/Public rehabilitation centre 
Private rehabilitation centre 
National/State/Public SCI centre 
Private SCI centre 
Medical centre/trauma centre 
Army hospital 
Other 
 
113 
72 
3 
7 
5 
5 
6 
4 
3 
 
51.8 
33.0 
1.4 
3.2 
2.3 
2.3 
2.8 
1.8 
1.4 
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5.4: Pain, MSKP and LBP; relation to demographic profile 
Table 5.4.1: Percentage of males and females reporting the pain categories  
and statistical differences in the pain presence between gender 
 Males  
%, n total 
Females  
%, n total  
Statistical Test 
 
Pain in general 91, n=134 93.8, n=81 χ2=0.53, df1, 
p=0.46 
MSKP 32.6, n=132 48.7, n=78 χ2=5.392, df1, 
p=0.02* 
Back pain 75, n=132 82.1, n=78 χ2=31.4, df1, 
p=0.23 
Lifetime LBP 69.4, n=134 81.5, n=81 χ2=3.82, df1, 
p=0.051 
Current (point ) 
LBP 
64.9, n=131 75, n=77 χ2=1.87, df1, 
p=0.17 
1 month LBP 64.1, n=131 76.6, n=77 χ2=4.78, df1, 
p=0.06 
3 months LBP 65.6, n=131 78.9, n=76 χ2=4.02, df1, 
p=0.04* 
Females reported higher frequencies on all categories of pain compared to males.   
No significant difference existed post application of the Bonferroni correction for  
the total group or when people without pain in general were excluded. 
*Not passing Bonferroni correction.  
Abbreviations: MSKP, Muskuloskeletal pain; LBP, Low Back Pain.  
Statistical test: χ², Pearson’s chi-square. 
 
 
 
 
 
 
 
 
 
 
Figure 5.4.1: Percentage of men and women reporting the pain categories  
Abbreviations: MSKP, Musculoskeletal pain; LBP, Low back pain. 
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Table 5.4.2: Within people with pain only, percentage of males and females  
reporting the pain categories and differences in pain presence between gender 
 Males  
%, n total 
Females  
%, n total 
Statistical Test 
 
MSKP 35.8, n=120 52.1, n=73 χ2=4.90, df1, 
p=0.02¹ 
Back pain 82.5, n=120 87.7, n=73 χ2=0.92, df1, 
p=0.33 
Lifetime LBP 76.2, n=122 86.8, n=76 χ2=3.33, df1, 
p=0.06 
Current (point ) 
LBP 
71.4, n=119 79.2, n=72 χ2=1.40, df1, 
p=0.23 
1 month LBP 70.6, n=119 81.9, n=72 χ2=3.07, df1, 
p=0.08 
3 months LBP 72.3, n=119 84.5, n=71 χ2=3.74, df1, 
p=0.053 
1not significant post Bonferroni correction;  
Abbreviations: MSKP, Muskuloskeletal pain; LBP, Low Back Pain.  
Statistical test: χ², Pearson’s Chi-square. 
 
 
Table 5.4.3: Differences in the proportion of pain within males  
and within females 
 Within Males 
Statistical Test 
Within Females 
Statistical Test 
MSKP Yes n=43, No n=89 
χ²=16.03 
p≤0.001*** 
Yes n=38, No n=39 
χ²=0.01 
p=0.29 
3 months LBP Yes n=86, No n=45 
χ²=12.82 
p≤0.001*** 
Yes n=60, No n=16 
χ²=25.47 
p≤0.001*** 
Correlation between 
MSKP & LBP over 3 
months 
n=128 
φ=0.17 
p=0.42 
n=75 
φ=0.39 
p≤0.001*** 
Within both males and females significantly more people reported  
having LBP over the last 3 months but only within males significantly  
more people reported not having MSKP. Within females a significant  
association existed between MSKP and LBP. 
***Significant at p≤0.001 level;  
in bold: singificant following application of the Bonferroni correction 
Abbreviations: MSKP, Muskuloskeletal pain; LBP, Low Back Pain 
Statistical test: χ², goodness of fit Chi-square. 
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Table 5.4.4: Percentage of people with traumatic and non-traumatic injury  
reporting the pain categories. Differences in pain presence between groups  
divided by cause of injury 
 Traumatic 
%, n total 
Non-traumatic 
%, n total 
Statistical Test 
 
Pain in general 91, n=141 92.2, n=64 χ2=0.08, df1, p=0.77 
MSKP 34, n=150 50, n=64 χ2=4.83, df1, p=0.02¹ 
Back pain 74, n=150 84.4, n=64 χ2=2.73, df1, p=0.09 
LBP life time  69.7, n=155 82.8, n=64 χ2=4.01, df1, p=0.04¹ 
LBP current  63.5, n=148 78.1, n=64 χ2=4.37, df1, 
p=0.003** 
LBP last 1 month  64.2, n=148 78.1, n=64 χ2=4.01, df1, p=0.04¹ 
LBP last 3 months  66, n=147 79.7, n=64 χ2=3.97, df1, p=0.04¹ 
1not significant post Bonferroni correction; **Significant at p≤0.01 level,  
in bold: significant following application of the Bonferroni correction 
Abbreviations: MSKP, Muskuloskeletal pain; LBP, Low Back Pain  
Statistical test: χ², Pearson’s chi-square 
 
 
Table 5.4.5: Within people with pain only, percentage of people with traumatic  
and non-traumatic injury reporting the pain categories. Differences in the pain 
presence between groups divided by cause of injury 
 Traumatic 
%, n total 
Non-traumatic 
%, n total 
Statistical Test 
 
MSKP 37.5, n=136 
 
54.2, n=59 χ2=4.71, df1  
p=0.03¹ 
Back pain 81.6, n=136 91.5, n=59 
 
χ2=3.10, df1  
p=0.07 
LBP life time  76.6, n=141 89.8, n=59 
 
χ2=4.64, df1  
p=0.03¹ 
LBP current  70.1, n=134 
 
84.7, n=59 χ2=4.60, df1  
p=0.03¹ 
LBP last 1 month  70.9, n=134 84.7, n=59 
 
χ2=4.20, df1  
p=0.04¹ 
LBP last 3 months  72.9, n=133 86.4, n=59 χ2=4.22, df1  
p=0.04¹ 
1not significant post Bonferroni correction;  
Abbreviations: MSKP, Muskuloskeletal pain; LBP, Low Back Pain 
Statistical test: χ², Pearson’s chi-square 
 
 
 
 
 
 
 
 Appendix 5 
 
146 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4.2: Percentage of people reporting the pain categories  
divided into groups by cause of  injury. 
Abbreviations: MSKP, Musculoskeletal pain; LBP, Low back pain. 
 
Table 5.4.6: Percentage of people with tetraplegia and paraplegia reporting the pain 
categories. Differences in pain presence between groups divided by cause of injury 
 Tetraplegia 
%, n total 
Paraplegia 
%, n total 
Statistical Test 
 
Pain in general  Tetraplegia 87.4, n=103 
 
Paraplegia 94.8, n=116 χ²= 3.28, df1 
p=0.51 
MSKP Tetraplegia 33, n=100 
 
Paraplegia 43.9, n=114 χ²= 2.64, df1 
p=0.10 
Back pain Tetraplegia 67 , n=100 
 
Paraplegia 86, n=114 χ²= 10.85, df1 
p≤0.001*** 
LBP lifetime Tetraplegia 62.1, n=103 
 
Paraplegia 83.6, n=116 χ²= 12.93, df1 
p≤0.001*** 
LBP current Tetraplegia 57.6, n=99 
 
Paraplegia 77, n=113 χ²= 9.13, df1 
p=0.003** 
LBP 1 month  Tetraplegia 57.6, n=99 
 
Paraplegia 77.9, n=113 χ²= 10.06, df1 
p=0.002** 
LBP 3 months Tetraplegia 57.6, n=99 
 
Paraplegia 81.3, n=113 χ²= 14.06, df1 
p≤0.001*** 
People with paraplegia reported higher percentages of all categories of pain and often there 
was a significant difference between people with and without the pain categories (see also 
Table 5.4.7). 
1not significant post Bonferroni correction; ***Significant at p≤0.001 level, 
 in bold: significant following application of the Bonferroni correction  
Abbreviations: MSKP, Muskuloskeletal pain; LBP, Low Back Pain  
Statistical test: χ², Pearson’s hi-square 
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Table 5.4.7: Within people with pain, percentage of the pain categories reported by 
people divided into groups by level of injury and difference in the pain presence 
between people with tetraplegia and paraplegia.  
 Tetraplegia 
%, n total 
Paraplegia 
%, n total 
Statistical Test 
 
Pain in general  Tetraplegia 54, n=200 Paraplegia 55, n=200 N/A 
MSKP Tetraplegia 37.9, n=87 Paraplegia 46.3, n=103 χ²= 1.37, df1 
p=0.24 
Back pain Tetraplegia 72.4, n=87 Paraplegia 88.9, n=108 χ²= 6.97, df1 
p=0.008¹ 
LBP lifetime Tetraplegia 71.1, n=90 Paraplegia 88.2, n=110 χ²= 9.18, df1 
p=0.002** 
LBP current Tetraplegia 66.3, n=86 Paraplegia 81.3, n=107 χ²= 5.93, df1 
p≤0.01¹ 
LBP 1 month Tetraplegia 66.3, n=86 Paraplegia 82.2, n=107 χ²= 6.50, df1 
p≤0.011 
LBP 3 months Tetraplegia 66.3, n=86 Paraplegia 85.8, n=106 χ²= 10.29, df1 
p≤0.001*** 
1not significant post Bonferroni correction; ***Significant at p≤0.001 level, in bold: significant 
following application of the Bonferroni correction.  
Abbreviations: MSKP, Muskuloskeletal pain; LBP, Low Back Pain.  
Statistical test: χ²= Chi-square. 
 
 
 
  
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure 5.4.3: Percentage of people reporting the categories of pain  
divided in groups by type of injury 
Abbreviations: LBP, Low back pain. 
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Table 5.4.8: Percentage of pain categories reported by people divided into groups  
by the level of injury. Differences in pain presence between groups 
 Level of injury – 
total sample, %, n 
total 
 
Statistical 
Test 
 
Level of injury – 
among people with 
pain only, %, n total 
Statistical 
Test 
 
Pain in 
general  
Cervical    87.4 n=103 
Thoracic     93.2 n=73 
Lumbar      97.7 n=43 
χ2=4.52, df2  
p=0.10 
N/A N/A 
MSKP Cervical       33 n=100 
Thoracic     37.5 n=72 
Lumbar      54.8 n=42 
χ2=5.97, df2  
p=0.051 
Cervical      37.9 n=87 
Thoracic     40.3 n=67 
Lumbar      56.1 n=41 
χ2=3.97, 
df2  
p=0.13 
Back pain Cervical       67 n=100 
Thoracic     81.9 n=72 
Lumbar      92.8 n=42 
χ2=12.64, df2  
p=0.002** 
Cervical         77 n=87 
Thoracic        88 n=67 
Lumbar      95.1 n=41 
χ2=7.95, 
df2  
p≤0.01¹ 
LBP 
lifetime 
Cervical    62.1 n=103 
Thoracic     78.1 n=73 
Lumbar          93 n=43 
χ2=16.03, df2  
p<0.001*** 
Cervical      72.4 n=87 
Thoracic     85.1 n=67 
Lumbar      95.1 n=41 
χ2=11.34, 
df2  
p≤0.003**
* 
LBP 
current 
Cervical      57.6 n=99 
Thoracic     74.6 n=71 
Lumbar          81 n=42 
χ2=9.61, df2  
p=0.008¹ 
Cervical      66.3 n=86 
Thoracic     80.3 n=66 
Lumbar       82.9 n=41 
χ2=5.77, 
df2  
p=0.056 
LBP 1 
month 
Cervical      57.6 n=99 
Thoracic     74.6 n=71 
Lumbar      83.3 n=44 
χ2=10.98, df2  
p=0.004** 
Cervical      66.3 n=86 
Thoracic     80.3 n=66 
Lumbar      85.4 n=41 
χ2=6.85, 
df2  
p=0.03¹ 
LBP 3 
months 
Cervical      57.6 n=99 
Thoracic     77.5 n=71 
Lumbar      87.8 n=41 
χ2=15.39, df2  
p<0.001*** 
Cervical      66.3 n=86 
Thoracic     83.3 n=66 
Lumbar          90 n=40 
χ2=10.92, 
df2  
p=0.004** 
1not significant post Bonferroni correction; **Significant at p≤0.01 level, ***Significant  
at p≤0.001 level, in bold: significant following application of the Bonferroni correction  
Abbreviations: MSKP, Muskuloskeletal pain; LBP, Low Back Pain 
Statistical test: χ², Pearson’s Chi-square 
 
 
 
 
 
 
 
Figure 5.4.4: 
Percentage of 
people reporting 
the categories of 
pain divided  
into groups by level 
of injury  
Abbreviations: LBP, 
Low Back Pain 
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Table 5.4.9: Two group differences in MSKP reported by people divided  
into groups by level of injury  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Two group comparisons showed that people with a lumbar level injury reported  
significantly more often MSKP, LBP and BP than people with a cervical injury.   
Equally, people with a thoracic injury reported significantly higher percentage  
of LBP presence than people with cervical injuries. 
*Significant at p≤0.05 level;  
Abbreviations: MSKP, Muskuloskeletal pain; BP, Back Pain; LBP, Low Back Pain 
Statistical test: χ², Pearson’s chi-square 
5.5: Pain and LBP; relation to pain/LBP days, free periods, onset 
Table 5.5.1: Percentage of people reporting the number of pain  
and LBP days felt per month 
Average pain days per 
month 
Pain in general 
%, total n=195 
LBP 
%, total n=195, n=156¹  
1-9 days per month 14.4 21 
26.3 
10-20 days per month 14.4 14.3 
17.9 
21-30 days per month 9.7 9.2 
11.5 
Have pain every day 61.5 35.4 
44.2 
No LBP n/a 20 
¹After removing the group with no LBP 
Abbreviation: LBP, Low Back Pain 
  
MSKP  Thoracic level Lumbar Level 
Cervical Level p=0.54 p=0.015* 
Thoracic Level  p=0.073 
BP  Thoracic level Lumbar Level 
Cervical Level p=0.029* p≤0.001*** 
Thoracic Level  p=0.10 
Lifetime LBP  Thoracic level Lumbar Level 
Cervical Level p=0.040* p≤0.001*** 
Thoracic Level  p=0.036* 
Current LBP  Thoracic level Lumbar Level 
Cervical Level p=0.008** p=0.008** 
Thoracic Level  p=0.44 
LBP over last 
1 month 
 Thoracic level Lumbar Level 
Cervical Level p=0.02* p<0.03* 
Thoracic Level  p=0.28 
LBP over last 
3 months 
 Thoracic level Lumbar Level 
Cervical Level p=0.07* p≤0.01*** 
Thoracic Level  p=0.17 
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Table 5.5.2: Percentage of people with and without MSKP and the number  
of their reported pain days felt per month. Difference in their number of  
pain days between people with and without MSKP 
 1-9 
days % 
10 – 20 
days % 
21 – 30 
days % 
Every day 
% 
Statistical Test 
 
Pain including 
MSKP  
(n=83) 
10.8 
n=9 
18.1 
n=15 
8.4 
n=7 
62.7 
n=52 
χ2=4.91, df3 
p=0.40 
Pain but no MSKP 
(n=112) 
17 
n=19 
11.6 
n=13 
10.7 
n=12 
60.7 
n=68 
People without any pain in general were excluded from analysis  
Abbreviations: MSKP, Musculoskeletal pain  
Statistical test: χ²,  Chi-Square 
 
 
Table 5.5.3: Percentage of people reporting frequency of pain and LBP  
free weeks  
Since pain/LBP started have 
you had 1 week or more or 
pain free period? 
Pain in general 
% n=185 
*LBP 
% ,n=123 
Yes, most of the time 9.2 13.8 
Yes frequently 9.7 7.3 
Yes, sometimes 10.8 11.4 
Yes, but not very often 7 8.9 
Yes, but rarely 11.4 19.5 
No, I always have pain 51.9 39 
*Excluding people who did not remember and those who do not feel LBP   
Abbreviation: LBP, Low Back Pain 
 
 
Table 5.5.4: Percentage of people reporting time of pain and LBP onset post iSCI 
Pain onset Pain onset % 
n=187 
LBP onset % 
n=144 
Immediately after SCI 41.7 32.6 
Within the 1st month post SCI 19.3 15.3 
Between 1-6 months post SCI 20.3 18.7 
Between 6 months & 1 year 
post SCI 
6.4 9.7 
After 1 year post SCI 12.3 22.2 
People with no pain or LBP and those who did not remember the onset of their  
pain or LBP were excluded  
Abbreviation: LBP, Low Back Pain  
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Appendix 6; Pain extent and 
LBP experience 
 Supplement to Chapter 6; part 2 
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6.1: Bonferroni Correction 
Table 6.1.1: Main variables used in analysis of MPQ and alpha value set following 
Bonferroni correction.  
Main Variables Tests with following variables Alpha value 
following 
Bonferroni 
correction 
S-PRI 
A-PRI 
T-PRI 
Intensity of current LBP 
Intensity of LBP over 1 
month 
Intensity of LBP over 3 
months 
PPI of LBP 
1)   With gender             7) With areas with pain 
With cause of injury       8) With pain days 
 With age                          9) With LBP days 
With type of injury        10) With pain free weeks 
With cause of injury      11) With LBP free weeks 
 With time since injury  12) With pain onset 
                                           13) With LBP onset 
0.05/13=0.0038 
p≤0.0038 
Abbreviations: EQ-5D index, Quality of Life index; EQ-VAS, Quality of Life Visual Analogue 
Scale; MSKP, Musculoskeletal Pain; LBP, Low Back Pain; PRI, Present Rating Index. 
 
6.2: Pain extent; general results 
In Figure 6.2.1 it is noticed that most people felt pain in two areas on their body 
(13.8%). This was closely followed by those reporting three areas with pain (12.8%). 
One person reported 41 areas and another one 45 areas making them extreme values 
in the sample (not shown in graph). When these two respondents were removed from 
the analysis the mean number of areas with pain dropped slightly to 7.44 (±6.05) but 
the median and the mode remained the same.  
 
Figure 6.2.1: 
Percentage of 
people reporting 
the number of areas 
with pain on the 
body chart divided 
into 45 areas. 
Division was 
according to 
Margolis et al{{738 
Margolis, R.R 1986}} 
 
 Appendix 6 
 
153 
6.2.1: Pain extent; general results; NRS vs VAS 
A brief analysis to identify possible reasons for the observed differences in the mean 
intensity scores of people while using the NRS or the VAS showed some differences. 
These differences were in the mean scores of the Greek group (using the VAS) 
compared to the UK and USA groups (using the NRS) for LBP intensity over the last 1 
and 3 months. This finding implied that nationality could have been a factor affecting 
the results. The respondents who completed the VAS mainly had a non-traumatic 
cause for their injury but further analysis did not reveal that this could be the reason 
for this difference. Further analysis would have been needed to identify the exact 
factors affecting these results. But, as this was beyond the aim of this study it was 
decided that it would have been inappropriate to pool together and analyse the above 
data. Consequently, only the data collected using the NRS, which was the largest of the 
two groups, were included in the analysis.  
 
 
 
 
 
 
 
 
 
Figure 6.2.2: Percentage of people reporting from 1 to 9 areas with pain. 
n=190 
 
 Appendix 6 
 
154 
Table 6.2.1: Percentage of people reporting internal and external pain in the area of 
the back 
 Internal 
pain 
(%) 
External 
pain 
(%) 
Both internal 
and external 
pain (%) 
Pain not 
described/other 
(%) 
Total 
(%) 
Upper back -  right 
side (n=190) 
3.2 1 4.2 2.6 11 
Upper back – 
midline (n=189) 
9.5 1.6 5.8 1.1 18 
Upper back –   left 
side (n=190) 
2.6 1.6 3.7 2.1 10 
Lower back – right 
side (n=132) 
19.7 2.3 8.3 3.8 34.1 
Lower back – 
midline (n=132) 
31.1 5.3 13.6 7.6 57.6 
Lower back – right 
side (n=132) 
18.9 3.0 9.8 3.8 35.5 
 
6.3: Pain extent; relation to demographic profile characteristics 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3.1: Mean number of areas with pain reported by males and females 
 
Figure 6.3.2: Mean 
number of areas with 
pain reported by people 
 with traumatic and non-
traumatic cause of 
injury.  
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Figure 6.3.3: Mean number of areas with pain reported by  
people with tetraplegia and paraplegia  
 
 
Table 6.3.1: Mean number of areas with pain in groups divided by level of injury  
 Cervical  
mean±SD, 
median, min-
max 
Thoracic 
mean±SD, 
median, min-
max 
Lumbar 
mean±SD, 
median, min-
max 
Statistical test 
Pain areas 3.3±1.9  
3, 1-9 n=84 
3.2±1.4  
3, 1-7 n=64 
3.3±1.3 
3, 1-6 n=39 
H=0.78, df2  
p=0.67 
Four outliers were eliminated.  
Abbreviation: SD, Standard Deviation.  
Statistical test: H, Kruskall-Wallis H test. 
 
 
6.4: Pain extent; relation to pain/LBP days, free periods, onset 
Table 6.4.1: Mean number of areas with pain in groups divided by the number of  
pain or LBP days per month 
  1-9 days  
mean±SD, 
median, 
min-max 
10-20 day  
mean±SD, 
median, min-
max 
21-30 days  
mean±SD, 
median, 
min-max 
Every day 
mean±SD, 
median, min-
max 
Number of 
areas with 
pain 
Pain days 2.4±1.2  
2, 1-5 n=27 
2.4±0.7  
2, 1-4 n=21 
3.1±1.4  
3, 1-7 n=18 
3.7±1.7 
4, 1-9 n=116 
LBP days 3.6±1.4  
3, 1-7 n=38 
3.4±1.0  
3, 2-5 n=24 
3.9±1.9  
4, 1-7 n=17 
3.9±1.5 
4, 1-8 n=64 
Seven outliers were eliminated.  
Abbreviation: LBP; Low Back Pain; SD, Standard Deviation.  
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Table 6.4.2: Mean number of areas with pain in groups divided by the frequency of 
pain and LBP breaks  
  Yes, most 
time  
mean±SD, 
median, 
min-max 
Yes, 
frequently  
mean±SD, 
median, 
min-max 
Yes, 
sometimes 
mean±SD, 
median, 
min-max 
Yes, but 
not often 
mean±SD, 
median, 
min-max 
Yes, but 
rarely  
mean±SD, 
median, 
min-max 
No, I always 
have pain  
mean±SD, 
median, min-
max 
Pain free 
weeks¹ 
2.3±0.9  
2, 1-4 
n=14 
2.9±0.8  
3, 1-5 
n=15 
2.8±1.1 
3, 1-5 
n=19 
2.7±0.9 
3, 1-4 
n=12 
3.2±1.8 
2.5, 1-7 
n=20 
3.7±1.8 
4, 1-9 
n=91 
LBP free 
weeks² 
3.2±0.9  
3, 2-5 
n=15 
3.6±1.0  
4, 2-5 
n=7 
3.7±2.7  
3.5, 1-6 
n=12 
3.1±0.4 
3, 2-4 
n=8 
3.3±2.8 
3, 2-8 
n=22 
4.2±1.5 
4, 2-8 
n=46 
¹Six outlier eliminated, ²Eight outliers eliminated.  
Abbreviations: SCIM, Spinal Cord Independence Measure; SD, Standard Deviation; LBP, Low 
Back Pain. 
 
 
Table 6.4.3: Mean number of areas with pain in groups divided by the time of onset of 
pain or LBP post iSCI  
  Immediatel
y after iSCI  
mean±SD, 
median, 
min-max 
Within the 
1st month 
post iSCI 
mean±SD, 
median, 
min-max 
Between 1-6 
months post 
iSCI 
mean±SD, 
median, min-
max 
Between 6 
months & 1 
year post 
iSCI 
mean±SD, 
median, min-
max 
After 1 year post 
iSCI 
mean±SD, 
median, min-
max 
Total 
number 
areas 
with pain 
Pain 
post iSCI  
3.7±1.9  
4, 1-9 n=75 
3.1±1.3  
3, 1-6 n=35 
3.0±1.4 
3, 1-7 n=37 
3.0±1.2 
3, 1-5 n=12 
3.1±1.8 
3, 1-7 n=21 
LBP post 
iSCI  
3.8±1.6  
4, 1-8 n=45 
3.5±1.4  
4, 1-6 n=21 
3.5±1.4 
3, 2-7 n=27 
3.7±1.7 
4, 1-8 n=13 
3.6±1.8 
3, 1-9 n=29 
Abbreviation: LBP, Low Back Pain; SD, Standard Deviation.  
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6.5: LBP quality and intensity; general results andrelation to 
demographic profile 
Table 6.5.1: Rank values of LBP descriptors  
LBP descriptors n 
(total n=152) 
SUM Median Mean SD 
Throbbing 149 115 0 0.8 1.1 
Shooting  151 139 0 0.9 1.1 
Stabbing  149 150 0 1.0 1.2 
Sharp  150 169 1 1.1 1.2 
Cramping  150 118 0 0.8 1.0 
Gnawing  152 150 1 1.0 1.0 
Hot-burning  149 155 1 1.0 1.1 
Aching  151 234 2 1.5 1.1 
Heavy  150 125 0 0.8 1.0 
Tender  150 123 0 0.8 1.1 
Splitting  147 77 0 0.5 0.9 
Tiring-exhausting 151 197 1 1.3 1.2 
Sickening  150 98 0 0.6 1.0 
Fearful  151 84 0 0.6 0.9 
Punishing-cruel  152 134 0 0.9 1.1 
Total Sensory 
(range 0-33) 
152 1555 8 10.2 7.8 
Total Affective 
(range 0-12) 
152 513 2 3.4 3.5 
Total (S+A) (range 
0-45) 
149 2068 10.5 13.6 10.8 
 
 
Figure 6.5.1: Mean LBP quality reported by men and women.  
Abbreviation: PRI, Pain Rating Index; S-PRI, Sensory PRI; A-PRI, Affective PRI 
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Figure 6.5.2: Mean LBP intensity reported by men and women. 
Abbreviation: LBP, Low Back Pain 
 
 
 
 
Figure 6.5.3: Mean LBP evaluative overall intensity reported by men and women. 
Abbreviation: PPI, Present Pain Intensity 
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Table 6.5.2: Mean LBP quality and intensity in men and women. Differences in  
mean reports between gender  
 Male  
mean±SD, min-max,  
Female  
mean±SD, min-max,  
Statistical Tests 
S-PRI  
(range 0-33) 
10.5±7.9, 0-33  
n=88 
9.7±7.8, 0-30  
n=62 
t=0.65, df148,  
p=0.67 
95% CI -1.69, 3.34 
A-PRI 
(range 0-12)  
3.4±3.6, 0-12 
n=88 
3.3±3.5, 0-12 
n=62 
t=0.33, df148 
p=0.74 
95% CI -0.96, 1.36 
Total PRI  
(range 0-45) 
13.4±10.8, 0-45 
n=88 
12.8±10.9, 0-41 
n=62 
t=0.34, df145 
p=0.70 
95% CI -2.78, 3.96 
Intensity for 
current LBP  
43.1±28.0, n=76 
0-100 
41.7±29.1, n=46 
0-97 
t=0.25, df120 
p=0.79 
95% CI -9.1, 11.9 
Intensity for LBP 
over last 1 
month 
45.9±27.0., n=76 
0-95 
49.0±27.0, n=46 
0-98 
t=-0.61, df120 
p=0.54 
95% CI -13.2, 6.9 
Intensity for LBP 
over last 3 
months 
46.3±26.7, n=76 
0-100 
50.7±27.1, n=45 
0-95 
t=-0.86, df119 
p=0.39 
95% CI =-14.3, 5.6 
PPI evaluative 
for LBP 
2.5±1.2, n=90 
0-5 
2.4±1.1, n=62 
1-5 
t=0.02, df150, 
p=0.98 
95% CI -0.4, 0.4 
Two people did not reported their gender.  
Abbreviations: PRI, Pain Rating Index; S-PRI, Sensory-PRI; A-PRI, Affective PRI; PPI, 
Present Pain Intensity; LBP, Low Back Pain.  
Statistical tests: t, independent t-test. 
 
 
Figure 6.5.4: 
Mean  LBP quality 
in groups divided 
by cause of injury. 
Abbreviations: 
PRI, Pain Rating 
Index; S-PRI, 
Sensory-PRI; A-
PRI,  
Affective PRI; PPI, 
Present Pain 
Intensity.  
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Table 6.5.3: Mean LBP quality and intensity in groups divided by cause of injury and 
between group differences 
 Traumatic  
mean±SD, min-max 
Non traumatic  
mean±SD, min-max 
Statistical test 
S-PRI  
(range 0-33) 
10.1±8.3, 0-33, 
n=100 
10.4±6.9, 0-26  
n=52 
t=-0.21, df150 
p=0.82, 95% CI -2.9, 2.3 
A-PRI 
(range 0-12)  
3.2±3.6, 0-12 
n=100 
3.6±3.5, 0-12 
n=52 
t=-0.6, df150 
p=0.99, 95% CI -1.7, 0.8 
Total PRI  
(range 0-45) 
13.4±11.4, 1-45 
n=100 
14.0±9.5, 1-38 
n=52 
t=0.72, df150 
p=0.20, 95% CI -4.3, 3.0 
Intensity for 
current LBP 
42.1±28.6, n=90 
0-100 
44.0±28.0, 0-97 
n=32 
t=0.32, df120 
p=0.74, 95% CI -13.5, 9.7 
Intensity  for 
LBP over last 
1 month 
45.5±27.4 
0-95 
n=90 
51.4±26.2 
0-98 
n=32 
t=-1.04, df120 
p=0.29, 95% CI -16.9, 5.2 
Intensity for 
LBP over last 
3 months 
46.5±26.7 
0-97 
n=92 
51.8±27.3 
0-100 
n=47 
t=-0.94, df119 
p=0.34, 95% CI =-16.2, 5.7 
PPI evaluative 
for LBP¹ 
2.2±0.9 
1-4 
2.3±0.8 
0-4 
t= -0.61, df140  
p=0.53, 95% CI -0.41, 0.21 
Abbreviations: PRI, Pain Rating Index; S-PRI, Sensory PRI; A-PRI, Affective PRI; PPI, Present Pain 
Intensity; LBP, Low Back Pain.  
Statistical tests: t= independent t-test. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.5.5: Mean LBP intensity in groups divided by cause of injury. 
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Figure 6.5.6: Mean LBP evaluative overall intensity in groups divided  
by cause of injury. 
 
 
Table 6.5.4: Quality and intensity of LBP in groups divided by level of injury 
 Cervical 
mean±SD, min-
max, n 
Thoracic 
mean±SD, min-
max, n 
Lumbar 
mean±SD, min-
max, n 
S-PRI  
(range 0-33) 
7.5±5.6,  
0-26, n=58 
12.1±7.9,  
1-29, n=54 
10.6±8.0,  
1-30, n=38 
A-PRI 
(range 0-12)  
2.5±3.0,  
0-12, n=58 
3.6±3.2,  
0-12, n=54 
3.9±4.1,  
0-12, n=38 
Total PRI  
(range 0-45) 
9.1±7.0,  
1-29, n=58 
15.3±9.9,  
1-37, n=54 
13.9±11.1,  
1-39, n=38 
Current LBP 
intensity 
37.7±25.8 
0-97, n=51 
43.6±27.7 
0-92, n=44 
50.2±32.8 
0-100, n=27 
Intensity of LBP 
over last 1 month   
40.9±26.8 
0-98, n=51 
51.6±24.8 
0-95, n=44 
51.1±30.0 
0-92, n=27 
Intensity of LBP 
over last 3 months 
40.6±27.8 
0-95, n=51 
50.9±22.3 
5-97, n=44 
57.4±29.0 
0-100¹, n=25 
 People with a thoracic injury reported significantly higher mean sensory PRI than  
people with a cervical injury (I-J=-4.62, p=0.003, Bonferroni post hoc). People with 
thoracic injury also reported significantly higher total PRI than people with cervical  
injuries (I-J=-6.19, p=0.002, Bonferroni post hoc). People with lumbar level injuries  
had significantly higher total PRI than people with cervical injuries (I-J=4.85, p=0.04,  
Bonferroni post hoc). No differences were found in the level of injury and affective  
PRI.  
People with lumbar injuries seemed to report higher mean intneisty, in most of the  
cases. A significant difference was found between people with lumbar injury and  
people with cervical injury (I-J=-16.79, p=0.02, Bonferroni post hoc). 
1missing two;²2 outliers eliminated, ³3 outliers eliminated.  
Abbreviations: PRI, Pain Rating Index; S-PRI, Sensory PRI; A-PRI, Affective PRI;  
NRS, Numeric Rating Scale; LBP, Low Back Pain, SD, Standard Deviation.  
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Table 6.5.5: Evaluative overall intensity of LBP in groups divided by level of injury  
and between group differences 
 Cervical  
mean±SD, min-
max 
Thoracic  
mean±SD, min-
max 
Lumbar  
mean±SD, min-
max 
Statistical 
test 
Evaluative PPI 
for LBP 
2.2±1.0 
1-5 n=58 
2.3±0.8 
1-4 n=52 
2.4±1.0 
0-4 n=33 
H =0.81, df2 
p=0.44 
People with injuries at any level reported very similar their evaluative overall intensity  
of LBP and not significant differences were found (F=0.81, p=0.44, One way ANOVA). 
Abbreviations: PPI, Present Pain Intensity; LBP, Low Back Pain.  
Statistical Test: One way ANOVA. 
 
 
  
Figure 6.5.7: Mean LBP quality in groups divided by level of injury. 
Abbreviations: PRI, Present Rating Index; S-PRI, Sensory PRI; A-PRI, Affective PRI; 
 LBP, Low Back Pain 
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Figure 6.5.8: Mean LBP intensity in groups divided by level of injury. 
Abbreviations: LBP, Low Back Pain; NRS, Numeric Rating Scale. 
 
 
 
 
Figure 6.5.9: Mean LBP evaluative overall intensity in groups by level  
of injury. 
Abbreviations: PPI, Present Pain Intensity; LBP, Low Back Pain. 
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6.6: LBP quality and intensity; relation with pain/LBP days, free period, 
onset 
Table 6.6.1: Correlations between pain days, pain free weeks and  
pain onset with LBP quality and intensity 
 Correlation 
between 
number of 
pain days and 
LBP quality 
and intensity 
Correlation 
between pain 
free weeks 
and LBP 
quality and 
intensity 
Correlation 
between pain 
onset  post iSCI 
and LBP quality 
and intensity 
S-PRI 
(range 0-33) 
ρ=0.14 
p=0.07, n=152 
ρ=0.25 
p=0.002** 
n=143 
ρ=-0.13 
p=0.10, n=152,  
95%CI -0.16, 0.14 
A-PRI 
(range 0-12) 
ρ=0.07 
p=0.33, n=152 
ρ=0.23 
p=0.004** 
n=143 
ρ=-0.06 
p=0.39, n=152 
95%CI -0.21, 0.09 
Total PRI 
(range 0-45) 
ρ=0.11 
p=0.17, n=149 
ρ=0.23 
p=0.004** 
n=140 
ρ=-0.14 
p=0.07, n=149 
95%CI -0.29, 0.01 
Intensity of 
current LBP 
ρ=0.29 
p≤0.01¹ 
 n=124 
ρ=0.42 
p≤0.001*** 
n=116 
ρ=0.08 
p=0.35, n=124 
95%CI -0.09, 0.25 
Intensity of LBP 
over 1 month 
ρ=0.25 
p=0.004¹ 
n=122 
ρ=0.35 
p≤0.001*** 
n=114 
ρ=0.08 
p=0.33, n=122 
95%CI -0.09, 0.25 
Intensity of LBP 
3 months 
ρ=0.20 
p=0.02¹ 
 n=121 
ρ=0.36 
p≤0.001*** 
n=113 
ρ=0.08 
p=0.34, n=121 
95%CI -0.09, 0.25 
Evaluative PPI 
of LBP 
ρ=0.14 
p=0.09, n=141 
ρ=0.22 
p≤0.01¹ 
 n=132 
ρ=-0.10 
p=0.23, n=141 
95%CI -0.25, 0.05 
1not significant post Bonferroni correction; **Significant at p≤0.01 level,  
***Significant at p≤0.001 level;  
in bold: significant following application of the Bonferroni correction. 
 Abbreviations: PRI, Pain Rating Index; S-PRI, Sensory PRI; A-PRI, Affective PRI;  
PPI, Present Pain Intensity; LBP, Low Back Pain; NRS, Numeric Rating Scale.  
Statistical test: ρ, Spearman’s rank correlation rho 
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Figure 6.6.1: Mean evaluative overall PPI for LBP by number of LBP  
Days felt in a month. 
Abbreviations: PPI, Present Pain Intensity; LBP, Low Back Pain. 
 
 
Figure 6.6.2: Mean evaluative overall PPI for LBP by gender. 
Abbreviations: PPI, Present Pain Intensity; LBP, Low Back Pain. 
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Appendix 7; Quality of Life 
Supplement to Chapter 7 
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7.1. Bonferroni Correction 
Table 7.1.1: Main variables used in analysis of QoL and alpha value set following 
Bonferroni correction 
Main Variable Tests with following variables Alpha value 
following 
Bonferroni 
correction 
EQ-5D index  
and 
EQ-VAS 
1) With pain                       11) With employment 
2) With MSKP                     12) With pain days 
3) With LBP (current)        13) With LBP days 
4) With gender                   14) With pain free weeks 
5) With cause of injury      15) With LBP free weeks 
6) With age                          16) With pain onset 
7) With type of injury        17) With LBP onset 
8) With time since injury  18) With areas with pain 
9) With education              19) With S-PRI       
      10) With marital status         20) With A-PRI 
                                                        21) With total PRI 
0.05/21=0.002 
p≤0.002 
Abbreviations: EQ-5D index, Quality of Life index; EQ-VAS, Quality of Life Visual Analogue 
Scale; MSKP, Musculoskeletal Pain; LBP, Low Back Pain; PRI, Present Rating Index; S-PRI, 
Sensory PRI; A-PRI, Affective PRI 
 
 
7.2: QoL; general results 
 
 
 
 
Figure 7.2.1: Bimodal 
distribution of EQ-5D 
Index (n=198).  
Abbreviations: EQ-5D 
index, Quality of Life index. 
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Table 7.2.1: Frequency distribution of all the  64 reported health profiles with mean 
index and EQ-VAS values 
Rank 
order 
EQ-5D profile Count % Mean index 
value 
(UK TTO) 
Mean EQ-
VAS 
Range of 
mean EQ-
VAS 
1 11111 1 0.5 1.000 90.0 90 
2 11211 2 1.0 0.883 72.5 70-75 
3 21111 4 2.0 0.850 89.7 70-99 
4 11112 1 0.5 0.848 60.0 60 
5 21211 1 0.5 0.814 80.0 80 
6 11121 2 1.0 0.796 88.5 80-95 
7 11221 1 0.5 0.760 75.0 75 
8 22111 3 1.5 0.746 96.0 95-98 
9 21212 2 1.0 0.743 60.0 50-70 
10 21121 8 4.0 0.727 85.4 80-95 
11 11122 2 1.0 0.725 54.5 40-69 
12 22211 3 1.5 0.710 73.3 65-85 
13 21221 16 8.1 0.691 72.0 29-90 
14 11222 3 1.5 0.689 69.3 58-90 
15 21122 6 3.0 0.656 74.6 49.5-100 
16 22212 5 2.5 0.639 59.0 50-85 
17 21222 20 10.0 0.620 67.6 40-95 
18 22221 10 5.1 0.587 58.0 20-90 
19 22222 20 10.1 0.516 56.1 40-80 
20 23211 2 1.0 0.331 90.0 90 
21 23311 1 0.5 0.273 100 100 
22 22321 2 1.0 0.260 41.5 33-50 
23 23221 1 0.5 0.208 90.0 90 
24 22213 1 0.5 0.205 38.0 38 
25 32211 1 0.5 0.196 95.0 95 
26 21131 3 1.5 0.195 88.3 80-100 
27 11132 1 0.5 0.193 90.0 90 
28 22322 4 2.0 0.189 48.0 35-62 
29 21223 1 0.5 0.186 50.0 50 
30 31221 1 0.5 0.177 80.0 80 
31 21231 3 1.5 0.159 73.3 40-98 
32 23321 2 1.0 0.150 80.0 75-85 
33 31122 2 1.0 0.142 70.0 60-80 
34 23222 2 1.0 0.137 82.5 70-95 
35 32212 1 0.5 0.125 30.0 30 
36 22123 1 0.5 0.118 77.0 77 
37 32121 1 0.5 0.109 88.0 88 
38 21232 4 2.0 0.088 55.0 35-80 
39 22223 3 1.5 0.082 49.3 30-40 
The table is ranked in order of decreasing health according to the mean health index value;  
in bold are the 12 most frequently reported health profiles.  
Abbreviations: EQ-5D, Quality of Life. 
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Table 7.2.1 continued: Frequency distribution of all the  64 reported health profiles 
with mean index and EQ-VAS values 
Rank 
order 
EQ-5D profile Count % Mean index 
value 
(UK TTO) 
Mean EQ-
VAS 
Range of 
mean EQ-
VAS 
40 32221 1 0.5 0.073 70.0 70 
41 22231 1 0.5 0.055 50.0 50 
42 33311 1 0.5 0.028 70.0 70 
43 32321 2 1.0 0.015 45.0 10-80 
44 32222 2 1.0 0.002 34.5 34-35 
45 22331 1 0.5 -0.003 70.0 70 
46 11233 1 0.5 -0.008 50.0 50 
47 22232 6 3.0 -0.016 40.0 20-60 
48 33221 1 0.5 -0.037 80.0 80 
49 21133 1 0.5 -0.041 32.0 32 
50 23231 1 0.5 -0.055 70.0 70 
51 32322 2 1.0 -0.056 42.5 40-45 
52 22332 6 3.0 -0.074 35.7 5-65 
53 21233 3 1.5 -0.077 65.0 40-80 
54 33321 2 1.0 -0.095 82.5 80-85 
55 33222 3 1.5 -0.108 56.7 30-90 
56 33322 2 1.0 -0.166 50.0 30-70 
57 22233 4 2.0 -0.181 32.5 0-50 
58 23332 1 0.5 -0.184 40.0 40 
59 31332 1 0.5 -0.215 35.0 35 
60 32323 1 0.5 -0.221 30.0 30 
61 22333 2 1.0 -0.239 34.0 28-40 
62 32232 1 0.5 -0.261 80.0 80 
63 33323 1 0.5 -0.331 70.0 70 
64 33333 3 1.5 -0.594 14.0 10-22 
The table is ranked in order of decreasing health according to the mean health index value;  
in bold are the 12 most frequently reported health profiles.  
Abbreviations: EQ-5D, Quality of Life. 
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  Figure 7.2: Histogram with normal curve and Q-Q plot for the EQ-VAS 
 Abbreviations: EQ-VAS, Quality of Life Visual Analogue Scale. 
 
 
7.3: QoL; relation to demographic profiles  
Table 7.3.1: Percentage of people reporting on health status dimensions divided into 
groups by gender, cause and level of injury 
 Total 
group 
% 
n=198 
Gender¹ % Cause of injury % Level of injury % 
Male 
n=12
0 
Female 
n=75 
Traumatic 
n=139 
Non 
traumatic 
n=59 
Tetraplegia 
n=91 
Paraplegia 
n=66 
Mobility Level 1 7.1 9.2 2.7 8.6 3.4 7.7 6.5 
Level 2 78.3 78.3 80.0 77.7 79.7 72.5 83.2 
Level 3 14.6 12.3 17.3 13.7 16.9 19.8 10.3 
Self-Care Level 1 45.5 45 46.7 47.5 40.7 33 56.1 
Level 2 42.9 42.5 42.7 38.8 52.5 44 42.1 
Level 3 11.6 12.5 10.7 13.7 6.8 23.1 1.9 
Usual 
Activities 
Level 1 18.7 20.8 14.7 20.9 13.6 18.7 18.7 
Level 2 64.1 65.8 61.3 63.3 66.1 59.3 68.2 
Level 3 17.2 13.3 24 15.8 20.3 22 13.1 
Pain / 
Discomfor
t 
Level 1 14.6 15.8 12 16.5 10.2 20.9 9.3 
Level 2 63.6 65 62.7 64 62.7 62.6 64.5 
Level 3 21.7 19.2 25.3 19.4 27.1 16.5 26.2 
Anxiety / 
Depressio
n 
Level 1 39.9 45.8 32 48 20.3 50.7 30.8 
Level 2 49 43.3 57.3 42.4 64.4 39.6 57.0 
Level 3 11.1 10.8 10.7 9.4 15.3 9.9 12.1 
¹3 respondents did not give their gender 
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Table 7.3.2: EQ-5D index  and EQ-VAS reported by males and females.  
Statistical difference of EQ-5D index and EQ-VAS between gender 
  Male Female Statistical Tests 
EQ-5D 
Index 
n 
Mean±SD 
Median 
Percentile 25th  
Percentile 75th  
120 
0.4±0.3 
0.5 
0.1 
0.7 
75 
0.3±0.3 
0.5 
-0.01 
0.6 
p=0.18 
t=1.48¹, df193 
95% CI -0.02, 0.1 
 U=3889.0, p=0.1 
EQ-VAS n 
Mean±SD 
Median 
Percentile 25th  
Percentile 75th  
120 
64.0±23.9 
70 
50 
85 
75 
61.7±20.3 
65 
45 
80 
p=0.50 
t=0.67, df193 
95% CI -4.33, 8.79 
 
¹Independent t-test could be used in this case because despite data being  
bimodal it was rather symmetric (mean and median approximately equal) therefore  
filling the assumptions for t-test.{{682 Peacock, J. 2007}}  
Abbreviations: EQ-5D, Quality of Life; EQ-VAS, Quality of Life Visual Analogue Scale SD, 
Standard Deviation.  
Statistical tests: t, Independent t-test; U, Mann-Whitney U test. 
 
 
Table 7.3.3: EQ-5D index and EQ-VAS reported betwenn gender.  
Statistical difference between gender reports. 
 With MSKP 
mean±SD, n 
Without MSKP 
mean±SD, n 
Statistical Test 
 EQ-5D Index 
Males 0.4±0.3, n=39 0.4±0.3, n=79 p=0.37, df116, t=0.88 
95% CI -0.07, 0.19, ES d=0.28 
Females 0.2±0.3, n=36 0.4±0.3, n=37 p=0.06, df71, t=1.90 
95% CI -0.006, 0.31, ES d=0.66 
 EQ-VAS 
Males 61.9±23.0, n=39 64.6±24.6, n=79 p=0.56, df116, t=0.57 
95% CI -6.6, -12.5, ES d=0.11 
Females 52.9±17.7, n=36 69.9±19.4, n=37 p≤0.001***, df71, t=3.89 
95% CI 8.3, 25.7, ES d=0.91 
In bold: significant following application of the Bonferroni correction.  
The only significant difference found was among females as those without MSKP had  
a better self-rated health that those with MSKP and the effect size was larger 
 than typical.  
Abbreviations: MSKP, Musculoskeletal pain, EQ-5D, Quality of Life, EQ-VAS, Quality  
of life Visual Analogue Scale. 
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Table 7.3.4: EQ-5Q index and EQ-VAS for people with traumatic and non-traumatic  
injury. Statistical difference of EQ-5D and EQ-VAS between groups by cause of injury 
  Traumatic Non-traumatic Statistical Test 
EQ-5D Index n 
Mean±SD 
Median 
Percentile 25th  
Percentile 75th  
Skewness 
Kyrtosis 
139 
0.4±0.3 
0.5 
0.08 
0.69 
-0.05 
-0.07 
59 
0.3±0.4 
0.5 
-0.04 
0.6 
-0.5 
-1.1 
U=3441.5 
p=0.07 
EQ-VAS n 
Mean±SD 
Median 
Percentile 25th  
Percentile 75th  
Skewness 
Kyrtosis 
139 
66.8±22.7 
71 
50 
85 
-0.8 
-0.1 
59 
53.8±19.5 
50 
40 
69 
0.008 
-0.3 
t=-2.85, df49 
p=0.006¹ 
95% CI -43.0,  
-7.5 
1not significant post Bonferroni correction 
Abbreviations: EQ-5D, Quality of Life; SD, EQ-VAS, Quality of Life Visual Analogue Scale 
Standard Deviation.  
Statistical test: U, Mann-Whitney U test; t, Independent t-test 
 
 
Table 7.3.5: EQ-5D index and EQ-VAS for people with tetraplegia and paraplegia.  
Differences in EQ-5D and EQ-VAS between groups divided by level of injury  
  Tetraplegia Paraplegia Statistical Test 
EQ-5D 
Index 
n 
Mean±SD 
Median 
Percentile 25th  
Percentile 75th  
Skewness 
Kurtosis 
91 
0.3±0.4 
0.3 
-0.01 
0.7 
-0.5 
-0.7 
107 
0.3±0.4 
0.3 
0.01 
0.7 
-0.5 
-0.7 
U=4772 
p=0.81 
EQ-VAS n 
Mean±SD 
Median 
Percentile 25th  
Percentile 75th  
Skewness 
Kurtosis 
91 
67.1±23.9 
70 
50 
85 
-0.8 
0.03 
107 
59.4±20.8 
60 
40 
80 
-0.2 
-0.7 
t=2.41, df196 
p≤0.01¹ 
95% CI 1.4, 13.9 
1Not siginifcant post application of the Bonferroni correction. 
Abbreviations: EQ-5D, Quality of Life; SD, EQ-VAS, Quality of Life Visual Analogue  
Scale Standard Deviation.  
Statistical test: U, Mann-Whitney U test; t, Independent t-test 
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Figure 7.3.1: Percentage of people, divided into groups by level of injury,  
reporting each health status dimension. 
Abbreviations: EQ-5D, Quality of Life 
 
 
Table 7.3.6: Characteristics of EQ-5D index and EQ-VAS per level of injury.  
Differences inEQ-5D and EQ-VAS between groups. 
  Cervical Thoracic Lumbar Statistical Test 
EQ-5D Index n 
Mean±SD 
Median 
Percentile 25th  
Percentile 75th  
Skewness 
Kurtosis 
95 
0.3±0.4 
0.3 
-0.008 
0.7 
-0.3 
-0.8 
66 
0.4±0.3 
0.6 
0.1 
0.6 
-0.8 
-0.6 
42 
0.3±0.4 
0.5 
-0.1 
0.7 
-0.2 
-1.5 
p=0.47 
H=1.5, df2 
 
EQ-VAS n 
Mean±SD 
Median 
Percentile 25th  
Percentile 75th  
Skewness 
Kurtosis 
91 
67.1±23.9 
70 
50 
85 
-0.8 
0.01 
66 
62.2±19.8 
65 
50 
80 
-0.3 
-0.5 
41 
55.0±22.8 
50 
40 
73 
-0.1 
-0.9 
p=0.015¹ 
F=4.28, df2 
 
1Not siginifcant post application of the Bonferroni correction. 
Abbreviations: EQ-5D, Quality of Life; SD, Standard Deviation; EQ-VAS, Quality of Life Visual 
Analogue Scale 
Statistical Test: H, Kruskal-Wallis H; F, One-way ANOVA 
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Table 7.3.7: Two group comparisons for EQ-VAS between  
groups divided by level of injury 
 Cervical Thoracic 
Thoracic I-J= 4.9 
p=0.36  
 
Lumbar I-J= 12.1 
p≤0.01** 
I-J= 7.2 
p=0.23  
**Significant at 0.01 level;  
in bold: significant following Bonferroni post hock 
Abbreviations: EQ-VAS, Quality of Life Visual Analogue Scale.  
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Table 7.3.8: Percentage of people reporting the EQ-5D dimensions divided in groups by age and time since injury 
 Age  
n=190¹ 
Time Since Injury  
n=197² 
 n Mean SD Median Min - Max n Mean SD Median Min - Max 
Mobility Level 1 12 48.9 13.2 48.2 33.4 - 70.6 14 7.0 5.1 6.0 0.6 – 19.4 
Level 2 150 50.9 14.2 51.3 19.8 – 91.7 155 11.8 10.9 8.1 0.3 – 44.0 
Level 3 28 46.0 15.8 43.7 23.0 – 90 29 12.3 11.7 8.1 0.3 – 44.2 
Self-Care Level 1 86 48.5 14.6 49.1 19.8 – 83.8 90 11.6 10.8 7 0.4 – 44.0 
Level 2 82 52.1 13.7 53 26.6 – 91.7 85 11.4 11.2 8.5 0.3 – 44.2 
Level 3 22 48.3 16.0 44.6 23.4 – 90 23 11.5 9.3 8.0 1.1 – 29.2 
Usual 
Activities 
Level 1 33 47.6 13.5 49.2 23.0 – 70.6 37 14.6 10.9 11.8 1.0 – 41.7 
Level 2 125 50.3 14.8 50.9 19.8 – 91.7 127 11.2 11.2 7.2 0.3 – 44.2 
Level 3 33 51.4 13.9 50 23.4 – 90 34 9.3 9.0 6.1 0.3 – 30.8 
Pain / 
Discomfort 
Level 1 26 46.7 15.0 41.9 26.6 – 79.9 29 10.1 9.6 8.9 0.9 – 41.7 
Level 2 121 51.1 14.4 51.6 23.0 – 91.7 126 11.2 11.0 6.8 0.3 – 44.2 
Level 3 43 49.1 14.2 48.7 19.8 – 89.1 43 13.2 10.8 9.1 0.5 – 43.2 
Anxiety / 
Depression 
Level 1 71 47.8 12.3 49.4 26.6 – 83.8 79 13.5 12.3 8.7 0.4 – 44.0 
Level 2 97 51.4 15.7 50.9 23.0 – 91.7 97 10.1 9.5 7.6 0.3 – 44.2 
Level 3 22 50.7 14.8 48.7 19.8 – 76.5 22 10.7 9.6 7.5 0.6 – 34.3 
¹n=8 did not report their age, ²n=1 did not report their time since injury 
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Table 7.3.9: Percentage of people, divided into groups by level of education,  
reporting the health status dimensions  
 No 
education or 
compulsory  
High school College, 
Associate  or 
Bachelor 
Degree 
Master of 
PhD 
Mobility Level 1 4.5 9.1 6.3 8.8 
Level 2 81.8 77.3 77.1 79.4 
Level 3 13.6 13.6 16.7 11.8 
Self-Care Level 1         36.4 45.5 45.8 50 
Level 2 54.5 36.4 43.8 41.2 
Level 3 9.1 18.2 10.4 8.8 
Usual 
Activities 
Level 1 9.1 15.9 21.9 17.6 
Level 2 77.3 59.1 36.5 64.7 
Level 3 13.6 25 14.6 17.6 
Pain / 
Discomfort 
Level 1 18.2 9.1 17.7 11.8 
Level 2 59.1 59.1 64.6          70.6 
Level 3 22.7 31.8 17.7 17.6 
Anxiety / 
Depression 
Level 1 27.3 38.6 40.6 47.1 
Level 2 54.5 50 49 47.1 
Level 3 18.2 11.4 10.4 5.9 
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7.4:  QoL; relation to pain/LBP days, free periods, onset  
Table 7.4.1: Number of pain and LBP days felt in a month and EQ-VAS 
  1-9 days  10 – 20 
days  
21 – 30 
days  
Every day  Statistical Test 
EQ-5D 
Index 
Pain days 
n 
Mean±SD 
Median            
Percentile 25th 
Percentile 75th 
Skewness 
Kurtosis  
 
27¹ 
0.5±0.3 
0.7 
0.6 
0.7 
-1.6 
1.2 
 
26 
0.4±0.3 
0.6 
0.1 
0.7 
-0.7 
-1.2 
 
18 
0.2±0.3 
0.2 
0.1 
0.6 
-0.7 
0.1 
 
105 
0.3±0.3 
0.2 
-0.01 
0.6 
-0.3 
-1.0 
 
p≤0.001*** 
ρ=-0.24 
n=176 
EQ-5D 
Index 
LBP days 
n 
Mean±SD 
Median            
Percentile 25th 
Percentile 75th 
Skewness 
Kurtosis  
 
39¹ 
0.4±0.4 
0.6 
0.1 
0.7 
 
27 
0.4±0.3 
0.6 
0.2 
0.7 
 
18 
0.2±0.3 
0.1 
-0.1 
0.5 
 
64 
0.2±0.3 
0.2 
-0.1 
0.6 
 
p≤0.001*** 
ρ=-0.24 
 n=148 
EQ-VAS Pain days 
n 
Mean±SD 
Median            
Percentile 25th 
Percentile 75th  
Skewness 
Kurtosis 
 
28 
70.5±17.9 
70 
58.5 
88.7 
-0.1 
-0.7 
 
26 
66.4±23.0 
72.5 
43.7 
83.7 
-0.5 
-1.5 
 
18 
60.9±22.9 
60 
40 
80 
-0.1 
-1.4 
 
105 
59.9±23.4 
60 
40 
80 
-0.5 
-0.5 
 
p=0.032 
ρ=-0.16 
n=177 
EQ-VAS LBP days 
n 
Mean±SD 
Median            
Percentile 25th 
Percentile 75th 
Skewness 
Kurtosis 
 
36 
68.8±19.6 
70 
52 
85 
-0.6 
-0.4 
 
27 
63.5±22.0 
66.5 
40 
80 
-0.5 
-1.0 
 
18 
54.5±19.1 
50 
40 
72 
-0.1 
-1.4 
 
58 
54.2±24.2 
57.5 
38.7 
75 
-0.5 
-0.5 
 
p=0.0032 
ρ=-0.35 
n=139 
¹One outlier eliminated from analysis; 2not significant post application of the Bonferroni 
correction;  ***significant at p≤0.01 level; in bold: significant following Bonferroni correction 
Abbreviations: EQ-5D, Quality of Life ; EQ-VAS, Quality of Life Visual Analogue Scale; SD, 
Standard Deviation.  
Statistical Test: ρ, Spearman’s rho.  
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Table 7.4.2: Percentage of people reporting the health status dimensions divided into groups by frequency of pain and LBP free weeks 
 1 week pain free week % 
n=167¹ 
1 week LBP free week % 
n=122¹ 
Yes, 
most 
of 
time 
Yes, 
frequently 
Yes, 
some 
times 
Yes, 
not 
often 
Yes, 
rarely 
No, 
always 
have 
pain 
Yes, 
most 
of 
time 
Yes, 
frequently 
Yes, 
some 
times 
Yes, 
not 
often 
Yes, 
rarely 
No,  
always 
have 
pain 
Mobility Level 1 13.3 11.8 0 0 5.3 7.1 12.5 11.1 7.1 0 4.2 8.5 
Level 2 73.3 70.6 77.8 92.3 78.9 81.2 81.3 77.8 71.4 100 83.3 76.6 
Level 3 13.3 17.6 22.2 7.7 15.8 11.8 6.3 11.1 21.4 0 12.5 14.9 
Self-Care Level 1 46.7 58.8 33.3 69.2 63.2 38.3 58.8 66.7 42.9 54.5 58.3 29.2 
Level 2 40.0 41.2 50 23.1 21.1 48.2 35.3 33.3 35.7 45.5 33.3 58.3 
Level 3 13.3 0 16.7 7.7 15.8 12.9 5.9 0 21.4 0 8.3 12.5 
Usual 
Activities 
Level 1 40.0 29.4 5.6 30.8 31.6 10.6 29.4 22.2 21.4 27.3 16.7 8.3 
Level 2 53.3 70.6 77.8 61.5 47.4 64.7 64.7 77.8 42.9 54.5 70.8 62.5 
Level 3 6.7 0 16.7 7.7 21.1 24.7 5.9 0 35.7 18.2 12.5 29.2 
Pain / 
Discomfort 
Level 1 33.3 11.8 5.6 0 5.3 1.2 5.9 0 7.1 0 8.7 0 
Level 2 66.7 88.2 94.4 61.5 78.9 60.0 70.6 88.9 85.7 63.6 73.9 54.2 
Level 3 0 0 0 38.5 15.8 38.8 23.5 11.1 7.1 36.4 17.4 45.8 
Anxiety / 
Depression 
Level 1 46.7 29.4 38.9 30.8 31.6 40.0 31.3 44.4 35.7 36.4 45.8 29.2 
Level 2 46.7 58.8 55.6 53.8 57.9 45.9 68.8 55.6 50 45.5 41.7 52.1 
Level 3 6.7 11.8 5.6 15.4 10.5 14.1 0 0 14.3 18.2 12.5 18.8 
¹Including only people with pain/LBP and excluding those who did not remember when the onset of their pain/LBP post SCI was.  
Abbreviations: EQ-5D, Quality of Life; LBP, Low Back Pain. 
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   Table 7.4.3: EQ-5D index in groups divided by frequency of pain and LBP free weeks 
 
¹One outlier eliminated, ²Two outliers eliminated.  
Abbreviations: EQ-5D, Quality of Life; SD, Standard Deviation; LBP, Low Back Pain.
 Appendix 7 
 
180 
Table 7.4.4: EQ-VAS in groups divided by regularity of pain and LBP free weeks 
 
¹One outliers eliminated.  
Abbreviations: EQ-VAS, Quality of Life Visual Analogue Scale; SD, Standard Deviation.  
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7.5 EQ-5D; relation to pain extent 
Table 7.5.1: Percentage of people reporting each EQ-5D dimension divided in groups 
by pain presence and number of days in pain 
 % of number of pain days per 
month  
n=177¹ 
% of number of LBP days per month  
n=139¹ 
1-9 10-20 21-30 Everyday 1-9 10-20 21-30 Everyday 
Mobility Level 1 7.1 11.5 0 5.5 5.6 11.1 0 6.9 
Level 2 78.6 65.4 83.3 81.9 83.3 77.8 77.8 81 
Level 3 14.3 23.1 16.7 12.4 11.1 11.1 22.2 12.1 
Self-Care Level 1 60.7 50 55.6 41.0 55.6 55.6 44.4 37.9 
Level 2 32.1 34.6 33.3 48.6 30.6 40.7 50 55.2 
Level 3 7.1 15.4 11.1 10.5 13.9 3.7 5.6 6.9 
Usual 
Activities 
Level 1 35.7 15.4 22.2 14.3 25.0 25.9 22.2 6.9 
Level 2 57.1 73.1 72.2 61.0 66.7 66.7 55.6 67.2 
Level 3 7.1 11.5 5.6 24.8 8.3 7.4 22.2 25.9 
Pain / 
Discomfort 
Level 1 25 7.7 0 0 11.1 11.1 0 0 
Level 2 71.4 88.5 61.1 67.6 77.8 74.1 61.1 65.5 
Level 3 3.6 3.8 38.9 32.4 11.1 14.8 38.9 34.5 
Anxiety / 
Depression 
Level 1 50 34.6 22.2 38.1 47.2 33.3 27.8 34.5 
Level 2 42.9 53.8 55.6 50.5 44.4 59.3 61.1 48.3 
Level 3 7.1 11.5 22.2 11.4 8.3 7.4 11.1 17.2 
¹Including only people with pain/LBP and excluding those who did not recall when the onset 
of their pain/LBP was.  
Abbreviations: EQ-5D, Quality of Life; LBP, Low Back Pain; MSKP, Musculoskeletal Pain. 
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8.1. Bonferroni correction 
Table 8.1.1: Main variables used in analysis of function and alpha value set following 
Bonferroni correction.  
Main Variables Tests with following variables Alpha value 
following 
Bonferroni 
correction 
Self-care, 
Respiration & 
Sphincter 
management, 
Mobility in room 
& toilet,  
Mobility indoor & 
outdoor, 
Total SCIM 
1) Pain                                13) LBP intensity 3 months 
2) MSKP                              14) With pain days 
3) LBP (current)                 15) With LBP days 
4) Gender                           16) With pain free weeks 
5) Cause of injury              17) With LBP free weeks 
6) Age                                  18) With pain onset 
7) Type of injury                19) With LBP onset 
8) Time since injury          20) With areas with pain 
9) Current LBP intensity   21) With S-PRI       
10)  LBP intensity 1 month  22) With A-PRI 
11)  EQ-5D index                   23) With total PRI 
12)  EQ-VAS 
0.05/23=0.002 
p≤0.002 
Abbreviations: EQ-5D index, Quality of Life index; EQ-VAS, Quality of Life Visual Analogue 
Scale; MSKP, Musculoskeletal Pain; LBP, Low Back Pain; PRI, Present Rating Index; S-PRI, 
Sensory PRI; A-PRI, Affective PRI 
 
 
8.2. Translation 
Table 8.2.1: Characteristics of forward translators 
   
Occupations n=2 Occupational Therapists 
n=1 Physiotherapist 
 
Years living in the UK  6.8±2.0 
(mean±SD) 
Hours to translate questionnaire  2.5±0.4 
(mean±SD) 
Use of dictionary n=2 “Yes, but rarely”  
n=1 “Yes, frequently” 
 
Overall difficulty to translate¹  4.3±3.0¹ 
(mean±SD) 
Easiest question to translate¹ Question 17 1.0±1.0¹ 
(mean±SD) 
The most difficult question to¹ 
translate 
Question 7 6.3±2.9¹ 
(mean±SD) 
¹0-10 NRS (0=very easy -10=the most difficult translation)-two translators  
failed to respond. 
Abbreviation: NRS, Numeric Rating Scale 
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8.3. GR-SCIM III; relation to demographic profile characteristics 
Table 8.3.1: Mean function scores and statistical differences in function between 
males and females  
 Males  n=23 
mean±SD, 
median, min-max 
Females n=18 
mean±SD, 
median, min-max 
Statistical Tests 
Self-care subscale 
(range 0-20) 
13.1±5.4  
15, 2-20 
16.0±4.8 
18, 6-20 
U=137.5 
p=0.065 
n=41 
Respiration & sphincter 
management 
(range 0-40) 
33.2±7.6  
36, 11-40 
35.2±8.1  
38.5, 15-40 
U=153.0 
p=0.15 
n=41 
Mobility room & toilet 
(range 0-10) 
8.3±2.6  
10, 0-10 
8.1±2.4  
10, 4-10 
U=193.0 
p=0.67 
n=41 
Mobility indoor & 
outdoor 
(range 0-30) 
18.6±10.0  
23, 1-30 
19.1±10.1  
20, 0-30 
U=195.0 
p=0.75 
n=41 
Total SCIM 
(range 0-100) 
73.2±21.6  
81, 34-95 
78.3±22.6  
83.50, 28-100 
U=158.5 
p=0.20 
n=41 
Abbreviation: SD, Standard Deviation;  
Statistical test: t, Independent t-test; U, Mann-Whitney U test. 
 
 
Table 8.3.2: Mean function scores, within gender, for people with and without MSKP. 
Differences within males and females 
Males   
with MSKP 
n, mean±SD 
Males   
without 
MSKP 
n,mean±SD 
Females  
with MSKP 
n, mean±SD 
Females  
without MSKP 
n, mean±SD 
n=6 
68.8±28.9  
15, 2-20 
n=6 
68.8±28.9  
15, 2-20 
n=6 
68.8±28.9  
15, 2-20 
n=6 
68.8±28.9  
15, 2-20 
Statistical test 
U= 41.0, p=0.75,  
Statistical test 
U=32.5, p=0.73,  
Abbreviation: SD, Standard Deviation; MSKP, Muskuloskeletal pain  
Statistical test: Mann-Whitney U test. 
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Table 8.3.3: Mean function score and statistical differences in function between 
people with traumatic and non-traumatic injury 
 Traumatic  
n=18, mean±SD, 
median, min-max 
Non traumatic 
n=27, mean±SD, 
median, min-max 
Statistical 
Tests 
Self-care subscale 
(range 0-20) 
13.1±5.3  
14, 2-20 
15.5±4.9 
17, 4-20 
U=175.5 
p=0.11, n=45 
Respiration & sphincter 
management 
(range 0-40) 
32.3±8.2  
35.5, 11-40 
35.4±6.9  
38, 15-40 
U=194.5 
p=0.25, n=45 
Mobility room & toilet 
(range 0-10) 
7.8±3.0  
10, 0-10 
8.5±2.1  
10, 4-10 
U=219.5 
p=0.54, n=45 
Mobility indoor & 
outdoor 
(range 0-30) 
17.1±10.2  
18.5, 4-30 
20.3±9.6  
26, 0-30 
U=201.5 
p=0.33, n=45 
Total SCIM 
(range 0-100) 
70.7±21.3  
74.5, 34-100 
79.7±21.0  
86, 28-99 
U=171.5 
p=0.09, n=45 
Abbreviation: SD, Standard Deviation;  
Statistical test: t= Independent t-test; U= Mann-Whitney U test. 
 
 
 
 
 
 
 
 
 
 
Figure 8.3.1: Scatterplot showing the correlation between total function  
score and age (n=45); 
 Abbreviations: SCIM, Spinal Cord Independence Measure.  
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Table 8.3.4: Mean function scores and statistical differences in function between 
people with tetraplegia and paraplegia 
 Tetraplegia  
 n=15, mean±SD, 
median, min-max 
Paraplegia  
n=30, mean±SD, 
median, min-max 
Statistical 
Tests 
Self-care subscale 
(range 0-20) 
12.3±6.1  
15, 2-20 
15.7±4.2 
17, 6-20 
U=152 
p=0.07, n=45 
Respiration & sphincter 
management 
(range 0-40) 
32.7±8.7  
38, 11-40 
36.0±6.1¹  
38, 15-40 
U=166.5 
p=0.26, n=45 
Mobility room & toilet 
(range 0-10) 
7.6±3.0  
10, 0-10 
8.5±2.1  
10, 4-10 
U=194.5 
p=0.41, n=45 
Mobility indoor & 
outdoor 
(range 0-30) 
15.7±11.3  
9, 1-30 
20.7±8.8  
23.5, 0-30 
U=185 
p=0.33, n=45 
Total SCIM 
(range 0-100) 
68.3±25.5  
61, 34-100 
83.3±13.6¹  
85.5, 45-99 
U=144.5 
p=0.09, n=45 
¹Two outliers eliminated;  
Abbreviation: SCIM: Spinal Cord Independence Measure; SD, Standard Deviation;  
Statistical test: U, Mann-Whitney U test. 
 
 
Table 8.3.5: Mean function scores and statistical differences in function between 
people divided into groups by level of injury 
 Cervical 
n=15 
mean±SD, 
median, min-
max 
Thoracic 
n=16 
mean±SD, 
median, min-
max 
Lumbar 
n=14 
mean±SD, 
median, min-
max 
Statistical 
Tests 
Self-care subscale 
(range 0-20) 
12.3±6.1  
15, 2-20 
15.2±4.1  
15, 8-20 
16.1±4.4 
17, 6-20 
H=3.55, df2 
p=0.16, n=45 
Respiration & 
sphincter 
management 
(range 0-40) 
32.7±8.7  
38, 11-40 
36.4±5.3  
39, 2-40 
33.8±8.2  
37.5, 15-40 
F=1.00, df2 
p=0.37, n=45 
 
Mobility room & 
toilet 
(range 0-10) 
7.6±3.0  
10, 0-10 
8.2±2.2  
9, 4-10 
8.9±2.0  
10, 4-10 
F=-0.94, df2 
 p=0.39, n=45 
 
Mobility indoor & 
outdoor 
(range 0-30) 
15.7±11.3  
9, 1-30 
20.8±9.2  
25, 5-30 
20.6±8.7  
21.5, 0-30 
F=1.28, df2 
p=0.28, n=45 
 
Total SCIM 
(range 0-100) 
68.3±25.5  
61, 34-100 
80.6±16.4  
84.5, 45-99 
79.4±20.5  
83.5, 28-98 
H=1.72, df2 
p=0.42, n=45 
Abbreviation: SCIM: Spinal Cord Independence Measure; SD, Standard Deviation;  
Statistical test: F, One-way ANOVA; H, Kruskal-Wallis H test. 
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8.4: GR-SCIM III; relation to pain, MSKP and LBP 
Table 8.4.1: Mean function scores reported by people with and without the categories 
of pain  
 Pain 
mean±SD, median, min-
max 
Current LBP 
mean±SD, median, min-
max 
MSKP 
mean±SD, median, 
min-max 
 Yes 
n=35 
No 
n=10 
Yes 
n=30 
No 
n=13 
Yes 
n=17 
No 
n=25 
Self-care 
subscale 
(range 0-20) 
14.6±5.6  
16, 2-20 
14.4±3.5  
15.5, 8-18 
15.0±5.4  
17, 2-20 
13.5±4.8  
15, 4-20 
14.5±5.7 
17, 4-20 
15.6±3.8 
16.5, 8-20 
 
Respiration 
& sphincter 
management 
(range 0-40) 
33.6±8.2  
38, 11-40 
36.9±2.8  
37.5, 31-40 
34.8±7.9¹  
37.5, 11-40 
36.3±6.2²  
38.0, 15-40 
33.5±9.6  
38, 11-40 
35.5±5.6  
37, 21-40 
 
Mobility 
room & toilet 
(range 0-10) 
8.1±2.6  
10, 0-10 
8.7±1.8  
10, 6-10 
8.4±2.2 
10, 4-10 
7.9±3.0 
10, 0-10 
 
8.5±2.2  
10, 4-10 
8.4±2.0 
10, 4-10 
Mobility 
indoor & 
outdoor 
(range 0-30) 
18.5±10.3  
23, 0-30 
20.8±8.4  
25, 6-30 
19.8±9.9  
23, 0-30 
19.2±9.5 
24, 4-30 
19.1±10.8  
23, 0-30 
20.6±8.7 
24, 6-30 
 
Total SCIM 
(range 0-100) 
74.8±23.2  
82, 28-100 
80.8±12.8  
82, 62-92 
77.9±21.6  
84, 28-100 
74.8±21.7 
78, 34-97 
75.6±25.2  
85, 28-
100 
79.6±17.2 
83, 44-99 
¹One outlier eliminated, ²Four outliers eliminated.  
Abbreviations: SCIM, Spinal Cord Independence Measure; LBP, Low Back Pain; MSKP, 
Musculoskeletal Pain.  
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8.5. GR-SCIM III; relation to pain/LBP days, free weeks, onset  
Table 8.5.1: Mean function scores in groups divided by the number of pain or LBP days 
felt in the month 
 Pain days 
felt in the month 
LBP days 
felt in the month 
 1-20 days 
n=21 
mean±SD, 
median, min-
max 
21-Every day 
n=11 
mean±SD, 
median, min-
max 
1-20 days  
n=13 
mean±SD, 
median, min-
max 
21-Every day 
n=18 
mean±SD, 
median, min-
max 
Self-care subscale 
(range 0-20) 
15.7±4.7  
17, 6-20 
13.5±6.8  
13, 2-20 
14.5±5.8 
17, 4-20 
16.3±4.2¹ 
17, 8-20 
Respiration & 
sphincter 
management 
(range 0-40) 
34.7±9.0¹  
38, 1-40 
33.8±6.3  
37, 22-40 
35.8±6.3¹  
38, 18-40 
35.4±7.1 
38, 15-40 
Mobility room & 
toilet 
(range 0-10) 
9.2±1.5²  
10, 6-10 
7.8±2.3  
8, 4-10 
8.0±2.2  
8, 4-10 
9.4±1.4²  
10, 6-10 
Mobility indoor & 
outdoor 
(range 0-30) 
22.2±9.6³  
28, 0-30 
15.9±9.0  
16, 1-30 
18.5±11.2  
23, 0-30 
21.2±9.0 
26, 5-30 
Total SCIM 
(range 0-100) 
90.9±19.9  
94, 61-100 
70.3±19.8  
81, 37-98 
76.1±22.8  
83, 28-100 
83.3±17.8¹ 
92, 44-99 
Table excludes people with no LBP or who did not remember number of pain days,  
¹One outlier eliminated, ²Two outliers eliminated, ³Three outliers eliminated. 
 Abbreviation: SCIM: Spinal Cord Independence Measure; SD, Standard Deviation.  
 
 
 
Table 8.5.2: Correlations between function and the number pain or LBP days felt per 
month  
 Self-care 
subscale 
(range 0-20) 
 
Respiration & 
sphincter 
management 
(range 0-40) 
Mobility 
room & 
toilet 
(range 0-10) 
Mobility 
indoor & 
outdoor 
(range 0-30) 
Total SCIM 
(range 0-100) 
 
Pain days 
(n=32)  
φ=0.50 
p=0.53 
φ=0.69 
p=0.21 
φ=0.26 
p=0.54 
φ=0.80 
p=0.11 
φ=0.91 
p=0.31 
LBP days 
(n=32) 
φ=0.72 
p=0.15 
φ=0.69 
p=0.17 
φ=0.35 
p=0.27 
φ=0.84 
p=0.03¹ 
φ=0.88 
p=0.40 
1not significant post Bonferroni correction;  
Abbreviations: SCIM, Spinal Cord Independence Measure, LBP, Low Back Pain. 
Statistical test: φ, Phi test. 
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Table 8.5.3: Mean function scores in groups divided by the frequency of pain and LBP 
free weeks 
 Pain free weeks LBP free weeks 
  Yes, most 
time, 
frequently, 
sometimes  
n=20, 
mean±SD, 
median, min-
max 
Yes, not often, 
rarely, no 
always have 
pain  
n=12, mean±SD, 
median, min-
max 
Yes, most time, 
frequently, 
sometimes  
n=20, mean±SD, 
median, min-
max 
Yes, not often, 
rarely, no always 
have pain  
n=10, mean±SD, 
median, min-max 
Self-care 
subscale 
(range 0-20) 
15.7±4.4 
17, 8-20 
12.3±7.1  
13.5, 2-20 
15.6±5.4 
17, 2-20 
14.4±5.8 
15, 4-20 
Respiration & 
sphincter 
management 
(range 0-40) 
34.9±7.8¹  
38, 15-40 
35.5±5.0¹  
38, 26-40 
35.7±7.2¹  
38, 15-40 
36.2±5.5¹ 
38, 22-40 
Mobility room 
& toilet 
(range 0-10) 
8.3±2.2  
10, 4-10 
7.6±3.3  
10, 0-10 
8.6±2.2  
10, 4-10 
8.6±1.9  
10, 6-10 
Mobility 
indoor & 
outdoor 
(range 0-30) 
20.5±9.7  
26, 0-30 
16.7±11.3  
16, 1-30 
22.9±7.7¹  
26, 6-30 
18.2±10.8 
19.5, 1-30 
Total SCIM 
(range 0-100) 
77.0±24.1  
88, 28-100 
72.8±24.3  
81, 34-98 
88.7±10.1²  
92, 61-100 
76.4±22.2 
81.5, 37-98 
Table excludes people with no pain or who did not remember frequency of pain free weeks, 
¹One outlier eliminated, ²Two outliers eliminated.  
Abbreviation: SCIM: Spinal Cord Independence Measure; LBP, Low Back Pain; SD, Standard 
Deviation.  
 
 
 
Table 8.5.4: Correlations between function and the frequency of pain or LBP free 
weeks  
 Self-care 
subscale 
 
Respiration & 
sphincter 
management 
Mobility 
room & 
toilet 
Mobility 
indoor & 
outdoor 
Total SCIM 
 
Pain free week  
(n=32) 
φ=0.70 
p=0.20 
φ=0.59 
p=0.43 
φ=0.31 
p=0.53 
φ=0.65 
p=0.54 
φ=0.80 
p=0.60 
LBP free weeks 
(n=30) 
φ=0.65 
p=0.38 
φ=0.51 
p=0.62 
φ=0.24 
p=0.62 
φ=0.59 
p=0.63 
φ=0.82 
p=0.56 
Abbreviations: SCIM, Spinal Cord Independence Measure, LBP, Low Back Pain.  
Statistical test: φ, phi test 
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8.6. GR-SCIM III; relation to pain extent 
Table 8.6.1: Correlations between function and the number of areas with pain 
 Self-care 
subscale 
 
Respiration & 
sphincter 
management 
Mobility 
room & 
toilet 
Mobility 
indoor & 
outdoor 
Total 
SCIM 
 
Statistical Test r=0.08 
p=0.66 
r=-0.009 
p=0.96 
r=0.30 
p=0.09 
r=0.28 
p=0.12 
r=0.17 
p=0.36 
Abbreviations: SCIM, Spinal Cord Independence Measure.  
Statistical test: r, Pearson’s correlation 
 
 
8.7. GR-SCIM III; relation to QoL  
 
 
 
 
 
 
 
 
 
Figure 8.7.1: Scatterplot showing the correlation between function and QoL 
classification (EQ-5D Index) n=31.  
Abbreviations: GR-SCIM, Greek Spinal Cord Independence Measure; EQ-5D, Quality of Life.  
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Figure 8.7.2: Scatterplot showing the correlation between function and QoL 
perception (EQ VAS) n=43.  
Abbreviations: GR-SCIM, Greek Spinal Cord Independence Measure; EQ-VAS, Quality of Life 
Visual Analogue Scale.  
 
8.8. SCIM III; relation to demographic profile characteristics 
Table 8.8.1: Mean function scores and statistical differences in function between 
males and females  
 Males  
n=111, mean±SD, 
median, min-max 
Females  
n=63, mean±SD, 
median, min-max 
Statistical Test 
Self-care subscale 
(range 0-20) 
11.8±5.9  
18, 0-20 
15.3±5.2 
17, 0-20 
t=-0.51, df172, p=0.60 
95% CI -2.23, 1.30 
Respiration & sphincter 
management 
(range 0-40) 
30.0±7.1¹  
31, 11-40 
28.0±7.4  
29, 12-40 
t=1.75, df171, p=0.08 
95% CI -0.24, 4.23 
Mobility room & toilet 
(range 0-10) 
8.0±3.4  
10, 0-10 
8.3±2.9  
10, 0-10 
t=-1019, df172, p=0.23 
95% CI -1.61, 0.39 
Mobility indoor & 
outdoor 
(range 0-30) 
13.9±8.8  
11, 0-30 
12.9±8.0  
14, 0-30 
t=0.74, df172, p=0.45 
95% CI -1.65, 3.65 
Total SCIM 
(range 0-100) 
66.7±20.9¹  
70, 18-100 
64.5±18.7  
67, 18-100 
t=0.69, df171, p=0.48 
95% CI -4.07, 8.50 
¹One outlier eliminated.  
Abbreviations: SCIM, Spinal Cord Independence Measure; SD, Standard Deviation;  
Statistical Test: Independent t-test 
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Table 8.8.2: Mean function and statistical differences of function between males or 
females with and without the pain or LBP  
 Males  
mean±SD,  
Statistical 
test  of 
Total SCIM 
Females  
mean±SD 
Statistical 
test  of 
Total SCIM 
Pain 
  Yes 
   
   No 
 
n=12 
70.5±1.1  
n=12 
70.5±1.1  
 
t=0.56, df32, 
p=0.57, 
95%CI -9.3, 
16.8 
 
n=5 
56.6±21.2  
n=76 
68.3±20.2  
 
U=140.5 
p=0.33 
Current LBP 
  Yes 
   
   No 
 
n=46 
66.0±25.7  
n=83 
69.2±18.5  
 
t=0.81, 
df127, 
p=0.41, 
95%CI -10.9, 
4.5 
 
n=19 
62.9±21.3  
n=58 
69.3±9.6 
 
t=1.2, df75, 
p=0.22, 95%CI   
 -16.9, 4.1 
MSKP 
  Yes 
   
   No 
 
n=43 
71.6±19.4  
n=89 
65.8±22.6  
 
t=1.4, 
df130, 
p=0.15, 
95%CI -13.8, 
2.1 
 
n=32 
65.0±0.7  
n=39 
69.4±20.7 
 
t=10.95, df75, 
p=0.34, 95%CI 
 -4.9, 13.8 
Total SCIM 
(range 0-
100) 
66.7±20.9¹  
70, 18-100 
 64.5±18.7  
67, 18-100 
 
Because of the unexpected result of people with pain, LBP or MSKP reporting slightly  
better, though not significant, function within gender differences were examined.  
No significant differences were found within the male or female groups. Females with  
pain or LBP reported  better function than those without pain or LBP. But, females with  
MSKP reported worse function than those without MSKP. Males with MSKP or LBP  
reported better function than those without MSKP or LBP. However, males with pain in  
general reported worse function than those without pain in general.    
Abbreviations: SCIM, Spinal Cord Independence Measure; LBP, Low Back Pain.  
Statistical tests: U, Mann-Whitney U test; t, Independent t-test. 
 
 
 Appendix 8 
 
193 
Table 8.8.3: Mean function scores and statistical differences in function between 
people divided into groups by cause of injury 
 Traumatic  
n=137, mean±SD, 
median, min-max 
Non traumatic 
n=37, mean±SD, 
median, min-max 
Statistical Tests 
Self-care subscale 
(range 0-20) 
14.6±5.9  
17, 0-20 
16.5±4.2 
18, 2-20 
U=2103.5, p=0.10 
Respiration & sphincter 
management 
(range 0-40) 
29.3±7.4¹  
30, 11-40 
29.6±6.0¹  
29.5, 17-40 
t=-0.25, df170, p=0.79 
95% CI -2.99, 2.30 
 
Mobility room & toilet 
(range 0-10) 
7.8±3.4  
10, 0-10 
8.3±2.5  
10, 0-10 
U=2497.5, p=0.88 
Mobility indoor & 
outdoor 
(range 0-30) 
13.5±8.6  
12, 0-30 
13.4±8.1  
10, 3-30 
t=0.05, df172, p=0.95 
95% CI -3.03, 3.21 
 
Total SCIM 
(range 0-100) 
65.5±21.2¹  
69.5, 18-100 
68.4±14.7¹  
66.5, 40-100 
U=2411.5, p=0.89 
¹One outlier eliminated.  
Abbreviations: SCIM, Spinal Cord Independence Measure.  
Statistical test: t, Independent t-test; U, Mann-Whitney U test.  
 
 
Table 8.8.4: Mean function scores and statistical differences in function between 
people divided into groups by level of injury 
 Tetraplegia 
n=103, mean±SD, 
median, min-max 
Paraplegia  
n=116, mean±SD, 
median, min-max 
Statistical Tests 
Self-care subscale 
(range 0-20) 
12.7±6.6  
15, 0-20 
16.9±3.4¹ 
18, 8-20 
t=-5.92, df216 
p≤0.001*** 
95% CI -5.5 - -2.7 
Respiration & sphincter 
management 
(range 0-40) 
29.7±8.3¹  
30, 11-40 
30.8±6.5  
32, 12-40 
t=-1.12, df216 
p=0.26 
95% CI -3.17, 0.87 
Mobility room & toilet 
(range 0-10) 
7.0±3.8  
9, 0-10 
9.1±1.5  
10, 4-10 
t=-5.35, df212 
p<0.001 
95% CI -2.9, 1.9 
U=4223, p≤0.001*** 
Mobility indoor & 
outdoor 
(range 0-30) 
13.3±9.5  
9, 0-30 
15.8±8.1³  
15.5, 0-30 
t=-2.04, df217 
p=0.04 
95% CI -4.9, 0.09 
Total SCIM 
(range 0-100) 
62.5±25.5  
65, 3-100 
73.4±13.6²  
73, 40-99 
t=-3.97, df214 
p≤0.001*** 
95% CI -16.35, -5.5 
¹Two outlier eliminated, ²Three outliers eliminated, ³Five outliers eliminates, ***Significant at 
p≤0.001 level; In bold: remained significant following application of the Bonferroni correction. 
Abbreviations: SCIM, Spinal Cord Independence Measure; SD, Standard Deviation.  
Statistical tests: t, Independent t-test; U, Mann-Whitney U test.  
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Table 8.8.5: Mean function scores and statistical differences in function between 
people divided into groups by level of injury 
 Cervical  
n=88, 
mean±SD, 
median, min-
max 
Thoracic 
n=57, 
mean±SD, 
median, min-
max 
Lumbar 
n=29, 
mean±SD, 
median, 
min-max 
Statistical Test 
Self-care subscale 
(range 0-20) 
12.8±6.7  
15, 0-20 
17.±3.4  
18, 8-20 
17.6±2.8 
18, 9-20 
H=12.58, df2 
p≤0.001*** 
Respiration & 
sphincter 
management 
(range 0-40) 
29.2±8.1¹  
29, 11-40 
29.4±5.6²  
30, 15-40 
30.2±5.9  
31, 18-40 
H=0.001, df2 
p=0.97 
 
Mobility room & 
toilet 
(range 0-10) 
6.9±3.9  
9, 0-10 
8.8±1.8  
10, 3-10 
9.3±1.3  
10, 6-10 
H=5.99, df2  
p=0.014³ 
 
Mobility indoor & 
outdoor 
(range 0-30) 
12.9±9.7  
9.5, 0-30 
12.9±7.1  
10, 4-30 
16.5±6.6  
17, 6-30 
H=1.13, df2  
p=0.28 
 
Total SCIM 
(range 0-100) 
61.5±25.6  
65.5, 3-100 
68.8±11.9²  
69, 40-96 
73.7±10.6  
73, 53-96 
H=1.36, df2 
p=0.24 
¹One outlier eliminated, ²Two outliers eliminated, 3not significant post Bonferroni correction 
***Significant at p≤0.001 level; In bold: remained significant following application of the 
Bonferroni correction;  
Abbreviations: SCIM, Spinal Cord Independence Measure; SD, Standard Deviation;  
Statistical Test: Kruskall-Wallis H Test. 
 
 
Table 8.8.6: Two group comparisons for total function scores between groups divided 
by level of injury  
  Thoracic Lumbar 
Self-Care 
Cervical 
U=1640.5 
p≤0.001*** 
U=755 
p≤0.001*** 
***Significant at p≤0.001 level,  
in bold: remained significant following Bonferroni post hoc;  
Abbreviations: SCIM, Spinal Cord Independence Measure.  
Statistical test: U, Mann-Whitney U test. 
 Appendix 8 
 
195 
8.9. SCIM III; relation to pain, LBP and MSKP 
Table 8.9.1: Mean function scores reported by people with and without the categories 
of pain 
 Pain  
mean±SD, median,  
min-max 
Current LBP 
mean±SD, median, min-
max 
MSKP 
mean±SD, median,  
min-max 
 Yes  
n=156 
No 
n=9 
Yes  
n=113 
No 
n=55 
Yes  
n=66 
No 
n=106 
Self-care 
subscale 
(range 0-20) 
16.0±4.46  
18, 3-20 
11.3±8.1  
13, 2-20 
15.8±4.4³  
18, 6-20 
14.2±7.1  
18 0-20 
15.6±4.5¹ 
18, 2-20 
15.2±30.6³ 
18, 2-20 
Respiration & 
sphincter 
management 
(range 0-40) 
29.5±7.8¹  
30, 11-40 
 
24.6±10.
1  
24, 13-
40 
 
29.5±7.1  
30, 11-40 
 
28.6±7.7¹  
29, 13-40 
29.4±7.4  
30, 12-40 
29.2±7.2¹  
30, 11-40 
 
Mobility room 
& toilet 
(range 0-10) 
8.0±3.0  
10, 0-10 
5.3±5.1  
8, 0-10 
8.6±2.4 
10, 0-10 
7.2±4.14 
10, 0-10 
 
9.0±2.15  
10, 0-10 
7.6±3.5 
10, 0-10 
Mobility 
indoor & 
outdoor 
(range 0-30) 
13.6±8.4  
11, 0-30 
11.2±10.
7  
7, 2-30 
14.1±8.1  
13.0, 0-30 
12.3±9.3 
8, 2-30 
14.3±8.5  
12, 0-30 
12.9±8.5 
10, 0-30 
 
Total SCIM 
(range 0-100) 
66.5±19²  
69, 18-
100 
52.4±30.
9  
53, 18-
100 
68.0±17.2²  
68.5, 31-
100 
62.3±24.7² 
68, 18-100 
68.0±17.9¹  
70, 29-100 
64.7±21.1¹ 
68, 18-100 
1One outlier eliminated, ²Two outliers eliminated, ³Four outliers eliminated, 4Six outliers  
Eliminated, 5Seven outliers eliminated, 6Nine outliers eliminated.  
Abbreviations: SCIM, Spinal Cord Independence Measure; LBP, Low Back Pain; MSKP, 
Musculoskeletal Pain. 
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8.10. SCIM III; relation to pain/LBP days, free weeks, onset 
Table 8.10.1: Mean function scores in groups divided by the number of pain  
days felt per month 
 1-9 days 
n=28 
mean±SD, 
median, 
min-max 
10-20 day 
n=28 
mean±SD, 
median, min-
max 
21-30 days 
n=19 
mean±SD, 
median, min-
max 
Every day 
n=120 
mean±SD, 
median, min-
max 
Self-care 
subscale 
(range 0-20) 
17.6±4.1  
18.5, 3-20 
13.8±7.2  
18, 0-20 
15.4±6.1 
18, 6-20 
15.0±5.2 
17, 0-20 
Respiration & 
sphincter 
management 
(range 0-40) 
33.4±4.7  
34.5, 23-40 
29.4±9.5  
32, 0-40 
29.2±8.4  
33, 12-40 
28.8±7.0 
29, 11-40 
Mobility room 
& toilet 
(range 0-10) 
9.1±2.5  
10, 0-10 
7.2±4.0  
10, 0-10 
8.1±3.5  
10, 0-10 
8.0±2.9  
10, 0-10 
Mobility indoor 
& outdoor 
(range 0-30) 
14.4±8.4  
11.5, 4-30 
11.6±8.1  
9, 3-30 
10.0±8.0  
7, 0-30 
14.2±8.3 
15, 0-30 
Total SCIM 
(range 0-100) 
74.5±15.7  
76, 30-96 
62.0±25.9  
71, 3-100 
62.7±22.2  
68, 21-100 
66.0±18.8 
67, 23-100 
Table excluded people with no LBP or who did not remember.  
Abbreviations: SCIM, Spinal Cord Independence Measure; SD, Standard Deviation.  
 
Table 8.10.2: Mean function scores in groups divided by the number of LBP  
days felt per month 
 
Table excluded people with no LBP or who did not remember.  
Abbreviations: SCIM, Spinal Cord Independence Measure; SD, Standard Deviation.  
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Table 8.10.3: Correlations between function and the number of pain or LBP days  
felt per month  
 Self-care 
subscale 
 
Respiration & 
sphincter 
management 
Mobility 
room & 
toilet 
Mobility 
indoor & 
outdoor 
Total 
SCIM 
 
Pain days  ρ=-0.11 
p=0.15 
n=195 
ρ=-0.19 
p≤0.01¹ 
n=195 
ρ=-0.08 
p=0.30 
n=195 
ρ=-0.09 
p=0.23 
n=195 
ρ=-0.07 
p=0.36 
n=195 
LBP days ρ=-0.18 
p=0.041 
n=151 
ρ=-0.07 
p=0.40 
n=151 
ρ=-0.15 
p=0.08 
n=151 
ρ=-0.02 
p=0.77 
n=151 
ρ=-0.80 
p=0.37 
n=151 
1not significant post Bonferroni correction;  
Abbreviations: SCIM, Spinal Cord Independence Measure; LBP, Low Back Pain.  
Statistical test: ρ, Spearman’s rank correlation rho. 
 
 
Table 8.10.4: Mean function scores in groups divided by the frequency of pain free 
weeks 
  Yes, most 
time  
n=12 
mean±SD, 
median, 
min-max 
Yes, 
frequently 
n=15 
mean±SD, 
median, 
min-max 
Yes, 
sometimes 
n=17 
mean±SD, 
median, 
min-max 
Yes, but 
not often 
n=12 
mean±SD, 
median, 
min-max 
Yes, but 
rarely  
n=18 
mean±SD, 
median, 
min-max 
No, I 
always 
have pain 
n=70 
mean±SD, 
median, 
min-max 
Self-care 
subscale 
Range 0-20 
16.1±6.8  
19, 1-20 
17.6±2.1  
18, 15-20 
11.6±6.9 
12, 0-20 
19.2±1.0 
19.5, 18-20 
18.8±6.0 
18, 3-20 
14.8±5.3 
16, 0-20 
Respiration 
& sphincter 
management 
Range 0-40 
31.5±7.1  
33, 18-40 
35.0±3.7  
35, 28-40 
28.3±6.6  
30, 15-38 
31.3±6.3 
33, 23-40 
27.5±7.4 
28, 15-40 
28.5±7.7 
29, 0-40 
Mobility 
room & toilet 
Range 0-10 
8.1±3.6  
10, 0-10 
9.7±0.6  
10, 8-10 
6.5±4.3  
18, 0-10 
Constant 8.0±2.9  
9.5, 0-10 
7.9±3.1 
10, 0-10 
Mobility 
indoor & 
outdoor 
Range 0-30 
12.4±8.6  
10, 3-28 
16.1±8.9  
18, 7-30 
9.8±8.7  
7, 0-30 
13.7±3.5 
14, 9-19 
13.5±8.2 
11.5, 3-29 
13.8±8.5 
13, 0-30 
Total SCIM 
Range 0-100 
68.2±22.6  
78, 25-91 
78.4±12.4  
79, 63-100 
56.3±23.8  
60, 18-96 
74.2±7.6 
73, 62-85 
63.9±20.6 
73, 23-86 
65.0±20.1 
66.5, 3-100 
Table excludes people with no pain or who did not remember any pain breaks.  
Abbreviations: SCIM, Spinal Cord Independence Measure; SD, Standard Deviation.  
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Table 8.10.5: Mean function scores in groups divided by the frequency of LBP free 
weeks 
LBP free 
weeks  
 Yes, most 
time  
n=17 
mean±SD, 
median, 
min-max 
Yes, 
frequently 
n=9 
mean±SD, 
median, 
min-max 
Yes, 
sometimes 
n=13 
mean±SD, 
median, 
min-max 
Yes, but 
not often 
n=11 
mean±SD, 
median, 
min-max 
Yes, but 
rarely  
n=24 
mean±SD, 
median, 
min-max 
No, I always 
have pain 
n=45 
mean±SD, 
median, min-
max 
Self-care 
subscale 
Range 0-20 
18.4±2.7  
20, 11-20 
18.0±2.8  
18, 16-20 
14.7±4.6 
15, 8-20 
18.0±1.2 
18, 17-20 
15.4±5.6 
18, 3-20 
14.6±5.0 
4.99, 0-20 
Respiration 
& sphincter 
management 
Range 0-40 
32.4±3.2  
33, 28-38 
34.5±0.7  
34.5, 34-35 
26.1±10.4  
26, 11-40 
28.0±3.5 
29, 23-32 
29.4±7.7 
31.50, 16-
40 
28.1±8.1 
29, 0-40 
Mobility 
room & 
toilet 
Range 0-10 
9.5±0.8  
10, 8-10 
9.6±1.1  
10, 7-10 
9.4±1.3  
10, 7-10 
9.5±1.0  
10, 7-10 
8.1±3.4 
10, 0-10 
8.0±2.8 
9.5, 0-10 
Mobility 
indoor & 
outdoor 
Range 0-30 
12.6±6.6  
10, 7-28 
16.1±8.9  
18, 7-30 
18.0±9.5  
15, 3-30 
15.8±8.7 
13, 8-29 
15.1±7.7 
15.5, 3-30 
14.3±8.6 
13.5, 0-30 
Total SCIM 
Range 0-100 
72.9±9.2  
73, 54-91 
73.5±7.8  
73.5, 68-79 
68.4±22.9  
73, 33-91 
71.2±9.0 
73, 62-82 
68.0±19.9 
74, 27-96 
65.1±19.9 
65.5, 3-100 
Table excludes people with no LBP or who did not remember any LBP breaks.  
Abbreviations: SCIM, Spinal Cord Independence Measure; SD, Standard Deviation.  
 
 
8.11. SCIM III; relation to pain extent 
Table 8.11.1: Correlations between function score and the number of areas with pain 
 Self-care 
subscale 
 
Respiration & 
sphincter 
management 
Mobility 
room & 
toilet 
Mobility 
indoor & 
outdoor 
Total 
SCIM 
 
Statistical test r=-0.14 
p=0.057 
n=142 
r=-0.12 
p=0.10 
n=142 
r=0.01 
p=0.83 
n=142 
r=-0.03 
p=0.66 
n=142 
r=-0.08 
p=0.21 
n=142 
Abbreviations: SCIM, Spinal Cord Independence Measure.  
Statistical test: r, Pearson’s correlation. 
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Appendix 9; Cross-national 
analysis 
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Part 1; 9.a. Demographic profile characteristics and 
pain presence across nations 
 
9.a.1. Bonferroni Correction 
Table 9.a.1.1: Main variables used in analysis of socio-demographic profile of 
respondents in cross-national analysis and alpha value set following Bonferroni 
correction 
Main Variable Tests with following variables Alpha value following 
Bonferroni correction 
Pain (in general) 1) Country                  5) Type of injury           
2) Gender                   6) Time since injury                      
3) Cause of injury       
4) Age                  
0.05/6=0.008 
p≤0.008 
Back pain 1) Country                  5) Type of injury           
2) Gender                   6) Time since injury 
3) Cause of injury                 
4) Age                                   
0.05/6=0.008 
p≤0.008 
Current LBP 1) Country                   5) Age 
2) MSKP                       6) Type of injury           
3) Gender                    7)  Time since injury                     
4) Cause of injury                        
0.05/7=0.007 
p≤0.007 
Lifetime LBP (post 
iSCI) 
1) Country                5) Age 
2) MSKP                    6) Type of injury           
3) Gender                 7)  Time since injury                     
4) Cause of injury                        
0.05/7=0.007 
p≤0.007 
LBP over last 1 
month 
1) Country                 5) Age 
2) MSKP                     6) Type of injury           
3) Gender                  7)  Time since injury                     
4) Cause of injury                        
0.05/7=0.007 
p≤0.007 
LBP over last 3 
months 
1) Country                  5) Age 
2) MSKP                      6) Type of injury           
3) Gender                   7)  Time since injury                     
4) Cause of injury                        
0.05/7=0.007 
p≤0.007 
MSKP  1) Country                  4) Age 
2) Gender                   5) Type of injury           
3) Cause of injury      6)  Time since injury                                            
0.05/6=0.008 
p≤0.008 
Abbreviations: LBP, Low Back Pain; iSCI, incomplete Spinal Cord Injury; MSKP, Musculoskeletal 
Pain;  
USA, United Stated of America; UK, United Kingdom 
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9.a.2. Demographic profile characteristics  
Table 9.a.2.1: General demographic profile characteristics of respondents across nations. Differences between groups  
 
¹ For the Greek language, 2not significant post Bonferroni correction; ***Significant at p≤0.001 level, in bold: significant following application of the 
Bonferroni correction or post hoc analysis; Statistical tests: χ², Chi square; H, Kruskal-Wallis H test; U, Mann-Whitney U test 
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Table 9.a.2.2: General demographic profile characteristics of respondents across nations. Differences between groups 
 Mean ± SD, % or min-max Statistical tests  Two group and post hoc analysis 
 USA UK GR   
Education (%)  
   PhD or equivalent 
    Master’s      
   Bachelors Degree 
   College or equivalent 
    High School 
    Other 
    No diploma/degree 
In two categories  
  Below High School 
  Above High School 
n=121 
4.9 
15.6  
18 
26.2 
29.5 
4.9 
.8 
 
29.5 
70.5 
n=50 
2 
16  
22 
28 
10 
6 
16 
 
10 
90 
n=44 
0.0 
6.8  
31.8 
2.3 
25 
34.1 
0.0 
 
25 
75 
χ²=58.8,df12,p≤0.001*** 
χ²=3.57,df2,p=0.059 
χ²=13.4,df2,p≤0.001*** 
χ²=4.12,df2,p=0.12 
χ²=30.9,df2,p≤0.001*** 
χ²=31.1,df2,p≤0.001*** 
χ²=12.2,df2,p=0.021 
χ²=1.0,df2,p=0.31 
χ²=7.41,df12,p=0.021 
 
 
 
 
 
 
 
 
 
Above vs Below highschool 
UK vs GR χ²=3.72, p=0.053 
UK vs USA χ²=7.43, p=0.006** 
USA vs GR χ²=0.32, p=0.56 
Cause of injury (%) 
  Traumatic 
  Non-traumatic 
n=122 
77.9 
22.1 
n=52 
80.8 
19.2 
n=45 
40 
60 
χ²=26.08,df2,p<0.001**** 
 
UK vs GR χ²=16.9, p≤0.001*** 
UK vs USA χ²=0.18, p=0.66 
USA vs GR χ²=21.5, p≤0.001*** 
Type of injury (%) 
  Incomplete tetraplegia 
  Incomplete paraplegia 
n=122 
52.5 
47.5 
n=52 
46.2 
53.8 
n=45 
33.3 
66.7 
χ²=4.84,df2,p=0.08 
 
 
Level of injury (%) 
  Cervical 
  Thoracic 
  Lumbar 
n=122 
52.5 
32 
15.6 
n=52 
46.2 
36.5 
17.3 
n=45 
33.3 
35.6 
31.1 
χ²=7.10,df4,p=0.13 
 
 
1not significant post Bonferroni correction; **Significant at p≤0.01 level, ***Significant at p≤0.001 level, in bold: significant following application of the 
Bonferroni correction or post hoc analysis;  
Abbreviation: PhD, Doctor of Philosophy. Statistical test: χ², extended or Pearson’s chi square 
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Table 9.a.2.3: General demographic profile characteristics of respondents across nations. Differences between groups 
 
1not significant post Bonferroni correction; 2Total sums to greater than 100% because respondents were allowed to choose more than one option; 
*Significant at p≤0.05 level, **Significant at p≤0.01 level, ***Significant at p≤0.001 level, in bold: significant following application of the Bonferroni 
correction or post hoc analysis, 1not significant post Bonferroni correction; Abbreviations: iSCI, incomplete Spinal Cord Injury. Statistical tests: χ², 
extended or Pearson’s Chi square. 
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Table 9.a.2.4: Cause of traumatic injury for respondents across nations. Differences between groups 
 
**Significant at p≤0.01 level, ***Significant at p≤0.001 level; in bold: significant following application of the Bonferroni correction or post hoc analysis. 
Statistical tests: χ², extended or Pearson’s chi square. 
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Table 9.a.2.5: Cause of traumatic injury for respondents across nations. Differences between groups 
 
1not significant post Bonferroni correction; *Significant at p≤0.05 level, **Significant at p≤0.01 level; in bold: significant following application of the 
Bonferroni correction or post hoc analysis;  1not significant post Bonferroni correction; Statistical tests: χ², extended or Pearson’s chi square.  
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Table 9.a.2.6: General demographic profile characteristics of participants across nations 
 
Abbreviation: iSCI, incomplete Spinal Cord Injury
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9.a.3: Pain, MSKP and LBP; relation to demographic profile characteristics 
Table 9.a.3.1: Presence of pain catagories, within each national group, divided by gender  
 Total group Only people with pain 
USA 
% 
UK 
% 
GR 
% 
USA 
% 
UK 
% 
GR 
% 
Pain in 
general 
Male 
Female 
93, n=81 
95.1, n=41 
96.7, n=30 
95.5, n=22 
73.9, n=23 
88.9, n=18 
n/a n/a n/a 
MSKP Male 
Female 
32.1, n=81 
46.2, n=39 
36.7, n=30 
50, n=22 
28.6, n=21 
52.9, n=17 
34.2, n=76 
48.6, n=37 
37.9, n=29 
52.4, n=21 
40, n=15 
60, n=15 
Back pain Male 
Female 
76.5, n=81 
79.5, n=39 
73.3, n=30 
81.8, n=22 
71.4, n=21 
88.2, n=17 
76.5, n=81 
79.5, n=39 
73.3, n=30 
81.8, n=22 
71.4, n=21 
88.2, n=17 
LBP 
lifetime 
Male 
Female 
70.4, n=81 
78, n=41 
70, n=30 
81.8, n=22 
65.2, n=23 
88.9, n=18 
70.4, n=81 
78, n=41 
70, n=30 
81.8, n=22 
65.2, n=23 
88.9, n=18 
LBP 
current 
Male 
Female 
76.5, n=81 
79.5, n=39 
73.3, n=30 
81.8, n=22 
71.4, n=21 
88.2, n=17 
64.6, n=79 
68.4, n=38 
65.5, n=29 
77.3, n=22 
63.6, n=22 
82.4, n=17 
LBP over 1 
month 
Male 
Female 
63.8, n=81 
68.4, n=38 
65.5, n=29 
81.8, n=22 
63.6, n=22 
88.2, n=17 
63.8, n=81 
68.4, n=38 
65.5, n=29 
81.8, n=22 
63.6, n=22 
88.2, n=17 
LBP over 3 
months 
Male 
Female 
66.3, n=80 
73, n=37 
65.5, n=29 
81.8, n=22 
63.9, n=22 
88.2, n=17 
66.3, n=80 
73, n=37 
65.5, n=29 
81.8, n=22 
63.9, n=22 
88.2, n=17 
Abbreviations: MSKP, Musculoskeletal Pain; LBP, Low Back Pain 
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Table 9.a.3.2: Presence of pain categories, within each national group, divided by cause of injury 
 Total group Only people with pain 
USA 
% 
UK 
% 
GR 
% 
USA 
% 
UK 
% 
GR 
% 
Pain in 
general 
Traumatic 
Non-Traumatic 
92.6, n=95 
100, n=27 
95.2, n=42 
100, n=10 
72.2, n=18 
81.5, n=27 
n/a n/a n/a 
MSKP Traumatic 
Non-Traumatic 
31.2, n=93 
55.6, n=27 
42.9, n=42 
40, n=10 
26.7, n=15 
48.1, n=27 
33.7, n=86 
55.6, n=27 
45, n=40 
40, n=10 
40, n=10 
59.1, n=22 
Back pain Traumatic 
Non-Traumatic 
73.1, n=93 
92.6, n=27 
78.6, n=42 
70, n=10 
66.7, n=15 
81.5, n=27 
79.1, n=86 
92.6, n=27 
82.5, n=40 
70, n=10 
100, n=10 
100, n=22 
LBP 
lifetime 
Traumatic 
Non-Traumatic 
68.4, n=95 
88.9, n=27 
76.2, n=42 
70, n=10 
61.1, n=18 
81.5, n=27 
73.9, n=88 
88.9, n=27 
80, n=40 
70, n=10 
84.6, n=13 
100, n=22 
LBP 
current 
Traumatic 
Non-Traumatic 
61.1, n=90 
81.5, n=27 
70.7, n=41 
70, n=10 
56.3, n=16 
77.8, n=27 
66.3, n=83 
81.5, n=27 
74.4, n=39 
70, n=10 
81.8, n=11 
95.5, n=22 
LBP over 1 
month 
Traumatic 
Non-Traumatic 
61.5, n=91 
77.8, n=27 
73.2, n=41 
70, n=10 
56.3, n=16 
81.5, n=27 
66.7, n=84 
77.8, n=27 
76.9, n=39 
70, n=10 
81.8, n=11 
100, n=22 
LBP over 3 
months 
Traumatic 
Non-Traumatic 
64.4, n=90 
81.5, n=27 
73.2, n=41 
70, n=10 
56.3, n=16 
81.5, n=27 
69.9, n=83 
81.5, n=27 
76.9, n=39 
70, n=10 
81.8, n=11 
100, n=22 
Abbreviations: MSKP, Musculoskeletal Pain; LBP, Low Back Pain 
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Table 9.a.3.3: Presence of the pain categories, within each national group, divided by level of injury  
 Total group Only people with pain 
USA 
% 
UK 
% 
GR 
% 
USA 
% 
UK 
% 
GR 
% 
Pain in 
general 
Tetraplegia 
Paraplegia 
89.1, n=64 
100, n=58 
91.7, n=24 
100, n=28 
73.3, n=15 
80, n=30 
n/a n/a n/a 
MSKP Tetraplegia 
Paraplegia 
30.2, n=63 
43.9, n=57 
33.3, n=24 
50, n=28 
46.2, n=13 
37.9, n=29 
33.9, n=56 
43.9, n=57 
36.4, n=22 
50, n=28 
66.7, n=9 
47.8, n=23 
Back pain Tetraplegia 
Paraplegia 
68.3, n=63 
87.7, n=57 
62.5, n=24 
89.3, n=28 
69.2, n=13 
79.3, n=29 
76.8, n=56 
87.7, n=57 
68.2, n=22 
89.3, n=28 
100, n=9 
100, n=23 
LBP 
lifetime 
Tetraplegia 
Paraplegia 
62.5, n=64 
84.5, n=58 
62.5, n=24 
85.7, n=28 
60, n=15 
80, n=30 
70.2, n=57 
84.5, n=58 
68.2, n=22 
85.7, n=28 
81.8, n=11 
100, n=24 
LBP 
current 
Tetraplegia 
Paraplegia 
55.7, n=61 
76.8, n=56 
60.9, n=23 
78.6, n=28 
57.1, n=14 
75.9, n=29 
63, n=54 
76.8, n=56 
66.7, n=21 
78.6, n=28 
80, n=10 
95.7, n=23 
LBP over 1 
month 
Tetraplegia 
Paraplegia 
58.1, n=62 
73.2, n=56 
56.5, n=23 
85.7, n=28 
57.1, n=14 
79.3, n=29 
65.5, n=55 
73.2, n=56 
61.9, n=21 
85.7, n=28 
80, n=10 
100, n=23 
LBP over 3 
months 
Tetraplegia 
Paraplegia 
58.1, n=62 
80, n=55 
56.5, n=23 
85.7, n=28 
57.1, n=14 
79.3, n=29 
65.5, n=55 
80, n=55 
61.9, n=21 
85.7, n=28 
80, n=10 
100, n=23 
Abbreviations: MSKP, Musculoskeletal Pain; LBP, Low Back Pain
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Table 9.a.3.4: Two-group differences between national groups  
differences in the proportion of pain reported by males and females 
  Greece 
  Males Female 
USA Male Fisher’s, p≤0.01*  
n=104 
 
Females  Fisher’s, p=0.57 
n=59 
UK Males Fisher’s, p=0.03*  
n=53 
 
Females  Fisher’s, p=0.57 
n=40 
 *Significant at p≤0.05 level;  
Statistical test: Fisher’s exact 
 
 
Table 9.a.3.5: Two-group differences between national groups  
differences in the proportion of pain reported by people divided  
into groups by cause of injury 
  Greece 
  Traumatic Non traumatic 
USA Traumatic Fisher’s, p=0.02*  
n=113 
 
Non traumatic  Fisher’s, p=0.01* 
n=54  
UK Traumatic Fisher’s, p=0.02*  
n=60 
 
Non traumatic  Fisher’s, p=0.29 
n=37 
 *Significant at p≤0.05 level;  
Statistical test: Fisher’s exact 
 
Table 9.a.3.6: Two-group differences, between national groups,  
in the proportion of pain reported by people divided into groups  
by level of injury 
  Greece 
  Tetraplegia Paraplegia 
UK Tetraplegia Fisher’s, p=0.180 
n=39 
 
Paraplegia  Fisher’s, p=0.024*  
n=58 
USA Tetraplegia Fisher’s, p=0.20 
n=79 
 
Paraplegia  Fisher’s, p≤0.001* 
n=88 
*Significant at p≤0.05 level, ***Significant at p≤0.001 level; 
Statistical test: Fisher’s exact 
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Table 9.a.3.7: Percentage of category of pain, within each national group, reported  
by people divided in groups by level of injury  
 USA  
Total n, % 
UK  
Total n, % 
GR  
Total n % 
Pain in 
general 
Cervical n=64         89.1  
Thoracic n=38         100  
Lumbar  n=20         100  
Cervical n=24         91.7  
Thoracic n=19         100  
Lumbar n=9             100  
Cervical n=15            73.3  
Thoracic n=16           68.8  
Lumbar n=14            92.9  
MSKP Cervical n=63        30.2  
Thoracic n=38       13.9  
Lumbar  n=19        47.4  
Cervical n=24         33.3  
Thoracic n=19        52.6  
Lumbar n=9           44.4  
Cervical n=13            46.2  
Thoracic n=15             6.7  
Lumbar n=14            71.4  
Back pain Cervical n=63         61.9  
Thoracic n=38        81.6  
Lumbar n=19         94.7  
Cervical n=24         62.5  
Thoracic n=19        84.2  
Lumbar n=9           88.9  
Cervical n=13            69.2  
Thoracic n=15           66.7  
Lumbar n=14            92.9  
LBP 
lifetime 
Cervical  n=64        62.5  
Thoracic n=38        78.9  
Lumbar  n=20           95  
Cervical n=24         62.5  
Thoracic n=19        84.2  
Lumbar n=9           88.9  
Cervical n=15               60  
Thoracic n=16           68.8  
Lumbar n=14            92.9  
LBP 
current 
Cervical n=61         57.7  
Thoracic n=38        78.9  
Lumbar n=18         72.2  
Cervical n=23         60.9  
Thoracic n=19        73.7  
Lumbar n=9           88.9  
Cervical n=13           53.8  
Thoracic n=16          68.8  
Lumbar n=14            85.7  
LBP over 1 
month 
Cervical  n=62        58.1  
Thoracic n=38        73.7  
Lumbar n=18         72.2  
Cervical n=23         56.5  
Thoracic n=19        84.2  
Lumbar n=9           88.9  
Cervical n=14            57.1  
Thoracic n=15           66.7  
Lumbar n=14            92.9  
LBP over 3 
months 
Cervical  n=60        56.7  
Thoracic n=38        78.9  
Lumbar n=17         82.4  
Cervical n=23         56.5  
Thoracic n=19        84.2  
Lumbar n=9           88.9  
Cervical n=14            57.1  
Thoracic n=15           66.7  
Lumbar n=14            87.5  
It is found that the lower the level of injury the higher the percentage of the pain  
categories reported across nations. There seems to be a wided differences in the reported  
cases of MSKP, between Greeks with different levels of injury. Indeed a significant difference 
was foundwithin the Greek group (Table 9.a.3.8).  
Abbreviations: MSKP, Musculoskeletal Pain; LBP, Low Back Pain 
 
Table 9.a.3.8: Within national group differences in the proportion of MSKP  
in groups divided by level of injury 
 Statistical Tests Cervical and 
Thoracic 
Cervical and 
Lumbar 
Thoracic and 
Lumbar 
UK p=0.44, χ2=2.57, df2    
USA p=0.22, χ2=1.638, df2    
Greece p=0.002** 
χ2=12.85, df2 
Fisher’s exact 
p=0.029 
p=0.182 
χ2=1.78, df1 
p≤0.001*** 
χ2=12.9, df1 
**Significant at p≤0.01 level, ***Significant at p≤0.001 level,  
in bold: remained significant following application of the Bonferroni correction;  
Abbreviations: MSKP, Musculoskeletal Pain.  
Statistical Tests: χ²=,Independent Chi-square 
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Table 9.a.3.9: Mean age of people with and without the presence of pain across nations  
 Total group 
USA 
mean±SD 
min-max, n 
UK 
mean±SD 
min-max, n 
GR 
mean±SD 
min-max, n 
 USA 
mean±SD 
min-max, n 
UK 
mean±SD 
min-max, n 
GR 
mean±SD 
min-max, n 
Pain in 
general 
Yes 
 
 
No 
45.8±10.8 
19.8-66.8,  
n=109 
41.9±10.4  
29.3-59.3, 
 n=7 
50.7±13.1  
26.1-73.2,  
n=48 
54.2±15.1  
43.5-64.9,  
n=2 
62.6±18.1  
26.5-91.7,  
n=35 
59.5±15.8  
37.5-79.7,  
n=10 
LBP 
current 
Yes 
 
 
No 
45.9±10.5 
19.8-40.7,  
n=73 
45.1±11.4  
26.9-66.8,  
n=38 
49.2±13.8  
26.1-73.2,  
n=36 
55.3±10.0  
39.1-70,  
n=13 
66.3±15.3  
30.9-91.7,  
n=29¹ 
56.7±15.6  
37.5-80.2,  
n=13 
MSKP Yes 
 
 
No 
46.4±10.2  
23.0-66.8,  
n=42 
43.3±111.1  
19.8-65.3,  
n=72 
45.7±13.1  
26.1-62.2,  
n=22  
56.0±10.4  
36.3-73.2,  
n=27¹ 
71.3±15.1  
38.4-91.7,  
n=17² 
61.4±12.8  
37.5-81.1,  
n=23 
LBP over 
1 month 
Yes 
 
 
No 
46.1±10.5  
19.8-60.5,  
n=74 
45.1±11.4  
26.9-66.8,  
n=38 
49.4±13.7  
26.1-73.2,  
n=37 
55.2±10.3  
39.1-70,  
n=12 
68.1±13.9  
37.6-91.7,  
n=29 
57.9±15.0  
37.5-79.9,  
n=12² 
Back pain Yes 
 
 
No 
45.4±10.4  
19.8-60.5,  
n=88 
46.8±41.9  
26.9-66.8,  
n=26 
49.5±13.4  
26.1-73.2,  
n=40 
54.5±11.7  
39.1-70,  
n=10 
67.6±13.8  
37.6-91.7,  
n=30 
59.5±15.6  
37.5-79.9,  
n=10 
LBP over 
3 months 
Yes 
 
 
No 
45.6±10.5  
19.8-60.5,  
n=76 
46.0±11.5  
26.9-66.8,  
n=36 
49.4±13.7  
26.1-73.2,  
n=37 
55.2±10.3  
39.1-70,  
n=12 
68.0±13.9  
37.6-91.7,  
n=29 
57.9±15.0  
37.5-79.9,  
n=12 
LBP 
lifetime 
Yes 
 
 
No 
45.3±10.3  
19.8-60.5,  
n=84 
46.2±11.9  
26.9-66.8,  
n=32 
49.6±13.4  
26.1-73.2,  
n=39 
55.2±10.8  
39.1-70,  
n=11 
64.9±17.3  
29.9-91.7,  
n=32¹ 
57.9±37.5  
37.5-79.9,  
n=12 
     
¹One outlier eliminated, ²Two outliers eliminated. When people without pain in general were excluded from this table the mean, SD, and range of the 
reported categories of pain did not change; Abbreviations: MSKP, Musculoskeletal Pain; LBP, Low Back Pain; SD, Standard Deviation 
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Table 9.a.3.10: Mean time since injury of people with and without presence of pain across nations  
 Total group 
USA 
mean±SD 
min-max, n 
UK 
mean±SD 
min-max, n 
GR 
mean±SD 
min-max, n 
  USA 
mean±SD 
min-max, n 
UK 
mean±SD 
min-max, n 
GR 
mean±SD 
min-max, n 
Pain in 
general 
Yes 
 
 
No 
9.7±9.4 
0.3-35.8,  
n=110³ 
7.1±5.8  
1.6-16.9,  
n=6¹ 
13.4±11.9  
0.9-43.8,  
n=50 
25.3±2.9  
23.2-27.4,  
n=2 
11.6±8.8  
1.4-34.3,  
n=35 
8.8±4.3  
1.5-14.1,  
n=10 
LBP 
current 
Yes 
 
 
No 
9.9±10.2  
0.3-35.8,  
n=74 
10.1±8.3  
0.5-29.7,  
n=38 
14.0±12.0  
0.9-43.8,  
n=36 
13.8±10.1  
1.1-28.4,  
n=15 
11.1±8.1  
1.4-31.0,  
n=30 
11.4±8.6  
1.5-34.3,  
n=13 
MSKP Yes 
 
 
No 
11.0±9.3  
0.3-35.6,  
n=43¹ 
8.8±9.0  
0.3-31.9,  
n=71³ 
13.5±11.8  
0.9-43.2,  
n=22  
14.5±12.0  
0.9-43.8, 
 n=29 
13.8±9.3  
2.4-34.3,  
n=17 
8.5±5.1  
1.4-20.7,  
n=22¹ 
LBP over 
1 month 
Yes 
 
 
No 
10.0±10.1  
0.3-35.8,  
n=74² 
9.6±8.3  
0.5-29.7,  
n=39² 
14.3±13.0  
0.9-43.8,  
n=37 
13.0±9.3  
1.1-27.4,  
n=14 
10.8±8.1  
1.4-31.0,  
n=31 
11.9±8.8  
1.5-34.3,  
n=12 
Back pain Yes 
 
 
No 
9.9±9.6  
0.-35.8,  
n=89¹ 
9.7±9.9  
0.4-29.7,  
n=26 
13.7±12.6  
0.9-43.8,  
n=40 
14.1±9.6  
1.1-27.4,  
n=12 
11.6±8.9  
1.4-34.3,  
n=32 
10.5±2.3  
7.6-14.1,  
n=8¹ 
LBP over 
3 months 
Yes 
 
 
No 
9.5±9.6  
0.3-35.8,  
n=77² 
12.4±11.3  
0.5-41.7,  
n=37 
14.3±13.0  
0.9-43.0,  
n=37 
13.0±9.3  
1.1-27.4,  
n=14 
10.8±8.1  
1.4-31.0,  
n=31 
11.9±8.8  
1.5-34.3,  
n=31 
LBP 
lifetime 
Yes 
 
 
No 
9.8±9.8  
0.3-35.8,  
n=85² 
9.6±8.4  
0.5-29.7,  
n=32¹ 
13.9±12.7  
0.9-43.8,  
n=39¹ 
13.6±27.4  
1.1-27.4,  
n=13 
10.0±7.1  
1.4-26.0,  
n=32 
11.9±8.8  
1.5-34.3,  
n=12 
     
¹One outlier eliminated, ²Two outliers eliminated, ³Four outliers eliminated. Abbreviations: MSKP, Musculoskeletal Pain; LBP, Low Back  
Pain; SD, Standard Deviation 
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Table 9.a.3.11: Two-group differences in the time since injury in groups divided  
by the presence of the pain categories 
  UK UK 
  Yes (pain category) No (pain category) 
USA 
Pain in general t=-1.3, df162, p=0.19 
95% CI -6.2, 1.2 
t=-1.99, df7, p=0.08 
95% CI -32.6, 2.7 
Back pain t=-1.26, df130, p=0.20 
95% CI -7.1, 1.5 
t=-0.88, df37, p=0.3 
95% CI -10.5, 4.1 
MSKP t=-0.67, df64, p=0.5 
95% CI -7.4, 3.7 
t=-1.55, df102, p=0.1 
95% CI -8.9, 1.0 
LBP lifetime t=-1.3, df135, p=0.19 
95% CI -7.4, 1.5 
t=-0.95, df44, p=0.34 
95% CI -9.5, 3.3 
LBP current t=-1.3, df110, p=0.18 
95% CI -7.9, 1.5 
t=-0.70, df53, p=0.48 
95% CI -8.4, 4.0 
LBP last 1 month t=-1.4, df111, p=0.16 
95% CI -8.0, 1.3 
t=-0.60, df53, p=0.54 
95% CI -8.2, 4.4 
LBP last 3 months t=-2.1, df112, p=0.03* 
95% CI -9.0, -0.4 
t=-0.17, df49, p=0.86 
95% CI -7.4, 6.2 
Greece 
Pain in general U=8.63 , p=0.91 U=0.00 , p=0.03* 
Back pain t=-0.07, df37, p=0.93 
95% CI -7.3, 6.8 
U=48.0  
p=0.42 
MSKP U=624.0 
p=0.85 
t=2.04, df52, p=0.04* 
95% CI -17.6, 7.8 
LBP lifetime U=605.0  
P=0.66 
t=0.47, df23, p=0.64 
95% CI -5.8, 9.2 
LBP current U=521.0  
p=0.8 
t=0.67, df26, p=0.5 
95% CI -4.9, 9.7 
LBP last 1 month U=536.0  
p=0.64 
t=0.31, df24, p=0.75 
95% CI -6.2, 8.0 
LBP last 3 months U=536.0  
p=0.64 
t=0.31, df24, p=0.75 
95% CI -6.2, 8.4 
*Significant at p≤0.05 level;  
Abbreviations: MSKP, Musculoskeletal Pain; LBP, Low Back Pain;  
Statistical tests: t, Independent t-test; U, Mann-Whitney U Test 
 
Appendix 9 
 
215 
9.a.4. Pain and LBP: relation to pain/LBP days, free periods, onset 
Table 9.a.4.1: Percentage of people reporting the number of pain and LBP days  
felt per month across nations 
Average pain days per 
month 
Pain in general 
% 
LBP 
% 
UK 
n=50 
USA n=113 Greece 
n=32 
UK 
n=37 
USA 
n=87 
Greece 
n=32 
1-9 days per month 8.0 10.6 37.5 21.6 24.1 37.5 
10-20 days per month 6.0 14.2 28.1 8.1 17.2 31.3 
21-30 days per month 8.0 9.7 12.5 10.8 10.3 15.6 
Have pain every day 78 65.5 21.9 59.5 48.3 15.6 
Abbreviation: LBP, Low Back Pain 
 
Table 9.a.4.2: Percentage of people reporting the number of pain days  
felt per month, within each national group, divided in groups by the  
presence of MSKP 
Average pain 
days per 
month 
USA with 
MSKP 
(%) 
USA no 
MSKP 
(%) 
UK with 
MSKP 
(%) 
UK no 
MSKP 
(%) 
Greece 
with MSKP 
(%) 
Greece 
no MSKP 
(%) 
1-9 days per 
month 
42.9 57.1 9.5 0 18.8 57.1 
10-20 days 
per month  
36.4 63.6 4.8 0 43.8 7.1 
21-30 days 
per month 
30 70 9.5 6.3 12.5 14.3 
Have pain 
every day 
49.1 50.9 76.2 93.8 25 21.4 
Statistical 
Test 
χ²=1.7, df6 
p=0.94, n=113 
χ²=4.8, df5 
p=0.43, n=49 
χ²=10.6, df6 
p=0.09, n=32 
Abbreviations: MSKP, Musculoskeletal Pain;   
Statistical test: χ², Chi-Square 
 
Table 9.a.4.3: Percentage of pain and LBP free weeks (since onset of pain/LBP) 
reported by people across nations 
 Pain in general  
(%) 
LBP  
(%) 
UK 
n=48 
USA 
n=105 
Greece 
n=32 
UK 
n=29 
USA 
n=64 
Greece 
n=30 
Yes, most of the time 8.3 6.7 18.8 6.9 14.1 20 
Yes frequently 4.2 8.6 21.9 6.9 0 23.3 
Yes, sometimes 8.3 8.6 21.9 6.9 7.8 23.3 
Yes, but not very often 6.3 2.9 21.9 6.9 4.7 20 
Yes, but rarely 10.4 14.3 31 20.7 25 6.7 
No, I always have pain 62.5 59 12.5 51.7 48.8 6.7 
Abbreviation: LBP, Low Back Pain 
 
Appendix 9 
 
216 
Table 9.a.4.4: Percentage of people reporting onset of pain and LBP post iSCI across 
nations 
Time of pain Onset Pain in general  
(%) 
LBP  
(%) 
 UK 
n=46 
USA 
n=108 
Greece 
n=33 
UK 
n=34 
USA 
n=77 
Greece 
n=31 
Immediately after iSCI  41.3 46.3 27.3 35.3 35.1 25.8 
Within 1st month of iSCI  21.7 19.4 15.2 17.6 14.3 16.1 
Between 1-6 months of iSCI  13.0 17.6 39.4 8.8 19.5 29.0 
Between 6 months & 1 year of 
iSCI 
8.7 4.6 9.1 2.9 9.1 19.4 
After 1 year of iSCI 15.2 12 9.1 35.3 22.1 9.7 
Abbreviation: iSCI, incomplete Spinal Cord Injury; LBP, Low Back Pain 
 
Table 9.a.4.5: Differences in LBP onset post iSCI per cause of injury of groups from  
the three countries 
 Onset 
immediately 
after iSCI 
Statistical 
Test 
Onset any 
other time 
post iSCI 
Statistical Test 
USA   Traumatic 
      Non-traumatic 
27.6%, n=16 
57.9%, n=11 
χ²=0.92  
p=0.33 
72.4%, n=42 
42.1%, n=8 
χ²=23.1 
p≤0.001*** 
UK     Traumatic 
      Non-traumatic 
37%, n=10 
28.6, n=2 
χ²=5.33  
p=0.02¹ 
63%, n=17 
71.4%, n=5 
χ²=6.54 
p=0.0011** 
Greece  Traumatic 
      Non-traumatic 
10%, n=1 
90%, n=7 
χ²=4.500  
p=0.03¹ 
33%, n=9 
66.7%, n=14 
χ²=1.08 
p=0.29 
1not significant post Bonferroni correction; **Significant at p≤0.01 level, ***Significant at 
p≤0.001 level;  in bold: significant following application of the Bonferroni correction;  
Abbreviation: iSCI, incomplete Spinal Cord Injury.  
Statistical test: χ², Chi-Square. 
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9.b. Pain extent and LBP experience across nations  
9.b.1. Bonferroni Correction 
Table 9.b.1.1: Main variables used in analysis of MPQ for cross-national and alpha 
value set following Bonferroni correction 
Main Variables Each main variable tested with the 
following variables 
Alpha value following 
Bonferroni correction 
S-PRI 
A-PRI 
T-PRI 
Intensity of current LBP 
Intensity of LBP over 1 
month 
Intensity of LBP over 3 
months 
PPI of LBP 
1) Country                         9) Pain days 
2) Gender                         10) LBP days 
3) Cause of injury            11) Pain free weeks 
4) Age                                12) LBP free weeks 
5) Type of injury               13) Pain onset 
6) Time since injury         14) LBP onset 
 7) With age            
8) Areas with pain  
                                                   
0.05/14=0.0035 
p≤0.0035 
Abbreviations: EQ-5D index, Quality of Life index; EQ-VAS, Quality of Life Visual Analogue 
Scale; MSKP, Musculoskeletal Pain; LBP, Low Back Pain; PRI, Present Rating Index 
 
 
9.b.2. Pain extent; general results 
Table 9.b.2.1: Mean number of areas with pain across nations. Difference in the 
number of areas with pain between nations 
Areas of pain on the 
body 
USA 
(%) 
 
UK 
(%) 
 
GR 
(%) 
 
Between countries 
differences 
Extended χ², p value 
n=190 
Head 2.7 n=3 2.1 n=1 3.1 n=1 χ²=0.09, df2, p=0.95 
Neck & shoulder 38.2 n=44 43.8 n=21 21.9 n=7 χ²=4.15, df2, p=0.12 
Upper extremities 16.4 n=18 31.3 n=15 9.4 n=3 χ²=7.11, df2,p=0.02¹  
Frontal torso & genitals 28.2 n=31 29.2 n=14 3.1 n=1 χ²=9.43, df2, p=0.09 
Upper back 18.2 n=20 12.5 n=6 28.1 n=9 χ²=3.12, df2, p=0.20 
Lower back 76.4 n=84 79.2 n=38 93.8 n=30 χ²=4.7, df2, p=0.09 
Buttocks 47.3 n=52 47.9 n=23 46.9 n=15 χ²=0.009, df2,p=0.99 
Thighs 51.8 n=57 60.4 n=29 68.6 n=22 χ²=3.23, df2, p=0.19 
Legs & feet 49.1 n=54 64.6 n=31 43.8 n=14 χ²=4.29, df2, p=0.11 
Mean, median of total 9 
areas 
Mean 3.29 
Median 3 
Mean 3.71 
Median 4 
Mean 3.19 
Median 3 
χ²=4.07, df2, p=0.13 
1not significant post Bonferroni correction; Statistical tests: χ², extended Chi-Square 
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Figure 9.b.2.1: Description of pain at the back area reported across nations   
 
  
 
Figure 9.b.2.2: Description of pain at the buttocks reported across nations 
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9.b.3. Pain extent; relation to LBP and MSKP 
Table 9.b.3.1: Mean number of areas with pain, within each national group, divided  
in groups by the presence of LBP or MSKP  
 USA UK Greece 
Yes 
mean±S 
min-max 
No 
mean±SD 
min-max 
Yes 
mean±SD 
min-max 
No 
mean±SD 
min-max 
Yes 
mean±SD 
min-max 
No 
mean±SD 
min-max 
Lifetime LBP 
 
3.8±1.7  
1-9, n=84 
1.6±0.7  
1-3, n=26 
3.9±1.5  
1-7, n=38 
2.8±1.1  
1-5, n=10¹ 
3.6±1.7  
2-9, n=16¹ 
2.6±1.1  
1-4, n=14 
Current LBP 3.8±1.8  
1-9, n=75 
1.7±1.1  
1-6, n=29 
3.9±1.6  
1-7, n=35 
2.9±1.1  
1-5, n=12 
3.3±1.6  
1-9, n=30¹ 
2.0±1.4  
1-3, n=2 
LBP presence 
over last 1 
month 
3.8±1.8  
1-9, n=75 
2.1±1.4  
1-6, n=34 
3.9±1.5  
1-7, n=36 
2.6±0.8  
1-4, n=10¹ 
3.1±1.2  
1-6,n=28 
2.3±1.1  
1-3, n=3 
LBP presence 
over last 3 
months 
3.8±1.8  
1-9, n=76 
1.8±1.3  
1-6, n=29¹ 
3.9±1.5  
1-7,n=36 
2.6±0.8  
1-4, n=10¹ 
3.1±1.2  
1-6, n=29¹ 
2.0±1.4  
1-3, n=2 
MSKP 4.0±1.8  
1-8, n=43¹ 
2.6±1.4  
1-7, n=65¹ 
4.2±1.8  
1-7, n=22 
3.2±1.1  
1-5, n=25 
3.1±1.2  
1-6, n=29¹ 
2.0±1.4  
1-3, n=2 
¹One outlier eliminated 
Abbreviations: MSKP, Musculoskeletal Pain; LBP, Low Back Pain; SD, Standard Deviation 
 
9.b.4. Pain extent; relation to demographic profile characteristics 
Table 9.b.4.1: Summary of statistical differences in the number of areas with pain,  
within national groups, divided by demographic profile characteristics 
 USA UK Greece 
 Statistical Tests Statistical Tests Statistical Tests 
Gender 
  Male 
  Female 
U=776 
p=0.02¹ 
95% CI -1.32, -0.40 
U=196 
p=0.06 
 
U=99.5 
p=0.57 
 
Cause of Injury 
  Traumatic 
  Non traumatic 
t=-2.5, df106 
p≤0.01¹ 
95% CI -1.6, 0.1 
U=174 
p=0.67 
U=104.5 
p=0.98 
Age r=0.01 
p=0.88, n=104 
r=-0.29 
p=0.04¹, n=46 
ρ=0.24 
p=0.16, n=32 
Type of injury 
  Tetraplegia 
  Paraplegia 
t=-0.78 
p=0.43, df105 
95% CI -0.8, 0.37 
U=249 
p=0.50 
U=90 
p=0.55 
 
Time since injury r=0.04 
p=0.68, n=109 
ρ=0.34 
p≤0.01¹, n=48 
ρ=0.05 
p=0.75, n=32 
1not significant post Bonferroni correction;  
Statistical tests: U, Mann-Whitney U test; t, Independent t-test; r, Pearson’s correlation;  
Ρ, Spearman’s rank correlation rho 
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Table 9.b.4.2: Mean number of areas with pain, within each national group,  
divided by demographic profile characteristics 
  USA 
mean±S 
UK 
mean±S 
Greece 
mean±SD 
Gender 
   
 
Male 2.8±1.4  
n=75¹ 
3.3±1.5  
n=27 
3.5±2.2  
n=15 
Female 4.0±1.9  
n=33¹ 
4.2±1.5  
n=21 
2.9±0.8  
n=15 
Cause of Injury 
   
 
Traumatic 3.0±1.5  
n=81 
3.7±1.4  
n=38 
3.0±1.4  
n=10 
Non Traumatic 3.9±2.0  
n=27 
3.6±1.9  
n=10 
3.0±1.1  
n=21¹ 
Type of injury 
   
 
Tetraplegia 3.0±1.7  
n=542² 
3.5±1.6  
n=20 
3.8±2.6  
n=9 
Paraplegia 3.3±1.5  
n=53² 
3.8±1.4  
n=28 
3.0±1.0  
n=23 
¹One outlier eliminated, ²Two outliers eliminated;   
Abbreviations: SD, Standard Deviation 
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Table 9.b.4.3: Mean number of areas with pain, within each national group, divided by gender 
 USA   
Males 
USA  
 Females 
UK   
Males 
UK   
Females 
Greece  
 Males 
Greece   
Females 
Yes 
mean±SD
median 
min-max 
No 
mean±SD
median 
min-max 
Yes 
mean±SD
median 
min-max 
No 
mean±SD
median 
min-max 
Yes 
mean±SD
median 
min-max 
No 
mean±SD
median 
min-max 
Yes 
mean±SD
median 
min-max 
No 
mean±SD
median 
min-max 
Yes 
mean±SD
median 
min-max 
No 
mean±SD
median 
min-max 
Yes 
mean±SD
median 
min-max 
No 
mean±SD
median 
min-max 
LBP 
lifetime 
3.4±1.5 
3, 1-9 
n=57 
3.4±1.5 
3, 1-9 
n=57 
4.8±1.8 
5, 2-9 
n=27 
1.9±0.9 
2, 1-3 
n=7 
3.5±1.5 
3.5, 1-6 
n=20 
2.7±1.4 
2, 1-5 
n=7 
4.4±1.5 
4.5, 2-7 
n=18 
3.00±0 
n=3 
3.7±2.2 
3, 1-9 
n=13 
2.0±1.4  
1-3, n=2 
4.5±1.5 
5, 4.5-
1.5, 
n=17 
n/a  
n=0 
LBP 
current 
3.4±1.5 
3, 1-9 
n=51 
1.8±1.2 
3, 1-6 
n=23 
4.7±1.9 
4.5, 2-9 
n=24 
2.6±1.7 
2, 1-6 
n=9 
3.4±1.5 
3, 1-6 
n=18 
2.9±1.3 
2.5, 1-5 
n=8 
4.5±1.5 
5, 2-7 
n=17 
3.00±0 
n=4 
3.7±2.2 
3, 1-9 
n=13 
2.0±1.4 
2, 1-3 
n=2 
2.9±0.9 
3, 1-4 
n=14 
n/a   
n=1 
LBP 
over 1 
month 
3.4±1.5 
3, 1-9 
n=51 
1.8±1.2 
1.5, 1-6 
n=24 
4.7±1.9 
4.5, 2-9 
n=24 
2.8±1.7 
2.5, 1-6 
n=57 
3.5±1.5 
3.5, 1-6 
n=18 
2.7±1.3 
2.5, 1-5 
n=8 
4.4±1.5 
4.5, 2-7 
n=18 
3.00±0 
n=3 
3.7±2.2 
3, 1-9 
n=13 
2.0±1.4 
2, 1-3 
n=2 
2.9±0.8 
3, 1-4 
n=15 
n/a   
n=0 
LBP 
over 3 
months 
3.3±1.5 
3, 1-9 
n=51 
1.8±1.2 
1.5, 1-6 
n=22 
4.8±1.9 
5, 2-9 
n=25 
2.4±1.7 
2, 1-6 
n=8 
3.5±1.5 
3.5, 1-6 
n=18 
2.7±1.3 
2.5, 1-5 
n=8 
4.4±1.5 
4.5, 2-7 
n=18 
3.00±0 
n=3 
3.7±2.2 
3, 1-9 
n=13 
2.0±1.4 
2, 1-3 
n=2 
2.9±0.8 
3, 1-4 
n=15 
n/a   
n=0 
Abbreviations: LBP, Low Back Pain; SD, Standard Deviation 
 
Appendix 9 
 
222 
Table 9.b.4.4: Differences in the number of areas with pain  
within males or females with and without LBP 
 USA 
Between Males 
USA 
Between females 
Lifetime LBP 
 
χ²=0.16, p=0.68 χ²=1.47, p=0.22 
Current LBP χ²=0.39, p=0.52 χ²=2.13, p=0.14 
LBP over last 1 
month 
χ²=0.65, p=0.41 χ²=4.26, p=0.03* 
LBP over last 3 
months 
χ²=0.35, p=0.55 χ²=2.7, p=0.1 
*significant at p≤0.05 level; 
Abbreviations: LBP, Low Back Pain;  
Statistical test: χ², Goodness of fit chi-Square 
 
 
9.b.5. Pain extent; relation to pain/LBP days, free periods, onset 
Table 9.b.5.1: Correlations between the number of areas with pain and the number  
of pain or LBP days felt per month within each national group 
 USA UK Greece 
Areas with pain and 
pain days 
ρ=0.32 
p=0.001***, n=110 
ρ=0.05 
p=0.71, n=48 
ρ=0.20 
p=0.26, n=31 
Areas with pain and 
LBP days 
ρ=0.20 
p=0.06, n=79 
ρ=0.12 
p=0.48, n=34 
ρ=0.32 
p=0.08, n=29 
***significant at p≤0.001 level; 
Abbreviations: LBP, Low Back Pain;  
Statistical test: ρ, Spearman’s rank correlation rho 
 
 
Table 9.b.5.2: Correlations between the number of areas with pain and the frequency 
of pain or LBP free weeks within each national group 
Correlation between USA UK Greece 
Areas with pain and 
pain free weeks 
ρ=0.16 
p=0.11, n=101 
ρ=0.26 
p=0.07, n=46 
ρ=-0.05 
p=0.77, n=31 
Areas with pain and 
LBP free weeks 
ρ=0.009 
p=0.94, n=61 
ρ=0.21 
p=0.26, n=44 
ρ=0.10 
p=0.57, n=29 
Abbreviations: LBP, Low Back Pain;  
Statistical test: ρ, Spearman’s rank correlation rho 
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9.b.6. LBP quality and intensity; relation to demographic profile 
characteristics 
Table 9.b.6.1: Differences in the LBP quality or intensity between gender, within each 
national group. Interaction effect between country of residence and gender on LBP 
quality or intensity 
 Comparisons within each country Effect of gender 
*country on DV  USA UK GR 
S-PRI t=-0.07, df81 
p=0.94 
95% CI -3.4, 3.1 
t=0.58, df36 
p=0.56 
95% CI -4.3, 7.9 
t=-0.04, df26 
p=0.96 
95% CI -3.3, 3.2 
F=0.23, p=0.78  
η²=0.001 
n=150 
A-PRI t=-0.68, df81 
p=0.49 
95% CI -2.1, 1.0 
t=0.09, df36 
p=0.92 
95% CI -2.4, 2.6 
t=1.73, df27 
p=0.09 
95% CI -0.36, 
4.4 
F=1.40, p=0.25  
η²=0.0093 
n=150 
Total PRI t=-0.68, df81 
p=0.49 
95% CI -2.1, 1.0 
t=0.09, df36 
p=0.92 
95% CI -2.4, 2.6 
t=1.34, df26 
p=0.19 
95% CI -0.7, 3.5 
F=0.84, p=0.43  
η²=0.0044 
n=147 
Intensity of 
current LBP 
t=-0.20, df83 
p=0.83 
95% CI 
-14.0, 11.4 
t=0.55, df34 
p=0.58 
95% CI-14.6, 2.5 
n/a F=0.71, p=0.49  
η²=0.0035 
n=124 
Intensity of 
LBP over 
last 1 month 
t=-0.60, df83 
p=0.54 
95% CI-16.2, 8.6 
t=-0.29, df32 
p=0.77 
95% CI 
-21.5, 16.1 
n/a F=0.84, p=0.43  
η²=0.0035 
n=122 
Intensity of 
LBP over 
last 3 
months 
t=-0.65, df82 
p=0.51 
95% CI-16.2, 8.1 
t=-0.67, df35 
p=0.50 
95% CI 
-25.9, 13.1 
n/a F=1.13, p=0.32  
η²=0.0045 
n=121 
Evaluative 
PPI of LBP 
t=-0.73, df76 
p=0.46 
95% CI -0.6, 0.2 
t=-0.27, df30 
p=0.78 
95% CI -0.7, 0.5 
t=1.07, df26 
p=0.29 
95% CI -0.2, 0.8 
F=0.83, p=0.43  
η²=0.0016 
n=139 
Abbreviations: PRI, Pain Rating Index; S-PRI, Sensory PRI; A-PRI, Affective PRI; LBP, Low Back 
Pain; PPI, Present Pain Intensity 
Statistical tests:  t, Independent t-test; F, Two-way ANOVA 
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Table 9.b.6.2: Two-group comparisons, within each national group, for differences in 
LBP quality within gender 
  UK 
  S-PRI A-PRI Total PRI 
  Male Female Male Female Male Female 
USA Male NT NT NT NT U=446.5 
P=0.46 
NT 
Female NT NT NT NT NT NT 
Greece Male U=86 
P=0.058 
NT NT NT U=99 
P=0.20 
NT 
Female NT U=94.5 
P=0.14 
NT U=97.5 
P=0.16 
NT U=98.5 
P=0.27 
Abbreviations: PRI, Present Rating Index; NT, Not Tested;  
Statistical Test: U, Mann-Whitney U Test 
 
Table 9.b.6.3: Differences, between the national groups, in LBP quality or intensity 
between groups divided by cause of injury. Interaction effect between country of 
residence and cause of injury on LBP quality or intensity 
 Comparisons within each country Effect of cause 
of injury 
*country on DV 
 USA UK GR 
S-PRI t=-1.70, df81, p=0.09 
95% CI -6.4, 0.4 
U=92.5 
p=0.54 
U=73.5 
p=0.33 
F=0.13, p=0.87  
η²=0.00061 
n=152 
A-PRI t=-1.12, df81, p=0.26 
95% CI -2.6, 0.7 
U=107 
p=0.95 
U=79.5 
p=0.48 
F=0.41, p=0.66  
η²=0.0028 
n=152 
Total PRI t=-1.94, df79, p=0.056 
95% CI -9.1, 0.1 
U=81 
p=0.41 
U=69.5 
p=0.25 
F=0.03, p=0.96  
η²=0.00018 
n=149 
Intensity of 
current LBP 
t=-0.19, df83, p=0.80 
95% CI -14.7, 12.1 
U=89.5 
p=0.63 
n/a F=0.12, p=0.88  
η²=0.00060 
n=124 
Intensity of LBP 
over last 1 
month 
t=-1.05, df83, p=0.29 
95% CI -20.0, 6.1 
U=75.5 
p=0.70 
n/a F=0.05, p=0.94  
η²=0.00022 
n=122 
Intensity of LBP 
over last 3 
months 
t=-0.83, df81, p=0.40 
95% CI -18.0, 7.3 
U=64.5 
p=0.37 
n/a F=0.08, p=0.92  
η²=0.00033 
n=121 
Evaluative PPI of 
LBP 
t=-1.05, df76, p=0.29 
95% CI -0.7, 0.2 
U=969 
p=0.53 
U=72.5 
p=0.28 
F=0.16, p=0.85  
η²=0.00032 
n=141 
Abbreviations: PRI, Pain Rating Index; S-PRI, Sensory PRI; A-PRI, Affective PRI; LBP, Low Back 
Pain; PPI, Present Pain Intensity; 
Statistical tests: U, Mann-Whitney U test; t, Independent t-test; F, Two-way ANOVA 
 
Appendix 9 
 
225 
Table 9.b.6.4: Two-group comparisons, within each national group, for differences in 
LBP quality in groups divided by cause of injury 
  Greece 
  S-PRI A-PRI Total PRI 
  Traumatic Non 
traumatic 
Traumatic Non 
traumatic 
Traumatic Non 
traumatic 
USA Traumatic U=154.5 
p=0.03* 
NT U=205.5 
p=0.23 
NT U=161 
p=0.058 
NT 
Non 
traumatic 
NT U=145.5 
p≤0.01** 
NT U=199 
p=0.20 
NT U=147 
p≤0.01** 
UK Traumatic U=80.5 
p=0.055 
NT NT NT U=81 
p=0.08 
NT 
Non 
traumatic 
NT U=33.5 
p=0.02* 
NT NT NT U=42.5 
p=0.078 
*significant at p≤0.05 level; **significant at p≤0.01 level; 
 in bold: significant following Bonferroni post hoc 
Abbreviations: PRI, Present Rating Index; S-PRI, Sensory PRI; A-PRI; NT, Not Tested;  
Statistical Test: U, Mann-Whitney U Test 
 
 
Table 9.b.6.5: Two-group comparisons, between the national groups, for differences in 
LBP quality in groups divided by level of injury  
  Greece 
  S-PRI A-PRI Total PRI 
  Tetraplegia Paraplegia Tetraplegia Paraplegia Tetraplegia Paraplegia 
USA Tetraplegia U=141.5 
p=0.76 
NT NT NT NT NT 
Paraplegia NT U=241 
p≤0.001* 
NT U=355 
p=0.03* 
NT U=258 
p≤0.01** 
UK Tetraplegia U=39.5 
p=0.51 
NT NT NT U=38.5 
p=0.46 
NT 
Paraplegia NT U=148 
p=0.06* 
NT NT NT U=167.5 
p=0.003** 
*significant at p≤0.05, **significant at p≤0.01; in bold: significant following Bonferroni post 
hoc; Abbreviations: PRI, Present Rating Index; S-PRI, Sensory PRI; A-PRI; NT, Not Tested;  
Statistical Test: U, Mann-Whitney U Test 
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Table 9.b.6.6: Correlations, within each national group, between quality or intensity  
of LBP and age or time since injury 
 Age of respondent Time since injury 
 USA UK GR USA UK GR 
S-PRI r=-0.004 
p=0.97  
n=79 
r=-0.19 
p=0.25  
n=38 
r=-0.30 
p=0.09  
n=31 
r=0.08 
p=0.44  
n=82 
r=-0.11 
p=0.48  
n=38 
r=-0.14 
p=0.43  
n=31 
A- PRI r=0.07 
p=0.51  
n=79 
r=-0.14 
p=0.37  
n=38 
r=-0.32 
p=0.07  
n=31 
r=0.02 
p=0.81  
n=82 
r=0.10 
p=0.54  
n=38 
r=-0.18 
p=0.33  
n=31 
Total PRI r=-0.02 
p=0.85  
n=78 
r=-0.17 
p=0.32  
n=36 
r=-0.33 
p=0.07  
n=31 
r=0.09 
p=0.38  
n=81 
r=0.24 
p=0.15  
n=36 
r=-0.16 
p=0.36  
n=31 
Intensity of 
current LBP 
r=-0.001 
p=0.99  
n=80 
r=-0.02 
p=0.90  
n=36 
r=0.33 
p=0.78  
n=3 
r=0.02 
p=0.84  
n=84 
r=0.22 
p=0.19  
n=36 
r=0.83 
p=0.36  
n=3 
Intensity of LBP 
over last 1 
month 
r=0.15 
p=0.16  
n=80 
r=-0.13 
p=0.45  
n=34 
r=0.33 
p=0.78  
n=3 
r=-0.07 
p=0.50  
n=84 
r=0.40 
p≤0.01¹ 
n=34 
r=0.83 
p=0.37  
n=3 
Intensity of LBP 
over last 3 
months 
r=0.13 
p=0.24  
n=80 
r=-0.15 
p=0.38 
n=34 
r=0.47 
p=0.68  
n=3 
r=-0.20 
p=0.058  
n=83 
r=0.34 
p=0.04¹ 
n=34 
r=0.90 
p=0.27  
n=3 
Evaluative PPI of 
LBP 
r=0.15 
p=0.19  
n=73 
r=-0.22 
p=0.21  
n=33 
r=0.02 
p=0.91  
n=30 
r=0.07 
p=0.51  
n=77 
r=-0.06 
p=0.72  
n=33 
r=0.12 
p=0.50  
n=30 
1not significant post Bonferroni correction; 
Abbreviations: PRI, Pain Rating Index; LBP, Low Back Pain; PPI, Present Pain Intensity. 
Statistical tests: r, Pearson’s correlation; ρ, Spearman’s rank correlation rho 
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9.b.7 LBP quality and intensity; general results 
Table 9.b.7.1: Percentage of used verbal descriptors to mark severity of LBP quality in groups across nations 
Verbal descriptors Reported pain total      None                                 Mild                                  Moderate                         Severe 
UK; n=36 
USA; n=83 
GR; n=30 
UK USA GR UK USA GR UK USA GR UK USA GR UK USA GR 
Throbbing  50 44.6 20 50 55.4 80 19.4 14.5 16.7 5.6 21.7 0 2.5 8.4 3.3 
Shooting  51.4 49.4 35.5 48.6 50.6 64.5 5.4 15.7 29 29.7 16.9 3.2 16.2 16.9 3.2 
Stabbing  54.3 44.6 38.7 45.7 55.4 61.3 8.6 7.2 19.4 20 18.1 6.5 25.7 19.3 12.9 
Sharp  55.6 50.6 61.3 44.4 49.4 38.7 8.3 12 25.8 27.8 19.3 19.4 19.4 19.3 16.2 
Cramping  50 50.6 35.5 50 49.4 64.5 27.8 20.5 22.6 16.7 20.5 12.9 5.6 9.6 0 
Gnawing  68.4 45.8 64.5 31.6 54.2 35.5 28.9 10.8 41.9 23.7 26.5 16.1 15.8 8.4 6.5 
Hot-burning  59.5 52.4 50 40.5 47.6 50 13.5 15.9 33.3 16.2 25.6 6.7 29.7 11 10 
Aching  86.5 84.3 41.9 13.5 15.7 58.1 18.9 18.1 19.4 27 48.2 16.1 40.5 18.1 6.5 
Heavy  56.8 42.7 35.5 43.2 57.3 64.5 24.3 12.2 16.1 13.5 22 16.1 18.9 8.5 3.2 
Tender  58.3 44.6 22.6 41.7 55.4 77.4 13.9 15.7 16.1 25 19.3 3.2 19.4 9.6 3.2 
Splitting  38.9 30 19.4 61.1 70 80.6 8.3 17.5 9.7 25 5 6.5 5.6 7.5 3.2 
Tiring-exhausting  64.9 65.1 48.4 35.1 34.9 51.6 10.8 15.7 12.9 21.6 28.9 25.8 32.4 20.5 9.7 
Sickening  45.9 31.7 32.3 54.1 68.3 67.7 13.5 13.4 22.6 16.2 9.8 3.2 16.2 8.5 6.5 
Fearful  31.6 29.3 35.5 68.4 70.7 64.5 13.2 11 22.6 10.5 12.2 3.2 7.9 6.1 9.7 
Punishing-cruel  47.4 49.4 38.7 52.6 50.6 61.3 15.8 15.7 25.8 18.4 19.2 6.5 13.2 14.5 6.5 
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Table 9.b.7.2: Characteristics of LBP quality descriptors across national groups 
Verbal descriptor  Median  Mean  SD  Skewness  Kurtosis  Sum  
UK; n=35-38  
USA; n=82-83  
GR; n=30-31  
UK  USA  GR  UK  USA  GR  UK  USA  GR  UK  USA  GR  UK  USA  GR  UK  USA  GR  
Throbbing  0.5  0  0  1.06  0.83  0.27  1.26  1.04  0.64  0.70  0.80  3.09  -1.24  -0.80  11.20  38  69  8  
Shooting  1  0  0  1.14  1  9.45  1.20  1.16  0.72  0.33  0.65  1.87  -1.58  -1.14  4.06  42  83  14  
Stabbing  1  0  0  1.26  1.01  0.71  1.29  1.23  1.07  0.27  0.61  1.32  -1.70  -1.34  0.40  44  84  22  
Sharp  1  1  1  1.22  1.08  1.13  1.22  1.21  1.11  0.24  0.50  0.49  -1.61  -1.38  -1.12  44  90  35  
Cramping  0.5  1  0  0.78  0.90  0.48  0.92  1.04  0.72  0.92  0.72  1.18  -0.14  -0.82  0.03  28  75  15  
Gnawing  1  0  1  1.24  0.89  0.94  1.07  1.07  0.89  0.32  0.64  0.73  -1.14  -1.11  -1.03  47  74  29  
Hot-
burning  
1  1  0.5  1.35  1  0.77  1.29  1.08  0.97  0.18  0.53  1.23  -1.72  -1.18  0.83  50  82  23  
Aching  2  2  0  1.95  1.69  0.71  1.07  0.94  0.97  -0.59  -0.46  1.10  -0.94  -0.62  0.82  72  140  22  
Heavy  1  0  0  1.08  0.82  0.58  1.16  1.05  0.88  0.61  0.82  1.27  -1.11  -0.81  0.44  40  67  18  
Tender  1  0  0  1.22  0.83  0.32  1.19  1.05  0.70  0.28  0.85  2.54  -1.51  -0.70  6.85  44  69  10  
Splitting  0  0  0  0.75  0.50  0.32  1.02  0.90  0.74  0.87  1.81  2.48  -0.80  2.27  5.4  27  40  10  
Tiring-
exhaustin
g  
2  1  0  1.51  1.35  0.94  1.28  1.16  1.09  -1.07  0.08  0.62  -1.72  -1.48  -1.13  56  112  29  
Sickening  0  0  0  0.95  0.59  0.48  1.17  0.98  0.85  0.75  1.48  1.95  -1.04  0.86  3.42  35  48  15  
Fearful  0  0  0  0.58  0.54  0.58  0.97  0.93  0.95  1.51  1.53  1.69  1.02  1.02  1.95  22  44  18  
Punishing-
cruel  
0  0  0  0.92  0.98  0.58  1.12  1.13  0.88  0.76  0.61  1.58  -0.92  -1.09  1.89  35  81  18  
Total S-
PRI  
(0-33)  
13  8  6  12.53  10.52  6.65  9.22  7.46  5.36  0.49  0.73  1.72  -0.71  -0.45  4.38  476  873  206  
Total A-
PRI  
(0-12)  
3.5  2  2  3.89  3.43  2.58  3.84  3.48  3.29  0.69  0.89  1.59  -0.61  -0.23  2.07  148  285  80  
Total PRI  
(0-45)  
15.5  12  6  16.42  13.95  9.23  12.74  10.21  8.23  0.57  0.70  1.83  
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Table 9.b.7.3: Mean LBP quality in groups across nations. Percentage of total or no 
usage of verbal descriptors 
 Total PRI 
 
S-PRI 
 
A-PRI 
 mean±SD 
range 
% mean±SD 
range 
% mean±SD 
range 
% 
USA 
n=83 
7.1±4.6 
1-15 
5.7% using 
all 
descriptors 
5.4±3.4 
1-11 
8.2% using all 
descriptors 
1.7±1.5 
0-4 
14.6% using all 
descriptors 
19.7% using no 
descriptors 
UK  
n=38 
7.9±5.1 
1-15 
11.5% 
using all 
descriptors 
6.06±3.8 
0-11 
13.5% using all 
descriptors 
19% using no 
descriptor 
1.9±1.6 
0-4 
15.4% using all 
descriptors 
23.1%% using no 
descriptor 
GR 
n=31 
5.8±4.6 
1-15 
2.2 using all 
descriptors 
4.2±3.2 
0-11 
2.2% using all 
descriptors 
2.2% using no 
descriptors 
1.5±1.6 
0-4 
13.3% using all 
descriptors 
26.7% using no 
descriptors 
Abbreviations: PRI, Pain Rating Index.  
Statistical test: F, One-way ANOVA 
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9.b.8. LBP quality and intensity; relation to pain/LBP days, free periods, 
onset 
Table 9.b.8.1: Correlation, within each national group, between the number of pain or 
LBP days and quality or intensity of LBP  
 Pain days LBP days 
 USA UK Greece USA UK Greece 
S-PRI ρ=0.13 
p=0.23 
 n=83 
ρ=0.06 
p=0.70 
 n=38 
ρ=-0.21 
p=0.23 
 n=31 
ρ=0.43 
p≤0.001*** 
 n=78 
ρ=0.45 
p=0.006¹ 
 n=34 
ρ=-0.13 
p=0.48 
 n=30 
A-PRI ρ=0.08 
p=0.46 
 n=83 
ρ=0.04 
p=0.78 
 n=38 
ρ=-0.25 
p=0.16 
 n=31 
ρ=0.34 
p=0.002** 
 n=78 
ρ=0.45 
p=0.006¹ 
 n=34 
ρ=-0.14 
p=0.44 
 n=30 
Total PRI  ρ=0.11 
p=0.30 
 n=82 
ρ=0.01 
p=0.95 
 n=36 
ρ=-0.28 
p=0.12 
 n=31 
ρ=0.43 
p≤0.001**** 
 n=77 
ρ=0.44 
p≤0.01¹ 
 n=32 
ρ=-0.16 
p=0.37 
 n=30 
Intensity of 
current LBP 
ρ=0.25 
p=0.021 
 n=85 
ρ=0.36 
p=0.03 
 n=36 
ρ=0.86 
p=0.33 
 n=3 
ρ=0.53 
p≤0.001*** 
 n=80 
ρ=0.54 
p≤0.001*** 
 n=32 
n=2 
n/a 
Intensity of 
LBP over last 1 
month 
ρ=0.22 
p=0.031 
 n=85 
ρ=0.27 
p=0.11 
 n=34 
ρ=0.86 
p=0.33 
 n=3 
ρ=0.56 
p≤0.001*** 
 n=80 
ρ=0.45 
p=0.01¹ 
 n=30 
n=2 
n/a 
Intensity of 
LBP over last 3 
months 
ρ=0.13 
p=0.22 
 n=84 
ρ=0.25 
p=0.14 
 n=34 
ρ=0.86 
p=0.33 
 n=3 
ρ=0.41 
p≤0.001*** 
 n=79 
ρ=0.54 
p=0.002** 
 n=30 
n=2 
n/a 
Evaluative PPI 
of LBP 
ρ=0.10 
p=0.38 
 n=78 
ρ=0.12 
p=0.49 
 n=33 
ρ=0.14 
p=0.44 
 n=30 
ρ=0.40 
p≤0.001*** 
 n=75 
ρ=0.49 
p=0.006¹ 
 n=30 
ρ=0.28 
p=0.13 
 n=28 
1not significant post Bonferroni correction; **significant at p≤0.01 level, ***significant at 
p≤0.001 level; In bold: remained significant following application of the Bonferroni correction. 
Abbreviations: PRI, Present Rating Index; LBP, Low Back Pain; PPI, Present Pain Intensity; 
Statistical Test: ρ, Spearman’s rank correlation rho 
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Table 9.b.8.2: Correlation, within each national group, between the number of pain or 
LBP free weeks and quality or intensity of LBP  
 Pain free weeks LBP free weeks 
 USA UK Greece USA UK Greece 
S-PRI ρ=0.19 
p=0.09 
 n=77 
ρ=0.27 
p=0.10 
 n=36 
ρ=-0.17 
p=0.34 
 n=30 
ρ=0.33 
p≤0.01¹ 
 n=60 
ρ=0.41 
p=0.02¹ 
 n=29 
ρ=-0.11 
p=0.55 
 n=30 
A-PRI ρ=0.17 
p=0.13 
 n=77 
ρ=0.33 
p=0.04¹ 
 n=36 
ρ=0.08 
p=0.65 
 n=30 
ρ=0.19 
p=0.14 
 n=60 
ρ=0.41 
p=0.009¹ 
 n=29 
ρ=0.05 
p=0.79 
 n=30 
Total PRI  ρ=0.19 
p=0.09 
 n=76 
ρ=0.23 
p=0.18 
 n=34 
ρ=-0.10 
p=0.59 
 n=30 
ρ=0.28 
p=0.02¹ 
 n=59 
ρ=0.39 
p=0.03¹ 
 n=28 
ρ=-0.03 
p=0.87 
 n=30 
Intensity 
of current 
LBP 
ρ=0.35 
p=0.01¹ 
 n=79 
ρ=0.58 
p≤0.001** 
 n=34 
ρ=1.000 
n/a 
 n=3 
ρ=0.53 
p≤0.001*** 
 n=61 
ρ=0.53 
p=0.004¹ 
 n=27 
ρ=1.000 
n/a 
n=2 
Intensity 
of LBP 
over last 1 
month 
ρ=0.33 
p=0.003** 
 n=85 
ρ=0.35 
p=0.04¹ 
 n=32 
ρ=1.000 
n/a 
 n=3 
ρ=0.46 
p≤0.001*** 
 n=61 
ρ=0.65 
p≤0.001*** 
 n=25 
ρ=1.000 
n/a 
n=2 
Intensity 
of LBP 
over last 3 
months 
ρ=0.29 
p=0.008¹ 
 n=78 
ρ=0.04 
p=0.02¹ 
 n=32 
ρ=1.000 
n/a 
 n=3 
ρ=0.34 
p=0.007¹ 
 n=60 
ρ=0.71 
p≤0.001*** 
 n=25 
ρ=1.000 
n/a 
n=2 
Evaluative 
PPI of LBP 
ρ=0.17 
p=0.14 
 n=72 
ρ=0.30 
p=0.10 
 n=31 
ρ=0.19 
p=0.32 
 n=29 
ρ=0.29 
p=0.03¹ 
 n=54 
ρ=0.57 
p=0.003*** 
 n=25 
ρ=0.40 
p=0.03¹ 
 n=29 
1not significant post Bonferroni correction; **significant at p≤0.01 level, ***significant at 
p≤0.001 level; In bold: remained significant following application of the Bonferroni correction. 
Abbreviations: PRI, Present Rating Index; S-PRI, Sensory PRI; A-PRI; LBP, Low Back Pain; PPI, 
Present Pain Intensity; 
Statistical Test: ρ, Spearman’s rank correlation rho 
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Table 9.b.8.3: Correlations, within each national group, between the number  
of areas with pain and LBP quality or intensity. Interaction effect of country of 
residence and the number of areas with pain on LBP quality or intensity.  
 USA UK GR Effect of number 
of areas with pain 
*country on DV 
S-PRI r=0.27 
p≤0.01¹  
n=80 
r=0.22 
p=0.18  
n=37 
r=0.35 
p=0.057  
n=30 
F=1.78, p=0.067  
η²=0.021 
n=147 
A-PRI r=0.20 
p=0.07  
n=81 
r=0.32 
p=0.05¹ 
 n=37 
r=0.31 
p=0.08  
n=30 
F=0.61, p=0.82  
η²=0.025 
n=148 
Total PRI r=0.26 
p≤0.01¹  
n=80 
r=0.30 
p=0.07  
n=35 
r=0.35 
p=0.0054  
n=30 
F=1.64, p=0.80  
η²=0.018 
n=145 
Intensity of 
current LBP 
r=0.18 
p=0.08  
n=83 
r=0.10 
p=0.56  
n=35 
ρ=0.50 
p=0.66  
n=3 
F=1.18, p=0.31  
η²=0.023 
n=121 
Intensity of LBP 
over last 1 
month 
r=0.12 
p=0.24  
n=83 
r=0.15 
p=0.39  
n=33 
ρ=0.50 
p=0.66  
n=3 
F=1.14, p=0.33  
η²=0.019 
n=119 
Intensity of LBP 
over last 3 
months 
r=0.23 
p=0.03¹  
n=82 
r=0.09 
p=0.59  
n=33 
ρ=0.50 
p=0.66  
n=3 
F=1.54, p≤0.01¹ 
η²=0.15 
n=118 
Evaluative PPI of 
LBP 
r=0.33 
p=0.003** 
n=80 
r=0.11 
p=0.52  
n=52 
r=0.25 
p=0.18  
n=29 
F=1.93, p=0.50  
η²=0.009 
n=137 
1not significant post Bonferroni correction; **significant at p≤0.01 level;  
In bold: remained significant following application of the Bonferroni correction. 
Abbreviations: PRI, Pain Rating Index; S-PRI, Sensory PRI; A-PRI; LBP, Low Back Pain;  
PPI, Present Pain Intensity; 
Statistical tests: r, Pearson’s correlation; F, Two-way ANOVA 
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9.c. Quality of life within and across nations 
9.c.1. Bonferroni Correction 
Table 9.c.1.1: Main variables used in analysis of EQ-5D for cross-national and alpha 
value set following Bonferroni correction 
Main Variables Each main variable tested with the following 
variables 
Alpha value 
following 
Bonferroni 
correction 
1) EQ-5D 
2) EQ-VAS 
1)   Pain                         13) Areas with pain   
2)   LBP                          14) Pain days 
3)   MSKP                       15) LBP days 
4)   Country                   16) Pain free weeks 
5)   Gender                    17) LBP free weeks 
6)   Cause of injury      18) Pain onset 
7)   Age                          19) LBP onset 
8)   Type of injury        20) S-PRI of LBP  
9)  Time since injury   21) A-PRI of LBP 
10) Marital status       22) T-PRI of LBP 
11) Education              23) Intensity of current LBP 
12) Employment         24) Intensity LBP last 1 month 
                                       25) Intensity LBP last 3 months           
                                       26) Evaluative PPI of LBP                      
0.05/26=0.002 
p≤0.002 
Abbreviations: EQ-5D index, Quality of Life index; EQ-VAS, Quality of Life Visual Analogue 
Scale; MSKP, Musculoskeletal Pain; LBP, Low Back Pain; PRI, Present Rating Index. 
 
9.c.2. EQ-5D; relation to pain, MSKP and LBP 
Figure 
9.c.2.1: 
Percentage 
of people, 
within each 
national 
group, 
without 
pain 
reporting 
each health 
status 
dimension; 
Abbreviatio
n: EQ-5D, 
Quality of 
Life 
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Figure 9.c.2.2: Percentage of people, within each national group, without MSKP  
reporting each health status dimension 
Abbreviation: EQ-5D, Quality of Life 
 
 
 
Figure 9.c.2.3: Percentage of people, within each national group, without LBP  
reporting each health status dimension; 
Abbreviation: EQ-5D, Quality of Life 
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Table 9.c.2.4: .Mean QoL, within each national group, of people with and without the pain presence  
 
¹Two outliers eliminated, ²one outlier eliminated;  
Abbreviation: EQ-5D, Quality of Life; EQ-VAS, Quality of Life Visual Analogue Scale; LBP, Low Back Pain; MSKP, Musculoskeletal Pain, SD, Standard 
Deviation 
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9.c.3. EQ-5D; relation to demographic profile characteristics 
Table 9.c.3.1: Percentage of males and females, within each national group, reporting each health status  
dimension  
Subscale Level Males (%) Subscale Level Females (%) 
  USA 
n=76 
UK 
n=22 
Greece 
n=22 
  USA 
n=37 
UK 
n=21 
Greece 
n=17 
Mobility 1 11.8 0 9.1 Mobility 1 2.7 0 5.9 
 2 75 90.9 77.3  2 78.4 85.7 76.5 
 3 13.2 9.1 13.6  3 18.9 14.3 17.6 
Self-care 1 51.3 36.4 31.8 Self-care 1 51.4 33.3 52.9 
 2 35.5 54.5 54.5  2 40.5 52.4 35.3 
 3 13.2 9.1 13.6  3 8.1 14.3 11.8 
Usual 
Activities 
1 23.7 22.7 9.1 Usual 
Activities 
1 16.2 9.5 17.6 
 2 63.2 63.6 77.3  2 54.1 71.4 64.7 
 3 13.2 13.6 13.6  3 29.7 19 17.6 
Pain/ 
discomfort 
1 13.2 9.1 31.8 Pain/ 
discomfort 
1 16.2 4.8 11.8 
 2 71.1 59.1 50  2 51.4 66.7 82.4 
 3 15.8 31.8 18.2  3 32.4 28.6 5.9 
Anxiety/ 
depression 
1 48.7 50 31.8 Anxiety/ 
depression 
1 35.1 42.9 11.8 
 2 42.1 36.4 54.5  2 54.1 52.4 70.6 
 3 9.2 13.6 13.6  3 10.8 4.8 17.6 
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Table 9.c.3.2: Differences in QoL, within each national group, between people with 
and without MSKP 
EQ-5D USA 
Without MSKP n=53 
With MSKP n=23 
UK 
Without MSKP n=12 
With MSKP n=10 
GR 
Without MSKP n=14 
With MSKP n=6 
Males t=0.55, df74 
p=0.58, d=0.55 
95%CI -0.12, 0.21 
t=-1.03, df20 
p=0.31, d=0.45 
95%CI -0.49, 0.16 
U=14.5 
p=0.02¹, r=0.51 
 
Females t=3.18, df33 
p=0.003¹, d=1.08 
95%CI 0.12, 0.54 
t=0.66, df18 
p=0.51, d=0.31 
95%CI -12.94, 24.94 
U=30.0 
p=0.55, r=0.14 
EQ-VAS    
Males t=0.84, df84 
p=0.4, d=0.21 
95%CI -6.36, 15.77 
t=3-0.97, df20 
p=0.34, d=0.42 
95%CI -37.5, 13.67 
U=35.5 
p=0.58, r=0.12 
Females t=3.81, df105 
p≤0.001***, d=1.29 
95%CI 7.4, 23.6 
t=-0.68, df18 
p=0.49, d=0.29 
95%CI -0.44, 0.22 
U=17.5 
p=0.07, r=0.43 
The presence of MSKP was examined within each gender and it was found that among  
males those with and without MSKP did not differ significantly in their mean classified  
or perceived health status. Within females, in the case of the USA the effect sizes were  
much larger than typical and statistically significant for perceived health status.  
1not significant post Bonferroni correction; ***Significant at p≤0.001 level, in bold: significant 
following application of the Bonferroni correction; 
Abbreviations: EQ-5D, Quality of Life, EQ-VAS, Quality of Life Visual Analogue Scale, MSKP, 
Musculoskeletal Pain; 
Statistical tests: U, Mann-Whitney U test; t, Independent t-test 
Appendix 9 
 
238 
Table 9.c.3.3: Percentage of people, within each national group, divided in groups by cause of injury, 
 reporting each health status dimension injury 
Subscale Level USA 
% 
UK 
% 
Greece 
% 
  Traumatic 
n=89 
Non-
traumatic 
n=24 
Traumatic 
n=34 
Non-
traumatic 
n=9 
Traumatic 
n=16 
Non-
traumatic 
n=26 
Mobility 1 10.1 4.2 0 0 18.8 3.8 
 2 75.3 79.2 88.2 88.9 68.8 76.9 
 3 14.6 16.7 11.8 11.1 12.5 19.2 
Self-care 1 52.8 45.8 38.2 22.2 37.5 42.3 
 2 32.6 54.2 50 66.7 50 46.2 
 3 14.6 0 11.8 11.1 12.5 11.5 
Usual 
Activities 
1 24.7 8.3 14.7 22.2 12.5 15.4 
 2 58.4 66.7 67.6 66.7 81.3 65.4 
 3 16.9 25 17.6 11.1 6.3 19.2 
Pain/ 
discomfort 
1 16.9 4.2 5.9 11.1 37.5 15.4 
 2 64 66.7 67.6 44.4 56.3 65.4 
 3 19.1 29.2 26.5 44.4 6.3 19.2 
Anxiety/ 
depression 
1 50.6 20.8 44.1 46.5 43.8 7.7 
 2 40.4 66.7 44.1 44.2 50 69.2 
 3 9 12.5 11.8 9.3 6.3 23.1 
 Abbreviation: EQ-5D, Quality of Life 
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Table 9.c.3.4: Percentage of people, within each national group, divided in groups by level of injury, 
 reporting each health status dimension  
 Level USA 
(%) 
UK 
(%) 
Greece 
(%) 
  Tetraplegia 
n=89 
Paraplegia 
n=24 
Tetraplegia 
n=15 
Paraplegia 
n=27 
Tetraplegia 
n=14 
Paraplegia 
n=28 
Mobility 1 9.8 7.7 0 0 7.1 10.7 
 2 68.9 84.6 86.7 88.9 71.4 75 
 3 21.3 7.7 13.3 11.1 21.4 14.3 
Self-care 1 39.3 65.4 20 44.4 21.4 50 
 2 39.3 34.6 46.7 55.6 57.1 42.9 
 3 21.3 0 33.3 0 21.4 7.1 
Usual 
Activities 
1 23 19.2 13.3 18.5 7.1 17.9 
 2 57.4 63.5 53.3 74.1 71.4 71.4 
 3 19.7 17.3 33.3 7.4 21.4 10.7 
Pain/ 
discomfort 
1 18 9.6 20 0 35.7 17.9 
 2 70.5 57.7 53.3 70.4 42.9 71.4 
 3 11.5 32.7 26.7 29.6 21.4 10.7 
Anxiety/ 
depression 
1 55.7 30.8 60 40.7 21.4 21.4 
 2 36.1 57.7 33.3 51.9 64.3 60.7 
 3 8.2 11.5 6.7 7.4 14.3 17.9 
 Abbreviation: EQ-5D, Quality of Life 
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Table 9.c.3.5: Differences in QoL, within each national group, between people with  
different level of injury 
 USA UK GR 
EQ-5D t=-0.26, df111 
p=0.79 
95%CI -0.1, 0.1 
U=189.5 
p=0.73 
U=170.5 
p=0.49 
EQ-VAS t=2.48, df111 
p≤0.01¹ 
95%CI 2.0, 17.6 
t=0.98, df39 
p=0.32 
95%CI -7.3, 21.4 
t=-0.16, df40 
p=0.86 
95%CI -13.6, 11.5 
1not significant post Bonferroni correction;  
Abbreviations: EQ-5D, Quality of Life, EQ-VAS, Quality of Life Visual Analogue Scale; 
Statistical tests: U, Mann-Whitney U test; t, Independent t-test 
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Table 9.c.3.6: Mean QoL for people, within each national group, divided into groups by demographic profile characteristics. Differences 
in mean QoL between groups within each national group 
 
1not significant post Bonferroni correction; Abbreviation: EQ-5D, Quality of Life; EQ-VAS, Quality of Life Visual Analogue Scale; SD, Standard Deviation; 
Statistical tests: t, Independent t-test, U, Mann-Whitney U test 
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Table 9.c.3.7: Correlations between QoL and age for respondents within each  
national group 
 EQ-5D EQ-VAS 
 USA UK GR USA UK GR 
Age r=0.005 
p=0.96 
n=107 
r=-0.12 
p=0.45 
n=41 
r=0.10 
p=0.51 
n=42 
r=-0.25 
p=0.008¹ 
n=107 
r=-0.27 
p=0.08 
n=41 
r=-0.29 
p=0.05¹ 
n=42 
1not significant post Bonferroni correction;  
Abbreviations: EQ-5D, Quality of Life, EQ-VAS, Quality of Life Visual Analogue Scale; 
Statistical test: r, Pearson’s correlation 
 
 
 
Figure 9.c.3.1: Mean age of respondents, within each national group, for each  
health status dimension 
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Table 9.c.3.8: Mean age of respondents, within each national group, in groups divided by each health status dimension 
 
Abbreviation: EQ-5D, Quality of Life; SD, Standard Deviation 
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Table 9.c.3.9: Correlations between QoL and time since injury for respondents within 
each national group 
 EQ-5D EQ-VAS 
 USA UK GR USA UK GR 
Time since 
injury 
r=0.001 
p=0.84 
n=112 
r=-0.16 
p=0.30 
n=43 
r=-0.07 
p=0.65 
n=42 
r=0.014 
p=0.13 
n=112 
r=-0.003 
p=0.98 
n=43 
r=-0.29 
p=0.22 
n=42 
**Significant at p≤0.01 level; 
Abbreviations: EQ-5D, Quality of Life, EQ-VAS, Quality of Life Visual Analogue Scale; 
Statistical test: r, Pearson’s correlation 
 
 
 
Figure 9.c.3.2: Mean time since injury of the respondents, within each national group, 
for each health status dimension 
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Table 9.c.3.10: Mean time since injury of respondents, within each national group, in groups divided by the health status dimensions 
 Level USA 
mean, SD  
mix-max 
UK  
mean, SD 
mix-max 
Greece  
mean, SD  
mix-max 
 Level USA  
mean, SD  
mix-max 
UK  
mean, SD  
mix-max 
Greece  
mean, SD  
mix-max 
  Time since 
injury n=112 
Time since 
injury n=43 
Time since 
injury n=42 
  Time since 
injury n=112 
Time since 
injury n=43 
Time since 
injury n=42 
Mobility 1 7.4±5.7 , 6.0 0.6 
– 19.4 
n/a as n=0 6.0±3.5, 6.6  
1.8 – 10.0 
Pain/ 
discomfort 
1 9.2±11.4, 3.9  
0.9 – 41.7 
17.5±9.3, 16.2  
8.9 – 27.4 
9.5±5.6, 9.6  
1.5 – 21.1 
 2 10.8±10.8, 6.5  
0.3 - 44 
13.5±12.6, 8.2  
0.9 – 43.8 
12.3±8.7, 9.5  
1.4 – 34.3 
 2 10.5±11.3, 5.9  
0.3 – 44.2 
12.4±12.1, 6.6  
0.9 – 43.8 
12.1±9.1, 8.9  
1.4 – 34.3 
 3 11.2±13.3, 3.2  
0.3 – 44.2 
19.7±10.0, 22  
8.1 – 30.8 
9.7±6.8, 7.6  
3.2 – 19.0 
 3 11.6±9.3, 9.3  
0.5 – 31.1 
17.4±13.7, 10.7  
3.3 – 43.2 
10.6±7.7, 8.6  
4.8 – 26.0 
Self-care 1 12.0±11.3, 6.6  
0.4 - 44 
12.1±11.8, 8.6  
0.9 – 34.9 
9.9±8.4, 8.1  
1.4 – 31.0 
Anxiety/ 
depression 
1 11.9±12.1, 6.1  
0.4 – 44.0 
17.6±13.5, 18.0  
1.3 – 43.8 
12.7±8.9, 9.8 
1.4 – 23.6 
 2 9.0±10.9, 3.9  
0.3 – 44.2 
14.7±13.3, 9.7  
0.9 – 43.8 
12.5±8.1, 9.7  
1.5 – 34.3 
 2 9.1±9.7, 5.7  
0.3 – 44.2 
12.7±11.5, 9.7  
0.9 – 35.1 
10.3±7.3, 8.9  
1.5 – 31.0 
 3 9.1±8.3, 5.5  
1.1 – 27.0 
18.4±11.0, 22  
5.5 – 29.2 
10.9±8.5, 6.4  
3.2 – 21.1 
 3 11.4±10.4, 7.0  
0.6 – 30.1 
5.1±2.2, 4.6  
3.3 – 8.1 
12.7±10.7, 9.0  
3.2 – 34.3 
Usual 
Activities 
1 15.0±11.7, 12.4  
2.4 – 41.7 
18.2±10.2, 19.7  
1.0 – 28.4 
8.7±6.5, 8.1  
1.6 – 20.7 
     
 2 10.0±11.3, 4.7  
0.3 – 44.2 
13.8±13.2, 7.8  
0.9 – 43.8 
12.0±8.7, 9.6  
1.4 – 34.3 
     
 3 7.2±6.1, 5.0  
0.3 – 17.5 
14.7±11.6, 8.1  
3.5 – 30.8 
10.3±7.1, 7.7  
3.2 – 19.0 
     
Abbreviation: EQ-5D, Quality of Life; SD, Standard Deviation 
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Table 9.c.3.11: Percentage of people, within each national group, divided in groups by marital status, reporting the health status 
dimensions  
 Level Total group  
% n=194 
USA % 
n=111 
UK % 
n=42 
Greece % 
n=41 
  Married¹ Single² Married¹ Single² Married¹ Single² Married¹ Single² 
Mobility 1 7.9 5.9 8.7 9.5 20 0 14.3 0 
 2 80.2 73.5 79.7 69 86.2 92.3 75 69.2 
 3 11.9 20.6 11.6 21.4 13.8 7.7 10.7 30.8 
Self-care 1 46.8 44.1 53.6 47.6 34.5 38.5 42.9 38.5 
 2 42.1 42.6 36.2 38.1 51.7 53.8 46.4 46.2 
 3 11.1 13.2 10.1 14.3 13.8 7.7 10.7 15.4 
Usual 
Activities 
1 17.5 20.6 17.4 26.2 13.8 23.1 21.4 0 
 2 61.9 67.6 60.9 59.5 62.1 76.9 64.3 84.6 
 3 20.6 11.8 21.7 14.3 24.1 0 14.3 15.4 
Pain/ 
discomfort 
1 15.9 13.2 13 16.7 6.9 7.7 32.1 7.7 
 2 59.5 70.6 62.3 69 62.1 61.5 50 84.6 
 3 24.6 16.2 24.6 14.3 31 30.8 17.9 7.7 
Anxiety/ 
depression 
1 38.1 44.1 43.5 47.6 44.8 46.2 17.9 30.8 
 2 50.8 45.6 49.3 40.5 44.8 46.2 60.7 61.5 
 3 11.1 10.3 7.2 11.9 10.3  21.4 7.7 
¹Married or in relationship, ²Single or divorced or widowed.   
Abbreviation:QoL, Quality of Life; EQ-5D, Quality of Life 
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Table 9.c.3.12: Percentage of people, within each national group, divided in groups by the level of education, reporting the health status 
dimensions  
 
Abbreviation: QoL, Quality of Life; EQ-5D, Quality of Life 
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Table 9.c.3.13: Percentage of people, within each national group, divided in groups by employment status, reporting the health status 
dimensions  
 Level Total group 
(%) 
USA 
(%) 
UK 
(%) 
Greece 
(%) 
  Employ
-ed 
n=105 
Unemploy
-ed 
n=61 
Retired 
n=31 
Employed 
n=70 
Unemplo
-yed 
n=39 
Retired 
n=3 
Employed 
n=70 
Unemplo
-yed 
n=39 
Retired 
n=3 
Employed 
n=70 
Unemplo
-yed 
n=39 
Retired 
n=3 
Mobility 1 9.5 6.6 0 11.4 5.1 0 0 0 0 11.8 33.3 0 
 2 77.2 72.1 93.5 74.3 76.9 100 100 68.6 100 64.7 50 89.5 
 3 13.3 21.3 6.5 14.3 17.9 0 0 31.3 0 23.5 16.7 10.5 
Self-care 1 50.3 41 38.7 55.7 43.6 66.7 44.4 31.3 22.2 35.3 50 42.1 
 2 40 41 54.8 34.3 41 33.3 50 50 66.7 52.9 16.7 52.6 
 3 9.5 18 6.5 10 15.4 0 5.6 18.8 11.1 11.8 33.3 5.3 
Usual 
Activities 
1 22.9 13.1 16.1 28.6 10.3 0 16.7 12.5 22.2 5.9 33.3 15.8 
 2 68.6 54.1 71 62.9 53.8 100 72.2 62.5 66.7 88.2 33.3 68.4 
 3 8.6 32.8 12.9 8.6 35.9 0 11.1 25 11.1 5.9 33.3 15.8 
Pain/ 
discomfort 
1 20 3.3 19.4 18.6 51 33.3 11.1 0 11.1 35.3 0 21.1 
 2 67.6 62.3 51.6 67.1 61.5 33.3 72.2 62.5 44.4 64.7 66.7 57.9 
 3 12.4 34.4 29 14.3 33.3 33.3 16.7 37.5 44.4 0 33.3 21.1 
Anxiety/ 
depression 
1 44.8 36.1 29 47.1 33.3 100 44.4 50 44.4 35.3 16.7 10.5 
 2 48.6 47.5 54.8 44.3 53.8 0 55.6 31.3 44.4 58.8 50 68.4 
 3 6.7 16.4 16.1 8.6 12.8 0 0 18.8 11.1 5.9 33.3 21.1 
Abbreviation: QoL, Quality of Life; EQ-5D, Quality of Life 
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Table 9.c.3.14: Differences in QoL between people, within each national group,  
with different marital status 
 USA  
n=111 
UK  
n=42 
GR  
n=41 
EQ-5D t=0.17, df109 
p=0.86,  
95%CI -0.12, 0.14 
U=159.5 
p=0.42 
U=126.5 
p=0.11 
EQ-VAS t=0.79, df109 
p=0.42 
95%CI -11.5, 0.49 
U=143 
p=0.21 
U=153.5 
p=0.42 
Abbreviations: EQ-5D, Quality of Life, EQ-VAS, Quality of Life Visual Analogue Scale; 
Statistical tests: U, Mann-Whitney U test; t, Independent t-test 
 
 
 
Table 9.c.3.15: Differences in QoL between people, within each national  
group, with different education level  
 USA 
n=111¹ 
UK 
n=42 
GR 
n=41 
EQ-5D H=5.16 
p=0.07 
H=3.12 
p=0.37 
H=6.54 
p=0.08 
EQ-VAS H=2.06 
p=0.55 
H=3.05 
p=0.38 
H=11.5 
p=0.009² 
¹“Compulsory/no education” category was excluded because it only  
included 1 respondent thus biasing analysis; ²not significant post Bonferroni  
correction;  
Abbreviations: EQ-5D, Quality of Life, EQ-VAS, Quality of Life Visual Analogue Scale; 
Statistical test: H, Kruskal-Wallis H test 
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9.c.4. EQ-5D; relation to pain/LBP days, free weeks, onset 
Table 9.c.4.1: Percentage of people,within each national group, divided in groups by the number of LBP days felt per month, reporting 
the health status dimensions 
 USA 
(%) 
UK 
(%) 
GR 
(%) 
 Level 1-9 days 10-20 
days 
21-30 
days 
Everyday 1-9 days 10-20 
days 
21-30 
days 
Everyday 1-9 
days 
10-20 
days 
21-30 
days 
Everyday 
Mobility 1 5.3 7.1 0 11.4 0 0 0 0 9.1 20 0 0 
 2 78.9 78.6 88.9 74.3 100 100 75 94.7 81.8 70 60 75 
 3 15.8 14.3 11.1 14.3 0 0 25 5.3 9.1 10 40 25 
Self-care 1 57.9 57.1 44.4 45.7 33.5 100 50 21.1 63.6 40 40 50 
 2 26.3 35.7 55.6 48.6 50 0 50 73.7 27.3 60 40 25 
 3 15.8 7.1 6 5.7 16.7 0 0 5.3 9.2 0 20 25 
Usual 
activities 
1 26.3 28.6 22.2 11.4 16.7 33.3 25 0 27.3 20 20 0 
 2 68.4 64.3 44.4 60 66.7 66.7 75 84.2 63.6 70 60 50 
 3 5.3 7.1 33.3 28.6 16.7 0 0 15.8 9.1 10 20 50 
Pain / 
Discomfort 
1 21.1 21.4 0 0 0 0 0 0 0 0 0 0 
 2 68.4 64.3 55.6 65.7 100 66.7 50 68.4 81.8 90 80 50 
 3 10.5 14.3 44.4 34.3 0 33.3 50 31.6 18.2 10 20 50 
Anxiety / 
Depression 
1 57.9 35.7 33.3 34.3 83.8 100 0 31.6 9.1 10 40 50 
 2 36.8 57.1 55.6 45.7 0 0 100 57.9 81.8 80 40 25 
 3 5.3 7.1 11.1 20 16.7 0 0 10.5 9.1 10 20 25 
Abbreviation: QoL, Quality of Life; EQ-5D, Quality of Life; LBP, Low Back Pain 
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Table 9.c.4.2:  Mean EQ-5D index for people, within each national group, divided in groups by the number of pain or LBP days felt 
monthly 
Number of 
pain days 
USA mean, SD, 
mix-max 
UK mean, SD, 
mix-max 
Greece mean, 
SD, mix-max 
Frequency  of 
pain free weeks 
USA mean, SD, 
mix-max 
UK mean, SD, 
mix-max 
Greece mean, 
SD, mix-max 
1-9 0.6±0.3 ,  0.7 
-0.1 – 1.0, n=12 
0.7±0.1 ,  0.7 
-0.6 – 0.8, n=4 
0.4±0.4, 0.6  
-0.3 – 0.7, n=12 
Most time 0.5±0.3, 0.7  
0.2 – 0.8, n=7 
0.7±0.1, 0.7  
0.6 – 0.8, n=3 
0.4±0.4, 0.5  
-0.3 – 0.7, n=5 
10-20 0.5±0.3 ,  0.6 
-0.1 – 0.7, n=15 
0.3±0.5, 0.3  
-0.1 – 0.7, n=15 
0.3±0.4, 0.5  
-0.2 – 0.7, n=9 
Frequently  0.5±0.2, 0.6  
0.1– 0.7, n=8 
0.4±0.4, 0.4  
0.1 – 0.7, n=2 
0.5±0.3, 0.6  
0.002–0.7, n=2 
21-30 0.2±0.4 ,  0.2 
-0.6 – 0.7, n=10 
0.3±0.4, 0.4  
-0.3 – 0.6, n=4 
0.4±0.3, 0.5  
-0.1 – 0.6, n=4 
Sometimes 0.3±0.3, 0.5  
-0.1 – 0.7, n=7 
0.4±0.3, 0.6  
-0.1 – 0.7, n=4 
0.5±0.3, 0.6  
-0.2 – 0.7, n=7 
Everyday 0.3±0.3 ,  0.2 
-0.2 – 0.8, n=67 
0.3±0.3, 0.5  
-0.6 – 0.7, n=32 
0.2±0.5, 0.3  
-0.6 – 0.7, n=6 
Not often 0.6±0.1, 0.6  
0.6 – 0.7, n=3 
0.3±0.3, 0.2  
-0.1 – 0.7, n=3 
0.2±0.4, -0.02  
-0.2 – 0.7, n=7 
Number of 
LBP days 
   Rarely 0.4±0.5, 0.6  
-0.6 – 1.0, n=13 
0.6±0.1, 0.6  
0.5 – 0.6, n=4 
n/a as n=0 
1-9 0.5±0.4 ,  0.6 
-0.6 – 1.0, n=19 
0.5±0.3 ,  0.6 
0.1 – 0.6, n=6 
0.4±0.4 ,  0.6 
-0.2 – 0.7, n=11 
Always have 
pain 
0.3±0.3, 0.2  
-0.2 – 0.8, n=57 
0.2±0.4, 0.1  
-0.6 – 0.7, n=24 
-0.1±0.4, -0.1  
-0.6 – 0.3, n=1 
10-20 0.4±0.3 ,  0.6 
-0.1 – 0.8, n=14 
0.5±0.3 ,  0.7 
0.2 – 0.5, n=3 
0.4±0.3 ,  0.5 
-0.2 – 0.7, n=10 
Frequency  of 
LBP free weeks 
   
21-30 0.2±0.3 ,  0.2 
-0.1 – 0.7, n=9 
0.2±0.4 ,  0.3 
-0.3 – 0.7, n=4 
0.2±0.4 ,  0.1 
-0.2 – 0.7, n=5 
Most time 0.5±0.2, 0.6  
0.1 – 0.7, n=7 
0.3±0.3, 0.3  
0.1 – 0.6, n=2 
0.5±0.3, 0.6  
-0.2 – 0.7, n=6 
Everyday 0.2±0.3 ,  0.2 
-0.2 – 0.8, n=35 
0.3±0.3 ,  0.5 
-0.2 – 0.7, n=19 
0.2±0.6 ,  0.3 
-0.6 – 0.7, n=4 
Frequently  n/a as n=0 0.4±0.3, 0.4  
0.2 – 0.7, n=2 
0.5±0.2, 0.6  
0.002–0.7, n=7 
    Sometimes 0.3±0.4, 0.1  
-0.1 – 0.7, n=3 
0.4±0.4, 0.4  
0.1 – 0.7, n=2 
0.4±0.4, 0.6  
-0.2 – 0.7, n=7 
    Not often 0.4±0.4, 0.6  
-0. – 1.0, n=15 
0.7±0.1, 0.7  
0.6 – 0.7, n=2 
n/a as n=1 
    Rarely 0.2±0.3, 0.2  
-0.2 – 0.8, n=30 
0.5±0.3, 0.6  
-0.1 – 0.1, n=6 
0.3±0.4, 0.3  
-0.2 – 0.6, n=6 
    Always have 
pain 
0.4±0.4, 0.6  
-0.3 – 0.7, n=12 
0.2±0.3, 0.1  
-0.3 – 0.6, n=13 
-0.3±0.3, -0.3  
-0.6 – -0.1, n=2 
Abbreviation: LBP, Low Back Pain; SD, Standard Deviation
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Table 9.c.4.3: Percentage of people, within each national group, divided in groups by the frequency of LBP free weeks, reporting each 
health status dimension 
 Abbreviation: EQ-5D, Quality of Life; LBP, Low Back Pain 
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Table 9.c.4.4: Percentage of people, within each national group, divided in groups by the frequency of pain free weeks, reporting each 
health status dimension 
Appendix 9 
 
254 
Table 9.c.4.5: Percentage of people, within each national group, divided in groups by the time of pain onset post iSCI, reporting each 
health status dimension 
 Abbreviation: EQ-5D, Quality of Life 
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Table 9.c.4.6: Percentage of people, within each national group, divided into groups by the time of LBP onset post iSCI, reporting each 
health status dimension 
 Abbreviation: EQ-5D, Quality of Life; LBP, Low Back Pain 
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Table 9.c.4.7: Mean EQ-5D index reported by people, within each national  
group, divided in groups by the time of pain or LBP onset post iSCI  
Pain onset USA  
mean, SD  
mix-max 
UK  
mean, SD  
mix-max 
Greece  
mean, SD  
mix-max 
Immediately after 
iSCI 
0.3±0.3 ,  0.2 
-0.2 – 1.0, n=48 
0.4±0.3 ,  0.5 
-0.2 – 0.7, n=18 
0.3±0.4, 0.5  
-0.6 – 0.7, n=9 
Within 1 month 
post iSCI 
0.4±0.3 ,  0.6 
-0.1 – 0.7, n=20 
0.4±0.2, 0.5  
0.1 – 0.6, n=7 
0.3±0.4, 0.5  
-0.2 – 0.7, n=5 
1-6 months post iSCI 0.3±0.3 ,  0.3 
-0.2 – 0.7, n=16 
0.4±0.4, 0.6  
-0.3 – 0.7, n=6 
0.3±0.4, 0.6  
-0.3 – 0.7, n=12 
6 months -1years 
post iSCI 
0.3±0.3 ,  0.2 
0.01 – 0.6, n=3 
0.2±0.3,- 0.1  
-0.6 – 0.1, n=4 
0.6±0.1, 0.6  
0.5 – 0.6, n=3 
After 1 year post 
iSCI 
0.4±0.4 ,  0.6 
-0.6 – 0.7, n=12 
0.4±0.4 ,  0.7 
-0.1 – 0.7, n=5 
0.4±0.5 ,  0.7 
-0.2 – 0.7, n=3 
LBP onset    
Immediately after 
iSCI 
0.3±0.4 ,  0.2 
-0.2 – 1.0, n=25 
0.3±0.3 ,  0.3 
-0.1 – 0.7, n=12 
0.2±0.5 ,  0.3 
-0.6 – 0.7, n=8 
Within 1 month 
post iSCI 
0.3±0.4 ,  0.5 
-0.2 – 0.8, n=9 
0.3±0.4 ,  0.5 
-0.2 – 0.6, n=5 
0.5±0.4 ,  0.6 
-0.2 – 0.7, n=5 
1-6 months post iSCI 0.4±0.3 ,  0.5 
-0.1 – 0.8, n=14 
0.1±0.4 , - 0.1 
-0.3 – 0.5, n=3 
0.4±0.4 ,  0.6 
-0.2 – 0.7, n=9 
6 months -1years 
post iSCI 
0.3±0.4 ,  0.2 
-0.2 – 0.7, n=7 
n/a as n=1 0.4±0.4 ,  0.6 
-0.2 – 0.7, n=5 
After 1 year post 
iSCI 
0.5±0.3 ,  0.6 
0.1 – 0.7, n=15¹ 
0.5±0.3 ,  0.6 
-0.2 – 0.7, n=9¹ 
0.7±0.1 ,  0.7 
0.7 – 0.7, n=2 
¹One outlier eliminated; 
Abbreviation: EQ-5D, Quality of Life; LBP, Low Back Pain; SD, Standard Deviation 
 
9.c.5 EQ-5D; relation to pain extent 
Table 9.c.5.1: Mean EQ-5D index reported by people, within each national  
group, divided in groups by the number of areas with pain  
Number of areas 
with pain 
USA  
mean, SD  
mix-max 
UK  
mean, SD  
mix-max 
Greece  
mean, SD  
mix-max 
1 0.5±0.3  n=16 n/a as n=1 0.4±0.3  n=4 
2 0.4±0.3  n=28 0.3±0.4  n=11 0.1±0.4  n=5 
3 0.4±0.4  n=17 0.2±0.3  n=8 0.4±0.3  n=13 
4 0.2±0.3  n=16 0.5±0.2  n=8 0.5±0.3  n=6 
5 0.2±0.4  n=13 0.3±0.3  n=8 0.5±0.0  n=2 
6 0.1±0.3  n=5 0.2±0.4  n=3 n/a as n=1 
7 0.1±0.3 n=2 0.2±0.7  n=2 n/a as n=0 
8 0.2±0.02 n=2 0.2±0.02  n=2 n/a as n=0 
9 0.2±0.01  n=2 n/a as n=1 n/a as n=0 
¹One outlier eliminated; 
Abbreviation: EQ-5D, Quality of Life; SD, Standard Deviation 
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9.d. Pain and function within and across nations 
9.d.1. Bonferroni correction 
Table 9.d.1.1: Main variables used in analysis of function for cross-national and alpha  
value set following Bonferroni correction 
Main Variables Tests with following variables Alpha value 
following 
Bonferroni 
correction 
Self-care 
Respiration & 
Sphincter 
management 
Mobility in room 
& toilet  
Mobility indoor & 
outdoor 
Total SCIM 
1) Pain                                      13) Country 
2) MSKP                                   14) Pain days 
3) LBP (current)                      15) LBP days 
4) Gender                                 16) Pain free weeks 
5) Cause of injury                   17) LBP free weeks 
6) Age                                       18) Pain onset 
7) Type of injury                     19) LBP onset 
8) With time since injury      20) Areas with pain 
9) Intensity of current LBP   21) S-PRI of LBP       
     10) LBP intensity 1 month         22) A-PRI of LBP 
     11) LBP intensity 3 months       23) T-PRI of LBP 
     12) Evaluative PPI of LBP           24) EQ-5D index 
                                                            25) EQ-VAS  
0.05/25=0.002 
p≤0.002 
Abbreviations: EQ-5D index, Quality of Life index; EQ-VAS, Quality of Life Visual Analogue Scale;  
MSKP, Musculoskeletal Pain; LBP, Low Back Pain; PRI, Present Rating Index 
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9.d.2 SCIM III; general results 
Table 9.d.2.1: Descriptive of subscales for SCIM III for USA and UK 
Task UK USA 
Mean SD Median Min - 
Max 
Mean SD Median Min - 
Max 
Feeding  2.6 0.6 3 0 -3 2.6 0.6 3 0 – 3 
Bathing upper body 1.8 0.9 2 0 – 3 2.2 0.9 2 0 – 3 
Bathing lower body 1.6 0.9 2 0 – 3 2.2 0.9 2 0 – 3 
Dressing upper body 2.6 1.5 3 0 – 4 3.2 1.3 4 0 – 4 
Dressing lower body 2.5 1.6 3 0 – 4 3.0 1.4 4 0 – 4 
Grooming 2.5 1.0 3 0 – 3 2.6 0.8 3 0 – 3 
Total self-care¹  13.4 5.7 15 0 – 20 15.7 5.5 18 0 – 20 
Respiration 9.8 0.9 10 4 – 10 9.9 1.3 10 0 – 19 
Sphincter 
management - 
bladder 
8.7 5.1 9 0 – 15 10.4 4.7 11 0 – 15 
Sphincter 
management – 
bowel 
6.0 3.1 6.5 0 – 10 6.0 3.5 8 0 – 10 
Use toilet 3.3 1.7 4 0 – 5 3.6 1.8 4 0 – 6 
Total respiration & 
sphincter 
management² 
27.4 7.7 29 11 – 40 29.8 7.4 30 0 – 40 
Mobility in bed 4.6 2.1 6 0 – 6 5.0 1.9 6 0 – 6 
Transfer bed – 
wheelchair 
1.6 0.7 2 0 – 2 1.6 0.7 2 0 – 2 
Transfer wheelchair 
– toilet – tub 
1.4 0.7 2 0 – 2 1.5 0.8 2 0 – 3 
Total mobility room 
& toilet³ 
7.6 3.4 9 0.10 8.1 3.1 10 0-10 
Mobility indoors 3.7 2.3 2.5 1 – 8 3.9 2.6 2 0 – 8 
Mobility moderate 
distance 
3.6 3.4 2 0 - 8 3.6 2.5 2 0 – 8 
Mobility outdoors 2.6 2.1 2 0 – 8 3.0 2.4 2 0 – 8 
Stair management 1.1 1.0 1 0 – 3 1.3 1.2 2 0 – 3 
Transfers wheelchair 
- car 
1.3 0.8 2 0 – 2 1.5 0.7 2 0 – 2 
Transfers ground – 
wheelchair 
0.5 0.5 1 0 – 1 0.7 0.7 1 0 – 6 
Total mobility 
indoors & outdoors4 
12.8 8.2 11 0-30 13.8 8.6 11.5 0-30 
Total sum5 61.1 20.4 65.5 18 - 100 67.4 20.5 70 3 - 100 
¹Score can range from 0-20, ²Score can range from 0-40, ³Score can range from 0-40, 4Score can 
range from 0-30 5Score can range from 0-40, 4Score can range from 0-100; 
Abbreviation: SCIM, Spinal Cord Independence Measure; SD, Standard Deviation 
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9.d.3. SCIM III; relation to demographic profile characteristics 
Table 9.d.3.1: Mean function scores for males and females, within each  
national group 
 USA  Males 
mean±SD 
median 
min-max 
USA  
Females 
mean±SD 
median 
min-max 
UK  Males 
mean±SD 
median 
min-max 
UK  Females 
mean±SD 
median 
min-max 
Self-care   
(range 0-20) 
15.2±6.0, 
18, 0-20, 
n=81 
16.7±4.3, 18, 
3-20, n=41 
13.8±5.7, 
15.5, 1-20, 
n=30 
12.8±5.8, 15, 
0-19, n=22 
Respiration & 
sphincter 
management  
(range 0-40) 
30.4±7.4, 
31, 0-40, 
n=81 
28.6±7.2, 28, 
15-40, n=41 
27.7±7.7, 
28.5, 11-40, 
n=81 
27.0±7.8, 29, 
12-37, n=22 
Mobility room and 
toilet  
(range 0-10) 
7.7±3.4, 10, 
0-10, n=81 
9.5±1.0, 10, 
6-10, n=37³ 
8.8±1.6, 10, 
4-10, n=26³ 
7.4±3.6, 9.5, 
0-10, n=22 
Mobility indoor & 
outdoor  
(range 0-30) 
13.6±8.9, 
10, 0-30, 
n=81 
14.3±8.3, 16, 
3-30, n=41 
14.6±8.8, 
11.5, 3-30, 
n=30 
10.3±6.7, 9, 
0-26, n=22 
Total SCIM  
(range 0-100) 
67.8±21.1, 
70, 21-100, 
n=80² 
71.5±12.971, 
40-100, 
n=38¹ 
63.8±20.7, 
67.5, 18-100, 
n=30 
57.4±19.8, 
63.5, 18-91, 
n=22 
¹One outlier eliminated ²Three outliers eliminated, ³Four outliers eliminated; 
Abbreviation: SCIM, Spinal Cord Independence Measure; SD, Standard Deviation 
 
 
Table 9.d.3.2: Differences in function between males and females within each national 
group 
 Self-care 
(range 0-20) 
Respiration & 
sphincter 
management 
(range 0-40) 
Mobility 
room and 
toilet 
(range 0-10) 
Mobility indoor 
& outdoor 
(range0-30) 
Total SCIM 
(range 0-
100) 
USA t=-1.37, df120 
p=0.17 
95% CI -3.5, 0.6 
U=1537.5 
p=0.49 
t=1.38, df120 
p=0.17 
95% CI -0.8, 4.7 
U=247 
 p=0.41 
t=-0.39, df129 
p=0.69 
95% CI -3.9, 2.6 
U=1449.5 
p=0.68 
 
UK U=283.5 
p=0.38 
 
t=0.30, df50 
p=0.76 
95% CI -3.7, 5.0 
U=153 
p=0.15 
 
t=1.92, df50 
p=0.06 
95% CI -0.1, 8.8 
t=1.1, df50 
p=0.27 
95% CI -5.1, 
17.8 
Greece Refer to Appendix 8: Table 8.3.1 
Abbreviation: SCIM, Spinal Cord Independence Measure; 
Statistical tests: U, Mann-Whitney U test; t, Independent t-test 
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Table 9.d.3.2: Differences in function between males and females within each 
national group 
 Self-care 
(range 0-20) 
Respiration & 
sphincter 
management 
(range 0-40) 
Mobility 
room and 
toilet 
(range 0-10) 
Mobility indoor 
& outdoor 
(range0-30) 
Total SCIM 
(range 0-
100) 
USA t=-1.37, df120 
p=0.17 
95% CI -3.5, 0.6 
U=1537.5 
p=0.49 
t=1.38, df120 
p=0.17 
95% CI -0.8, 4.7 
U=247 
 p=0.41 
t=-0.39, df129 
p=0.69 
95% CI -3.9, 2.6 
U=1449.5 
p=0.68 
 
UK U=283.5 
p=0.38 
 
t=0.30, df50 
p=0.76 
95% CI -3.7, 5.0 
U=153 
p=0.15 
 
t=1.92, df50 
p=0.06 
95% CI -0.1, 8.8 
t=1.1, df50 
p=0.27 
95% CI -5.1, 
17.8 
Greece Refer to Appendix 8: Table 8.3.1 
Abbreviation: SCIM, Spinal Cord Independence Measure; 
Statistical tests: U, Mann-Whitney U test; t, Independent t-test 
 
 
 
Table 9.d.3.3: Differences in function between people, within each national group, 
with traumatic and non-traumatic injury  
 Self-care 
(range 0-
20) 
Respiration & 
sphincter 
management 
(range 0-40) 
Mobility room 
and toilet 
(range 0-10) 
Mobility indoor 
& outdoor 
(range0-30) 
Total SCIM 
(range 0-100) 
USA U=1097.5 
p=0.24 
U=1199 
p=0.60 
 
U=1218 
 p=0.65 
t=-0.45, df120 
p=0.65 
95% CI -4.6, 2.8 
t=-0.66, df120 
p=0.51 
95% CI -11.8, 
5.9 
UK U=175.5 
p=0.41 
 
U=203.5  
p=0.88 
 
U=195.5 
p=0.72 
 
t=0.92, df50 
p=0.35 
95% CI -3.1, 8.4 
U=187  
p=0.59 
 
Greece Refer to Appendix 8: Table 8.3.3 
Abbreviation: SCIM, Spinal Cord Independence Measure; 
Statistical tests: U, Mann-Whitney U test; t, Independent t-test 
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Table 9.d.3.4: Mean function scores for people, within each national  
group, with traumatic and non-traumatic cause of injury 
 USA UK 
 Traumatic 
mean±SD 
median 
min-max 
Non 
Traumatic 
mean±SD 
median 
min-max 
Traumatic 
mean±SD 
median 
min-max 
Non 
Traumatic 
mean±SD 
median 
min-max 
Self-care   
(range 0-20) 
15.2±6.0 
18, 0-20 
n=95 
17.3±3.2 
18, 9-20 
n=27 
13.1±5.7 
14.5, 0-20 
n=42 
14.5±5.9, 17 
2-20, n=10 
Respiration & 
sphincter 
management  
(range 0-40) 
29.8±7.8 
30, 0-40 
n=95 
29.6±6.0 
30, 17-40 
n=27 
27.4±7.7 
29.5, 11-40 
n=42 
28.0±8.2 
28.5, 12-40 
n=10 
Mobility room and 
toilet  
(range 0-10) 
8.0±3.4, 10 
0-10, n=95 
8.3±2.2, 10 
2-10, n=27 
7.5±3.5, 9  
0-10, n=42 
8.1±3.1, 9.5 
0-10, n=10 
Mobility indoor & 
outdoor  
(range 0-30) 
13.7±8.9 
12, 0-30 
n=95 
14.5±8.0 
11, 4-30 
n=27 
13.3±8.2, 
11.5, 0-30 
n=42 
10.6±8.2, 8 
3-30, n=10 
Total SCIM  
(range 0-100) 
67.7±21.1 
70, 3-100 
n=95 
69.7±13.7 
71, 42-98 
n=27 
61.1±20.8 
67.5, 18-91 
n=42 
61.2±19.7 
61.5, 32-100 
n=10 
For Greece refer to Appendix 8: Table 8.3.3 
Abbreviation: SCIM, Spinal Cord Independence Measure; SD, Standard Deviation 
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Table 9.d.3.5. Mean function scores for people, within each national  
group, with tetraplegia and paraplegia  
                                                  USA                      UK  
  Tetraplegia  
mean±SD 
median  
min-max 
Paraplegia  
mean±SD 
median  
min-max  
Tetraplegia  
mean±SD  
median  
min-max  
Paraplegia  
mean±SD 
median  
min-max  
Self-care  
(range 0-20)  
14.4±1.5, 15 
0-20, n=31  
18.0±2.4, 18 
9-20, n=16  
10.9±6.8 
12.5, 0-20 
n=28  
15.3±3.9 
17.5, 8-20 
n=22  
Respiration & 
sphincter 
management  
(range 0-40)  
30.1±7.8, 30 
15-40, n=63¹  
29.9±5.8 30.5  
15-40, n=58  
27.0±8.9, 29 
11-40, n=42  
29.3±5.5, 31 
16-37, n=26²  
Mobility 
room and 
toilet  
(range 0-10)  
7.1±3.8, 9.5 
0-10, n=64  
9.1±1.6, 10 3-
10, n=58  
6.3±4.7, 8.5  
0-10, n=22  
8.7±1.7, 10 4-
10, n=28  
Mobility 
indoor & 
outdoor  
(range 0-30)  
13.4±9.8  
9.5, 0-30 
n=64  
14.3±7.2, 13 
4-30, n=58  
11.4±9.6 8.5, 
0-30 n=22  
13.7±6.9 
12.5, 4-27 
n=28  
Total SCIM  
(range 0-100)  
63.7±25.6 
67.5  
3-100, n=95  
71.5±11.7 71, 
42-96 n=58  
55.6±25.6 
61.5, 18-100 
n=22  
65.8±14.2 68, 
32-90 n=28  
For Greece refer to Appendix 8: Table 8.3.5  
¹One outlier eliminated, ²Two outliers eliminated;. 
Abbreviation: SCIM, Spinal Cord Independence Measure; SD, Standard Deviation 
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Table 9.d.3.6: Interaction effect between the country of residency and  
gender on the cause or the level of injury 
Subscales Interaction 
effect of gender 
*country on DV 
Interaction effect 
of cause of injury 
*country on DV 
Interaction effect 
of type of injury 
*country on DV 
Self-care   
(range 0-20) 
F=1.55 p=0.021  
η²=0.00017 
n=215 
F=0.07 
p=0.92  
η²=0.00008 
n=219 
F=0.56 
p=0.57  
η²=0.0053 
n=214 
Respiration & 
sphincter 
management  
(range 0-40) 
F=1.03 p=0.35  
η²=0.00057 
n=215 
F=0.59 p=0.55  
η²=0.00031 
n=219 
F=0.83 
p=0.43  
η²=0.0003 
n=214 
Mobility room 
and toilet  
(range 0-10) 
F=1.21 p=0.29  
η²=0.0014 
n=215 
F=0.05 p=0.95  
η²=0.00005 
n=219 
F=0.77 
p=0.46  
η²=0.0008 
n=217 
Mobility indoor 
& outdoor  
(range 0-30) 
F=1.48 p=0.22  
η²=0.00036 
n=215 
F=1.03 p=0.35  
η²=0.0024 
n=219 
F=0.79 
p=0.45  
η²=0.0019 
n=217 
Total SCIM  
(range 0-100) 
F=0.95 p=0.38  
η²=0.00077 
n=215 
F=0.49 p=0.61  
η²=0.00038 
n=219 
F=0.15 
p=0.85  
η²=0.00012 
n=217 
Abbreviation: SCIM, Spinal Cord Independence Measure; 
Statistical test: F, Two-way ANOVA 
 
Table 9.d.3.7: Correlation between age or time since injury and  
function, within national groups¹ 
 Age of respondent Time since injury 
 USA UK USA UK 
Self-care   
(range 0-20) 
r=-0.11 
p=0.22 
n=116 
r=-0.01 
p=0.292 
n=50 
r=0.065 
p=0.48 
n=121 
r=-0.33 
p≤0.01² 
n=52 
Respiration & 
sphincter 
management  
(range 0-40) 
r=0.04 
p=0.65  
n=116 
r=-0.16 
p=0.24 
n=50 
r=0.05 
p=0.53  
n=121 
r=-0.13 
p=0.23 
n=52 
Mobility room 
and toilet  
(range 0-10) 
r=-0.13 
p=0.13 
n=116 
r=0.13 
p=0.34  
n=50 
r=-0.02 
p=0.83 
n=121 
r=-0.08 
p=0.54 
n=52 
Mobility indoor 
& outdoor  
(range 0-30) 
r=-0.01 
p=0.85 
n=116 
r=0.13 
p=0.35  
n=50 
r=-0.15 
p=0.08 
n=121 
r=-0.14 
p=0.29 
n=52 
Total SCIM  
(range 0-100) 
r=-0.07 
p=0.43 
n=116 
r=0.13 
p=0.94  
n=50 
r=-0.03 
p=0.73 
n=121 
r=-0.23 
p=0.09  
n=52 
Appendix 8: Figure 8.3.1   
¹For Greek group refer to; ²not significant post Bonferroni correction;  
Abbreviation: SCIM, Spinal Cord Independence Measure; 
Statistical tests: r, Pearson’s correlation 
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Table 9.d.3.8: Mean function scores within males or females with and without pain across nations. Differences in the mean function 
scores within each gender per national groups 
 
1not significant post Bonferroni correction; Staristical Tests: Independent t-test;  
Abbreviation: SCIM, Spinal Cord Independence Measure; MSKP, Musculoskeletal Pain; SD, Standard Deviation 
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Table 9.d.3.8 continued: Mean function scores within males or females with and without pain across nations. Differences in the mean 
function scores within each gender per national groups  
 UK 
Females 
Greece 
Males 
 
Greece 
Females 
Yes 
mean±S 
median 
min-max 
No 
mean±SD 
median 
min-max 
Statistical 
Test 
Yes 
mean±SD 
median 
min-max 
No 
mean±SD 
median 
min-max 
Statistical 
test 
Yes 
mean±SD 
median 
min-max 
No 
mean±SD 
median min-
max 
Statistical 
test 
Self-care   
(range 0-20) 
12.1±5.2 
18, 2-19 
n=11 
12.9±6.6 
15.5, 0-18 
n=10 
t=0.3, df19 
p=0.75 95% 
CI -4.6, 6.2 
11.5±5.9 
 10, 4-20 
n=6 
14.2±5.0 
16, 2-20 
n=15 
U=33.5 
p=0.36 
16.0±5.4 
19, 6-20 
n=9 
16.6±4.8 
15.8, 8-20 
n=8 
U=33.5 
p=0.79 
Respiration & 
sphincter 
management  
(range 0-40) 
26.4±8.7 
29, 12-36 
n=11 
27.1±7.5 
29, 15-37 
n=10 
t=0.2, df19 
p=0.83, 95%  
CI -6.6, 8.1 
32.1±11.6 
38, 11-40 
n=6 
34.7±5.4 
36, 22-40 
n=15 
U=40.0 
p=0.69 
33.3±9.6 
38, 15-40 
n=9 
36.9±6.6 40, 
21-40 n=8 
U=18.0 
p=0.07 
Mobility room 
and toilet  
(range 0-10) 
7.3±3.5  
9, 0-10 
n=11 
7.3±4.0  
9.5, 0-10 
n=10 
t=0.01, df19 
p=0.98, 95% 
CI -3.4, 3.4 
8.0±2.2, 8 
6-10, n=6 
8.8±2.0 10, 
4-10 n=15 
U=36.0 
p=0.41 
8.4±2.4 10, 
4-10 n=9 
8.1±2.3, 9 4-
10, n=8 
U=32.5 
p=0.70 
Mobility indoor 
& outdoor  
(range 0-30) 
9.4±7.3  
7, 0-26 
n=11 
10.9±6.6 
12, 2-26 
n=10 
t=0.50, df19 
p=0.62, 95% 
CI -4.8, 7.9 
17.8±13.2 
18.5, 1-30 
n=6 
20.9±8.0 
23, 6-30 
n=15 
U=44.5 
p=0.96 
18.7±10.21
6, 0-30 n=9 
21.2±9.7 26, 
6-30 n=8 
U=32.5 
p=0.73 
Total SCIM  
(range 0-100) 
55.1±18.9 
50, 32-91 
n=11 
58.2±21.8 
65.5  
18-82,n=10 
t=0.35, df19 
p=0.73, 95% 
CI -15.4,21.7,  
68.8±28.9 
75, 34-98 
n=6 
78.6±16.3 
82, 44-95 
n=15 
U=41.0 
p=0.75 
76.4±25.48
2, 28-100 
n=9 
82.9±20.4 
95.5, 45-99 
n=8 
U=32.5 
p=0.73 
Abbreviation: SCIM, Spinal Cord Independence Measure; MSKP, Musculoskeletal Pain; SD, Standard Deviation;  
Statistical Tests: Independent t-test; Mann-Whitney U test 
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Table 9.d.3.9: Two-group differences on function,  
within male or females, for people with and without  
MSKP  
 Total SCIM 
Male 
Total SCIM 
Female 
USA   
MSKP t=-2.1, df79  
p=0.03 
95%CI -21.2, 0.7 
t=0.79, df37  
p=0.43 
95%CI -6.8, 15.7 
UK   
MSKP t=-0.5, df28  
p=0.62 
95%CI -3.9, 7.9 
t=0.35, df19  
p=0.73 
95%CI -15.4, 21.7 
Greece Refer back to Appendix 8: Table8.3.2 
Abbreviation: SCIM, Spinal Cord Independence Measure;  
MSKP, Musculoskeletal Pain.  
Statistical tests: t, Independent t-test 
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9.d.4. SCIM III; relation to pain, LBP and MSKP 
Table 9.d.4.1: Within national groups function scores reported by people with and without the pain categories 
¹One outlier eliminated; 
Abbreviation: SCIM, Spinal Cord Independence Measure; LBP, Low Back Pain; MSKP, Musculoskeletal Pain; SD, Standard Deviation
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9.d.5. SCIM III; relation to pain extent 
Table 9.d.5.1: Correlation, within each national group, between function and the number of 
areas with pain. Interaction effect between country of residence and the number of areas 
with pain on function 
Correlations Self-care 
subscale 
(range 0-20) 
 
Respiration & 
sphincter 
management 
(range 0-40) 
Mobility 
room & 
toilet 
(range 0-10) 
Mobility indoor 
& outdoor 
(range 0-30) 
Total SCIM 
(range 0-
100) 
 
USA      
Areas of pain 
and function 
r=-0.07 
p=0.56, n=61 
r=-0.13 
p=0.31, n=61 
r=0.14 
p=0.38, n=61 
r=0.03 
p=0.80, n=61 
r=-0.04 
p=0.75, 
n=61 
UK      
Areas of pain 
and function 
r=-0.46 
p≤0.01¹, 
n=28 
r=0.01 
p=0.93, n=28 
r=-0.16 
p=0.39, n=28 
r=-0.26 
p=0.18, n=28 
r=-0.27 
p=0.15, 
n=28 
Greece Refer  to Appendix 8: Table 8.6.1   
Interaction 
effect of 
pain areas 
*country on 
DV  
F=1.04, 
p=0.41  
η²=0.0008 
n=118 
F=0.40, p=0.95  
η²=0.0022 
n=118 
F=0.78, 
p=0.66  
η²=0.0071 
n=118 
F=1.84,p=0.051 
η²=0.0043 
n=118 
F=0.84, 
p=0.60  
η²=0.0055 
n=118 
1not significant post Bonferroni correction;  
Abbreviation: SCIM, Spinal Cord Independence Measure; 
Statistical tests: r, Pearson’s correlation; F, Two-way ANOVA 
 
 
 
